screen,dose,Drug.Name,repurposing_target,MOA,IDs,Synonyms
REP.PRIMARY,2.5,8-BROMO-CGMP,PRKG1,PKA ACTIVATOR,BRD:BRD-A00077618-236-07-6,
REP.PRIMARY,2.5,NIFURTIMOX,,DNA INHIBITOR,BRD:BRD-A00100033-001-08-9,
REP.PRIMARY,2.5,BALAGLITAZONE,PPARG,"INSULIN SENSITIZER, PPAR RECEPTOR PARTIAL AGONIST",BRD:BRD-A00147595-001-01-5,
REP.PRIMARY,2.5,FLUTRIMAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A00218260-001-03-4,
REP.PRIMARY,2.5,KBG,MME,NEPRILYSIN INHIBITOR,BRD:BRD-A00376169-001-01-6,
REP.PRIMARY,2.5,OTENZEPAD,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A00520476-001-07-4,
REP.PRIMARY,2.5,BIPERIDEN,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A00546892-001-02-6,
REP.PRIMARY,2.5,ZALTOPROFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A00578795-001-04-3,
REP.PRIMARY,2.5,NORETYNODREL,PGR,PROGESTOGEN HORMONE,BRD:BRD-A00758722-001-04-9,
REP.PRIMARY,2.5,DYPHYLLINE,"ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B","ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-A00827783-001-24-6,
REP.PRIMARY,2.5,ALPRENOLOL,"ADRB1, ADRB2, HTR1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A00993607-003-24-6,
REP.PRIMARY,2.5,AZELNIDIPINE,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-A01098288-001-02-9,
REP.PRIMARY,2.5,HYDROXYPROPYL-BETA-CYCLODEXTRIN,,,BRD:BRD-A01412266-001-01-0,
REP.PRIMARY,2.5,WB-4101,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A01493904-003-12-1,
REP.PRIMARY,2.5,CLEVIPREX,"CACNA1C, CACNA1D, CACNA1F, CACNA1S",CALCIUM CHANNEL BLOCKER,BRD:BRD-A01563671-001-02-7,
REP.PRIMARY,2.5,CHLORMADINONE-ACETATE,PGR,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-A01593789-001-03-1,
REP.PRIMARY,2.5,BUPIVACAINE,"KCNA5, PTGER1, SCN10A, SCN4A",SODIUM CHANNEL BLOCKER,BRD:BRD-A01636364-003-15-1,
REP.PRIMARY,2.5,PREDNISOLONE-ACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A01643550-001-04-9,
REP.PRIMARY,2.5,NAFTOPIDIL,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A01787639-003-16-9,
REP.PRIMARY,2.5,FK-33-824,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-A01907367-001-01-7,
REP.PRIMARY,2.5,NITRENDIPINE,"CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4",CALCIUM CHANNEL BLOCKER,BRD:BRD-A02006392-001-16-4,
REP.PRIMARY,2.5,BETAMETHASONE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A02180903-001-04-5,
REP.PRIMARY,2.5,MEPTAZINOL,BCHE,OPIOID RECEPTOR AGONIST,BRD:BRD-A02710418-003-11-8,
REP.PRIMARY,2.5,CILNIDIPINE,CACNA1B,CALCIUM CHANNEL BLOCKER,BRD:BRD-A02743701-001-03-6,
REP.PRIMARY,2.5,BETAXOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A02759312-003-24-5,
REP.PRIMARY,2.5,LOFEXIDINE,ADRA2A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A02990301-003-06-6,
REP.PRIMARY,2.5,ALIZAPRIDE,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A03061970-003-07-3,
REP.PRIMARY,2.5,MEPIVACAINE,SCN10A,"POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",BRD:BRD-A03216249-003-24-3,
REP.PRIMARY,2.5,ICI-89406,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A03359064-001-02-3,
REP.PRIMARY,2.5,XL888,,HSP INHIBITOR,BRD:BRD-A03506276-001-01-5,
REP.PRIMARY,2.5,METOPROLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A03623303-045-09-5,
REP.PRIMARY,2.5,BISMUTH-SUBCITRATE-POTASSIUM,,,BRD:BRD-A03880619-001-01-0,
REP.PRIMARY,2.5,METHSCOPOLAMINE,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A03932035-004-04-3,
REP.PRIMARY,2.5,PIRICAPIRON,HTR2A,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A04203391-001-08-3,
REP.PRIMARY,2.5,EPERISONE,CYP2J2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A04252265-003-01-4,
REP.PRIMARY,2.5,ISOPRENALINE,"ADRB1, ADRB2, ADRB3, MAPK1, PIK3R1, PIK3R2, PIK3R3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04322457-003-17-9,
REP.PRIMARY,2.5,SYNEPHRINE,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04327189-001-15-1,
REP.PRIMARY,2.5,SYNEPHRINE,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04327189-003-03-3,
REP.PRIMARY,2.5,MARAVIROC,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A04352665-001-05-3,
REP.PRIMARY,2.5,TRILOSTANE,"ESR1, ESR2, HSD3B1, HSD3B2",3BETA-HYDROXY-DELTA5-STEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A04497688-001-04-2,
REP.PRIMARY,2.5,STEPRONIN,,MUCOLYTIC AGENT,BRD:BRD-A04506385-001-01-2,
REP.PRIMARY,2.5,CHLORPHENAMINE,"HRH1, SLC6A2, SLC6A3, SLC6A4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A04553218-050-16-2,
REP.PRIMARY,2.5,2-PMDQ,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A04661934-001-02-9,
REP.PRIMARY,2.5,BUPROPION,"CHRNA3, SLC6A2, SLC6A3",DOPAMINE UPTAKE INHIBITOR,BRD:BRD-A05186015-003-19-8,
REP.PRIMARY,2.5,LISOFYLLINE,,"INTERLEUKIN RECEPTOR ANTAGONIST, STAT INHIBITOR",BRD:BRD-A05334458-001-02-8,
REP.PRIMARY,2.5,BAY-K-8644-(+/-),,"L-TYPE CALCIUM CHANNEL ACTIVATOR, L-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-A05457250-001-08-4,
REP.PRIMARY,2.5,ERDOSTEINE,,MUCOLYTIC AGENT,BRD:BRD-A05515753-001-03-2,
REP.PRIMARY,2.5,TELMESTEINE,,MUCOLYTIC AGENT,BRD:BRD-A05523972-001-01-5,
REP.PRIMARY,2.5,"D,L-MEVALONIC-ACID-LACTONE",,,BRD:BRD-A05674712-001-06-0,"MEVALONIC-D,-L-ACID-LACTONE"
REP.PRIMARY,2.5,"MEVALONIC-D,-L-ACID-LACTONE",,,BRD:BRD-A05674712-001-06-0,"MEVALONIC-D,-L-ACID-LACTONE"
REP.PRIMARY,2.5,CPCCOET,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A05729358-001-02-0,
REP.PRIMARY,2.5,LAPPACONITE,,SODIUM CHANNEL BLOCKER,BRD:BRD-A05906449-004-01-1,
REP.PRIMARY,2.5,TERFENADINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, KCNH1, KCNH2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A06352418-001-25-9,
REP.PRIMARY,2.5,SB-218078,CHEK1,CHK INHIBITOR,BRD:BRD-A06352508-001-03-7,
REP.PRIMARY,2.5,HYDROQUINIDINE,,ANTIARRHYTHMIC,BRD:BRD-A06390036-001-04-6,
REP.PRIMARY,2.5,DICLAZURIL,,ANTIPROTOZOAL AGENT,BRD:BRD-A06426627-001-03-5,
REP.PRIMARY,2.5,MONENSIN,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A06627858-236-03-0,
REP.PRIMARY,2.5,ANISOTROPINE,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A06771424-004-01-7,
REP.PRIMARY,2.5,CPI-613,PDHA1,PYRUVATE DEHYDROGENASE INHIBITOR,BRD:BRD-A06916187-001-02-9,
REP.PRIMARY,2.5,FUSIDIC-ACID,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A06935312-001-04-3,
REP.PRIMARY,2.5,HYDROCORTISONE-HEMISUCCINATE,,,BRD:BRD-A07000685-001-04-4,
REP.PRIMARY,2.5,MELUADRINE,,,BRD:BRD-A07164067-001-01-2,
REP.PRIMARY,2.5,RO-20-1724,"PDE3A, PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A07207424-001-13-2,
REP.PRIMARY,2.5,8-M-PDOT,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-A07232941-001-02-7,
REP.PRIMARY,2.5,ESMOLOL,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07395371-003-10-0,
REP.PRIMARY,2.5,LABETALOL,"ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07440155-003-25-4,
REP.PRIMARY,2.5,BOPINDOLOL,"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A07563059-035-01-3,
REP.PRIMARY,2.5,MECLOCYCLINE-SULFOSALICYLATE,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A07600638-060-05-2,
REP.PRIMARY,2.5,ISOFLOXYTHEPIN,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A07704283-001-01-3,
REP.PRIMARY,2.5,METAPROTERENOL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A07780951-001-08-9,
REP.PRIMARY,2.58,METAPROTERENOL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A07780951-065-10-0,
REP.PRIMARY,2.5,KAKONEIN,,"GABA RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A07815743-001-01-1,
REP.PRIMARY,2.5,BICUCULLINE-(+),"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1",GABA RECEPTOR ANTAGONIST,BRD:BRD-A07870296-001-07-4,
REP.PRIMARY,2.5,VIGABATRIN,"ABAT, GABBR1, SLC32A1",GABA AMINOTRANSFERASE INHIBITOR,BRD:BRD-A07893380-213-01-7,
REP.PRIMARY,2.5,METITEPINE,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",ANTI-HCVE2,BRD:BRD-A07932845-050-15-8,
REP.PRIMARY,2.5,BUPARVAQUONE,,ANTIPROTOZOAL AGENT,BRD:BRD-A07947329-001-01-4,
REP.PRIMARY,2.5,GALETERONE,"AR, CYP17A1",ANDROGEN RECEPTOR MODULATOR,BRD:BRD-A07986123-001-02-8,
REP.PRIMARY,2.5,CDBA,,,BRD:BRD-A08079565-001-01-8,
REP.PRIMARY,2.5,RACECADOTRIL,MME,ENKEPHALINASE INHIBITOR,BRD:BRD-A08187463-001-12-9,
REP.PRIMARY,2.5,FAMPROFAZONE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A08255417-001-14-7,
REP.PRIMARY,2.5,ETONOGESTREL,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A08302182-001-01-7,
REP.PRIMARY,2.38,DOXYCYCLINE,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-003-07-8,
REP.PRIMARY,2.5,DOXYCYCLINE,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-003-08-6,
REP.PRIMARY,2.5,DOXYCYCLINE,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-311-01-8,
REP.PRIMARY,2.5,DOXYCYCLINE,MMP8,METALLOPROTEINASE INHIBITOR,BRD:BRD-A08545410-311-03-4,
REP.PRIMARY,2.5,IODIXANOL,,RADIOPAQUE MEDIUM,BRD:BRD-A08660406-001-05-9,
REP.PRIMARY,2.87,L-THEANINE,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A08715367-001-01-7,
REP.PRIMARY,2.5,CID-5458317,MAPK3,MAP KINASE PHOSPHATASE INHIBITOR,BRD:BRD-A08840375-001-01-3,
REP.PRIMARY,2.5,ALFUZOSIN,"ADRA1A, ADRA1B, ADRA1D, KCNH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A09056319-003-07-7,
REP.PRIMARY,2.5,AMYLEINE,,LOCAL ANESTHETIC,BRD:BRD-A09062839-003-10-0,
REP.PRIMARY,2.5,STRYCHNINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A09094913-065-01-0,
REP.PRIMARY,2.5,NORETHINDRONE-ACETATE,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A09349126-001-10-7,
REP.PRIMARY,2.5,IOXILAN,,RADIOPAQUE MEDIUM,BRD:BRD-A09370961-001-01-0,
REP.PRIMARY,2.5,MEBEVERINE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A09467419-003-22-4,
REP.PRIMARY,2.5,FLECAINIDE,"KCNA5, KCNA7, SCN4A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A09472452-015-23-4,
REP.PRIMARY,2.5,VERAPAMIL,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4",CALCIUM CHANNEL BLOCKER,BRD:BRD-A09533288-003-31-2,
REP.PRIMARY,2.5,8-BROMO-CAMP,,PKA ACTIVATOR,BRD:BRD-A09554849-236-07-6,
REP.PRIMARY,2.5,CYCLOPHOSPHAMIDE,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP3A7",DNA ALKYLATING AGENT,BRD:BRD-A09722536-002-18-0,
REP.PRIMARY,2.5,BOCEPREVIR,"CMA1, CTSA, CTSF, CTSK, CTSL, CTSS",HCV INHIBITOR,BRD:BRD-A09735281-001-02-5,
REP.PRIMARY,2.5,SKF-81297,"DRD1, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A09828896-004-11-0,
REP.PRIMARY,2.5,ETILEFRINE,"ADRA1A, ADRB1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A09925278-003-05-6,
REP.PRIMARY,2.5,TIPRANAVIR,,HIV PROTEASE INHIBITOR,BRD:BRD-A10039652-001-01-2,
REP.PRIMARY,2.5,PROPRANOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10070317-003-28-3,
REP.PRIMARY,2.5,ADENOSINE-PHOSPHATE,"ACSL1, ACSS1, ACSS2, ADCY1, ADK, CREB1, FBP1, HINT1, PDE4B, PDE4D, PIM1, PRKAA1, PRKAB1, PRKAB2, PYGL, TRPM4",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A10111329-001-04-6,
REP.PRIMARY,2.5,CYCLOPIAZONIC-ACID,ATP2A1,ATPASE INHIBITOR,BRD:BRD-A10420615-001-04-4,
REP.PRIMARY,2.5,GSK429286A,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-A10523515-001-07-9,
REP.PRIMARY,2.5,FOSFOMYCIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A10652366-238-04-1,
REP.PRIMARY,2.5,PRENYLAMINE,"CALM1, MYLK2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A10662413-043-11-2,
REP.PRIMARY,2.5,EFAROXAN,ADORA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10739734-003-10-6,
REP.PRIMARY,2.5,IMILOXAN,"ADRA2A, ADRA2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10903566-003-07-7,
REP.PRIMARY,2.5,GRANISETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A10967948-003-06-3,
REP.PRIMARY,2.5,CARVEDILOL,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A10977446-001-12-1,
REP.PRIMARY,2.5,CARBAZOCHROME,,,BRD:BRD-A11070335-236-02-1,
REP.PRIMARY,2.5,NADIDE,"AHCY, AKR1A1, ALDH2, BLVRA, DHPS, DLD, GALE, HMGCR, HSD17B1, HSD17B4, IMPDH2, MGAM, P2RY11, SORD, TRPM2",ELECTRON ACCEPTOR,BRD:BRD-A11132253-001-08-2,
REP.PRIMARY,2.5,DEHYDROCHOLATE-ACID,,,BRD:BRD-A11551002-001-04-6,
REP.PRIMARY,2.5,MEPARFYLON,,,BRD:BRD-A11662333-001-03-3,
REP.PRIMARY,2.5,BAY-85-8050,,,BRD:BRD-A11731518-001-01-7,
REP.PRIMARY,2.5,ENILCONAZOLE,"CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2",STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A11776908-065-01-5,
REP.PRIMARY,2.5,AM-92016,GRIN1,POTASSIUM CHANNEL BLOCKER,BRD:BRD-A11813248-003-02-4,
REP.PRIMARY,2.5,PROSCILLARIDIN-A,,,BRD:BRD-A11815689-001-01-1,
REP.PRIMARY,2.5,LORAZEPAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A11990600-001-03-4,
REP.PRIMARY,2.5,CEFEPIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A12077521-003-01-5,
REP.PRIMARY,2.5,NUTLIN-3,"MDM2, TP53",MDM INHIBITOR,BRD:BRD-A12230535-001-06-7,
REP.PRIMARY,2.5,L-CITRULLINE,"ASS1, DDAH1, DDAH2, GPRC6A, NOS1, NOS2, NOS3, OTC, PADI1, PADI2, PADI3, PADI4, PADI6",NITRIC OXIDE STIMULANT,BRD:BRD-A12237696-001-04-2,
REP.PRIMARY,2.31,USNIACIN-(+),PTPN1,MAP KINASE ACTIVATOR,BRD:BRD-A12417644-001-07-6,
REP.PRIMARY,2.5,L-HYDROXYPROLINE,,,BRD:BRD-A12454076-001-01-9,
REP.PRIMARY,2.5,CISAPRIDE,"HTR2A, HTR3A, HTR4, KCNH2",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A12896037-001-04-3,
REP.PRIMARY,2.5,POMALIDOMIDE,"CRBN, PTGS2, TNF","ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-A12994259-001-02-1,
REP.PRIMARY,2.5,TROGLITAZONE,"ACSL4, CYP2C8, ESRRA, ESRRG, PPARG, SERPINE1, SLC29A1, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A13084692-001-17-3,
REP.PRIMARY,2.5,FLUOROMETHOLONE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A13133631-001-04-0,
REP.PRIMARY,2.5,DOXAZOSIN,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A13188892-066-21-5,
REP.PRIMARY,2.5,PERILLYL-ALCOHOL,FNTA,"APOPTOSIS STIMULANT, FARNESYLTRANSFERASE INHIBITOR",BRD:BRD-A13323580-001-04-8,
REP.PRIMARY,2.5,ORNITHINE,"ARG1, ARG2, GATM, GPRC6A, OAT, OAZ1, OAZ2, OAZ3, OTC, SLC25A15, SLC25A2, SLC7A1, SLC7A2, SLC7A3, SLC7A4",NFKB PATHWAY MODULATOR,BRD:BRD-A13561534-003-02-0,
REP.PRIMARY,2.5,5'-CHLORO-5'-DEOXY-ENBA-(+/-),ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-A13598753-001-01-2,
REP.PRIMARY,2.5,SULINDAC,"AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A13946108-001-17-1,
REP.PRIMARY,2.5,TC1,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-A13964793-001-02-6,
REP.PRIMARY,2.5,OXYPHENONIUM,"CHRM1, CHRM3",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A14208071-004-19-8,
REP.PRIMARY,2.5,OCTOPAMINE,"F10, TAAR1",TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-A14240607-003-26-1,
REP.PRIMARY,2.5,GUANADREL,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-A14262390-065-01-8,
REP.PRIMARY,2.5,SN-6,,SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-A14316475-001-02-3,
REP.PRIMARY,2.5,IDRA-21,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A14344385-001-03-2,
REP.PRIMARY,2.5,MESORIDAZINE,"DRD2, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A14395271-074-17-8,
REP.PRIMARY,2.5,UB-165,"CHRNA3, CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A14574269-051-02-2,
REP.PRIMARY,2.5,NORGESTREL,"AR, ESR1, PGR, SRD5A1",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A14886633-001-01-6,
REP.PRIMARY,2.5,DOFEQUIDAR,ABCB1,"MRP INHIBITOR, P GLYCOPROTEIN INHIBITOR",BRD:BRD-A14941520-051-01-0,
REP.PRIMARY,2.5,ALAPROCLATE,SLC6A4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A14966924-003-07-7,
REP.PRIMARY,2.5,DIADENOSINE-TETRAPHOSPHATE,"P2RY13, P2RY2",ADENOSINE KINASE INHIBITOR,BRD:BRD-A15035311-001-01-8,
REP.PRIMARY,2.5,MILNACIPRAN,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A15202882-003-02-7,
REP.PRIMARY,2.5,FLUOCINOLONE-ACETONIDE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A15297126-001-04-3,
REP.PRIMARY,2.5,L-CYSTINE,"CTNS, SLC3A1, SLC7A11, SLC7A9",,BRD:BRD-A15397381-001-02-5,
REP.PRIMARY,2.5,GW-1929,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A15415227-003-02-9,
REP.PRIMARY,2.5,BMY-14802,HTR1A,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-A15435692-003-02-3,
REP.PRIMARY,2.5,SDZ-21009,"HTR1A, HTR1B","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A15530910-001-02-1,
REP.PRIMARY,2.5,REBAMIPIDE,FPR1,FREE RADICAL SCAVENGER,BRD:BRD-A15909516-001-06-6,
REP.PRIMARY,2.5,BUCLADESINE,PRKACA,"ADENOSINE RECEPTOR AGONIST, CAMP STIMULANT",BRD:BRD-A15931911-001-03-8,
REP.PRIMARY,2.5,INDOBUFEN,"PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",BRD:BRD-A16296925-001-01-3,
REP.PRIMARY,2.5,THIOCTIC-ACID,"ACHE, LIAS, LIPT1, PTGS2, SLC5A6",REDUCING AGENT,BRD:BRD-A16347691-001-13-1,
REP.PRIMARY,2.5,DORAMECTIN,,,BRD:BRD-A16350940-001-01-9,
REP.PRIMARY,2.5,QUINESTROL,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A16439188-001-01-1,
REP.PRIMARY,2.5,BUTOCONAZOLE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A16665823-001-02-0,
REP.PRIMARY,2.5,BADGE,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-A16694057-001-06-8,
REP.PRIMARY,2.5,ISOXSUPRINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A16700644-003-04-4,
REP.PRIMARY,2.5,PROTIRELIN,TRHR,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,BRD:BRD-A16997652-001-02-3,
REP.PRIMARY,2.5,DEHYDROACETIC-ACID,,,BRD:BRD-A17300716-001-01-5,
REP.PRIMARY,2.5,ALCLOMETASONE-DIPROPIONATE,"CYP3A4, NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A17407635-001-04-0,
REP.PRIMARY,2.5,CARPROFEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A17411484-001-11-9,
REP.PRIMARY,2.5,BW-723C86,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A17428743-003-09-0,
REP.PRIMARY,2.5,MDL-72832,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A17453586-003-02-3,
REP.PRIMARY,2.5,BAMBUTEROL,"ADRB2, BCHE",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A17462676-003-11-6,
REP.PRIMARY,2.5,IBUPROFEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A17655518-001-24-4,
REP.PRIMARY,2.5,TROLOX,,ANTIOXIDANT,BRD:BRD-A17846016-001-13-9,
REP.PRIMARY,2.5,LENALIDOMIDE,"CDH5, CRBN, PTGS2, TNF, TNFSF11",ANTICANCER AGENT,BRD:BRD-A17883755-001-06-1,
REP.PRIMARY,2.5,PHENSUXIMIDE,"CACNA1G, CACNA1H, CACNA1I",SUCCINIMIDE ANTIEPILEPTIC,BRD:BRD-A18043272-001-09-9,
REP.PRIMARY,2.5,METHACHOLINE,"CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A18056626-003-22-3,
REP.PRIMARY,2.5,AGN-192403,NISCH,IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-A18074780-003-02-0,
REP.PRIMARY,2.5,BEVANTOLOL,"ADRA1A, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A18233884-003-02-7,
REP.PRIMARY,2.56,MALIC-ACID,"CS, ME2, PKD2L1",,BRD:BRD-A18396475-001-15-3,
REP.PRIMARY,2.5,TAZOBACTAM,,BETA LACTAMASE INHIBITOR,BRD:BRD-A18611368-001-01-5,
REP.PRIMARY,2.5,CYANOCOBALAMIN,"MMAA, MMACHC, MTHFR, MTR, MTRR, MUT","METHYLMALONYL COA MUTASE STIMULANT, VITAMIN B",BRD:BRD-A18627414-001-04-9,
REP.PRIMARY,2.5,IDAZOXAN,"ADRA2A, PTGS2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A18696154-003-22-6,
REP.PRIMARY,2.5,BAX-CHANNEL-BLOCKER,BAX,CYTOCHROME C RELEASE INHIBITOR,BRD:BRD-A18763547-300-05-5,
REP.PRIMARY,2.5,7-HYDROXY-DPAT,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A18795974-004-07-3,
REP.PRIMARY,2.5,NALTRIBEN,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A19102171-066-01-4,
REP.PRIMARY,2.5,TRIMIPRAMINE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",BRD:BRD-A19195498-050-14-1,
REP.PRIMARY,2.5,METHYLPHENIDATE,"SLC6A2, SLC6A3, SLC6A4",DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A19585813-003-03-3,
REP.PRIMARY,2.5,PERHEXILINE,"CPT1A, CPT2",CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-A19633847-050-32-1,
REP.PRIMARY,2.5,MIANSERIN,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A19661776-003-27-6,
REP.PRIMARY,2.5,ONDANSETRON,"HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A19736161-001-06-7,
REP.PRIMARY,2.5,ATOVAQUONE,DHODH,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,BRD:BRD-A19795905-001-08-0,
REP.PRIMARY,2.5,CLOSANTEL,,"CHITINASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-A19952358-001-11-3,
REP.PRIMARY,2.5,TUAMINOHEPTANE,,,BRD:BRD-A19958636-065-04-4,
REP.PRIMARY,2.5,MECAMYLAMINE,"CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A20119038-003-07-8,
REP.PRIMARY,2.5,ATENOLOL-(+/-),"ADRB1, ADRB2, LTF, PLA2G2E",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A20239487-001-24-9,
REP.PRIMARY,2.5,CHLORMEZANONE,"GABRA1, TSPO",GABA RECEPTOR MODULATOR,BRD:BRD-A20348246-001-15-8,
REP.PRIMARY,2.5,HALOTHANE,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A20550616-001-02-9,
REP.PRIMARY,2.5,CANRENONE,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-A20644369-001-08-6,
REP.PRIMARY,2.5,PRASTERONE-ACETATE,,,BRD:BRD-A20758144-001-04-5,
REP.PRIMARY,2.5,PLOVAMER-ACETATE,"TAT, TH, YARS, YARS2",,BRD:BRD-A20781140-001-01-7,
REP.PRIMARY,2.5,CEFMENOXIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A20839672-003-01-5,
REP.PRIMARY,2.5,"2,6-DIMETHYLPIPERIDINE",,,BRD:BRD-A21276153-001-01-1,
REP.PRIMARY,2.5,MEDETOMIDINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A21607826-003-05-1,
REP.PRIMARY,2.5,PRAZIQUANTEL,,ANTHELMINTIC AGENT,BRD:BRD-A21858158-001-23-5,
REP.PRIMARY,2.5,AMLODIPINE,"CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A22032524-074-06-5,
REP.PRIMARY,2.5,SULMAZOLE,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A22081593-001-11-1,
REP.PRIMARY,2.5,PHENOTHRIN,,,BRD:BRD-A22106989-001-05-0,
REP.PRIMARY,2.5,ESTROPIPATE,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-A22143024-231-03-8,
REP.PRIMARY,2.5,TRIDIHEXETHYL,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A22152765-003-10-0,
REP.PRIMARY,2.5,TERAZOSIN,"ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A22256192-003-22-7,
REP.PRIMARY,2.5,DROFENINE,,,BRD:BRD-A22267103-003-13-1,
REP.PRIMARY,2.5,BENFLUOREX,HMGCR,GLUCONEOGENESIS INHIBITOR,BRD:BRD-A22305049-003-13-6,
REP.PRIMARY,2.51,PANTOPRAZOLE,ATP4A,ATPASE INHIBITOR,BRD:BRD-A22380646-236-05-8,
REP.PRIMARY,2.5,LICARBAZEPINE,SCN5A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A22642447-001-01-9,
REP.PRIMARY,2.5,SB-205384,"GABRA3, GABRA5, GABRA6",GABA RECEPTOR MODULATOR,BRD:BRD-A22707317-001-10-8,
REP.PRIMARY,2.5,HOMOCHLORCYCLIZINE,HRH1,ANTIHISTAMINE,BRD:BRD-A22769835-300-05-7,
REP.PRIMARY,2.5,TENOXICAM,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A22844106-001-26-0,
REP.PRIMARY,2.5,ITRACONAZOLE,CYP51A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A23067620-300-01-3,
REP.PRIMARY,2.5,PHENIRAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A23072235-050-18-5,
REP.PRIMARY,2.5,SCLAREOL,,,BRD:BRD-A23127772-001-02-3,
REP.PRIMARY,2.5,SIBUTRAMINE,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A23359898-003-10-0,
REP.PRIMARY,2.5,RIFAMPIN,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3",RNA POLYMERASE INHIBITOR,BRD:BRD-A23603052-001-03-2,
REP.PRIMARY,2.5,SACLOFEN,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A24122750-001-03-7,
REP.PRIMARY,2.5,IFENPRODIL,"GRIN1, GRIN2B","ADRENERGIC RECEPTOR ANTAGONIST, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-A24191444-046-02-1,
REP.PRIMARY,2.4000000000000004,IFENPRODIL,"GRIN1, GRIN2B","ADRENERGIC RECEPTOR ANTAGONIST, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-A24191444-046-03-9,
REP.PRIMARY,2.5,OFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A24228527-213-01-9,
REP.PRIMARY,2.5,ANABASINE,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A24284985-001-09-9,
REP.PRIMARY,2.5,TROLEANDOMYCIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A24297246-001-03-9,
REP.PRIMARY,2.5,NADIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A24397426-001-10-4,
REP.PRIMARY,2.5,WARFARIN,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A24514565-001-09-7,
REP.PRIMARY,2.5,NORNICOTINE,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A24543851-001-05-7,
REP.PRIMARY,2.5,EFATUTAZONE,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A24560335-300-01-2,
REP.PRIMARY,2.5,ISOETHARINE,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A24587114-066-22-5,
REP.PRIMARY,2.5,ERASTIN,VDAC2,ION CHANNEL ANTAGONIST,BRD:BRD-A25004090-001-08-4,
REP.PRIMARY,2.5,HYDROCORTISONE-VALERATE,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A25143711-001-02-2,
REP.PRIMARY,2.5,AMINOGLUTETHIMIDE,"CYP11A1, CYP19A1",GLUCOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-A25234499-001-18-3,
REP.PRIMARY,2.5,KI-16425,"LPAR1, LPAR3",LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-A25569250-001-03-3,
REP.PRIMARY,2.5,NARASIN,,ANTIPROTOZOAL AGENT,BRD:BRD-A25608658-001-01-1,
REP.PRIMARY,2.5,FADROZOLE,"CYP11B1, CYP19A1",AROMATASE INHIBITOR,BRD:BRD-A25619068-003-03-4,
REP.PRIMARY,2.5,EMETINE,RPS2,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A25687296-300-04-3,
REP.PRIMARY,2.5,L-CYSTEINESULFINIC-ACID,"GRM1, GRM5, GSR, HMGCS2, PAPOLA, PRDX2",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A25800195-001-02-2,
REP.PRIMARY,2.5,ZALDARIDE,CALM1,CALMODULIN ANTAGONIST,BRD:BRD-A26032986-050-02-1,
REP.PRIMARY,2.5,PROPAFENONE,"ADRB1, ADRB2, KCNA5, KCNH2, SCN5A",ANTIARRHYTHMIC,BRD:BRD-A26334849-001-06-2,
REP.PRIMARY,2.5,CHLORTHALIDONE,"CA1, CA12, CA14, CA2, CA4, CA7, SLC12A1, SLC12A3",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-A26384407-001-25-1,
REP.PRIMARY,2.5,ERGONOVINE,"ADRA1A, HTR1E","ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-A26387268-050-04-4,
REP.PRIMARY,2.5,FORMESTANE,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-A26503646-001-16-6,
REP.PRIMARY,2.5,SAQUINAVIR,CYP3A4,HIV PROTEASE INHIBITOR,BRD:BRD-A26690767-066-01-9,
REP.PRIMARY,2.5,NICARDIPINE,"ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B",CALCIUM CHANNEL BLOCKER,BRD:BRD-A26711594-003-10-6,
REP.PRIMARY,2.5,ISAMOLTANE,"HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A26845397-051-01-9,
REP.PRIMARY,2.5,DIARYLPROPIONITRILE,ESR2,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A27143604-001-02-0,
REP.PRIMARY,2.5,ATROPINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A27290375-330-01-1,
REP.PRIMARY,2.5,CYCLANDELATE,"CACNA2D1, CES1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A27370296-001-03-0,
REP.PRIMARY,2.5,LESTAURTINIB,"FLT3, NTRK1","FLT3 INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR, JAK INHIBITOR",BRD:BRD-A27376179-001-01-3,
REP.PRIMARY,2.5,TOLPERISONE,"CYP2C19, CYP2D6",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A27732521-003-08-3,
REP.PRIMARY,2.5,ALEXIDINE,PTPMT1,PHOSPHATIDYLGLYCEROPHOSPHATASE INHIBITOR,BRD:BRD-A27883417-300-01-6,
REP.PRIMARY,2.5,PREDNISOLONE,"NR3C1, NR3C2, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A27887842-001-04-0,
REP.PRIMARY,2.5,2-HYDROXYSACLOFEN,"GABBR1, GABBR2",GABA RECEPTOR ANTAGONIST,BRD:BRD-A27924917-001-03-3,
REP.PRIMARY,2.5,AROTINOLOL,ADRB3,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A28044053-001-01-7,
REP.PRIMARY,2.5,SALINOMYCIN,,,BRD:BRD-A28301258-001-03-0,
REP.PRIMARY,2.5,SALINOMYCIN,,,BRD:BRD-A28301258-001-04-8,
REP.PRIMARY,2.5,AMINOMETHYLTRANSFERASE,NOS2,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-A28318179-003-08-5,
REP.PRIMARY,2.5,MTPG,"GRM2, GRM3",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A28329383-001-02-1,
REP.PRIMARY,2.5,PKI-179,MTOR,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-A28467416-002-01-0,
REP.PRIMARY,2.5,SELEGILINE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A28545468-003-16-6,
REP.PRIMARY,2.5,TETRAHYDROZOLINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A28856712-003-26-0,
REP.PRIMARY,2.5,PROXYPHYLLINE,,,BRD:BRD-A28887267-001-19-3,
REP.PRIMARY,2.5,TRICHLORMETHIAZIDE,"ATP1A1, CA1, CA2, CA4, PTGS1, PTGS2, SLC12A1, SLC12A3",CHLORIDE CHANNEL BLOCKER,BRD:BRD-A28940325-001-24-0,
REP.PRIMARY,2.5,CENTPROPAZINE,,INOSITOL MONOPHOSPHATASE INHIBITOR,BRD:BRD-A28958257-001-01-2,
REP.PRIMARY,2.5,PUROMYCIN,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A28970875-300-04-9,
REP.PRIMARY,2.5,ETHISTERONE,TYR,PROGESTOGEN HORMONE,BRD:BRD-A29111201-001-04-8,
REP.PRIMARY,2.5,ACEBUTOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A29260609-003-26-0,
REP.PRIMARY,2.5,CLORPRENALINE,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A29281099-003-03-2,
REP.PRIMARY,2.5,PCA-4248,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A29289453-001-04-7,
REP.PRIMARY,2.5,DROPROPIZINE,,ANTITUSSIVE,BRD:BRD-A29349577-001-23-0,
REP.PRIMARY,2.5,CARBINOXAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A29426959-050-13-2,
REP.PRIMARY,2.5,BICALUTAMIDE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-A29485665-001-12-8,
REP.PRIMARY,2.5,ACIFRAN,"HCAR2, HCAR3",CHOLESTEROL INHIBITOR,BRD:BRD-A29520968-001-02-7,
REP.PRIMARY,2.5,ANISODAMINE,ADRA1A,LIPID PEROXIDASE INHIBITOR,BRD:BRD-A29623586-001-01-3,
REP.PRIMARY,2.5,NOMIFENSINE,"DRD2, MAOA, MAOB, MPO, SLC6A2, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, NORADRENALINE UPTAKE INHIBITOR",BRD:BRD-A29644307-050-17-0,
REP.PRIMARY,2.5,CARBENOXOLONE,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A29700858-304-01-8,
REP.PRIMARY,2.5,CARBENOXOLONE,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-A29700858-304-02-6,
REP.PRIMARY,2.5,17-HYDROXYPROGESTERONE-CAPROATE,"AR, ESR1, ESR2, NR1H4, NR1I2, NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A29731977-001-04-5,
REP.PRIMARY,2.5,DISOPYRAMIDE,"CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A29734509-011-13-6,
REP.PRIMARY,2.5,ABT-202,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A29844814-300-01-5,
REP.PRIMARY,2.5,LORGLUMIDE,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A29854054-236-12-6,
REP.PRIMARY,2.5,PROXODOLOL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A29944538-003-08-3,
REP.PRIMARY,2.5,AMIKACIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A30051119-002-01-8,
REP.PRIMARY,2.5,ETHOTOIN,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-A30205217-001-11-2,
REP.PRIMARY,0.25,EDELFOSINE,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-A30403214-001-03-3,
REP.PRIMARY,2.5,TILETAMINE,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A30582499-003-05-1,
REP.PRIMARY,2.5,MR-16728,,ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-A30590053-003-02-9,
REP.PRIMARY,2.5,LFM-A13,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A30655177-001-14-0,
REP.PRIMARY,2.5,DIPERODON,,LOCAL ANESTHETIC,BRD:BRD-A30693873-003-12-8,
REP.PRIMARY,2.5,GANGLIOSIDE-GM1,,,BRD:BRD-A30703952-201-01-2,
REP.PRIMARY,2.5,FELODIPINE,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A30815329-001-10-5,
REP.PRIMARY,2.5,FLORFENICOL,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A30886737-001-02-9,
REP.PRIMARY,2.5,GDC-0834,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A30984645-001-01-5,
REP.PRIMARY,2.5,MOZAVAPTAN,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-A31095847-001-02-3,
REP.PRIMARY,2.5,FLUOXETINE,"ANO1, HTR2B, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A31159102-003-30-4,
REP.PRIMARY,2.5,MONOSTEARIN,,,BRD:BRD-A31454688-001-01-6,
REP.PRIMARY,2.5,METHOCARBAMOL,CA1,MUSCLE RELAXANT,BRD:BRD-A31521121-001-26-4,
REP.PRIMARY,2.5,ISOFLURANE,"ATP2C1, ATP5D, CALM1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9",INHALED ANAESTHETIC,BRD:BRD-A31564021-001-01-8,
REP.PRIMARY,2.5,PROCYCLIDINE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A31800922-003-25-1,
REP.PRIMARY,2.5,MILTEFOSINE,PLA2G1B,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-A31811760-001-06-7,
REP.PRIMARY,2.5,ADENOSINE-TRIPHOSPHATE,"ABCA1, ABCB1, ABCB11, ABCC2, ABCC8, ABCC9, ABCG1, ABL1, ABL2, ACSL1, ACSS1, ACSS2, ACVR1, ACVR1B, ACVRL1, ADCY1, ADRBK1, ADRBK2, AFG3L2, AKT1, ALK, AMHR2, APAF1, ARAF, ASNA1, ASNS, ASS1, CDK15, GPR17, ITPR1, NAE1, NT5C2, P2RY1, P2RY11, P2RY13, P2RY2, P2RY4, PRKAA1, RYR1, RYR2, RYR3, SLC25A4, TNK2, TRPM4, TRPM7",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A31990649-304-02-3,
REP.PRIMARY,2.5,METHIOPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A32172948-001-07-6,
REP.PRIMARY,2.5,VGX-1027,TLR4,TUMOR NECROSIS FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A32269193-001-01-5,
REP.PRIMARY,2.5,TRANDOLAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A32505112-001-04-4,
REP.PRIMARY,2.5,LETOSTEINE,,MUCOLYTIC AGENT,BRD:BRD-A32597168-001-03-6,
REP.PRIMARY,2.5,ACECLIDINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A32673558-003-03-9,
REP.PRIMARY,2.5,HEPTAMINOL,,VASOCONSTRICTOR,BRD:BRD-A32988684-003-08-7,
REP.PRIMARY,2.5,TIOCONAZOLE,CYP51A1,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A33084557-001-06-6,
REP.PRIMARY,2.5,SOTALOL,"ADRB1, ADRB2, KCNH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A33168282-003-18-0,
REP.PRIMARY,2.5,OXFENDAZOLE,,ANTHELMINTIC AGENT,BRD:BRD-A33447119-001-10-8,
REP.PRIMARY,2.5,N-BENZYLNALTRINDOLE,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A33514596-003-01-2,
REP.PRIMARY,2.5,ZIDOVUDINE,TERT,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-A33692381-001-01-9,
REP.PRIMARY,2.5,FENTICONAZOLE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A33697453-008-02-4,
REP.PRIMARY,2.5,METIXENE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A33711280-003-03-1,
REP.PRIMARY,2.5,SUPROFEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A34006693-001-15-4,
REP.PRIMARY,2.5,SULOCTIDIL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A34205397-001-04-5,
REP.PRIMARY,2.5,ROLIPRAM,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A34255068-001-34-5,
REP.PRIMARY,2.5,SARPOGRELATE,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A34358106-003-01-6,
REP.PRIMARY,2.5,AMPA-(RS),GRIN1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A34716233-004-03-5,
REP.PRIMARY,2.5,HOMOSALATE,,HSP INDUCER,BRD:BRD-A34751532-001-06-9,
REP.PRIMARY,2.5,SPHINGOSYLPHOSPHORYLCHOLINE,GPR12,GENE EXPRESSION STIMULANT,BRD:BRD-A35379661-001-04-6,
REP.PRIMARY,2.5,TENIPOSIDE,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-A35588707-001-05-5,
REP.PRIMARY,2.5,CGP-37157,SLC8A1,"MITOCHONDRIAL NA+/CA2+ EXCHANGER ANTAGONIST, SODIUM/CALCIUM EXCHANGE INHIBITOR",BRD:BRD-A35623999-001-05-7,
REP.PRIMARY,2.5,TROVENTOL,,,BRD:BRD-A35868371-005-01-6,
REP.PRIMARY,2.5,PREGNENOLONE-SUCCINATE,CYP17A1,GABA RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-A35912562-001-02-8,
REP.PRIMARY,2.5,MEGESTROL-ACETATE,"NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A35989968-001-04-2,
REP.PRIMARY,2.5,AMCINONIDE,"ANXA1, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A36010170-001-04-0,
REP.PRIMARY,2.5,BRUCEANTIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A36057565-001-01-0,
REP.PRIMARY,2.5,REMACEMIDE,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A36074203-003-07-6,
REP.PRIMARY,2.5,SULFINPYRAZONE,"ABCC1, ABCC2, FPR1, SLC22A12",URICOSURIC BLOCKER,BRD:BRD-A36217750-001-16-3,
REP.PRIMARY,2.5,BUPHENINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A36267905-003-18-4,
REP.PRIMARY,2.5,NECROSTATIN-1,RIPK1,RIPK INHIBITOR,BRD:BRD-A36318220-001-08-8,
REP.PRIMARY,2.5,OPROZOMIB,,PROTEASOME INHIBITOR,BRD:BRD-A36331462-001-02-1,
REP.PRIMARY,2.5,COLISTIN-B-SULFATE,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A36456202-001-01-3,
REP.PRIMARY,2.5,AMFEPRAMONE,"SLC6A2, SLC6A3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A37288617-003-02-2,
REP.PRIMARY,2.5,BRL-52537,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-A37347161-003-02-6,
REP.PRIMARY,2.5,AMOROLFINE,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-A37390343-003-03-5,
REP.PRIMARY,2.5,TULOBUTEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A37441042-003-04-8,
REP.PRIMARY,2.5,IOCETAMIC-ACID,,RADIOPAQUE MEDIUM,BRD:BRD-A37492983-001-10-3,
REP.PRIMARY,2.5,SB-203580,"AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF",P38 MAPK INHIBITOR,BRD:BRD-A37704979-001-10-7,
REP.PRIMARY,2.5,GLAFENINE,CFTR,DELTAF508-CFTR CORRECTORS,BRD:BRD-A38076815-003-10-3,
REP.PRIMARY,2.5,METENKEPHALIN,OPRD1,IMMUNOSTIMULANT,BRD:BRD-A38218502-001-01-2,
REP.PRIMARY,2.5,KETOCONAZOLE,"AR, CYP19A1, CYP21A2, KCNA10",STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A38350138-001-04-9,
REP.PRIMARY,2.5,TIMONACIC,ANXA5,ANTIOXIDANT,BRD:BRD-A38592941-001-02-7,
REP.PRIMARY,2.5,KU14R,,IMIDAZOLINE RECEPTOR ANTAGONIST,BRD:BRD-A38747044-001-02-3,
REP.PRIMARY,2.5,MOSAPRIDE,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A39052811-048-11-0,
REP.PRIMARY,2.5,METHOXAMINE,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A39189014-003-22-7,
REP.PRIMARY,2.5,CHLORPHENSIN-CARBAMATE,,MUSCLE RELAXANT,BRD:BRD-A39230911-001-10-2,
REP.PRIMARY,2.5,DCPIB,SLC1A2,"CHLORIDE CHANNEL BLOCKER, GAP JUNCTION MODULATOR, GLUTAMATE INHIBITOR",BRD:BRD-A39255369-001-03-1,
REP.PRIMARY,2.5,RABEPRAZOLE,ATP4A,"ATPASE INHIBITOR, GASTRIN INHIBITOR",BRD:BRD-A39390670-236-10-7,
REP.PRIMARY,2.5,HYDROXYPROGESTERONE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A39791822-001-05-1,
REP.PRIMARY,2.5,TEROXIRONE,,DNA INHIBITOR,BRD:BRD-A39935389-001-05-9,
REP.PRIMARY,2.5,CGP-12177,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A40084411-003-07-7,
REP.PRIMARY,2.5,NTNCB,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A40413915-003-01-2,
REP.PRIMARY,2.5,KETOROLAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A40639672-234-18-0,
REP.PRIMARY,2.5,AMINOHYDROXYBUTYRIC-ACID,,,BRD:BRD-A40777960-001-04-2,
REP.PRIMARY,2.5,GEMIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A40787240-066-04-6,
REP.PRIMARY,2.5,IBUPROXAM,ALOX5,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",BRD:BRD-A40940854-001-01-1,
REP.PRIMARY,2.5,CYCLOPENTHIAZIDE,,THIAZIDE DIURETIC,BRD:BRD-A41250306-001-11-7,
REP.PRIMARY,2.5,PRACTOLOL,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A41304429-001-14-8,
REP.PRIMARY,2.5,BORNYL-ACETATE,,,BRD:BRD-A41385909-001-01-3,
REP.PRIMARY,2.5,TOSUFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A41450521-075-10-8,
REP.PRIMARY,2.5,PK-11195,TSPO,BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-A41451487-001-11-2,
REP.PRIMARY,2.5,TGX-221,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-A41692738-001-07-6,
REP.PRIMARY,2.5,BILOBALIDE,"GLRA1, GLRA2, GLRB, HTR3A, HTR3B",GABA RECEPTOR MODULATOR,BRD:BRD-A41714661-001-02-0,
REP.PRIMARY,2.5,ALGESTONE-ACETOPHENIDE,,,BRD:BRD-A41774846-001-01-4,
REP.PRIMARY,2.5,BRUCINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",GLYCINE RECEPTOR ANTAGONIST,BRD:BRD-A41995253-001-04-5,
REP.PRIMARY,2.5,CARTEOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A42167015-003-10-2,
REP.PRIMARY,2.5,TENATOPRAZOLE,IDO1,ATPASE INHIBITOR,BRD:BRD-A42270467-001-04-4,
REP.PRIMARY,2.5,L-152804,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A42553870-001-14-3,
REP.PRIMARY,2.5,CETIRIZINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A42571354-300-12-0,
REP.PRIMARY,2.5,IOPANIC-ACID,,THYROID HORMONE INHIBITOR,BRD:BRD-A42628519-001-12-4,
REP.PRIMARY,2.5,TERIFLUNOMIDE,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-A42699921-001-02-8,
REP.PRIMARY,2.6,TERIFLUNOMIDE,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-A42699921-001-03-6,
REP.PRIMARY,2.5,MELENGESTROL-ACETATE,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A42746051-001-02-9,
REP.PRIMARY,2.5,ORNIDAZOLE,,ANTIPROTOZOAL AGENT,BRD:BRD-A42759514-001-20-5,
REP.PRIMARY,2.5,LINALOOL,,ANTICONVULSANT,BRD:BRD-A43082461-001-06-3,
REP.PRIMARY,2.5,LOXOPROFEN,PTGS2,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A43082555-001-01-1,
REP.PRIMARY,2.5,LOXOPROFEN,PTGS2,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A43082555-001-02-9,
REP.PRIMARY,2.5,MERCAPTOSUCCINIC-ACID,,,BRD:BRD-A43435802-001-02-0,
REP.PRIMARY,2.5,3-ALPHA-HYDROXY-5-BETA-ANDROSTAN-17-ONE,"HSD17B11, IGHG2, SULT2A1",,BRD:BRD-A43598550-001-09-4,
REP.PRIMARY,2.5,OXPRENOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A43671941-003-11-9,
REP.PRIMARY,2.5,CLOBUTINOL,,ANTITUSSIVE,BRD:BRD-A43809092-003-02-1,
REP.PRIMARY,2.5,PINACIDIL,"ABCC8, ABCC9","ATP CHANNEL ACTIVATOR, POTASSIUM CHANNEL ACTIVATOR",BRD:BRD-A43882281-001-15-5,
REP.PRIMARY,2.5,SID-7969543,NR5A1,STEROIDOGENIC FACTOR ANTAGONIST,BRD:BRD-A43885598-001-08-1,
REP.PRIMARY,2.5,L-368899,"AVPR1A, AVPR2, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-A43930669-003-02-8,
REP.PRIMARY,2.5,HOMATROPINE-METHYLBROMIDE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A43999749-004-04-1,
REP.PRIMARY,2.5,DOXYLAMINE,"CHRM1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A44008656-036-25-8,
REP.PRIMARY,2.5,INDOPROFEN,"CXCR1, CXCR2, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-A44090213-001-25-6,
REP.PRIMARY,2.5,AZASETRON,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A44133049-003-07-8,
REP.PRIMARY,2.5,PENTOBARBITAL,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B","BARBITURATE ANTIEPILEPTIC, GABA RECEPTOR MODULATOR",BRD:BRD-A44448661-001-04-8,
REP.PRIMARY,2.5,FLI-06,,NOTCH SIGNALING INHIBITOR,BRD:BRD-A44500574-001-01-8,
REP.PRIMARY,2.5,ACETYL-11-KETO-BETA-BOSWELLIC-ACID,"HSD11B1, HSD11B2",LIPOXYGENASE INHIBITOR,BRD:BRD-A44696962-001-01-4,
REP.PRIMARY,2.5,PROGLUMIDE,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A44863528-001-13-2,
REP.PRIMARY,2.5,CEPHALOSPORIN-C-ZN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A44936478-001-01-1,
REP.PRIMARY,2.5,METHYLPREDNISOLONE-SODIUM-SUCCINATE,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A45044890-236-02-3,
REP.PRIMARY,2.5,SALUBRINAL,EIF2S1,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,BRD:BRD-A45107007-001-03-4,
REP.PRIMARY,2.5,BIMATOPROST,"AKR1C3, PTGER1, PTGER3, PTGFR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-A45153512-001-01-0,
REP.PRIMARY,2.5,WYE-125132,MTOR,MTOR INHIBITOR,BRD:BRD-A45498368-001-07-1,
REP.PRIMARY,2.5,METRIZAMIDE,,RADIOPAQUE MEDIUM,BRD:BRD-A45543382-001-10-0,
REP.PRIMARY,2.5,SAL003,EIF2A,EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR,BRD:BRD-A45869167-001-10-0,
REP.PRIMARY,2.5,MEPACRINE,"PLA2G1B, PLA2G4A, PLA2G6, PLCL1","CYTOKINE PRODUCTION INHIBITOR, NFKB PATHWAY INHIBITOR, TP53 ACTIVATOR",BRD:BRD-A45889380-300-07-1,
REP.PRIMARY,2.5,K-MAP,,,BRD:BRD-A45906415-001-01-9,
REP.PRIMARY,2.5,CLIDINIUM,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A46066006-004-22-6,
REP.PRIMARY,2.5,DOXAPRAM,"KCNK3, KCNK9",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A46179541-311-02-0,
REP.PRIMARY,2.5,HYDROCORTISONE-PHOSPHATE,"ANXA1, NOS2, NR3C1",,BRD:BRD-A46186775-369-02-0,
REP.PRIMARY,2.5,TETRAMISOLE,"ALPPL2, CHRNA3",IMMUNOSTIMULANT,BRD:BRD-A46393198-003-16-6,
REP.PRIMARY,2.5,AZLOCILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A46717658-236-02-5,
REP.PRIMARY,2.5,IODODEXETIMIDE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A46813902-001-01-6,
REP.PRIMARY,2.5,LEVOBUNOLOL-(+/-),,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A46876182-003-02-8,
REP.PRIMARY,2.5,NALTRINDOLE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A47342814-003-01-8,
REP.PRIMARY,2.5,SK&F-10047-(+),SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-A47364545-003-02-6,
REP.PRIMARY,2.5,IPRATROPIUM,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A47449001-004-13-7,
REP.PRIMARY,2.5,DIPIVEFRINE,"ACHE, ADRA1A, ADRA2A, ADRB2, BCHE",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A47494775-003-11-3,
REP.PRIMARY,2.5,CITALOPRAM,"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A47598013-004-16-0,
REP.PRIMARY,2.5,BUTHIONINE-SULFOXIMINE,GCLM,GLUTATHIONE TRANSFERASE INHIBITOR,BRD:BRD-A47706533-001-02-6,
REP.PRIMARY,2.61,BALOFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A47790386-001-03-6,
REP.PRIMARY,2.5,CYANOPINDOLOL,"ADRB1, HTR1A, HTR1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A47884604-051-01-2,
REP.PRIMARY,2.5,ECAMSULE-TRIETHANOLAMINE,,,BRD:BRD-A47953250-001-01-7,
REP.PRIMARY,2.5,8-HYDROXY-DPAT,"CDK1, CHEK1, CHEK2, GSK3B, HTR5A, HTR7, LCK, MAPK14, MARK1, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG",SEROTONIN RECEPTOR AGONIST,BRD:BRD-A48015106-004-08-9,
REP.PRIMARY,2.5,TRIHEXYPHENIDYL,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A48180038-003-24-3,
REP.PRIMARY,2.5,MITOMYCIN-C,,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",BRD:BRD-A48237631-001-04-8,
REP.PRIMARY,2.5,ARGATROBAN,F2,THROMBIN INHIBITOR,BRD:BRD-A48261811-001-08-1,
REP.PRIMARY,2.5,AJMALINE,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-A48300215-001-04-8,
REP.PRIMARY,2.5,PIOGLITAZONE,"PPARG, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A48430263-003-17-2,
REP.PRIMARY,2.5,TESTOSTERONE-PROPIONATE,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-A48720949-001-04-0,
REP.PRIMARY,2.39,METHACYCLINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A49035384-003-28-9,
REP.PRIMARY,2.5,METHACYCLINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A49035384-003-30-5,
REP.PRIMARY,2.5,SKF-89976A,SLC6A1,GABA UPTAKE INHIBITOR,BRD:BRD-A49046702-003-08-3,
REP.PRIMARY,2.5,DONEPEZIL,"ACHE, HTR2A",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-A49160188-003-12-7,
REP.PRIMARY,2.5,LANSOPRAZOLE,"ATP4A, ATP4B",ATPASE INHIBITOR,BRD:BRD-A49172652-001-27-1,
REP.PRIMARY,2.5,ALIMEMAZINE,HRH1,HISTAMINE RECEPTOR AGONIST,BRD:BRD-A49225603-045-10-0,
REP.PRIMARY,2.5,CIPROFIBRATE,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-A49358627-001-14-6,
REP.PRIMARY,2.5,DESMOPRESSIN-ACETATE,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-A49399758-015-01-8,
REP.PRIMARY,2.5,DESOXIMETASONE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A49447682-001-02-4,
REP.PRIMARY,2.5,AC-7954-(+/-),UTS2R,UROTENSIN RECEPTOR AGONIST,BRD:BRD-A49544621-003-02-8,
REP.PRIMARY,2.5,FAROPENEM,,LACTAMASE INHIBITOR,BRD:BRD-A49622760-001-01-9,
REP.PRIMARY,2.5,FLUDROXYCORTIDE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A49765801-001-04-1,
REP.PRIMARY,2.5,PHENPROCOUMON,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A49838158-001-01-1,
REP.PRIMARY,2.5,SCOPOLAMINE-N-OXIDE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A49906757-004-09-8,
REP.PRIMARY,2.5,TCS2002,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-A50028488-001-01-6,
REP.PRIMARY,2.5,OXAZEPAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-A50049929-001-01-9,
REP.PRIMARY,2.5,FLUMETHASONE-PIVALATE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A50064262-001-04-7,
REP.PRIMARY,2.5,TERBUTALINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A50157456-065-20-6,
REP.PRIMARY,2.5,MECLIZINE,"HRH1, NR1I3",CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,BRD:BRD-A50311610-300-10-4,
REP.PRIMARY,2.5,FIPRONIL,,"CHLORIDE CHANNEL BLOCKER, GABA GATED CHLORIDE CHANNEL BLOCKER",BRD:BRD-A50675702-001-07-1,
REP.PRIMARY,2.5,FENOLDOPAM,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD4, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A50684349-003-02-9,
REP.PRIMARY,2.5,CGK-733,"ATM, ATR","ATM KINASE INHIBITOR, ATR KINASE INHIBITOR",BRD:BRD-A50737080-001-03-0,
REP.PRIMARY,2.5,MDL-73005EF,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A50764878-003-02-8,
REP.PRIMARY,2.5,VALGANCICLOVIR,,DNA SYNTHESIS INHIBITOR,BRD:BRD-A50922295-001-01-3,
REP.PRIMARY,2.5,PALOMID-529,MTOR,"AKT INHIBITOR, MTOR INHIBITOR",BRD:BRD-A50998626-001-02-1,
REP.PRIMARY,2.5,DICLOFENSINE,"DRD1, MAOA, MAOB",DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A51078674-003-01-0,
REP.PRIMARY,2.5,NEBRACETAM,CHRM1,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A51355958-003-01-9,
REP.PRIMARY,2.5,FOSINOPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-A51382177-236-03-0,
REP.PRIMARY,2.5,2-OCTYLDODECAN-1-OL,,,BRD:BRD-A51407134-001-01-9,
REP.PRIMARY,2.5,HYPOESTOXIDE,"IKBKB, IL1B, TNF",IKK INHIBITOR,BRD:BRD-A51571244-001-01-9,
REP.PRIMARY,2.5,3-CPMT,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A51713165-003-02-6,
REP.PRIMARY,2.5,VENLAFAXINE,"SLC6A2, SLC6A3, SLC6A4","ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-A51714012-003-13-6,
REP.PRIMARY,2.5,MOPROLOL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A51747092-003-03-0,
REP.PRIMARY,2.5,ECONAZOLE,"CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5","LANOSTEROL DEMETHYLASE INHIBITOR, STEROL DEMETHYLASE INHIBITOR",BRD:BRD-A51820102-008-28-9,
REP.PRIMARY,2.5,BRL-15572,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A51829654-003-07-7,
REP.PRIMARY,2.5,ENFLURANE,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4",MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-A51831848-001-01-7,
REP.PRIMARY,2.5,HALOFANTRINE,"KCNH2, KCNN4",ANTIMALARIAL AGENT,BRD:BRD-A51964809-003-12-6,
REP.PRIMARY,2.5,METHYLATROPINE-NITRATE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A52460047-001-01-3,
REP.PRIMARY,2.5,SKF-83566,"DRD1, DRD5",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A52588987-004-08-2,
REP.PRIMARY,2.5,TETRINDOLE,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A52660433-066-02-1,
REP.PRIMARY,2.5,GALLOPAMIL,ATP2A2,L-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-A52922642-001-03-7,
REP.PRIMARY,2.5,BTZ043-RACEMATE,,DPRE1 INHIBITOR,BRD:BRD-A53037217-001-02-0,
REP.PRIMARY,2.5,2-FLUORO-2-DEOXY-D-GALACTOSE,LCT,,BRD:BRD-A53037300-001-01-0,
REP.PRIMARY,2.5,RO-106-9920,,NFKB PATHWAY INHIBITOR,BRD:BRD-A53134341-001-03-2,
REP.PRIMARY,2.5,PREDNISOLONE-TEBUTATE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-A53151380-001-01-2,
REP.PRIMARY,2.5,NEO-GILURYTMAL,,,BRD:BRD-A53539450-004-01-7,
REP.PRIMARY,2.5,PIPENZOLATE,CHRM1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A53561827-004-23-1,
REP.PRIMARY,2.5,ANECORTAVE-ACETATE,,ANGIOGENESIS INHIBITOR,BRD:BRD-A53566267-001-01-9,
REP.PRIMARY,2.5,ORPHENADRINE,"GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A53576514-048-14-3,
REP.PRIMARY,2.5,PGL5001,"MAPK10, MAPK8, MAPK9",JNK INHIBITOR,BRD:BRD-A53813595-001-01-8,
REP.PRIMARY,2.5,BUTYLSCOPOLAMINE-BROMIDE,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A53951045-004-01-6,
REP.PRIMARY,2.5,PRILOCAINE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",LOCAL ANESTHETIC,BRD:BRD-A53952395-003-25-1,
REP.PRIMARY,2.5,EPHEDRINE-(RACEMIC),"ADRA1A, ADRA2A, ADRB1, ADRB2, ATF1, ATF2, ATF3, ATF4, ATF5, ATF6, ATF7, FOS, IL2, JDP2, JUN, NFATC1, SLC6A2, SLC6A3, SLC6A4, TNF",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A54236247-003-04-3,
REP.PRIMARY,2.5,LANOCONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A54275602-001-01-0,
REP.PRIMARY,2.5,PIRLINDOLE,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A54490543-066-11-9,
REP.PRIMARY,2.5,KF-38789,SELP,P SELECTIN INHIBITOR,BRD:BRD-A54927599-001-16-9,
REP.PRIMARY,2.5,SULPIRIDE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A55272860-001-14-6,
REP.PRIMARY,2.5,SULPIRIDE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A55272860-001-15-3,
REP.PRIMARY,1.24,K-STROPHANTHIDIN,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A55312468-001-04-7,
REP.PRIMARY,2.5,TESTOSTERONE,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-A55393291-001-09-9,
REP.PRIMARY,2.5,METHOTREXATE,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-A55424491-001-19-9,
REP.PRIMARY,2.5,"2-ETHYL-1,3-HEXANEDIOL",,,BRD:BRD-A55455283-001-01-3,
REP.PRIMARY,2.5,3-(4-METHYLBENZYLIDENE)CAMPHOR,,ENDOCRINE DISRUPTOR,BRD:BRD-A55464252-001-01-2,
REP.PRIMARY,2.5,MEPHENESIN,,MUSCLE RELAXANT,BRD:BRD-A55469827-001-07-4,
REP.PRIMARY,2.5,BNTX,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A55484088-050-02-5,
REP.PRIMARY,2.5,SODIUM-TETRADECYL-SULFATE,"PROC, PROS1",,BRD:BRD-A55664972-236-02-6,
REP.PRIMARY,2.5,PRIMAQUINE,"KRT7, NQO2","ANTIMALARIAL AGENT, DNA INHIBITOR",BRD:BRD-A55913614-316-09-6,
REP.PRIMARY,2.5,OMEPRAZOLE,"ATP4A, CLCN2",ATPASE INHIBITOR,BRD:BRD-A55962179-001-22-1,
REP.PRIMARY,2.5,LGX818,BRAF,RAF INHIBITOR,BRD:BRD-A56085258-001-01-8,
REP.PRIMARY,2.5,DIMERCAPROL,,CHELATING AGENT,BRD:BRD-A56152450-001-02-0,
REP.PRIMARY,2.5,ZILEUTON,ALOX5,"LEUKOTRIENE SYNTHESIS INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-A56359832-001-11-1,
REP.PRIMARY,2.5,AGI-5198,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-A56371469-001-03-3,
REP.PRIMARY,2.5,PX-12,"CNR1, TXN, TXNRD1",THIOREDOXIN INHIBITOR,BRD:BRD-A56592690-001-04-3,
REP.PRIMARY,2.5,ALTHIAZIDE,,DIURETIC,BRD:BRD-A56675431-001-12-3,
REP.PRIMARY,2.5,CEFADROXIL,"SLC15A1, SLC15A2, SLC22A6, SLC22A8",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A56858165-001-04-4,
REP.PRIMARY,2.5,SQ-22536,ADCY1,ADENYLYL CYCLASE INHIBITOR,BRD:BRD-A56987319-001-12-9,
REP.PRIMARY,2.5,CHLORCYCLIZINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A57133233-003-11-0,
REP.PRIMARY,2.5,PIROXICAM,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A57382968-001-29-0,
REP.PRIMARY,2.5,METHSUXIMIDE,"CACNA1G, CACNA1H, CACNA1I","T-TYPE CALCIUM CHANNEL BINDER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-A57592049-001-01-6,
REP.PRIMARY,2.5,PD-318088,MAP2K1,MEK INHIBITOR,BRD:BRD-A57798112-001-03-7,
REP.PRIMARY,2.5,BICUCULLINE-METHOCHLORIDE-(-),,GABA RECEPTOR ANTAGONIST,BRD:BRD-A57798559-004-02-3,
REP.PRIMARY,2.5,OXYMATRINE,,,BRD:BRD-A57833392-001-01-7,
REP.PRIMARY,2.5,GOLGICIDE-A,GBF1,ARF INHIBITOR,BRD:BRD-A57886255-001-01-1,
REP.PRIMARY,2.5,HYDRASTININE,,HAEMOSTATIC AGENT,BRD:BRD-A57900429-003-05-8,
REP.PRIMARY,2.5,CITIOLONE,,"LIPOTROPIC, MUCOLYTIC AGENT",BRD:BRD-A57957888-001-08-0,
REP.PRIMARY,2.5,NIMODIPINE,"AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A58048407-001-18-8,
REP.PRIMARY,2.5,OXYPHENCYCLIMINE,"CHRM1, CHRM2, CHRM3",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A58193911-003-18-7,
REP.PRIMARY,2.5,SELAMECTIN,,NEMATOCIDE,BRD:BRD-A58564983-001-04-6,
REP.PRIMARY,2.5,SULFORAPHANE,NFE2L2,"ANTICANCER AGENT, ARYL HYDROCARBON RECEPTOR ANTAGONIST",BRD:BRD-A58955223-001-03-8,
REP.PRIMARY,2.5,GINKGOLIDE-B,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B",PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-A59001851-001-02-1,
REP.PRIMARY,2.5,RITODRINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A59174698-003-18-5,
REP.PRIMARY,2.5,VILOXAZINE,SLC6A2,NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A59198242-003-02-9,
REP.PRIMARY,2.5,QUINETHAZONE,"CA1, CA2, SLC12A1, SLC12A2, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-A59303141-001-10-4,
REP.PRIMARY,2.5,XAMOTEROL,ADRB1,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A59337442-051-05-3,
REP.PRIMARY,2.5,DEXPANTHENOL,,,BRD:BRD-A59413292-001-08-2,
REP.PRIMARY,2.5,PHCCC,"GRM1, GRM4",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A59709458-001-01-8,
REP.PRIMARY,2.5,AMISULPRIDE,"DRD2, DRD3, HTR2A, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A60197193-001-14-6,
REP.PRIMARY,2.5,IOHEXOL,,RADIOPAQUE MEDIUM,BRD:BRD-A60217728-001-11-2,
REP.PRIMARY,2.5,8-HYDROXY-PIPAT,"DRD2, DRD3",DOPAMINE RECEPTOR LIGAND,BRD:BRD-A60594020-034-01-1,
REP.PRIMARY,2.5,SODIUM-STIBOGLUCONATE,"PTPN6, TOP1",TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-A60786380-412-01-5,
REP.PRIMARY,2.5,GLICLAZIDE,"ABCC8, VEGFA","ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE",BRD:BRD-A61154809-001-15-9,
REP.PRIMARY,2.5,BENSERAZIDE,DDC,DOPA DECARBOXYLASE INHIBITOR,BRD:BRD-A61194565-003-27-0,
REP.PRIMARY,2.5,MEDROXYPROGESTERONE-ACETATE,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-A61221616-001-04-3,
REP.PRIMARY,2.5,ELIPRODIL,"GRIN1, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A61392169-001-02-7,
REP.PRIMARY,2.5,CLIMBAZOLE,,ENZYME INDUCER,BRD:BRD-A61676498-001-06-6,
REP.PRIMARY,2.5,METOLAZONE,SLC12A3,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-A61793559-001-15-6,
REP.PRIMARY,2.5,ALPHA-TOCHOPHERYL-ACETATE,,ANTIOXIDANT,BRD:BRD-A61850409-001-10-7,
REP.PRIMARY,2.5,WAY-161503,HTR2C,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A62021152-003-03-4,
REP.PRIMARY,2.5,MDL-11939,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A62057054-001-03-1,
REP.PRIMARY,2.5,SIGUAZODAN,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A62071884-001-04-6,
REP.PRIMARY,2.5,ZM-226600,,KIR6 CHANNEL (KATP) ACTIVATOR,BRD:BRD-A62209527-001-04-5,
REP.PRIMARY,2.5,MEPENZOLATE,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A62421304-004-18-9,
REP.PRIMARY,2.5,HYDROXYZINE,HRH1,ANTIHISTAMINE,BRD:BRD-A62428732-300-06-3,
REP.PRIMARY,2.5,CORTISONE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A62731508-001-05-8,
REP.PRIMARY,2.5,MIGLITOL,"GAA, GANAB, GANC, MGAM",GLUCOSIDASE INHIBITOR,BRD:BRD-A63310107-001-04-8,
REP.PRIMARY,2.5,ME0328,PARP3,PARP INHIBITOR,BRD:BRD-A63444178-001-01-5,
REP.PRIMARY,2.5,RO-04-5595,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A63546914-003-02-0,
REP.PRIMARY,2.5,BRIVUDINE,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-A63675168-001-01-6,
REP.PRIMARY,2.5,FIDARESTAT,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A63752151-001-01-2,
REP.PRIMARY,2.5,HYPERIN,"ACE, AKR1B1",ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A63780829-001-11-4,
REP.PRIMARY,2.5,ANDROSTENONE,,STEROID,BRD:BRD-A64011898-001-01-0,
REP.PRIMARY,2.5,SANGIVAMYCIN,,DNA INHIBITOR,BRD:BRD-A64064900-001-02-3,
REP.PRIMARY,2.5,MEXILETINE,"AHR, PLAU, SCN4A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A64092382-003-18-3,
REP.PRIMARY,2.5,DEHYDROCHOLATE,,,BRD:BRD-A64125466-236-04-6,
REP.PRIMARY,2.5,SKF-77434,DRD1,DOPAMINE RECEPTOR AGONIST,BRD:BRD-A64227845-004-09-3,
REP.PRIMARY,2.5,LANATOSIDE-C,,CARDIAC GLYCOSIDE,BRD:BRD-A64242993-001-05-6,
REP.PRIMARY,2.5,TIMOFIBRATE,LPL,"CHOLESTEROL INHIBITOR, LIPASE CLEARING FACTOR INHIBITOR",BRD:BRD-A64406146-001-01-2,
REP.PRIMARY,2.68,DPI-201106,ADRB2,SODIUM CHANNEL ACTIVATOR,BRD:BRD-A64553394-001-04-4,
REP.PRIMARY,2.5,PRANOPROFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A64610707-001-04-4,
REP.PRIMARY,2.5,LEVO-PHENCYNONATE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A64698388-003-01-7,
REP.PRIMARY,2.5,ISOMETHEPTENE-MUCATE,"ADRA1A, SLC18A2",,BRD:BRD-A64743628-001-01-5,
REP.PRIMARY,2.5,AH11110,ADRA1B,ADRENERGIC RECEPTOR LIGAND,BRD:BRD-A64808605-003-02-7,
REP.PRIMARY,2.5,MIRTAZAPINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A64977602-001-15-9,
REP.PRIMARY,2.5,OXYBUTYNIN,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A65013509-003-24-4,
REP.PRIMARY,2.5,ACENOCOUMAROL,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-A65051990-001-12-9,
REP.PRIMARY,2.5,ATPA,"GRIA2, GRIK1",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A65145453-001-06-1,
REP.PRIMARY,2.5,EMD-53998,TNNC1,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A65248799-001-01-7,
REP.PRIMARY,2.5,MOLINDONE,"CHRM1, DRD2, HRH1, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A65280694-003-13-7,
REP.PRIMARY,2.5,CIMATEROL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A65440446-001-04-1,
REP.PRIMARY,2.5,FLUNISOLIDE,NR3C1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A65449987-001-10-4,
REP.PRIMARY,2.5,RX-821002,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A65597028-003-07-3,
REP.PRIMARY,2.5,ZACOPRIDE,"HTR3A, HTR3B, HTR4, HTR5A",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A65615053-003-02-2,
REP.PRIMARY,2.5,CANDESARTAN-CILEXETIL,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-A65671304-001-07-5,CANDESARTAN-CILEXTIL
REP.PRIMARY,2.5,CANDESARTAN-CILEXTIL,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-A65671304-001-07-5,CANDESARTAN-CILEXTIL
REP.PRIMARY,2.5,HYDROCORTISONE-ACETATE,"NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A65767837-001-04-4,
REP.PRIMARY,2.5,DEPTROPINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A65797496-048-09-3,
REP.PRIMARY,2.5,IOVERSOL,,RADIOPAQUE MEDIUM,BRD:BRD-A65818372-001-05-3,
REP.PRIMARY,2.5,AM-1241,"CNR1, CNR2",CANNABINOID RECEPTOR AGONIST,BRD:BRD-A66116161-001-02-3,
REP.PRIMARY,2.5,IXAZOMIB-CITRATE,,PROTEASOME INHIBITOR,BRD:BRD-A66419424-001-02-4,
REP.PRIMARY,2.5,HTMT,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-A66435872-332-01-8,
REP.PRIMARY,2.5,DIFLORASONE-DIACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A66869276-001-02-9,
REP.PRIMARY,2.5,FENIGAM,"GABBR1, GABBR2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A66920069-001-01-3,
REP.PRIMARY,2.5,NM107,,RNA POLYMERASE INHIBITOR,BRD:BRD-A66966115-001-01-0,
REP.PRIMARY,2.5,SNAP,PTPN1,NITRIC OXIDE DONOR,BRD:BRD-A67006024-001-04-8,
REP.PRIMARY,2.5,ALBENDAZOLE-OXIDE,,ANTHELMINTIC AGENT,BRD:BRD-A67060370-001-02-9,
REP.PRIMARY,2.5,IFOSFAMIDE,"CYP2A6, CYP2B6, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP3A4, CYP3A5, CYP3A7, PTGS1",DNA ALKYLATING AGENT,BRD:BRD-A67097164-001-18-7,
REP.PRIMARY,2.5,HYGROMYCIN-B,,POLYPEPTIDE SYNTHESIS INHIBITOR,BRD:BRD-A67101513-001-03-7,
REP.PRIMARY,2.5,GADOBUTROL,,RADIOPAQUE MEDIUM,BRD:BRD-A67181951-001-01-2,
REP.PRIMARY,2.5,DIHYDROSTREPTOMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A67363467-001-01-3,
REP.PRIMARY,2.5,4-P-PDOT,"MTNR1A, MTNR1B",MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-A67482312-001-02-6,
REP.PRIMARY,2.5,FURALTADONE,,BACTERIAL DNA INHIBITOR,BRD:BRD-A67514145-003-05-8,
REP.PRIMARY,2.5,LAFUTIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A67516570-001-02-8,
REP.PRIMARY,2.5,PIMONIDAZOLE,,,BRD:BRD-A67521319-001-01-6,
REP.PRIMARY,2.5,LEVOMEQUITAZINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A67616246-001-07-9,
REP.PRIMARY,2.5,K-858,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-A67748489-001-10-0,
REP.PRIMARY,2.5,NAFTIDROFURYL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A67862938-034-14-9,
REP.PRIMARY,2.5,NSC-405020,MMP1,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-A67975844-001-01-8,
REP.PRIMARY,2.5,PRANIDIPINE,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-A68083442-001-01-6,
REP.PRIMARY,0.25,REV-5901,ALOX5,"LEUKOTRIENE RECEPTOR ANTAGONIST, LIPOXYGENASE INHIBITOR",BRD:BRD-A68281735-001-18-6,
REP.PRIMARY,2.5,BTS-54505,"SLC6A2, SLC6A3, SLC6A4",DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-A68304895-003-02-2,
REP.PRIMARY,2.5,MAZINDOL,"SLC6A2, SLC6A3, SLC6A4","DOPAMINE REUPTAKE INHIBITOR, SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)",BRD:BRD-A68464583-001-02-5,
REP.PRIMARY,2.5,SIMEPREVIR,"CYP1A2, CYP3A4",HCV INHIBITOR,BRD:BRD-A68493689-001-01-9,
REP.PRIMARY,2.5,ETHYLNOREPINEPHRINE,,BRONCHODILATOR,BRD:BRD-A68509429-003-03-9,
REP.PRIMARY,2.5,TROXIPIDE,,GLUCOSAMINE SYNTHETASE STIMULANT,BRD:BRD-A68589262-001-04-3,
REP.PRIMARY,2.5,EVODIAMINE,TRPV1,"ATPASE INHIBITOR, TRPV AGONIST",BRD:BRD-A68631409-001-05-4,
REP.PRIMARY,2.5,BROMPHENIRAMINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A68723818-050-32-5,
REP.PRIMARY,2.5,AZELASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A68888262-003-15-1,
REP.PRIMARY,2.5,AMITIFADINE,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN TRANSPORTER (SERT) INHIBITOR,BRD:BRD-A68942014-003-01-7,
REP.PRIMARY,2.57,ECHINOMYCIN,,DNA INTERCALATING AGENT,BRD:BRD-A68969091-001-12-7,
REP.PRIMARY,2.5,PINITOL,,GAMMA SECRETASE INHIBITOR,BRD:BRD-A69275535-001-01-5,
REP.PRIMARY,2.5,DILTIAZEM,"CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5",CALCIUM CHANNEL BLOCKER,BRD:BRD-A69636825-003-04-7,
REP.PRIMARY,2.5,MINOCYCLINE,"ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA",BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A69651145-003-07-2,
REP.PRIMARY,2.5,FLUMEQUINE,,TOPOISOMERASE INHIBITOR,BRD:BRD-A69777949-001-24-2,
REP.PRIMARY,2.5,CYCLOSPORIN-A,PPP3CA,CALCINEURIN INHIBITOR,BRD:BRD-A69815203-001-07-6,
REP.PRIMARY,2.5,AMINOPENTAMIDE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A69917777-065-02-2,
REP.PRIMARY,2.5,SECNIDAZOLE,,"ACETYLCHOLINESTERASE INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-A70083328-001-23-5,
REP.PRIMARY,2.5,SECNIDAZOLE,,"ACETYLCHOLINESTERASE INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-A70083328-001-24-3,
REP.PRIMARY,2.5,PG-9,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A70268693-050-01-2,
REP.PRIMARY,2.5,PSB-36,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A70407468-001-02-0,
REP.PRIMARY,2.5,ARTICAINE,,LOCAL ANESTHETIC,BRD:BRD-A70514680-003-11-2,
REP.PRIMARY,2.5,SULCONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A70649075-008-30-8,
REP.PRIMARY,2.5,ESTRAMUSTINE,"ESR1, ESR2, MAP1A, MAP2",DNA ALKYLATING AGENT,BRD:BRD-A70858459-001-01-7,
REP.PRIMARY,2.5,PINAVERIUM,CACNA1C,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-A70998768-004-01-1,
REP.PRIMARY,2.5,FENDILINE,HTR2B,CALCIUM CHANNEL BLOCKER,BRD:BRD-A71033472-003-23-9,
REP.PRIMARY,2.5,FURSULTIAMINE,,VITAMIN B,BRD:BRD-A71157293-003-10-0,
REP.PRIMARY,2.5,NAFADOTRIDE,"DRD2, DRD3, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A71262238-001-08-4,
REP.PRIMARY,2.5,INIMUR,,OTHER ANTIFUNGAL,BRD:BRD-A71407503-001-01-8,
REP.PRIMARY,2.5,METOXIBUTROPATE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A71725768-001-01-3,
REP.PRIMARY,2.5,LUFENURON,,CHITIN INHIBITOR,BRD:BRD-A71774530-001-05-9,
REP.PRIMARY,2.5,MIFOBATE,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-A72066420-001-04-5,
REP.PRIMARY,2.5,EPRAZINONE,,MUCOLYTIC AGENT,BRD:BRD-A72212290-300-01-4,
REP.PRIMARY,2.5,METERGOLINE,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A72309220-001-04-1,
REP.PRIMARY,2.5,CHOLINE-ALFOSCERATE,GM2A,ACETYLCHOLINE PRECURSOR,BRD:BRD-A72390365-001-15-2,
REP.PRIMARY,2.5,SPIROXATRINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A72483914-001-03-7,
REP.PRIMARY,2.5,SKF-96365,"CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A72703248-003-04-9,
REP.PRIMARY,2.5,LASALOCID,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A72711497-236-03-8,
REP.PRIMARY,0.91,PERUVOSIDE,,CARDIAC GLYCOSIDE,BRD:BRD-A72716251-001-01-5,
REP.PRIMARY,2.5,NALMEFENE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A72767275-003-01-6,
REP.PRIMARY,2.5,FEXOFENADINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A73368467-003-17-6,
REP.PRIMARY,2.5,ADAPREV,"AKR1B1, GPI, HK1, IGF2R, M6PR, PYGM",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-A73427433-240-01-3,
REP.PRIMARY,2.5,TAGATOSE,PYGL,PHOSPHORYLASE INHIBITOR,BRD:BRD-A73556557-001-06-4,
REP.PRIMARY,2.5,LB-100,,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-A73709786-001-01-3,
REP.PRIMARY,2.5,NANCHANGMYCIN,,OTHER ANTIBIOTIC,BRD:BRD-A73871920-236-03-6,
REP.PRIMARY,2.5,EX-527,SIRT1,SIRT INHIBITOR,BRD:BRD-A73908300-001-06-7,
REP.PRIMARY,2.5,5-HYDROXYTRYPTOPHAN,"SLC36A1, SLC36A2",NEUROTRANSMITTER,BRD:BRD-A73930134-001-03-0,
REP.PRIMARY,2.5,CGP-54626,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A74208568-003-01-5,
REP.PRIMARY,2.5,PMPA,FOLH1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A74387232-001-02-5,
REP.PRIMARY,2.5,IBUTILIDE,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A74391928-051-01-3,
REP.PRIMARY,2.64,IBUTILIDE,"CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6",POTASSIUM CHANNEL BLOCKER,BRD:BRD-A74391928-051-02-1,
REP.PRIMARY,2.5,ETODOLAC,"PTGS1, PTGS2, RXRA",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A74667430-001-23-6,
REP.PRIMARY,2.5,ESTRADIOL-BENZOATE,ESR1,CONTRACEPTIVE AGENT,BRD:BRD-A74765037-001-01-1,
REP.PRIMARY,2.5,PRALATREXATE,"DHFR, TYMS",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-A74914197-001-02-9,
REP.PRIMARY,2.5,HOMATROPINE,"CES1, CHRM1",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A74975734-004-10-7,
REP.PRIMARY,2.5,GATIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A74980173-001-11-9,
REP.PRIMARY,2.5,"ISOQUINOLINE,-6,7-DIMETHOXY-1-METHYL-1,2,3,4-TETRAHYDRO,",,,BRD:BRD-A75140635-003-10-9,
REP.PRIMARY,2.5,ANIDULAFUNGIN,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-A75305484-001-01-3,
REP.PRIMARY,2.5,VITAMIN-B12,,,BRD:BRD-A75369945-001-01-2,
REP.PRIMARY,2.5,RIMANTADINE,,"ANTIVIRAL, RNA SYNTHESIS INHIBITOR",BRD:BRD-A75479906-001-02-4,
REP.PRIMARY,2.5,ISOXICAM,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A75552914-001-15-0,
REP.PRIMARY,2.5,CLENBUTEROL,"ADRB1, ADRB2, ADRB3, NGF, TNF",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A75726477-003-21-3,
REP.PRIMARY,2.5,SDM25N,OPRD1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-A75769826-003-02-1,
REP.PRIMARY,2.5,BLEBBISTATIN-(+/-),"MYH14, MYH2",ATPASE INHIBITOR,BRD:BRD-A75817871-001-06-7,
REP.PRIMARY,2.5,LOMEFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A75850590-213-01-0,
REP.PRIMARY,2.5,LEUCOVORIN,TYMS,FOLATE RECEPTOR LIGAND,BRD:BRD-A75919782-399-02-6,
REP.PRIMARY,2.5,CLINDAMYCIN-PALMITATE,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A76672327-003-02-0,
REP.PRIMARY,2.5,SYM-2206,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A77218119-001-03-5,
REP.PRIMARY,2.5,CYCLOPENTOLATE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A77291778-003-22-0,
REP.PRIMARY,2.5,PALMITOYLCARNITINE,,PROTEIN KINASE INHIBITOR,BRD:BRD-A77577770-003-08-9,
REP.PRIMARY,2.5,MRS-1845,,CALCIUM CHANNEL BLOCKER,BRD:BRD-A78093359-001-06-3,MRS1845
REP.PRIMARY,2.5,MRS1845,,CALCIUM CHANNEL BLOCKER,BRD:BRD-A78093359-001-06-3,MRS1845
REP.PRIMARY,2.5,IMEXON,"RRM1, RRM2","APOPTOSIS STIMULANT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-A78195072-001-06-2,
REP.PRIMARY,2.5,DOBUTAMINE,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A78322124-003-14-0,
REP.PRIMARY,2.5,REGADENOSON,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-A78341343-001-01-6,
REP.PRIMARY,2.5,MONASTROL,KIF11,KINESIN INHIBITOR,BRD:BRD-A78377521-001-05-5,
REP.PRIMARY,2.5,PREDNISOLONE-HEMISUCCINATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A78391468-001-02-8,
REP.PRIMARY,2.5,EDITOL,,,BRD:BRD-A78588743-001-03-4,
REP.PRIMARY,2.5,CEFOTETAN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A78723049-001-01-2,
REP.PRIMARY,2.5,NEFOPAM,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A78877355-001-03-0,
REP.PRIMARY,2.5,A740003,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A78952587-001-01-5,
REP.PRIMARY,2.5,3-DEAZAADENOSINE,AHCY,ADENOSYLHOMOCYSTEINASE INHIBITOR,BRD:BRD-A79431551-001-01-1,
REP.PRIMARY,2.5,TROPICAMIDE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A79672927-001-20-7,
REP.PRIMARY,2.5,SIROLIMUS,"FGF2, FKBP1A, MTOR",MTOR INHIBITOR,BRD:BRD-A79768653-001-12-0,
REP.PRIMARY,2.5,MEMANTINE,"CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A79803969-003-16-1,
REP.PRIMARY,2.5,MIDODRINE,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A79981887-003-16-4,
REP.PRIMARY,2.5,BENDROFLUMETHIAZIDE,"CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-A80017228-001-25-7,
REP.PRIMARY,2.5,NSC-23766,,RAS GTPASE INHIBITOR,BRD:BRD-A80213327-305-08-3,
REP.PRIMARY,2.5,HYDROXYAMPHETAMINE,TAAR1,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-A80871782-004-06-9,
REP.PRIMARY,2.5,CLOPERASTINE,,ANTITUSSIVE,BRD:BRD-A80908310-003-13-8,
REP.PRIMARY,2.5,FENOPROFEN,"PTGS1, PTGS2, SLC5A8",PROSTAGLANDIN INHIBITOR,BRD:BRD-A81129465-001-03-8,
REP.PRIMARY,2.5,GLYCOPYRROLATE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A81233518-004-16-1,
REP.PRIMARY,2.5,BI-D1870,"RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6",RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-A81370665-001-03-6,
REP.PRIMARY,2.5,SAXAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A81513827-001-03-6,
REP.PRIMARY,2.5,OLIGOMYCIN-A,ATP5A1,"ATP SYNTHASE INHIBITOR, ATPASE INHIBITOR",BRD:BRD-A81541225-001-06-8,
REP.PRIMARY,2.5,FENCLONINE-(+/-),"PAH, TPH1, TPH2",TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-A81615860-003-01-7,
REP.PRIMARY,2.5,TOLVAPTAN,"AVPR1A, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-A82035391-001-02-7,
REP.PRIMARY,2.5,MICONAZOLE,"KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A82396632-008-29-0,
REP.PRIMARY,2.5,TIBOLONE,ESR1,"ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST, PROGESTERONE RECEPTOR AGONIST",BRD:BRD-A82522119-001-01-7,
REP.PRIMARY,2.5,MEPAZINE,MALT1,MALT1 INHIBITOR (JH),BRD:BRD-A82772293-001-03-2,
REP.PRIMARY,2.5,PRASUGREL,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A83029242-001-05-3,
REP.PRIMARY,2.5,ARDEPARIN,"SERPINC1, SERPIND1",THROMBIN INHIBITOR,BRD:BRD-A83644949-236-01-6,
REP.PRIMARY,2.5,A61603,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A83650191-004-02-8,
REP.PRIMARY,2.5,DEXAMETHASONE-SODIUM-PHOSPHATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A83802939-304-04-2,
REP.PRIMARY,2.5,MEPHENYTOIN,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-A83937277-001-10-5,
REP.PRIMARY,2.5,MELOXICAM,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A84174393-236-07-1,
REP.PRIMARY,2.5,"TROPANYL-3,5-DIMETHYLBENZOATE","HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A84389633-001-05-7,
REP.PRIMARY,2.5,THIORIDAZINE,"ADRA1A, ADRA1B, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCNH2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A84481105-003-31-3,
REP.PRIMARY,2.5,PIMOBENDAN,PDE3A,"CALCIUM SENSITIZER, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-A84575140-001-02-4,
REP.PRIMARY,2.5,NILVADIPINE,"CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A84687895-001-03-2,
REP.PRIMARY,2.5,ALCURONIUM,"CHRM1, CHRM2, CHRM3, CHRM4, CHRNA7",MUSCLE RELAXANT,BRD:BRD-A84907376-300-03-8,
REP.PRIMARY,2.5,NCS-382,"GABBR1, GABBR2, SLC52A2",GABA RECEPTOR ANTAGONIST,BRD:BRD-A85025557-001-02-5,
REP.PRIMARY,2.5,3-ALPHA-BIS-(4-FLUOROPHENYL)-METHOXYTROPANE,"CHRM1, SLC6A2, SLC6A3, SLC6A4",DOPAMINE UPTAKE INHIBITOR,BRD:BRD-A85216385-003-02-4,
REP.PRIMARY,2.5,ASCORBIC-ACID,"ALKBH2, ALKBH3, BBOX1, DBH, EGLN1, EGLN2, EGLN3, KDM5D, LCT, OGFOD1, OGFOD2, P3H1, P3H2, P3H3, P4HA1, P4HTM, PAM, PHYH, PLOD1, PLOD2, PLOD3, SLC23A1, SLC23A2, TMLHE",ANTIOXIDANT,BRD:BRD-A85242401-001-12-3,
REP.PRIMARY,2.5,L-670596,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A85472596-001-02-2,
REP.PRIMARY,2.5,PIKETOPROFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A85548292-001-01-8,
REP.PRIMARY,2.5,BEMESETRON,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A85587465-001-03-3,
REP.PRIMARY,2.5,CLOPAMIDE,,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-A85651701-001-19-7,
REP.PRIMARY,2.5,FULVESTRANT,"ESR1, ESR2, GPER1",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-A85667082-001-12-7,
REP.PRIMARY,2.5,NIBENTAN,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-A85876464-001-01-5,
REP.PRIMARY,2.5,FLURBIPROFEN-(+/-),"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A86044036-001-26-5,
REP.PRIMARY,2.5,VARENICLINE,"CHRNA3, CHRNA4, CHRNA6, CHRNA7",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A86216746-046-02-6,
REP.PRIMARY,2.5,TETRAHYDROURIDINE,CDA,CYTIDINE DEAMINASE INHIBITOR,BRD:BRD-A86248581-001-01-4,
REP.PRIMARY,2.5,L-(+)-RHAMNOSE-MONOHYDRATE,,,BRD:BRD-A86354194-002-01-7,
REP.PRIMARY,2.5,RACTOPAMINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A86414188-003-01-5,
REP.PRIMARY,2.5,"1-(1,2-DIPHENYLETHYL)PIPERIDINE-(+/-)",,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A86415025-050-01-0,
REP.PRIMARY,2.5,ANDROGRAPHOLIDE,NFKB1,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-A86619021-001-04-8,
REP.PRIMARY,2.5,NICARAVEN,,FREE RADICAL SCAVENGER,BRD:BRD-A86871940-001-01-9,
REP.PRIMARY,2.5,MASOPROCOL,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-A87130939-001-07-9,
REP.PRIMARY,2.5,AZD7545,PDK1,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-A87435144-001-01-6,
REP.PRIMARY,2.5,TENIDAP,"KCNJ4, PTGS1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A87479750-001-02-7,
REP.PRIMARY,2.5,MOGUISTEINE,,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,BRD:BRD-A87673115-001-04-1,
REP.PRIMARY,2.5,PRONETHALOL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A87715314-003-14-4,
REP.PRIMARY,2.5,BENZOTRIPT,"CCKAR, CCKBR",CCK RECEPTOR ANTAGONIST,BRD:BRD-A87983072-001-01-1,
REP.PRIMARY,2.5,EQUILIN,HSD17B1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A88080608-001-04-2,
REP.PRIMARY,2.5,HALCINONIDE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A88138582-001-04-8,
REP.PRIMARY,2.5,TRELAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A88369366-001-01-7,
REP.PRIMARY,2.5,SKF-38393,"CALY, DRD1, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-A88548664-004-02-7,
REP.PRIMARY,2.5,BUCETIN,,ANALGESIC AGENT,BRD:BRD-A88684804-001-04-3,
REP.PRIMARY,2.5,SORBINIL,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A89164055-001-03-3,
REP.PRIMARY,2.5,BISOPROLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A89175223-051-14-8,
REP.PRIMARY,2.5,DALARGIN,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-A89196962-300-01-7,
REP.PRIMARY,2.5,PD-102807,CHRM4,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A89337244-001-02-9,
REP.PRIMARY,2.5,MEFLOQUINE,"ADORA2A, HBA1","ADENOSINE RECEPTOR ANTAGONIST, HEMOGLOBIN ANTAGONIST",BRD:BRD-A89585551-003-16-6,
REP.PRIMARY,2.5,CARNITINE-(D/L),,,BRD:BRD-A89594340-003-11-5,
REP.PRIMARY,2.5,CGP-55845,"GABBR1, GABBR2, KCTD12, KCTD16, KCTD8",GABA RECEPTOR ANTAGONIST,BRD:BRD-A89672324-001-03-0,
REP.PRIMARY,2.5,CGP-37849,"GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A90272038-001-01-7,
REP.PRIMARY,2.5,GUAIFENESIN,,EXPECTORANT,BRD:BRD-A90515964-001-16-5,
REP.PRIMARY,2.5,EPTIFIBATIDE,"ITGA2B, ITGB3",PLATELET AGGREGATION INHIBITOR,BRD:BRD-A90547603-001-02-5,
REP.PRIMARY,2.5,LORNOXICAM,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A90551241-001-10-8,
REP.PRIMARY,2.5,CLINOFIBRATE,LPL,LIPASE CLEARING FACTOR INHIBITOR,BRD:BRD-A90625545-001-02-0,
REP.PRIMARY,2.5,MANIDIPINE,"CACNA1C, CACNA1D",CALCIUM CHANNEL BLOCKER,BRD:BRD-A90695733-001-07-4,
REP.PRIMARY,2.5,ISRADIPINE,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2",CALCIUM CHANNEL BLOCKER,BRD:BRD-A90799790-001-19-9,
REP.PRIMARY,2.5,ADRAFINIL,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A90926615-001-01-9,
REP.PRIMARY,2.5,BEPRIDIL,"ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A91008255-003-24-8,
REP.PRIMARY,2.5,EPRINOMECTIN,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A91366704-001-01-9,
REP.PRIMARY,2.5,ESTRADIOL-CYPIONATE,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A91452556-001-04-0,
REP.PRIMARY,2.5,CHLOROQUINE,"GSTA2, MRGPRX1, TLR9, TNF",ANTIMALARIAL AGENT,BRD:BRD-A91699651-316-10-9,
REP.PRIMARY,2.5,CAMYLOFINE-CHLORHYDRATE,,,BRD:BRD-A91733352-300-04-5,
REP.PRIMARY,2.5,PICROTIN,"GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-A91822151-001-05-0,
REP.PRIMARY,2.5,TETRAHYDROPAPAVERINE,,,BRD:BRD-A91831168-003-02-5,
REP.PRIMARY,2.5,SHIKIMIC-ACID,,,BRD:BRD-A92096630-001-02-8,
REP.PRIMARY,2.5,TRIAMCINOLONE-ACETONIDE,NR3C1,"GLUCOCORTICOID RECEPTOR AGONIST, IMMUNOSUPPRESSANT",BRD:BRD-A92439610-001-05-7,
REP.PRIMARY,2.5,DANAZOL,"AR, CCL2, ESR1, GNRHR, GNRHR2, PGR","ESTROGEN RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST",BRD:BRD-A92537424-001-04-7,
REP.PRIMARY,2.5,TRIMEBUTINE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-A92630576-050-24-1,
REP.PRIMARY,2.5,TOCAINIDE,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-A92670106-003-05-4,
REP.PRIMARY,2.5,TIE2-KINASE-INHIBITOR,"KDR, MAPK14",TIE TYROSINE KINASE INHIBITOR,BRD:BRD-A92800748-001-05-5,
REP.PRIMARY,2.5,LUPANINE,INS,SODIUM CHANNEL BLOCKER,BRD:BRD-A92826379-001-01-5,
REP.PRIMARY,2.5,N-ACETYLMANNOSAMINE,CHIT1,,BRD:BRD-A92872453-001-01-8,
REP.PRIMARY,2.5,SM-21,PGRMC1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-A92933783-050-01-6,
REP.PRIMARY,2.5,CIGLITAZONE,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A93000692-001-08-1,
REP.PRIMARY,2.5,TEMAZEPAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-A93093700-001-02-9,
REP.PRIMARY,2.5,DIGITOXIN,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A93236127-001-04-5,
REP.PRIMARY,2.5,THALIDOMIDE,"CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF",TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-A93255169-001-28-3,
REP.PRIMARY,2.5,ISOCONAZOLE,CYP17A1,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-A93353767-008-02-2,
REP.PRIMARY,2.5,ALLOPURINOL-RIBOSIDE,,"ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR",BRD:BRD-A93407926-001-01-1,
REP.PRIMARY,2.5,PETCM,CASP3,CASPASE ACTIVATOR,BRD:BRD-A93477898-001-04-2,
REP.PRIMARY,2.47,NICOTINE,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A93695607-322-02-5,
REP.PRIMARY,2.5,SODIUM-DANSHENSU,,,BRD:BRD-A93699261-236-03-4,
REP.PRIMARY,2.5,CLINAFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A93964801-003-03-3,
REP.PRIMARY,2.5,TELITHROMYCIN,"CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7","BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",BRD:BRD-A94008949-001-01-9,
REP.PRIMARY,2.5,AZD6765,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A94033181-001-01-4,
REP.PRIMARY,2.5,TALINOLOL,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A94276798-001-01-4,
REP.PRIMARY,2.5,KI16198,LPA,LIPOPROTEIN ANTAGONIST,BRD:BRD-A94323479-001-02-8,
REP.PRIMARY,2.5,PREDNISOLONE-SODIUM-PHOSPHATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A94523291-304-02-7,
REP.PRIMARY,2.5,BIFONAZOLE,CYP2B6,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A94543220-001-24-7,
REP.PRIMARY,2.5,BUCLADESINE,PRKACA,"ADENOSINE RECEPTOR AGONIST, CAMP STIMULANT",BRD:BRD-A94624445-236-17-0,
REP.PRIMARY,2.5,METAXALONE,,MUSCLE RELAXANT,BRD:BRD-A94709349-001-08-3,
REP.PRIMARY,2.5,DIGOXIN,ATP1A1,ATPASE INHIBITOR,BRD:BRD-A94756469-001-04-7,
REP.PRIMARY,2.5,VILDAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A94993966-001-04-4,
REP.PRIMARY,2.63,VILDAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-A94993966-001-05-1,
REP.PRIMARY,2.5,GINKGOLIDE-A,"GLRA1, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-A95121829-001-08-9,
REP.PRIMARY,2.5,METHYCLOTHIAZIDE,"CA1, CA2, CA4, SLC12A1, SLC12A3",CHLORIDE REABSORPTION INHIBITOR,BRD:BRD-A95340155-001-09-7,
REP.PRIMARY,2.5,CELIPROLOL,"ADRA2A, ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A95602221-003-02-1,
REP.PRIMARY,2.5,NISOXETINE,"SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-A95696066-003-13-8,
REP.PRIMARY,2.5,TALAROZOLE,CYP26A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-A95755460-001-01-3,
REP.PRIMARY,2.5,INDAPAMIDE,"CA2, HTR3A, KCNE1, KCNQ1, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-A95869247-001-26-9,
REP.PRIMARY,2.5,COLFOSCERIL-PALMITATE,,PULMONARY SURFACTANT,BRD:BRD-A95886749-001-03-5,
REP.PRIMARY,2.5,SERTACONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-A95939040-001-01-2,
REP.PRIMARY,2.5,EFLORNITHINE,"ARG2, ODC1",ORNITHINE DECARBOXYLASE INHIBITOR,BRD:BRD-A96292436-003-16-1,
REP.PRIMARY,2.5,ALLANTOIN,,COSMETIC,BRD:BRD-A96407378-001-15-1,
REP.PRIMARY,2.5,FPL-55712,,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-A96456596-001-02-2,
REP.PRIMARY,2.5,EBPC,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A96485169-001-14-3,
REP.PRIMARY,2.5,ISOSTEVIOL,,,BRD:BRD-A96529864-001-01-3,
REP.PRIMARY,2.5,M-14157,KCNQ1,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-A96977263-001-03-7,
REP.PRIMARY,2.5,FENOTEROL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A97104540-004-15-0,
REP.PRIMARY,2.5,ROSIGLITAZONE,"ACSL4, FFAR1, PPARG, TRPC5, TRPM3","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-A97437073-050-14-5,
REP.PRIMARY,2.5,PIPERIDOLATE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A97479839-003-13-3,
REP.PRIMARY,2.5,RANOLAZINE,"SCN10A, SCN4A, SCN5A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-A97674275-001-11-8,
REP.PRIMARY,2.5,PINDOLOL,"ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A97701745-001-16-0,
REP.PRIMARY,2.5,HEXYLCAINE,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-A97730597-003-11-5,
REP.PRIMARY,2.5,KETOPROFEN,"CXCR1, PTGS1, PTGS2, SLC5A8",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A97739905-001-26-5,
REP.PRIMARY,2.5,CHLORALOSE,,,BRD:BRD-A98174560-001-02-1,
REP.PRIMARY,2.5,"HYDROXYTACRINE-MALEATE-(R,S)",ACHE,CHOLINESTERASE INHIBITOR,BRD:BRD-A98299281-050-09-6,
REP.PRIMARY,2.5,TALNIFLUMATE,CLCA1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A98378129-001-02-2,
REP.PRIMARY,2.5,DESVENLAFAXINE,"SLC6A2, SLC6A3, SLC6A4",SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI),BRD:BRD-A98845662-036-03-7,
REP.PRIMARY,2.5,EPINASTINE,"ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A98990573-003-01-3,
REP.PRIMARY,2.5,HYDROXYCHLOROQUINE,"TLR7, TLR9",ANTIMALARIAL AGENT,BRD:BRD-A99117172-065-04-0,
REP.PRIMARY,2.5,METIPRANOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A99388803-001-01-5,
REP.PRIMARY,2.5,ETHOSUXIMIDE,"CACNA1G, CACNA1H, CACNA1I",SUCCINIMIDE ANTIEPILEPTIC,BRD:BRD-A99633051-001-07-0,
REP.PRIMARY,2.5,BETHANECHOL,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A99833829-003-27-1,
REP.PRIMARY,2.38,PALIPERIDONE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A99888680-001-03-8,
REP.PRIMARY,2.5,PALIPERIDONE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A99888680-001-04-6,
REP.PRIMARY,2.5,CARISOPRODOL,CYP2C19,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A99939097-001-24-2,
REP.PRIMARY,2.5,ESTRAMUSTINE-PHOSPHATE,"ESR1, ESR2, MAP1A, MAP2","DNA SYNTHESIS INHIBITOR, MICROTUBULE INHIBITOR",BRD:BRD-K00077635-304-01-2,
REP.PRIMARY,2.5,RWJ-21757,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K00091711-001-01-2,
REP.PRIMARY,2.5,ADAROTENE,"RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K00152668-001-01-5,
REP.PRIMARY,2.5,COLCHICINE,"GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",MICROTUBULE INHIBITOR,BRD:BRD-K00259736-001-16-4,
REP.PRIMARY,2.5,PPT,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K00312224-001-09-5,
REP.PRIMARY,2.4000000000000004,RITA,MDM2,MDM INHIBITOR,BRD:BRD-K00317371-001-06-1,
REP.PRIMARY,2.5,NU-7441,PRKDC,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K00337317-001-06-6,
REP.PRIMARY,2.5,PHLOROGLUCIN,,,BRD:BRD-K00405906-001-01-9,
REP.PRIMARY,2.5,RO-08-2750,"NGF, NGFR",NGF BINDING INHIBITOR,BRD:BRD-K00486786-001-02-2,
REP.PRIMARY,2.5,TROVAFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K00494077-066-01-9,
REP.PRIMARY,2.39,PERAMIVIR,,NEURAMINIDASE INHIBITOR,BRD:BRD-K00519864-341-03-3,
REP.PRIMARY,2.5,ATN-161,"ITGA5, ITGAV, ITGB1, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K00521308-019-01-9,
REP.PRIMARY,2.5,9-AMINOACRIDINE,,,BRD:BRD-K00535541-001-05-5,
REP.PRIMARY,2.5,9-AMINOACRIDINE,,,BRD:BRD-K00535541-001-06-3,
REP.PRIMARY,2.5,DELAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00573984-003-01-5,
REP.PRIMARY,2.5,TICLOPIDINE,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00603606-003-24-0,
REP.PRIMARY,2.5,ALTANSERIN,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00610438-003-02-5,
REP.PRIMARY,2.5,AG-14361,PARP1,PARP INHIBITOR,BRD:BRD-K00615600-001-12-9,
REP.PRIMARY,2.5,TUBASTATIN-A,HDAC6,HDAC INHIBITOR,BRD:BRD-K00627859-003-03-7,
REP.PRIMARY,2.5,CL-218872,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K00662280-001-09-4,
REP.PRIMARY,2.5,FAMOTIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00673382-001-18-9,
REP.PRIMARY,2.5,ORTERONEL,CYP17A1,"ANDROGEN BIOSYNTHESIS INHIBITOR, ANDROGEN RECEPTOR ANTAGONIST, CYTOCHROME P450 INHIBITOR",BRD:BRD-K00674894-001-01-4,
REP.PRIMARY,2.5,BREXPIPRAZOLE,DRD2,DOPAMINE RECEPTOR PARTIAL AGONIST,BRD:BRD-K00911143-001-01-9,
REP.PRIMARY,2.5,D-PHENYLALANINE,"CCBL1, CRH, HCAR3",ENKEPHALINASE INHIBITOR,BRD:BRD-K00911807-003-01-2,
REP.PRIMARY,2.5,IMREG-1,,,BRD:BRD-K00926464-001-01-8,
REP.PRIMARY,2.5,SULFAMETHOXYPYRIDAZINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K00938507-001-17-8,
REP.PRIMARY,2.52,CHROMIUM-PICOLINATE,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-01-4,PICOLINIC-ACID
REP.PRIMARY,2.52,PICOLINIC-ACID,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-01-4,PICOLINIC-ACID
REP.PRIMARY,2.5,SOFALCONE,CBR1,MUCUS PROTECTING AGENT,BRD:BRD-K01039503-001-01-2,
REP.PRIMARY,2.5,FINASTERIDE,"AKR1D1, SRD5A1, SRD5A2",5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K01095011-001-15-9,
REP.PRIMARY,2.5,NITISINONE,HPD,HYDROXYPHENYLPYRUVATE DIOXYGENASE INHIBITOR,BRD:BRD-K01109406-001-03-7,
REP.PRIMARY,2.5,ANAMORELIN,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K01174345-001-01-9,
REP.PRIMARY,2.5,CLOXACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K01244426-236-12-1,
REP.PRIMARY,2.5,PIMOZIDE,"CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K01292756-001-25-0,
REP.PRIMARY,2.5,SUCROSE-OCTAACETATE,,,BRD:BRD-K01294196-001-01-5,
REP.PRIMARY,2.5,URIC-ACID,PYGL,,BRD:BRD-K01295354-001-02-8,
REP.PRIMARY,2.5,CZC24832,PIK3CG,PI3K INHIBITOR,BRD:BRD-K01377300-001-01-1,
REP.PRIMARY,2.5,APIGENIN,"AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1","CASEIN KINASE INHIBITOR, CELL PROLIFERATION INHIBITOR",BRD:BRD-K01493881-001-29-4,
REP.PRIMARY,2.5,RIFAMPIN,"NR1I2, SLCO1A2, SLCO1B1, SLCO1B3",RNA POLYMERASE INHIBITOR,BRD:BRD-K01507359-001-22-9,
REP.PRIMARY,2.5,PYRAZOLANTHRONE,"MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK",JNK INHIBITOR,BRD:BRD-K01567962-001-23-0,
REP.PRIMARY,2.5,ADENOSINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, PI4K2A, PI4K2B, TRPM4",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K01577834-001-15-1,
REP.PRIMARY,2.5,DIHYDROMYRICETIN,,,BRD:BRD-K01614093-001-02-6,
REP.PRIMARY,2.5,MALTOBIONIC-ACID,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K01624185-001-05-7,
REP.PRIMARY,2.5,INDATRALINE,"MAOA, MAOB",NOREPINEPHRINE TRANSPORTER INHIBITOR,BRD:BRD-K01649396-003-07-1,
REP.PRIMARY,2.5,CHLORINDANOL,,,BRD:BRD-K01653460-001-01-1,
REP.PRIMARY,2.5,DIPHENIDOL,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K01663662-003-20-2,
REP.PRIMARY,2.5,TRIAPINE,"RRM1, RRM2",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K01669786-001-02-2,
REP.PRIMARY,2.5,HISTAMINE,"HRH1, HRH2, HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K01674964-300-06-3,
REP.PRIMARY,2.5,TAK-901,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K01683783-001-02-6,
REP.PRIMARY,2.5,CIPROXIFAN,"ADRA2A, ADRA2C, HRH3, HRH4, HTR3A",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K01767299-050-02-1,
REP.PRIMARY,2.59,UNC2250,MERTK,MER TYROSINE KINASE INHIBITOR,BRD:BRD-K01773560-001-02-4,
REP.PRIMARY,2.5,INDOLE-3-CARBINOL,AHR,"ARYL HYDROCARBON RECEPTOR AGONIST, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K01815685-001-15-5,
REP.PRIMARY,2.5,DPCPX,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K01824921-001-18-5,
REP.PRIMARY,2.5,RS-23597-190,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K01868942-003-02-7,
REP.PRIMARY,2.5,PIRINIXIC-ACID,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K01902415-001-11-7,
REP.PRIMARY,2.5,OXOTREMORINE-M,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K01942991-005-08-2,
REP.PRIMARY,2.5,SUCCINYLSULFATHIAZOLE,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K01950558-001-14-7,
REP.PRIMARY,2.5,GUVACINE,"SLC6A1, SLC6A11, SLC6A12, SLC6A13",GABA UPTAKE INHIBITOR,BRD:BRD-K01980392-003-11-6,
REP.PRIMARY,2.5,AMG-9810,TRPV1,TRPV ANTAGONIST,BRD:BRD-K01995783-001-01-6,
REP.PRIMARY,2.5,NVP-BSK805,JAK2,JAK INHIBITOR,BRD:BRD-K02017404-300-06-2,
REP.PRIMARY,2.5,OXATOMIDE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K02079473-001-01-3,
REP.PRIMARY,2.5,OLAPARIB,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K02113016-001-15-4,
REP.PRIMARY,2.5,JNJ-38877605,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K02123250-001-06-7,
REP.PRIMARY,2.5,PANOBINOSTAT,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K02130563-001-11-4,
REP.PRIMARY,2.5,CHIR-124,CHEK1,CHK INHIBITOR,BRD:BRD-K02241333-001-02-7,
REP.PRIMARY,2.5,AMOXAPINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K02265150-001-26-5,
REP.PRIMARY,2.5,CEFOPERAZONE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02292852-001-02-1,
REP.PRIMARY,2.5,EPITIOSTANOL,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K02314383-001-01-3,
REP.PRIMARY,2.5,RG2833,"HDAC1, HDAC3",HDAC INHIBITOR,BRD:BRD-K02389548-001-02-5,
REP.PRIMARY,2.5,CAFFEINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3","ADENOSINE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K02404261-001-16-7,
REP.PRIMARY,2.5,PARBENDAZOLE,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K02407574-001-09-7,
REP.PRIMARY,2.5,ETHYL-PARABEN,,,BRD:BRD-K02464583-001-02-2,
REP.PRIMARY,2.5,ETHOPABATE,,ANTIPROTOZOAL AGENT,BRD:BRD-K02475039-001-01-0,
REP.PRIMARY,2.5,S18986,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K02501528-001-01-1,
REP.PRIMARY,2.5,SULFANILAMIDE,"CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K02594908-001-16-4,
REP.PRIMARY,2.5,CELECOXIB,"CA12, PDPK1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K02637541-001-18-0,
REP.PRIMARY,2.5,GEDUNIN,HSP90AA1,HSP INHIBITOR,BRD:BRD-K02703275-001-07-5,
REP.PRIMARY,2.5,"HYDRASTINE-(1R,-9S)",,TYROSINE HYDROXYLASE INHIBITOR,BRD:BRD-K02715688-001-02-1,"HYDRASTINE-(1R,9S)"
REP.PRIMARY,2.5,"HYDRASTINE-(1R,9S)",,TYROSINE HYDROXYLASE INHIBITOR,BRD:BRD-K02715688-001-02-1,"HYDRASTINE-(1R,9S)"
REP.PRIMARY,2.5,CEFUROXIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02733959-236-07-7,
REP.PRIMARY,2.5,METHIAZOLE,,ANTHELMINTIC AGENT,BRD:BRD-K02764365-001-13-6,
REP.PRIMARY,2.5,CRT0044876,,,BRD:BRD-K02816415-001-01-9,
REP.PRIMARY,2.5,MINAPRINE,"ACHE, CHRM1, DRD1, DRD2, HTR2A, HTR2B, HTR2C, MAOA, SLC6A4",SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K02867583-300-08-9,
REP.PRIMARY,2.5,KIFUNENSINE,"MAN1B1, MAN2A1",MANNOSIDASE INHIBITOR,BRD:BRD-K02898090-001-02-7,
REP.PRIMARY,2.5,CLOFOCTOL,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K02900412-001-11-3,
REP.PRIMARY,2.5,PRECLAMOL,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K02908048-003-06-4,
REP.PRIMARY,2.5,DASABUVIR,,HCV INHIBITOR,BRD:BRD-K02943813-001-01-9,
REP.PRIMARY,2.5,BMS-299897,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K02950022-001-02-9,
REP.PRIMARY,2.5,NARINGIN,SLCO1A2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K02953697-001-09-2,
REP.PRIMARY,2.5,SU-11274,MET,"HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K02965346-001-07-5,SU11274
REP.PRIMARY,2.5,SU11274,MET,"HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K02965346-001-07-5,SU11274
REP.PRIMARY,0.25,SECALCIFEROL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K02965577-001-03-4,
REP.PRIMARY,2.5,LAMIVUDINE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K02992638-001-11-8,
REP.PRIMARY,2.5,PF-477736,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K03063480-001-05-8,
REP.PRIMARY,2.42,PF-477736,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K03063480-001-06-6,
REP.PRIMARY,2.5,LEVOSIMENDAN,"KCNJ11, KCNJ8, PDE3A, TNNC1",CALCIUM SENSITIZER,BRD:BRD-K03095347-001-06-1,
REP.PRIMARY,2.5,NSC-663284,"CDC25A, CDC25B, CDC25C",CDC INHIBITOR,BRD:BRD-K03109492-001-02-2,
REP.PRIMARY,2.5,GSK3787,PPARD,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K03155172-001-02-2,
REP.PRIMARY,2.5,THIAZOVIVIN,,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K03164761-001-02-1,
REP.PRIMARY,2.5,ROFLUMILAST,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K03194791-001-04-8,
REP.PRIMARY,2.37,TRIFLURIDINE,TYMS,"DNA DIRECTED DNA POLYMERASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K03243820-001-23-8,
REP.PRIMARY,2.5,TRIFLURIDINE,TYMS,"DNA DIRECTED DNA POLYMERASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K03243820-001-25-3,
REP.PRIMARY,2.5,1-AZAKENPAULLONE,"CCNB1, CDK1, CDK5, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K03273112-001-01-8,
REP.PRIMARY,2.5,CCT137690,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K03289018-001-02-7,
REP.PRIMARY,2.5,LERSIVIRINE,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K03289534-001-01-4,
REP.PRIMARY,2.5,NU-6027,"CCNA2, CDK2",CDK INHIBITOR,BRD:BRD-K03294269-001-08-0,NU6027
REP.PRIMARY,2.5,NU6027,"CCNA2, CDK2",CDK INHIBITOR,BRD:BRD-K03294269-001-08-0,NU6027
REP.PRIMARY,2.5,A-7,,CALMODULIN ANTAGONIST,BRD:BRD-K03301001-003-02-5,
REP.PRIMARY,2.5,ECABET,NOXO1,"GASTRIN INHIBITOR, UREASE INHIBITOR",BRD:BRD-K03353589-236-01-4,
REP.PRIMARY,2.5,ROQUINIMEX,,"ANGIOGENESIS INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K03384561-001-02-7,
REP.PRIMARY,2.5,COBIMETINIB,MAP2K1,MEK INHIBITOR,BRD:BRD-K03390685-001-01-7,
REP.PRIMARY,2.5,AZACITIDINE,"DNMT1, DNMT3A",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K03406345-001-27-8,
REP.PRIMARY,2.5,FORETINIB,"FLT1, FLT4, KDR, MET",VEGFR INHIBITOR,BRD:BRD-K03449891-001-08-6,
REP.PRIMARY,2.5,AMYGDALIN,CASP3,CASPASE ACTIVATOR,BRD:BRD-K03504028-001-07-6,
REP.PRIMARY,2.5,XL388,MTOR,MTOR INHIBITOR,BRD:BRD-K03549949-001-01-0,
REP.PRIMARY,2.5,DMNB,,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K03564313-001-03-3,
REP.PRIMARY,2.5,IXABEPILONE,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",MICROTUBULE STABILIZING AGENT,BRD:BRD-K03601870-001-01-2,
REP.PRIMARY,2.5,HYPOXANTHINE,PNP,PARP INHIBITOR,BRD:BRD-K03739921-001-06-8,
REP.PRIMARY,2.5,RACLOPRIDE,"DRD2, DRD3, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K04111260-001-10-0,
REP.PRIMARY,2.5,NEPAFENAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K04112579-001-07-0,
REP.PRIMARY,2.5,BERGENIN,"IL1B, TNF",INTERLEUKIN INHIBITOR,BRD:BRD-K04176066-001-08-3,
REP.PRIMARY,2.5,OXYBUPROCAINE,SCN10A,LOCAL ANESTHETIC,BRD:BRD-K04185004-003-11-9,
REP.PRIMARY,2.5,OXCARBAZEPINE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K04196797-001-24-4,
REP.PRIMARY,2.5,FAVIPIRAVIR,,RNA POLYMERASE INHIBITOR,BRD:BRD-K04264130-001-01-4,
REP.PRIMARY,2.49,DROSPIRENONE,"AR, NR3C2, PGR",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K04394237-001-03-7,
REP.PRIMARY,2.5,DROSPIRENONE,"AR, NR3C2, PGR",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K04394237-001-06-0,
REP.PRIMARY,2.5,SB-222200,TACR3,TACHYKININ ANTAGONIST,BRD:BRD-K04414442-001-08-3,
REP.PRIMARY,2.5,7-NITROINDAZOLE,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K04430056-001-17-7,
REP.PRIMARY,2.5,7-NITROINDAZOLE,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K04430056-236-02-1,
REP.PRIMARY,2.5,LITHOCHOLIC-ACID,"GPBAR1, NR1H4, NR1I2, VDR","FXR ANTAGONIST, VITAMIN D RECEPTOR AGONIST",BRD:BRD-K04497194-001-02-1,
REP.PRIMARY,2.5,EPIRUBICIN,"CHD1, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K04548931-003-16-5,
REP.PRIMARY,5,4-PYRIMIDINECARBONITRILE,,,BRD:BRD-K04552268-001-02-4,
REP.PRIMARY,2.5,OCTENIDINE,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K04568635-300-01-4,
REP.PRIMARY,2.5,YO-01027,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K04622161-001-02-3,
REP.PRIMARY,2.5,BIBR-1532,TERT,TELOMERASE INHIBITOR,BRD:BRD-K04623885-001-07-5,
REP.PRIMARY,2.5,D-DELTA-TOCOPHEROL,,,BRD:BRD-K04657451-001-01-0,
REP.PRIMARY,2.5,AGI-6780,IDH2,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K04691817-001-01-8,
REP.PRIMARY,2.5,CLEMIZOLE,,HCV INHIBITOR,BRD:BRD-K04704168-003-14-3,
REP.PRIMARY,2.5,CIPROFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K04804440-001-09-5,
REP.PRIMARY,2.5,GSK1904529A,"IGF1R, INSR","IGF-1 INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, INSULIN RECEPTOR LIGAND",BRD:BRD-K04833372-001-06-2,
REP.PRIMARY,2.5,ALOE-EMODIN,CASP8,ANTICANCER AGENT,BRD:BRD-K04851519-001-06-8,
REP.PRIMARY,2.5,GSK-3-INHIBITOR-IX,"GSK3A, GSK3B","GLYCOGEN SYNTHASE KINASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K04923131-001-15-4,
REP.PRIMARY,2.5,NEBIVOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K04956647-003-02-5,
REP.PRIMARY,2.5,LY2334737,,"ANTITUMOR AGENT, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K04993719-001-01-7,
REP.PRIMARY,1.57,PHYTOSPHINGOSINE,,,BRD:BRD-K05048137-001-03-9,
REP.PRIMARY,2.5,PD-184352,"MAP2K1, MAP3K1, MAP3K2",MEK INHIBITOR,BRD:BRD-K05104363-001-10-0,
REP.PRIMARY,2.5,ZK-164015,"ESR1, ESR2",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K05151076-001-02-6,
REP.PRIMARY,2.5,NGB-2904,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K05181084-003-03-7,
REP.PRIMARY,2.5,LUTEOLIN,TOP1,GLUCOSIDASE INHIBITOR,BRD:BRD-K05236810-001-19-0,
REP.PRIMARY,2.5,SC-10,PRKCA,PROTEIN KINASE ACTIVATOR,BRD:BRD-K05361803-001-03-9,
REP.PRIMARY,2.5,NICOTINE,"CHAT, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB2, CHRNB3, CHRNB4, CYP19A1, TBXAS1, TRPA1",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K05395900-322-05-4,
REP.PRIMARY,2.5,HA-1004,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K05434375-001-06-5,
REP.PRIMARY,2.5,E7449,"PARP1, PARP2, TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K05444225-001-01-7,
REP.PRIMARY,2.57,WP1066,STAT3,STAT INHIBITOR,BRD:BRD-K05445342-001-05-3,
REP.PRIMARY,2.5,LEDIPASVIR,,HCV INHIBITOR,BRD:BRD-K05446112-001-01-8,
REP.PRIMARY,2.5,JX-401,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K05464208-001-05-7,
REP.PRIMARY,2.5,DRONEDARONE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K05524748-003-04-4,
REP.PRIMARY,2.5,L-745870,"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K05528470-305-02-2,
REP.PRIMARY,2.5,TOBRAMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K05619559-001-12-7,
REP.PRIMARY,2.5,SEVOFLURANE,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K05638300-001-01-2,
REP.PRIMARY,2.5,RALTEGRAVIR,,HIV INTEGRASE INHIBITOR,BRD:BRD-K05658747-001-02-9,
REP.PRIMARY,2.5,DICLOXACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K05673000-236-12-1,
REP.PRIMARY,2.5,PSI-7976,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-01-7,SOFOSBUVIR
REP.PRIMARY,2.5,SOFOSBUVIR,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-01-7,SOFOSBUVIR
REP.PRIMARY,2.5,PSI-7976,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-02-5,SOFOSBUVIR
REP.PRIMARY,2.5,SOFOSBUVIR,,"HCV INHIBITOR, RNA POLYMERASE INHIBITOR",BRD:BRD-K05674516-001-02-5,SOFOSBUVIR
REP.PRIMARY,2.5,PACOCF3,PLA2G4A,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K05677083-001-05-4,
REP.PRIMARY,2.5,AZ 628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-06-0,AZ-628;BRD-K05804044-001-18-5
REP.PRIMARY,2.5,AZ-628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-06-0,AZ-628;BRD-K05804044-001-18-5
REP.PRIMARY,2.5,BRD-K05804044-001-18-5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-06-0,AZ-628;BRD-K05804044-001-18-5
REP.PRIMARY,2.5,SOTAGLIFLOZIN,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K05850076-001-01-5,
REP.PRIMARY,2.5,SODIUM-BUTYRATE,"BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K05878375-236-05-7,
REP.PRIMARY,2.47,DEXLANSOPRAZOLE,"ATP4A, ATP4B",ATPASE INHIBITOR,BRD:BRD-K05900209-001-03-4,
REP.PRIMARY,2.5,LIMONIN,,HIV PROTEASE INHIBITOR,BRD:BRD-K05906022-001-05-1,
REP.PRIMARY,2.5,NONIVAMIDE,TRPV1,TRPV AGONIST,BRD:BRD-K05907307-001-07-1,
REP.PRIMARY,2.5,DIXANTHOGEN,,,BRD:BRD-K05919151-001-01-6,
REP.PRIMARY,2.5,FLUCONAZOLE,CYP51A1,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K05977355-001-19-0,
REP.PRIMARY,2.5,TELENZEPINE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K06147391-300-06-8,
REP.PRIMARY,2.5,METHOXYFLURANE,"ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1",MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K06152156-001-01-8,
REP.PRIMARY,2.5,CARBETAPENTANE,CHRM2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K06181161-048-15-1,
REP.PRIMARY,2.5,YS-035,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K06208435-003-08-2,
REP.PRIMARY,2.5,DUP-697,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K06221026-001-06-8,
REP.PRIMARY,2.5,POSACONAZOLE,CYP3A4,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K06222852-001-03-2,
REP.PRIMARY,2.5,LY364947,TGFBR1,"P38 MAPK INHIBITOR, TGF BETA RECEPTOR INHIBITOR",BRD:BRD-K06234293-001-04-2,
REP.PRIMARY,2.5,RILPIVIRINE,"NR1I2, SCN10A",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K06240250-001-01-6,
REP.PRIMARY,2.5,UK-383367,BMP1,"PROCOLLAGEN C-ENDOPEPTIDASE INHIBITOR, PROCOLLAGEN C-ENDOPEPTIDASE INHIBITORS",BRD:BRD-K06294530-001-01-5,
REP.PRIMARY,2.5,TIZANIDINE,"ADRA2A, ADRA2B, ADRA2C, NISCH",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K06335600-003-20-7,
REP.PRIMARY,2.5,PRAMIPEXOLE,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K06388322-312-02-6,
REP.PRIMARY,2.5,FLUDROCORTISONE-ACETATE,"AR, NR3C1, NR3C2",,BRD:BRD-K06408664-001-03-5,
REP.PRIMARY,2.5,RYUVIDINE,"CDK2, CDK4",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K06426971-001-02-7,
REP.PRIMARY,2.5,ASP3026,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K06542892-001-01-9,
REP.PRIMARY,2.5,BISINDOLYLMALEIMIDE-IX,"AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1",PKC INHIBITOR,BRD:BRD-K06543683-066-02-1,
REP.PRIMARY,2.5,VORICONAZOLE,"CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1",CYTOCHROME P450 INHIBITOR,BRD:BRD-K06557128-001-07-0,
REP.PRIMARY,2.5,LE-135,RARB,RETINOID RECEPTOR AGONIST,BRD:BRD-K06593056-001-04-8,
REP.PRIMARY,2.5,OLEAMIDE,"HTR7, PLA2G2A",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K06644925-001-03-0,
REP.PRIMARY,2.5,NAFAMOSTAT,"ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7",SERINE PROTEASE INHIBITOR,BRD:BRD-K06674495-334-03-2,
REP.PRIMARY,2.5,GSK1838705A,"ALK, IGF1R, INSR, RPS6KA1",INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K06749501-001-02-1,
REP.PRIMARY,2.5,NOBILETIN,MAP2K1,MEK INHIBITOR,BRD:BRD-K06753942-001-14-5,
REP.PRIMARY,2.5,ISBUFYLLINE,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K06762493-001-08-1,
REP.PRIMARY,2.5,FOSBRETABULIN,CDH5,"TUBULIN POLYMERIZATION INHIBITOR, VE-CADHERIN ANTAGONIST",BRD:BRD-K06814349-304-01-9,
REP.PRIMARY,2.5,AM-580,RARA,RETINOID RECEPTOR AGONIST,BRD:BRD-K06854232-001-19-9,
REP.PRIMARY,2.5,CABAZITAXEL,"TUBA4A, TUBB, TUBB1",MICROTUBULE INHIBITOR,BRD:BRD-K06858286-001-01-3,
REP.PRIMARY,2.5,DEFERIPRONE,UGT1A6,CHELATING AGENT,BRD:BRD-K06878038-001-18-6,
REP.PRIMARY,2.5,TEBIPENEM,CNR1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K06900071-001-01-2,
REP.PRIMARY,2.5,MINOXIDIL,"ABCC9, KCNJ1, KCNJ10, KCNJ11, KCNJ8, PTGS1","KATP ACTIVATOR, KIR6 CHANNEL (KATP) ACTIVATOR, VASODILATOR",BRD:BRD-K06902185-003-01-7,
REP.PRIMARY,2.5,PROMAZINE,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K06980535-003-25-9,
REP.PRIMARY,2.5,BMS-599626,"EGFR, ERBB2, ERBB4","EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K07106112-003-03-8,
REP.PRIMARY,2.5,FIACITABINE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K07160047-001-01-3,
REP.PRIMARY,2.5,STREPTOMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K07166362-330-02-8,
REP.PRIMARY,2.5,FRENTIZOLE,,IMMUNOSUPPRESSANT,BRD:BRD-K07202345-001-19-4,
REP.PRIMARY,2.5,TRIMETHOPRIM,"DHFR, TYMS",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K07208025-001-29-7,
REP.PRIMARY,2.5,CINNARAZINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K07220430-001-18-4,
REP.PRIMARY,2.5,CINNARAZINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K07220430-001-19-2,
REP.PRIMARY,2.5,MOCLOBEMIDE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K07237224-001-19-6,
REP.PRIMARY,2.61,DEXRAZOXANE,"TOP2A, TOP2B","CHELATING AGENT, TOPOISOMERASE INHIBITOR",BRD:BRD-K07265709-003-05-6,
REP.PRIMARY,2.5,OXYCLOZANIDE,,,BRD:BRD-K07283971-001-01-3,
REP.PRIMARY,2.5,PF-04691502,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07310275-001-02-5,
REP.PRIMARY,2.45,BENFOTIAMINE,AGER,ANTIOXIDANT,BRD:BRD-K07359318-001-03-9,
REP.PRIMARY,2.5,PAROXYPROPIONE,,GONADOTROPIN INHIBITOR,BRD:BRD-K07441213-001-18-9,
REP.PRIMARY,2.5,BAM7,BAX,BAX ACTIVATOR,BRD:BRD-K07442505-001-03-6,
REP.PRIMARY,2.5,WHI-P154,"EGFR, JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K07487750-001-03-3,
REP.PRIMARY,2.5,BRL-37344,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K07507905-236-02-6,
REP.PRIMARY,2.48,CURCUMIN,"APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CHRM3, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH","CYCLOOXYGENASE INHIBITOR, HISTONE ACETYLTRANSFERASE INHIBITOR, LIPOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K07572174-001-39-4,
REP.PRIMARY,2.5,DEXLOXIGLUMIDE,CCKAR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K07609981-001-01-7,
REP.PRIMARY,2.59,SPARFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K07612980-001-05-3,
REP.PRIMARY,2.5,SPARFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K07612980-001-07-9,
REP.PRIMARY,2.5,ROSCOVITINE,"CDK2, CDK9",CDK INHIBITOR,BRD:BRD-K07691486-001-15-5,
REP.PRIMARY,2.51,VX-702,"IL1B, IL6, MAPK11, MAPK12, MAPK14, TNF",P38 MAPK INHIBITOR,BRD:BRD-K07736136-001-04-6,
REP.PRIMARY,2.5,ACECAINIDE,SCN5A,POLARIZATION INHIBITOR,BRD:BRD-K07753030-003-17-6,
REP.PRIMARY,2.5,AMINOPURVALANOL-A,"CDK1, CDK2, CDK5, CDK6","CDK INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K07762753-001-04-4,
REP.PRIMARY,2.5,PSI-6130,,RNA POLYMERASE INHIBITOR,BRD:BRD-K07798980-001-01-9,
REP.PRIMARY,2.5,ALVIMOPAN,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K07857022-002-01-1,
REP.PRIMARY,2.5,DANUSERTIB,"AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK","AURORA KINASE INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K07881437-001-03-8,
REP.PRIMARY,2.41,DANUSERTIB,"AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK","AURORA KINASE INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K07881437-001-04-6,
REP.PRIMARY,2.5,QUININE,"GP9, KCNB2, KCNN4, SLC29A4",HEMOZOIN BIOCRYSTALLIZATION INHIBITOR,BRD:BRD-K07940445-310-02-9,
REP.PRIMARY,2.5,2-IMINOBIOTIN,"NOS1, NOS2",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K07954936-001-01-3,
REP.PRIMARY,2.5,PF-05212384,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07955840-001-02-3,
REP.PRIMARY,2.5,GSK2126458,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K07972848-001-02-0,
REP.PRIMARY,2.5,LINCOMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K08033334-003-04-3,
REP.PRIMARY,2.5,ARBUTIN,TYR,MELANIN INHIBITOR,BRD:BRD-K08037784-001-12-6,
REP.PRIMARY,2.5,TETRANDRINE,SLC6A3,CALCIUM CHANNEL BLOCKER,BRD:BRD-K08078237-001-19-8,
REP.PRIMARY,2.5,I-BET-762,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K08109215-001-06-4,
REP.PRIMARY,2.5,L-701324,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K08109516-001-07-8,
REP.PRIMARY,2.5,DANOPREVIR,,HCV INHIBITOR,BRD:BRD-K08111240-001-02-8,
REP.PRIMARY,2.5,CHLORAMPHENICOL,CD55,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K08111712-001-16-7,
REP.PRIMARY,2.5,ASTRAGALOSIDE-A,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT",BRD:BRD-K08188887-001-02-4,
REP.PRIMARY,2.5,ENTECAVIR,,"DNA REPLICATION INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K08206212-002-01-0,
REP.PRIMARY,2.5,WAY-200070,"ERBB2, ERBB3, ERBB4, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K08223200-001-01-1,
REP.PRIMARY,2.5,PROPOXUR,,,BRD:BRD-K08231299-001-08-1,
REP.PRIMARY,2.5,LCL-161,"BIRC2, XIAP",XIAP INHIBITOR,BRD:BRD-K08248804-001-01-8,
REP.PRIMARY,2.5,FALECALCITRIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K08251020-001-01-0,
REP.PRIMARY,2.5,DICLOFENAC,"AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K08252256-236-33-8,
REP.PRIMARY,2.5,GRISEOFULVIN,KRT12,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K08273968-001-19-0,
REP.PRIMARY,2.5,BUTYL-PARABEN,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K08287586-001-14-3,
REP.PRIMARY,2.5,1-ETHYL-2-PYRROLIDONE,,TRANSDERMAL ABSORPTION-ENHANCING COMPOUND,BRD:BRD-K08288352-001-03-6,
REP.PRIMARY,2.5,CHLORPYRIFOS,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K08303368-001-10-0,
REP.PRIMARY,2.5,AG-1024,IGF1R,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K08310154-001-03-8,
REP.PRIMARY,2.5,XYLOMETAZOLINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K08356259-003-24-7,
REP.PRIMARY,2.5,SALICYL-ALCOHOL,,,BRD:BRD-K08493205-001-04-9,
REP.PRIMARY,2.5,SARAFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K08525451-003-05-2,
REP.PRIMARY,0.8,GAMBOGIC-ACID,BCL2,CASPASE ACTIVATOR,BRD:BRD-K08542803-001-03-1,
REP.PRIMARY,2.5,IRINOTECAN,"TOP1, TOP1MT",TOPOISOMERASE INHIBITOR,BRD:BRD-K08547377-394-03-5,
REP.PRIMARY,2.5,RAMATROBAN,"PTGDR2, TBXA2R",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K08586861-001-01-1,
REP.PRIMARY,2.5,THIOPROPERAZINE,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K08619574-334-05-4,
REP.PRIMARY,2.5,TREMORINE,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K08619838-300-05-7,
REP.PRIMARY,2.5,RS-100329,"ADRA1A, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K08640512-003-02-3,
REP.PRIMARY,2.5,IBANDRONATE,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K08681769-323-03-7,
REP.PRIMARY,2.5,3-AMINO-BENZAMIDE,PARP1,PARP INHIBITOR,BRD:BRD-K08703257-001-12-1,
REP.PRIMARY,2.5,FENACLON,,,BRD:BRD-K08791496-001-01-0,
REP.PRIMARY,2.5,PELITINIB,EGFR,EGFR INHIBITOR,BRD:BRD-K08799216-001-05-3,
REP.PRIMARY,2.5,NARINGENIN,"CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1","AROMATASE INHIBITOR, TRPV ANTAGONIST",BRD:BRD-K08832567-001-11-5,
REP.PRIMARY,2.5,ACTINOQUINOL,,,BRD:BRD-K08837089-236-01-6,
REP.PRIMARY,2.5,DU-728,"ITGA2B, ITGB3",STRUCTURAL GLYCOPROTEIN ANTAGONIST,BRD:BRD-K08859203-001-01-9,
REP.PRIMARY,2.5,FEXARAMINE,NR1H4,FXR AGONIST,BRD:BRD-K08864679-001-02-2,
REP.PRIMARY,2.52,CCG-50014,"RGS4, RGS8",G PROTEIN SIGNALING INHIBITOR,BRD:BRD-K08893438-001-04-9,
REP.PRIMARY,2.5,PALONOSETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K08924299-003-06-1,
REP.PRIMARY,2.5,U-0521,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K08953028-001-09-6,
REP.PRIMARY,2.5,AZELAIC-ACID,"AKR1D1, SRD5A2, TYR",TYROSINASE INHIBITOR,BRD:BRD-K08976401-001-18-5,
REP.PRIMARY,2.5,ZOLANTIDINE,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K08996725-332-01-7,
REP.PRIMARY,2.5,FANANSERIN,HTR2A,"DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K08998509-001-02-4,
REP.PRIMARY,2.5,PIPEMIDIC-ACID,,TOPOISOMERASE INHIBITOR,BRD:BRD-K08999871-213-01-5,
REP.PRIMARY,2.5,FIROCOXIB,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K09090523-001-02-1,
REP.PRIMARY,2.5,"CP-945,598",CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K09090949-001-01-9,
REP.PRIMARY,2.5,NEPICASTAT,DBH,DOPAMINE BETA HYDROXYLASE INHIBITOR,BRD:BRD-K09126848-003-01-9,
REP.PRIMARY,2.5,D-4476,"CSNK1A1, CSNK1D, TGFB1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K09132007-001-07-5,
REP.PRIMARY,2.5,CLIOQUINOL,OPRK1,CHELATING AGENT,BRD:BRD-K09255212-001-16-6,
REP.PRIMARY,2.5,CARZENIDE,"CA1, CA12, CA14, CA2, CA6, CA9",,BRD:BRD-K09295674-001-09-8,
REP.PRIMARY,2.5,1-OCTANOL,"GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1",,BRD:BRD-K09338665-001-07-1,
REP.PRIMARY,2.5,TARIQUIDAR,ABCB1,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K09353376-001-03-9,
REP.PRIMARY,2.5,MERIMEPODIB,IMPDH1,INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K09372874-001-01-0,
REP.PRIMARY,2.5,SR-57227A,HTR3A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K09397065-003-06-1,
REP.PRIMARY,2.5,LOVASTATIN,"HDAC2, HMGCR, ITGAL, NR1I2",HMGCR INHIBITOR,BRD:BRD-K09416995-001-39-9,
REP.PRIMARY,2.5,TAS-103,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K09426783-300-01-0,
REP.PRIMARY,2.5,PHA-680632,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K09443272-001-03-3,
REP.PRIMARY,2.5,LEVOFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K09471561-001-18-2,
REP.PRIMARY,2.5,NU-7026,PRKDC,"DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K09537769-001-04-0,
REP.PRIMARY,2.5,MIBEFRADIL,"ANO1, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CATSPER1, CATSPER2, CATSPER3, CATSPER4",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K09549677-300-03-4,
REP.PRIMARY,2.5,FORSKOLIN,"ADCY2, ADCY5, GNAS",ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-K09602097-001-13-6,
REP.PRIMARY,2.5,CD-1530,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K09619322-001-03-8,
REP.PRIMARY,2.5,DS2-(806622),,,BRD:BRD-K09619578-001-01-3,
REP.PRIMARY,2.5,M-3M3FBS,"PLCB2, PLCB3, PLCD1, PLCG1, PLCG2",PHOSPHOLIPASE ACTIVATOR,BRD:BRD-K09635314-001-03-4,
REP.PRIMARY,2.5,LORECLEZOLE,"GABRB2, GABRB3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K09659835-003-01-4,
REP.PRIMARY,2.5,VARESPLADIB,PLA2G2A,SECRETORY PHOSPHOLIPASE INHIBITOR,BRD:BRD-K09711437-001-04-3,
REP.PRIMARY,2.5,ATAZANAVIR,,HIV PROTEASE INHIBITOR,BRD:BRD-K09757388-065-04-0,
REP.PRIMARY,2.5,FGIN-1-27,TSPO,INOSITOL MONOPHOSPHATASE INHIBITOR,BRD:BRD-K09778810-001-10-6,
REP.PRIMARY,2.5,BAKUCHIOL,HIF1A,DNA POLYMERASE INHIBITOR,BRD:BRD-K09785578-001-01-2,
REP.PRIMARY,2.5,VS-4718,,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K09877029-001-01-2,
REP.PRIMARY,2.5,CAFFEIC-ACID,"ALOX5, MIF","HIV INTEGRASE INHIBITOR, LIPOXYGENASE INHIBITOR, NITRIC OXIDE PRODUCTION INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K09900591-001-26-7,
REP.PRIMARY,2.5,DABRAFENIB,"BRAF, LIMK1, NEK11, RAF1, SIK1",RAF INHIBITOR,BRD:BRD-K09951645-001-06-8,
REP.PRIMARY,2.5,ENISAMIUM-IODIDE,,,BRD:BRD-K10029415-005-06-9,
REP.PRIMARY,2.5,DANTRON,,LAXATIVE,BRD:BRD-K10065684-001-07-4,
REP.PRIMARY,2.5,ERTUGLIFLOZIN,SLC5A2,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K10071630-001-01-0,
REP.PRIMARY,2.5,L-701252,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K10176267-001-03-3,
REP.PRIMARY,2.5,PSB-11,"ADORA1, ADORA2A, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K10177585-003-02-4,
REP.PRIMARY,2.5,BESIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K10196357-003-02-0,
REP.PRIMARY,2.5,MECLOFENOXATE,,NOOTROPIC AGENT,BRD:BRD-K10314788-003-12-7,
REP.PRIMARY,2.5,TENIPOSIDE,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K10362825-001-03-4,
REP.PRIMARY,2.5,MRS-3777,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K10575656-034-01-0,MRS3777
REP.PRIMARY,2.5,MRS3777,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K10575656-034-01-0,MRS3777
REP.PRIMARY,2.5,HEXAMETHONIUM,"CHRNA2, CHRNA3, CHRNA4, CHRNA6",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K10598093-303-06-1,
REP.PRIMARY,2.5,SULFASALAZINE,"ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K10670311-001-15-5,
REP.PRIMARY,2.5,SULFAPHENAZOLE,DHPS,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K10671814-001-14-8,
REP.PRIMARY,2.5,S-ISOPROPYLISOTHIOUREA,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K10673031-004-02-0,
REP.PRIMARY,2.5,GW-405833,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K10705233-001-02-2,
REP.PRIMARY,2.5,RIVASTIGMINE,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K10706131-046-03-6,
REP.PRIMARY,2.5,XYLOSE,,,BRD:BRD-K10759144-001-04-3,
REP.PRIMARY,2.5,TEMOCAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K10784860-003-02-3,
REP.PRIMARY,2.5,CLOBETASOL-PROPIONATE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K10799896-001-26-2,
REP.PRIMARY,2.5,SITAFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K10836013-001-01-3,
REP.PRIMARY,2.5,PHENYLBUTAZONE,"PTGIS, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K10843433-001-22-7,
REP.PRIMARY,2.58,PHENYLBUTAZONE,"PTGIS, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K10843433-001-23-5,
REP.PRIMARY,2.5,TILUDRONATE,"ATP6V1A, MMP2, PTPN1","BONE RESORPTION INHIBITOR, OSTEOCLAST INHIBITOR",BRD:BRD-K10845183-304-01-6,
REP.PRIMARY,2.5,TOLCAPONE,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K10852020-001-04-5,
REP.PRIMARY,2.57,TOLCAPONE,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K10852020-001-05-2,
REP.PRIMARY,2.5,APD668,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K10859802-001-01-0,
REP.PRIMARY,2.5,OAC1,,OCT ACTIVATOR,BRD:BRD-K10878147-001-02-2,
REP.PRIMARY,2.67,SILODOSIN,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K10906636-001-02-9,
REP.PRIMARY,2.5,LATANOPROST,PTGFR,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K10961822-001-05-1,
REP.PRIMARY,2.5,DILOXANIDE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K10974103-001-21-1,
REP.PRIMARY,2.5,CLOTIAPINE,,,BRD:BRD-K10990317-001-04-5,
REP.PRIMARY,2.5,VUF10166,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K11046126-001-02-0,
REP.PRIMARY,2.5,ICI-162846,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K11071038-001-01-7,
REP.PRIMARY,2.5,CPI-1189,TNF,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,BRD:BRD-K11073688-001-01-6,
REP.PRIMARY,2.5,ACETANILIDE,,HYDROGEN PEROXIDE DECOMPOSITION INHIBITOR,BRD:BRD-K11094367-001-10-1,
REP.PRIMARY,2.5,GADOTERATE-MEGLUMINE,,RADIOPAQUE MEDIUM,BRD:BRD-K11099631-001-07-6,
REP.PRIMARY,2.5,CEFTIBUTEN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K11124378-001-04-6,
REP.PRIMARY,2.5,GEMFIBROZIL,"LPL, PPARA, SLCO1B1, SLCO1B3, SLCO2B1",LIPOPROTEIN LIPASE ACTIVATOR,BRD:BRD-K11129031-001-27-5,
REP.PRIMARY,2.5,INIPARIB,PARP1,PARP INHIBITOR,BRD:BRD-K11153516-001-05-5,
REP.PRIMARY,2.5,NORFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K11196887-001-21-2,
REP.PRIMARY,2.49,NORFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K11196887-001-22-0,
REP.PRIMARY,2.31,TAZEMETOSTAT,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K11215326-001-03-7,
REP.PRIMARY,2.5,AMBAZONE,,DNA DAMAGE INDUCER,BRD:BRD-K11244467-001-08-5,
REP.PRIMARY,2.5,ALECTINIB,"ALK, MET",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K11267252-001-04-4,
REP.PRIMARY,2.5,AMBENONIUM,ACHE,CHOLINESTERASE INHIBITOR,BRD:BRD-K11292736-300-02-8,
REP.PRIMARY,2.5,ZD-7155,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K11373525-003-02-1,
REP.PRIMARY,2.5,PHENFORMIN,"KCNJ8, PRKAA1",AMPK ACTIVATOR,BRD:BRD-K11399644-003-11-3,
REP.PRIMARY,2.5,NOV-002,"GSR, GSTM2",,BRD:BRD-K11411329-001-01-3,
REP.PRIMARY,2.5,ASPIRIN,"AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K11433652-001-17-0,
REP.PRIMARY,2.5,TEPRENONE,,MUCUS PROTECTING AGENT,BRD:BRD-K11510141-001-01-8,
REP.PRIMARY,2.5,DROXINOSTAT,"HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K11558771-001-13-9,
REP.PRIMARY,2.49,MORIN,"ADORA2A, ESR2, FASN, MCL1, SLC22A12",CYTOCHROME P450 INHIBITOR,BRD:BRD-K11590034-002-03-4,
REP.PRIMARY,2.5,DIPEPTAMIN,,,BRD:BRD-K11595419-001-01-4,
REP.PRIMARY,2.5,CARMOFUR,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K11630072-001-13-2,
REP.PRIMARY,2.58,SESAMIN,,NFKB PATHWAY INHIBITOR,BRD:BRD-K11631773-001-10-8,
REP.PRIMARY,2.5,JNJ-7706621,"AURKA, AURKB, CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K11636097-001-03-1,
REP.PRIMARY,2.5,SULFAMETHAZINE,,PABA ANTAGONIST,BRD:BRD-K11640013-001-15-8,
REP.PRIMARY,2.5,SULFAMETHAZINE,,PABA ANTAGONIST,BRD:BRD-K11640013-236-10-1,
REP.PRIMARY,2.5,PYROXAMIDE,HDAC1,HDAC INHIBITOR,BRD:BRD-K11663430-001-02-3,
REP.PRIMARY,2.5,ROSTAFUROXINE,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K11672787-001-01-5,
REP.PRIMARY,2.5,BU-239,,"IMIDAZOLINE RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR LIGAND",BRD:BRD-K11696279-003-02-3,
REP.PRIMARY,2.5,BENZBROMARONE,ABCC1,CHLORIDE CHANNEL BLOCKER,BRD:BRD-K11717138-001-30-3,
REP.PRIMARY,2.5,TRIPROLIDINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K11742128-003-23-4,
REP.PRIMARY,2.5,FURAZOLIDONE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K11756522-001-09-9,
REP.PRIMARY,2.5,NBQX,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K11796549-001-04-5,
REP.PRIMARY,2.5,PJ-34,"EEF2, PARP1, PARP15, PARP3",PARP INHIBITOR,BRD:BRD-K11853856-001-01-7,
REP.PRIMARY,2.5,METHYLTHIOURACIL,,,BRD:BRD-K11900042-001-14-4,
REP.PRIMARY,2.5,GR-127935,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K11911061-003-11-9,
REP.PRIMARY,2.5,ER-27319,SYK,"MEDIATOR RELEASE INHIBITOR, SYK INHIBITOR",BRD:BRD-K11927976-050-02-9,
REP.PRIMARY,2.5,TIPIRACIL,TYMP,THYMIDINE PHOSPHORYLASE INHIBITOR,BRD:BRD-K11973162-003-01-8,
REP.PRIMARY,2.5,BETAINE,,NITRIC OXIDE DONOR,BRD:BRD-K12014493-001-02-2,
REP.PRIMARY,2.5,AT7867,"AKT2, GSK3B, PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K12040459-001-06-0,
REP.PRIMARY,2.5,PALIFOSFAMIDE,,DNA ALKYLATING AGENT,BRD:BRD-K12047401-001-01-5,
REP.PRIMARY,2.36,LY2608204,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K12068470-001-02-5,
REP.PRIMARY,2.5,LY2608204,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K12068470-001-04-1,
REP.PRIMARY,2.5,PD-160170,NPY1R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K12079898-001-02-6,
REP.PRIMARY,2.5,NIALAMIDE,"COMT, MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K12102668-001-25-5,
REP.PRIMARY,2.5,GR-144053,"ITGA2B, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K12120659-305-02-2,
REP.PRIMARY,2.5,NVP-BEZ235,"ATR, MTOR, PIK3CA, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K12184916-001-15-4,
REP.PRIMARY,2.5,GLIPIZIDE,"ABCC8, KCNJ10, KCNJ11, PPARG",SULFONYLUREA,BRD:BRD-K12219985-001-26-1,
REP.PRIMARY,2.5,MEK1-2-INHIBITOR,MAP2K2,MEK INHIBITOR,BRD:BRD-K12244279-001-05-8,
REP.PRIMARY,2.5,VINCRISTINE,"TUBA4A, TUBB",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K12251893-065-04-7,
REP.PRIMARY,2.5,ANDROSTERONE,,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K12329651-001-18-8,
REP.PRIMARY,2.5,TRAMETINIB,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K12343256-001-08-9,
REP.PRIMARY,2.5,FEDRATINIB,"BRD4, JAK1, JAK2, JAK3, TYK2","FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K12502280-001-08-0,TG-101348
REP.PRIMARY,2.5,TG-101348,"BRD4, JAK1, JAK2, JAK3, TYK2","FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K12502280-001-08-0,TG-101348
REP.PRIMARY,2.5,FENBUFEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K12513978-001-24-1,
REP.PRIMARY,2.5,SULBUTIAMINE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K12539416-001-01-4,
REP.PRIMARY,2.5,NOCODAZOLE,HPGDS,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K12539581-001-23-7,
REP.PRIMARY,2.5,AMIDOPYRINE,,ANALGESIC AGENT,BRD:BRD-K12568846-001-14-6,
REP.PRIMARY,2.5,EXALAMIDE,,MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K12609457-001-03-1,
REP.PRIMARY,2.5,CGS-21680,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K12614344-003-01-8,
REP.PRIMARY,2.5,HARMANE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K12630395-001-14-9,
REP.PRIMARY,2.5,TG-100801,"CSK, FGFR1, FLT1, FLT4, KDR, SRC","SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K12735121-001-01-4,
REP.PRIMARY,2.5,VELIPARIB,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K12737986-001-01-4,
REP.PRIMARY,2.5,XAV-939,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K12762134-001-06-2,
REP.PRIMARY,2.5,PNU-37883,,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K12769093-003-01-3,
REP.PRIMARY,2.5,CX-5461,,RNA POLYMERASE INHIBITOR,BRD:BRD-K12787259-001-04-3,
REP.PRIMARY,2.5,KAEMPFEROL,"AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1","BONE RESORPTION INHIBITOR, ESTROGEN-RELATED RECEPTOR INVERSE AGONIST",BRD:BRD-K12807006-001-18-5,
REP.PRIMARY,2.5,MECHLORETHAMINE,,DNA INHIBITOR,BRD:BRD-K12829205-003-02-8,
REP.PRIMARY,2.5,PCI-24781,"HDAC1, HDAC2, HDAC3, HDAC6",HDAC INHIBITOR,BRD:BRD-K12867552-001-04-7,
REP.PRIMARY,2.5,DAPIVIRINE,"CYP3A4, CYP3A5",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K12885236-001-02-7,
REP.PRIMARY,2.5,YM-976,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K12932420-001-02-3,
REP.PRIMARY,2.5,BERGAPTEN,,,BRD:BRD-K12968785-001-13-3,
REP.PRIMARY,2.5,VALDECOXIB,"CA12, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K12994359-001-18-4,
REP.PRIMARY,2.5,CICLOPIROX,ATP1A1,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K13044802-213-20-7,
REP.PRIMARY,2.5,BMS-754807,"AKT1, IGF1R",IGF-1 INHIBITOR,BRD:BRD-K13049116-001-05-7,
REP.PRIMARY,2.5,URIDINE,"LSM6, TYMP",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13050303-001-17-3,
REP.PRIMARY,2.5,URIDINE,"LSM6, TYMP",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13050303-001-18-1,
REP.PRIMARY,2.8000000000000003,ACIVICIN,CTPS1,"GAMMA GLUTAMYLTRANSFERASE INHIBITOR, GAMMA GLUTAMYLTRANSFERASE INHIBITORS",BRD:BRD-K13050541-001-01-9,
REP.PRIMARY,2.5,HYDROCHLOROTHIAZIDE,"CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A3",THIAZIDE DIURETIC,BRD:BRD-K13078532-001-28-4,
REP.PRIMARY,2.5,CGP-52411,EGFR,EGFR INHIBITOR,BRD:BRD-K13087974-001-02-5,
REP.PRIMARY,2.63,PFI-1,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K13094524-001-07-5,
REP.PRIMARY,2.5,ARTEMISININ,CYP2B6,DNA SYNTHESIS INHIBITOR,BRD:BRD-K13112821-001-17-4,
REP.PRIMARY,2.5,AR-42,HDAC1,HDAC INHIBITOR,BRD:BRD-K13167095-001-02-9,
REP.PRIMARY,2.5,NSC-3852,HDAC1,HDAC INHIBITOR,BRD:BRD-K13169950-001-14-4,
REP.PRIMARY,2.5,PENTAMIDINE,TRDMT1,ANTI-PNEUMOCYSTIS AGENT,BRD:BRD-K13183738-317-10-2,
REP.PRIMARY,2.5,L-741742,"DRD3, DRD4, SCN1A, SCN3A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K13211965-003-02-8,
REP.PRIMARY,2.5,HALOPROGIN,,OTHER ANTIFUNGAL,BRD:BRD-K13238168-001-02-0,
REP.PRIMARY,2.5,CARSALAM,,ANALGESIC AGENT,BRD:BRD-K13238618-001-05-9,
REP.PRIMARY,2.5,PIPERAZINE,GABRB3,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K13249881-001-02-3,
REP.PRIMARY,2.5,QUINELORANE,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K13261168-300-01-0,
REP.PRIMARY,2.5,RIMONABANT,"CNR1, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K13296708-001-05-8,
REP.PRIMARY,2.5,KY02111,DKK1,WNT PATHWAY INHIBITOR,BRD:BRD-K13302470-001-02-7,
REP.PRIMARY,2.5,EBASTINE,"CYP3A4, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K13314656-001-01-0,
REP.PRIMARY,2.5,METHAZOLAMIDE,"CA1, CA12, CA14, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K13356952-001-25-1,
REP.PRIMARY,2.5,THONZONIUM,ATP6V1C1,ATPASE INHIBITOR,BRD:BRD-K13387373-004-14-5,
REP.PRIMARY,2.5,AT-7519,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK9",CDK INHIBITOR,BRD:BRD-K13390322-001-06-3,
REP.PRIMARY,2.5,ISOPROPYL-MYRISTATE,,,BRD:BRD-K13409143-001-01-9,
REP.PRIMARY,2.5,AMINOTHIAZOLE,NOS2,CYCLIN D INHIBITOR,BRD:BRD-K13421763-001-06-2,
REP.PRIMARY,2.5,"L-655,708","GABRA1, GABRA2, GABRA3, GABRA5, GABRG2",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K13474508-001-01-2,
REP.PRIMARY,2.5,SULFACARBAMIDE,,,BRD:BRD-K13486660-001-01-0,
REP.PRIMARY,2.5,CREATININE,,,BRD:BRD-K13495773-001-11-4,
REP.PRIMARY,2.5,NARINGIN-DIHYDROCHALCONE,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K13511380-001-01-4,
REP.PRIMARY,2.5,EVEROLIMUS,MTOR,MTOR INHIBITOR,BRD:BRD-K13514097-001-05-3,
REP.PRIMARY,2.5,BMS-345541,"CHUK, IKBKB",IKK INHIBITOR,BRD:BRD-K13566078-001-02-3,
REP.PRIMARY,2.5,PEPSTATIN,"CTSB, CTSD, CTSL, REN",ASPARTIC PROTEASE INHIBITOR,BRD:BRD-K13571841-001-14-4,
REP.PRIMARY,2.5,P5091,USP7,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K13606314-001-01-3,
REP.PRIMARY,2.5,ACEGLUTAMIDE,,,BRD:BRD-K13619941-213-01-8,
REP.PRIMARY,2.5,MIDOSTAURIN,"FLT3, PRKCG","FLT3 INHIBITOR, KIT INHIBITOR, PKC INHIBITOR",BRD:BRD-K13646352-001-03-8,
REP.PRIMARY,2.5,DINACICLIB,"CDK1, CDK2, CDK5, CDK9",CDK INHIBITOR,BRD:BRD-K13662825-001-07-5,
REP.PRIMARY,2.5,BITOPERTIN,"SLC6A5, SLC6A9","GLYCINE TRANSPORTER INHIBITOR, GLYT-1 INHIBITOR",BRD:BRD-K13756951-001-01-4,
REP.PRIMARY,2.5,PARECOXIB,LTF,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K13800121-001-01-5,
REP.PRIMARY,2.5,GIVINOSTAT,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K13810148-311-03-2,
REP.PRIMARY,2.4000000000000004,DESOXYPEGANINE,ACHE,"ACETYLCHOLINESTERASE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",BRD:BRD-K13819402-003-10-2,
REP.PRIMARY,2.5,IEM1460,GRIA2,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K13829090-303-02-9,
REP.PRIMARY,2.5,LY2365109,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K13888115-003-02-2,
REP.PRIMARY,2.5,VARDENAFIL,"PDE5A, PDE6G, PDE6H",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K13926615-003-03-3,
REP.PRIMARY,2.5,TENOVIN-6,"SIRT1, SIRT2, SIRT3",SIRT INHIBITOR,BRD:BRD-K13949769-001-01-7,
REP.PRIMARY,2.5,PROPRANOLOL-(S),"ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13994703-003-15-8,
REP.PRIMARY,2.46,RITODRINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K14003026-003-09-0,
REP.PRIMARY,2.5,LY2603618,CHEK1,CHK INHIBITOR,BRD:BRD-K14109347-001-03-4,
REP.PRIMARY,2.5,SULFAMONOMETHOXINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K14116214-001-09-6,
REP.PRIMARY,2.5,ISOPROPAMIDE-IODIDE,"CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K14127446-005-22-7,
REP.PRIMARY,2.5,MK-0812,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K14175878-001-01-6,
REP.PRIMARY,2.5,GTS21,CHRNA7,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K14235254-001-01-2,
REP.PRIMARY,2.5,BAY-K-8644-(S)-(-),CACNA1C,L-TYPE CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K14329163-001-03-9,
REP.PRIMARY,2.5,PYRIDOXINE,"DDC, PDXK",VITAMIN B,BRD:BRD-K14349461-003-13-1,
REP.PRIMARY,2.59,FG-4592,"EGLN1, EGLN2, EGLN3",HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K14385366-001-04-4,
REP.PRIMARY,2.5,NECA,"ADORA1, ADORA2A, ADORA2B, ADORA3, HSP90B1",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K14395568-001-16-3,
REP.PRIMARY,2.5,AVOBENZONE,TYR,"TOPICAL SUNSCREEN AGENT, UV BLOCKER",BRD:BRD-K14401183-001-10-7,
REP.PRIMARY,2.5,BROMOCRIPTINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K14496212-066-04-8,
REP.PRIMARY,2.5,MEISOINDIGO,STAT3,STAT INHIBITOR,BRD:BRD-K14529030-001-01-9,
REP.PRIMARY,2.5,TG-02,"CDK1, CDK2, CDK7, CDK9, FLT3, JAK2","CDK INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K14560436-001-01-4,
REP.PRIMARY,2.5,IKK-16,IKBKB,IKK INHIBITOR,BRD:BRD-K14618467-001-04-6,
REP.PRIMARY,2.5,ALTRENOGEST,PGR,PROGESTOGEN HORMONE,BRD:BRD-K14619660-001-01-5,
REP.PRIMARY,2.5,TASQUINIMOD,HDAC4,"ANGIOGENESIS INHIBITOR, S100A9 INHIBITOR",BRD:BRD-K14653796-001-01-1,
REP.PRIMARY,2.5,CINOXACIN,,TOPOISOMERASE INHIBITOR,BRD:BRD-K14704277-001-22-6,
REP.PRIMARY,2.5,SULFATHIAZOLE,,DIHYDROPTEROATE SYNTHASE INHIBITOR,BRD:BRD-K14705039-001-16-4,
REP.PRIMARY,2.5,PF-4708671,RPS6KB1,RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-K14711741-001-02-1,
REP.PRIMARY,2.5,I-BZA,,,BRD:BRD-K14762862-001-01-9,
REP.PRIMARY,2.5,FLUROTHYL,,,BRD:BRD-K14763542-001-02-3,
REP.PRIMARY,2.5,VESAMICOL,SLC18A3,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K14765469-003-12-2,
REP.PRIMARY,2.5,SC-560,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K14767410-001-02-3,
REP.PRIMARY,2.5,BERBERINE,LDLR,LDL RECEPTOR ACTIVATOR,BRD:BRD-K14796088-003-26-8,
REP.PRIMARY,2.5,SB-221284,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K14807180-001-02-5,
REP.PRIMARY,2.5,R-428,AXL,AXL KINASE INHIBITOR,BRD:BRD-K14870255-001-02-3,
REP.PRIMARY,2.5,GW-501516,"PPARA, PPARD",PPAR RECEPTOR AGONIST,BRD:BRD-K14880289-001-02-2,
REP.PRIMARY,2.5,ERYTHROSINE,,COLORING AGENT,BRD:BRD-K14920963-304-02-7,
REP.PRIMARY,2.5,IBUPROFEN-(S),"ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K14965640-001-12-4,
REP.PRIMARY,2.5,GSK650394,"SGK1, SGK2",SERUM/GLUCOCORTICOID REGULATED KINASE INHIBITOR,BRD:BRD-K14991967-001-02-6,
REP.PRIMARY,2.5,BEMEGRIDE,GABRA1,CHEMORECEPTOR AGONIST,BRD:BRD-K14993104-001-05-9,
REP.PRIMARY,2.5,EMEDASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15010214-364-02-7,
REP.PRIMARY,2.5,BAY-11-7082,RELA,NFKB PATHWAY INHIBITOR,BRD:BRD-K15025317-001-15-1,
REP.PRIMARY,2.5,SALAZODINE,,,BRD:BRD-K15045219-001-01-8,
REP.PRIMARY,2.5,TIOTIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15071410-001-01-1,
REP.PRIMARY,2.5,JNJ-10191584,HRH4,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K15086322-050-01-3,
REP.PRIMARY,2.5,GEMCITABINE,"CMPK1, RRM1, RRM2, TYMS",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K15108141-001-06-6,
REP.PRIMARY,2.5,APOPTOSIS-ACTIVATOR-II,"BCHE, CES1",CARBOXYLESTERASE INHIBITOR,BRD:BRD-K15164005-001-05-6,
REP.PRIMARY,2.89,SWAINSONINE,MAN2A1,ALPHA MANNOSIDASE INHIBITOR,BRD:BRD-K15170068-001-03-2,
REP.PRIMARY,2.5,NVP-ADW742,IGF1R,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K15179513-001-03-4,
REP.PRIMARY,2.5,CARFILZOMIB,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9",PROTEASOME INHIBITOR,BRD:BRD-K15179879-001-03-2,
REP.PRIMARY,2.5,IBC-293,HCAR3,HYDROXYCARBOXYLIC ACID RECEPTOR AGONIST,BRD:BRD-K15196155-001-02-3,
REP.PRIMARY,2.5,HEMOMEX-S,PPARG,,BRD:BRD-K15231341-001-01-5,
REP.PRIMARY,2.5,AMMONIUM-GLYCYRRHIZINATE,"HSD11B1, HSD11B2, SLCO1B1, SLCO1B3",THROMBIN INHIBITOR,BRD:BRD-K15318383-201-01-5,
REP.PRIMARY,2.5,PRIMA1,ACHE,TP53 INHIBITOR,BRD:BRD-K15318909-001-10-5,
REP.PRIMARY,2.5,C-751,,,BRD:BRD-K15337272-001-01-3,
REP.PRIMARY,2.5,PENFLURIDOL,CACNA1G,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K15409150-001-05-8,
REP.PRIMARY,2.5,SB-228357,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15424032-001-03-6,
REP.PRIMARY,2.5,IGURATIMOD,PTGS2,"CYCLOOXYGENASE INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K15426076-001-01-2,
REP.PRIMARY,2.5,NEVIRAPINE,"CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K15502390-001-20-9,
REP.PRIMARY,2.5,TESAGLITAZAR,"PPARA, PPARG","INSULIN SENSITIZER, PPAR RECEPTOR AGONIST",BRD:BRD-K15507868-001-03-7,
REP.PRIMARY,2.5,CS-110266,SLC6A3,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K15519488-050-01-3,
REP.PRIMARY,2.5,PHLORETIN,"AQP9, CLCN3, SLC23A1",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K15563106-001-18-0,
REP.PRIMARY,2.5,PAPAVERINE,"PDE10A, PDE4B, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K15567136-003-27-2,
REP.PRIMARY,2.5,R-96544,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15588452-003-02-7,
REP.PRIMARY,2.5,OBATOCLAX,BCL2,BCL INHIBITOR,BRD:BRD-K15600710-066-04-1,
REP.PRIMARY,2.5,SEW-2871,S1PR1,LYSOPHOSPHOLIPID RECEPTOR AGONIST,BRD:BRD-K15601958-001-03-9,
REP.PRIMARY,2.5,URSODIOL,"AKR1C2, NR1H4","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K15697815-001-16-2,
REP.PRIMARY,2.5,CEFDINIR,MPO,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K15766189-001-09-8,
REP.PRIMARY,2.5,L-733060,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K15791587-003-02-5,
REP.PRIMARY,2.5,LOBENDAZOLE,,ANTHELMINTIC AGENT,BRD:BRD-K15834839-001-02-3,
REP.PRIMARY,2.5,SDZ-205-557,"HTR3A, HTR3B",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K15868788-003-07-7,
REP.PRIMARY,2.45,TENOFOVIR,,"HIV INTEGRASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K15891719-001-05-1,
REP.PRIMARY,2.5,MAYTANSINOL-ISOBUTYRATE,,,BRD:BRD-K15898725-001-01-7,
REP.PRIMARY,2.5,CLOTRIMAZOLE,"CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8","CYTOCHROME P450 INHIBITOR, IMIDAZOLINE RECEPTOR LIGAND",BRD:BRD-K15916496-001-27-9,
REP.PRIMARY,2.5,ROPINIROLE,"ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K15933101-003-06-1,
REP.PRIMARY,2.5,TELBIVUDINE,TK2,DNA POLYMERASE INHIBITOR,BRD:BRD-K15976406-001-03-3,
REP.PRIMARY,2.5,Z160,CACNA2D1,N-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K16037980-001-01-1,
REP.PRIMARY,2.5,FENTIAZAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K16077845-001-06-1,
REP.PRIMARY,2.5,PYRITHIONE-ZINC,"KCNQ1, KCNQ2, KCNQ4, KCNQ5",ATP SYNTHASE INHIBITOR,BRD:BRD-K16136380-001-01-7,
REP.PRIMARY,2.5,CHIR-99021,"CDK1, GSK3A, GSK3B, MAPK1",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K16189898-003-03-3,
REP.PRIMARY,2.5,OXYMETAZOLINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K16195444-003-26-0,
REP.PRIMARY,2.5,PIPERACETAZINE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K16277217-001-10-9,
REP.PRIMARY,2.5,ATRASENTAN,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K16295392-003-01-3,
REP.PRIMARY,2.5,CCMI,CHRNA7,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K16338837-001-02-6,
REP.PRIMARY,2.5,IBUDILAST,"IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A","LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K16444452-001-09-1,
REP.PRIMARY,2.5,METACETAMOL,,ANALGESIC AGENT,BRD:BRD-K16474819-001-09-6,
REP.PRIMARY,2.5,PLX-4720,"BRAF, KDR",RAF INHIBITOR,BRD:BRD-K16478699-001-09-2,PLX4720
REP.PRIMARY,2.5,PLX4720,"BRAF, KDR",RAF INHIBITOR,BRD:BRD-K16478699-001-09-2,PLX4720
REP.PRIMARY,2.5,METOCURINE,"CHRM2, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K16484091-001-01-1,
REP.PRIMARY,2.5,MOCETINOSTAT,"HDAC1, HDAC11, HDAC2, HDAC3",HDAC INHIBITOR,BRD:BRD-K16485616-001-08-9,
REP.PRIMARY,2.5,DIAZEPAM,"ADRA1A, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K16508793-001-05-9,
REP.PRIMARY,2.5,ZAPRINAST,"GPR35, PDE1A, PDE4D, PDE5A, PDE9A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K16542329-001-13-5,
REP.PRIMARY,2.5,EVACETRAPIB,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K16551357-001-03-2,
REP.PRIMARY,2.5,PNU-22394,"HTR2A, HTR2B, HTR2C, MAOA, MAOB",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K16551401-003-03-4,
REP.PRIMARY,2.5,GTP-14564,"CSF1R, FLT3, KIT, PDGFRB","FLT3 INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K16664969-001-03-3,
REP.PRIMARY,2.5,REGORAFENIB,"ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK","FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K16730910-001-07-3,
REP.PRIMARY,2.5,MK-0893,GCGR,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K16732600-001-01-7,
REP.PRIMARY,2.5,PRX-08066,HTR2B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K16757695-050-02-5,
REP.PRIMARY,2.5,PERFLUAMINE,,,BRD:BRD-K16758059-001-01-8,
REP.PRIMARY,2.5,SOTRASTAURIN,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ",PKC INHIBITOR,BRD:BRD-K16761703-001-03-8,
REP.PRIMARY,2.5,FILGOTINIB,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K16803204-001-01-6,
REP.PRIMARY,2.5,LGK-974,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K16810791-001-01-0,
REP.PRIMARY,2.5,BEVIRIMAT-DIMEGLUMINE,,HIV CAPSID ASSEMBLY INHIBITOR,BRD:BRD-K16898998-001-01-6,
REP.PRIMARY,2.5,BD-1008,,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K17008822-303-02-1,
REP.PRIMARY,2.5,ESTRIOL,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K17016787-001-16-7,
REP.PRIMARY,2.5,PIBENZIMOL,,DNA INHIBITOR,BRD:BRD-K17026858-001-01-2,
REP.PRIMARY,2.5,STATTIC,,,BRD:BRD-K17061841-001-03-5,
REP.PRIMARY,2.5,BENDAMUSTINE,,DNA INHIBITOR,BRD:BRD-K17068645-003-04-2,
REP.PRIMARY,2.5,CHLOROXINE,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17075857-001-17-6,
REP.PRIMARY,2.5,CHLOROXINE,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17075857-001-18-4,
REP.PRIMARY,2.5,LY2874455,"FGFR1, FGFR2, FGFR3, FGFR4, KDR",FGFR ANTAGONIST,BRD:BRD-K17203476-001-01-9,
REP.PRIMARY,2.5,SULFAMETOPYRAZINE,,PABA ANTAGONIST,BRD:BRD-K17205817-001-06-1,
REP.PRIMARY,2.5,CHLOROXYLENOL,,ATP SYNTHASE INHIBITOR,BRD:BRD-K17223896-001-10-0,
REP.PRIMARY,2.5,CLEBOPRIDE,"ACHE, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K17294426-050-12-3,
REP.PRIMARY,2.5,ADRENOSTERONE,"HSD11B1, HSD11B2",11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K17368287-001-18-3,
REP.PRIMARY,2.5,BP-897,"ADRA1A, ADRA1D, ADRA2A, DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2B",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K17378184-300-05-9,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-835,EGFR,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K17415526-001-03-5,
REP.PRIMARY,2.5,ABACAVIR,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K17443395-065-02-2,
REP.PRIMARY,2.5,BUTEIN,ACE,"EGFR INHIBITOR, SRC INHIBITOR",BRD:BRD-K17497770-001-03-6,
REP.PRIMARY,2.5,BETAXOLOL,"ADRB1, ADRB2, CHRNA2","ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST",BRD:BRD-K17498618-344-02-6,CISATRACURIUM
REP.PRIMARY,2.5,CISATRACURIUM,"ADRB1, ADRB2, CHRNA2","ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR ANTAGONIST",BRD:BRD-K17498618-344-02-6,CISATRACURIUM
REP.PRIMARY,2.5,BROPIRIMINE,,INTERFERON INDUCER,BRD:BRD-K17500877-001-02-1,
REP.PRIMARY,2.5,FIRATEGRAST,ITGA4,INTEGRIN ANTAGONIST,BRD:BRD-K17513304-001-01-9,
REP.PRIMARY,2.5,PENICILLAMINE-(D),,CHELATING AGENT,BRD:BRD-K17518951-001-03-0,
REP.PRIMARY,2.5,TALMAPIMOD,"IL1B, MAPK11, MAPK14, MT-CO2, TNF",P38 MAPK INHIBITOR,BRD:BRD-K17555800-003-01-5,
REP.PRIMARY,2.5,AMIODARONE,"ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K17561142-003-32-5,
REP.PRIMARY,2.5,PRIDINOL,,MUSCLE RELAXANT,BRD:BRD-K17565903-066-23-1,
REP.PRIMARY,2.5,PD-168393,"EGFR, ERBB2, SRC",EGFR INHIBITOR,BRD:BRD-K17702546-001-03-2,
REP.PRIMARY,2.5,JTC-801,OPRL1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K17705806-003-04-4,
REP.PRIMARY,2.5,BELINOSTAT,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K17743125-001-08-4,
REP.PRIMARY,2.5,KB-R7943,"SLC8A1, TRPC3, TRPC5, TRPC6",SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-K17743697-066-03-6,
REP.PRIMARY,2.5,JNJ-7777120,HRH4,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K17774839-001-02-9,
REP.PRIMARY,2.5,TRANILAST,"HPGDS, HRH1",ANGIOGENESIS INHIBITOR,BRD:BRD-K17849083-001-31-1,
REP.PRIMARY,2.43,TRANILAST,"HPGDS, HRH1",ANGIOGENESIS INHIBITOR,BRD:BRD-K17849083-001-32-9,
REP.PRIMARY,2.5,CLOPROSTENOL-(+/-),"PTGDR, PTGER1, PTGER3, PTGFR, TBXA2R",PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K17850764-236-11-9,
REP.PRIMARY,2.5,BRL-54443,"HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K17868609-001-05-0,
REP.PRIMARY,2.5,2-PYRIDYLETHYLAMINE,HRH1,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K17874705-300-03-2,
REP.PRIMARY,2.5,INDIRUBIN,"CDK1, CDK5, GSK3A","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K17894950-001-14-3,
REP.PRIMARY,2.5,LY2886721,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K17953908-001-01-7,
REP.PRIMARY,2.5,OXELAIDIN,,ANTITUSSIVE,BRD:BRD-K17977438-048-02-4,
REP.PRIMARY,2.5,EPROBEMIDE,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K17979676-001-01-2,
REP.PRIMARY,2.5,L-168049,GCGR,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K18036262-001-02-8,
REP.PRIMARY,0.25,GAMMA-LINOLENIC-ACID,"PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR AGONIST",BRD:BRD-K18059238-001-10-4,
REP.PRIMARY,2.5,ETHOXZOLAMIDE,"CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K18131774-001-17-6,
REP.PRIMARY,2.5,CHENODEOXYCHOLIC-ACID,"HSD11B1, NR1H4","11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR, FXR AGONIST",BRD:BRD-K18135438-001-16-7,
REP.PRIMARY,2.5,FDCYD,,DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18157228-001-01-7,
REP.PRIMARY,2.48,HA14-1,BCL2,BCL INHIBITOR,BRD:BRD-K18163608-001-05-6,
REP.PRIMARY,2.5,ELTANOLONE,"GABRA1, GABRB2, GABRG2",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K18172896-001-02-5,
REP.PRIMARY,2.5,MEPHENTERMINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18194590-065-08-0,
REP.PRIMARY,2.5,PROPOXYCAINE,,LOCAL ANESTHETIC,BRD:BRD-K18250272-003-11-0,
REP.PRIMARY,2.5,O-1918,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K18316707-001-02-7,
REP.PRIMARY,2.5,URIDINE-TRIACETATE,,,BRD:BRD-K18323388-001-01-1,
REP.PRIMARY,2.5,BUDIPINE,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K18324993-001-01-6,
REP.PRIMARY,2.5,SPERMINE,"CA14, CA4, CA6, CA9, CASR, GRIN1, GRIN2A, KCNJ4, ODC1, SMOX, SMS, TRPM4, TRPM5",,BRD:BRD-K18375018-376-02-3,
REP.PRIMARY,2.5,TG-100572,"KDR, SRC","SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K18424115-003-01-3,
REP.PRIMARY,2.5,DIGITOXIGENIN,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K18518344-001-15-9,
REP.PRIMARY,2.5,NAFCILLIN,"CYP1A2, CYP3A4, SLC22A6",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K18574842-236-17-7,
REP.PRIMARY,2.51,NAFCILLIN,"CYP1A2, CYP3A4, SLC22A6",BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K18574842-323-10-8,
REP.PRIMARY,2.5,MEXENEONE,,,BRD:BRD-K18613660-001-05-5,
REP.PRIMARY,2.5,DIGOXIGENIN,,STEROID,BRD:BRD-K18619710-001-14-4,
REP.PRIMARY,2.5,FOLIC-ACID,"FOLR2, FOLR3, SLC19A1, SLC46A1",FOLATE RECEPTOR LIGAND,BRD:BRD-K18673820-001-15-5,
REP.PRIMARY,2.5,ZD-7288,"HCN1, HCN2, HCN3, HCN4",HCN CHANNEL BLOCKER,BRD:BRD-K18678457-003-02-8,
REP.PRIMARY,2.5,BENZOQUINONIUM-DIBROMIDE,CHRNA1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K18772613-303-02-4,
REP.PRIMARY,2.5,BIFEMELANE,"MAOA, MAOB",ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-K18779551-003-07-8,
REP.PRIMARY,2.5,U-0126,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K18787491-001-08-6,
REP.PRIMARY,2.5,LB42708,,FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K18834913-001-01-1,
REP.PRIMARY,2.61,DALCETRAPIB,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K18849474-001-04-4,
REP.PRIMARY,2.5,MK-0752,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K18850819-001-04-6,
REP.PRIMARY,2.5,OLANZAPINE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K18895904-001-16-1,
REP.PRIMARY,2.5,ST-91,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18905250-003-02-4,
REP.PRIMARY,2.58,ESTRADIOL,"ESR1, ESR2, GPER1, KCNMA1, NR1I2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K18910433-001-36-6,
REP.PRIMARY,2.5,ESTRADIOL,"ESR1, ESR2, GPER1, KCNMA1, NR1I2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K18910433-001-43-2,
REP.PRIMARY,2.5,NEOSTIGMINE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K18922609-004-23-1,
REP.PRIMARY,2.5,CLEVUDINE,,DNA POLYMERASE INHIBITOR,BRD:BRD-K18948558-001-01-9,
REP.PRIMARY,2.5,LY2801653,MET,MET INHIBITOR,BRD:BRD-K18961567-001-01-1,
REP.PRIMARY,2.5,PACRITINIB,"FLT3, JAK1, JAK2, JAK3","FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K19034817-001-01-4,
REP.PRIMARY,2.5,MUBRITINIB,"EGFR, ERBB2",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K19061412-001-02-4,
REP.PRIMARY,2.5,DARAPLADIB,PLA2G7,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K19085898-001-01-8,
REP.PRIMARY,2.5,CLOFIBRIC-ACID,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K19111024-001-20-9,
REP.PRIMARY,2.5,INDIRUBIN-3-MONOXIME,"CDK1, CDK2, CDK5, CDK5R1, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K19136521-001-08-9,
REP.PRIMARY,2.5,CP-91149,PYGL,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-K19171642-001-02-3,
REP.PRIMARY,2.5,MEPROBAMATE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",,BRD:BRD-K19180152-001-02-6,
REP.PRIMARY,2.5,SPP301,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K19203487-001-01-4,
REP.PRIMARY,2.5,PHENOLPHTHALEIN,UGT1A9,INDICATOR DYE,BRD:BRD-K19227686-001-18-6,
REP.PRIMARY,2.5,SALVINORIN-A,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K19284129-001-02-6,
REP.PRIMARY,2.29,GOSSYPOL,BCL2,"BCL INHIBITOR, MCL1 INHIBITOR",BRD:BRD-K19295594-015-14-3,
REP.PRIMARY,2.5,SR-95639A,CHRM1,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K19309090-300-05-5,
REP.PRIMARY,2.5,FR-139317,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K19318328-001-01-3,
REP.PRIMARY,2.5,RKI-1447,"CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K19333160-001-01-3,
REP.PRIMARY,2.5,PROCHLORPERAZINE,"DRD1, DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K19352500-070-12-4,
REP.PRIMARY,2.5,COLFORSIN-DAPROATE,,ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-K19388745-003-01-7,
REP.PRIMARY,2.5,SB-242235,"HSPB1, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K19412355-001-01-0,
REP.PRIMARY,2.5,SITAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K19416115-001-05-3,
REP.PRIMARY,2.5,CNQX,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K19438463-001-05-5,
REP.PRIMARY,2.5,PIRACETAM,"GRIA1, GRIA2, GRIA3, GRIA4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K19456237-001-27-6,
REP.PRIMARY,2.5,BUFLOMEDIL,ADRA1A,"ADRENERGIC RECEPTOR ANTAGONIST, CALCIUM CHANNEL BLOCKER",BRD:BRD-K19462402-003-24-6,
REP.PRIMARY,2.5,SGX523,MET,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K19477839-001-07-6,
REP.PRIMARY,2.38,MEGESTROL-ACETATE,"NR3C1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K19507340-001-22-1,
REP.PRIMARY,2.5,SARACATINIB,"ABL1, LCK, SRC, YES1",SRC INHIBITOR,BRD:BRD-K19540840-001-09-4,
REP.PRIMARY,2.5,RUXOLITINIB-(S),"JAK1, JAK2",JAK INHIBITOR,BRD:BRD-K19601669-001-03-5,
REP.PRIMARY,2.5,ZM-241385,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K19605405-001-02-7,
REP.PRIMARY,2.5,CREATINE,"CKB, CKM, CKMT1A, CKMT2, GAMT, SLC6A8",,BRD:BRD-K19615002-001-02-3,
REP.PRIMARY,2.5,COMPOUND-401,"MTOR, PRKDC",DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K19655798-001-01-9,
REP.PRIMARY,2.5,GGTI-298,CDKN1A,GGTASE INHIBITOR,BRD:BRD-K19669037-001-01-1,
REP.PRIMARY,2.5,ETHIMIZOL,,,BRD:BRD-K19672466-001-02-3,
REP.PRIMARY,2.5,LAPATINIB,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K19687926-379-07-4,
REP.PRIMARY,2.5,VERNAKALANT,KCNA5,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K19741547-003-01-7,
REP.PRIMARY,2.5,EPLERENONE,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K19761926-001-02-8,
REP.PRIMARY,2.45,EPLERENONE,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K19761926-001-03-6,
REP.PRIMARY,2.5,SONIDEGIB,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K19796430-001-05-6,
REP.PRIMARY,2.5,TIC10,"AKT1, MAPK1","AKT INHIBITOR, TRAIL MODULATOR",BRD:BRD-K19939891-001-05-4,
REP.PRIMARY,2.5,OCTINOXATE,,,BRD:BRD-K19972289-001-01-4,
REP.PRIMARY,2.5,APABETALONE,BRD3,APOLIPOPROTEIN EXPRESSION ENHANCER,BRD:BRD-K20001883-001-02-7,
REP.PRIMARY,2.5,LCQ908,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K20008181-001-01-3,
REP.PRIMARY,2.5,LY411575,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K20013301-001-02-6,
REP.PRIMARY,2.5,BETAZOLE,HRH2,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K20075662-300-04-0,
REP.PRIMARY,2.5,RUFINAMIDE,"GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K20079257-001-09-6,
REP.PRIMARY,2.5,ATOMOXETINE,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4",NOREPINEPHRINE TRANSPORTER INHIBITOR,BRD:BRD-K20141153-003-13-7,
REP.PRIMARY,2.5,DIHOMO-GAMMA-LINOLENIC-ACID,"PTGS1, PTGS2",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K20152659-001-04-6,
REP.PRIMARY,2.5,VECURONIUM,CHRNA2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K20168442-004-06-3,
REP.PRIMARY,2.5,R406,"RET, SYK",SYK INHIBITOR,BRD:BRD-K20285085-001-07-1,
REP.PRIMARY,2.5,R406,"RET, SYK",SYK INHIBITOR,BRD:BRD-K20285085-074-04-5,
REP.PRIMARY,2.5,BIX-02188,MAP2K5,MEK INHIBITOR,BRD:BRD-K20290250-001-01-3,
REP.PRIMARY,2.38,BIX-02188,MAP2K5,MEK INHIBITOR,BRD:BRD-K20290250-001-02-1,
REP.PRIMARY,2.5,ROSMARINIC-ACID,"MCL1, TYR",GABA TRANSAMINASE INHIBITOR,BRD:BRD-K20313525-001-04-6,
REP.PRIMARY,2.5,CEFACLOR,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K20338176-001-17-7,
REP.PRIMARY,2.5,DROXIDOPA,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH",NOREPINEPHRINE PRECURSOR,BRD:BRD-K20372197-001-03-1,
REP.PRIMARY,2.5,OXINIACIC-ACID,,,BRD:BRD-K20417253-001-01-9,
REP.PRIMARY,2.5,BENZOYLPAS,,,BRD:BRD-K20431737-001-08-1,
REP.PRIMARY,2.5,RUTIN,AKR1C3,"ANTIOXIDANT, CAPILLARY STABILIZING AGENT, NITRIC OXIDE SCAVENGER",BRD:BRD-K20482099-001-09-4,
REP.PRIMARY,2.5,RUTIN,AKR1C3,"ANTIOXIDANT, CAPILLARY STABILIZING AGENT, NITRIC OXIDE SCAVENGER",BRD:BRD-K20482099-001-11-0,
REP.PRIMARY,2.5,BARDOXOLONE,"NOS2, PPARG","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K20545304-001-01-6,
REP.PRIMARY,2.5,SCP-1,,ANALGESIC AGENT,BRD:BRD-K20548681-001-01-3,
REP.PRIMARY,2.5,NSC-697923,UBE2N,UBIQUITIN-CONJUGATING ENZYME INHIBITOR,BRD:BRD-K20605374-001-05-4,
REP.PRIMARY,2.5,MEFEXAMIDE,,PSYCHOACTIVE DRUG,BRD:BRD-K20655524-003-12-0,
REP.PRIMARY,2.5,RS-56812,HTR3A,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K20714604-003-02-9,
REP.PRIMARY,2.5,CEP-32496,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K20722021-001-02-1,
REP.PRIMARY,2.5,DAZMEGREL,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K20738689-001-01-2,
REP.PRIMARY,2.5,RS-39604,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K20742498-003-02-9,
REP.PRIMARY,2.5,OLPRINONE,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K20745393-003-01-0,
REP.PRIMARY,2.5,SKI-II,SPHK1,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K20755323-001-05-9,
REP.PRIMARY,2.5,CASTANOSPERMINE,"GAA, GBA",GLUCOSIDASE INHIBITOR,BRD:BRD-K20897876-001-10-0,
REP.PRIMARY,2.5,CROMOGLICIC-ACID,"KCNMA1, S100P",IMMUNOSUPPRESSANT,BRD:BRD-K20920669-304-09-1,
REP.PRIMARY,2.5,TH-302,,DNA ALKYLATING AGENT,BRD:BRD-K20958582-001-01-4,
REP.PRIMARY,2.5,U-54494A,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K20995441-001-02-5,
REP.PRIMARY,2.5,NVP-TAE226,PTK2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K21025364-001-04-9,
REP.PRIMARY,2.44,NVP-TAE226,PTK2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K21025364-001-05-6,
REP.PRIMARY,2.5,VP-20629,"PLA2G2E, SLC36A1",BETA AMYLOID ANTAGONIST,BRD:BRD-K21071223-001-02-8,
REP.PRIMARY,2.5,PRAMIRACETAM,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K21123171-001-02-9,
REP.PRIMARY,2.5,DEXTROAMPHETAMINE,"ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K21160401-065-01-0,
REP.PRIMARY,2.5,BETA-NAPHTHOL,,,BRD:BRD-K21164796-001-02-8,
REP.PRIMARY,2.5,RILUZOLE,"KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11",GLUTAMATE INHIBITOR,BRD:BRD-K21283037-001-21-5,
REP.PRIMARY,2.5,SENICAPOC,KCNN4,INTERMEDIATE CONDUCTANCE POTASSIUM CHANNEL BLOCKER,BRD:BRD-K21295289-001-01-6,
REP.PRIMARY,2.5,SELINEXOR,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K21361524-001-01-1,
REP.PRIMARY,2.5,CEFETAMET-PIVOXIL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K21372554-003-01-7,
REP.PRIMARY,2.5,MARIMASTAT,"MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K21396683-001-04-8,
REP.PRIMARY,2.5,BENZTHIAZIDE,"CA1, CA12, CA2, CA4, CA9, SLC12A3",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K21450440-001-14-6,
REP.PRIMARY,2.5,CHLORAZANIL,,,BRD:BRD-K21452876-003-01-8,
REP.PRIMARY,2.5,SULFACETAMIDE,,PABA ANTAGONIST,BRD:BRD-K21520694-236-02-6,
REP.PRIMARY,2.44,DESONIDE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K21528677-001-02-8,
REP.PRIMARY,2.5,DESONIDE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K21528677-001-03-6,
REP.PRIMARY,2.5,SUFENTANIL,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR MODULATOR,BRD:BRD-K21547160-001-01-4,
REP.PRIMARY,2.5,MORACIZINE,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K21548250-003-19-1,
REP.PRIMARY,2.5,XYLAZINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K21565985-001-22-5,
REP.PRIMARY,2.5,ACETOHYDROXAMIC-ACID,MMP12,UREASE INHIBITOR,BRD:BRD-K21615095-001-08-4,
REP.PRIMARY,2.5,CARIPORIDE,SLC9A1,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K21670884-001-01-9,
REP.PRIMARY,2.5,RO-28-1675,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K21672174-001-03-0,
REP.PRIMARY,2.5,BF2.649,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K21673112-003-01-3,PITOLISANT
REP.PRIMARY,2.5,PITOLISANT,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K21673112-003-01-3,PITOLISANT
REP.PRIMARY,2.5,MITOXANTRONE,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K21680192-300-14-4,
REP.PRIMARY,2.5,KW-2449,"ABL1, AURKA, AURKB, FLT3","ABL KINASE INHIBITOR, AURORA KINASE INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K21718444-001-06-8,
REP.PRIMARY,2.5,AMG900,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K21728777-001-02-3,
REP.PRIMARY,2.5,ROFECOXIB,"ELN, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K21733600-001-14-1,
REP.PRIMARY,2.5,MERBROMIN,,ANTISEPTIC,BRD:BRD-K21771665-304-04-2,
REP.PRIMARY,2.5,AMG458,MET,MET INHIBITOR,BRD:BRD-K21782625-001-02-4,
REP.PRIMARY,2.45,AMG458,MET,MET INHIBITOR,BRD:BRD-K21782625-001-03-2,
REP.PRIMARY,2.5,GSK2816126,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K21867462-001-02-9,
REP.PRIMARY,2.5,MIZOLASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K21884483-001-03-7,
REP.PRIMARY,2.36,UNC669,L3MBTL1,L3MBTL ANTAGONIST,BRD:BRD-K21906513-001-04-0,
REP.PRIMARY,2.5,AZD1208,"PIM1, PIM2, PIM3",PIM KINASE INHIBITOR,BRD:BRD-K21908111-001-01-8,
REP.PRIMARY,2.5,"2,4-DINITROPHENOL",APP,ATP SYNTHASE INHIBITOR,BRD:BRD-K21910317-001-12-3,
REP.PRIMARY,2.5,FLUORESCEIN,SLC22A6,,BRD:BRD-K21913543-001-02-4,
REP.PRIMARY,2.53,LOXISTATIN-ACID,CTSB,CYSTEINE PEPTIDASE INHIBITOR,BRD:BRD-K21937671-001-09-2,
REP.PRIMARY,2.5,LOXISTATIN-ACID,CTSB,CYSTEINE PEPTIDASE INHIBITOR,BRD:BRD-K21937671-001-10-0,
REP.PRIMARY,2.5,PHENPROBAMATE,,MUSCLE RELAXANT,BRD:BRD-K22009844-001-12-5,
REP.PRIMARY,2.5,RG4733,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K22024824-001-03-7,
REP.PRIMARY,2.5,U-18666A,NPC1,OXIDOSQUALENE CYCLASE INHIBITOR,BRD:BRD-K22025381-003-01-9,
REP.PRIMARY,2.5,DIFLUNISAL,"PTGS1, PTGS2",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K22031190-001-23-6,
REP.PRIMARY,2.5,OCO-1112,,CHOLESTEROL INHIBITOR,BRD:BRD-K22097830-001-01-9,
REP.PRIMARY,2.58,CRENOLANIB,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K22127577-001-03-7,
REP.PRIMARY,2.5,SIMVASTATIN,"HMGCR, ITGB2",HMGCR INHIBITOR,BRD:BRD-K22134346-001-22-3,
REP.PRIMARY,2.42,SIMVASTATIN,"HMGCR, ITGB2",HMGCR INHIBITOR,BRD:BRD-K22134346-001-24-9,
REP.PRIMARY,2.5,DIOXYBENZONE,,TOPICAL SUNSCREEN AGENT,BRD:BRD-K22193694-001-13-6,
REP.PRIMARY,2.5,PIRODAVIR,,,BRD:BRD-K22261391-001-01-2,
REP.PRIMARY,2.5,CH223191,AHR,ARYL HYDROCARBON RECEPTOR ANTAGONIST,BRD:BRD-K22314899-001-02-4,
REP.PRIMARY,2.5,IDO5L,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K22356203-001-01-8,
REP.PRIMARY,2.5,LY303511,"BRD2, BRD3, BRD4","CASEIN KINASE INHIBITOR, MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K22385716-001-02-5,
REP.PRIMARY,2.5,DALFAMPRIDINE,"KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K22482860-001-21-4,
REP.PRIMARY,2.5,SCRIPTAID,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K22503835-001-11-0,
REP.PRIMARY,2.5,DVD-111,,,BRD:BRD-K22520627-001-01-7,
REP.PRIMARY,2.5,GANCICLOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K22662435-001-18-3,
REP.PRIMARY,2.5,GANCICLOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K22662435-001-19-1,
REP.PRIMARY,2.5,WIN-64338,BDKRB2,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K22662557-300-01-7,
REP.PRIMARY,2.5,ROXARSONE,,ANTIPROTOZOAL AGENT,BRD:BRD-K22685337-001-13-4,
REP.PRIMARY,2.5,2-BFI,"ADRA2A, ADRA2B, ADRA2C, MAOA, MAOB",IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K22745370-003-02-3,
REP.PRIMARY,2.5,ABT-239,"HRH1, HRH2, HRH3",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K22749967-046-02-3,
REP.PRIMARY,2.5,ODANACATIB,CTSK,CATHEPSIN INHIBITOR,BRD:BRD-K22822991-001-02-3,
REP.PRIMARY,2.5,ZCL-278,CDC42,CDC INHIBITOR,BRD:BRD-K22829793-001-01-0,
REP.PRIMARY,2.5,CHRYSIN,"AKR1B1, CDK6, CYP19A1, CYP1B1",BREAST CANCER RESISTANCE PROTEIN INHIBITOR,BRD:BRD-K22861715-001-17-4,
REP.PRIMARY,2.5,DIPHENYLPYRALINE,"HRH1, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K22936972-003-23-6,
REP.PRIMARY,2.4000000000000004,ZANAMIVIR,NEU2,NEURAMINIDASE INHIBITOR,BRD:BRD-K23067689-001-02-1,
REP.PRIMARY,2.5,BUTACLAMOL,"DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K23082237-003-01-5,
REP.PRIMARY,2.5,DIZOCILPINE-(-),,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K23163214-050-15-1,
REP.PRIMARY,2.5,AV-412,"EGFR, ERBB2",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K23190681-001-01-1,
REP.PRIMARY,2.5,BUSULFAN,,DNA INHIBITOR,BRD:BRD-K23204545-001-16-4,
REP.PRIMARY,2.5,GDC-0980,"FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K23228615-001-02-8,
REP.PRIMARY,2.5,CAMICINAL,MLNR,MOTILIN RECEPTOR AGONIST,BRD:BRD-K23248433-001-01-8,
REP.PRIMARY,2.63,BROXYQUINOLINE,,ANTIPROTOZOAL AGENT,BRD:BRD-K23301018-001-11-7,
REP.PRIMARY,2.5,AMN-082,GRM7,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K23335153-300-02-5,
REP.PRIMARY,2.5,CYT-997,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K23363278-001-02-1,
REP.PRIMARY,2.5,T-0901317,"NCOA1, NCOA2, NR1H2, NR1H3, NR1I2, RXRB",LXR AGONIST,BRD:BRD-K23383398-001-09-9,
REP.PRIMARY,2.5,BENZYLDIMETHYLHEXADECYLAMMONIUM,,CATIONIC SURFACTANT,BRD:BRD-K23403298-003-01-9,
REP.PRIMARY,2.5,DIMAPRIT,"HRH2, HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K23541596-300-07-2,
REP.PRIMARY,2.5,NILUTAMIDE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K23566484-001-15-1,
REP.PRIMARY,2.5,CLINDAMYCIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K23586533-001-03-6,
REP.PRIMARY,2.5,VOLINANSERIN,"HTR2A, HTR2B, HTR2C, KCNH2",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K23647661-001-02-2,
REP.PRIMARY,2.5,BCI-540,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K23672206-001-01-4,
REP.PRIMARY,2.5,VORELOXIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K23677682-003-01-2,
REP.PRIMARY,2.5,TAFAMIDIS-MEGLUMINE,TTR,TRANSTHYRETIN AMYLOID INHIBITOR,BRD:BRD-K23728141-001-01-2,
REP.PRIMARY,2.5,DICHLORVOS,,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K23779958-001-05-8,
REP.PRIMARY,2.5,COUMARIN,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6",VITAMIN K ANTAGONIST,BRD:BRD-K23913458-001-20-7,
REP.PRIMARY,2.5,ARECAIDINE-PROPARGYL-ESTER,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K23922020-075-02-9,
REP.PRIMARY,2.5,ORIDONIN,BCL2,BCL INHIBITOR,BRD:BRD-K23925186-001-01-0,
REP.PRIMARY,2.51,ORIDONIN,BCL2,BCL INHIBITOR,BRD:BRD-K23925186-001-02-8,
REP.PRIMARY,2.5,AM095,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-01-8,BMS-986020
REP.PRIMARY,2.5,BMS-986020,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-01-8,BMS-986020
REP.PRIMARY,2.5,TRAVOPROST,PTGFR,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K23976833-001-01-0,
REP.PRIMARY,2.5,SORAFENIB,"BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAF INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K23984367-075-15-2,
REP.PRIMARY,2.59,ABIRATERONE-ACETATE,CYP17A1,ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K24048528-001-01-7,
REP.PRIMARY,2.5,ABIRATERONE-ACETATE,CYP17A1,ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K24048528-001-02-5,
REP.PRIMARY,2.5,PARAXANTHINE,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K24084088-001-11-3,
REP.PRIMARY,2.5,ARSANILIC-ACID,LYZ,,BRD:BRD-K24179883-001-16-7,
REP.PRIMARY,2.5,VU0238429,CHRM5,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K24187789-001-01-7,
REP.PRIMARY,2.5,SB-269970,HTR7,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K24201553-003-11-5,
REP.PRIMARY,2.5,AMINEPTINE,"SLC6A2, SLC6A4",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K24219278-001-01-6,
REP.PRIMARY,2.5,TC2559,CHRNA4,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K24227647-364-01-5,
REP.PRIMARY,2.5,GW-2580,CSF1R,CFMS KINASE INHIBITOR,BRD:BRD-K24242599-001-02-8,
REP.PRIMARY,2.5,FLUOXYMESTERONE,"AR, ESR1, NR3C1, PRLR",ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K24255045-001-05-3,
REP.PRIMARY,2.5,VANILLIN,"ABAT, ALDH5A1",,BRD:BRD-K24258499-001-05-8,
REP.PRIMARY,2.5,URETHANE,,LOCAL ANESTHETIC,BRD:BRD-K24297741-001-05-2,
REP.PRIMARY,2.5,TECOVIRIMAT,,ORTHOPOXVIRUS EGRESS INHIBITOR,BRD:BRD-K24312986-001-01-2,
REP.PRIMARY,2.5,ETEBENECID,,URICOSURIC BLOCKER,BRD:BRD-K24443618-001-10-2,
REP.PRIMARY,2.5,CINTRIAMIDE,,,BRD:BRD-K24507548-001-01-8,
REP.PRIMARY,2.5,EVANS-BLUE,"GRIA1, PTPN1",GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K24548560-342-02-1,
REP.PRIMARY,2.45,DEOXYCORTICOSTERONE-ACETATE,NR3C2,PROGESTOGEN HORMONE,BRD:BRD-K24556098-001-16-7,
REP.PRIMARY,2.5,DEOXYCORTICOSTERONE-ACETATE,NR3C2,PROGESTOGEN HORMONE,BRD:BRD-K24556098-001-19-1,
REP.PRIMARY,2.5,ETP-46464,,ATR KINASE INHIBITOR,BRD:BRD-K24556407-001-02-3,
REP.PRIMARY,2.5,SD-208,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K24566386-001-01-9,
REP.PRIMARY,2.5,AT-9283,"AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A","AURORA KINASE INHIBITOR, JAK INHIBITOR",BRD:BRD-K24576554-001-04-8,
REP.PRIMARY,2.54,AZD3463,"ALK, IGF1R","ALK TYROSINE KINASE RECEPTOR INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K24593301-001-02-3,
REP.PRIMARY,2.5,PHLORIZIN,"SLC5A1, SLC5A11, SLC5A2, SLC5A3",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K24601397-001-01-1,
REP.PRIMARY,2.5,5-HYDROXYMETHYL-TOLTERODINE,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K24603946-001-02-1,
REP.PRIMARY,2.5,PROCAINE,"CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3",HMGCR INHIBITOR,BRD:BRD-K24616672-003-20-1,
REP.PRIMARY,2.5,3-BROMO-7-NITROINDAZOLE,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K24689407-001-06-3,
REP.PRIMARY,2.5,NVP-AEW541,"IGF1R, INSR",IGF-1 INHIBITOR,BRD:BRD-K24696047-001-02-3,
REP.PRIMARY,2.5,BUCILLAMINE,,IMMUNOSUPPRESSANT,BRD:BRD-K24697665-001-01-4,
REP.PRIMARY,2.53,ETHACRIDINE-LACTATE-MONOHYDRATE,,DNA INTERCALATING AGENT,BRD:BRD-K24715592-406-02-1,
REP.PRIMARY,2.5,SOLIFENACIN-SUCCINATE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K24723746-036-02-5,
REP.PRIMARY,2.5,AMPALEX,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K24771047-001-01-6,
REP.PRIMARY,2.5,TRICAPRYLIN,,,BRD:BRD-K24790130-001-07-1,
REP.PRIMARY,2.5,CH-170,,,BRD:BRD-K24820488-001-01-7,
REP.PRIMARY,2.5,SGC-CBP30,"CREBBP, EP300",BROMODOMAIN INHIBITOR,BRD:BRD-K24821794-001-01-4,
REP.PRIMARY,2.5,5-FLUOROURACIL,"DPYD, TYMS",THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K24844714-001-24-5,
REP.PRIMARY,2.5,CNX-2006,EGFR,EGFR INHIBITOR,BRD:BRD-K24869513-001-02-1,
REP.PRIMARY,2.5,GRAZOPREVIR,,HCV INHIBITOR,BRD:BRD-K24943235-001-01-3,
REP.PRIMARY,2.5,SB-683698,"ITGA4, ITGAV, ITGB1, ITGB7",INTEGRIN ANTAGONIST,BRD:BRD-K24968862-001-01-0,
REP.PRIMARY,2.5,LIMAPROST-ALFADEX,PTGER1,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K25015158-001-01-2,
REP.PRIMARY,2.5,AMINOGUANIDINE,"AKR1B1, NOS2, TIMP3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K25114078-003-08-1,
REP.PRIMARY,2.5,CX-516,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K25140590-001-03-0,
REP.PRIMARY,2.5,TANGERITIN,,CELL CYCLE INHIBITOR,BRD:BRD-K25186396-001-09-6,
REP.PRIMARY,2.5,PRITELIVIR,,HELICASE PRIMASE INHIBITOR,BRD:BRD-K25204779-001-01-1,
REP.PRIMARY,2.5,PIRENPERONE,"HTR2A, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K25224017-001-25-0,
REP.PRIMARY,2.68,APATINIB,"CSK, KDR, KIT, RET",RET TYROSINE KINASE INHIBITOR,BRD:BRD-K25244359-066-03-4,
REP.PRIMARY,2.5,MK-8745,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K25279140-001-01-5,
REP.PRIMARY,2.5,KU-55933,"ATM, PRKDC",ATM KINASE INHIBITOR,BRD:BRD-K25311561-001-10-7,
REP.PRIMARY,2.5,MATRINE,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K25312248-001-01-5,
REP.PRIMARY,2.5,MODALINE,,,BRD:BRD-K25317177-065-01-4,
REP.PRIMARY,2.58,OSI-930,"FLT1, KDR, KIT","KIT INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K25340465-001-11-1,
REP.PRIMARY,2.5,WZ811,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K25359048-001-02-6,
REP.PRIMARY,2.5,OXAPROZIN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K25394294-001-14-9,
REP.PRIMARY,2.5,GSK2110183,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K25412176-001-01-9,
REP.PRIMARY,2.5,MAPROTILINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2","NOREPINEPHRINE REPUTAKE INHIBITOR, TRICYCLIC ANTIDEPRESSANT",BRD:BRD-K25433859-003-25-4,
REP.PRIMARY,2.5,DRF053-(R),CSNK1A1,CDK INHIBITOR,BRD:BRD-K25486274-300-01-0,
REP.PRIMARY,2.5,JNJ-16259685,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K25596805-001-01-8,
REP.PRIMARY,2.5,LY2784544,"JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K25630527-001-03-8,
REP.PRIMARY,2.5,2-IODOMELATONIN,"MTNR1A, MTNR1B, NQO2",MELATONIN RECEPTOR AGONIST,BRD:BRD-K25649279-001-02-0,
REP.PRIMARY,2.5,PHYSOSTIGMINE,"ACHE, BCHE","ACETYLCHOLINESTERASE INHIBITOR, CHOLINESTERASE INHIBITOR",BRD:BRD-K25650355-065-02-0,
REP.PRIMARY,2.5,4-IODO-6-PHENYLPYRIMIDINE,MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-K25690923-001-02-4,
REP.PRIMARY,2.5,CHUANXIONGZINE,,,BRD:BRD-K25691735-001-09-5,
REP.PRIMARY,2.5,TAPENTADOL,"HTR3A, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4",OPIOID RECEPTOR AGONIST,BRD:BRD-K25699529-003-01-1,
REP.PRIMARY,2.5,AZILSARTAN-MEDOXOMIL,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K25723200-001-02-7,
REP.PRIMARY,2.5,PRT062070,SYK,"JAK INHIBITOR, SYK INHIBITOR",BRD:BRD-K25835157-001-01-4,
REP.PRIMARY,2.5,JOSAMYCIN,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K25837718-001-03-8,
REP.PRIMARY,2.5,SC-9,PRKCA,PROTEIN TYROSINE KINASE ACTIVATOR,BRD:BRD-K25875056-001-02-0,
REP.PRIMARY,2.5,IMMEPIP,"HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K25906698-303-02-7,
REP.PRIMARY,2.5,BLONANSERIN,"DRD2, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K25943794-001-02-3,
REP.PRIMARY,2.5,BMS-649,RXRA,RETINOID RECEPTOR AGONIST,BRD:BRD-K25991633-001-01-9,
REP.PRIMARY,2.5,GRAMINE,,NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K26005076-001-12-8,
REP.PRIMARY,2.5,LICOCHALCONE-A,PTPN1,TOPOISOMERASE INHIBITOR,BRD:BRD-K26011976-001-01-0,
REP.PRIMARY,2.5,ADENINE,"ACACB, ACP1, APRT, MTAP, PECR, SRPK2",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K26060080-065-05-6,
REP.PRIMARY,2.5,RS-45041-190,,IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K26160755-003-02-6,
REP.PRIMARY,2.5,MAGNOLOL,"GABRA1, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K26168087-001-09-7,
REP.PRIMARY,2.5,"TRANS-10,CIS-12-CONJUGATED-LINOLEIC-ACID",,,BRD:BRD-K26222048-001-01-7,
REP.PRIMARY,2.5,NMS-873,VCP,ATPASE INHIBITOR,BRD:BRD-K26253904-001-01-5,
REP.PRIMARY,2.5,ACAMPROSATE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K26262077-238-01-5,
REP.PRIMARY,2.5,K-RAS(G12C)-INHIBITOR-6,,K-RAS INHIBITOR,BRD:BRD-K26305185-001-02-1,
REP.PRIMARY,2.5,API-001,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K26325692-003-01-3,
REP.PRIMARY,2.5,L-ERGOTHIONEINE,,FREE RADICAL SCAVENGER,BRD:BRD-K26341917-001-01-3,
REP.PRIMARY,2.5,OG-L002,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K26349472-001-01-3,
REP.PRIMARY,2.5,IKK-2-INHIBITOR,IKBKB,"IKK INHIBITOR, SYK INHIBITOR",BRD:BRD-K26373640-001-05-1,
REP.PRIMARY,2.5,VANITIOLIDE,,,BRD:BRD-K26502378-001-07-9,
REP.PRIMARY,2.5,EPZ-5676,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26531771-001-01-4,
REP.PRIMARY,2.35,EPZ-5676,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26531771-001-02-2,
REP.PRIMARY,2.5,QUINPIROL-(-),"DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K26548821-003-10-5,
REP.PRIMARY,2.5,DMAB-ANABASEINE,CHRNA7,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K26573499-300-02-1,
REP.PRIMARY,2.5,BIFENDATE,,,BRD:BRD-K26581543-001-01-6,
REP.PRIMARY,2.5,PD-153035,"EGFR, KDR",EGFR INHIBITOR,BRD:BRD-K26603252-003-04-9,
REP.PRIMARY,2.5,THIOCOLCHICOSIDE,"GABRA1, GABRB2, GABRG2, GLRA1, GLRB",GABA RECEPTOR ANTAGONIST,BRD:BRD-K26619122-001-02-1,
REP.PRIMARY,2.5,TILMICOSIN,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K26634012-001-04-9,
REP.PRIMARY,2.5,IMIQUIMOD,"TLR7, TLR8","INTERFERON INDUCER, TOLL-LIKE RECEPTOR AGONIST",BRD:BRD-K26657438-001-15-2,
REP.PRIMARY,2.5,TAK-733,MAP2K1,MEK INHIBITOR,BRD:BRD-K26667523-001-02-5,
REP.PRIMARY,2.5,TEGOBUVIR,,"HCV INHIBITOR, PROTEASE INHIBITOR",BRD:BRD-K26701552-001-01-8,
REP.PRIMARY,2.5,VX-765,CASP1,CASPASE INHIBITOR,BRD:BRD-K26712974-001-01-5,
REP.PRIMARY,2.5,FENSPIRIDE,,BRONCHODILATOR,BRD:BRD-K26739552-003-15-4,
REP.PRIMARY,2.5,VE-821,ATR,ATR KINASE INHIBITOR,BRD:BRD-K26756394-001-02-2,
REP.PRIMARY,2.5,PIPAMPERONE,"DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K26801045-001-02-9,
REP.PRIMARY,2.5,AKLOMIDE,,,BRD:BRD-K26807903-001-04-3,
REP.PRIMARY,2.5,BIX-01294,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26818574-305-04-3,
REP.PRIMARY,2.5,GW-842166,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K26823213-001-02-9,
REP.PRIMARY,2.5,AZOMYCIN-(2-NITROIMIDAZOLE),,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K26824830-001-02-0,
REP.PRIMARY,2.5,COSTUNOLIDE,,TELOMERASE INHIBITOR,BRD:BRD-K26833429-001-02-8,
REP.PRIMARY,2.5,AST-1306,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K26838195-075-04-9,
REP.PRIMARY,2.5,DIOSMETIN,CYP1B1,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K26862302-001-05-2,
REP.PRIMARY,2.5,LUMIRACOXIB,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K26901728-001-06-2,
REP.PRIMARY,2.5,UNC1999,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26989966-001-03-5,
REP.PRIMARY,2.5,D-64131,TUBB,MICROTUBULE INHIBITOR,BRD:BRD-K26997899-001-02-2,
REP.PRIMARY,2.5,CHLOROTRIANISENE,"ESR1, ESR2",ESTROGENIC HORMONE,BRD:BRD-K27062708-001-23-1,
REP.PRIMARY,2.5,XANTHONE,,ANTIMALARIAL AGENT,BRD:BRD-K27135764-001-08-7,
REP.PRIMARY,2.5,SB-203186,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K27141178-003-07-3,
REP.PRIMARY,2.5,SDZ-220-581,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K27168049-001-02-8,
REP.PRIMARY,2.5,METATINIB,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K27182532-001-02-3,
REP.PRIMARY,2.5,LEVOCETIRIZINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K27184429-300-01-3,
REP.PRIMARY,2.5,BALICATIB,CTSK,CATHEPSIN INHIBITOR,BRD:BRD-K27204852-001-01-9,
REP.PRIMARY,2.5,BUTAMBEN,,SODIUM CHANNEL BLOCKER,BRD:BRD-K27217864-001-22-3,
REP.PRIMARY,2.5,LY294002,"AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIM1, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1","DNA DEPENDENT PROTEIN KINASE INHIBITOR, MTOR INHIBITOR, PHOSPHODIESTERASE INHIBITOR, PI3K INHIBITOR, PLK INHIBITOR",BRD:BRD-K27305650-001-16-6,
REP.PRIMARY,2.44,CALCITRIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K27316855-001-13-3,
REP.PRIMARY,2.5,CALCITRIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K27316855-001-19-0,
REP.PRIMARY,2.5,RHEIN,HSP90AA1,,BRD:BRD-K27335680-001-10-0,
REP.PRIMARY,2.5,NOMEGESTROL-ACETATE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K27351809-001-09-5,
REP.PRIMARY,2.5,PIPERAQUINE-PHOSPHATE,,ANTIMALARIAL AGENT,BRD:BRD-K27382019-418-01-9,
REP.PRIMARY,2.5,XIPAMIDE,SLC12A3,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K27393415-001-01-0,
REP.PRIMARY,2.5,ACETYL-L-LEUCINE,,,BRD:BRD-K27406233-001-07-7,
REP.PRIMARY,2.5,CLOPIDOGREL,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K27721098-065-08-6,
REP.PRIMARY,2.5,H-89,"GSG2, PKIA, PRKACA",PKA INHIBITOR,BRD:BRD-K27737647-300-03-0,
REP.PRIMARY,2.5,CLINDAMYCIN-PHOSPHATE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K27771035-001-02-5,
REP.PRIMARY,2.52,CYCLOVIROBUXIN-D,,CALCIUM CHANNEL MODULATOR,BRD:BRD-K27799744-001-02-8,
REP.PRIMARY,2.5,"1S,2R-PHENYLPROPANOLAMINE","ADRA1A, ADRA2A, ADRB1, ADRB2, DRD1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K27853494-003-04-7,
REP.PRIMARY,2.5,FLUCLOXACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27871792-001-01-8,
REP.PRIMARY,2.5,"CHROMANOL-293B-(-)-[3R,4S]",,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K27911943-001-02-8,
REP.PRIMARY,2.5,ASA-404,,ANGIOGENESIS INHIBITOR,BRD:BRD-K27938825-001-02-4,
REP.PRIMARY,2.5,LOMEGUATRIB,MGMT,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,BRD:BRD-K27955832-001-02-9,
REP.PRIMARY,2.5,RO-60-0175,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K28007504-051-01-2,
REP.PRIMARY,2.5,DOLASETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K28029915-001-02-2,
REP.PRIMARY,5,,,,BRD:BRD-K28042756-001-01-9,
REP.PRIMARY,2.5,INCB-003284,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K28059174-334-01-2,
REP.PRIMARY,2.5,APAFANT,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K28115081-001-02-7,
REP.PRIMARY,2.5,PARTHENOLIDE-(ALTERNATE-STEREO),"IKBKB, RELA",NFKB PATHWAY INHIBITOR,BRD:BRD-K28120222-001-08-4,
REP.PRIMARY,2.5,N-ACETYLGLYCYL-D-GLUTAMIC-ACID,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K28121004-001-01-1,
REP.PRIMARY,2.5,CYPROHEPTADINE,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28143534-001-02-2,
REP.PRIMARY,2.5,CYPROHEPTADINE,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28143534-003-25-9,
REP.PRIMARY,2.5,PROGUANIL,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K28183345-003-11-4,
REP.PRIMARY,2.5,SPIRADOLINE,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K28192623-066-08-1,
REP.PRIMARY,2.5,CEPHALOTHIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K28210218-236-08-1,
REP.PRIMARY,2.5,GANAXOLONE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6",GABA RECEPTOR MODULATOR,BRD:BRD-K28217197-001-01-4,
REP.PRIMARY,2.5,FLUTAMIDE,"AHR, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K28307902-001-21-7,
REP.PRIMARY,2.5,ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(S)-(+),HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K28308851-303-01-8,
REP.PRIMARY,2.5,20-HYDROXYECDYSONE,,ECDYSONE RECEPTOR MODULATOR,BRD:BRD-K28343777-001-01-6,
REP.PRIMARY,2.5,CH5132799,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K28352084-001-02-3,
REP.PRIMARY,2.31,TW-37,"BCL2, BCL2L1, MCL1",BCL INHIBITOR,BRD:BRD-K28360340-001-08-3,
REP.PRIMARY,2.5,AP1903,MTOR,,BRD:BRD-K28383148-001-01-4,
REP.PRIMARY,2.5,AZD4547,"FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR",FGFR INHIBITOR,BRD:BRD-K28392481-001-05-1,
REP.PRIMARY,2.5,MECARBINATE,,,BRD:BRD-K28405228-001-06-7,
REP.PRIMARY,2.5,BRIVANIB,"CYP3A4, FGFR1, FLT1, KCNH2, KDR","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K28428262-001-04-1,
REP.PRIMARY,2.5,R-1479,,HCV INHIBITOR,BRD:BRD-K28442028-001-01-3,
REP.PRIMARY,2.5,NITROCARAMIPHEN,CHRM1,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K28453807-003-11-2,
REP.PRIMARY,2.5,SEOCALCITOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K28456624-001-01-1,
REP.PRIMARY,2.5,PICONOL,,,BRD:BRD-K28492574-001-01-6,
REP.PRIMARY,2.5,SULFAMETHOXAZOLE,,PABA ANTAGONIST,BRD:BRD-K28494619-001-28-2,
REP.PRIMARY,2.5,BENZYDAMINE,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K28542495-003-13-5,
REP.PRIMARY,2.5,A-803467,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K28570407-001-02-0,
REP.PRIMARY,2.5,CILOSTAMIDE,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K28578425-001-07-0,
REP.PRIMARY,2.5,MEGLUMINE,,EXCIPIENT,BRD:BRD-K28595280-001-04-5,
REP.PRIMARY,2.5,PYRAZINAMIDE,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K28667793-001-28-1,
REP.PRIMARY,2.5,DIOSGENIN,,STEROID,BRD:BRD-K28690501-001-02-1,
REP.PRIMARY,2.5,ZUCLOPENTHIXOL,"ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28761384-300-01-0,
REP.PRIMARY,2.5,RAMELTEON,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K28761891-001-10-1,
REP.PRIMARY,2.5,RESMINOSTAT,"HDAC1, HDAC3, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K28822270-001-01-1,
REP.PRIMARY,2.5,GENIPIN,,CHOLERETIC AGENT,BRD:BRD-K28824103-001-02-8,
REP.PRIMARY,2.5,GENIPIN,,CHOLERETIC AGENT,BRD:BRD-K28824103-001-04-4,
REP.PRIMARY,2.5,MESALAZINE,"ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K28849549-001-13-4,
REP.PRIMARY,2.5,A922500,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K28861668-001-01-9,
REP.PRIMARY,2.5,PNU-282987,CHRNA7,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K28863208-001-02-0,
REP.PRIMARY,2.5,CD-437,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K28907958-001-04-3,
REP.PRIMARY,2.5,NICOTINAMIDE,"BST1, LDHA, PARP1, SIRT5",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K28912512-001-23-2,
REP.PRIMARY,2.5,KETOTIFEN,"HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD","HISTAMINE RECEPTOR AGONIST, LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K28936863-051-33-0,KETOTIFEN (FUMARATE)
REP.PRIMARY,2.5,KETOTIFEN (FUMARATE),"HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD","HISTAMINE RECEPTOR AGONIST, LEUKOTRIENE RECEPTOR ANTAGONIST, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K28936863-051-33-0,KETOTIFEN (FUMARATE)
REP.PRIMARY,2.5,BVD-523,,MAP KINASE INHIBITOR,BRD:BRD-K28965160-001-01-1,
REP.PRIMARY,2.5,ZD-7114,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K28971625-003-01-4,
REP.PRIMARY,2.5,EMOXIPIN,,,BRD:BRD-K28982731-001-01-6,
REP.PRIMARY,2.5,"ICI-185,282",,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K29133151-001-03-2,
REP.PRIMARY,2.5,ISOFLUPREDONE-ACETATE,NR3C1,,BRD:BRD-K29173907-001-09-2,
REP.PRIMARY,2.5,ESZOPICLONE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K29220403-001-10-8,
REP.PRIMARY,2.5,THIRAM,JAK2,,BRD:BRD-K29254801-001-14-7,
REP.PRIMARY,2.5,EDOXABAN,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K29322660-001-01-9,
REP.PRIMARY,2.5,EBSELEN,ALB,"CYCLOOXYGENASE INHIBITOR, GLUTATHIONE PEROXIDASE AGONIST, H+/K+-ATPASE INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K29359156-001-30-1,
REP.PRIMARY,2.5,PANTOTHENIC-ACID,,COENZYME A PRECURSOR,BRD:BRD-K29392254-001-02-2,
REP.PRIMARY,2.5,PIK-93,"PI4KB, PIK3C3, PIK3CG",PI3K INHIBITOR,BRD:BRD-K29395450-001-06-8,
REP.PRIMARY,2.5,BGT226,"MTOR, PIK3CA, PIK3CB, PIK3CG",PI3K INHIBITOR,BRD:BRD-K29415052-050-04-8,
REP.PRIMARY,2.5,CHLORAMBUCIL,,DNA INHIBITOR,BRD:BRD-K29458283-001-29-9,
REP.PRIMARY,2.5,DESERPIDINE,"ACE, SLC18A2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K29462201-001-01-9,
REP.PRIMARY,2.5,AMLEXANOX,"FGF1, IL3, PDE4A, PDE4B, PDE4C, PDE4D, S100A12, S100A13",HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K29530284-001-06-2,
REP.PRIMARY,2.5,1-NAPHTHYL-PP1,SRC,SRC INHIBITOR,BRD:BRD-K29542628-001-03-9,
REP.PRIMARY,2.5,SNC-80,OPRD1,,BRD:BRD-K29546239-001-02-3,
REP.PRIMARY,2.5,ZIPRASIDONE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K29582115-066-01-2,
REP.PRIMARY,2.5,FLUNARIZINE,"CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1",CALCIUM CHANNEL BLOCKER,BRD:BRD-K29582677-300-10-6,
REP.PRIMARY,2.5,TOPIRAMATE,"CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","CARBONIC ANHYDRASE INHIBITOR, GLUTAMATE RECEPTOR ANTAGONIST, KAINATE RECEPTOR ANTAGONIST",BRD:BRD-K29653726-001-13-4,
REP.PRIMARY,2.5,MK-8245,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K29656036-001-02-5,
REP.PRIMARY,2.5,BD-1063,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K29668683-300-02-2,
REP.PRIMARY,2.5,HYPERICIN,,TYROSINE KINASE INHIBITOR,BRD:BRD-K29673530-001-05-4,
REP.PRIMARY,2.5,MEBHYDROLIN,,ANTIHISTAMINE,BRD:BRD-K29713308-001-01-7,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE",,ANTIHISTAMINE,BRD:BRD-K29713308-001-01-7,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,MEBHYDROLIN,,ANTIHISTAMINE,BRD:BRD-K29713308-077-04-1,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE",,ANTIHISTAMINE,BRD:BRD-K29713308-077-04-1,"MEBHYDROLINE-1,5-NAPHTALENEDISULFONATE"
REP.PRIMARY,2.5,OSTARINE,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K29735307-001-02-9,
REP.PRIMARY,2.5,MYRICITRIN,"NOS1, PRKCA",PKC INHIBITOR,BRD:BRD-K29834313-001-01-4,
REP.PRIMARY,2.5,SKLB1002,KDR,VEGFR INHIBITOR,BRD:BRD-K29895144-001-01-0,
REP.PRIMARY,2.5,AXITINIB,"CSF1, FLT1, FLT4, KDR, PLK4","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K29905972-001-06-3,
REP.PRIMARY,2.5,GLUCOSAMINE,"IFNG, IL1B, MMP9, NFKB2, TNF",GLYCOSYLATED PROTEIN PRECURSOR,BRD:BRD-K29918010-003-04-1,
REP.PRIMARY,2.5,CLOMIFENE,ESR1,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K29950728-048-17-4,
REP.PRIMARY,2.5,KX2-391,SRC,"SRC INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K29968218-001-03-2,
REP.PRIMARY,2.5,DEXFOSFOSERINE,"CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K30019776-003-01-5,
REP.PRIMARY,2.5,ALISKIREN-HEMIFUMARATE,REN,RENIN INHIBITOR,BRD:BRD-K30020243-051-02-5,
REP.PRIMARY,2.5,METHENAMINE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K30114692-001-15-9,
REP.PRIMARY,2.5,DIMESNA,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30126819-304-02-7,
REP.PRIMARY,2.5,FENOFIBRIC-ACID,"CLCN1, PPARA",CYTOCHROME P450 INHIBITOR,BRD:BRD-K30213273-001-01-6,
REP.PRIMARY,2.5,1400W,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K30237152-300-02-5,
REP.PRIMARY,2.5,CLEMASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K30240666-051-15-9,
REP.PRIMARY,2.5,ASC-J9,AR,ANDROGEN RECEPTOR ENHANCER,BRD:BRD-K30331124-001-01-7,
REP.PRIMARY,2.5,DUTASTERIDE,"SRD5A1, SRD5A2, SRD5A3",5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K30373883-001-02-8,
REP.PRIMARY,2.5,MANNITOL-D,,DIURETIC,BRD:BRD-K30374899-001-09-3,
REP.PRIMARY,2.5,TIMOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K30421593-050-04-9,
REP.PRIMARY,2.5,DOMIPHEN,,,BRD:BRD-K30431096-004-01-3,
REP.PRIMARY,2.5,ELLAGIC-ACID,"CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK","GLUTATHIONE TRANSFERASE INHIBITOR, NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K30466858-001-09-6,
REP.PRIMARY,2.5,TORASEMIDE,SLC12A1,"ELECTROLYTE REABSORPTION INHIBITOR, THROMBOXANE RECEPTOR ANTAGONIST",BRD:BRD-K30480208-001-18-5,
REP.PRIMARY,2.5,HOMOQUINOLINIC-ACID,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K30519779-001-03-1,
REP.PRIMARY,2.5,PF-04620110,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K30550578-001-01-3,
REP.PRIMARY,2.5,HESPERETIN,"DGAT1, MTTP, SOAT1, SOAT2",ACAT INHIBITOR,BRD:BRD-K30553453-001-13-2,
REP.PRIMARY,2.5,RIFABUTIN,"HSP90AA1, HSP90B1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K30563334-001-02-9,
REP.PRIMARY,2.5,CTEP,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K30572193-001-02-0,
REP.PRIMARY,2.5,DOCETAXEL,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30577245-001-04-3,
REP.PRIMARY,2.5,DOCETAXEL,"BCL2, MAP2, MAP4, MAPT, NR1I2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K30577245-341-01-9,
REP.PRIMARY,2.5,LEVALLORPHAN,"CHRNA2, OPRM1","OPIOID ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K30634073-046-01-0,
REP.PRIMARY,2.5,MAFENIDE,"CA12, CA14, CA2, CA4, CA6, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K30649484-003-13-7,
REP.PRIMARY,2.5,ELETRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K30652337-004-02-1,
REP.PRIMARY,2.5,LEVOTHYROXINE,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K30685142-001-15-4,
REP.PRIMARY,2.5,PNU-74654,"CTNNB1, TCF4",BETA-CATENIN INHIBITOR,BRD:BRD-K30707190-001-04-1,
REP.PRIMARY,2.5,ISOPROPYL-PALMITATE,,COSMETIC MOISTURIZER,BRD:BRD-K30758549-001-01-8,
REP.PRIMARY,2.5,SB-216641,"HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K30867024-003-03-3,
REP.PRIMARY,2.5,UNBS-5162,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K30933884-001-01-0,
REP.PRIMARY,2.5,PIK-293,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K30977212-001-02-8,
REP.PRIMARY,2.5,FR-122047,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K30990140-003-02-4,
REP.PRIMARY,2.5,BMY-7378,"ADRA1A, ADRA1B, ADRA1D, HTR1A","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K31054881-300-04-7,
REP.PRIMARY,2.5,NH125,,EUKARYOTIC TRANSLATION ELONGATION FACTOR 2 INHIBITOR,BRD:BRD-K31086665-005-04-6,
REP.PRIMARY,2.5,DONITRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR5A, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K31092604-003-03-5,
REP.PRIMARY,2.5,DIMETHYL-FUMARATE,KEAP1,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K31111078-001-04-2,
REP.PRIMARY,2.5,IB-MECA,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K31135544-001-07-0,
REP.PRIMARY,2.5,TOFACITINIB,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K31283835-048-04-4,
REP.PRIMARY,2.5,LUCITANIB,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K31309378-001-01-5,
REP.PRIMARY,2.5,BS-181,CDK7,CDK INHIBITOR,BRD:BRD-K31313613-003-04-2,
REP.PRIMARY,2.5,LIRIMILAST,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K31339321-001-03-6,
REP.PRIMARY,2.5,IVABRADINE,"HCN1, HCN3, HCN4","HCN CHANNEL ANTAGONIST, POTASSIUM CHANNEL BLOCKER, SODIUM CHANNEL BLOCKER",BRD:BRD-K31385749-003-01-3,
REP.PRIMARY,2.5,OXONIC-ACID,,URICASE INHIBITOR,BRD:BRD-K31468676-237-01-8,
REP.PRIMARY,2.5,AZD9668,ELANE,ELASTASE INHIBITOR,BRD:BRD-K31476763-001-01-5,
REP.PRIMARY,2.5,1-PHENYLBIGUANIDE,"HTR3A, HTR3B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K31491153-003-05-9,
REP.PRIMARY,2.5,AZD7687,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K31495718-001-01-1,
REP.PRIMARY,2.5,PF-02545920,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K31519811-001-02-2,
REP.PRIMARY,2.5,ZIBOTENTAN,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K31553034-001-03-0,
REP.PRIMARY,2.5,OLVANIL,"CNR1, GPR119, TRPV1",TRPV AGONIST,BRD:BRD-K31560319-001-01-5,
REP.PRIMARY,2.5,RIMEXOLONE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K31627533-001-09-5,
REP.PRIMARY,2.5,DAU-5884,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K31633810-003-02-8,
REP.PRIMARY,2.5,SULFAMETHIZOLE,,BACTERIAL ANTIFOLATE,BRD:BRD-K31682896-001-24-0,
REP.PRIMARY,2.5,ICOTINIB,EGFR,EGFR INHIBITOR,BRD:BRD-K31698212-001-02-9,
REP.PRIMARY,2.5,PEMIROLAST,HRH1,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K31731454-237-02-5,
REP.PRIMARY,2.5,LEVOBUNOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K31812033-003-11-0,
REP.PRIMARY,2.5,OXYPURINOL,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K31841515-001-07-8,
REP.PRIMARY,2.5,T-0070907,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K31843556-001-04-1,
REP.PRIMARY,2.5,TAK-632,BRAF,RAF INHIBITOR,BRD:BRD-K31866293-001-01-6,
REP.PRIMARY,2.5,MESTRANOL,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K31920458-001-23-6,
REP.PRIMARY,2.5,BARASERTIB,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K31928526-001-02-1,
REP.PRIMARY,3.16,ENOCITABINE,"CMPK1, RRM1, TYMS",DNA SYNTHESIS INHIBITOR,BRD:BRD-K32007074-001-02-9,
REP.PRIMARY,2.5,SULFACHLORPYRIDAZINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K32021043-001-14-3,
REP.PRIMARY,2.5,LX1031,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K32101625-001-01-6,
REP.PRIMARY,2.5,TEMOZOLOMIDE,MGMT,DNA ALKYLATING AGENT,BRD:BRD-K32107296-001-16-9,
REP.PRIMARY,2.5,TOLAZAMIDE,"ABCC8, KCNJ1, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K32164935-001-30-8,
REP.PRIMARY,2.5,MBX-2982,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K32218650-001-01-6,
REP.PRIMARY,2.5,PRIMIDONE,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",GABA RECEPTOR ANTAGONIST,BRD:BRD-K32247306-001-29-4,
REP.PRIMARY,2.5,SULFADIAZINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K32273377-001-17-9,
REP.PRIMARY,2.5,AMG-208,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K32285926-001-02-1,
REP.PRIMARY,2.5,EHOP-016,"RAC1, RAC3",RAS GTPASE INHIBITOR,BRD:BRD-K32289541-001-01-0,
REP.PRIMARY,2.5,CGP-53353,"EGFR, PRKCB","EGFR INHIBITOR, PKC INHIBITOR",BRD:BRD-K32292990-001-03-6,
REP.PRIMARY,2.5,NIFEKALANT,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K32311154-001-01-0,
REP.PRIMARY,2.5,ACYCLOVIR,PNP,DNA POLYMERASE INHIBITOR,BRD:BRD-K32318651-001-23-7,
REP.PRIMARY,2.5,ACYCLOVIR,PNP,DNA POLYMERASE INHIBITOR,BRD:BRD-K32318651-001-24-5,
REP.PRIMARY,2.5,D-7193,,,BRD:BRD-K32372024-001-01-0,
REP.PRIMARY,2.5,ETOMOXIR,CPT1A,CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-K32405725-001-02-8,
REP.PRIMARY,2.5,VANOXERINE,SLC6A3,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K32501161-300-06-2,
REP.PRIMARY,2.5,OROTIC-ACID,DHODH,,BRD:BRD-K32572029-001-04-4,
REP.PRIMARY,2.5,2-AMINOBENZENESULFONAMIDE,"CA12, CA14, CA2, CA6, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K32681104-001-11-6,
REP.PRIMARY,2.5,SU3327,MAPK8,JNK INHIBITOR,BRD:BRD-K32730239-001-01-0,
REP.PRIMARY,2.5,DISULFIRAM,"ALDH2, DBH","ALDEHYDE DEHYDROGENASE INHIBITOR, DNA METHYLTRANSFERASE INHIBITOR, TRPV AGONIST",BRD:BRD-K32744045-001-31-2,
REP.PRIMARY,2.5,VONOPRAZAN,ATP4A,POTASSIUM-COMPETITIVE ACID ANTAGONIST,BRD:BRD-K32768103-051-02-6,
REP.PRIMARY,2.5,AZATHIOPRINE,"HPRT1, IMPDH1, PPAT",DEHYDROGENASE INHIBITOR,BRD:BRD-K32821942-001-21-3,
REP.PRIMARY,2.5,GUANFACINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K32830106-001-02-6,
REP.PRIMARY,2.5,GUANFACINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K32830106-003-20-4,
REP.PRIMARY,2.5,SPARTEINE-SULFATE,,,BRD:BRD-K32847234-065-04-6,
REP.PRIMARY,2.5,EUGENOL,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K32977963-001-05-0,
REP.PRIMARY,2.5,RETAPAMULIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K33082088-001-03-3,
REP.PRIMARY,2.5,ADAPALENE,"RARA, RARB, RARG, RXRA, RXRB, RXRG",RETINOID RECEPTOR AGONIST,BRD:BRD-K33127281-001-05-6,
REP.PRIMARY,2.5,L-NAME,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K33141550-003-05-7,
REP.PRIMARY,2.5,DEOXYEPINEPHRINE,"ADRA1A, DRD1, DRD2","ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K33151569-003-09-7,
REP.PRIMARY,2.5,IMETIT,"HRH3, HRH4",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K33183200-303-02-4,
REP.PRIMARY,2.5,DEXTROMETHORPHAN,"CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4","GLUTAMATE RECEPTOR ANTAGONIST, SIGMA RECEPTOR AGONIST",BRD:BRD-K33211335-004-01-7,
REP.PRIMARY,2.5,ALLYLISOTHIOCYANATE,TRPA1,TRPV AGONIST,BRD:BRD-K33219225-001-01-9,
REP.PRIMARY,2.5,INDINAVIR,"CYP3A4, CYP3A5, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K33226500-001-01-0,
REP.PRIMARY,2.5,MIGLUSTAT,UGCG,GLYCOSYL TRANSFERASE INHIBITOR,BRD:BRD-K33251802-001-01-3,
REP.PRIMARY,2.5,OUABAIN,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K33277808-331-01-3,
REP.PRIMARY,2.5,TIVANTINIB,MET,TYROSINE KINASE INHIBITOR,BRD:BRD-K33379087-001-07-5,
REP.PRIMARY,0.25,ALPHA-LINOLENIC-ACID,"ELOVL4, FADS1, FADS2, FFAR1, FFAR4, PTGS2, SLC8A1, TRPV1",OMEGA 3 FATTY ACID STIMULANT,BRD:BRD-K33396764-001-08-7,
REP.PRIMARY,2.5,EXEMESTANE,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K33425534-001-12-5,
REP.PRIMARY,2.5,LEVOCABASTINE,"HRH1, NTSR2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K33453211-003-11-5,
REP.PRIMARY,2.5,DITOLYLGUANIDINE,"GRIN1, GRIN2A, GRIN2B, SIGMAR1",SIGMA RECEPTOR AGONIST,BRD:BRD-K33459542-001-07-4,
REP.PRIMARY,2.5,ACTARIT,,INTERLEUKIN RECEPTOR AGONIST,BRD:BRD-K33483813-001-10-0,
REP.PRIMARY,2.5,VANILLYLACETONE,,,BRD:BRD-K33510429-001-03-1,
REP.PRIMARY,2.5,ISOLIQUIRITIGENIN,GABBR1,GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K33583600-001-16-1,
REP.PRIMARY,2.5,OBIDOXIME,ACHE,CHOLINESTERASE REACTIVATOR,BRD:BRD-K33588785-001-01-9,
REP.PRIMARY,2.5,ROCILETINIB,EGFR,EGFR INHIBITOR,BRD:BRD-K33610132-001-02-9,
REP.PRIMARY,2.5,ABEMACICLIB,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K33622447-066-01-9,
REP.PRIMARY,2.5,PRUCALOPRIDE,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33681278-036-01-2,
REP.PRIMARY,2.5,5-BDBD,P2RX4,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K33690734-001-01-5,
REP.PRIMARY,2.5,DIFLUPREDNATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K33720171-001-01-0,
REP.PRIMARY,2.5,METHYLNALTREXONE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K33732501-004-01-0,
REP.PRIMARY,2.5,ML133,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K33743361-003-02-6,
REP.PRIMARY,2.5,SCMC-LYS,GSTP1,MUCOLYTIC AGENT,BRD:BRD-K33809398-001-01-8,
REP.PRIMARY,2.5,VALNEMULIN,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K33813875-003-01-8,
REP.PRIMARY,2.6,LUBIPROSTONE,CLCN2,CHLORIDE CHANNEL ACTIVATOR,BRD:BRD-K33814251-001-01-4,
REP.PRIMARY,2.5,LUBIPROSTONE,CLCN2,CHLORIDE CHANNEL ACTIVATOR,BRD:BRD-K33814251-001-02-2,
REP.PRIMARY,2.5,GW-3965,"NR1H2, NR1H3",LXR AGONIST,BRD:BRD-K33818169-003-04-6,
REP.PRIMARY,2.5,AROFYLLINE,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K33852358-001-09-9,
REP.PRIMARY,2.5,LY225910,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K33864865-001-02-5,
REP.PRIMARY,2.5,ZK-93423,"GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K33882852-003-02-8,
REP.PRIMARY,2.5,ML347,"ACVR1, ACVRL1, BMPR1A",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K33892651-001-02-4,
REP.PRIMARY,2.5,CLOFARABINE,"POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K34022604-001-06-6,
REP.PRIMARY,2.5,BETAMETHASONE-VALERATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K34032314-001-04-1,
REP.PRIMARY,2.5,CEFONICID,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K34058848-304-03-1,
REP.PRIMARY,2.54,TANSHINONE-I,IFNG,AP INHIBITOR,BRD:BRD-K34073885-001-09-3,
REP.PRIMARY,2.5,DENATONIUM-BENZOATE,,,BRD:BRD-K34122555-057-11-5,
REP.PRIMARY,2.5,TRACAZOLATE,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-K34154330-003-06-4,
REP.PRIMARY,2.5,CIMETIDINE,"HRH2, SLC29A4, SLC47A1, SLC47A2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K34157611-001-16-0,
REP.PRIMARY,2.5,AMG-517,TRPV1,TRPV ANTAGONIST,BRD:BRD-K34185671-001-02-8,
REP.PRIMARY,2.5,LY215490,"GRIA1, GRIA2, GRIA3, GRIA4, GRIK1",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K34313798-001-01-6,
REP.PRIMARY,2.5,CGP-71683,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K34321528-003-01-2,
REP.PRIMARY,2.5,MF-101,"CYP19A1, XDH",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K34328244-001-01-4,
REP.PRIMARY,2.5,IMIDAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K34332569-001-01-3,
REP.PRIMARY,2.5,GLASDEGIB,SMO,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K34341643-001-01-4,
REP.PRIMARY,2.5,METHICILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K34388247-236-08-2,
REP.PRIMARY,2.5,STREPTOZOTOCIN,SLC2A2,DNA ALKYLATING AGENT,BRD:BRD-K34411947-001-12-5,
REP.PRIMARY,2.5,TRIMETHOBENZAMIDE,DRD2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K34415467-003-13-0,
REP.PRIMARY,2.47,MOEXIPRIL,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K34441861-003-07-0,
REP.PRIMARY,2.5,LEVALBUTEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K34469523-003-03-0,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-494,EGFR,EGFR INHIBITOR,BRD:BRD-K34533029-001-08-5,
REP.PRIMARY,2.5,TILORONE,,INTERFERON INDUCER,BRD:BRD-K34568562-001-04-3,
REP.PRIMARY,2.5,METHOPRENE-(S),,,BRD:BRD-K34591242-001-04-3,
REP.PRIMARY,2.5,GP2A,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K34608650-001-02-4,
REP.PRIMARY,2.5,6-CHLOROMELATONIN,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K34663752-001-09-1,
REP.PRIMARY,2.5,HEMADO,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K34672903-001-01-7,
REP.PRIMARY,2.5,METHYLERGOMETRINE,"DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K34685430-050-12-5,
REP.PRIMARY,2.5,PD-123319,AGTR2,ANGIOTENSIN ANTAGONIST,BRD:BRD-K34713073-001-01-3,
REP.PRIMARY,2.5,LEVODOPA,"DRD1, DRD2, DRD3, DRD4, DRD5, GPR143",DOPAMINE PRECURSOR,BRD:BRD-K34730807-001-17-6,
REP.PRIMARY,2.5,GLIMEPIRIDE,"ABCC8, KCNJ1, KCNJ11",INSULIN SECRETAGOGUE,BRD:BRD-K34776109-001-16-6,
REP.PRIMARY,2.5,AZD5069,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K34801930-001-01-9,SRT3190
REP.PRIMARY,2.5,SRT3190,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K34801930-001-01-9,SRT3190
REP.PRIMARY,2.5,PARTHENOLIDE-(-),HDAC1,NFKB PATHWAY INHIBITOR,BRD:BRD-K34851558-001-02-3,
REP.PRIMARY,2.5,ADOPRAZINE,"DRD2, HTR1A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K34870043-001-01-8,
REP.PRIMARY,2.5,THEOBROMINE,"ADORA1, ADORA2A, PDE4B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K34888156-213-01-4,
REP.PRIMARY,2.5,ENPROFYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K35007173-001-07-5,
REP.PRIMARY,2.5,BUNAZOSIN,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35034482-001-01-8,
REP.PRIMARY,2.71,ASIATIC-ACID,PYGM,APOPTOSIS STIMULANT,BRD:BRD-K35079116-001-02-5,
REP.PRIMARY,2.5,ASIATIC-ACID,PYGM,APOPTOSIS STIMULANT,BRD:BRD-K35079116-001-03-3,
REP.PRIMARY,2.5,TARANABANT,CNR1,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K35169477-001-01-9,
REP.PRIMARY,2.5,CAPRYLIC-ACID,,,BRD:BRD-K35170555-001-09-5,
REP.PRIMARY,2.5,LEVONORGESTREL,"AR, ESR1, PGR, SRD5A1","ESTROGEN RECEPTOR AGONIST, GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR AGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K35189033-001-26-1,
REP.PRIMARY,2.5,METHYLPREDNISOLONE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K35240538-001-26-2,
REP.PRIMARY,2.5,CICLESONIDE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K35245662-001-01-2,
REP.PRIMARY,2.5,GZD824,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K35329391-334-01-7,
REP.PRIMARY,2.5,SR-59230A,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35430135-003-02-3,
REP.PRIMARY,2.5,ALRESTATIN,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K35498378-001-06-1,
REP.PRIMARY,2.5,DACARBAZINE,"PGD, POLA2",DNA ALKYLATING AGENT,BRD:BRD-K35520305-001-17-7,
REP.PRIMARY,2.5,LEVOMEPROMAZINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K35559145-050-08-5,
REP.PRIMARY,2.5,YOHIMBINE,"ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K35586044-003-15-4,
REP.PRIMARY,2.5,DANEGAPTIDE,,GAP JUNCTION MODULATOR,BRD:BRD-K35589454-003-01-1,
REP.PRIMARY,2.5,CS-917,FBP1,FRUCTOSE BIPHOSPHATE INHIBITOR,BRD:BRD-K35601925-001-01-9,
REP.PRIMARY,2.5,SR-27897,CCKAR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K35629949-001-02-0,
REP.PRIMARY,2.5,GIMERACIL,DPYD,DIHYDROPYRIMIDINE DEHYDROGENASE INHIBITOR,BRD:BRD-K35687421-001-02-5,
REP.PRIMARY,2.5,LAUROCAPRAM,,,BRD:BRD-K35698076-001-01-2,
REP.PRIMARY,2.5,ROTUNDINE,"DRD1, DRD2, DRD3, HTR1A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K35719256-001-02-6,
REP.PRIMARY,2.5,LIRANAFTATE,,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K35775715-001-03-1,
REP.PRIMARY,2.5,SANT-2,"SHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K35781423-001-01-6,
REP.PRIMARY,2.5,CALCIUM-GLUCEPTATE,,,BRD:BRD-K35952844-236-01-6,SODIUM-GLUCOHEPTONATE
REP.PRIMARY,2.5,SODIUM-GLUCOHEPTONATE,,,BRD:BRD-K35952844-236-01-6,SODIUM-GLUCOHEPTONATE
REP.PRIMARY,2.5,CALCIUM-GLUCEPTATE,,,BRD:BRD-K35952844-238-01-2,SODIUM-GLUCOHEPTONATE
REP.PRIMARY,2.5,SODIUM-GLUCOHEPTONATE,,,BRD:BRD-K35952844-238-01-2,SODIUM-GLUCOHEPTONATE
REP.PRIMARY,2.5,NICLOSAMIDE,STAT3,"DNA REPLICATION INHIBITOR, STAT INHIBITOR",BRD:BRD-K35960502-001-20-0,
REP.PRIMARY,2.5,KU-60019,ATM,ATM KINASE INHIBITOR,BRD:BRD-K36016295-001-04-5,
REP.PRIMARY,2.5,ABT-702,ADK,ADENOSINE KINASE INHIBITOR,BRD:BRD-K36021395-300-02-4,
REP.PRIMARY,2.5,TXA127,,ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K36040345-001-01-1,
REP.PRIMARY,2.5,CYCLOHEXIMIDE,RPL3,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K36055864-001-19-2,
REP.PRIMARY,2.5,PYRITHYLDIONE,,PSYCHOACTIVE DRUG,BRD:BRD-K36116267-001-15-3,
REP.PRIMARY,2.5,WAY-170523,MMP13,METALLOPROTEINASE INHIBITOR,BRD:BRD-K36198571-001-02-0,
REP.PRIMARY,2.52,CHLORPROTHIXENE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K36207157-001-07-0,
REP.PRIMARY,2.5,CHLORPROTHIXENE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K36207157-001-09-6,
REP.PRIMARY,2.5,BROXALDINE,,,BRD:BRD-K36222532-001-01-8,
REP.PRIMARY,2.5,CARMUSTINE,GSR,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K36234266-001-09-8,
REP.PRIMARY,2.5,AZ-10417808,CASP3,CASPASE INHIBITOR,BRD:BRD-K36258877-001-03-1,
REP.PRIMARY,2.5,ACENEURAMIC-ACID,"AZGP1, CES1, MBL2, REG1A, SELE, SELP, SIGLEC1",,BRD:BRD-K36262466-001-06-3,
REP.PRIMARY,2.5,ASYMMETRICAL-DIMETHYLARGININE,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K36269323-300-02-6,
REP.PRIMARY,2.5,ESCULIN,,ANTIOXIDANT,BRD:BRD-K36270037-001-01-7,
REP.PRIMARY,2.5,I-BET151,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K36363294-001-04-2,
REP.PRIMARY,2.5,NOR-BINALTORPHIMINE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K36381762-300-02-7,NOR-BINALTORPHIMINE-DIHYDROCHLORIDE
REP.PRIMARY,2.5,NOR-BINALTORPHIMINE-DIHYDROCHLORIDE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K36381762-300-02-7,NOR-BINALTORPHIMINE-DIHYDROCHLORIDE
REP.PRIMARY,2.5,DOLUTEGRAVIR,"CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1",HIV INTEGRASE INHIBITOR,BRD:BRD-K36386086-001-01-1,
REP.PRIMARY,2.5,SB-206553,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K36395411-003-02-2,
REP.PRIMARY,2.5,COPPER-HISTIDINE,"HAL, HARS, HDC, SLC15A3, SLC15A4, SLC38A3, SLC38A5",,BRD:BRD-K36449075-001-01-0,
REP.PRIMARY,2.5,PICROTOXININ,"GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B",GABA RECEPTOR ANTAGONIST,BRD:BRD-K36461289-001-05-8,
REP.PRIMARY,2.5,BINDARIT,"CCL2, CCL7, CCL8",NFKB PATHWAY INHIBITOR,BRD:BRD-K36467523-001-02-8,
REP.PRIMARY,2.5,PU-H71,HSP90AA1,HSP INHIBITOR,BRD:BRD-K36529613-001-02-6,
REP.PRIMARY,2.5,TAMIBAROTENE,"RARA, RARB",RETINOID RECEPTOR AGONIST,BRD:BRD-K36627727-001-05-4,
REP.PRIMARY,2.5,BUFEXAMAC,"HDAC10, HDAC6",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K36660044-001-24-2,
REP.PRIMARY,2.5,OMECAMTIV-MECARBIL,MYBPC3,CARDIAC MYOSIN ACTIVATOR,BRD:BRD-K36680103-001-01-6,
REP.PRIMARY,2.5,CYROMAZINE,,,BRD:BRD-K36711084-001-02-0,
REP.PRIMARY,2.5,SETIPTILINE,"HRH1, HTR2A, HTR2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K36732695-001-01-9,
REP.PRIMARY,2.5,STEMREGENIN-1,AHR,ARYL HYDROCARBON RECEPTOR ANTAGONIST,BRD:BRD-K36739687-001-03-0,
REP.PRIMARY,2.5,GSK1070916,"AURKA, AURKB, AURKC, CYP2D6, CYP3A4",AURORA KINASE INHIBITOR,BRD:BRD-K36740062-001-06-6,
REP.PRIMARY,2.5,ETHAVERINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K36756879-003-08-7,
REP.PRIMARY,2.5,DMEOB,GRM5,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K36775483-001-01-4,
REP.PRIMARY,2.5,RIBOCICLIB,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K36788280-001-01-2,
REP.PRIMARY,2.5,SAPROPTERIN,"NOS3, PAH, TH, TPH1",PHENYLALANINE 4-HYDROXYLASE STIMULANT,BRD:BRD-K36859431-300-02-3,
REP.PRIMARY,2.5,HYDROFLUMETHIAZIDE,"ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-K36862742-001-25-6,
REP.PRIMARY,2.5,BD-1047,SIGMAR1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K36864847-303-02-5,
REP.PRIMARY,2.5,TETRAMETHYLTHIURAM-MONOSULFIDE,,,BRD:BRD-K36889451-001-01-1,
REP.PRIMARY,2.5,GLYBURIDE,"ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1","ATP CHANNEL BLOCKER, INSULIN SECRETAGOGUE, SULFONYLUREA",BRD:BRD-K36927236-001-32-6,
REP.PRIMARY,2.5,M-CHLOROPHENYLBIGUANIDE,"HTR3A, HTR3B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K36965586-003-08-8,
REP.PRIMARY,2.5,TONABERSAT,,"GAP JUNCTION MODULATOR, NITRIC OXIDE PRODUCTION INHIBITOR",BRD:BRD-K36970462-001-01-6,
REP.PRIMARY,2.5,GO-6983,"PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ",PROTEIN KINASE INHIBITOR,BRD:BRD-K36984403-001-02-7,
REP.PRIMARY,2.5,FEXINIDAZOLE,,,BRD:BRD-K37069697-001-01-3,
REP.PRIMARY,2.5,LYCOPENE,,FREE RADICAL SCAVENGER,BRD:BRD-K37083340-001-02-3,
REP.PRIMARY,2.5,TRIENTINE,CA14,CHELATING AGENT,BRD:BRD-K37111771-300-02-6,
REP.PRIMARY,2.5,RIVAROXABAN,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K37130656-001-04-6,
REP.PRIMARY,2.5,1-HEXADECANOL,,,BRD:BRD-K37203094-001-02-5,
REP.PRIMARY,2.5,CEP-33779,JAK2,JAK INHIBITOR,BRD:BRD-K37237504-001-02-7,
REP.PRIMARY,2.5,ASTEMIZOLE,"HRH1, KCNH1, KCNH2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37249724-001-25-7,
REP.PRIMARY,2.66,MIFEPRISTONE,"AR, NR1I2, NR3C1, PGR","GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K37270826-001-27-6,
REP.PRIMARY,2.5,MIFEPRISTONE,"AR, NR1I2, NR3C1, PGR","GLUCOCORTICOID RECEPTOR ANTAGONIST, PROGESTERONE RECEPTOR ANTAGONIST",BRD:BRD-K37270826-001-31-8,
REP.PRIMARY,2.5,CLOZAPINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K37289225-001-36-4,
REP.PRIMARY,2.5,KENPAULLONE,"CCNB1, CDK1, CDK5, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K37312348-001-15-0,
REP.PRIMARY,2.5,EFAPROXIRAL,"HBA1, HBB","HAEMOGLOBIN OXYGEN RELEASE STIMULANT, HEMOGLOBIN OXYGEN RELEASE STIMULANT",BRD:BRD-K37355418-236-01-6,
REP.PRIMARY,2.5,FILANESIB,KIF11,"KINESIN INHIBITOR, KINESIN-LIKE SPINDLE PROTEIN INHIBITOR",BRD:BRD-K37379014-001-01-2,
REP.PRIMARY,2.5,CONIVAPTAN,"AVPR1A, AVPR2",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K37385792-003-02-1,
REP.PRIMARY,2.5,IDEBENONE,,CALCIUM CHANNEL MODULATOR,BRD:BRD-K37516142-001-10-5,
REP.PRIMARY,2.5,ZARDAVERINE,PDE4D,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37561857-001-15-5,
REP.PRIMARY,2.5,GSK256066,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37590257-001-02-8,
REP.PRIMARY,2.5,MRS-1220,"ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K37618799-001-03-0,
REP.PRIMARY,2.44,PIROMIDIC-ACID,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K37682401-001-09-3,
REP.PRIMARY,2.5,PIROMIDIC-ACID,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K37682401-213-01-1,
REP.PRIMARY,2.5,AZD8330,MAP3K1,MEK INHIBITOR,BRD:BRD-K37687095-001-06-9,
REP.PRIMARY,2.5,RU-28318,NR3C2,CYTOCHROME P450 INHIBITOR,BRD:BRD-K37687387-237-01-7,
REP.PRIMARY,2.5,FIPEXIDE,,PSYCHOACTIVE DRUG,BRD:BRD-K37688416-003-13-1,
REP.PRIMARY,2.5,DOXEPIN,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37694030-003-12-7,
REP.PRIMARY,2.5,ABT-724,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K37714784-305-02-1,
REP.PRIMARY,2.5,SB-525334,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K37720887-001-07-8,
REP.PRIMARY,2.5,DIOSCIN,CXCR3,APOPTOSIS STIMULANT,BRD:BRD-K37723606-001-01-5,
REP.PRIMARY,2.5,TYLOSIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K37753391-046-03-2,
REP.PRIMARY,2.5,PF-03758309,PAK4,P21 ACTIVATED KINASE INHIBITOR,BRD:BRD-K37764012-001-04-1,
REP.PRIMARY,2.5,AFOBAZOLE,,ANXIOLYTIC,BRD:BRD-K37793595-003-01-7,
REP.PRIMARY,2.5,ETOPOSIDE,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K37798499-001-27-2,
REP.PRIMARY,2.5,ACEPROMAZINE,"ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K37814297-050-09-6,
REP.PRIMARY,0.25,"3,3'-DIINDOLYLMETHANE","AR, HIF1A, IFNG, PI3","CHK INHIBITOR, CYTOCHROME P450 ACTIVATOR, INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K37846922-001-09-4,
REP.PRIMARY,2.5,LY2183240,FAAH,"FAAH INHIBITOR, FAAH REUPTAKE INHIBITOR",BRD:BRD-K37865504-001-04-1,
REP.PRIMARY,2.5,TIROFIBAN,"ITGA2B, ITGB3","PLATELET AGGREGATION INHIBITOR, STRUCTURAL GLYCOPROTEIN ANTAGONIST",BRD:BRD-K37872686-003-01-9,
REP.PRIMARY,2.5,CAMPTOTHECIN,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K37890730-001-15-1,
REP.PRIMARY,2.5,ETIDRONIC-ACID,"ATP6V1A, PTPRS",BONE RESORPTION INHIBITOR,BRD:BRD-K37949327-001-06-3,
REP.PRIMARY,2.5,"L-732,138","TACR1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K37952347-001-01-4,
REP.PRIMARY,2.5,PAROXETINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K37991163-003-13-4,
REP.PRIMARY,2.5,CLOCORTOLONE-PIVALATE,"NR3C1, PLA2G1B",STEROID,BRD:BRD-K38003476-001-09-1,
REP.PRIMARY,2.5,ETHAMIVAN,,RESPIRATORY STIMULANT,BRD:BRD-K38055836-001-21-1,
REP.PRIMARY,2.5,GADODIAMIDE,,RADIOPAQUE MEDIUM,BRD:BRD-K38140108-002-01-2,
REP.PRIMARY,2.5,TRAXOPRODIL,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K38158531-001-02-1,
REP.PRIMARY,2.5,CLONAZEPAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, TSPO",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K38183498-001-02-0,
REP.PRIMARY,2.5,BUMETANIDE,"CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5",SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K38197229-001-29-9,
REP.PRIMARY,2.5,NARLAPREVIR,,HCV INHIBITOR,BRD:BRD-K38287497-001-01-2,
REP.PRIMARY,2.5,DOMPERIDONE,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K38305202-001-17-4,
REP.PRIMARY,2.5,PHENACETIN,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K38323065-001-19-9,
REP.PRIMARY,2.5,UPROSERTIB,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K38332599-001-01-3,
REP.PRIMARY,2.5,FK-3311,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K38350380-001-01-8,
REP.PRIMARY,2.5,3-AQC,HTR3A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K38370968-050-01-3,
REP.PRIMARY,2.5,THIAMET-G,MGEA5,GLCNAC PHOSPHOTRANSFERASE INHIBITOR,BRD:BRD-K38380126-001-01-4,
REP.PRIMARY,2.5,IMIPRAMINE,"ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K38436528-003-26-1,
REP.PRIMARY,2.5,DIAZOOXONORLEUCINE,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K38458514-001-01-8,
REP.PRIMARY,2.5,CILOMILAST,"PDE4A, PDE4B, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K38473998-001-02-0,
REP.PRIMARY,2.5,VER-49009,HSP90AA1,HSP INHIBITOR,BRD:BRD-K38548312-001-01-0,
REP.PRIMARY,2.5,SEROTONIN,"DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, SLC36A1",GROWTH FACTOR RECEPTOR ACTIVATOR,BRD:BRD-K38580127-003-15-4,
REP.PRIMARY,2.5,SULISOBENZONE,,,BRD:BRD-K38602774-001-03-2,
REP.PRIMARY,2.5,ROXITHROMYCIN,"ABCB1, MLNR",BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K38684403-001-05-4,
REP.PRIMARY,2.5,BETA-AMYLOID-SYNTHESIS-INHIBITOR,APP,BETA AMYLOID SYNTHESIS INHIBITOR,BRD:BRD-K38687824-001-02-5,
REP.PRIMARY,2.46,PD-128907,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K38797369-003-01-1,
REP.PRIMARY,2.5,GANETESPIB,HSP90AA1,HSP INHIBITOR,BRD:BRD-K38852836-001-02-1,
REP.PRIMARY,2.5,JK-184,,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K38860038-001-01-2,
REP.PRIMARY,2.5,MK-0773,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K38868394-001-01-3,
REP.PRIMARY,2.5,HESPERIDIN,"AURKB, CACNA1B",FLAVANONE GLYCOSIDE,BRD:BRD-K38903228-001-13-5,
REP.PRIMARY,2.5,SAR131675,FLT4,VEGFR INHIBITOR,BRD:BRD-K38904395-001-02-3,
REP.PRIMARY,2.5,APRACLONIDINE,"ADRA1A, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K38911213-003-01-6,
REP.PRIMARY,2.5,AZIMILIDE,"KCNA5, KCNE1, KCNH2, KCNQ1",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K38913877-300-01-9,
REP.PRIMARY,2.5,MORNIFLUMATE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K38938675-001-01-4,
REP.PRIMARY,2.5,OCTOCRYLENE,,,BRD:BRD-K39023557-001-01-7,
REP.PRIMARY,2.62,BETA-GLYCEROPHOSPHORIC-ACID,,,BRD:BRD-K39061174-001-01-0,
REP.PRIMARY,2.5,CINCHONIDINE,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K39079086-001-07-6,
REP.PRIMARY,2.5,BITHIONOL,"ESR1, ESR2, MCL1",AUTOTAXIN INHIBITOR,BRD:BRD-K39120595-304-04-7,
REP.PRIMARY,2.5,4-CHLOROPHENYLGUANIDINE,PLAUR,UROKINASE INHIBITOR,BRD:BRD-K39160765-003-02-9,
REP.PRIMARY,2.5,ID-8,,,BRD:BRD-K39166528-001-01-0,
REP.PRIMARY,2.5,STF-118804,NAMPT,NAMPT INHIBITOR,BRD:BRD-K39171998-001-01-1,
REP.PRIMARY,2.5,ATIPAMEZOLE,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K39252998-003-01-5,
REP.PRIMARY,2.5,EPIRIZOLE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K39339537-001-21-0,
REP.PRIMARY,2.5,CYACETACIDE,,,BRD:BRD-K39371216-001-01-3,
REP.PRIMARY,2.5,DMH1,ACVR1,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K39381259-001-01-0,
REP.PRIMARY,2.5,DEXCHLORPHENIRAMINE,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K39462424-050-09-8,
REP.PRIMARY,2.5,NITHIAMIDE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K39467894-001-05-9,
REP.PRIMARY,2.5,NITHIAMIDE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K39467894-001-06-7,
REP.PRIMARY,2.5,TRIPTOLIDE,RELA,RNA POLYMERASE INHIBITOR,BRD:BRD-K39484304-001-16-5,
REP.PRIMARY,2.5,CHLOROBUTANOL,,,BRD:BRD-K39495750-001-01-2,
REP.PRIMARY,2.5,QUIFLAPON,"ALOX5, ALOX5AP",LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K39503511-001-03-9,
REP.PRIMARY,2.5,SDZ-WAG-994,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K39558284-001-01-2,
REP.PRIMARY,2.5,ADL5859,OPRD1,OPIOID RECEPTOR AGONIST,BRD:BRD-K39624409-003-02-6,
REP.PRIMARY,2.5,AMTHAMINE,HRH2,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K39670393-303-02-1,
REP.PRIMARY,2.5,N-SALICOYLAMINOPHENOL,,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K39693230-001-01-2,
REP.PRIMARY,2.5,L-161982,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K39733634-001-02-6,
REP.PRIMARY,2.5,TPPS4,,,BRD:BRD-K39805756-001-01-6,
REP.PRIMARY,2.5,TG-101209,"JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K39841531-001-02-1,
REP.PRIMARY,2.5,LOXAPINE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K39915878-036-24-4,
REP.PRIMARY,2.5,LENVATINIB,"FLT4, KDR","FGFR INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K39974922-001-04-3,
REP.PRIMARY,2.45,LOTEPREDNOL,NR3C1,"GLUCOCORTICOID RECEPTOR AGONIST, PHOSPHOLIPASE INHIBITOR",BRD:BRD-K39983086-001-06-1,
REP.PRIMARY,2.5,BISACODYL,,LAXATIVE,BRD:BRD-K39987650-001-24-1,
REP.PRIMARY,2.5,SB-505124,TGFBR1,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K40109029-001-02-9,
REP.PRIMARY,2.5,TORIN-1,MTOR,MTOR INHIBITOR,BRD:BRD-K40175214-001-11-6,
REP.PRIMARY,1.7000000000000002,VINBURNINE,"CHRM1, CHRM2, CHRM3, CHRM4",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K40227168-001-12-9,
REP.PRIMARY,2.5,TYRPHOSTIN-A9,,"PROTEIN TYROSINE KINASE INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K40255344-001-17-6,
REP.PRIMARY,2.5,CATHEPSIN-INHIBITOR-1,"CTSB, CTSL, CTSV",CATHEPSIN INHIBITOR,BRD:BRD-K40269473-001-02-2,
REP.PRIMARY,2.5,PF-5274857,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K40302533-001-02-9,
REP.PRIMARY,2.54,CRIZOTINIB-(S),NUDT1,MTH1 INHIBITOR,BRD:BRD-K40308497-001-01-2,
REP.PRIMARY,2.5,CRIZOTINIB-(S),NUDT1,MTH1 INHIBITOR,BRD:BRD-K40308497-001-02-0,
REP.PRIMARY,2.5,CR8-(R),CCNA2,CDK INHIBITOR,BRD:BRD-K40331046-305-01-5,
REP.PRIMARY,2.5,CAY10505,PIK3CG,PI3K INHIBITOR,BRD:BRD-K40366680-001-03-3,
REP.PRIMARY,2.5,SPERMIDINE,"KCNJ4, TXNRD1",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K40438880-305-06-6,
REP.PRIMARY,2.34,ELTROMBOPAG,MPL,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K40496271-396-01-1,
REP.PRIMARY,2.5,HYOSCYAMINE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K40530731-001-11-6,
REP.PRIMARY,2.5,GR-79236,"ADORA1, ADORA2A",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K40578143-001-02-6,
REP.PRIMARY,2.5,PENTETIC-ACID,PGD,CHELATING AGENT,BRD:BRD-K40621224-001-06-7,
REP.PRIMARY,2.5,DITIOCARB-SODIUM-TRIHYDRATE,"CA1, CA2, CA4",IMMUNOSTIMULANT,BRD:BRD-K40654626-236-01-5,
REP.PRIMARY,2.5,MEDORINONE,,,BRD:BRD-K40715924-001-01-1,
REP.PRIMARY,2.5,AEE788,"EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K40718343-001-02-6,
REP.PRIMARY,2.5,BMS-777607,"AXL, MERTK, MET, MST1R, TYRO3","AXL KINASE INHIBITOR, C-MET INHIBITOR, FLT3 INHIBITOR, HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K40738845-001-05-0,
REP.PRIMARY,2.5,EFAVIRENZ,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4",HIV PROTEASE INHIBITOR,BRD:BRD-K40758068-001-08-2,
REP.PRIMARY,2.5,QX-222,,SODIUM CHANNEL BLOCKER,BRD:BRD-K40782193-003-02-9,
REP.PRIMARY,2.5,LACITOL,,"LAXATIVE, OSMOSIS STIMULANT",BRD:BRD-K40787673-001-02-1,
REP.PRIMARY,2.5,SC-12267,IL17A,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K40797222-001-01-8,
REP.PRIMARY,2.5,CT-7758,ITGA4,INTEGRIN ANTAGONIST,BRD:BRD-K40870905-001-01-7,
REP.PRIMARY,2.5,RITANSERIN,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K40887525-001-21-9,
REP.PRIMARY,2.5,CINANSERIN,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K40901640-003-01-6,
REP.PRIMARY,2.5,PHENACEMIDE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K40905133-001-04-9,
REP.PRIMARY,2.5,PARACHLOROPHENOL,,ANTIINFECTIVE DRUG,BRD:BRD-K40992116-001-09-7,
REP.PRIMARY,2.5,4-PHENOLSULFONIC-ACID,,,BRD:BRD-K41024817-325-01-0,
REP.PRIMARY,2.5,GSK2656157,,PERK INHIBITOR,BRD:BRD-K41104902-001-01-3,
REP.PRIMARY,2.5,CYPROTERONE-ACETATE,"ADORA1, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41141507-001-16-2,
REP.PRIMARY,2.5,N20C,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41143549-003-02-4,
REP.PRIMARY,2.5,FENOBAM,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41160163-001-06-8,
REP.PRIMARY,2.5,DEOXYCHOLIC-ACID,"EFTUD1, FPR1, GPBAR1","BILIVERDIN REDUCTASE A ACTIVATOR, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K41170226-001-13-8,
REP.PRIMARY,2.5,AMBRISENTAN,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K41185545-001-02-3,
REP.PRIMARY,2.5,KW-2478,,HSP INHIBITOR,BRD:BRD-K41213548-001-02-0,
REP.PRIMARY,0.03,ICOMUCRET,LTB4R2,MUCIN PRODUCTION ENHANCER,BRD:BRD-K41234004-001-03-1,
REP.PRIMARY,2.5,DEHYDROEPIANDROSTERONE,"ESR1, ESR2, G6PD, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, HSD17B1, NR1I2, NR1I3, PPARA, SIGMAR1, SULT2A1, SULT2B1",PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K41256143-001-12-7,
REP.PRIMARY,2.5,VALPROIC-ACID,"ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","BENZODIAZEPINE RECEPTOR AGONIST, HDAC INHIBITOR",BRD:BRD-K41260949-236-16-8,
REP.PRIMARY,2.5,CUDC-101,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K41278234-001-03-0,
REP.PRIMARY,2.46,TETRAETHYLENEPENTAMINE,"SOD1, SOD2",SUPEROXIDE DISMUTASE INHIBITOR,BRD:BRD-K41298358-395-03-4,
REP.PRIMARY,2.5,HA-966-(S)-(-),GRIA1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41304947-001-03-2,
REP.PRIMARY,2.5,GW-441756,NTRK1,GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K41312087-001-02-7,
REP.PRIMARY,2.5,ZM-306416,"EGFR, FLT1, FLT4, KDR","ABL KINASE INHIBITOR, SRC INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K41337261-001-03-0,
REP.PRIMARY,2.5,SULFAPYRIDINE,,PABA ANTAGONIST,BRD:BRD-K41406082-001-16-2,
REP.PRIMARY,2.5,BALSALAZIDE,"ALOX5, PPARG, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K41410256-304-02-2,
REP.PRIMARY,2.5,ORG-9768,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K41434598-003-01-9,
REP.PRIMARY,2.5,PERAMPANEL,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K41438959-001-01-7,
REP.PRIMARY,2.5,ALFAXALONE,GABBR1,"BENZODIAZEPINE RECEPTOR AGONIST, CHLORIDE CHANNEL AGONIST",BRD:BRD-K41445866-001-18-8,
REP.PRIMARY,2.5,PARACETAMOL,"FAAH, PTGS1, PTGS2, TRPV1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K41524689-001-23-5,
REP.PRIMARY,2.5,PURVALANOL-B,"CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2",TYROSINE KINASE INHIBITOR,BRD:BRD-K41564320-001-02-0,
REP.PRIMARY,2.5,SB-334867,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K41567364-001-04-6,
REP.PRIMARY,2.5,COUMOPHOS,,CHOLINESTERASE INHIBITOR,BRD:BRD-K41567533-001-08-3,
REP.PRIMARY,2.5,LONAFARNIB,"FNTA, HRAS, KRAS, NRAS",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K41599323-001-02-3,
REP.PRIMARY,2.5,CERAMIDE,,"PHOSPHOENOLPYRUVATE CARBOXYLASE ACTIVATOR, SERINE/THREONINE PROTEIN PHOSPHATASE ACTIVATOR",BRD:BRD-K41707108-001-05-6,
REP.PRIMARY,2.5,E-4031,"KCNH1, KCNH2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K41713976-300-02-6,
REP.PRIMARY,2.5,TRICLOSAN,DNMT1,ANTIBACTERIAL AGENT,BRD:BRD-K41731458-001-15-1,
REP.PRIMARY,2.5,TOLIMIDONE,"LYN, SRC",SRC ACTIVATOR,BRD:BRD-K41772907-001-01-2,
REP.PRIMARY,2.5,CB-03-01,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41779183-001-01-2,
REP.PRIMARY,2.5,STA-5326,IL12A,INTERLEUKIN SYNTHESIS INHIBITOR,BRD:BRD-K41783120-001-02-8,
REP.PRIMARY,2.5,"1,3-DIPROPYL-8-PHENYLXANTHINE",,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K41853443-001-02-9,
REP.PRIMARY,2.5,NVP-AUY922,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K41859756-001-06-8,
REP.PRIMARY,2.5,2-HYDROXYETHYL-SALICYLATE,,,BRD:BRD-K41866823-001-01-3,
REP.PRIMARY,2.5,2-PHENYLMELATONIN,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K41869275-001-02-8,
REP.PRIMARY,2.5,TIOXOLONE,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K41876534-001-13-7,
REP.PRIMARY,2.5,A-769662,,AMPK ACTIVATOR,BRD:BRD-K41918892-001-05-9,
REP.PRIMARY,2.43,TRICHLOROACETIC-ACID,,,BRD:BRD-K42090719-001-06-5,
REP.PRIMARY,2.5,DAIDZEIN,"ESRRA, ESRRB, ESRRG, TRPC5",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K42095107-001-17-1,
REP.PRIMARY,2.5,PROTRIPTYLINE,"SLC6A2, SLC6A4",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K42098891-003-20-5,
REP.PRIMARY,2.5,BUPARLISIB,"PIK3CA, PIK3CG",PI3K INHIBITOR,BRD:BRD-K42191735-001-05-3,
REP.PRIMARY,2.5,"3,4-METHYLENEDIOXY-BETA-NITROSTYRENE","SRC, SYK","SRC INHIBITOR, SYK INHIBITOR",BRD:BRD-K42205652-001-02-7,"MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)"
REP.PRIMARY,2.5,"MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)","SRC, SYK","SRC INHIBITOR, SYK INHIBITOR",BRD:BRD-K42205652-001-02-7,"MNS-(3,4-METHYLENEDIOXY-NITROSTYRENE)"
REP.PRIMARY,2.5,NNC-711,"SIGMAR1, SLC6A1",GABA UPTAKE INHIBITOR,BRD:BRD-K42221274-003-07-7,
REP.PRIMARY,2.48,EZETIMIBE,"ANPEP, NPC1L1, SOAT1","CHOLESTEROL INHIBITOR, NIEMANN-PICK C1-LIKE 1 PROTEIN ANTAGONIST",BRD:BRD-K42260897-001-07-6,
REP.PRIMARY,2.5,EZETIMIBE,"ANPEP, NPC1L1, SOAT1","CHOLESTEROL INHIBITOR, NIEMANN-PICK C1-LIKE 1 PROTEIN ANTAGONIST",BRD:BRD-K42260897-001-09-2,
REP.PRIMARY,2.5,CYCLOBENZAPRINE,HTR2A,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K42348709-003-13-1,
REP.PRIMARY,2.5,ANANDAMIDE,"CACNA1G, CACNA1H, CACNA1I, CNR1, CNR2, GLRA1, GPR18, GPR55, KCNA2, KCNK3, KCNK9, TRPM8, TRPV1",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K42352790-001-05-3,
REP.PRIMARY,2.5,BUTORPHANOL-(+)-TARTRATE,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K42417338-045-01-9,
REP.PRIMARY,2.5,AZ20,"ATR, MTOR",ATR KINASE INHIBITOR,BRD:BRD-K42436189-001-01-2,
REP.PRIMARY,2.5,EO-1428,"MAPK11, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K42452249-001-02-5,
REP.PRIMARY,2.5,TASISULAM,,APOPTOSIS STIMULANT,BRD:BRD-K42495768-001-01-7,
REP.PRIMARY,2.5,SATRAPLATIN,,DNA ALKYLATING AGENT,BRD:BRD-K42497885-001-01-1,
REP.PRIMARY,2.5,CGP-57380,"AURKB, LCK, MKNK1, MKNK2, SGK1",MAP KINASE INHIBITOR,BRD:BRD-K42500029-001-03-5,
REP.PRIMARY,2.5,YM-58483,"TRPC3, TRPC5, TRPM4",CALCIUM CHANNEL BLOCKER,BRD:BRD-K42563464-001-01-9,
REP.PRIMARY,2.5,Y-27152,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K42679050-001-02-1,
REP.PRIMARY,2.5,XE-991,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K42748308-300-02-0,
REP.PRIMARY,2.5,EPIANDROSTERONE,G6PD,STEROID,BRD:BRD-K42756753-001-01-9,
REP.PRIMARY,2.5,OSIMERTINIB,EGFR,EGFR INHIBITOR,BRD:BRD-K42805893-001-04-9,
REP.PRIMARY,2.5,SUNITINIB,"CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K42828737-044-09-0,
REP.PRIMARY,2.5,CFM-2,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K42859542-001-03-3,
REP.PRIMARY,2.5,TEMSIROLIMUS,MTOR,MTOR INHIBITOR,BRD:BRD-K42898655-001-01-8,
REP.PRIMARY,2.5,ACETOPHENAZINE,"DRD1, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K42938903-332-01-1,
REP.PRIMARY,2.5,AMD11070,"CCR5, CXCR4",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K42948882-305-01-1,
REP.PRIMARY,2.5,TRANS-2-UNDECENOIC-ACID,,,BRD:BRD-K42959922-001-01-5,
REP.PRIMARY,2.5,CHIR-98014,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K42973005-001-04-0,
REP.PRIMARY,2.5,MIBAMPATOR,GRIA1,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K42981054-001-01-9,
REP.PRIMARY,2.5,CREATINOL-PHOSPHATE,,,BRD:BRD-K42991124-001-03-0,
REP.PRIMARY,2.5,SR-33805,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K43002771-034-01-6,
REP.PRIMARY,2.5,ADD-233089,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K43055376-001-01-2,IMEPITOIN
REP.PRIMARY,2.5,IMEPITOIN,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K43055376-001-01-2,IMEPITOIN
REP.PRIMARY,2.5,GALLAMINE-TRIETHIODIDE,"ACHE, CHRM2, CHRNA1, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43106192-320-11-8,
REP.PRIMARY,2.5,MYRICETIN,PIK3CG,"ANDROGEN RECEPTOR AGONIST, CYTOCHROME P450 INHIBITOR",BRD:BRD-K43149758-001-22-7,
REP.PRIMARY,2.5,CHOLIC-ACID,"ADH1C, CES1, COX4I1, COX5A, COX5B, COX6A2, COX6B1, COX6C, COX7A1, COX7B, COX7C, COX8A, ESRRG, FABP6, FECH, GPBAR1, MT-CO1, MT-CO2, MT-CO3, PLA2G1B",BILE ACID,BRD:BRD-K43164539-001-11-5,
REP.PRIMARY,2.52,GDC-0349,PIK3CA,PIM KINASE INHIBITOR,BRD:BRD-K43187018-001-03-3,
REP.PRIMARY,2.5,3-INDOLEBUTYRIC-ACID,"B2M, HLA-A, TRAC, TRBC1",,BRD:BRD-K43187796-001-02-3,
REP.PRIMARY,2.5,METHYLLYCACONITINE,CHRNA7,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43192255-048-03-6,
REP.PRIMARY,2.6,POLYDATIN,ICAM1,ICAM1 EXPRESSION INHIBITOR,BRD:BRD-K43236057-001-07-1,
REP.PRIMARY,2.5,ROCURONIUM,"CHRM2, CHRNA2, HTR3A",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K43305603-004-02-8,
REP.PRIMARY,2.5,ATGLISTATIN,,ADIPOSE TRIGLYCERIDE LIPASE INHIBITOR,BRD:BRD-K43363084-001-01-3,
REP.PRIMARY,2.5,FLOPROPIONE,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K43383936-001-05-2,
REP.PRIMARY,2.35,DAUNORUBICIN,"TOP2A, TOP2B","RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K43389675-003-16-7,
REP.PRIMARY,2.5,DAUNORUBICIN,"TOP2A, TOP2B","RNA SYNTHESIS INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K43389675-003-20-9,
REP.PRIMARY,2.4000000000000004,BMS-387032,"CDK2, CDK7, CDK9","CDK INHIBITOR, CELL CYCLE INHIBITOR, MCL1 INHIBITOR",BRD:BRD-K43389698-001-09-9,
REP.PRIMARY,2.5,MLN2480,,RAF INHIBITOR,BRD:BRD-K43410529-001-02-3,
REP.PRIMARY,2.5,ONCRASIN-1,,APOPTOSIS STIMULANT,BRD:BRD-K43449605-001-01-0,
REP.PRIMARY,2.5,ACETAZOLAMIDE,"AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K43457670-001-27-8,
REP.PRIMARY,2.69,OTX015,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K43471985-001-03-0,
REP.PRIMARY,2.5,OTX015,"BRD2, BRD3, BRD4",BROMODOMAIN INHIBITOR,BRD:BRD-K43471985-001-05-5,
REP.PRIMARY,2.5,DEFACTINIB,PTK2,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K43578482-001-01-4,
REP.PRIMARY,2.5,LACIDIPINE,CACNA1C,CALCIUM CHANNEL BLOCKER,BRD:BRD-K43586850-001-02-9,
REP.PRIMARY,2.5,CP-673451,"KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K43621685-001-02-5,
REP.PRIMARY,2.38,WP1130,"JAK2, UCHL5, USP14, USP9X",DEUBIQUITINASE INHIBITOR,BRD:BRD-K43644456-001-04-0,
REP.PRIMARY,2.5,OPIPRAMOL,,SIGMA RECEPTOR AGONIST,BRD:BRD-K43786866-300-02-3,
REP.PRIMARY,2.5,GENISTEIN,"CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5",TYROSINE KINASE INHIBITOR,BRD:BRD-K43797669-001-30-4,
REP.PRIMARY,2.5,AMG-837,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K43802723-340-01-9,
REP.PRIMARY,2.5,CAMOSTAT-MESILATE,PRSS1,PROTEASE INHIBITOR,BRD:BRD-K43806473-066-02-1,
REP.PRIMARY,2.5,IOBENGUANE,,ANTINEOPLASTIC AGENT,BRD:BRD-K43860855-065-11-9,
REP.PRIMARY,2.5,ILEPCIMIDE,,ANTICONVULSANT,BRD:BRD-K43873574-001-01-8,
REP.PRIMARY,2.5,PREGNENOLONE,"CYP17A1, SULT2B1",GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K43880410-001-14-4,
REP.PRIMARY,2.5,DOPAMINE,"DBH, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR7, SLC6A2, SLC6A3, SLC6A4",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K43887077-003-26-3,
REP.PRIMARY,2.5,"L-798,106",PTGER3,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K43905307-001-01-2,L-798106
REP.PRIMARY,2.5,L-798106,PTGER3,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K43905307-001-01-2,L-798106
REP.PRIMARY,2.5,BIBN4096,"CALCA, CALCRL, RAMP1",CALCITONIN ANTAGONIST,BRD:BRD-K43927145-001-01-2,
REP.PRIMARY,2.5,PENICILLIN-V-POTASSIUM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K43966364-237-04-8,
REP.PRIMARY,2.5,ACEFYLLINE,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K44004064-001-07-3,
REP.PRIMARY,2.5,HYODEOXYCHOLIC-ACID,,ATHEROSCLEROSIS FORMATION INHIBITOR,BRD:BRD-K44009692-001-02-3,
REP.PRIMARY,2.5,FLUFENAMIC-ACID,"AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5",CHLORIDE CHANNEL BLOCKER,BRD:BRD-K44067360-001-30-3,
REP.PRIMARY,2.5,Y-27632,"PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K44084986-300-08-4,
REP.PRIMARY,2.5,SULBACTAM,,BETA LACTAMASE INHIBITOR,BRD:BRD-K44133266-001-10-0,
REP.PRIMARY,2.5,PONATINIB,"ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK","BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K44227013-001-06-4,
REP.PRIMARY,2.5,TOLNAFTATE,,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K44273375-001-25-0,
REP.PRIMARY,2.5,ACARBOSE,"AMY2A, GAA, MGAM, SI",GLUCOSIDASE INHIBITOR,BRD:BRD-K44276885-001-07-4,
REP.PRIMARY,2.5,DEXNIGULDIPINE,ADORA3,CALMODULIN ANTAGONIST,BRD:BRD-K44309363-003-02-1,
REP.PRIMARY,2.5,NATEGLINIDE,"ABCC8, KCNJ10, KCNJ11, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K44353683-001-08-3,
REP.PRIMARY,2.5,ANACETRAPIB,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K44366189-001-01-9,
REP.PRIMARY,2.5,2-METHOXYESTRADIOL,"COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB",HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K44408410-001-17-6,
REP.PRIMARY,2.5,PIDOTIMOD,,"INTERFERON RECEPTOR AGONIST, INTERLEUKIN RECEPTOR AGONIST",BRD:BRD-K44442813-001-12-9,
REP.PRIMARY,2.5,TU-2100,,,BRD:BRD-K44590731-001-01-7,
REP.PRIMARY,2.5,BROMOSPORINE,,BROMODOMAIN INHIBITOR,BRD:BRD-K44665581-001-01-8,
REP.PRIMARY,2.5,IBUTAMOREN,"GHR, GHSR",GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K44771174-066-01-0,
REP.PRIMARY,2.5,FH1,,HEPATOCYTE FUNCTION ENHANCER,BRD:BRD-K44777625-001-03-5,
REP.PRIMARY,2.5,BECLAMIDE,,ANTICONVULSANT,BRD:BRD-K44824027-001-02-1,
REP.PRIMARY,2.5,ZAPA,,,BRD:BRD-K44825564-065-01-4,
REP.PRIMARY,2.5,VISMODEGIB,SMO,"HEDGEHOG PATHWAY INHIBITOR, SMOOTHENED RECEPTOR ANTAGONIST",BRD:BRD-K44827188-001-06-0,
REP.PRIMARY,2.5,TASELISIB,PIK3CA,PI3K INHIBITOR,BRD:BRD-K44844162-001-01-6,
REP.PRIMARY,2.5,CAPSAZEPINE,"TRPV1, TRPV4",TRPV AGONIST,BRD:BRD-K44849676-001-10-5,
REP.PRIMARY,2.5,ZOLPIDEM,"GABRA1, GABRA2, GABRA3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K44876623-001-03-7,
REP.PRIMARY,2.5,FOMOCAINE,,VOLTAGE-GATED SODIUM CHANNEL MODULATOR,BRD:BRD-K44942188-001-09-1,
REP.PRIMARY,2.5,PENTOLINIUM,"CHRNA10, CHRNA3, CHRNA4, CHRNB4",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44942604-346-05-4,
REP.PRIMARY,2.5,HQK-1001,,,BRD:BRD-K44963273-001-06-9,
REP.PRIMARY,2.5,TICAGRELOR,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44974079-001-01-3,
REP.PRIMARY,2.5,ATENOLOL-(-),,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K44993696-001-12-3,
REP.PRIMARY,2.5,EPHEDRINE,"ACHE, ADRA1A, ADRB2, SLC18A2, SLC6A2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K45014108-003-01-8,
REP.PRIMARY,2.5,FAMCICLOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K45033733-001-12-2,
REP.PRIMARY,2.5,TETRACAINE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K45071273-003-25-6,
REP.PRIMARY,2.5,SULFAGUANIDINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K45086103-001-15-5,
REP.PRIMARY,2.5,SULFAGUANIDINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K45086103-001-16-3,
REP.PRIMARY,2.35,MEZLOCILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K45114938-236-01-8,
REP.PRIMARY,2.5,Y-26763,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K45117373-001-02-9,
REP.PRIMARY,2.5,MERBARONE,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K45152786-001-08-4,
REP.PRIMARY,2.5,VALSARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K45158365-001-11-4,
REP.PRIMARY,2.5,MIDAFOTEL,"GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K45163704-001-01-5,
REP.PRIMARY,2.5,SB-756050,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K45168550-001-01-9,
REP.PRIMARY,2.5,MEQUINOL,TYR,,BRD:BRD-K45216060-001-10-0,
REP.PRIMARY,2.5,MEQUINOL,TYR,,BRD:BRD-K45216060-001-11-8,
REP.PRIMARY,2.5,SUCCINIC-ACID,"ALDH5A1, ASPH, BBOX1, HSD17B6, OXCT1, OXCT2, P3H1, P3H2, P3H3, P4HA1, P4HA2, PLOD1, PLOD3, SDHA, SDHB, SDHC, SDHD, SLC13A1, SLC13A2, SLC13A3, SLC25A10, SUCLA2, SUCLG1, SUCLG2, SUCNR1, TMLHE",,BRD:BRD-K45238818-001-02-6,
REP.PRIMARY,2.5,URSODEOXYCHOLYLTAURINE,,CHOLESTEROL INHIBITOR,BRD:BRD-K45245728-335-01-4,
REP.PRIMARY,2.5,CLOFIBRATE,"LPL, PPARA",PPAR RECEPTOR AGONIST,BRD:BRD-K45252063-001-13-6,
REP.PRIMARY,2.5,BETRIXABAN,KCNH2,COAGULATION FACTOR INHIBITOR,BRD:BRD-K45275534-001-01-3,
REP.PRIMARY,2.5,7-HYDROXYSTAUROSPORINE,"CDK1, CHEK1, CHEK2, GSK3B, LCK, MAPK14, MARK1, MARK3, PDPK1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG","CDK INHIBITOR, CHK INHIBITOR, PKC INHIBITOR",BRD:BRD-K45293975-001-02-0,
REP.PRIMARY,2.5,DIETHYLSTILBESTROL,"ESR1, ESR2, ESRRB, ESRRG",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K45330754-001-21-7,
REP.PRIMARY,2.5,SX-011,MAPK14,MAP KINASE INHIBITOR,BRD:BRD-K45385835-001-02-4,
REP.PRIMARY,2.5,BETULINIC-ACID,GPBAR1,"APOPTOSIS STIMULANT, NFKB PATHWAY INHIBITOR",BRD:BRD-K45401373-001-20-9,
REP.PRIMARY,2.5,BETULINIC-ACID,GPBAR1,"APOPTOSIS STIMULANT, NFKB PATHWAY INHIBITOR",BRD:BRD-K45401373-001-22-5,
REP.PRIMARY,2.5,SCH-23390,"DRD1, DRD5, HTR2C, KCNJ4, KCNJ6",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K45435259-003-11-1,
REP.PRIMARY,2.5,5-METHYLFURMETHIODIDE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K45437867-005-03-3,
REP.PRIMARY,2.5,JZL-184,MGLL,MONOACYLGLUCEROL LIPASE INHIBITOR,BRD:BRD-K45446451-001-05-0,
REP.PRIMARY,2.5,VU0361737,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K45462423-001-03-7,
REP.PRIMARY,2.5,BP-554,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K45479396-050-01-5,
REP.PRIMARY,2.5,DELIVERT,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K45503887-001-01-1,
REP.PRIMARY,2.5,RN-1747,TRPV4,TRPV AGONIST,BRD:BRD-K45519571-001-01-8,
REP.PRIMARY,2.5,M-344,HDAC8,HDAC INHIBITOR,BRD:BRD-K45528773-001-06-4,
REP.PRIMARY,2.59,M-344,HDAC8,HDAC INHIBITOR,BRD:BRD-K45528773-001-07-2,
REP.PRIMARY,2.5,DIETHYLCARBAMAZINE,"ALOX5, PTGS1",LIPOXYGENASE INHIBITOR,BRD:BRD-K45542189-048-22-1,
REP.PRIMARY,2.49,MPI-0479605,TTK,MITOTIC KINASE INHIBITOR,BRD:BRD-K45551181-001-02-1,
REP.PRIMARY,2.5,3'-FLUOROBENZYLSPIPERONE,DRD2,DOPAMINE RECEPTOR LIGAND,BRD:BRD-K45662124-050-01-5,
REP.PRIMARY,2.52,PREDNISOLONE-ACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K45664306-001-19-6,
REP.PRIMARY,1.36,ANGUIDINE,SLC5A1,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K45724504-001-01-6,
REP.PRIMARY,2.5,CC-401,MAPK8,JNK INHIBITOR,BRD:BRD-K45746021-003-01-9,
REP.PRIMARY,2.65,IU1,USP14,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,BRD:BRD-K45841694-001-11-7,
REP.PRIMARY,2.5,AZAPERONE,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K45861246-001-13-4,
REP.PRIMARY,2.5,XBD173,TSPO,BENZODIAZEPINE RECEPTOR LIGAND,BRD:BRD-K45875383-001-01-2,
REP.PRIMARY,2.5,WZ4003,"NUAK1, NUAK2",AMPK INHIBITOR,BRD:BRD-K45909031-001-01-5,
REP.PRIMARY,2.5,DANOFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K45916615-066-02-5,
REP.PRIMARY,2.5,AMRINONE,"PDE3A, PDE3B, PDE4B, TNF",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K45924332-001-16-8,
REP.PRIMARY,2.5,BEZAFIBRATE,"PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K46018455-001-27-6,
REP.PRIMARY,2.5,DESOGESTREL,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K46061689-001-01-9,
REP.PRIMARY,2.5,NXY-059,,FREE RADICAL SCAVENGER,BRD:BRD-K46133855-304-03-8,
REP.PRIMARY,2.5,RS-67333,HTR4,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K46142322-003-02-4,
REP.PRIMARY,2.5,TOLAZOLINE,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K46211610-003-26-7,
REP.PRIMARY,0.25,GABA-LINOLEAMIDE,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K46254452-001-01-5,
REP.PRIMARY,2.5,PRELADENANT,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K46290096-001-01-1,
REP.PRIMARY,2.5,PROADIFEN,NOS1,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K46317332-003-17-8,
REP.PRIMARY,2.5,ETHYNODIOL-DIACETATE,"ESR1, PGR",,BRD:BRD-K46331928-001-05-8,
REP.PRIMARY,2.38,ETHYNODIOL-DIACETATE,"ESR1, PGR",,BRD:BRD-K46331928-001-06-6,
REP.PRIMARY,2.5,O-3M3FBS,,PHOSPHOLIPASE ACTIVATOR,BRD:BRD-K46384212-001-02-9,
REP.PRIMARY,2.5,ARRY-334543,ERBB2,EGFR INHIBITOR,BRD:BRD-K46386702-001-02-1,
REP.PRIMARY,2.5,TG-100713,,PI3K INHIBITOR,BRD:BRD-K46392623-001-02-5,
REP.PRIMARY,2.5,HYMECROMONE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K46424862-001-14-1,
REP.PRIMARY,2.5,LIOTHYRONINE-(ISOMER),,,BRD:BRD-K46428823-001-02-5,
REP.PRIMARY,2.5,TRICHLOROETHYLENE,,,BRD:BRD-K46435528-001-04-4,
REP.PRIMARY,2.5,VALACICLOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K46435977-003-11-1,
REP.PRIMARY,2.5,SACCHARIN,"CA1, CA12, CA2, CA9",DNA POLYMERASE INHIBITOR,BRD:BRD-K46493214-001-06-7,
REP.PRIMARY,2.5,PRAMOXINE,,TOPICAL ANESTHETIC,BRD:BRD-K46523383-003-22-9,
REP.PRIMARY,2.5,POTASSIUM-CANRENOATE,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K46556543-001-01-4,
REP.PRIMARY,2.5500000000000003,POTASSIUM-CANRENOATE,NR3C2,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K46556543-237-10-5,
REP.PRIMARY,2.5,ACETYLSALICYLSALICYLIC-ACID,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46585355-001-14-3,
REP.PRIMARY,2.5,ZOFENOPRIL-CALCIUM,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K46654563-238-01-0,
REP.PRIMARY,2.5,KP-1212,,,BRD:BRD-K46690591-001-01-2,
REP.PRIMARY,2.5,UMECLIDINIUM,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K46692793-004-01-8,
REP.PRIMARY,2.5,FESOTERODINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K46731503-050-01-8,
REP.PRIMARY,1.58,CAFESTOL,,PREGNANE X RECEPTOR AGONIST,BRD:BRD-K46741531-001-02-4,
REP.PRIMARY,2.5,ALOSETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K46742498-003-11-0,
REP.PRIMARY,2.5,S-14506,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K46766488-003-02-0,
REP.PRIMARY,2.5,STANOZOLOL,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K46791647-001-01-2,
REP.PRIMARY,2.5,CINEPAZIDE,,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K46839850-050-04-2,
REP.PRIMARY,2.5,DIBENZOTHIOPHENE,,,BRD:BRD-K46863940-001-06-2,
REP.PRIMARY,2.5,ZIMELIDINE,"MAOA, MAOB, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K46914825-300-01-0,
REP.PRIMARY,2.5,PHENAZONE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46937689-001-15-0,
REP.PRIMARY,2.5,CEFOZOPRAN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K46970505-003-01-9,
REP.PRIMARY,2.5,CLOXYQUIN,KCNK18,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K46982791-001-09-4,
REP.PRIMARY,1.04,CYTOCHALASIN-B,ACTB,MICROTUBULE INHIBITOR,BRD:BRD-K47000838-001-01-6,
REP.PRIMARY,2.5,TRANYLCYPROMINE,"KDM1A, MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K47029922-003-10-9,
REP.PRIMARY,2.5,EUPATILIN,,MUCUS PROTECTING AGENT,BRD:BRD-K47031502-001-01-6,
REP.PRIMARY,2.5,BAN-ORL-24,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,BRD:BRD-K47049295-300-01-5,
REP.PRIMARY,2.5,CETRIMONIUM,,,BRD:BRD-K47079459-004-04-6,
REP.PRIMARY,2.5,TALNETANT,"TACR2, TACR3",TACHYKININ ANTAGONIST,BRD:BRD-K47095176-001-01-6,
REP.PRIMARY,2.5,AG-490,"EGFR, JAK2, JAK3","EGFR INHIBITOR, JAK INHIBITOR",BRD:BRD-K47105409-001-14-5,
REP.PRIMARY,2.58,CHLOROGENIC-ACID,SLC37A4,ANTIOXIDANT,BRD:BRD-K47114202-001-14-6,
REP.PRIMARY,2.5,KI-8751,KDR,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K47150025-001-05-3,
REP.PRIMARY,2.5,DAPT,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K47177710-001-03-1,
REP.PRIMARY,0.25,ICOSAPENT,"ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1",PLATELET AGGREGATION INHIBITOR,BRD:BRD-K47192521-001-05-4,
REP.PRIMARY,2.5,ACEDOBEN,,,BRD:BRD-K47195926-001-06-6,
REP.PRIMARY,2.5,PSORALEN,"MAOA, MAOB",,BRD:BRD-K47264279-001-08-9,
REP.PRIMARY,2.5,DIPHENHYDRAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K47278471-003-26-3,
REP.PRIMARY,2.5,METHAPYRILENE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K47323024-003-24-4,
REP.PRIMARY,2.5,4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)-PIPERIDINE,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K47337578-034-02-5,
REP.PRIMARY,2.5,ECABAPIDE,,,BRD:BRD-K47371940-001-01-6,
REP.PRIMARY,2.5,JNJ-1661010,FAAH,FAAH INHIBITOR,BRD:BRD-K47376733-001-08-1,
REP.PRIMARY,2.5,NIFENAZONE,,ANALGESIC AGENT,BRD:BRD-K47407372-001-17-1,
REP.PRIMARY,2.5,TETRADECYLTHIOACETIC-ACID,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K47539947-001-03-7,
REP.PRIMARY,2.5,EPEREZOLID,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K47554101-001-01-2,
REP.PRIMARY,2.5,LY2109761,"TGFBR1, TGFBR2",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K47557313-001-02-7,
REP.PRIMARY,2.5,PP-1,"HCK, RET",SRC INHIBITOR,BRD:BRD-K47598052-001-15-8,
REP.PRIMARY,2.5,BROMHEXINE,,MUCOLYTIC AGENT,BRD:BRD-K47631482-003-06-2,
REP.PRIMARY,2.5,DEXAMETHASONE-ACETATE,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K47635719-001-21-1,
REP.PRIMARY,2.5,FLAVOXATE,"CHRM1, CHRM2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K47639036-003-06-6,
REP.PRIMARY,2.5,PICLAMILAST,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K47642186-001-01-3,
REP.PRIMARY,2.5,EMD-386088,HTR6,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K47659338-003-02-8,
REP.PRIMARY,2.5,BROMFENAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K47679368-236-01-7,
REP.PRIMARY,2.5,PENCICLOVIR,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-K47780086-001-07-9,
REP.PRIMARY,2.5,AMPRENAVIR,,HIV PROTEASE INHIBITOR,BRD:BRD-K47827687-001-02-2,
REP.PRIMARY,2.5,FLOXURIDINE,TYMS,DNA SYNTHESIS INHIBITOR,BRD:BRD-K47832606-001-30-1,
REP.PRIMARY,2.5,PODOPHYLLOTOXIN,"IGF1R, TOP2A, TUBA4A, TUBB","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K47869605-001-32-0,
REP.PRIMARY,2.5,BEPHENIUM-HYDROXYNAPHTHOATE,,ANTHELMINTIC AGENT,BRD:BRD-K47878171-086-06-0,
REP.PRIMARY,2.5,NALIDIXIC-ACID,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K47886988-001-21-4,
REP.PRIMARY,2.5,PIRIBEDIL,"ADRA1A, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR2B",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K47936004-003-11-4,
REP.PRIMARY,2.56,MIRABEGRON,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K47949423-001-03-1,
REP.PRIMARY,2.5,BALAPIRAVIR,,RNA POLYMERASE INHIBITOR,BRD:BRD-K47976015-001-01-2,
REP.PRIMARY,2.5,TROMETAMOL,"AMD1, CANT1, DCN, NEIL1, VEGFA",,BRD:BRD-K47978074-001-02-4,
REP.PRIMARY,2.5,BENZTROPINE-MESYLATE,"CHRM1, HRH1, SLC6A3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K48061146-066-01-7,
REP.PRIMARY,2.5,TENELIGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K48068743-001-01-6,
REP.PRIMARY,2.5,CEBRANOPADOL,"OPRL1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K48141473-001-01-7,
REP.PRIMARY,2.5,PROPYLTHIOURACIL,"DIO1, TPO",THYROID PEROXIDASE INHIBITOR,BRD:BRD-K48168960-001-19-2,
REP.PRIMARY,2.5,AMELTOLIDE,,ANTICONVULSANT,BRD:BRD-K48173020-001-01-8,
REP.PRIMARY,2.5,ETHINYL-ESTRADIOL,"ESR1, ESR2, NR1I2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K48195008-001-19-9,
REP.PRIMARY,2.5,TECASTEMIZOLE,KCNH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K48195801-001-01-6,
REP.PRIMARY,2.5,CC-930,,JNK INHIBITOR,BRD:BRD-K48213016-001-01-8,
REP.PRIMARY,2.5,DIATRIZOIC-ACID,,,BRD:BRD-K48247567-001-01-9,
REP.PRIMARY,2.5,ZONISAMIDE,"CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A","SODIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-K48300629-001-14-5,
REP.PRIMARY,2.5,"6,_7-DEHYDRO-17-ACETOXY-PROGESTERONE",,STEROIDAL PROGESTIN,BRD:BRD-K48329353-001-01-3,"6,7-DEHYDRO-17-ACETOXY-PROGESTERONE"
REP.PRIMARY,2.5,"6,7-DEHYDRO-17-ACETOXY-PROGESTERONE",,STEROIDAL PROGESTIN,BRD:BRD-K48329353-001-01-3,"6,7-DEHYDRO-17-ACETOXY-PROGESTERONE"
REP.PRIMARY,2.5,FEBUXOSTAT,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K48367671-001-05-9,
REP.PRIMARY,2.5,CNX-774,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K48443249-001-01-0,
REP.PRIMARY,2.5,YM-201636,,PI3K INHIBITOR,BRD:BRD-K48488978-001-05-3,
REP.PRIMARY,2.5,VU0155069,PLD1,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K48535733-003-01-2,
REP.PRIMARY,2.5,METHYLDOPA,"ADRA2A, ADRA2B, ADRA2C, DDC",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K48578705-001-16-8,
REP.PRIMARY,2.5,METHYLDOPA,"ADRA2A, ADRA2B, ADRA2C, DDC",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K48578705-001-17-6,
REP.PRIMARY,2.54,METHSCOPOLAMINE,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K48619321-004-16-8,
REP.PRIMARY,2.5,BAY-11-7085,NFKBIA,NFKB PATHWAY INHIBITOR,BRD:BRD-K48684885-001-04-2,
REP.PRIMARY,2.5,NU-1025,PARP1,PARP INHIBITOR,BRD:BRD-K48692744-001-02-0,
REP.PRIMARY,2.5,DILAZEP,SLC29A1,ADENOSINE REUPTAKE INHIBITOR,BRD:BRD-K48722258-300-10-2,
REP.PRIMARY,2.5,ILOPERIDONE,"ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K48722833-001-07-6,
REP.PRIMARY,2.5,MACITENTAN,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K48812570-001-02-3,
REP.PRIMARY,2.5,S26948,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-K48826825-001-01-8,
REP.PRIMARY,2.5,OMDM-2,GPR119,FAAH INHIBITOR,BRD:BRD-K48830578-001-01-9,
REP.PRIMARY,2.5,CG-400549,,FABI INHIBITOR,BRD:BRD-K48888725-001-01-9,
REP.PRIMARY,2.5,SASAPYRINE,"PTGS1, PTGS2",NFKB PATHWAY INHIBITOR,BRD:BRD-K48892307-001-04-1,
REP.PRIMARY,2.5,LAROPIPRANT,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K48894757-001-01-8,
REP.PRIMARY,2.5,CYTOCHLOR,,,BRD:BRD-K48988407-001-01-2,
REP.PRIMARY,2.5,PENTACOSANOIC-ACID,,,BRD:BRD-K48996094-001-01-3,
REP.PRIMARY,2.5,PSB-1115,"ADORA1, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K49027941-001-01-1,
REP.PRIMARY,2.5,CGS-15943,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K49049886-001-08-7,
REP.PRIMARY,2.5,A66,PIK3CA,PI3K INHIBITOR,BRD:BRD-K49055432-001-04-2,
REP.PRIMARY,2.5,SECURININE,GABRA1,"GABA RECEPTOR ANTAGONIST, TP53 ACTIVATOR",BRD:BRD-K49071277-001-04-7,
REP.PRIMARY,2.5,NINTEDANIB,"FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K49075727-001-08-5,
REP.PRIMARY,2.5,PRAZOSIN,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K49111258-003-29-7,
REP.PRIMARY,2.5,TMPH,,,BRD:BRD-K49119234-003-02-6,
REP.PRIMARY,2.5,CV-1808,ADORA2A,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K49197823-001-09-8,
REP.PRIMARY,2.5,GSK2636771,PIK3CB,PI3K INHIBITOR,BRD:BRD-K49215523-001-04-2,
REP.PRIMARY,2.5,6-IODO-NORDIHYDROCAPSAICIN,TRPV1,TRPV ANTAGONIST,BRD:BRD-K49236613-001-02-3,
REP.PRIMARY,2.5,BIBU-1361,EGFR,EGFR INHIBITOR,BRD:BRD-K49294207-300-03-8,
REP.PRIMARY,2.5,RIBITOL,,,BRD:BRD-K49313711-001-05-4,
REP.PRIMARY,2.5,DASATINIB,"ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1","BCR-ABL KINASE INHIBITOR, EPHRIN INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K49328571-001-15-0,
REP.PRIMARY,2.5,ETOFIBRATE,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K49338325-001-03-4,
REP.PRIMARY,2.5,THIOGUANINE,"IMPDH1, IMPDH2",PURINE ANTAGONIST,BRD:BRD-K49350383-001-13-7,
REP.PRIMARY,2.5,PIK-75,"PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","DNA PROTEIN KINASE INHIBITOR, PI3K INHIBITOR",BRD:BRD-K49371609-003-03-8,
REP.PRIMARY,2.5,LEVETIRACETAM,"CACNA1B, SCN1A, SV2A",CALCIUM CHANNEL BLOCKER,BRD:BRD-K49404994-001-10-9,
REP.PRIMARY,2.5,PILARALISIB,,PI3K INHIBITOR,BRD:BRD-K49456274-001-01-9,
REP.PRIMARY,2.5,10058-F4,,C-MYC INHIBITOR,BRD:BRD-K49460120-001-02-5,
REP.PRIMARY,2.5,GALANTAMINE,"ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K49481516-004-18-3,
REP.PRIMARY,2.5,SEP-227900,DAO,D-AMINO ACID OXIDASE INHIBITOR,BRD:BRD-K49504902-001-01-6,
REP.PRIMARY,2.5,LY2140023,GRM3,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K49519144-001-04-6,
REP.PRIMARY,2.53,ALFACALCIDOL,"CYP27B1, VDR",VITAMIN D RECEPTOR AGONIST,BRD:BRD-K49522529-001-02-9,
REP.PRIMARY,2.5,ALFACALCIDOL,"CYP27B1, VDR",VITAMIN D RECEPTOR AGONIST,BRD:BRD-K49522529-001-03-7,
REP.PRIMARY,2.5,"4,4-PENTAMETHYLENEPIPERIDINE",,M2 CHANNEL BLOCKER,BRD:BRD-K49545903-003-01-4,
REP.PRIMARY,2.5,CAREBASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K49554218-001-01-0,
REP.PRIMARY,2.5,BMS-707035,,HIV INTEGRASE INHIBITOR,BRD:BRD-K49555808-001-03-9,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-18,EGFR,"EGFR INHIBITOR, TYROSINE KINASE INHIBITOR",BRD:BRD-K49657628-001-14-8,
REP.PRIMARY,2.5,CLARITHROMYCIN,CYP3A4,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K49668410-001-18-8,
REP.PRIMARY,2.5,BX-912,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1",PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-K49669041-001-08-4,
REP.PRIMARY,2.5,KETANSERIN,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K49671696-045-08-5,
REP.PRIMARY,2.5,TTNPB,"RARA, RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K49685476-001-15-9,
REP.PRIMARY,2.5,SNAP-94847,"ADRA1A, DRD2",,BRD:BRD-K49702221-003-01-6,
REP.PRIMARY,2.5,AGMATINE,"ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K49738308-065-04-9,
REP.PRIMARY,2.5,4-HYDROXY-PHENAZONE,,,BRD:BRD-K49759007-001-11-9,
REP.PRIMARY,2.5,DECAMETHONIUM,"ACHE, CHRNA2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K49783248-303-08-4,
REP.PRIMARY,2.5,BENAZEPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K49807096-003-15-5,
REP.PRIMARY,2.5,NSC-9965,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K49811169-004-06-6,
REP.PRIMARY,2.5,ETOFYLLINE-CLOFIBRATE,PPARA,PLATELET AGGREGATION INHIBITOR,BRD:BRD-K49840922-001-05-1,
REP.PRIMARY,2.5,PD-0325901,MAP2K1,MEK INHIBITOR,BRD:BRD-K49865102-001-08-4,
REP.PRIMARY,2.5,CEPHAPIRIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K49880111-236-09-2,
REP.PRIMARY,2.5,GR-113808,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K49945136-001-10-0,
REP.PRIMARY,2.5,MESNA,,ANTIOXIDANT,BRD:BRD-K49954789-001-02-9,
REP.PRIMARY,2.5,BAICALIN,PREP,BETA GLUCURONIDASE INHIBITOR,BRD:BRD-K49962337-001-01-1,
REP.PRIMARY,2.56,BAICALIN,PREP,BETA GLUCURONIDASE INHIBITOR,BRD:BRD-K49962337-001-02-9,
REP.PRIMARY,2.5,PHA-767491,"CDK1, RPS6KB1",CDC INHIBITOR,BRD:BRD-K50000283-001-04-4,
REP.PRIMARY,2.5,RS-67506,HTR4,SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K50018155-003-02-1,
REP.PRIMARY,2.5,PF-04447943,PDE9A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K50031829-001-01-6,
REP.PRIMARY,2.5,DOCOSANOL,TLR7,LIPASE CLEARING FACTOR INHIBITOR,BRD:BRD-K50050533-001-02-1,
REP.PRIMARY,2.5,ABIRATERONE,"CYP11B1, CYP17A1",ANDROGEN BIOSYNTHESIS INHIBITOR,BRD:BRD-K50071428-001-03-3,
REP.PRIMARY,2.5,TOLFENAMIC-ACID,,"CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K50133271-001-18-7,
REP.PRIMARY,2.5,GBR-12935,"AGTR1, SLC6A3","DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K50135270-300-02-3,
REP.PRIMARY,2.5,NVP-TAE684,"ALK, INSR",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K50140147-001-10-1,
REP.PRIMARY,2.5,ACRIVASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50163129-001-01-4,
REP.PRIMARY,2.5,CANERTINIB,"AKT1, EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K50168500-001-07-9,
REP.PRIMARY,2.5,MM77,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50293352-300-02-1,
REP.PRIMARY,2.5,UCL-2077,,SLOW AFTERHYPERPOLARIZATION CHANNEL BLOCKER,BRD:BRD-K50325075-001-02-1,
REP.PRIMARY,2.5,FENOFIBRATE,"MMP25, PPARA",PPAR RECEPTOR AGONIST,BRD:BRD-K50388907-001-30-4,
REP.PRIMARY,2.5,MECLOFENAMIC-ACID,"ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K50398167-236-22-7,
REP.PRIMARY,2.5,HYCANTHONE,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K50406511-001-26-0,
REP.PRIMARY,2.5,ETICLOPRIDE,"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50417881-003-17-4,
REP.PRIMARY,2.5,CLOMETHIAZOLE,GABRA1,"GABA RECEPTOR ANTAGONIST, GABA RECEPTOR MODULATOR",BRD:BRD-K50422030-001-05-3,
REP.PRIMARY,2.5,SRC-KINASE-INHIBITOR-I,"CSK, LCK, RIPK2",SRC INHIBITOR,BRD:BRD-K50495309-001-02-0,
REP.PRIMARY,2.5,TALADEGIB,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K50498985-001-03-3,
REP.PRIMARY,2.5,E-2012,"APH1A, APH1B, PSENEN",GAMMA SECRETASE MODULATOR,BRD:BRD-K50564936-001-01-6,
REP.PRIMARY,2.5,CAPSAICIN,"CFTR, TRPV1",TRPV AGONIST,BRD:BRD-K50590187-001-19-9,
REP.PRIMARY,2.5,PIK-294,"PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K50631926-001-02-3,
REP.PRIMARY,2.5,OXIRACETAM,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K50677762-001-01-5,
REP.PRIMARY,2.5,CYCLAMIC-ACID,,,BRD:BRD-K50785021-001-02-1,
REP.PRIMARY,2.5,PANCURONIUM,"CHRM2, CHRM3, CHRNA1, CHRNA2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K50817623-303-05-7,
REP.PRIMARY,2.5,PURVALANOL-A,"CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC",CDK INHIBITOR,BRD:BRD-K50836978-001-02-5,
REP.PRIMARY,2.5,ACESULFAME-POTASSIUM,,,BRD:BRD-K50850824-237-04-8,
REP.PRIMARY,2.5,DIENOGEST,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K50853363-001-02-3,
REP.PRIMARY,2.5,SULFAFURAZOLE,,BACTERIAL ANTIFOLATE,BRD:BRD-K50859149-001-19-5,
REP.PRIMARY,2.5,TROPISETRON,"GLRA1, GLRA2, GLRB, HTR3A, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50866992-003-09-5,
REP.PRIMARY,2.5,TROPISETRON,"GLRA1, GLRA2, GLRB, HTR3A, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K50866992-003-10-3,
REP.PRIMARY,2.5,GR-103691,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K50891186-001-04-4,
REP.PRIMARY,2.5,SUMATRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K50938287-036-13-8,
REP.PRIMARY,2.5,ROPIVACAINE,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K50938786-003-11-8,
REP.PRIMARY,2.5,TRAMADOL,"CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4","NOREPINEPHRINE REPUTAKE INHIBITOR, OPIOID RECEPTOR AGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K51033547-003-02-6,
REP.PRIMARY,2.5,COBICISTAT,"CYP3A4, CYP3A43, CYP3A5, CYP3A7",CYTOCHROME P450 INHIBITOR,BRD:BRD-K51040301-001-02-1,
REP.PRIMARY,2.5,TIRASEMTIV,,TROPONIN ACTIVATOR,BRD:BRD-K51087630-001-01-6,
REP.PRIMARY,2.5,LURASIDONE,"ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K51143828-003-03-1,
REP.PRIMARY,2.5,FLUOROMETHYLCHOLINE,,,BRD:BRD-K51199656-003-01-4,
REP.PRIMARY,2.5,ETHIONAMIDE,,MYCOLIC SYNTHESIS INHIBITOR,BRD:BRD-K51207550-001-23-0,
REP.PRIMARY,2.5,IPRAGLIFLOZIN-L-PROLINE,SLC5A2,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K51247865-001-01-2,
REP.PRIMARY,2.5,SARCOSINE,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K51263939-001-08-6,
REP.PRIMARY,2.5,PALBOCICLIB,"CDK4, CDK6",CDK INHIBITOR,BRD:BRD-K51313569-003-03-3,
REP.PRIMARY,2.5,FENBENDAZOLE,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K51318897-001-15-3,
REP.PRIMARY,2.5,MEGLITINIDE,CCR2,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K51324732-001-01-0,
REP.PRIMARY,2.5,SIRAMESINE,"ADRA1A, ADRA1B, ADRA1D",SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K51333959-003-01-3,
REP.PRIMARY,2.5,TOREMIFENE,ESR1,"ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K51350053-048-16-5,
REP.PRIMARY,2.5,DEXTROSE,,,BRD:BRD-K51431759-001-02-9,
REP.PRIMARY,2.5,DEMECARIUM,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K51471001-303-04-7,
REP.PRIMARY,2.5,TAURINE,,ANTIOXIDANT,BRD:BRD-K51474575-001-10-4,
REP.PRIMARY,2.5,RITONAVIR,"CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K51485625-001-08-4,
REP.PRIMARY,2.5,LAZABEMIDE,MAOB,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K51486818-003-02-8,
REP.PRIMARY,2.5,RO-25-6981,GRIN2B,"GLUTAMATE RECEPTOR ANTAGONIST, MONAMINE TRANSPORTER MODULATOR",BRD:BRD-K51541829-050-01-0,
REP.PRIMARY,2.5,CABOZANTINIB,"KDR, MET, RET","RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K51544265-001-04-2,
REP.PRIMARY,2.5,TPCA-1,IKBKB,IKK INHIBITOR,BRD:BRD-K51575138-001-13-2,
REP.PRIMARY,2.5,DAPOXETINE,"HTR1A, HTR1B, HTR2C, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K51579475-003-02-4,
REP.PRIMARY,2.5,ILOMASTAT,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51662849-001-05-4,
REP.PRIMARY,2.61,ILOMASTAT,"ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51662849-001-08-8,
REP.PRIMARY,2.5,LEVOSULPIRIDE,"CA1, CA12, CA7, DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51671335-001-10-6,
REP.PRIMARY,2.5,ERYTHROMYCIN-ETHYLSUCCINATE,"ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1","CYTOCHROME P450 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K51677086-001-12-0,
REP.PRIMARY,2.5,HYDROXYUREA,"RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K51747290-001-12-3,
REP.PRIMARY,2.5,HYDROXYUREA,"RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K51747290-001-13-1,
REP.PRIMARY,2.5,ALFADOLONE-ACETATE,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K51751936-001-09-1,
REP.PRIMARY,2.5,JNJ-17203212,TRPV1,TRPV ANTAGONIST,BRD:BRD-K51770398-001-01-9,
REP.PRIMARY,2.5,P276-00,"CDK1, CDK4, CDK9",CDK INHIBITOR,BRD:BRD-K51791723-003-01-7,
REP.PRIMARY,2.5,QUINOLINIC-ACID,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K51885093-001-11-2,
REP.PRIMARY,2.5,NEMORUBICIN,"TOP1, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K51911221-001-01-2,
REP.PRIMARY,2.5,IODOPHENPROPIT,"HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51918615-303-02-9,
REP.PRIMARY,2.5,BILASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K51937257-001-01-4,
REP.PRIMARY,2.5,BIIB021,HSP90AA1,HSP INHIBITOR,BRD:BRD-K51967704-001-03-6,
REP.PRIMARY,2.5,METRONIDAZOLE,"CYP2C9, CYP3A4",DNA INHIBITOR,BRD:BRD-K52020312-001-26-8,
REP.PRIMARY,5.6000000000000005,CERULENIN,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K52075040-001-09-7,
REP.PRIMARY,2.5,OXIBENDAZOLE,"TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K52075715-001-06-7,
REP.PRIMARY,2.5,NANDROLONE,"AR, CYP19A1, MAOA, MAOB",IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K52080565-001-09-2,
REP.PRIMARY,2.5,CP-339818,KCNA3,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K52113681-003-02-1,
REP.PRIMARY,2.5,ANASTROZOLE,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K52172416-001-11-4,
REP.PRIMARY,2.5,ICI-63197,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K52219182-001-02-4,
REP.PRIMARY,2.5,R547,"CDK1, CDK2, CDK4, CDK7",CDK INHIBITOR,BRD:BRD-K52233191-001-02-4,
REP.PRIMARY,2.5,CHLORHEXIDINE,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K52256627-300-06-6,
REP.PRIMARY,2.5,CHINIOFON,,ANTIPROTOZOAL AGENT,BRD:BRD-K52284881-236-02-4,
REP.PRIMARY,2.5,TACEDINALINE,HDAC1,HDAC INHIBITOR,BRD:BRD-K52313696-001-12-3,
REP.PRIMARY,2.5,GR-159897,"TAC1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K52394958-001-02-7,
REP.PRIMARY,2.5,CF102,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K52396582-001-06-7,
REP.PRIMARY,2.5,AMPEROZIDE,"FAAH, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K52397688-003-06-4,
REP.PRIMARY,2.5,CLOBAZAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K52408781-001-02-8,
REP.PRIMARY,2.5,KAINIC-ACID,"GRIA1, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5",KAINATE RECEPTOR AGONIST,BRD:BRD-K52459018-001-09-1,
REP.PRIMARY,2.5,ALPROSTADIL,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGER1, PTGER2, PTGER4, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K52459643-001-17-7,
REP.PRIMARY,2.5,"ICI-215,001",ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K52487250-003-01-2,
REP.PRIMARY,2.5,SC-19220,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K52512893-001-08-9,
REP.PRIMARY,2.5,N-ACETYLCARNOSINE,,,BRD:BRD-K52523550-001-01-5,
REP.PRIMARY,2.5,MONOSODIUM-ALPHA-LUMINOL,,,BRD:BRD-K52559566-001-02-9,
REP.PRIMARY,2.5,INOSITOL,"CDIPT, GBA",INSULIN SENSITIZER,BRD:BRD-K52618540-001-09-9,
REP.PRIMARY,2.5,LIDOCAINE,"EGFR, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HISTAMINE RECEPTOR AGONIST,BRD:BRD-K52662033-003-21-2,
REP.PRIMARY,2.5,CIS-UROCANIC-ACID,HTR2A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K52670952-003-01-4,
REP.PRIMARY,2.5,TAK-715,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K52751261-001-06-1,
REP.PRIMARY,2.5,DIRITHROMYCIN,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K52756523-001-24-7,
REP.PRIMARY,2.5,EPOTHILONE-D,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K52762805-001-01-2,
REP.PRIMARY,2.5,IVACAFTOR,CFTR,CFTR CHANNEL POTENTIATOR,BRD:BRD-K52818472-001-02-2,
REP.PRIMARY,2.5,GDC-0941,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K52911425-001-09-8,
REP.PRIMARY,2.5,MITIGLINIDE,"ABCC8, KCNJ10, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K52959329-238-01-9,
REP.PRIMARY,2.5,CLOMIPRAMINE,"GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4",SEROTONIN TRANSPORTER (SERT) INHIBITOR,BRD:BRD-K52989797-003-26-4,
REP.PRIMARY,2.5,OZAGREL,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K53061490-003-13-9,
REP.PRIMARY,2.5,"1,5-DICAFFEOYLQUINIC-ACID",,,BRD:BRD-K53083666-001-01-0,
REP.PRIMARY,2.5,PTEROSTILBENE,PTGS2,"CYCLOOXYGENASE INHIBITOR, PPAR RECEPTOR AGONIST",BRD:BRD-K53097745-001-01-5,
REP.PRIMARY,2.5,NIRIDAZOLE,,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K53123955-001-10-5,
REP.PRIMARY,0.03,LTB4,"LTB4R, LTB4R2",LEUKOCYTE ACTIVATOR,BRD:BRD-K53124401-001-03-8,
REP.PRIMARY,2.5,BUTYLATED-HYDROXYTOLUENE,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K53153417-001-10-4,
REP.PRIMARY,2.5,AFALANINE,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K53205568-001-02-6,
REP.PRIMARY,2.5,TRIMETOZINE,,SEDATIVE,BRD:BRD-K53220666-001-02-6,
REP.PRIMARY,2.5,IWP-L6,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K53234107-001-01-6,
REP.PRIMARY,2.5,CITCO,NR1I3,CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) AGONIST,BRD:BRD-K53263234-001-05-2,
REP.PRIMARY,2.5,VINPOCETINE,"PDE1A, PDE1C","PHOSPHODIESTERASE INHIBITOR, SODIUM CHANNEL BLOCKER",BRD:BRD-K53318339-001-24-9,
REP.PRIMARY,2.5,BENZOIC-ACID,"DAO, HRSP12, PRDX5, RAB9A",FOOD PRESERVATIVE,BRD:BRD-K53397409-001-12-3,
REP.PRIMARY,2.5,TIVOZANIB,"FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB",VEGFR INHIBITOR,BRD:BRD-K53414658-001-08-2,
REP.PRIMARY,2.5,OTS167,MELK,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE INHIBITOR,BRD:BRD-K53417444-003-03-1,
REP.PRIMARY,2.5,ACADESINE,,AMPK ACTIVATOR,BRD:BRD-K53448858-001-07-0,
REP.PRIMARY,2.5,CTS-1027,"MMP1, MMP13, MMP2, MMP3, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K53508936-001-01-0,
REP.PRIMARY,2.5,FLUVOXAMINE,SLC6A4,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K53517854-051-01-4,
REP.PRIMARY,2.5,ARCTIGENIN,"CHUK, MAP2K1",MEK INHIBITOR,BRD:BRD-K53523901-001-04-4,
REP.PRIMARY,2.5,U-50488-(-),OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K53532120-003-09-5,
REP.PRIMARY,2.5,U-50488-(-),OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K53532120-003-11-1,
REP.PRIMARY,2.5,AURORA-A-INHIBITOR-I,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K53561341-001-07-5,
REP.PRIMARY,2.5,BARICITINIB,"JAK1, JAK2",JAK INHIBITOR,BRD:BRD-K53581288-001-02-9,
REP.PRIMARY,2.5,MK-5108,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K53665955-001-03-0,
REP.PRIMARY,2.5,CINALUKAST,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K53720352-001-03-2,
REP.PRIMARY,2.66,PRT062607,"FGR, MAP3K9, SYK",SYK INHIBITOR,BRD:BRD-K53734668-003-02-0,
REP.PRIMARY,2.5,PRT062607,"FGR, MAP3K9, SYK",SYK INHIBITOR,BRD:BRD-K53734668-003-04-6,
REP.PRIMARY,2.5,AMITRIPTYLINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4","NOREPINEPHRINE INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-K53737926-003-27-8,
REP.PRIMARY,2.5,EMPAGLIFLOZIN,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K53765467-001-02-1,
REP.PRIMARY,2.5,RIPASUDIL,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K53814070-310-01-3,
REP.PRIMARY,2.5,MENBUTONE,,,BRD:BRD-K53852914-001-01-8,
REP.PRIMARY,2.5,RISPERIDONE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K53857191-001-22-7,
REP.PRIMARY,2.5,SB-408124,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K53913732-001-05-9,
REP.PRIMARY,2.5,VORTIOXETINE,"HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K53963539-004-02-0,
REP.PRIMARY,2.5,RUXOLITINIB,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K53972329-001-07-0,
REP.PRIMARY,2.5,ALX-5407,SLC6A9,"GLYCINE TRANSPORTER 1 INHIBITOR, GLYCINE TRANSPORTER INHIBITOR",BRD:BRD-K53979406-003-02-8,
REP.PRIMARY,2.5,FORMOTEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K54006094-051-01-7,
REP.PRIMARY,2.5,CABALETTA,,PHARMACOLOGICAL CHAPERONE,BRD:BRD-K54028654-001-02-6,
REP.PRIMARY,2.5,ISOBUTYRAMIDE,"HBE1, HBG1",GENE EXPRESSION STIMULANT,BRD:BRD-K54057105-001-01-2,
REP.PRIMARY,2.5,REMOXIPRIDE,"DRD2, DRD3, DRD4, HTR2A, SIGMAR1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K54094468-003-11-1,
REP.PRIMARY,2.5,CMPD-1,"GNRHR, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K54095730-001-03-1,
REP.PRIMARY,2.5,CIRAZOLINE,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K54142781-003-11-8,
REP.PRIMARY,2.51,DICHLORISONE-ACETATE,,,BRD:BRD-K54187111-001-08-4,
REP.PRIMARY,2.5,DICHLORISONE-ACETATE,,,BRD:BRD-K54187111-001-09-2,
REP.PRIMARY,2.5,HALOFUGINONE,"COL1A1, MMP2",COLLAGENASE INHIBITOR,BRD:BRD-K54247840-004-01-3,
REP.PRIMARY,2.5,MK-1775,WEE1,WEE1 KINASE INHIBITOR,BRD:BRD-K54256913-001-08-7,
REP.PRIMARY,2.5,MONOBENZONE,TYR,MELANIN INHIBITOR,BRD:BRD-K54262262-001-09-0,
REP.PRIMARY,2.5,ZOLMITRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K54314721-001-10-2,
REP.PRIMARY,2.5,TOLTERODINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K54316499-046-04-5,
REP.PRIMARY,2.5,SB-202190,"AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1",P38 MAPK INHIBITOR,BRD:BRD-K54330070-001-15-4,
REP.PRIMARY,2.5,PR-619,,DUB INHIBITOR,BRD:BRD-K54395039-001-01-7,
REP.PRIMARY,2.5,METHIMAZOLE,TPO,ANTITHYROID AGENT,BRD:BRD-K54416256-001-19-9,
REP.PRIMARY,2.5,ELVITEGRAVIR,,HIV INTEGRASE INHIBITOR,BRD:BRD-K54472332-001-03-4,
REP.PRIMARY,2.5,PROPACETAMOL,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54496168-003-01-2,
REP.PRIMARY,2.5,LXR-623,"AR, NR1H2, NR1H3, NR1I2, NR3C1",LXR AGONIST,BRD:BRD-K54520417-001-01-2,
REP.PRIMARY,2.5,THIODIGLYCOL,,,BRD:BRD-K54521836-001-02-1,
REP.PRIMARY,2.5,CAPTOPRIL,"ACE, LTA4H, MMP2, MMP9",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K54529596-001-26-3,
REP.PRIMARY,2.5,JQ1-(+),"BRD4, BRDT",BROMODOMAIN INHIBITOR,BRD:BRD-K54606188-001-13-1,
REP.PRIMARY,2.5,ARTESUNATE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K54634444-001-05-9,
REP.PRIMARY,2.5,WAY-362450,NR1H4,FXR AGONIST,BRD:BRD-K54640016-001-04-7,
REP.PRIMARY,2.5,R-59022,DGKA,"DIACYLGLYCEROL KINASE INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K54665485-001-07-9,
REP.PRIMARY,2.5,NTZDPA,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-K54708045-001-02-1,
REP.PRIMARY,2.5,DOSULEPIN,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4","NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), TRICYCLIC ANTIDEPRESSANT",BRD:BRD-K54759182-003-08-0,
REP.PRIMARY,2.5,ETORICOXIB,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54770957-001-04-3,
REP.PRIMARY,2.5,TRIOXSALEN,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K54790157-001-15-5,
REP.PRIMARY,2.5,PROCODAZOLE,,IMMUNOSTIMULANT,BRD:BRD-K54824716-001-04-0,
REP.PRIMARY,2.5,FUDOSTEINE,,MUCOLYTIC AGENT,BRD:BRD-K54838207-001-02-0,
REP.PRIMARY,2.5,FUDOSTEINE,,MUCOLYTIC AGENT,BRD:BRD-K54838207-001-03-8,
REP.PRIMARY,2.5,EQUOL,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K54847683-001-03-2,
REP.PRIMARY,2.5,EQUOL,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K54847683-001-04-0,
REP.PRIMARY,2.5,DMP-777,MPO,ELASTASE INHIBITOR,BRD:BRD-K54936858-001-01-6,
REP.PRIMARY,2.5,ALPELISIB,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K54997624-001-06-0,
REP.PRIMARY,2.5,LORCASERIN,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55013654-003-02-3,
REP.PRIMARY,2.5,PEFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K55034111-066-17-1,
REP.PRIMARY,2.5,AMOXICILLIN,"CYP2C19, SLC15A1, SLC15A2, SLC22A6",PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55044200-001-14-6,
REP.PRIMARY,2.5,AMOXICILLIN,"CYP2C19, SLC15A1, SLC15A2, SLC22A6",PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55044200-001-15-3,
REP.PRIMARY,2.5,ETOMIDATE,"ADRA2B, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",GABA RECEPTOR MODULATOR,BRD:BRD-K55055802-001-10-2,
REP.PRIMARY,2.5,FLUPHENAZINE,"CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55127134-300-11-2,
REP.PRIMARY,2.5,BENZO[D]THIAZOLE-2(3H)-THIONE,,,BRD:BRD-K55160477-001-04-7,
REP.PRIMARY,2.5,EFLOXATE,,VASODILATOR,BRD:BRD-K55166090-001-09-0,
REP.PRIMARY,2.5,RIGOSERTIB,PLK1,"CELL CYCLE INHIBITOR, PLK INHIBITOR",BRD:BRD-K55187425-236-05-2,
REP.PRIMARY,2.5,BENZYLPENICILLIN,,PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K55191674-237-18-3,
REP.PRIMARY,2.5,SULFADOXINE,,DIHYDROPTEROATE SYNTHASE INHIBITOR,BRD:BRD-K55250441-001-13-0,
REP.PRIMARY,2.5,SC-144,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K55305701-001-01-2,
REP.PRIMARY,2.5,BU-224,"MAOA, MAOB",IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K55344148-003-02-6,
REP.PRIMARY,2.5,ANPIRTOLINE,HTR1B,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55424922-003-02-8,
REP.PRIMARY,2.5,AM-404,"CNR1, CNR2, FAAH, TRPV1","CYCLOOXYGENASE INHIBITOR, FAAH INHIBITOR, TRPV ANTAGONIST",BRD:BRD-K55462201-001-07-3,
REP.PRIMARY,2.5,SPIPERONE,"ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55468218-001-26-1,
REP.PRIMARY,2.5,MK-8033,MET,C-MET INHIBITOR,BRD:BRD-K55512740-001-01-6,
REP.PRIMARY,2.5,FORMONONETIN,"ADH1C, SLC5A2",ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K55567017-001-12-3,
REP.PRIMARY,2.5,TORCETRAPIB,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K55675242-001-03-0,
REP.PRIMARY,2.5,CO-101244,GRIN2B,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K55677650-003-02-9,
REP.PRIMARY,2.5,LATREPIRDINE,"HRH1, HTR6",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K55703048-001-07-7,
REP.PRIMARY,2.5,PENBUTOLOL,"ADRB1, ADRB2, HTR1A, HTR1B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K55705469-065-01-0,
REP.PRIMARY,2.5,SCH-28080,ATP4A,ATPASE INHIBITOR,BRD:BRD-K55748775-001-02-2,
REP.PRIMARY,2.5,BMS-806,,HIV ATTACHMENT INHIBITOR,BRD:BRD-K55773932-001-02-0,
REP.PRIMARY,2.5,BMS-927711,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-K55781385-001-01-7,RIMEGEPANT
REP.PRIMARY,2.5,RIMEGEPANT,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-K55781385-001-01-7,RIMEGEPANT
REP.PRIMARY,2.5,LOBENZARIT,,IMMUNOSUPPRESSANT,BRD:BRD-K55847762-304-01-7,
REP.PRIMARY,2.5,SORBIC-ACID,,,BRD:BRD-K55892330-001-01-8,
REP.PRIMARY,2.5,PHENYTOIN,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",HYDANTOIN ANTIEPILEPTIC,BRD:BRD-K55930204-236-24-3,
REP.PRIMARY,2.5,ORANTINIB,"AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K55966568-001-05-4,
REP.PRIMARY,2.5,AP26113,"ALK, EGFR",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K56032964-001-02-1,
REP.PRIMARY,2.5,5-METHYLHYDANTOIN-(L),,,BRD:BRD-K56033645-001-07-5,
REP.PRIMARY,2.5,RHC-80267,"DAGLA, DAGLB",TRIACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K56047318-001-06-3,
REP.PRIMARY,2.5,MMPX,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K56077740-001-09-2,
REP.PRIMARY,2.5,OXICONAZOLE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K56104152-008-04-1,
REP.PRIMARY,2.5,BU226,,IMIDAZOLINE RECEPTOR LIGAND,BRD:BRD-K56115039-003-02-1,
REP.PRIMARY,2.5,BENZNIDAZOLE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K56156805-001-09-6,
REP.PRIMARY,2.5,LOSMAPIMOD,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K56195681-001-01-0,
REP.PRIMARY,2.5,MGCD-265,"AXL, MET",VEGFR INHIBITOR,BRD:BRD-K56277358-001-07-5,
REP.PRIMARY,2.5,VOXTALISIB,"MTOR, PIK3CA","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K56291712-001-01-0,
REP.PRIMARY,2.5,ABT-737,"BCL2, BCL2L1, BCL2L2",BCL INHIBITOR,BRD:BRD-K56301217-001-07-4,
REP.PRIMARY,2.5,AMONAFIDE,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K56334280-001-05-1,
REP.PRIMARY,2.5,VEMURAFENIB,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K56343971-001-10-6,
REP.PRIMARY,2.5,MK-2461,"FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K56405753-001-02-4,
REP.PRIMARY,2.5,CHICAGO-SKY-BLUE-6B,MIF,"GLUTAMATE INHIBITOR, MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR",BRD:BRD-K56483981-342-06-4,
REP.PRIMARY,2.5,MEDRYSONE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K56515112-001-21-6,
REP.PRIMARY,2.5,CEFPIROME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K56542719-065-01-4,
REP.PRIMARY,2.5,ADX-47273,GRM5,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K56543881-001-02-7,
REP.PRIMARY,2.5,AMBROXOL,CYP3A4,SODIUM CHANNEL BLOCKER,BRD:BRD-K56558538-003-11-9,
REP.PRIMARY,2.5,QX-314,"MAPK14, TGFBR1",SODIUM CHANNEL BLOCKER,BRD:BRD-K56596464-004-10-7,
REP.PRIMARY,2.5,CLOFAZIMINE,,GK0582 INHIBITOR,BRD:BRD-K56614220-001-19-0,
REP.PRIMARY,2.5,PIKAMILONE,,,BRD:BRD-K56691760-001-01-2,
REP.PRIMARY,2.5,NITARSONE,,,BRD:BRD-K56707426-001-02-0,
REP.PRIMARY,2.5,CARBADOX,,OTHER ANTIBIOTIC,BRD:BRD-K56735750-001-06-8,
REP.PRIMARY,2.5,Y-39983,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K56751279-300-01-4,
REP.PRIMARY,2.5,FOMEPIZOLE,"ADH1A, ADH1B, ADH1C, AKR1A1, CAT",ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K56810756-001-03-0,
REP.PRIMARY,2.5,ENZALUTAMIDE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K56851771-001-06-8,
REP.PRIMARY,2.5,FLUROXENE,,LOCAL ANESTHETIC,BRD:BRD-K56908511-001-01-2,
REP.PRIMARY,2.5,OXETHAZAINE,,LOCAL ANESTHETIC,BRD:BRD-K56940463-001-13-8,
REP.PRIMARY,2.5,CRESOL,,,BRD:BRD-K56940914-001-04-2,
REP.PRIMARY,2.5,DACINOSTAT,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K56957086-001-06-3,
REP.PRIMARY,2.5,TRIPELENNAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57033106-003-19-7,
REP.PRIMARY,2.5,DABIGATRAN-ETEXILATE,F2,THROMBIN INHIBITOR,BRD:BRD-K57041787-001-02-6,
REP.PRIMARY,2.5,SELUMETINIB,MAP2K1,MEK INHIBITOR,BRD:BRD-K57080016-001-15-9,
REP.PRIMARY,2.5,CCT129202,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K57136142-001-02-4,
REP.PRIMARY,2.5,DACOMITINIB,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K57169635-001-04-5,
REP.PRIMARY,2.5,CROTAMITON,,ANTIPRURITIC,BRD:BRD-K57179821-001-15-4,
REP.PRIMARY,2.5,INDOMETHACIN,"GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K57222227-001-30-1,
REP.PRIMARY,2.5,CILENGITIDE,"ITGAV, ITGB3",INTEGRIN ANTAGONIST,BRD:BRD-K57252450-001-02-5,
REP.PRIMARY,2.61,GENIPOSIDE,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-K57275767-001-02-4,
REP.PRIMARY,2.5,GENIPOSIDE,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-K57275767-001-03-2,
REP.PRIMARY,2.5,RO-9187,,HCV INHIBITOR,BRD:BRD-K57284066-001-01-6,
REP.PRIMARY,2.5,MOROXYDINE,,ANTIVIRAL,BRD:BRD-K57291914-003-09-4,
REP.PRIMARY,2.5,PRE-084,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K57304726-003-06-9,
REP.PRIMARY,2.5,PIDOLIC-ACID,"ADAM28, AMY1A, AMY2A, AMY2B, ANG, CCL8, HCRT, IGLC1, KRTAP5-2, TFF2, VEGFA",,BRD:BRD-K57313110-001-06-8,
REP.PRIMARY,2.5,FIDAXOMICIN,,RNA POLYMERASE INHIBITOR,BRD:BRD-K57371763-001-01-7,
REP.PRIMARY,2.5,TIAPRIDE,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57432881-003-21-8,
REP.PRIMARY,2.5,ENALAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K57545991-050-23-1,
REP.PRIMARY,2.5,PENTOXIFYLLINE,"ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K57569181-001-27-5,
REP.PRIMARY,2.5,ORG-27569,CNR1,CANNABINOID RECEPTOR MODULATOR,BRD:BRD-K57597776-001-01-2,
REP.PRIMARY,2.5,5-AMINOLEVULINIC-ACID,ALAD,OXIDIZING AGENT,BRD:BRD-K57631554-003-06-2,
REP.PRIMARY,2.5,PENTYLENETETRAZOL,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K57718010-001-11-9,
REP.PRIMARY,2.5,EPZ005687,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K57754230-001-02-7,
REP.PRIMARY,2.5,CARIPRAZINE,"DRD2, DRD3",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K57764956-001-02-8,
REP.PRIMARY,2.5,OLSALAZINE,"IFNG, TPMT",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K57853941-304-02-5,
REP.PRIMARY,2.5,BW-180C,"OPRD1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K57927309-001-01-7,
REP.PRIMARY,2.5,VILAZODONE,"DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4",SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K58010567-003-02-2,
REP.PRIMARY,2.5,HA-966-(R)-(+),GRIA1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K58046914-001-03-8,
REP.PRIMARY,2.5,THIOSTREPTON,FOXM1,"FOXM1 INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K58049875-001-04-7,
REP.PRIMARY,2.5,RASAGILINE,"BCL2, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K58114536-001-01-6,
REP.PRIMARY,2.5,HESPERADIN,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K58122457-001-02-2,
REP.PRIMARY,2.5,BETAMETHASONE-DIPROPIONATE,NR3C1,ANTI-INFLAMMATORY AGENT,BRD:BRD-K58148589-001-03-6,
REP.PRIMARY,2.5,DAPAGLIFLOZIN,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K58160573-001-05-4,
REP.PRIMARY,2.5,DOXIFLURIDINE,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K58262659-001-09-7,
REP.PRIMARY,2.5,METICRANE,,DIURETIC,BRD:BRD-K58265391-001-12-7,
REP.PRIMARY,2.5,RO-90-7501,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K58299615-001-03-5,
REP.PRIMARY,2.5,DY131,"ESRRB, ESRRG",ESTROGEN-RELATED RECEPTOR AGONIST,BRD:BRD-K58343622-001-01-6,
REP.PRIMARY,2.5,AT13387,HSP90AA1,"HSP ANTAGONIST, HSP INHIBITOR",BRD:BRD-K58435339-001-03-0,
REP.PRIMARY,2.5,PALMATINE-CHLORIDE,CYP3A4,DOPAMINE SYNTHESIS INHIBITOR,BRD:BRD-K58466253-003-14-0,
REP.PRIMARY,2.5,REPARIXIN,"CXCR1, CXCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K58486055-001-02-7,
REP.PRIMARY,2.5,POTASSIUM-P-AMINOBENZOATE,,,BRD:BRD-K58497451-237-10-7,
REP.PRIMARY,2.5,TAK-875,FFAR1,INSULIN SECRETAGOGUE,BRD:BRD-K58501140-002-01-0,
REP.PRIMARY,2.5,PAMIDRONATE,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K58513245-304-02-7,
REP.PRIMARY,2.5,FK-866,NAMPT,NIACINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITOR,BRD:BRD-K58550667-001-08-7,
REP.PRIMARY,2.5,K02288,BMP1,BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K58568447-001-01-1,
REP.PRIMARY,2.5,DEXFENFLURAMINE,"HTR2C, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K58626373-003-07-8,
REP.PRIMARY,2.5,CRESOPIRINE,,,BRD:BRD-K58648841-001-04-7,
REP.PRIMARY,2.5,EMODIN,CSNK2A1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K58685305-001-20-4,
REP.PRIMARY,2.5,CIANIDANOL,PTGS1,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K58736316-001-09-5,
REP.PRIMARY,2.5,NMS-E973,,HSP INHIBITOR,BRD:BRD-K58770988-001-01-8,
REP.PRIMARY,2.5,AZD6482,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K58772419-001-07-0,
REP.PRIMARY,2.5,BENTIROMIDE,HPN,,BRD:BRD-K58794715-001-01-8,
REP.PRIMARY,2.5,2-THIOURACIL,,,BRD:BRD-K58819470-001-05-9,
REP.PRIMARY,2.5,DIZOCILPINE-(+),"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K58930050-050-15-8,
REP.PRIMARY,2.5,GLUTATHIONE-MONOISOPROPYL-ESTER,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K58937086-001-01-4,
REP.PRIMARY,2.5,SUCRALOSE,,,BRD:BRD-K58968598-001-03-6,
REP.PRIMARY,2.5,AM-24,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K59013864-001-01-1,
REP.PRIMARY,2.5,ML161,,PROTEASE-ACTIVATED RECEPTOR INHIBITOR,BRD:BRD-K59036917-001-16-7,
REP.PRIMARY,2.5,OXYBENZONE,LIPE,LIPASE INHIBITOR,BRD:BRD-K59037100-001-14-7,
REP.PRIMARY,2.5,FAROPENEM-MEDOXOMIL,,LACTAMASE INHIBITOR,BRD:BRD-K59045783-001-01-1,
REP.PRIMARY,2.5,ACETYLCYSTEINE,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11",MUCOLYTIC AGENT,BRD:BRD-K59058747-001-18-3,
REP.PRIMARY,2.5,ACETYLCYSTEINE,"ACY1, CHUK, GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3A, GSS, IKBKB, RELA, SLC7A11",MUCOLYTIC AGENT,BRD:BRD-K59058747-001-20-9,
REP.PRIMARY,2.5,FOSAMPRENAVIR,,HIV PROTEASE INHIBITOR,BRD:BRD-K59110290-238-01-7,
REP.PRIMARY,2.5,AZ3146,,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K59146805-001-03-7,
REP.PRIMARY,2.5,SB-216763,"CCNA2, CDK2, GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K59184148-001-21-6,
REP.PRIMARY,2.5,NAPROXEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K59197931-001-04-5,
REP.PRIMARY,2.5,DBEQ,CASP3,ATPASE INHIBITOR,BRD:BRD-K59204667-001-03-1,
REP.PRIMARY,2.5,LY2228820,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K59227464-334-02-4,
REP.PRIMARY,2.5,PROPENTOFYLLINE,PDE1A,"ADENOSINE REUPTAKE INHIBITOR, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K59273480-001-10-6,
REP.PRIMARY,2.5,CHRYSOPHANIC-ACID,"EGFR, MTOR",EGFR INHIBITOR,BRD:BRD-K59284035-001-07-9,
REP.PRIMARY,2.5,MLN0128,"MTOR, PIK3CA, PIK3CD, PIK3CG",MTOR INHIBITOR,BRD:BRD-K59317601-001-05-5,
REP.PRIMARY,2.5,DELANZOMIB,"CMA1, CTSG, CYP3A4, ELANE",PROTEASOME INHIBITOR,BRD:BRD-K59325863-001-02-8,
REP.PRIMARY,2.46,DELANZOMIB,"CMA1, CTSG, CYP3A4, ELANE",PROTEASOME INHIBITOR,BRD:BRD-K59325863-001-03-6,
REP.PRIMARY,2.5,LINOPIRDINE,"KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K59332007-300-02-7,
REP.PRIMARY,2.5,NIGULDIPINE-(S)-(+),ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K59333713-003-02-0,
REP.PRIMARY,2.5,AH6809,"PTGDR, PTGER1, PTGER2, PTGER3",PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K59339270-001-02-6,
REP.PRIMARY,2.5,TOZASERTIB,"AURKA, AURKB, AURKC, LCK","AURORA KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, FLT3 INHIBITOR, JAK INHIBITOR",BRD:BRD-K59369769-001-20-3,
REP.PRIMARY,2.5,TARAFENACIN,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K59390331-045-01-5,
REP.PRIMARY,2.5,AM-281,"CNR1, CNR2, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K59419204-001-02-7,
REP.PRIMARY,2.5,L-VALINE,"BCAT1, PCCB, VARS",,BRD:BRD-K59424860-001-01-4,VAL
REP.PRIMARY,2.5,VAL,"BCAT1, PCCB, VARS",,BRD:BRD-K59424860-001-01-4,VAL
REP.PRIMARY,2.5,ICI-192605,TBXA2R,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K59433843-001-01-7,
REP.PRIMARY,2.5,TEDIZOLID,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K59436580-001-01-7,
REP.PRIMARY,2.51,METHOTREXATE,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K59456551-001-22-6,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-879,"ERBB2, KDR, NTRK1",TYROSINE KINASE INHIBITOR,BRD:BRD-K59469039-001-08-0,
REP.PRIMARY,2.5,TARGININE,NOS3,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K59506194-015-04-9,
REP.PRIMARY,2.5,PIPERINE,"MAOA, MAOB, TRPV1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K59522102-001-14-6,
REP.PRIMARY,2.46,PIPERINE,"MAOA, MAOB, TRPV1",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K59522102-001-15-3,
REP.PRIMARY,2.5,MARIBAVIR,PYGM,"CYTOMEGALOVIRUS INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K59524082-001-01-3,
REP.PRIMARY,2.5,S-SULFO-L-CYSTEINE,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K59527975-236-01-8,S-SULFO-L-CYSTEINE-SODIUM-SALT
REP.PRIMARY,2.5,S-SULFO-L-CYSTEINE-SODIUM-SALT,,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K59527975-236-01-8,S-SULFO-L-CYSTEINE-SODIUM-SALT
REP.PRIMARY,2.5,UBENIMEX,"LTA4H, RNPEP",LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K59574735-001-11-8,
REP.PRIMARY,2.5,PHENOTHIAZINE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K59597909-001-17-6,
REP.PRIMARY,2.5,QUINIDINE,"KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4",SODIUM CHANNEL BLOCKER,BRD:BRD-K59632282-052-03-1,
REP.PRIMARY,2.5,LEVOCARNITINE,"CRAT, CROT",,BRD:BRD-K59647213-001-10-5,
REP.PRIMARY,2.5,PASIREOTIDE,"SSTR1, SSTR2, SSTR3, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K59715032-362-01-4,
REP.PRIMARY,2.5,PHT-427,"AKT2, PDPK1","AKT INHIBITOR, PYRUVATE DEHYDROGENASE INHIBITOR",BRD:BRD-K59745944-001-02-0,
REP.PRIMARY,2.5,LDN-212854,"ABL1, ACVR1, RIPK2",BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K59831625-001-01-6,
REP.PRIMARY,2.5,FPL-62064,,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K59875992-001-01-8,
REP.PRIMARY,2.5,CB-10-277,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K59929863-001-01-9,
REP.PRIMARY,2.5,SULFABENZAMIDE,,BACTERIAL ANTIFOLATE,BRD:BRD-K59983611-001-21-9,
REP.PRIMARY,2.5,AMINOLEVULINIC-ACID-BENZYL-ESTER,,,BRD:BRD-K59998349-003-01-4,
REP.PRIMARY,2.5,S-111,PARP1,PARP INHIBITOR,BRD:BRD-K60005752-001-01-9,
REP.PRIMARY,2.5,CRYSTAL-VIOLET,,OTHER ANTIBIOTIC,BRD:BRD-K60025295-003-06-6,
REP.PRIMARY,2.5,L-NIL,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K60036103-003-01-6,
REP.PRIMARY,2.5,IRBESARTAN,"AGTR1, JUN, SLC10A1",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K60038276-001-09-0,
REP.PRIMARY,2.5,N-METHYLLIDOCAINE-IODIDE,,ANTIARRHYTHMIC MEDICATION,BRD:BRD-K60060639-005-02-2,
REP.PRIMARY,2.5,ALIBENDOL,,ANTISPASMODIC,BRD:BRD-K60102752-001-02-2,
REP.PRIMARY,2.5,N6-CYCLOPENTYLADENOSINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, SLC29A1",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K60150510-001-15-6,
REP.PRIMARY,2.5,TIAGABINE,SLC6A1,GABA UPTAKE INHIBITOR,BRD:BRD-K60160658-003-11-2,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-99,EGFR,TYROSINE KINASE INHIBITOR,BRD:BRD-K60184833-001-05-6,
REP.PRIMARY,2.5,NERIDRONIC-ACID,FDPS,BONE RESORPTION INHIBITOR,BRD:BRD-K60212747-236-01-1,
REP.PRIMARY,2.4000000000000004,MG-132,PSMB1,PROTEASOME INHIBITOR,BRD:BRD-K60230970-001-17-5,
REP.PRIMARY,2.5,NIACIN,"DGAT2, HCAR1, HCAR2, HCAR3, NNMT, QPRT","NAD PRECURSOR, VITAMIN B",BRD:BRD-K60237333-001-27-1,
REP.PRIMARY,2.5,CARGLUMIC-ACID,CPS1,CARBAMOYL PHOSPHATE SYNTHASE ACTIVATOR,BRD:BRD-K60240222-001-01-4,
REP.PRIMARY,2.5,"5,7-DICHLOROKYNURENIC-ACID","GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60287130-001-05-7,
REP.PRIMARY,2.5,GSK1292263,GRPR,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K60341624-001-02-2,
REP.PRIMARY,2.5,BRILLIANT-GREEN,,,BRD:BRD-K60348325-065-09-9,
REP.PRIMARY,2.5,RIBAVIRIN,"ADK, ENPP1, IMPDH1, IMPDH2, NT5C2",ANTIVIRAL,BRD:BRD-K60369935-001-18-3,
REP.PRIMARY,2.5,MUSCIMOL,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K60441002-001-04-8,
REP.PRIMARY,2.5,CHLORMIDAZOLE,,FUNGAL LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-K60443845-001-08-6,
REP.PRIMARY,2.5,ONX-0914,,PROTEASOME INHIBITOR,BRD:BRD-K60446698-001-01-2,
REP.PRIMARY,2.5,PRAVASTATIN,"HMGCR, SLCO1B1",HMGCR INHIBITOR,BRD:BRD-K60511616-236-08-9,
REP.PRIMARY,2.5,DIMPYLATE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K60567437-001-10-2,
REP.PRIMARY,2.5,PARICALCITOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K60585088-001-01-5,
REP.PRIMARY,2.5,MOMETASONE-FUROATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K60640630-001-11-0,
REP.PRIMARY,2.5,MPEP,"GRM1, GRM4, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60690191-001-03-3,
REP.PRIMARY,2.47,PERGOLIDE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K60770992-066-25-0,
REP.PRIMARY,2.5,IDELALISIB,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K60866521-001-07-1,
REP.PRIMARY,2.5,ADIPHENINE,CHRNA1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K60907894-003-23-5,
REP.PRIMARY,2.5,ETOSALAMIDE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K60914966-001-01-4,
REP.PRIMARY,2.56,LAQUINIMOD,CXCL2,IMMUNOSUPPRESSANT,BRD:BRD-K60918217-001-03-8,
REP.PRIMARY,2.5,PD-166793,"MMP13, MMP2, MMP3","COLLAGENASE INHIBITOR, METALLOPROTEINASE INHIBITOR",BRD:BRD-K60984070-001-01-0,
REP.PRIMARY,2.5,PHA-848125,"CDK2, CDK4, CDK7, NTRK1","CDK INHIBITOR, GROWTH FACTOR RECEPTOR INHIBITOR",BRD:BRD-K60997853-001-02-3,
REP.PRIMARY,2.5,NEOHESPERIDIN-DIHYDROCHALCONE,,,BRD:BRD-K61032563-001-02-9,
REP.PRIMARY,2.5,RUCINOL,TYR,TYROSINASE INHIBITOR,BRD:BRD-K61036791-001-01-6,
REP.PRIMARY,2.5,SB-218795,TACR3,TACHYKININ ANTAGONIST,BRD:BRD-K61097567-001-08-5,
REP.PRIMARY,2.5,MDIVI-1,DNM1,DYNAMIN INHIBITOR,BRD:BRD-K61128465-001-09-9,
REP.PRIMARY,2.5,NBI-27914,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K61177364-003-02-9,
REP.PRIMARY,2.54,CAPECITABINE,TYMS,"DNA SYNTHESIS INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K61192372-001-05-5,
REP.PRIMARY,2.5,CAPECITABINE,TYMS,"DNA SYNTHESIS INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K61192372-001-08-9,
REP.PRIMARY,2.5,COMBRETASTATIN-A-4,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K61195623-001-01-4,
REP.PRIMARY,2.5,SGI-1027,"DNMT1, DNMT3A, DNMT3B",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K61228301-001-01-2,
REP.PRIMARY,2.5,TIRATRICOL,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K61236135-001-08-2,
REP.PRIMARY,2.5,ESLICARBAZEPINE-ACETATE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K61237927-001-01-7,
REP.PRIMARY,2.5,FPH1-(BRD-6125),,HEPATOCYTE FUNCTION ENHANCER,BRD:BRD-K61250484-001-02-3,
REP.PRIMARY,2.5,LOPERAMIDE,"CACNA1A, CALM1, OPRD1, OPRK1, OPRM1, POMC",OPIOID RECEPTOR AGONIST,BRD:BRD-K61250553-003-32-2,
REP.PRIMARY,2.5,DAPHNETIN,,PROTEIN KINASE INHIBITOR,BRD:BRD-K61269089-001-05-5,
REP.PRIMARY,2.5,OXALOACETATE,"CS, SPR",GLUTAMATE RELEASE INHIBITOR,BRD:BRD-K61279411-001-02-0,
REP.PRIMARY,2.5,BLEBBISTATIN-(-),,ATPASE INHIBITOR,BRD:BRD-K61295575-001-03-6,
REP.PRIMARY,2.5,ENDO-IWR-1,"TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K61314889-001-04-4,
REP.PRIMARY,2.5,ENDO-IWR-1,"TNKS, TNKS2",PARP INHIBITOR,BRD:BRD-K61314889-001-05-1,
REP.PRIMARY,2.5,SB-225002,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K61323504-001-04-0,
REP.PRIMARY,2.5,NARATRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K61337602-003-02-1,
REP.PRIMARY,2.5,ROMIDEPSIN,"HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K61397605-001-03-4,
REP.PRIMARY,2.5,ESOMEPRAZOLE,ATP4A,ATPASE INHIBITOR,BRD:BRD-K61443506-239-01-6,
REP.PRIMARY,2.5,THIOMERSAL,OXCT1,OTHER ANTIBIOTIC,BRD:BRD-K61443650-236-13-1,
REP.PRIMARY,2.5,EMTRICITABINE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K61452026-001-04-6,
REP.PRIMARY,2.5,FLUMETHASONE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K61496577-001-20-2,
REP.PRIMARY,2.5,SB-366791,TRPV1,TRPV ANTAGONIST,BRD:BRD-K61536336-001-01-7,
REP.PRIMARY,2.5,RESATORVID,TLR4,"TOLL-LIKE RECEPTOR ANTAGONIST, TOLL-LIKE RECEPTOR INHIBITOR",BRD:BRD-K61567297-001-01-9,
REP.PRIMARY,2.5,3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(S),"GRM1, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K61585876-001-01-0,
REP.PRIMARY,2.5,FERB-033,ERBB2,EGFR INHIBITOR,BRD:BRD-K61642990-001-01-0,
REP.PRIMARY,2.5,BYK-204165,PARP1,PARP INHIBITOR,BRD:BRD-K61665160-001-01-5,
REP.PRIMARY,2.5,RGFP966,HDAC3,HDAC INHIBITOR,BRD:BRD-K61688984-001-02-9,
REP.PRIMARY,2.5,PF-03084014,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K61691541-001-01-1,
REP.PRIMARY,2.5,PYRAZINOYLGUANIDINE,,DIURETIC,BRD:BRD-K61693562-300-01-7,
REP.PRIMARY,2.5,FLEROXACIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K61717546-001-04-3,
REP.PRIMARY,2.47,FLEROXACIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K61717546-001-05-0,
REP.PRIMARY,2.5,"2,3-DCPE",BCL2L1,BCL-XL DOWNREGULATOR,BRD:BRD-K61734568-003-02-1,
REP.PRIMARY,2.5,CHLORINDIONE,,,BRD:BRD-K61802864-001-08-8,
REP.PRIMARY,2.5,TENOFOVIR-DISOPROXIL,CYP1A2,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K61868322-050-01-7,
REP.PRIMARY,2.5,AS-1949490,INPP5D,SHIP2 PHOSPHATASE INHIBITOR,BRD:BRD-K61936403-001-01-7,
REP.PRIMARY,2.5,DOCONEXENT-ETHYL-ESTER,,OMEGA 3 FATTY ACID STIMULANT,BRD:BRD-K61937613-001-01-1,
REP.PRIMARY,2.5,FG-7142,,GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K61951118-001-07-9,
REP.PRIMARY,2.5,MOXIDECTIN,,CHLORIDE CHANNEL ANTAGONIST,BRD:BRD-K61988078-001-01-2,
REP.PRIMARY,2.5,PACLITAXEL,"BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K62008436-001-22-1,
REP.PRIMARY,2.44,ACITRETIN,"RARA, RARB, RARG, RBP1, RXRA, RXRB, RXRG, STAT3",RETINOID RECEPTOR AGONIST,BRD:BRD-K62012036-001-14-4,
REP.PRIMARY,2.5,N-METHYLQUIPAZINE,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K62056274-332-01-8,
REP.PRIMARY,2.5,HYDROXYSTILBAMIDINE,,,BRD:BRD-K62186992-334-02-8,
REP.PRIMARY,2.5,AVN-944,"IMPDH1, IMPDH2",INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K62196610-001-01-6,
REP.PRIMARY,2.5,ANAGRELIDE,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K62200014-003-10-5,
REP.PRIMARY,2.5,DIHYDROARTEMISININ,,ANTIMALARIAL AGENT,BRD:BRD-K62213621-001-01-6,
REP.PRIMARY,1.2000000000000002,PYM50028,,NEUROTROPHIC AGENT,BRD:BRD-K62277907-001-01-6,
REP.PRIMARY,2.5,DEFOROLIMUS,MTOR,MTOR INHIBITOR,BRD:BRD-K62304154-001-04-2,
REP.PRIMARY,2.5,FLUTICASONE-PROPIONATE,"NR3C1, NR3C2, PGR, PLA2G4A",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K62310379-001-10-5,
REP.PRIMARY,2.5,DICHLOROPHEN,,ANTICESTODAL AGENT,BRD:BRD-K62326629-001-19-0,
REP.PRIMARY,2.5,(R)-BACLOFEN,"GABBR1, GABBR2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K62353271-001-04-7,BACLOFEN-(R)
REP.PRIMARY,2.5,BACLOFEN-(R),"GABBR1, GABBR2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K62353271-001-04-7,BACLOFEN-(R)
REP.PRIMARY,2.5,DAPSONE,DHFR,BACTERIAL ANTIFOLATE,BRD:BRD-K62363391-001-24-9,
REP.PRIMARY,2.5,RUFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K62374253-001-07-8,
REP.PRIMARY,2.5,BASIMGLURANT,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K62387885-001-01-9,
REP.PRIMARY,2.5,VENETOCLAX,BCL2,BCL INHIBITOR,BRD:BRD-K62391742-001-03-0,
REP.PRIMARY,2.5,LERISETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K62398570-300-01-2,
REP.PRIMARY,2.5,PARA-TOLUENESULFONAMIDE,"CA12, CA2, CA6, CA9",,BRD:BRD-K62412084-001-07-1,
REP.PRIMARY,2.5,NMDA,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K62414032-001-12-0,
REP.PRIMARY,2.5,AS-77,"KCNA3, KCNA5, KCNN4",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K62427771-001-01-0,
REP.PRIMARY,2.5,PD-128907,"DRD2, DRD3",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K62456038-003-07-1,
REP.PRIMARY,2.5,4-IBP,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K62537556-001-02-5,
REP.PRIMARY,2.5,SR-2640,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K62562723-003-02-7,
REP.PRIMARY,2.5,3-MPPI,ADRA1A,ADRENERGIC RECEPTOR LIGAND,BRD:BRD-K62581435-001-03-8,
REP.PRIMARY,2.5,GR125487,HTR4,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K62594868-082-08-6,
REP.PRIMARY,2.62,AZTREONAM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K62607865-001-09-7,
REP.PRIMARY,2.5,SRPIN340,"SRPK1, SRPK2",SERINE ARGININE PROTEIN KINASE INHIBITOR,BRD:BRD-K62621335-001-01-7,
REP.PRIMARY,2.5,IDASANUTLIN,"MDM2, TP53",MDM INHIBITOR,BRD:BRD-K62627508-001-01-5,
REP.PRIMARY,2.5,GUANETHIDINE,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-K62676709-065-05-5,
REP.PRIMARY,2.5,TRIPTORELIN,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K62685538-001-01-7,
REP.PRIMARY,2.5,G-1,GPER1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K62696033-001-01-4,
REP.PRIMARY,2.5,ARGLABIN,"FNTA, NFKB1",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K62734952-001-01-0,
REP.PRIMARY,2.41,GUANABEN-ACETATE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K62736196-015-11-0,
REP.PRIMARY,2.5,GUANABEN-ACETATE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K62736196-015-13-6,
REP.PRIMARY,2.5,GABAPENTIN,"ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62737565-003-02-6,
REP.PRIMARY,2.5,RU-58841,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K62762455-001-01-3,
REP.PRIMARY,2.38,CHOLECALCIFEROL,VDR,,BRD:BRD-K62779383-001-05-5,
REP.PRIMARY,2.5,TIOTROPIUM,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K62782754-337-02-5,
REP.PRIMARY,2.5,PD-98059,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K62810658-001-12-2,
REP.PRIMARY,2.5,BMS-265246,"CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K62814476-001-03-3,
REP.PRIMARY,2.5,LOMERIZINE,"CACNA1B, SCN5A",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62858456-001-01-8,
REP.PRIMARY,2.5,6-BENZYLAMINOPURINE,,PURINERGIC RECEPTOR ACTIVATOR,BRD:BRD-K62929068-001-16-5,
REP.PRIMARY,2.5,TIPIFARNIB,"FNTA, FNTB",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K62965247-001-04-9,
REP.PRIMARY,2.5,LIDOFLAZINE,"SCN1A, SCN3A, SLC29A1",CALCIUM CHANNEL BLOCKER,BRD:BRD-K62996583-001-10-3,
REP.PRIMARY,2.5,ORBIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K63001556-001-08-8,
REP.PRIMARY,2.57,ORBIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K63001556-001-09-6,
REP.PRIMARY,2.5,ZSTK-474,"PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K63068307-001-08-9,
REP.PRIMARY,2.5,S-METHYLCYSTEINE,"CTSD, MGMT",,BRD:BRD-K63123526-001-01-2,
REP.PRIMARY,2.5,EPINEPHRINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, TNF","ADRENERGIC RECEPTOR AGONIST, CARBONIC ANHYDRASE ACTIVATOR, NEUROTRANSMITTER",BRD:BRD-K63126190-003-01-6,
REP.PRIMARY,2.5,JTE-907,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K63150726-001-02-1,
REP.PRIMARY,2.5,MNITMT,,LYMPHOCYTE INHIBITOR,BRD:BRD-K63151507-001-02-4,
REP.PRIMARY,2.5,NORCYCLOBENZAPRINE,,"ADRENERGIC RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K63165456-001-10-8,
REP.PRIMARY,2.5,U-0124,,MEK INHIBITOR,BRD:BRD-K63169195-001-01-5,
REP.PRIMARY,2.5,TELOTRISTAT,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K63178091-001-01-1,
REP.PRIMARY,2.5,ORLISTAT,"CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP",LIPASE INHIBITOR,BRD:BRD-K63343048-001-12-2,
REP.PRIMARY,2.5,METHOXSALEN,"CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4",DNA SYNTHESIS INHIBITOR,BRD:BRD-K63430059-001-17-2,
REP.PRIMARY,2.5,SEMAXANIB,"FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET",VEGFR INHIBITOR,BRD:BRD-K63504947-001-15-4,
REP.PRIMARY,2.5,T-0156,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K63516691-003-02-0,
REP.PRIMARY,2.5,AM-630,"CNR1, CNR2",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K63533170-001-02-9,
REP.PRIMARY,2.5,ERYTHROMYCIN,MLNR,NFKB PATHWAY INHIBITOR,BRD:BRD-K63550407-001-12-7,
REP.PRIMARY,2.5,ERYTHROMYCIN,MLNR,NFKB PATHWAY INHIBITOR,BRD:BRD-K63550407-001-13-5,
REP.PRIMARY,2.5,ETACRYNIC-ACID,"ATP1A1, SLC12A1",SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR,BRD:BRD-K63630713-001-25-8,
REP.PRIMARY,2.5,TRIFLUPROMAZINE,"CHRM1, CHRM2, DRD1, DRD2, HTR2B",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K63675182-003-23-6,
REP.PRIMARY,2.5,TEMOPORFIN,,RADICAL FORMATION STIMULANT,BRD:BRD-K63712959-001-01-8,
REP.PRIMARY,2.5,ACIPIMOX,HCAR2,CHOLESTEROL INHIBITOR,BRD:BRD-K63736853-001-04-8,
REP.PRIMARY,2.5,MYCOPHENOLIC-ACID,"IMPDH1, IMPDH2","DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",BRD:BRD-K63750851-001-20-7,
REP.PRIMARY,2.51,10-HYDROXYCAMPTOTHECIN,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K63784565-001-06-2,
REP.PRIMARY,2.5,ARECAIDINE-BUT-2-YNYL-ESTER,CHRM2,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K63792901-075-02-1,
REP.PRIMARY,2.5,SITAXENTAN,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K63806092-236-02-6,
REP.PRIMARY,2.5,RALOXIFENE,"ESR1, ESR2","ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K63828191-003-32-1,
REP.PRIMARY,2.5,MOLSIDOMINE,GUCY1A3,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K63861289-001-19-6,
REP.PRIMARY,2.5,THIOPERAMIDE,"HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K63874012-001-02-9,
REP.PRIMARY,2.5,AS-604850,"PIK3CA, PIK3CG",PI3K INHIBITOR,BRD:BRD-K63915849-001-03-7,
REP.PRIMARY,2.5,APTIGANEL,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K63919159-003-07-0,
REP.PRIMARY,2.5,BARASERTIB-HQPA,AURKB,AURORA KINASE INHIBITOR,BRD:BRD-K63923597-001-10-0,
REP.PRIMARY,2.5,2'-MECCPA,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K63932022-001-01-5,
REP.PRIMARY,2.5,GEFITINIB,EGFR,EGFR INHIBITOR,BRD:BRD-K64052750-001-17-5,
REP.PRIMARY,0.25,EPOPROSTENOL,"P2RY12, PTGER1, PTGER4, PTGIR, PTGIS",PROSTACYCLIN ANALOG,BRD:BRD-K64054020-001-03-5,
REP.PRIMARY,2.5,2-METHYL-5-HYDROXYTRYPTAMINE,"HTR1B, HTR1D, HTR1E, HTR1F, HTR3A, HTR3B, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K64137799-003-02-5,
REP.PRIMARY,2.5,ZD-2079,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K64157027-003-02-7,
REP.PRIMARY,2.5,BTS,,,BRD:BRD-K64178227-001-09-0,
REP.PRIMARY,2.5,"CBS,-N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE",,,BRD:BRD-K64191834-001-03-1,N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE
REP.PRIMARY,2.5,N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE,,,BRD:BRD-K64191834-001-03-1,N-CYCLOHEXYL-2-BENZOTHIAZOLESULFENAMIDE
REP.PRIMARY,2.5,MILACEMIDE,MAOB,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K64338723-001-01-6,
REP.PRIMARY,2.5,CFM-1571,,GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K64341947-003-02-4,
REP.PRIMARY,2.5,ULIPRISTAL,PGR,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K64381438-001-03-8,
REP.PRIMARY,2.5,DNQX,"GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K64400208-001-08-3,
REP.PRIMARY,2.5,N-ALPHA-METHYLHISTAMINE-DIHYDROCHLORIDE,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K64422603-300-02-7,
REP.PRIMARY,2.5,TOLTRAZURIL,,ANTIPROTOZOAL AGENT,BRD:BRD-K64514229-001-05-2,
REP.PRIMARY,2.5,RO-4987655,MAP2K1,MEK INHIBITOR,BRD:BRD-K64538373-001-01-4,
REP.PRIMARY,2.5,ZOTEPINE,"ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K64557645-001-02-4,
REP.PRIMARY,2.5,SALICIN,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K64614248-001-12-3,
REP.PRIMARY,2.5,D-ALPHA-TOCOPHERYL-SUCCINATE,,,BRD:BRD-K64636206-001-02-7,
REP.PRIMARY,2.5,PHTHALYLSULFATHIAZOLE,,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K64659768-001-12-8,
REP.PRIMARY,2.5,NEDOCROMIL,"CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K64716392-001-01-3,
REP.PRIMARY,2.5,ETAZOLATE,"GABRB3, PDE4A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K64755930-003-03-2,
REP.PRIMARY,2.5,TG100-115,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K64785675-001-04-0,
REP.PRIMARY,2.5,PHA-793887,"CDK1, CDK2, CDK4, CDK5, CDK7, CDK9",CDK INHIBITOR,BRD:BRD-K64800655-001-07-4,
REP.PRIMARY,2.5,ML167,"CLK4, DYRK1B","CLK INHIBITOR, DYRK INHIBITOR",BRD:BRD-K64835161-001-02-8,
REP.PRIMARY,2.5,DIPRAGLURANT,GRM5,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K64838454-001-01-0,
REP.PRIMARY,2.5,CYC116,"AURKA, AURKB, KDR",AURORA KINASE INHIBITOR,BRD:BRD-K64866502-001-03-9,
REP.PRIMARY,1.13,NSC-4644,PYGM,"ACAT INHIBITOR, STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR",BRD:BRD-K64874225-001-04-7,
REP.PRIMARY,2.5,ISPINESIB,KIF11,KINESIN INHIBITOR,BRD:BRD-K64881305-001-03-7,
REP.PRIMARY,2.5,AZ960,JAK2,JAK INHIBITOR,BRD:BRD-K64888243-001-03-7,
REP.PRIMARY,2.5,BI-2536,"BRD4, PLK1, PLK2, PLK3",PLK INHIBITOR,BRD:BRD-K64890080-001-13-8,
REP.PRIMARY,2.5,AMG-232,MDM2,MDM INHIBITOR,BRD:BRD-K64925568-001-01-8,
REP.PRIMARY,2.5,AMINOCAPROIC-ACID,"LPA, PLAT, PLG",PLASMINOGEN ACTIVATOR INHIBITOR,BRD:BRD-K64931368-003-01-4,
REP.PRIMARY,2.5,SCOPOLAMINE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K64990126-004-01-1,
REP.PRIMARY,2.5,APOCYNIN,NOX4,NADPH OXIDASE INHIBITOR,BRD:BRD-K64990520-001-08-4,
REP.PRIMARY,2.5,PROGESTERONE,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, CYP17A1, ESR1, NR3C2, OPRK1, PGR, TRPC5",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K64994968-001-32-5,
REP.PRIMARY,2.5,NABUMETONE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K65146499-001-27-9,
REP.PRIMARY,2.5,APREPITANT,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K65170927-001-01-6,
REP.PRIMARY,2.5,NPC-15199,PPARG,ICAM1 ANTAGONIST,BRD:BRD-K65275554-001-04-7,
REP.PRIMARY,2.5,GP1A,CNR2,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K65285700-001-02-3,
REP.PRIMARY,2.5,EGLUMETAD,"GRM2, GRM3, GRM6, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K65359424-001-01-3,
REP.PRIMARY,2.58,7-AMINOCEPHALOSPORANIC-ACID,,BETA LACTAMASE INHIBITOR,BRD:BRD-K65377893-001-07-4,
REP.PRIMARY,2.5,MEPRYLCAINE,,LOCAL ANESTHETIC,BRD:BRD-K65417056-003-10-1,
REP.PRIMARY,2.5,CORDYCEPIN,,DNA INHIBITOR,BRD:BRD-K65428967-001-08-4,
REP.PRIMARY,2.5,CCT018159,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K65503129-001-06-3,
REP.PRIMARY,2.5,CILAZAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K65518078-002-01-1,
REP.PRIMARY,2.5,4-AMINOHIPPURIC-ACID,SLC22A6,,BRD:BRD-K65544384-001-15-8,
REP.PRIMARY,2.5,ICARIIN,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65639003-001-09-0,
REP.PRIMARY,2.5,KINETIN,,CELL DIVISION INDUCER,BRD:BRD-K65667145-001-14-0,
REP.PRIMARY,2.5,NEFIRACETAM,CHRM1,"ACETYLCHOLINE RECEPTOR AGONIST, BENZODIAZEPINE RECEPTOR AGONIST",BRD:BRD-K65678996-001-05-5,
REP.PRIMARY,2.5,EXIFONE,TYR,NOOTROPIC AGENT,BRD:BRD-K65716359-001-02-1,
REP.PRIMARY,2.5,AVANAFIL,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65781196-001-03-0,
REP.PRIMARY,2.5,CGP-7930,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K65786282-001-07-5,
REP.PRIMARY,2.5,DIPHENYLENEIODONIUM,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K65814004-003-02-9,
REP.PRIMARY,2.5,SDZ-NKT-343,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K65820248-001-01-8,
REP.PRIMARY,2.5,(S)-(+)-ROLIPRAM,"PDE4B, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65856711-001-04-4,ROLIPRAM-S(+)
REP.PRIMARY,2.5,ROLIPRAM-S(+),"PDE4B, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K65856711-001-04-4,ROLIPRAM-S(+)
REP.PRIMARY,2.5,HALOBETASOL-PROPIONATE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K65877271-001-01-8,
REP.PRIMARY,2.5,SSR128129E,,,BRD:BRD-K65890018-236-01-1,
REP.PRIMARY,2.5,TANDOSPIRONE,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K65904673-001-01-4,
REP.PRIMARY,2.5,SERDEMETAN,MDM2,MDM INHIBITOR,BRD:BRD-K65924316-001-03-1,
REP.PRIMARY,2.5,AZD1480,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K65928735-001-04-3,
REP.PRIMARY,2.5,SB-705498,TRPV1,TRPV ANTAGONIST,BRD:BRD-K65991129-001-02-9,
REP.PRIMARY,2.5,PIRENOXINE,,AGE INHIBITOR,BRD:BRD-K65992024-001-01-5,
REP.PRIMARY,2.5,SALIDROSIDE,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K66030860-001-03-6,
REP.PRIMARY,2.5,SORBITOL,,MUCOLYTIC AGENT,BRD:BRD-K66035042-001-10-1,
REP.PRIMARY,2.5,FGIN-1-43,TSPO,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66093087-001-03-1,
REP.PRIMARY,2.5,CPP,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K66094457-001-01-5,
REP.PRIMARY,2.5,TMC-353121,,RSV FUSION INHIBITOR,BRD:BRD-K66097663-001-01-8,
REP.PRIMARY,2.5,AFATINIB,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K66175015-001-09-0,
REP.PRIMARY,2.5,CINROMIDE,,,BRD:BRD-K66241279-001-01-8,
REP.PRIMARY,2.63,FLUVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K66296774-236-11-3,
REP.PRIMARY,2.5,ZOXAZOLAMINE,,MYORELAXANT,BRD:BRD-K66353228-001-14-6,
REP.PRIMARY,2.5,NALBUPHINE,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K66404838-310-01-1,
REP.PRIMARY,2.5,PAZUFLOXACIN,,TOPOISOMERASE INHIBITOR,BRD:BRD-K66412701-066-01-6,
REP.PRIMARY,2.5,ACPC,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K66465025-001-05-1,
REP.PRIMARY,2.5,ISOGUVACINE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66480997-003-10-0,
REP.PRIMARY,2.5,VU0364770,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K66527818-001-02-6,
REP.PRIMARY,2.5,AMUVATINIB,"KIT, MET","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, RAD51 INHIBITOR, RET TYROSINE KINASE INHIBITOR",BRD:BRD-K66538826-001-07-2,
REP.PRIMARY,2.5,MOXIFLOXACIN,TOP2A,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K66615216-003-14-8,
REP.PRIMARY,2.5,4-IODO-L-PHENYLALANINE,DPP4,,BRD:BRD-K66664625-001-01-2,
REP.PRIMARY,2.5,UH-232-(+),"DRD2, DRD3, DRD4, HTR1A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K66715657-050-01-0,
REP.PRIMARY,2.5,ESTRADIOL-VALERATE,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K66766661-001-19-2,
REP.PRIMARY,2.5,FLUDARABINE,"ADA, DCK, POLA1, RRM1, RRM2",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K66788707-001-14-3,
REP.PRIMARY,2.5,OXYQUINOLINE,METAP2,CHELATING AGENT,BRD:BRD-K66808046-065-03-7,
REP.PRIMARY,2.5,VOGLIBOSE,MGAM,GLUCOSIDASE INHIBITOR,BRD:BRD-K66850609-001-07-4,
REP.PRIMARY,2.5,LINEZOLID,"MAOA, MAOB",BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K66876909-001-12-6,
REP.PRIMARY,2.5,IPIDACRINE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K66896231-001-08-1,
REP.PRIMARY,2.5,MK-3207,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-K66911501-003-01-2,
REP.PRIMARY,2.5,LODOXAMIDE,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K66937583-001-01-2,
REP.PRIMARY,2.5,OLEOYLETHANOLAMIDE,"CNR1, GPR119, GPR55, PPARA","CANNABINOID RECEPTOR AGONIST, GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST, POTASSIUM CHANNEL BLOCKER, PPAR RECEPTOR AGONIST",BRD:BRD-K66956375-001-11-3,
REP.PRIMARY,2.5,CILOSTAZOL,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K67017579-001-28-1,
REP.PRIMARY,2.5,ALTRETAMINE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K67043667-001-26-4,
REP.PRIMARY,2.5,ORE1001,ACE2,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67068943-001-01-0,
REP.PRIMARY,2.5,MILRINONE,"PDE2A, PDE3A, PDE3B, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K67080878-001-15-4,
REP.PRIMARY,2.5,PIVMECILLINAM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K67100011-003-06-3,
REP.PRIMARY,2.5,PHENYLBUTYRATE,HDAC1,HDAC INHIBITOR,BRD:BRD-K67102207-236-07-7,
REP.PRIMARY,2.5,APIXABAN,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K67121414-001-03-3,
REP.PRIMARY,2.39,4E1RCAT,"EIF4E, EIF4G1",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K67173685-001-06-9,
REP.PRIMARY,2.5,FENTHION,,CHOLINESTERASE INHIBITOR,BRD:BRD-K67217586-001-08-0,
REP.PRIMARY,2.5,IODIPAMIDE,ALB,RADIOPAQUE MEDIUM,BRD:BRD-K67261995-001-11-7,
REP.PRIMARY,2.5,PICOTAMIDE,TBXA2R,"THROMBOXANE RECEPTOR ANTAGONIST, THROMBOXANE SYNTHASE INHIBITOR",BRD:BRD-K67277431-002-10-5,
REP.PRIMARY,2.5,SB-431542,"ACVR1C, TGFBR1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K67298865-001-09-0,
REP.PRIMARY,2.5,SKA-31,KCNN4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K67304264-001-08-5,
REP.PRIMARY,2.5,NALOXONE,"CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K67511046-001-02-3,
REP.PRIMARY,2.5,ZK-200775,,KAINATE RECEPTOR ANTAGONIST,BRD:BRD-K67525671-001-02-5,
REP.PRIMARY,2.5,CYCLOCYTIDINE,,"DNA SYNTHESIS INHIBITOR, RNA SYNTHESIS INHIBITOR",BRD:BRD-K67536197-003-11-4,
REP.PRIMARY,2.5,PQ-401,IGF1R,IGF-1 INHIBITOR,BRD:BRD-K67537649-001-04-5,
REP.PRIMARY,2.5,ACEMETACIN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K67563174-001-17-6,
REP.PRIMARY,2.5,KU-0063794,MTOR,MTOR INHIBITOR,BRD:BRD-K67566344-001-07-5,
REP.PRIMARY,2.38,GDC-0879,BRAF,RAF INHIBITOR,BRD:BRD-K67578145-001-09-7,
REP.PRIMARY,2.5,GDC-0879,BRAF,RAF INHIBITOR,BRD:BRD-K67578145-001-12-1,
REP.PRIMARY,2.5,ALMOTRIPTAN,"HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K67601717-037-02-4,
REP.PRIMARY,2.5,OLOPATADINE,"HRH1, S100A1, S100A12, S100A13, S100A2, S100B",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K67637637-003-12-6,
REP.PRIMARY,2.5,CI-966,SLC6A1,GAT INHIBITOR,BRD:BRD-K67680372-003-02-6,
REP.PRIMARY,2.5,RHEOCHRYSIDIN,PTPN1,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K67772619-001-05-1,
REP.PRIMARY,2.5,HALOPERIDOL,"DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K67783091-001-26-1,
REP.PRIMARY,2.5,ADATANSERIN,"HTR1A, HTR2A","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K67789209-001-01-0,
REP.PRIMARY,2.5,ZM-323881,KDR,VEGFR INHIBITOR,BRD:BRD-K67831364-003-03-3,
REP.PRIMARY,2.5,PEVONEDISTAT,"NAE1, UBA3",NEDD ACTIVATING ENZYME INHIBITOR,BRD:BRD-K67844266-003-01-9,
REP.PRIMARY,2.5,AR-A014418,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K67860401-001-05-6,
REP.PRIMARY,2.5,PI-103,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K67868012-001-07-6,
REP.PRIMARY,2.5,AVASIMIBE,CES1,ACAT INHIBITOR,BRD:BRD-K67901620-001-02-0,
REP.PRIMARY,2.5,LISURIDE,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR6",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K67943528-050-01-4,
REP.PRIMARY,2.5,LISINOPRIL,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67966701-001-11-6,
REP.PRIMARY,2.5,LISINOPRIL,"ACE, ACE2",ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K67966701-001-12-4,
REP.PRIMARY,2.5,EPROSARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K67977190-066-02-3,
REP.PRIMARY,2.5,MK-2206,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K68065987-300-09-1,
REP.PRIMARY,2.5,PALMITOYLETHANOLAMIDE,"CNR2, GPR119, GPR55",CANNABINOID RECEPTOR AGONIST,BRD:BRD-K68095457-001-10-1,
REP.PRIMARY,2.5,CGS-20625,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6","BENZODIAZEPINE RECEPTOR AGONIST, GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST",BRD:BRD-K68103045-001-02-9,
REP.PRIMARY,2.5,TERBINAFINE,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K68132782-003-13-8,
REP.PRIMARY,2.5,EPOTHILONE-B,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B","MICROTUBULE STABILIZING AGENT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K68164687-001-01-6,
REP.PRIMARY,2.5,TORIN-2,MTOR,MTOR INHIBITOR,BRD:BRD-K68174511-001-06-6,
REP.PRIMARY,2.5,URSOLIC-ACID,"HSD11B1, PLA2G1B, PTPN1, PYGM","ATPASE INHIBITOR, NFKB PATHWAY INHIBITOR, STAT INHIBITOR",BRD:BRD-K68185022-001-14-8,
REP.PRIMARY,2.5,NIFUROXAZIDE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K68188368-001-09-4,
REP.PRIMARY,2.63,TRICHOSTATIN-A,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K68202742-001-16-5,
REP.PRIMARY,2.5,ETIZOLAM,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K68232413-001-01-2,
REP.PRIMARY,2.5,LACOSAMIDE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","COLLAPSIN RESPONSE MEDIATOR PROTEIN INHIBITOR, COLLAPSIN RESPONSE MEDIATOR PROTEIN STIMULANT, SODIUM CHANNEL BLOCKER",BRD:BRD-K68232650-001-02-2,
REP.PRIMARY,2.5,BRIMONIDINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68264559-045-02-4,
REP.PRIMARY,2.58,BRIMONIDINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68264559-045-04-0,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-1478,"EGFR, MAPK14",EGFR INHIBITOR,BRD:BRD-K68336408-001-10-9,
REP.PRIMARY,2.5,AMSACRINE,"KCNH2, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K68346641-001-01-4,
REP.PRIMARY,2.5,AMSACRINE,"KCNH2, TOP2A",TOPOISOMERASE INHIBITOR,BRD:BRD-K68346641-001-02-2,
REP.PRIMARY,2.5,ZK-93426,"GABRA1, GABRA2, GABRA3, GABRA5",BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-K68392338-003-02-0,
REP.PRIMARY,2.5,EVP4593,,NFKB PATHWAY INHIBITOR,BRD:BRD-K68395654-001-03-1,
REP.PRIMARY,2.5,ML-9,TRPC6,MYOSIN LIGHT CHAIN KINASE INHIBITOR,BRD:BRD-K68402494-003-03-5,ML9
REP.PRIMARY,2.5,ML9,TRPC6,MYOSIN LIGHT CHAIN KINASE INHIBITOR,BRD:BRD-K68402494-003-03-5,ML9
REP.PRIMARY,2.5,SPAGLUMIC-ACID,GRM3,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68405354-001-06-4,
REP.PRIMARY,2.5,SPAGLUMIC-ACID,GRM3,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68405354-001-07-2,
REP.PRIMARY,2.5,PROFLAVINE-HEMISULFATE,F2,TOPICAL ANESTHETIC,BRD:BRD-K68408467-065-01-8,
REP.PRIMARY,2.5,MM-102,,WDR5/MLL INTERACTION INHIBITOR,BRD:BRD-K68474068-001-01-8,
REP.PRIMARY,2.5,ENMD-2076,"AURKA, FLT3, KDR, PDGFRA, PTK2, SRC","AURORA KINASE INHIBITOR, FLT3 INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K68488863-001-04-9,
REP.PRIMARY,2.5,DIANHYDROGALACTITOL,,DNA ALKYLATING AGENT,BRD:BRD-K68502831-001-01-2,
REP.PRIMARY,2.5,DICYCLOVERINE,"CHRM1, CHRM2, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K68507560-003-24-6,
REP.PRIMARY,2.5,SB-743921,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K68532323-003-02-8,
REP.PRIMARY,2.5,ACECLOFENAC,PTGS2,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K68538666-001-12-3,
REP.PRIMARY,2.03,12-O-TETRADECANOYLPHORBOL-13-ACETATE,"KCNT2, TRPV4",PKC ACTIVATOR,BRD:BRD-K68552125-001-05-3,
REP.PRIMARY,2.5,TODRALAZINE,,ANTIHYPERTENSIVE AGENT,BRD:BRD-K68553471-003-12-3,
REP.PRIMARY,2.5,DERACOXIB,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K68558722-001-04-0,
REP.PRIMARY,2.5,BVT-948,"PTPN1, PTPN11, PTPN2",TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K68567222-001-01-2,
REP.PRIMARY,2.5,DYDROGESTERONE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K68620903-001-11-4,
REP.PRIMARY,2.5,ACDPP,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K68633617-003-02-9,
REP.PRIMARY,2.5,PICOLAMINE,,,BRD:BRD-K68653965-001-01-1,
REP.PRIMARY,2.5,LIDAMIDINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K68693535-001-03-4,
REP.PRIMARY,2.5,PF-03814735,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K68747584-001-02-0,
REP.PRIMARY,2.5,FR-180204,"MAPK1, MAPK3",MAP KINASE INHIBITOR,BRD:BRD-K68756823-001-07-1,
REP.PRIMARY,2.5,AZOSEMIDE,"SLC12A1, SLC12A2",ELECTROLYTE REABSORPTION INHIBITOR,BRD:BRD-K68770713-001-01-8,
REP.PRIMARY,2.5,PAFURAMIDINE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K68805147-001-01-8,
REP.PRIMARY,2.5,ADIPORON,"ADIPOR1, ADIPOR2",ADIPONECTIN RECEPTOR AGONIST,BRD:BRD-K68810443-001-01-9,
REP.PRIMARY,2.5,QUETIAPINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K68867920-051-11-5,
REP.PRIMARY,2.5,FLUMATINIB,"ABL1, PDGFRB",BCR-ABL KINASE INHIBITOR,BRD:BRD-K68870568-066-01-5,
REP.PRIMARY,2.5,CEPHALOMANNINE,,DNA POLYMERASE INHIBITOR,BRD:BRD-K68904758-001-03-5,
REP.PRIMARY,2.5,GDC-0152,"BIRC2, BIRC3, BIRC7, XIAP",XIAP INHIBITOR,BRD:BRD-K68938568-001-01-7,
REP.PRIMARY,2.5,PF-3845,FAAH,FAAH INHIBITOR,BRD:BRD-K68997413-001-05-1,
REP.PRIMARY,2.5,GOLVATINIB,"KDR, MET",VEGFR INHIBITOR,BRD:BRD-K69001009-001-02-8,
REP.PRIMARY,2.5,OMEPRAZOLE-SULFIDE,,ATPASE INHIBITOR,BRD:BRD-K69035426-001-01-3,
REP.PRIMARY,2.5,EPZ004777,DOT1L,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K69070623-003-01-7,
REP.PRIMARY,2.5,SERTINDOLE,"ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, KCNH2","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K69116396-001-04-1,
REP.PRIMARY,2.5,DIACEREIN,IL1B,INTERLEUKIN INHIBITOR,BRD:BRD-K69122748-001-10-1,
REP.PRIMARY,2.5,CISPLATIN,XIAP,"DNA ALKYLATING AGENT, DNA SYNTHESIS INHIBITOR",BRD:BRD-K69172251-001-08-9,
REP.PRIMARY,2.5,NAN-190,"ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K69195780-004-08-4,
REP.PRIMARY,2.5,IODOANTIPYRINE,,,BRD:BRD-K69216798-001-01-9,
REP.PRIMARY,2.86,TRIGONELLINE,,,BRD:BRD-K69231085-003-05-7,
REP.PRIMARY,2.5,LUMACAFTOR,CFTR,CFTR CHANNEL AGONIST,BRD:BRD-K69236721-001-02-7,
REP.PRIMARY,2.5,AFLOQUALONE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K69247067-001-01-8,
REP.PRIMARY,2.5,HEXESTROL,"AKR1C1, ESR1, ESR2",SYNTHETIC ESTROGEN,BRD:BRD-K69253806-001-02-0,
REP.PRIMARY,2.5,VINORELBINE,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K69280563-001-01-8,
REP.PRIMARY,2.5,GLUTATHIONE,"ESD, GGT1, GLO1, GLRX, GLRX2, GPX1, GPX2, GPX3, GPX4, GPX5, GPX6, GPX7, GPX8, GSR, GSS, GSTA1, GSTA2, GSTA3, GSTA4, GSTA5, GSTK1, GSTM1, GSTM2, GSTM3, GSTM4, GSTM5, GSTO1, GSTO2, GSTP1, GSTT1, GSTZ1, HAGH, HPGDS, LTC4S, MGST1, MGST2, MGST3, TXNDC12",ANTIOXIDANT,BRD:BRD-K69346723-001-04-8,
REP.PRIMARY,2.5,TROSPIUM,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K69469734-003-02-5,
REP.PRIMARY,2.5,MONTELUKAST,"ALOX5, CYSLTR1",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K69470111-236-08-9,
REP.PRIMARY,2.5,SGC-0946,,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K69577666-001-01-3,
REP.PRIMARY,2.5,THIETHYLPERAZINE,"DRD1, DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K69600043-328-05-5,
REP.PRIMARY,2.5,TACROLIMUS,FKBP1A,CALCINEURIN INHIBITOR,BRD:BRD-K69608737-001-10-2,
REP.PRIMARY,2.48,IDARUBICIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K69650333-003-13-2,
REP.PRIMARY,2.5,IDARUBICIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K69650333-003-14-0,
REP.PRIMARY,2.5,MESTINON,"ACHE, BCHE",CHOLINESTERASE INHIBITOR,BRD:BRD-K69688083-004-23-1,
REP.PRIMARY,2.5,BARDOXOLONE-METHYL,"PPARG, STAT3","LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K69694239-001-02-2,
REP.PRIMARY,2.5,ATORVASTATIN,"AHR, DPP4, HMGCR",HMGCR INHIBITOR,BRD:BRD-K69726342-238-02-4,
REP.PRIMARY,2.5,MERICITABINE,,HCV INHIBITOR,BRD:BRD-K69726595-001-01-2,
REP.PRIMARY,2.5,VOLASERTIB,PLK1,PLK INHIBITOR,BRD:BRD-K69776681-001-03-8,
REP.PRIMARY,2.5,WAY-100635,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K69812556-305-02-0,
REP.PRIMARY,2.5,TRAP-101,OPRL1,"NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST, OPIOID RECEPTOR ANTAGONIST",BRD:BRD-K69837166-003-02-0,
REP.PRIMARY,2.5,FLURBIPROFEN-(S)-(+),"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K69907333-001-10-6,
REP.PRIMARY,2.5,AZD8055,MTOR,MTOR INHIBITOR,BRD:BRD-K69932463-001-10-6,
REP.PRIMARY,2.5,SM-108,,,BRD:BRD-K70053378-001-01-1,
REP.PRIMARY,2.5,2-CHLORO-N6-CYCLOPENTYLADENOSINE,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K70088346-001-01-6,
REP.PRIMARY,2.5,SMI-4A,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K70159787-001-01-1,
REP.PRIMARY,2.42,VATALANIB,"EGFR, FLT1, FLT4, KDR, PDGFRB","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K70163715-300-05-7,
REP.PRIMARY,2.5,INH1,NDC80,HEC1 INHIBITOR,BRD:BRD-K70177501-003-01-4,
REP.PRIMARY,2.5,RIBOFLAVIN,"BLVRB, RFK",VITAMIN B2,BRD:BRD-K70246307-001-04-1,
REP.PRIMARY,2.5,U-99194,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70281171-050-08-9,
REP.PRIMARY,2.5,IBRUTINIB,"BLK, BMX, BTK",BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K70301465-001-02-6,
REP.PRIMARY,2.5,ESCITALOPRAM,"ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K70301876-034-13-7,
REP.PRIMARY,2.5,SURAMIN,"F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5",DNA SYNTHESIS INHIBITOR,BRD:BRD-K70327167-348-13-4,
REP.PRIMARY,2.5,BENZOXIQUINE,,ANTIINFECTIVE DRUG,BRD:BRD-K70327191-001-02-2,
REP.PRIMARY,2.5,AMANTADINE,"DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K70330367-003-07-9,
REP.PRIMARY,2.5,ARIPIPRAZOLE,"ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7","SEROTONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K70358946-001-15-7,
REP.PRIMARY,2.5,ERLOTINIB,"EGFR, NR1I2",EGFR INHIBITOR,BRD:BRD-K70401845-003-09-6,
REP.PRIMARY,2.5,NEXTURASTAT-A,"HDAC1, HDAC6",HDAC INHIBITOR,BRD:BRD-K70402238-001-02-8,
REP.PRIMARY,2.5,BAY-87-2243,HIF1A,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K70463136-001-01-5,
REP.PRIMARY,2.5,FLUPENTIXOL,"ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70487031-001-02-8,
REP.PRIMARY,2.5,RIMCAZOLE,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K70490179-300-01-2,
REP.PRIMARY,2.5,RANITIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K70505054-003-12-4,
REP.PRIMARY,2.5,DOXOFYLLINE,"ADORA1, PDE4A, PDE4B, PDE4C, PDE4D",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K70507123-001-09-7,
REP.PRIMARY,2.5,HMN-214,PLK1,PLK INHIBITOR,BRD:BRD-K70511574-001-06-9,
REP.PRIMARY,2.5,ZOSUQUIDAR,"ABCB1, ABCB4",P GLYCOPROTEIN INHIBITOR,BRD:BRD-K70557564-305-03-6,
REP.PRIMARY,2.5,1-EBIO,"KCNN1, KCNN2, KCNN3, KCNN4",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K70586315-001-02-4,
REP.PRIMARY,2.5,PHENYLACETYLGLUTAMINE,,"DNA METHYLASE INHIBITOR, PROTEIN SYNTHESIS INHIBITOR",BRD:BRD-K70592483-001-01-0,
REP.PRIMARY,2.5,VX-222,,HCV INHIBITOR,BRD:BRD-K70610771-001-02-9,
REP.PRIMARY,2.5,TRAZODONE,"ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4","ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K70778732-003-26-7,
REP.PRIMARY,2.5,10-DEBC,PIM1,AKT INHIBITOR,BRD:BRD-K70792160-003-04-6,
REP.PRIMARY,2.5,4-METHYLHISTAMINE,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K70821460-300-02-4,
REP.PRIMARY,2.5,NALOXONE-BENZOYLHYDRAZONE,"OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K70898774-001-03-5,
REP.PRIMARY,2.5,CO-102862,"SCN4A, SCN9A",SODIUM CHANNEL BLOCKER,BRD:BRD-K70912147-001-01-8,
REP.PRIMARY,2.5,BIBX-1382,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K70914287-300-02-8,
REP.PRIMARY,2.5,AMTOLMETIN-GUACIL,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K70924353-001-01-2,
REP.PRIMARY,2.5,MASITINIB,"FGFR3, KIT, PDGFRA, PDGFRB","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, SRC INHIBITOR",BRD:BRD-K71035033-001-07-1,
REP.PRIMARY,2.5,ETAMSYLATE,,"HAEMOSTATIC AGENT, HEMOSTATIC AGENT",BRD:BRD-K71055333-224-05-8,
REP.PRIMARY,2.5,LULICONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K71058253-001-01-9,
REP.PRIMARY,2.5,CEFIXIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K71059170-001-11-6,
REP.PRIMARY,2.5,DORZOLAMIDE,"CA1, CA12, CA14, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K71075609-003-01-0,
REP.PRIMARY,2.5,DULOXETINE,"HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4","NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR (SNRI), SEROTONINâNOREPINEPHRINE REUPTAKE INHIBITOR (SNRI)",BRD:BRD-K71103788-003-12-0,
REP.PRIMARY,2.5,FLUDARABINE-PHOSPHATE,"DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K71106091-001-06-1,
REP.PRIMARY,2.5,SULPHADIMETHOXINE,,DIHYDROPTEROATE SYNTHETASE INHIBITOR,BRD:BRD-K71125014-001-27-1,
REP.PRIMARY,2.5,KD-023,"ACACA, ACACB",ACAT INHIBITOR,BRD:BRD-K71164191-001-01-0,
REP.PRIMARY,2.5,BIRINAPANT,"BIRC2, XIAP",XIAP INHIBITOR,BRD:BRD-K71221037-001-01-6,
REP.PRIMARY,2.5,PSB-06126,ENTPD3,NTPDASE INHIBITOR,BRD:BRD-K71266197-236-02-7,
REP.PRIMARY,2.5,SNX-2112,,HSP INHIBITOR,BRD:BRD-K71281111-001-04-3,
REP.PRIMARY,2.5,ZAFIRLUKAST,"CYSLTR1, CYSLTR2",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K71289571-001-11-4,
REP.PRIMARY,2.5,BUTALBITAL,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K71350836-001-02-4,
REP.PRIMARY,2.5,CLOBENPROPIT,"HRH1, HRH2, HRH3, HRH4",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K71430621-303-02-3,
REP.PRIMARY,2.5,KPT-185,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K71467466-001-02-3,
REP.PRIMARY,2.5,GDC-0068,"AKT1, AKT2, AKT3, PRKG1",AKT INHIBITOR,BRD:BRD-K71480163-001-01-4,
REP.PRIMARY,2.5,DICLOFENAMIDE,"CA1, CA12, CA2, CA4, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K71499074-001-12-9,
REP.PRIMARY,2.5,SNS-314,"AURKA, AURKB, AURKC",AURORA KINASE INHIBITOR,BRD:BRD-K71512533-066-02-8,
REP.PRIMARY,2.5,GW-9508,"FFAR1, FFAR4","FREE FATTY ACID RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K71534238-001-10-0,
REP.PRIMARY,2.5,EVP-6124,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71603915-003-01-8,
REP.PRIMARY,2.5,I-BZA2,,,BRD:BRD-K71698503-003-01-6,
REP.PRIMARY,2.5,PNU-120596,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71731651-001-04-3,
REP.PRIMARY,2.5,CARBAMAZEPINE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A",CARBOXAMIDE ANTIEPILEPTIC,BRD:BRD-K71799949-001-36-4,
REP.PRIMARY,2.5,D-SERINE,"GLRA1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SERPINB3",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K71822263-001-03-2,
REP.PRIMARY,2.5,EPOTHILONE-A,,MICROTUBULE STABILIZING AGENT,BRD:BRD-K71823332-001-03-7,
REP.PRIMARY,2.5,CYTARABINE,"POLA1, POLB, POLD1, POLE",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K71847383-001-12-5,CYTIDINE
REP.PRIMARY,2.5,CYTIDINE,"POLA1, POLB, POLD1, POLE",RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K71847383-001-12-5,CYTIDINE
REP.PRIMARY,2.5,MARBOFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K71926323-001-13-8,
REP.PRIMARY,2.52,MARBOFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K71926323-001-14-6,
REP.PRIMARY,2.5,CFTRINH-172,CFTR,CHLORIDE CHANNEL BLOCKER,BRD:BRD-K72004355-001-01-9,
REP.PRIMARY,2.5,VT-464,CYP17A1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K72005722-001-01-2,
REP.PRIMARY,2.5,PROBUCOL,"ABCA1, ABCB11, CES1",ATHEROGENESIS INHIBITOR,BRD:BRD-K72029282-001-22-0,
REP.PRIMARY,2.5,VIDARABINE,ADA,ANTIVIRAL,BRD:BRD-K72093121-001-16-3,
REP.PRIMARY,2.5,PROCYANIDIN-B-2,,,BRD:BRD-K72093555-001-01-0,
REP.PRIMARY,2.5,SYM-2081,"GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2",KAINATE RECEPTOR ANTAGONIST,BRD:BRD-K72106461-001-02-1,
REP.PRIMARY,2.5,DIHYDROERGOTAMINE,"ADRA2A, DRD2, HTR1B, HTR1D, HTR1E, HTR1F, HTR2B, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K72166146-066-05-4,
REP.PRIMARY,2.5,CEFDITOREN-PIVOXIL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72167406-001-02-1,
REP.PRIMARY,2.5,CEFDITOREN-PIVOXIL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72167406-001-03-9,
REP.PRIMARY,2.5,ACEXAMIC-ACID,GAST,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K72215350-001-06-5,
REP.PRIMARY,2.5,QUINAPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K72222507-003-16-8,
REP.PRIMARY,2.5,TAME,,,BRD:BRD-K72231366-001-02-3,
REP.PRIMARY,2.5,BAICALEIN,"ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH",LIPOXYGENASE INHIBITOR,BRD:BRD-K72327355-001-14-7,
REP.PRIMARY,2.5,CEFOSELIS,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-02-1,
REP.PRIMARY,2.5,CEFOSELIS,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-03-9,
REP.PRIMARY,2.5,CEFOSELIS,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K72339976-065-04-7,
REP.PRIMARY,2.5,AZD4282,"AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K72369578-001-04-1,
REP.PRIMARY,2.5,SULBENTINE,,OTHER ANTIFUNGAL,BRD:BRD-K72384124-001-08-0,
REP.PRIMARY,2.5,AZD5438,KCNH2,CDK INHIBITOR,BRD:BRD-K72414522-001-06-7,
REP.PRIMARY,2.5,WZ-4002,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K72420232-001-12-3,
REP.PRIMARY,2.5,C-1,PRKCA,PROTEIN KINASE INHIBITOR,BRD:BRD-K72462751-001-02-7,
REP.PRIMARY,2.5,CLODRONIC-ACID,"SLC25A4, SLC25A5, SLC25A6",BONE RESORPTION INHIBITOR,BRD:BRD-K72542090-304-02-4,
REP.PRIMARY,2.5,VU0364439,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K72687424-001-02-6,
REP.PRIMARY,2.5,ZM-447439,"AURKA, AURKB",AURORA KINASE INHIBITOR,BRD:BRD-K72703948-001-10-1,
REP.PRIMARY,2.5,BENZETHONIUM,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K72723676-003-17-8,
REP.PRIMARY,2.5,ARCYRIAFLAVIN-A,"CCND1, CDK4",CDK INHIBITOR,BRD:BRD-K72726508-001-02-1,
REP.PRIMARY,2.5,DIMETRIDAZOLE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K72728560-001-01-4,
REP.PRIMARY,2.5,XANOMELINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K72815923-034-01-2,
REP.PRIMARY,2.5,CEP-37440,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K72827473-001-01-0,
REP.PRIMARY,2.5,NNC-63-0532,OPRL1,OPIOID RECEPTOR AGONIST,BRD:BRD-K72904818-001-01-1,
REP.PRIMARY,2.5,TELAPREVIR,"CTSA, PGR",HCV INHIBITOR,BRD:BRD-K72912098-001-02-3,
REP.PRIMARY,2.5,CINCHOPHEN,,ANALGESIC AGENT,BRD:BRD-K72915123-001-18-1,
REP.PRIMARY,2.5,SCLAREOLIDE,,OTHER ANTIFUNGAL,BRD:BRD-K72925150-001-11-1,
REP.PRIMARY,2.5,VALRUBICIN,TOP2A,"DNA INHIBITOR, TOPOISOMERASE INHIBITOR",BRD:BRD-K72951360-001-01-4,
REP.PRIMARY,2.5,ZLN005,,,BRD:BRD-K73073971-001-01-7,
REP.PRIMARY,2.5,LEVAMISOLE,"ALPL, ALPPL2, CHRNA3",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K73107279-003-12-5,
REP.PRIMARY,2.5,DIAZOXIDE,"ATP1A1, CA1, CA2, KCNJ11, KCNJ8, KCNMA1, SLC12A3",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K73109821-001-20-1,
REP.PRIMARY,2.5,PHENYL-AMINOSALICYLATE,,,BRD:BRD-K73157543-001-04-1,
REP.PRIMARY,2.5,ALIZARIN,,,BRD:BRD-K73191876-001-11-2,
REP.PRIMARY,2.5,URAPIDIL,HTR1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K73196317-003-14-8,
REP.PRIMARY,2.5,SNX-5422,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K73197500-001-02-2,
REP.PRIMARY,2.5,LITHIUM-ACETOACETATE,FAH,,BRD:BRD-K73234506-235-02-1,
REP.PRIMARY,2.5,TACALCITOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K73237276-001-01-0,
REP.PRIMARY,2.5,CLORGILINE,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K73251053-003-22-2,
REP.PRIMARY,2.5,ICI-199441,"CYP2D6, OPRD1, OPRK1, OPRM1, UTS2R",OPIOID RECEPTOR AGONIST,BRD:BRD-K73290745-003-02-6,
REP.PRIMARY,2.5,WZ-3146,EGFR,EGFR INHIBITOR,BRD:BRD-K73293050-001-03-1,
REP.PRIMARY,2.5,4-METHYLGENISTEIN,"CYP19A1, ESRRA, ESRRB, ESRRG, FASN",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K73303757-001-21-6,
REP.PRIMARY,2.5,OSI-420,EGFR,EGFR INHIBITOR,BRD:BRD-K73309154-003-02-8,
REP.PRIMARY,2.5,PF-04217903,MET,C-MET INHIBITOR,BRD:BRD-K73319509-001-08-0,
REP.PRIMARY,2.5,LEVOBUNOLOL-(+),,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K73323637-003-10-9,
REP.PRIMARY,2.5,BIX-02189,"MAP2K5, MAPK7",MEK INHIBITOR,BRD:BRD-K73368362-001-07-5,
REP.PRIMARY,2.5,5-FLUORO-3-PYRIDYL-METHANOL,,,BRD:BRD-K73381198-001-01-1,
REP.PRIMARY,2.5,PHENYLEPHRINE,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K73381542-003-23-4,
REP.PRIMARY,2.56,C646,EP300,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K73383190-001-02-3,
REP.PRIMARY,2.5,C646,EP300,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K73383190-001-03-1,
REP.PRIMARY,2.5,DIMETHISOQUIN,,LOCAL ANESTHETIC,BRD:BRD-K73391359-003-10-2,
REP.PRIMARY,2.5,OXOLINIC-ACID,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K73394555-237-01-1,
REP.PRIMARY,2.5,PURMORPHAMINE,SMO,SMOOTHENED RECEPTOR AGONIST,BRD:BRD-K73397362-001-06-6,
REP.PRIMARY,2.5,BEKANAMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K73425385-065-04-8,
REP.PRIMARY,2.5,CINACIGUAT,"GUCY1A3, GUCY1B3",GUANYLATE CYCLASE ACTIVATOR,BRD:BRD-K73440166-001-01-3,
REP.PRIMARY,2.5,NEDAPLATIN,,DNA INHIBITOR,BRD:BRD-K73469236-001-01-8,
REP.PRIMARY,2.5,DIBUTYL-PHTHALATE,TRPA1,,BRD:BRD-K73477617-001-08-5,
REP.PRIMARY,2.5,ST-1859,,ANTIAMYLOIDOGENIC AGENT,BRD:BRD-K73524797-001-01-1,
REP.PRIMARY,2.5,TROXERUTIN,,ANTIOXIDANT,BRD:BRD-K73529671-001-02-9,
REP.PRIMARY,2.5,TROXERUTIN,,ANTIOXIDANT,BRD:BRD-K73529671-001-04-5,
REP.PRIMARY,2.5,ETOFENAMATE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73541271-001-03-6,
REP.PRIMARY,2.5,CORTICOSTERONE,"HSD11B1, NCOA1, NR3C2",MINERALOCORTICOID RECEPTOR AGONIST,BRD:BRD-K73589401-001-23-6,
REP.PRIMARY,2.5,NIZATIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K73589491-001-11-2,
REP.PRIMARY,2.5,BROMOPRIDE,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K73642618-001-13-3,
REP.PRIMARY,2.5,N-ACETYLTRYPTAMINE,,MELATONIN RECEPTOR AGONIST,BRD:BRD-K73700643-001-11-2,
REP.PRIMARY,2.44,GENIPOSIDIC-ACID,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73771095-001-02-5,
REP.PRIMARY,2.5,GENIPOSIDIC-ACID,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K73771095-001-03-3,
REP.PRIMARY,2.5,ZM-336372,"BRAF, LCK, MAPK14, RAF1",RAF INHIBITOR,BRD:BRD-K73789395-001-10-7,
REP.PRIMARY,2.5,HC-030031,TRPA1,TRPA1 CHANNEL BLOCKER,BRD:BRD-K73815512-001-02-5,
REP.PRIMARY,2.5,CINACALCET,CASR,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K73838513-003-05-5,
REP.PRIMARY,2.5,DIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K73923631-003-02-9,
REP.PRIMARY,2.5,BI-78D3,MAPK8,JNK INHIBITOR,BRD:BRD-K73982490-001-02-9,
REP.PRIMARY,2.5,TELMISARTAN,"AGTR1, PPARG",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K73999723-001-11-3,
REP.PRIMARY,2.5,INDIBULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K74057757-001-01-9,
REP.PRIMARY,2.5,DORAMAPIMOD,"MAPK11, MAPK12, MAPK13, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K74065929-001-07-2,
REP.PRIMARY,2.5,NELFINAVIR,"CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7",HIV PROTEASE INHIBITOR,BRD:BRD-K74117820-066-10-8,
REP.PRIMARY,2.5,NAFTIFINE,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K74141488-003-11-2,
REP.PRIMARY,2.5,CYTISINE,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K74186897-001-12-4,
REP.PRIMARY,2.5,CYTISINE,"CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7, CHRNB2, CHRNB4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K74186897-001-13-2,
REP.PRIMARY,2.5,RESORCINOL,"CA12, CA14, CA2, PTGS1",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K74190368-001-04-3,
REP.PRIMARY,2.5,PHENYLMERCURIC-ACETATE,,OTHER ANTIFUNGAL,BRD:BRD-K74193284-001-04-8,
REP.PRIMARY,2.5,IRSOGLADINE,PDE4A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K74195153-050-12-1,
REP.PRIMARY,2.5,SE-METHYLSELENOCYSTEINE,,,BRD:BRD-K74227499-001-01-1,
REP.PRIMARY,2.5,ACITAZANOLAST,,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K74236708-001-01-9,
REP.PRIMARY,2.5,IKK-2-INHIBITOR-V,IKBKB,"IKK INHIBITOR, NFKB PATHWAY INHIBITOR",BRD:BRD-K74305673-001-06-2,
REP.PRIMARY,2.5,TAMSULOSIN,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K74339692-001-01-9,
REP.PRIMARY,2.5,ACLIDINIUM,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K74363950-004-01-0,
REP.PRIMARY,2.5,NSI-189,,NEUROTROPHIC AGENT,BRD:BRD-K74371986-001-01-7,
REP.PRIMARY,2.5,AZITHROMYCIN,MLNR,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K74501079-001-18-1,
REP.PRIMARY,2.5,PAZOPANIB,"CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K74514084-001-03-9,
REP.PRIMARY,2.5,"ICI-118,551","ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K74603273-003-01-1,
REP.PRIMARY,2.5,SELENOMETHIONINE,,,BRD:BRD-K74664543-213-01-2,
REP.PRIMARY,2.5,ETRAVIRINE,"CYP2C19, CYP2C9, CYP3A4",NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K74717603-001-02-2,
REP.PRIMARY,2.5,BOSENTAN,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K74763371-002-04-0,
REP.PRIMARY,0.25,TOMELUKAST,CYSLTR1,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K74765201-001-16-7,
REP.PRIMARY,2.5,BRINZOLAMIDE,"CA1, CA12, CA14, CA2, CA4, CA5A, CA7",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K74913225-001-12-4,
REP.PRIMARY,2.5,BW-373U86,OPRD1,OPIOID RECEPTOR AGONIST,BRD:BRD-K74990253-001-02-8,
REP.PRIMARY,2.43,SCH-900776,"CDK2, CHEK1",CHK INHIBITOR,BRD:BRD-K75009076-001-02-1,
REP.PRIMARY,2.5,LESINURAD,SLC22A12,URIC ACID DIURETIC,BRD:BRD-K75024268-001-01-0,
REP.PRIMARY,2.5,CARBACHOL,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K75037734-003-13-9,
REP.PRIMARY,2.5,"TRANS-4-[8-(3-FLUOROPHENYL)-1,7-NAPHTHYRIDIN-6-YL]CYCLOHEXANECARBOXYLIC-ACID",,,BRD:BRD-K75080769-001-01-6,
REP.PRIMARY,2.5,PROCAINAMIDE,"DNMT1, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K75089421-003-24-5,
REP.PRIMARY,2.5,TIRACIZINE,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K75250001-001-01-3,
REP.PRIMARY,2.5,BL-5583,,HYPERCALCAEMIC AGENT,BRD:BRD-K75282704-001-02-4,
REP.PRIMARY,2.5,ALISERTIB,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K75295174-001-05-0,
REP.PRIMARY,2.5,SAR-245409,"MTOR, PIK3CG",PI3K INHIBITOR,BRD:BRD-K75308783-001-07-0,
REP.PRIMARY,2.5,KPT-276,XPO1,EXPORTIN ANTAGONIST,BRD:BRD-K75352575-001-01-3,
REP.PRIMARY,2.5,PROTIONAMIDE,,,BRD:BRD-K75360161-001-18-0,
REP.PRIMARY,2.5,BENZOCAINE,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K75466013-001-14-4,
REP.PRIMARY,2.5,GS-39783,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K75478907-001-02-3,
REP.PRIMARY,2.5,NPS-2143,CASR,CALCIUM RECEPTOR ANTAGONIST,BRD:BRD-K75506300-001-01-6,
REP.PRIMARY,2.5,(R)-(-)-ROLIPRAM,"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K75516118-001-03-3,ROLIPRAM-R(-)
REP.PRIMARY,2.5,ROLIPRAM-R(-),"PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K75516118-001-03-3,ROLIPRAM-R(-)
REP.PRIMARY,2.5,ALENDRONATE,"ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS",BONE RESORPTION INHIBITOR,BRD:BRD-K75527158-360-04-9,
REP.PRIMARY,2.5,HYDROXYTOLUIC-ACID,,,BRD:BRD-K75608666-001-08-3,
REP.PRIMARY,2.5,TALIPEXOLE,"ADRA2A, DRD2, HTR3A","ADRENERGIC RECEPTOR AGONIST, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K75615183-300-03-9,
REP.PRIMARY,2.5,METOCLOPRAMIDE,"CHRM1, DRD2, HTR3A, HTR3B, HTR4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K75641298-003-25-0,
REP.PRIMARY,2.5,TIOGUANINE,,PURINE ANTAGONIST,BRD:BRD-K75649340-001-13-1,
REP.PRIMARY,2.5,RIZATRIPTAN,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K75699339-057-08-1,
REP.PRIMARY,2.5,MCPP,"HTR1A, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K75844781-003-08-0,
REP.PRIMARY,2.5,IODOQUINOL,,ANTISEPTIC,BRD:BRD-K75855670-001-14-2,
REP.PRIMARY,2.5,IOPAMIDOL,,RADIOPAQUE MEDIUM,BRD:BRD-K75868704-001-05-3,
REP.PRIMARY,2.5,SU014813,KDR,"PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K75911534-001-01-6,
REP.PRIMARY,2.5,SCOPINE,,,BRD:BRD-K75923785-003-02-1,
REP.PRIMARY,2.5,VCH-916,,HCV INHIBITOR,BRD:BRD-K75956464-237-01-5,
REP.PRIMARY,2.5,PIZOTIFEN,"HTR1A, HTR2A, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K75958195-037-09-4,
REP.PRIMARY,2.5,PITAVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K75958547-238-01-0,
REP.PRIMARY,2.5,OSELTAMIVIR-PHOSPHATE,"CES1, NEU1, NEU2",NEURAMINIDASE INHIBITOR,BRD:BRD-K76011241-001-01-8,
REP.PRIMARY,2.5,(R)-(-)-APOMORPHINE,"ADRA2A, ADRA2B, ADRA2C, CALY, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K76022557-003-02-7,R(-)-APOMORPHINE
REP.PRIMARY,2.5,R(-)-APOMORPHINE,"ADRA2A, ADRA2B, ADRA2C, CALY, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K76022557-003-02-7,R(-)-APOMORPHINE
REP.PRIMARY,2.5,GUANIDINE,"ALDH2, DLG4, GAMT, RNASE1",HSP INHIBITOR,BRD:BRD-K76037122-001-02-5,
REP.PRIMARY,2.5,TYRPHOSTIN-AG-1296,FLT3,FLT3 INHIBITOR,BRD:BRD-K76064317-001-07-3,
REP.PRIMARY,2.5,JIB04,KDM4E,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K76180386-001-01-6,
REP.PRIMARY,2.5,LOSARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K76205745-237-16-5,
REP.PRIMARY,2.5,RESIQUIMOD,"TLR7, TLR8",TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K76210423-001-01-6,
REP.PRIMARY,2.5,BMS-690514,"EGFR, ERBB2, FLT3, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K76239644-001-01-8,
REP.PRIMARY,2.5,PHENAZOPYRIDINE,SCN1A,LOCAL ANESTHETIC,BRD:BRD-K76304753-003-20-3,
REP.PRIMARY,2.5,PHENAZOPYRIDINE,SCN1A,LOCAL ANESTHETIC,BRD:BRD-K76304753-003-21-1,
REP.PRIMARY,2.5,NITROMIDE,,,BRD:BRD-K76381435-001-08-6,
REP.PRIMARY,2.5,CCT128930,"PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K76406695-001-02-9,
REP.PRIMARY,2.5,PIPERONYL-BUTOXIDE,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K76452401-001-03-6,
REP.PRIMARY,2.5,ENROFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K76534306-001-22-7,
REP.PRIMARY,2.5,PHTPP,ESR2,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K76568384-001-02-2,
REP.PRIMARY,2.5,3-CARBOXY-4-HYDROXYPHENYLGLYCINE-(R),"GRIN1, GRIN2A, GRIN2B, GRIN2C",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K76592088-001-02-1,
REP.PRIMARY,2.5,NICOTINYL-ALCOHOL-TARTRATE,,,BRD:BRD-K76600340-045-04-9,
REP.PRIMARY,2.5,MEBICAR,,ANXIOLYTIC,BRD:BRD-K76606751-001-01-7,
REP.PRIMARY,2.5,IMIDACLOPRID,CHRFAM7A,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K76609936-001-08-4,
REP.PRIMARY,2.5,FASUDIL,"PKIA, PRKACA, ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K76617868-003-11-9,
REP.PRIMARY,2.5,IDOXURIDINE,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K76634210-001-14-7,
REP.PRIMARY,2.5,HOMOHARRINGTONINE,RPL3,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K76674262-001-03-3,
REP.PRIMARY,2.5,AJ76-(+),"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K76677554-003-02-1,
REP.PRIMARY,2.5,YM-155,BIRC5,SURVIVIN INHIBITOR,BRD:BRD-K76703230-004-03-3,
REP.PRIMARY,2.5,YM-155,BIRC5,SURVIVIN INHIBITOR,BRD:BRD-K76703230-004-04-1,
REP.PRIMARY,2.5,NIMESULIDE,"LTF, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76775527-001-30-2,
REP.PRIMARY,2.5,SB-415286,"GSK3A, GSK3B, RPS6KB1",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K76805682-001-15-9,
REP.PRIMARY,2.5,NICERGOLINE,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76810206-001-07-3,
REP.PRIMARY,2.5,NICERGOLINE,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76810206-001-08-1,
REP.PRIMARY,2.5,L-ARGININE,"ARG2, ASL, ASS1, AZIN2, GPRC6A, NOS2, NOS3, SLC7A1, SLC7A3, SLC7A4",NITRIC OXIDE PRECURSOR,BRD:BRD-K76811153-003-01-3,
REP.PRIMARY,2.5,METAMIZOLE,PTGS1,"CYCLOOXYGENASE INHIBITOR, OPIOID RECEPTOR AGONIST",BRD:BRD-K76812510-236-14-8,
REP.PRIMARY,2.5,RS-17053,"ADRA1A, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76840893-003-02-5,
REP.PRIMARY,2.5,TAZAROTENE,"RARA, RARB, RARG, RXRB",RETINOID RECEPTOR AGONIST,BRD:BRD-K76841105-001-04-7,
REP.PRIMARY,2.5,SULFANITRAN,,,BRD:BRD-K76845197-001-05-4,
REP.PRIMARY,2.5,TRIAZOLAM,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GABRR1, GABRR2, GABRR3, TSPO",GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K76890464-001-02-3,
REP.PRIMARY,2.5,CP-724714,ERBB2,"EGFR INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K76908866-001-07-6,
REP.PRIMARY,2.5,INDORAMIN,"ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76953762-001-08-5,
REP.PRIMARY,2.01,TRYPTANTHRIN,IDO1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76973696-001-12-6,
REP.PRIMARY,2.5,WYE-354,MTOR,MTOR INHIBITOR,BRD:BRD-K77008974-001-03-2,
REP.PRIMARY,2.5,AY-9944,,HEDGEHOG PATHWAY MODULATOR,BRD:BRD-K77012840-300-01-6,
REP.PRIMARY,2.5,AZD1283,P2RY12,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K77060810-001-01-5,
REP.PRIMARY,2.5,PHTHALYLSULFACETAMIDE,,,BRD:BRD-K77115421-001-02-6,
REP.PRIMARY,2.5,PROXYFAN,HRH3,HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K77171813-034-01-8,
REP.PRIMARY,2.5,GAMMA-AMINOBUTYRIC-ACID,"GABBR1, GABBR2, GABRA1, GABRA2, GABRA3, GABRA5, GABRB2, GABRG2, GATM, KCTD12, KCTD16, KCTD8, SLC6A1",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K77245796-003-01-6,
REP.PRIMARY,2.5,SODIUM-PICOSULFATE,,,BRD:BRD-K77251551-304-02-9,
REP.PRIMARY,2.5,LACTULOSE,,LAXATIVE,BRD:BRD-K77258318-001-04-6,
REP.PRIMARY,2.5,CHOLINE,"ACHE, BCHE, CHRNA2, PCYT1A, PCYT1B, PHOSPHO1, PLD1, PLD2",ACETYLCHOLINE PRECURSOR,BRD:BRD-K77300776-001-02-5,
REP.PRIMARY,2.5,GALLIC-ACID,"CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP","BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR, PPAR RECEPTOR AGONIST",BRD:BRD-K77345217-001-05-0,
REP.PRIMARY,2.5,NVP-DPP728,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K77396579-300-01-0,
REP.PRIMARY,2.5,ADEFOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K77484724-001-02-0,
REP.PRIMARY,2.5,TIQUIZIUM,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K77552740-004-01-0,
REP.PRIMARY,2.57,TRIAMCINOLONE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K77554836-001-11-6,
REP.PRIMARY,2.5,TRIAMCINOLONE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K77554836-001-14-0,
REP.PRIMARY,2.5,TOPIROXOSTAT,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K77561571-001-01-1,
REP.PRIMARY,2.5,DETOMIDINE,ADRA2A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K77597856-003-02-5,
REP.PRIMARY,2.5,VANDETANIB,"EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA","EGFR INHIBITOR, RET TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K77625799-001-07-7,
REP.PRIMARY,2.5,A205804,"ICAM1, SELE",ICAM1 EXPRESSION INHIBITOR,BRD:BRD-K77627880-001-04-0,
REP.PRIMARY,2.5,AEG3482,,HSP INDUCER,BRD:BRD-K77634909-001-03-5,
REP.PRIMARY,2.5,CUDC-907,"HDAC2, PIK3R1",PI3K INHIBITOR,BRD:BRD-K77638923-001-02-0,
REP.PRIMARY,2.5,NAPHAZOLINE,"ADRA1A, ADRA2A",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K77641333-003-27-1,
REP.PRIMARY,2.5,SB-200646,"HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K77677632-003-02-6,
REP.PRIMARY,2.5,DEQUALINIUM,"KCNN1, KCNN3",PKC INHIBITOR,BRD:BRD-K77685957-300-09-1,
REP.PRIMARY,2.5,TIABENDAZOLE,,ANGIOGENESIS INHIBITOR,BRD:BRD-K77695569-001-30-0,
REP.PRIMARY,2.5,MOXONIDINE,"ADRA2A, ADRA2B, ADRA2C",IMIDAZOLINE RECEPTOR AGONIST,BRD:BRD-K77771411-003-10-7,
REP.PRIMARY,2.5,3-DEAZANEPLANOCIN-A,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77791657-001-01-1,
REP.PRIMARY,2.67,3-DEAZANEPLANOCIN-A,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77791657-003-01-7,
REP.PRIMARY,2.5,HYDROXYFASUDIL,"PKIA, PRKACA, ROCK1",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K77793136-003-03-0,
REP.PRIMARY,2.5,AZATADINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K77821588-364-01-2,
REP.PRIMARY,2.5,BREFELDIN-A,"ARF1, CYTH2",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K77841042-001-14-1,
REP.PRIMARY,2.5,U-104,"CA1, CA12, CA2, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K77867004-001-02-7,
REP.PRIMARY,2.5,ENTINOSTAT,"HDAC1, HDAC2, HDAC3, HDAC9",HDAC INHIBITOR,BRD:BRD-K77908580-001-09-6,
REP.PRIMARY,2.5,QUIPAZINE,"HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, SLC6A4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K77925998-050-14-3,
REP.PRIMARY,2.5,NVP-BVU972,MET,MET INHIBITOR,BRD:BRD-K77943374-001-02-8,
REP.PRIMARY,2.5,FLUSPIRILENE,"CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K77947974-001-16-3,
REP.PRIMARY,2.5,UPF-1069,PARP2,PARP INHIBITOR,BRD:BRD-K77950083-001-03-3,
REP.PRIMARY,2.5,MEBENDAZOLE,"TUBA1A, TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K77987382-001-13-2,
REP.PRIMARY,2.5,FUROSEMIDE,"CA2, GPR35, SLC12A1, SLC12A2",DIURETIC,BRD:BRD-K78010432-001-21-5,
REP.PRIMARY,2.5,LY2090314,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K78055238-001-01-8,
REP.PRIMARY,2.5,4-PPBP,SIGMAR1,SIGMA RECEPTOR LIGAND,BRD:BRD-K78061844-050-01-9,
REP.PRIMARY,2.5,GW-788388,"LCK, MAPK14, TGFBR1",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K78086729-001-02-7,
REP.PRIMARY,2.5,OXIPEROMIDE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K78096648-001-05-7,
REP.PRIMARY,2.5,ENOXACIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K78113049-001-16-2,
REP.PRIMARY,2.5,LY2157299,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K78118466-001-03-3,
REP.PRIMARY,2.5,NNC-55-0396,"CATSPER1, CATSPER2, CATSPER3, CATSPER4",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K78122587-300-02-7,
REP.PRIMARY,2.5,MENADIONE,"AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1","MITOCHONDRIAL DNA POLYMERASE INHIBITOR, PHOSPHATASE INHIBITOR",BRD:BRD-K78126613-001-28-5,
REP.PRIMARY,2.5,A-674563,"AKT1, PKIA, PRKACA",AKT INHIBITOR,BRD:BRD-K78177893-001-02-4,
REP.PRIMARY,2.5,OSTHOL,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K78294846-001-12-4,
REP.PRIMARY,2.5,MEPIROXOL,,,BRD:BRD-K78299798-001-02-2,
REP.PRIMARY,2.5,GLYCITEIN,TNF,TUMOR NECROSIS FACTOR RELEASE INHIBITOR,BRD:BRD-K78303961-001-02-3,
REP.PRIMARY,2.5,PF-4981517,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-K78318619-001-02-7,
REP.PRIMARY,2.5,HEMATOXYLIN,,,BRD:BRD-K78342372-001-02-4,
REP.PRIMARY,2.5,CRIZOTINIB,"ALK, MET",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K78431006-001-10-2,
REP.PRIMARY,2.5,WNT-C59,PORCN,PORCUPINE INHIBITOR,BRD:BRD-K78455053-001-01-2,
REP.PRIMARY,2.5,OLMESARTAN-MEDOXOMIL,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K78485176-001-07-8,
REP.PRIMARY,2.5,SCS,,,BRD:BRD-K78496197-001-03-9,
REP.PRIMARY,2.5,LONIDAMINE,GCK,GLUCOKINASE INHIBITOR,BRD:BRD-K78513633-001-15-7,
REP.PRIMARY,2.5,DOLASTATIN-10,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K78567475-001-01-4,
REP.PRIMARY,2.5,EXO-1,,ARF INHIBITOR,BRD:BRD-K78633253-001-10-3,
REP.PRIMARY,2.5,LY320135,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K78637815-001-02-2,
REP.PRIMARY,2.5,BROMPERIDOL,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K78643075-001-11-6,
REP.PRIMARY,2.5,IXAZOMIB,,PROTEASOME INHIBITOR,BRD:BRD-K78659596-001-03-9,
REP.PRIMARY,2.5,PROCATEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K78666826-003-01-6,
REP.PRIMARY,2.5,LEFLUNOMIDE,"AHR, DHODH, PTK2B","DIHYDROOROTATE DEHYDROGENASE INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K78692225-001-24-5,
REP.PRIMARY,2.5,SB-328437,,CCR ANTAGONIST,BRD:BRD-K78720403-001-01-6,
REP.PRIMARY,2.5,BARNIDIPINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K78781788-003-01-9,
REP.PRIMARY,2.5,PENTAGASTRIN,CCKBR,CCK RECEPTOR AGONIST,BRD:BRD-K78789465-001-01-6,
REP.PRIMARY,2.5,PENTAGASTRIN,CCKBR,CCK RECEPTOR AGONIST,BRD:BRD-K78789465-001-02-4,
REP.PRIMARY,2.5,SB-590885,BRAF,RAF INHIBITOR,BRD:BRD-K78809024-001-05-7,
REP.PRIMARY,2.5,SUXIBUZONE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K78815826-001-14-6,
REP.PRIMARY,2.5,N-[2-(PIPERIDINYLAMINO)ETHYL]-4-IODOBENZAMIDE,,SIGMA RECEPTOR LIGAND,BRD:BRD-K78844995-001-02-6,
REP.PRIMARY,2.5,SB-742457,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K78941306-001-02-4,
REP.PRIMARY,2.5,FPL-64176,"CACNA1C, CACNA1S",CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K78959463-001-13-2,
REP.PRIMARY,2.5,OXALIPLATIN,,DNA INHIBITOR,BRD:BRD-K78960041-001-03-2,
REP.PRIMARY,2.54,OXALIPLATIN,,DNA INHIBITOR,BRD:BRD-K78960041-001-05-7,
REP.PRIMARY,2.5,NITROFURAZONE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K79092138-001-11-0,
REP.PRIMARY,2.5,BROXURIDINE,,ANTIMETABOLITE,BRD:BRD-K79095980-001-09-6,
REP.PRIMARY,2.5,IDALOPIRDINE,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K79102359-003-01-6,
REP.PRIMARY,2.5,PROXYMETACAINE,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K79116891-003-15-1,
REP.PRIMARY,2.5,IOXAGLIC-ACID,,RADIOPAQUE MEDIUM,BRD:BRD-K79124250-001-08-9,
REP.PRIMARY,2.5,ALBENDAZOLE,"TUBA1A, TUBB, TUBB4B",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K79131256-001-17-9,
REP.PRIMARY,2.5,PIBENZIMOL,,DNA INHIBITOR,BRD:BRD-K79132813-001-09-0,
REP.PRIMARY,2.5,NIMORAZOLE,,BACTERIAL DNA INHIBITOR,BRD:BRD-K79145628-001-05-5,
REP.PRIMARY,2.5,DIBENZEPINE,,NOREPINEPHRINE REPUTAKE INHIBITOR,BRD:BRD-K79145749-003-02-2,
REP.PRIMARY,2.5,PF-573228,"CDK1, CDK2, CDK7, GSK3B, IKBKB",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K79239947-001-06-8,
REP.PRIMARY,2.5,DECITABINE,"DNMT1, DNMT3A",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K79254416-001-22-6,
REP.PRIMARY,2.5,NVP-BHG712,EPHB4,EPHRIN INHIBITOR,BRD:BRD-K79259477-001-04-9,
REP.PRIMARY,2.5,METHOXYAMINE,APEX1,DNA REPAIR ENZYME INHIBITOR,BRD:BRD-K79277568-003-04-7,
REP.PRIMARY,2.5,ERYTHRITOL,,,BRD:BRD-K79315489-001-07-8,
REP.PRIMARY,2.5,ENZASTAURIN,"AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG",PKC INHIBITOR,BRD:BRD-K79404599-001-09-3,
REP.PRIMARY,2.5,BENPERIDOL,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K79425933-001-09-3,
REP.PRIMARY,2.5,ACETYL-FARNESYL-CYSTEINE,PPARG,METHYLTRANSFERASE INHIBITOR,BRD:BRD-K79437791-001-05-7,
REP.PRIMARY,2.5,CYCLIZINE,"HRH1, SULT1E1",HISTAMINE RECEPTOR MODULATOR,BRD:BRD-K79501723-001-04-6,
REP.PRIMARY,2.5,RI-1,RAD51,,BRD:BRD-K79555887-001-01-0,
REP.PRIMARY,2.5,CGM097,MDM2,MDM INHIBITOR,BRD:BRD-K79584249-001-01-3,
REP.PRIMARY,2.5,BAVISANT,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K79595931-312-01-3,
REP.PRIMARY,2.5,METFORMIN,"ACACB, PRKAB1",INSULIN SENSITIZER,BRD:BRD-K79602928-003-19-9,
REP.PRIMARY,2.62,INOSINE,"PARP1, PNP",NEUROTROPHIC AGENT,BRD:BRD-K79612754-001-19-1,
REP.PRIMARY,2.5,INOSINE,"PARP1, PNP",NEUROTROPHIC AGENT,BRD:BRD-K79612754-001-21-7,
REP.PRIMARY,2.5,XILOBAM,,,BRD:BRD-K79633074-001-01-8,
REP.PRIMARY,2.5,RO-10-5824,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K79684402-300-02-8,
REP.PRIMARY,2.5,THIAMPHENICOL,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K79711234-001-18-3,
REP.PRIMARY,2.5,UBP-302,GRIK1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K79753741-001-01-7,
REP.PRIMARY,2.5,SILDENAFIL,"PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K79759585-048-04-8,
REP.PRIMARY,2.5,RETINALDEHYDE,,,BRD:BRD-K79884267-001-01-4,
REP.PRIMARY,2.5,PHENOLSULFONPHTHALEIN,,,BRD:BRD-K79892937-001-02-5,
REP.PRIMARY,2.5,GABAZINE,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K79905821-004-03-6,
REP.PRIMARY,2.5,GW-583340,"EGFR, ERBB2",EGFR INHIBITOR,BRD:BRD-K79930101-300-03-7,
REP.PRIMARY,2.5,RIVANICLINE,"CHRNA4, CHRNB2, CXCL8",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K79966802-034-01-2,
REP.PRIMARY,2.5,NESBUVIR,,RNA POLYMERASE INHIBITOR,BRD:BRD-K79989959-001-01-4,
REP.PRIMARY,2.5,"CIS-9,TRANS-11-CONJUGATED-LINOLEIC-ACID",,,BRD:BRD-K80025777-001-01-4,
REP.PRIMARY,2.5,ALPHA-METHYLHISTAMINE-DIHYDROBROMIDE-(R)-(-),HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K80028314-303-02-6,
REP.PRIMARY,2.5,CLOPIDOL,,,BRD:BRD-K80036624-001-04-0,
REP.PRIMARY,2.5,SODIUM-GUALENATE,,ANTACID,BRD:BRD-K80043866-236-01-1,
REP.PRIMARY,2.46,IEM1754,GRIA1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K80060353-303-03-9,
REP.PRIMARY,2.5,OTAMIXABAN,F10,COAGULATION FACTOR INHIBITOR,BRD:BRD-K80082640-001-01-0,
REP.PRIMARY,2.5,URACIL,"DPYD, UCKL1",,BRD:BRD-K80129304-001-08-1,
REP.PRIMARY,2.5,AMIFAMPRIDINE,,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K80262108-001-07-0,
REP.PRIMARY,2.5,AMINOSALICYLATE,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-001-17-7,
REP.PRIMARY,2.5,AMINOSALICYLATE,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-001-19-3,
REP.PRIMARY,2.5,DPPE,"ABCB1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K80315159-051-02-0,
REP.PRIMARY,2.5,TAK-285,ERBB2,EGFR INHIBITOR,BRD:BRD-K80343549-001-02-6,
REP.PRIMARY,2.5,SILIBININ,ALOX5,CYTOCHROME P450 INHIBITOR,BRD:BRD-K80353138-001-12-1,
REP.PRIMARY,2.5,GLIQUIDONE,"ABCC8, KCNJ10, KCNJ8",SULFONYLUREA,BRD:BRD-K80396088-001-12-0,
REP.PRIMARY,2.49,TRICIRIBINE,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K80431395-001-07-3,
REP.PRIMARY,2.5,TRICIRIBINE,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K80431395-001-09-9,
REP.PRIMARY,2.5,ZAMIFENACIN,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K80451230-051-02-6,
REP.PRIMARY,2.5,REPSOX,TGFBR1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K80480517-001-02-4,
REP.PRIMARY,2.5,ERTEBEREL,"ESR1, ESR2",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K80608265-001-01-6,
REP.PRIMARY,2.5,SB-258585,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K80639402-003-02-9,
REP.PRIMARY,2.5,N-ACETYL-D-GLUCOSAMINE,"B4GALT1, B4GALT2, B4GALT3, B4GALT4, NAGK, NAGLU, NAGPA, RENBP",,BRD:BRD-K80653534-001-01-7,
REP.PRIMARY,2.5,SGI-1776,"FLT3, PIM1, PIM2, PIM3",PIM KINASE INHIBITOR,BRD:BRD-K80700417-001-04-2,
REP.PRIMARY,2.5,RS-16566,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K80725821-300-02-9,
REP.PRIMARY,2.5,RO-19-4605,"GABRA1, GABRA2, GABRA3, GABRA5",GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K80778372-001-02-5,
REP.PRIMARY,2.5,AZ191,DYRK1B,DYRK INHIBITOR,BRD:BRD-K80935598-001-01-1,
REP.PRIMARY,2.5,INC-280,MET,C-MET INHIBITOR,BRD:BRD-K81016934-001-02-0,
REP.PRIMARY,2.5,TAUROCHOLATE,"CEL, FABP6, SLCO1C1",G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K81062487-001-05-8,
REP.PRIMARY,2.5,AZILSARTAN,"AGTR1, AGTR2",ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K81074237-001-02-3,
REP.PRIMARY,2.5,PHENACAINE,,LOCAL ANESTHETIC,BRD:BRD-K81092066-311-01-6,
REP.PRIMARY,2.5,FOSFOMYCIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K81101512-234-01-9,
REP.PRIMARY,2.5,EDROPHONIUM,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K81128206-003-24-4,
REP.PRIMARY,2.5,SALICYLAMIDE,,ANALGESIC AGENT,BRD:BRD-K81130846-001-17-4,
REP.PRIMARY,2.5,LEUCYLLEUCINE-METHYL-ESTER,,,BRD:BRD-K81136890-003-01-6,
REP.PRIMARY,2.5,MOXISYLYTE,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K81144366-003-19-7,
REP.PRIMARY,2.5,NSC-632839,"SENP2, USP1, USP2, USP7",UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K81197548-003-01-4,
REP.PRIMARY,2.5,SCH-58261,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K81225797-001-02-3,
REP.PRIMARY,2.5,DANTROLENE,"RYR1, RYR3",CALCIUM CHANNEL BLOCKER,BRD:BRD-K81272440-236-13-5,
REP.PRIMARY,2.5,4-MU-8C,ERN1,IRE1 INHIBITOR,BRD:BRD-K81316007-001-01-8,
REP.PRIMARY,2.5,ZOMEPIRAC,PTGDR2,PROSTAGLANDIN SYNTHESIS INHIBITOR,BRD:BRD-K81326768-001-04-0,
REP.PRIMARY,2.38,TIDEGLUSIB,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K81330143-001-04-8,
REP.PRIMARY,2.5,MAXACALCITOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K81332461-001-01-4,
REP.PRIMARY,2.5,TCS-359,FLT3,FLT3 INHIBITOR,BRD:BRD-K81376179-001-04-8,
REP.PRIMARY,2.5,VORINOSTAT,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9",HDAC INHIBITOR,BRD:BRD-K81418486-001-47-5,
REP.PRIMARY,2.58,LINCOMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K81447180-003-21-4,
REP.PRIMARY,2.5,CX-4945,"CSNK2A1, CSNK2A2, DAPK3, HIPK3",CASEIN KINASE INHIBITOR,BRD:BRD-K81458380-001-04-9,
REP.PRIMARY,2.5,TANESPIMYCIN,HSP90AA1,HSP INHIBITOR,BRD:BRD-K81473043-001-14-6,
REP.PRIMARY,2.5,TACRINE,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K81473089-003-26-1,
REP.PRIMARY,2.5,NILOTINIB,"ABL1, KIT","ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR",BRD:BRD-K81528515-001-13-8,
REP.PRIMARY,2.5,AC-264613,F2RL1,PAR AGONIST,BRD:BRD-K81548480-001-01-2,
REP.PRIMARY,2.5,CK-636,"ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5",ACTIN RELATED PROTEIN INHIBITOR,BRD:BRD-K81572616-001-01-9,
REP.PRIMARY,2.5,GASTRODIN,,,BRD:BRD-K81613478-001-01-8,
REP.PRIMARY,2.5,EIT-HYDROBROMIDE,"NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K81623406-004-08-3,
REP.PRIMARY,2.5,NKP-1339,,HSP INHIBITOR,BRD:BRD-K81645297-236-01-1,
REP.PRIMARY,2.5,CAPTAMINE,,,BRD:BRD-K81645907-001-01-1,
REP.PRIMARY,2.5,3-METHYLADENINE,PI3,PI3K INHIBITOR,BRD:BRD-K81647657-001-04-3,
REP.PRIMARY,2.5,DINOPROST,"PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R",PROSTACYCLIN ANALOG,BRD:BRD-K81672972-001-03-1,
REP.PRIMARY,2.5,VTP-27999,REN,RENIN INHIBITOR,BRD:BRD-K81694556-003-01-9,
REP.PRIMARY,2.5,WZ8040,EGFR,EGFR INHIBITOR,BRD:BRD-K81728688-001-04-4,
REP.PRIMARY,2.5,AQ-RA741,CHRM2,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K81729199-001-02-8,
REP.PRIMARY,2.5,EXHERIN,CDH2,CADHERIN ANTAGONIST,BRD:BRD-K81795818-019-01-4,
REP.PRIMARY,2.5,PP-121,"ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K81801188-001-02-8,
REP.PRIMARY,2.5,N6-METHYLADENOSINE,,,BRD:BRD-K81807412-001-10-6,
REP.PRIMARY,2.6,ESTRONE,"ESR1, ESR2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K81839095-001-25-1,
REP.PRIMARY,2.5,ESTRONE,"ESR1, ESR2","ESTROGEN RECEPTOR AGONIST, ESTROGENIC HORMONE",BRD:BRD-K81839095-001-30-1,
REP.PRIMARY,2.5,ROXATIDINE-ACETATE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K81855038-003-13-9,
REP.PRIMARY,2.5,CP-93129,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K81876028-300-02-0,
REP.PRIMARY,2.5,TRICLABENDAZOLE,DNMT1,MICROTUBULE INHIBITOR,BRD:BRD-K81916719-001-13-9,
REP.PRIMARY,2.5,SEMAGACESTAT,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K81957469-001-01-0,
REP.PRIMARY,2.5,DFB,GRM5,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K82002057-001-01-2,
REP.PRIMARY,2.5,2-HYDROXYFLUTAMIDE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K82027074-001-07-5,
REP.PRIMARY,2.5,CGH2466,"ADORA1, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K82028950-300-02-9,
REP.PRIMARY,2.5,SERTRALINE,"SLC6A3, SLC6A4",SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K82036761-003-20-3,
REP.PRIMARY,2.5,SB-239063,"MAPK11, MAPK14, PTGS2",P38 MAPK INHIBITOR,BRD:BRD-K82091397-001-03-0,
REP.PRIMARY,2.5,ETHYL-VANILLIN,,,BRD:BRD-K82104468-001-05-0,
REP.PRIMARY,2.5,AMFENAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82122102-323-01-1,
REP.PRIMARY,2.5,ELESCLOMOL,HSPA1A,OXIDATIVE STRESS INDUCER,BRD:BRD-K82135108-001-04-3,
REP.PRIMARY,2.5,BETAMIPRON,,PANIPENEM UPTAKE INHIBITOR,BRD:BRD-K82142815-001-19-1,
REP.PRIMARY,2.5,FLUCYTOSINE,DNMT1,OTHER ANTIFUNGAL,BRD:BRD-K82143716-001-19-9,
REP.PRIMARY,2.5,ANDARINE,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K82164249-001-03-5,
REP.PRIMARY,2.5,SODIUM-OXYBATE,"GABRB1, HCAR1, SLC52A2",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K82166906-236-02-8,
REP.PRIMARY,2.5,PYRITINOL,,,BRD:BRD-K82181219-001-04-3,
REP.PRIMARY,2.5,ISOSORBIDE-MONONITRATE,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",NITRIC OXIDE STIMULANT,BRD:BRD-K82225283-001-03-1,
REP.PRIMARY,2.5,TRAMIPROSATE,APP,BETA AMYLOID PROTEIN NEUROTOXICITY INHIBITOR,BRD:BRD-K82234479-001-09-4,
REP.PRIMARY,2.5,"N-METHYL-(-)EPHEDRINE-[1R,2S]",,,BRD:BRD-K82236108-001-04-9,
REP.PRIMARY,2.5,DICOUMAROL,"CRYZ, NQO1, VKORC1",NADPH INHIBITOR,BRD:BRD-K82236179-213-01-0,
REP.PRIMARY,2.5,BINIMETINIB,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K82244583-001-01-3,MEK162
REP.PRIMARY,2.5,MEK162,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K82244583-001-01-3,MEK162
REP.PRIMARY,2.5,PROPOFOL,"FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, SCN2A, SCN4A",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K82255054-001-15-9,
REP.PRIMARY,2.5,ADRENALONE,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K82343404-003-02-4,
REP.PRIMARY,2.5,DESLORATADINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K82357231-001-17-5,
REP.PRIMARY,2.5,ACETYLCHOLINE,"ACHE, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K82381502-003-23-1,
REP.PRIMARY,2.5,IPAG,,,BRD:BRD-K82421491-001-02-6,
REP.PRIMARY,2.5,SB-271046,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K82467063-001-02-7,
REP.PRIMARY,2.5,CARMOXIROLE,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K82484965-003-03-5,
REP.PRIMARY,2.5,N6022,ADH5,ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K82522873-001-01-1,
REP.PRIMARY,2.5,TOLMETIN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82562631-236-04-6,
REP.PRIMARY,2.5,ETHYLENEDIAMINETETRAACETIC-ACID,,PKC INHIBITOR,BRD:BRD-K82603084-408-01-1,
REP.PRIMARY,2.5,ALMITRINE,ATP1A1,NEUROTRANSMITTER AGONIST,BRD:BRD-K82677201-001-01-6,
REP.PRIMARY,2.5,OLOMOUCINE,"CDK1, CDK2, CDK5, MAPK1",CDK INHIBITOR,BRD:BRD-K82731415-001-07-0,
REP.PRIMARY,2.5,NAVITOCLAX,"BCL2, BCL2L1, BCL2L2",BCL INHIBITOR,BRD:BRD-K82746043-001-15-1,
REP.PRIMARY,2.5,DAZOXIBEN,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K82767007-001-01-1,
REP.PRIMARY,2.5,LORATADINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K82795137-001-26-2,
REP.PRIMARY,2.5,INOSITOL-HEXANICOTINATE,,,BRD:BRD-K82800842-001-01-9,
REP.PRIMARY,2.39,BATIMASTAT,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K82818427-001-02-2,
REP.PRIMARY,2.5,BATIMASTAT,"ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K82818427-001-04-8,
REP.PRIMARY,2.5,RO-15-4513,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB2, GABRG2",GABA BENZODIAZEPINE SITE RECEPTOR INVERSE AGONIST,BRD:BRD-K82823076-001-02-6,
REP.PRIMARY,2.5,PD-407824,WEE1,PKC INHIBITOR,BRD:BRD-K82823804-001-04-1,
REP.PRIMARY,2.5,REPAGLINIDE,"ABCC8, KCNJ11, PPARG",INSULIN SECRETAGOGUE,BRD:BRD-K82846253-001-15-4,
REP.PRIMARY,2.5,NAVARIXIN,"CXCR1, CXCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K82850175-001-01-1,
REP.PRIMARY,2.5,DACLATASVIR,,HCV INHIBITOR,BRD:BRD-K82861010-001-02-5,
REP.PRIMARY,2.5,"3,3'-DICHLOROBENZALDAZINE",GRM5,"GLUTAMATE RECEPTOR ALLOSTERIC LIGAND, GLUTAMATE RECEPTOR MODULATOR",BRD:BRD-K82903013-001-01-4,
REP.PRIMARY,2.5,ACY-1215,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K82928847-001-04-7,
REP.PRIMARY,2.46,DOXERCALCIFEROL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K82928892-001-02-5,
REP.PRIMARY,2.5,ROSUVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K82941592-238-04-5,
REP.PRIMARY,2.5,CEFTIOFUR,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K82960980-003-01-9,
REP.PRIMARY,2.36,CEFTIOFUR,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K82960980-003-02-7,
REP.PRIMARY,2.5,MIRODENAFIL,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K82967685-300-01-2,
REP.PRIMARY,2.5,GW-0742,PPARD,PPAR RECEPTOR AGONIST,BRD:BRD-K82983861-001-04-3,
REP.PRIMARY,2.35,ALOGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K83003151-057-02-4,
REP.PRIMARY,2.5,CI-844,,,BRD:BRD-K83022601-001-01-0,
REP.PRIMARY,2.5,GR-135531,,MELATONIN RECEPTOR AGONIST,BRD:BRD-K83023055-001-02-7,
REP.PRIMARY,2.5,SALICYLANILIDE,,OTHER ANTIBIOTIC,BRD:BRD-K83036479-001-09-2,
REP.PRIMARY,2.5,RS-102895,CCR2,CCR ANTAGONIST,BRD:BRD-K83063356-003-02-5,
REP.PRIMARY,2.5,ETOFYLLINE,ADORA1,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K83064458-001-23-0,
REP.PRIMARY,2.5,AZD1981,PTGDR2,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K83186168-001-01-8,
REP.PRIMARY,2.5,UNC1215,L3MBTL3,L3MBTL ANTAGONIST,BRD:BRD-K83189926-001-03-1,
REP.PRIMARY,2.5,DIMETHINDENE-(S)-(+),HRH1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K83192048-050-02-7,
REP.PRIMARY,2.5,PILSICAINIDE,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K83245588-001-01-4,
REP.PRIMARY,2.5,CHLOROPYRAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K83257731-003-23-5,
REP.PRIMARY,2.5,L-693403,"DRD2, SIGMAR1","SIGMA RECEPTOR AGONIST, SIGMA RECEPTOR ANTAGONIST",BRD:BRD-K83322645-050-01-9,
REP.PRIMARY,2.5,CHLOROXOQUINOLINE,,,BRD:BRD-K83335125-001-07-0,
REP.PRIMARY,2.5,BARBITAL,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2",SEDATIVE,BRD:BRD-K83359602-001-02-3,
REP.PRIMARY,2.5,PIMAVANSERIN,"DRD2, HTR2A",SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K83405785-001-01-5,
REP.PRIMARY,2.5,SINOMENINE,,ANGIOGENESIS INHIBITOR,BRD:BRD-K83459933-001-05-4,
REP.PRIMARY,2.5,FK-888,"TACR1, TACR2",TACHYKININ ANTAGONIST,BRD:BRD-K83508485-001-02-7,
REP.PRIMARY,2.5,LEVODROPROPIZINE,,ANTITUSSIVE,BRD:BRD-K83551379-001-01-8,
REP.PRIMARY,2.5,LEVODROPROPIZINE,,ANTITUSSIVE,BRD:BRD-K83551379-001-02-6,
REP.PRIMARY,2.5,PARGYLINE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K83597974-003-22-2,
REP.PRIMARY,2.5,SKEPINONE-L,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K83607951-001-02-2,
REP.PRIMARY,2.5,ENTACAPONE,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K83636919-001-04-8,
REP.PRIMARY,2.5,NMS-1286937,"FLT3, PLK1, PLK2, PLK3",PLK INHIBITOR,BRD:BRD-K83699324-001-01-1,
REP.PRIMARY,2.5,AVAGACESTAT,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K83720053-001-03-8,
REP.PRIMARY,2.5,METIROSINE,TH,TYROSINE HYDROXYLASE INHIBITOR,BRD:BRD-K83766205-001-03-8,
REP.PRIMARY,2.5,PALOVAROTENE,RARG,RETINOID RECEPTOR AGONIST,BRD:BRD-K83794243-001-01-8,
REP.PRIMARY,2.5,PTC-209,,BMI-1 INHIBITOR,BRD:BRD-K83834509-001-01-1,
REP.PRIMARY,2.5,JNJ-26481585,"HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2",HDAC INHIBITOR,BRD:BRD-K83837640-001-04-8,
REP.PRIMARY,2.5,GLUTAMINE-(L),"CTPS1, GLUL, GPRC6A, PPAT",,BRD:BRD-K83896451-001-06-7,L-GLUTAMINE
REP.PRIMARY,2.5,L-GLUTAMINE,"CTPS1, GLUL, GPRC6A, PPAT",,BRD:BRD-K83896451-001-06-7,L-GLUTAMINE
REP.PRIMARY,2.5,MLN-8054,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K83963101-001-06-9,MLN8054
REP.PRIMARY,2.5,MLN8054,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-K83963101-001-06-9,MLN8054
REP.PRIMARY,2.5,ALVESPIMYCIN,HSP90AA1,HSP INHIBITOR,BRD:BRD-K83988098-001-02-0,
REP.PRIMARY,2.5,ALVESPIMYCIN,HSP90AA1,HSP INHIBITOR,BRD:BRD-K83988098-003-03-4,
REP.PRIMARY,2.5,NIZOFENONE,,ION CHANNEL ANTAGONIST,BRD:BRD-K84011460-051-01-7,
REP.PRIMARY,2.5,2-CHLOROPYRAZINE,,,BRD:BRD-K84075000-001-05-5,
REP.PRIMARY,2.5,CANDESARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K84091759-001-07-1,
REP.PRIMARY,2.5,ERCALCITRIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K84163249-001-01-9,
REP.PRIMARY,2.5,7-CHLOROKYNURENIC-ACID,"GRIN1, GRIN2A, GRIN2B, GRIN2C",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K84214706-001-05-7,
REP.PRIMARY,2.5,BRL-50481,"PDE7A, PDE7B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K84266862-001-03-2,
REP.PRIMARY,2.5,NELARABINE,POLA1,"DNA SYNTHESIS INHIBITOR, T CELL INHIBITOR",BRD:BRD-K84466663-001-05-4,
REP.PRIMARY,2.5,SODIUM-TETRADECYL-SULFATE,"PROC, PROS1",,BRD:BRD-K84544951-236-01-0,
REP.PRIMARY,2.5,TELATINIB,KDR,"KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K84564571-001-02-4,
REP.PRIMARY,2.5,TREQUINSIN,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K84663978-003-02-9,
REP.PRIMARY,2.5,RADEZOLID,,"BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR, BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR",BRD:BRD-K84683831-001-01-0,
REP.PRIMARY,2.5,AGOMELATINE,"HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B","MELATONIN RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K84698278-001-03-4,
REP.PRIMARY,2.5,VICRIVIROC,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K84748119-050-01-1,
REP.PRIMARY,2.5,RIOCIGUAT,"GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3",GUANYLATE CYCLASE STIMULANT,BRD:BRD-K84783599-001-01-0,
REP.PRIMARY,2.5,DIDEOXYADENOSINE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K84794093-001-07-5,
REP.PRIMARY,2.5,SODIUM-TANSHINONE-II-A-SULFONATE,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K84798689-236-02-9,
REP.PRIMARY,2.5,ALMOREXANT,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K84810405-003-01-1,
REP.PRIMARY,2.5,IOWH032,CFTR,CFTR CHANNEL ANTAGONIST,BRD:BRD-K84892605-001-01-1,
REP.PRIMARY,2.5,BMY-45778,PTGIR,IP1 PROSTACYCLIN RECEPTOR AGONIST,BRD:BRD-K84895041-001-02-4,
REP.PRIMARY,2.5,T-5224,JUN,AP INHIBITOR,BRD:BRD-K84925803-001-01-9,
REP.PRIMARY,2.5,SIROLIMUS,"FGF2, FKBP1A, MTOR",MTOR INHIBITOR,BRD:BRD-K84937637-001-09-9,
REP.PRIMARY,2.5,DARUNAVIR,CYP3A4,HIV PROTEASE INHIBITOR,BRD:BRD-K84986517-001-01-8,
REP.PRIMARY,2.5,AZD3514,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K84996356-001-01-1,
REP.PRIMARY,2.5,AZD2461,,PARP INHIBITOR,BRD:BRD-K85014146-001-02-5,
REP.PRIMARY,2.5,NNC-05-2090,SLC6A12,"GABA UPTAKE INHIBITOR, GAT INHIBITOR",BRD:BRD-K85015012-003-02-9,
REP.PRIMARY,2.5,RAMOSETRON,HTR3A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K85046107-003-01-2,
REP.PRIMARY,2.5,GLY-GLN,,,BRD:BRD-K85066592-001-01-6,
REP.PRIMARY,2.5,PILOCARPINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K85090592-008-22-7,
REP.PRIMARY,2.5,TOLBUTAMIDE,"ABCC8, KCNJ1, KCNJ11, KCNJ8",ATP CHANNEL BLOCKER,BRD:BRD-K85119730-001-28-9,
REP.PRIMARY,2.5,APHIDICOLIN,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K85140930-001-12-7,
REP.PRIMARY,2.5,FOSCARNET,,DNA POLYMERASE INHIBITOR,BRD:BRD-K85146014-314-05-4,
REP.PRIMARY,2.5,FOSTAMATINIB,SYK,SYK INHIBITOR,BRD:BRD-K85178109-001-02-3,
REP.PRIMARY,2.5,NOVOBIOCIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K85307935-236-09-5,
REP.PRIMARY,2.5,NOVOBIOCIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K85307935-236-10-3,
REP.PRIMARY,2.5,RAMIFENAZONE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K85333151-003-13-4,
REP.PRIMARY,2.5,OTILONIUM,CACNA1C,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K85337334-004-02-6,
REP.PRIMARY,2.5,DOVITINIB,"CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB","EGFR INHIBITOR, FGFR INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K85402309-001-06-6,
REP.PRIMARY,2.5,DOVITINIB,"CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB","EGFR INHIBITOR, FGFR INHIBITOR, FLT3 INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K85402309-389-03-2,
REP.PRIMARY,2.5,SOBETIROME,"THRA, THRB",THYROID HORMONE RECEPTOR AGONIST,BRD:BRD-K85406984-001-01-0,
REP.PRIMARY,2.5,STF-62247,,AUTOPHAGY INDUCER,BRD:BRD-K85479953-001-11-3,
REP.PRIMARY,2.5,PEROSPIRONE,"DRD2, DRD3, DRD4","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K85503079-001-02-8,
REP.PRIMARY,2.5,IVERMECTIN,"CHRNA7, GABRB3, GLRA3, P2RX7",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K85554912-001-06-3,
REP.PRIMARY,2.5,IVERMECTIN,"CHRNA7, GABRB3, GLRA3, P2RX7",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K85554912-001-08-9,
REP.PRIMARY,2.5,NERATINIB,"EGFR, ERBB2, KDR",EGFR INHIBITOR,BRD:BRD-K85606544-001-09-1,
REP.PRIMARY,2.5,REFAMETINIB,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K85751432-001-03-3,
REP.PRIMARY,2.5,NIFURSOL,,BACTERIAL DNA INHIBITOR,BRD:BRD-K85757157-001-01-7,
REP.PRIMARY,2.5,AZD2858,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K85849709-001-01-5,
REP.PRIMARY,2.5,KYNURENIC-ACID,"GPR35, GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K85872723-001-15-9,
REP.PRIMARY,2.5,PREDNISONE,"HSD11B1, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K85883481-001-25-7,
REP.PRIMARY,2.5,WAY-600,MTOR,MTOR INHIBITOR,BRD:BRD-K85920262-001-02-1,
REP.PRIMARY,2.5,ZALCITABINE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K85925969-001-17-4,
REP.PRIMARY,2.5,FLUBENDAZOLE,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K86003836-001-10-5,
REP.PRIMARY,2.5,VU0357121,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K86109159-001-02-6,
REP.PRIMARY,2.5,LINSITINIB,"IGF1R, INSR, INSRR",IGF-1 INHIBITOR,BRD:BRD-K86118762-001-01-8,
REP.PRIMARY,2.52,CORTISONE-ACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K86161929-001-11-7,
REP.PRIMARY,2.5,CORTISONE-ACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K86161929-001-13-3,
REP.PRIMARY,2.5,TERCONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K86204871-001-16-2,
REP.PRIMARY,2.5,SCHISANDRIN-B,ATR,ANTIOXIDANT,BRD:BRD-K86294588-001-01-9,
REP.PRIMARY,2.5,DIPYRIDAMOLE,"ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K86301799-001-34-8,
REP.PRIMARY,2.5,ALLOPURINOL,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K86307448-001-17-5,
REP.PRIMARY,2.5,ALLOPURINOL,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K86307448-001-19-1,
REP.PRIMARY,2.5,LINSIDOMINE,,NITRIC OXIDE DONOR,BRD:BRD-K86344238-003-04-6,
REP.PRIMARY,2.5,PERCHLOZONE,,,BRD:BRD-K86435560-001-01-0,
REP.PRIMARY,2.5,LANDIOLOL,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K86436199-003-01-3,
REP.PRIMARY,2.5,AZD7762,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K86525559-001-04-5,
REP.PRIMARY,2.52,AZD7762,"CHEK1, CHEK2",CHK INHIBITOR,BRD:BRD-K86525559-001-07-8,
REP.PRIMARY,2.5,RS-79948,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K86600316-003-02-0,
REP.PRIMARY,2.5,R306465,,HDAC INHIBITOR,BRD:BRD-K86687746-001-01-3,
REP.PRIMARY,2.5,EMBELIN,XIAP,"HCV INHIBITOR, XIAP INHIBITOR",BRD:BRD-K86727142-001-12-4,
REP.PRIMARY,2.5,SB-939,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9",HDAC INHIBITOR,BRD:BRD-K86797399-001-04-4,
REP.PRIMARY,2.5500000000000003,SB-939,"HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC9",HDAC INHIBITOR,BRD:BRD-K86797399-001-05-1,
REP.PRIMARY,2.5,5-HMF,,,BRD:BRD-K86799112-001-02-0,
REP.PRIMARY,2.5,PF-04457845,FAAH,FAAH INHIBITOR,BRD:BRD-K86816506-001-01-8,
REP.PRIMARY,2.5,CABERGOLINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K86882815-001-03-2,
REP.PRIMARY,2.59,DOFETILIDE,"KCNH1, KCNH2, KCNJ12, KCNK2",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K86887724-001-10-6,
REP.PRIMARY,2.5,EDOXUDINE,,DNA DIRECTED DNA POLYMERASE INHIBITOR,BRD:BRD-K86892782-001-17-0,
REP.PRIMARY,2.5,CEDIRANIB,"CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB","KIT INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K86930074-001-05-0,
REP.PRIMARY,2.5,OLTIPRAZ,ANG,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K86972824-001-01-4,
REP.PRIMARY,2.5,OLTIPRAZ,ANG,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K86972824-001-02-2,
REP.PRIMARY,2.5,PHENELZINE,"ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K87024524-065-17-7,
REP.PRIMARY,2.5,ASUNAPREVIR,,HCV INHIBITOR,BRD:BRD-K87028197-001-01-3,
REP.PRIMARY,2.5,AZODICARBONAMIDE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K87036601-001-01-6,
REP.PRIMARY,2.5,RS-102221,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K87048468-003-02-7,
REP.PRIMARY,2.5,PP242,"MTOR, PASK",MTOR INHIBITOR,BRD:BRD-K87112191-001-04-5,
REP.PRIMARY,2.5,OSI-027,MTOR,MTOR INHIBITOR,BRD:BRD-K87124298-001-03-4,
REP.PRIMARY,2.5,CARBIMAZOLE,TPO,ANTITHYROID AGENT,BRD:BRD-K87156652-001-12-7,
REP.PRIMARY,2.5,BENZAMIL,"ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1",SODIUM CHANNEL BLOCKER,BRD:BRD-K87158025-001-01-6,
REP.PRIMARY,2.5,ISONIAZID,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-001-32-6,PASINIAZID
REP.PRIMARY,2.5,PASINIAZID,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-001-32-6,PASINIAZID
REP.PRIMARY,2.5,ISONIAZID,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-061-04-9,PASINIAZID
REP.PRIMARY,2.5,PASINIAZID,"CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4","CYCLOOXYGENASE INHIBITOR, FABI INHIBITOR",BRD:BRD-K87202646-061-04-9,PASINIAZID
REP.PRIMARY,2.5,ARMODAFINIL,SLC6A3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K87278688-001-01-0,
REP.PRIMARY,2.5,BETA-CCB,"GABRA1, GABRG2",BENZODIAZEPINE RECEPTOR LIGAND,BRD:BRD-K87349602-001-03-8,
REP.PRIMARY,2.36,NOREPINEPHRINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, PAH, SLC18A1, SLC18A2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K87349682-347-03-8,
REP.PRIMARY,2.5,SULFAMETER,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K87492696-001-16-5,
REP.PRIMARY,2.5,RS-504393,"CCL2, CCR2",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K87510569-001-02-8,
REP.PRIMARY,2.5,TALTOBULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K87512222-019-01-7,
REP.PRIMARY,2.53,"5-AMINO-3-D-RIBOFURANOSYLTHIAZOLO[4,5-D]PYRIMIDIN-2,7(3H,6H)-DIONE",TLR7,,BRD:BRD-K87535339-001-01-6,
REP.PRIMARY,2.5,LY456236,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K87696786-003-04-4,
REP.PRIMARY,2.5,CETYLPYRIDINIUM,,,BRD:BRD-K87700323-003-05-1,
REP.PRIMARY,2.5,CYT387,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K87737963-001-06-0,
REP.PRIMARY,2.5,ISTRADEFYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K87774949-001-03-9,
REP.PRIMARY,2.5,AVL-292,"BTK, YES1",BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K87782578-001-01-4,
REP.PRIMARY,2.5,MELPHALAN,,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K87827419-001-16-8,
REP.PRIMARY,2.5,ALVOCIDIB,"CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM",CDK INHIBITOR,BRD:BRD-K87909389-003-03-4,
REP.PRIMARY,2.5,CDK1-5-INHIBITOR,"CDK1, CDK5, GSK3B","CDK INHIBITOR, GLYCOGEN SYNTHASE KINASE INHIBITOR",BRD:BRD-K87932577-001-02-4,
REP.PRIMARY,2.5,PIRETANIDE,"SLC12A1, SLC12A2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K87990216-001-10-2,
REP.PRIMARY,2.5,FINGOLIMOD,"S1PR1, S1PR5","IMMUNOSUPPRESSANT, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K88025533-003-03-3,
REP.PRIMARY,2.5,UREA,"ARG1, CA2, CTNNB1",HYDROXY RADICAL FORMATION STIMULANT,BRD:BRD-K88052444-001-08-8,
REP.PRIMARY,2.5,MIZORIBINE,IMPDH1,"IMMUNOSUPPRESSANT, INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR",BRD:BRD-K88061624-001-21-4,
REP.PRIMARY,2.5,PIMETHIXENE,,ANTIHISTAMINE,BRD:BRD-K88090157-050-10-8,
REP.PRIMARY,2.42,NALTREXONE,"OPRD1, OPRK1, OPRM1, SIGMAR1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K88172511-003-20-3,
REP.PRIMARY,2.5,NALTREXONE,"OPRD1, OPRK1, OPRM1, SIGMAR1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K88172511-003-21-1,
REP.PRIMARY,2.5,GW-4064,NR1H4,FXR AGONIST,BRD:BRD-K88186167-001-04-8,
REP.PRIMARY,2.5,ASARALDEHYDE,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K88219015-001-10-8,
REP.PRIMARY,2.5,ETHENZAMIDE,,ANALGESIC AGENT,BRD:BRD-K88308881-001-06-8,
REP.PRIMARY,2.5,XALIPRODEN,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K88358234-003-04-8,
REP.PRIMARY,2.5,TRIMETAZIDINE,ACAA2,3-KETOACYL COA THIOLASE INHIBITOR,BRD:BRD-K88366685-300-06-0,
REP.PRIMARY,2.5,THONZYLAMINE,,ANTIHISTAMINE,BRD:BRD-K88405679-003-03-1,
REP.PRIMARY,2.5,PYRIMETHAMINE,"DHFR, SLC47A1",DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K88429204-001-35-1,
REP.PRIMARY,2.5,KD025,ROCK2,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K88506063-001-01-8,
REP.PRIMARY,2.5,BORTEZOMIB,"PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA","NFKB PATHWAY INHIBITOR, PROTEASOME INHIBITOR",BRD:BRD-K88510285-001-11-1,
REP.PRIMARY,2.5,CI-976,"ACAT1, CES1",ACAT INHIBITOR,BRD:BRD-K88544581-001-06-1,
REP.PRIMARY,2.5,BENURESTAT,,UREASE INHIBITOR,BRD:BRD-K88553858-001-02-7,
REP.PRIMARY,2.5,RUCAPARIB,"PARP1, PARP2",PARP INHIBITOR,BRD:BRD-K88560311-011-06-3,
REP.PRIMARY,2.5,IPRONIAZID,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K88568253-011-19-9,
REP.PRIMARY,2.5,ANIRACETAM,"DRD2, GRIA1, GRIA2, GRIA3, GRIA4, HTR2A",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K88611939-001-22-4,
REP.PRIMARY,2.5,NONOXYNOL-9,,MEMBRANE INTEGRITY INHIBITOR,BRD:BRD-K88625236-001-04-2,
REP.PRIMARY,2.5,ARECOLINE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K88646909-004-16-2,
REP.PRIMARY,2.5,PD-198306,"MAP2K1, MAP2K2","MAP KINASE INHIBITOR, MEK INHIBITOR",BRD:BRD-K88677950-001-03-9,
REP.PRIMARY,2.5,CHLOROTHIAZIDE,"CA1, CA2, CA4, SLC12A3",DIURETIC,BRD:BRD-K88682005-001-15-8,
REP.PRIMARY,2.5,DIMERCAPTOSUCCINIC-ACID,DNMT1,CHELATING AGENT,BRD:BRD-K88701661-001-02-9,
REP.PRIMARY,2.5,PCI-34051,"HDAC1, HDAC10, HDAC6, HDAC8",HDAC INHIBITOR,BRD:BRD-K88742110-001-07-9,
REP.PRIMARY,2.5,EMD-66684,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K88759641-003-02-8,
REP.PRIMARY,2.5,LETROZOLE,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K88789588-001-14-9,
REP.PRIMARY,2.5,ELACRIDAR,ABCB1,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K88807631-001-01-3,
REP.PRIMARY,2.5,"1-((Z)-3-CHLOROALLYL)-1,3,5,7-TETRAAZAADAMANTAN-1-IUM",,,BRD:BRD-K88956297-003-01-9,
REP.PRIMARY,2.5,AS-703026,"MAP2K1, MAP2K2",MEK INHIBITOR,BRD:BRD-K89014967-001-04-3,
REP.PRIMARY,2.5,GSK923295,CENPE,CENTROMERE ASSOCIATED PROTEIN INHIBITOR,BRD:BRD-K89015388-001-01-7,
REP.PRIMARY,2.5,PUERARIN,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K89048337-001-06-9,
REP.PRIMARY,2.5,VLX600,"TP53, USP14","ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",BRD:BRD-K89053832-001-01-0,
REP.PRIMARY,2.5,ALVERINE,HTR1A,MUSCLE RELAXANT,BRD:BRD-K89055274-048-22-7,
REP.PRIMARY,2.5,CHLOROCRESOL,,RYANODINE RECEPTOR ACTIVATOR,BRD:BRD-K89056082-001-07-7,
REP.PRIMARY,0.25,CTS21166,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K89071957-001-01-1,
REP.PRIMARY,2.5,2-TEDC,ALOX12,LIPOXYGENASE INHIBITOR,BRD:BRD-K89072800-001-01-8,
REP.PRIMARY,2.5,GABOXADOL,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRD, GABRR1, GABRR2, GABRR3",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89104321-003-14-8,
REP.PRIMARY,2.5,TINIDAZOLE,,ANTIPROTOZOAL AGENT,BRD:BRD-K89125793-001-26-0,
REP.PRIMARY,2.5,LIOTHYRONINE,"THRA, THRB",THYROID HORMONE STIMULANT,BRD:BRD-K89152108-236-07-6,
REP.PRIMARY,2.5,TANDUTINIB,"CSF1R, FLT3, KIT, PDGFD, PDGFRB","FLT3 INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K89162000-001-06-4,
REP.PRIMARY,2.5,INDACATEROL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K89208535-051-01-5,
REP.PRIMARY,2.5,BIOTIN,"ACACA, ACACB, HLCS, MCCC1, MCCC2, PC, PCCA, PCCB, SLC5A6",VITAMIN B,BRD:BRD-K89210380-001-13-7,
REP.PRIMARY,2.5,NPPB,"ANO1, CLCN2, CLCN7, TRPA1",CHLORIDE CHANNEL BLOCKER,BRD:BRD-K89272762-001-12-7,
REP.PRIMARY,2.5,DMP-543,,ACETYLCHOLINE RELEASE ENHANCER,BRD:BRD-K89274813-001-02-3,
REP.PRIMARY,2.5,DCEBIO,"KCNN2, KCNN3, KCNN4",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K89299012-001-06-0,
REP.PRIMARY,2.5,ML130,,NOD1 INHIBITOR,BRD:BRD-K89306950-001-12-5,
REP.PRIMARY,2.5,RAMIPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K89348303-001-14-7,
REP.PRIMARY,2.5,PIRENZEPINE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K89375097-300-08-8,
REP.PRIMARY,2.5,RG108,"DNMT1, DNMT3B",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K89391146-001-08-0,
REP.PRIMARY,2.5,L-655240,PTGES,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K89402695-001-02-3,
REP.PRIMARY,2.5,SN-38,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K89561498-001-01-7,
REP.PRIMARY,2.5,TAGATOSE,PYGL,PHOSPHORYLASE INHIBITOR,BRD:BRD-K89588135-001-01-9,
REP.PRIMARY,2.5,ALLYLTHIOUREA,,NITRIFICATION INHIBITOR,BRD:BRD-K89634775-001-09-9,
REP.PRIMARY,2.5,TESTOSTERONE-ENANTHATE,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K89657519-001-01-8,
REP.PRIMARY,2.5,1-DEOXYMANNOJIRIMYCIN,MAN2A1,ALPHA MANNOSIDASE INHIBITOR,BRD:BRD-K89665618-003-02-5,
REP.PRIMARY,2.5,VINCAMINE,"CHRM1, CHRM2, CHRM3, CHRM4",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K89704198-001-12-3,
REP.PRIMARY,2.57,2-OXOGLUTARIC-ACID,OXGR1,,BRD:BRD-K89712525-001-02-1,
REP.PRIMARY,2.5,TEPOXALIN,ALOX5,"CYCLOOXYGENASE INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-K89714990-001-01-5,
REP.PRIMARY,2.5,TRIFLUOPERAZINE,"ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K89732114-300-14-7,
REP.PRIMARY,2.5,RALTITREXED,"FPGS, TYMS",THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K89839824-001-05-3,
REP.PRIMARY,2.5,RETIGABINE,"KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K89917372-001-01-2,
REP.PRIMARY,2.5,CHLORPROMAZINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K89997465-003-43-0,
REP.PRIMARY,2.5,AMPROLIUM,,THIAMINE UPTAKE BLOCKER,BRD:BRD-K90027121-003-01-7,
REP.PRIMARY,2.44,SPIRONOLACTONE,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K90027355-001-13-3,
REP.PRIMARY,2.5,SPIRONOLACTONE,"AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG",MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K90027355-001-19-0,
REP.PRIMARY,2.5,5-IODO-A-85380,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K90065682-300-02-6,
REP.PRIMARY,2.5,THIOPHANATE,,,BRD:BRD-K90168339-001-08-6,
REP.PRIMARY,2.5,BAZEDOXIFENE,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K90195324-003-02-5,
REP.PRIMARY,2.5,AMG-487,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K90239174-001-01-8,
REP.PRIMARY,2.5,PHENTOLAMINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K90333595-003-21-4,
REP.PRIMARY,2.5,CHLORQUINALDOL,,OTHER ANTIBIOTIC,BRD:BRD-K90374350-001-09-2,
REP.PRIMARY,2.5,GW-843682X,"PLK1, PLK3",PLK INHIBITOR,BRD:BRD-K90382497-001-10-7,
REP.PRIMARY,2.5,AR-12,PDPK1,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K90497590-001-04-2,
REP.PRIMARY,2.5,MY-5445,PDE5A,"PHOSPHODIESTERASE INHIBITOR, PLATELET AGGREGATION INHIBITOR",BRD:BRD-K90524085-001-07-8,
REP.PRIMARY,2.5,IPSAPIRONE,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K90574421-001-03-5,
REP.PRIMARY,2.5,BUTENAFINE,SQLE,FUNGAL SQUALENE EPOXIDASE INHIBITOR,BRD:BRD-K90630139-003-05-9,
REP.PRIMARY,2.5,OLEANOLIC-ACID,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K90647725-001-06-5,
REP.PRIMARY,2.5,OLEANOLIC-ACID,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K90647725-001-07-3,
REP.PRIMARY,2.5,CUTAMESINE,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K90777969-300-01-2,
REP.PRIMARY,2.5,NEFAZODONE,"ADRA1A, ADRA1B, ADRA2A, CYP3A4, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A3, SLC6A4","ADRENERGIC INHIBITOR, NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K90789829-001-07-8,
REP.PRIMARY,2.5,BEDAQUILINE,,ATPASE INHIBITOR,BRD:BRD-K90817094-001-02-6,
REP.PRIMARY,2.5,RS-127445,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K90825648-001-02-0,
REP.PRIMARY,2.5,CANAGLIFLOZIN,"SLC5A1, SLC5A2",SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K90868879-001-03-8,
REP.PRIMARY,2.5,PROPANTHELINE,"CHRM1, CHRM2, CHRM3, CHRM4",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K90885812-004-24-2,
REP.PRIMARY,2.5,CARBOPLATIN,,"DNA ALKYLATING AGENT, DNA INHIBITOR",BRD:BRD-K90947825-001-02-7,
REP.PRIMARY,2.5,INDIPLON,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K90948141-001-01-4,
REP.PRIMARY,2.5,KRN-633,"FLT1, FLT4, KDR",VEGFR INHIBITOR,BRD:BRD-K90993449-001-02-7,
REP.PRIMARY,2.5,VANCOMYCIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K91065602-003-05-5,
REP.PRIMARY,2.5,ROTIGOTINE,"ADRA2B, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K91111634-001-01-2,
REP.PRIMARY,2.5,M-THP,,,BRD:BRD-K91147684-001-01-5,
REP.PRIMARY,2.5,TELCAGEPANT,"CALCRL, RAMP1",CALCITONIN ANTAGONIST,BRD:BRD-K91159026-001-01-7,
REP.PRIMARY,2.5,ALOXISTATIN,CTSG,PROTEASE INHIBITOR,BRD:BRD-K91188791-001-18-3,
REP.PRIMARY,2.5,NORTRIPTYLINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, HTR6, KCNJ10, PGRMC1, SIGMAR1, SLC6A2, SLC6A4",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K91263825-003-21-4,
REP.PRIMARY,2.5,AMODIAQUINE,HNMT,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K91290917-300-01-8,
REP.PRIMARY,2.5,NOSCAPINE,SIGMAR1,"BRADYKININ RECEPTOR ANTAGONIST, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K91301684-003-05-5,
REP.PRIMARY,2.5,APALUTAMIDE,,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K91308639-001-02-7,
REP.PRIMARY,2.5,BETAHISTINE,"HRH1, HRH3","HISTAMINE RECEPTOR AGONIST, HISTAMINE RECEPTOR ANTAGONIST",BRD:BRD-K91315211-300-05-7,
REP.PRIMARY,2.5,MESULERGINE,"HTR2A, HTR2B, HTR2C, HTR3A, HTR3B, HTR6, HTR7",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K91336023-003-01-0,
REP.PRIMARY,2.5,ANISOMYCIN,"NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1",DNA SYNTHESIS INHIBITOR,BRD:BRD-K91370081-001-25-1,
REP.PRIMARY,2.5,TROMARIL,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K91422571-001-01-8,
REP.PRIMARY,2.5,SACUBITRIL,MME,NEPRILYSIN INHIBITOR,BRD:BRD-K91456750-238-01-7,
REP.PRIMARY,2.5,AGP-103,,MEMBRANE PERMEABILITY INHIBITOR,BRD:BRD-K91495480-001-02-2,
REP.PRIMARY,2.5,PICEATANNOL,"ATP5A1, ATP5B, ATP5C1, IRF3",SYK INHIBITOR,BRD:BRD-K91509126-001-23-6,
REP.PRIMARY,2.5,NIKETHAMIDE,,IMMUNOSTIMULANT,BRD:BRD-K91544578-001-03-8,
REP.PRIMARY,2.5,MERCAPTOPURINE,"HPRT1, IMPDH1, IMPDH2, PPAT","IMMUNOSUPPRESSANT, PROTEIN SYNTHESIS INHIBITOR, PURINE ANTAGONIST",BRD:BRD-K91601245-001-12-0,
REP.PRIMARY,2.5,TRANS-4-HYDROXYCROTONIC-ACID,,GAMMA HYDROXYBUTYRIC ACID LIGAND,BRD:BRD-K91614056-001-02-2,
REP.PRIMARY,2.46,ABT-751,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K91623615-001-05-0,
REP.PRIMARY,2.5,BENZONATATE,SCN5A,LOCAL ANESTHETIC,BRD:BRD-K91699951-001-10-2,
REP.PRIMARY,2.38,U-0126,"AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1",MEK INHIBITOR,BRD:BRD-K91701654-001-03-1,
REP.PRIMARY,2.5,FELBINAC,CTSL,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K91740057-001-19-8,
REP.PRIMARY,2.5,4-HQN,PARP1,PARP INHIBITOR,BRD:BRD-K91758890-001-10-0,
REP.PRIMARY,2.5,TORCITABINE,"DCK, TK2",DNA POLYMERASE INHIBITOR,BRD:BRD-K91822704-003-07-2,
REP.PRIMARY,2.5,ZK-811752,CCR1,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K91825936-001-01-2,ZK811752
REP.PRIMARY,2.5,ZK811752,CCR1,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K91825936-001-01-2,ZK811752
REP.PRIMARY,2.5,2-[1-(4-PIPERONYL)PIPERAZINYL]BENZOTHIAZOLE,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K91868854-001-03-6,
REP.PRIMARY,2.5,SD-169,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K91904471-001-02-4,
REP.PRIMARY,2.5,AM-251,"CNR1, GPR18, GPR55",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K92000912-001-12-6,
REP.PRIMARY,2.5,GBR-12783,,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K92015269-300-01-2,
REP.PRIMARY,2.5,O6-BENZYLGUANINE,MGMT,O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INHIBITOR,BRD:BRD-K92041145-001-09-5,
REP.PRIMARY,2.5,TRIAMTERENE,"SCNN1A, SCNN1B, SCNN1D, SCNN1G",SODIUM CHANNEL BLOCKER,BRD:BRD-K92049597-001-20-8,
REP.PRIMARY,2.5,NORETHINDRONE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92073408-001-16-5,
REP.PRIMARY,2.5,DOXORUBICIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K92093830-003-30-8,
REP.PRIMARY,2.5,PIMECROLIMUS,"FKBP1A, MTOR",CALCINEURIN INHIBITOR,BRD:BRD-K92107055-001-01-9,
REP.PRIMARY,2.5,ISOXEPAC,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K92116564-001-01-4,
REP.PRIMARY,2.5,EXATECAN-MESYLATE,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K92150287-066-01-2,
REP.PRIMARY,2.5,LOMITAPIDE,MTTP,MICROSOMAL TRIGYLCERIDE TRANSFER PROTEIN INHIBITOR,BRD:BRD-K92213669-001-01-3,
REP.PRIMARY,2.5,TOSEDOSTAT,"ANPEP, LAP3, NPEPPS",PEPTIDASE INHIBITOR,BRD:BRD-K92241597-001-06-0,
REP.PRIMARY,0.25,"16,16-DIMETHYLPROSTAGLANDIN-E2",HPGD,PROSTANOID RECEPTOR AGONIST,BRD:BRD-K92301463-001-05-5,
REP.PRIMARY,2.5,OGLEMILAST,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K92303087-001-01-6,
REP.PRIMARY,2.5,5-CARBOXAMIDOTRYPTAMINE,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K92382976-050-01-1,
REP.PRIMARY,2.5,L-QUISQUALIC-ACID,"FOLH1, GRIA2, GRIK1, GRIK2, GRM1, GRM2, GRM3, GRM5, GRM7, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K92404805-001-07-0,
REP.PRIMARY,2.5,MYCOPHENOLATE-MOFETIL,"IMPDH1, IMPDH2","DEHYDROGENASE INHIBITOR, INOSITOL MONOPHOSPHATASE INHIBITOR",BRD:BRD-K92428153-001-04-4,
REP.PRIMARY,2.5,GSK461364,PLK1,PLK INHIBITOR,BRD:BRD-K92428232-001-10-6,
REP.PRIMARY,2.5,BEXAROTENE,"RXRA, RXRB, RXRG",RETINOID RECEPTOR AGONIST,BRD:BRD-K92441787-001-04-1,
REP.PRIMARY,2.5,ZATEBRADINE,"HCN1, HCN2, HCN3, HCN4",HCN CHANNEL BLOCKER,BRD:BRD-K92446736-003-02-2,
REP.PRIMARY,2.5,OXANDROLONE,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K92467929-001-01-1,
REP.PRIMARY,2.5,LY255283,"LTB4R, LTB4R2",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K92492521-001-02-9,
REP.PRIMARY,2.5,AMPA-(S),"GRIA2, GRIN1",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K92493880-001-03-0,
REP.PRIMARY,2.5,GBR-13069,SLC6A3,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR",BRD:BRD-K92577649-300-01-2,
REP.PRIMARY,2.5,2-CMDO,"DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K92588747-051-02-7,
REP.PRIMARY,2.5,SAFINAMIDE,MAOB,"DOPAMINE REUPTAKE INHIBITOR, DOPAMINE UPTAKE INHIBITOR, GLUTAMATE INHIBITOR, MONOAMINE OXIDASE INHIBITOR",BRD:BRD-K92613113-066-02-7,
REP.PRIMARY,2.5,ZALEPLON,"GABRA1, GABRB1, GABRG2, TSPO",BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K92657060-001-05-7,
REP.PRIMARY,2.5,IMATINIB,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-06-7,
REP.PRIMARY,2.5,PERINDOPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K92731339-227-04-9,
REP.PRIMARY,1.44,MD-920,AADACL2,NFKB PATHWAY INHIBITOR,BRD:BRD-K92758126-001-18-8,
REP.PRIMARY,2.43,RIBOFLAVIN,"BLVRB, RFK","VITAMIN B, VITAMIN B2",BRD:BRD-K92760278-001-07-3,
REP.PRIMARY,2.5,MEFENAMIC-ACID,"KCNQ1, PTGS1, PTGS2, TRPM3",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K92778217-001-32-7,
REP.PRIMARY,2.5,PROPRANOLOL-(R),"ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K92830582-003-10-5,
REP.PRIMARY,2.5,RIFAXIMIN,NR1I2,RNA SYNTHESIS INHIBITOR,BRD:BRD-K92838188-001-01-9,
REP.PRIMARY,2.5,TRIACETIN,,,BRD:BRD-K92844263-001-09-8,
REP.PRIMARY,2.5,DIMINAZENE-ACETURATE,"AOC1, PRDX5, PRSS1",ANGIOTENSIN CONVERTING ENZYME ACTIVATOR,BRD:BRD-K92848252-001-01-9,
REP.PRIMARY,2.5,CEFPIRAMIDE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K92872987-001-02-9,
REP.PRIMARY,2.5,TIRAPAZAMINE,,DNA INHIBITOR,BRD:BRD-K92968657-001-01-6,
REP.PRIMARY,2.5,GUANOSINE,PNP,,BRD:BRD-K92976206-001-01-5,
REP.PRIMARY,2.5,3-BROMOPYRUVATE,HK2,HEXOKINASE INHIBITOR,BRD:BRD-K92980438-001-03-3,
REP.PRIMARY,2.5,MELPERONE,"DRD2, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K92984783-003-05-7,
REP.PRIMARY,2.5,PERFLUBRON,,CONTRAST AGENT,BRD:BRD-K92988025-001-01-9,
REP.PRIMARY,2.5,PAC-1,CASP3,CASPASE ACTIVATOR,BRD:BRD-K92991072-001-04-9,
REP.PRIMARY,2.5,CLADRIBINE,"ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B","ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K93034159-001-25-8,
REP.PRIMARY,2.5,BUTYLATED-HYDROXYANISOLE,,ANTIOXIDANT,BRD:BRD-K93035859-001-07-6,
REP.PRIMARY,2.5,TOZADENANT,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K93045741-001-01-0,
REP.PRIMARY,2.5,RAF265,BRAF,"RAF INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K93123848-001-04-1,
REP.PRIMARY,2.5,AC-55649,"RARA, RARB",RETINOID RECEPTOR AGONIST,BRD:BRD-K93176058-001-03-6,
REP.PRIMARY,2.5,ARC-239,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K93188295-300-02-2,
REP.PRIMARY,2.5,APREMILAST,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K93208532-001-02-5,
REP.PRIMARY,2.5,ETHAMBUTOL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K93231391-300-05-6,
REP.PRIMARY,2.5,DINITOLMIDE,,,BRD:BRD-K93240442-001-08-4,
REP.PRIMARY,2.5,INDOXIMOD,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K93255255-001-02-1,
REP.PRIMARY,2.5,GW-9662,"NCOA2, PPARG, RXRA",PPAR RECEPTOR ANTAGONIST,BRD:BRD-K93258693-001-17-3,
REP.PRIMARY,2.5,DIPHEMANIL,CHRM3,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K93441486-067-12-8,
REP.PRIMARY,2.5,LAMOTRIGINE,"SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A","SEROTONIN RECEPTOR ANTAGONIST, SODIUM CHANNEL BLOCKER",BRD:BRD-K93460210-001-23-7,
REP.PRIMARY,2.5,BUSPIRONE,"DRD2, HTR1A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K93461745-003-25-0,
REP.PRIMARY,2.5,DUVELISIB,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K93468883-001-02-0,IPI-145
REP.PRIMARY,2.5,IPI-145,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K93468883-001-02-0,IPI-145
REP.PRIMARY,2.5,AMYLENE-HYDRATE,,LOCAL ANESTHETIC,BRD:BRD-K93502141-001-01-6,
REP.PRIMARY,2.5,SULFAMERAZINE,,BACTERIAL ANTIFOLATE,BRD:BRD-K93524252-001-24-7,
REP.PRIMARY,2.5,HYDROCORTISONE,"ANXA1, NOS2, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K93568044-001-32-0,
REP.PRIMARY,2.5,DIACETAMATE,,,BRD:BRD-K93611241-001-02-2,
REP.PRIMARY,2.5,IPRIFLAVONE,,BONE RESORPTION INHIBITOR,BRD:BRD-K93618743-001-21-0,
REP.PRIMARY,2.5,HORDENINE,,,BRD:BRD-K93631643-001-02-4,
REP.PRIMARY,2.5,SALICYLIC-ACID,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-17-2,SODIUM-SALICYLATE
REP.PRIMARY,2.5,SODIUM-SALICYLATE,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-17-2,SODIUM-SALICYLATE
REP.PRIMARY,2.5,SALICYLIC-ACID,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-18-0,SODIUM-SALICYLATE
REP.PRIMARY,2.5,SODIUM-SALICYLATE,"AKR1C1, ASIC3, PTGS1, PTGS2","CYCLOOXYGENASE INHIBITOR, PROSTANOID RECEPTOR ANTAGONIST",BRD:BRD-K93632104-001-18-0,SODIUM-SALICYLATE
REP.PRIMARY,2.5,TADALAFIL,"PDE11A, PDE5A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K93645900-001-11-3,
REP.PRIMARY,2.5,TAMOXIFEN,"EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ","ESTROGEN RECEPTOR ANTAGONIST, SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)",BRD:BRD-K93754473-048-20-2,
REP.PRIMARY,2.5,OSELTAMIVIR-CARBOXYLATE,,NEURAMINIDASE INHIBITOR,BRD:BRD-K93767137-001-01-1,
REP.PRIMARY,2.5,INGENOL-MEBUTATE,"PRKCA, PRKCB, PRKCD, PRKCE, PRKCG",PKC ACTIVATOR,BRD:BRD-K93779381-001-01-9,
REP.PRIMARY,2.5,N-MPPP,,OPIOID RECEPTOR AGONIST,BRD:BRD-K93806173-003-01-8,
REP.PRIMARY,2.5,TALTIRELIN,TRHR,THYROTROPIN RELEASING HORMONE RECEPTOR AGONIST,BRD:BRD-K93869735-001-01-1,
REP.PRIMARY,2.5,STAVUDINE,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR",BRD:BRD-K93880783-001-26-6,
REP.PRIMARY,2.5,QUIZARTINIB,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET",FLT3 INHIBITOR,BRD:BRD-K93918653-001-08-9,
REP.PRIMARY,0.25,SAFINGOL,TRPM3,PKC INHIBITOR,BRD:BRD-K93944989-001-08-0,
REP.PRIMARY,2.5,DIETHYLTOLUAMIDE,,IONOTROPIC RECEPTOR IR40A ACTIVATOR,BRD:BRD-K94080537-001-09-7,
REP.PRIMARY,2.5,COTININE,,NICOTINE METABOLITE,BRD:BRD-K94144010-001-13-9,
REP.PRIMARY,2.5,TWS-119,"GSK3B, JUN, MYC",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K94176593-001-09-4,
REP.PRIMARY,2.5,PAEONOL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K94239562-001-05-5,
REP.PRIMARY,2.5,RONIDAZOLE,,ANTIPROTOZOAL AGENT,BRD:BRD-K94266545-001-24-1,
REP.PRIMARY,2.5,LETERMOVIR,,CMV TERMINASE INHIBITOR,BRD:BRD-K94288301-001-01-7,
REP.PRIMARY,2.5,SUVOREXANT,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K94293891-001-01-3,
REP.PRIMARY,2.5,FLUOCINOLONE-ACETONIDE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K94353609-001-21-6,
REP.PRIMARY,2.5,DAPTOMYCIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K94358652-001-02-1,
REP.PRIMARY,2.5,BML-190,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K94379058-001-06-8,
REP.PRIMARY,2.5,PF-04136309,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K94420399-001-01-9,
REP.PRIMARY,2.5,DIOSMIN,AHR,"ARYL HYDROCARBON RECEPTOR AGONIST, CAPILLARY STABILIZING AGENT",BRD:BRD-K94436377-001-10-2,
REP.PRIMARY,2.6,MEVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K94441233-001-13-0,
REP.PRIMARY,2.5,MEVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K94441233-001-17-1,
REP.PRIMARY,2.5,ICG-001,CTNNB1,BETA-CATENIN INHIBITOR,BRD:BRD-K94455792-001-01-8,
REP.PRIMARY,2.5500000000000003,LDN-57444,,UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR,BRD:BRD-K94485812-001-02-9,
REP.PRIMARY,2.5,LY2811376,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K94534639-001-02-5,
REP.PRIMARY,2.5,TELOTRISTAT-ETHYL,TPH1,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K94559059-091-01-6,
REP.PRIMARY,2.5,TAXIFOLIN,ADIPOR2,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K94649603-001-10-6,
REP.PRIMARY,1.95,PINOCEMBRIN,CYP1B1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K94689771-001-09-0,
REP.PRIMARY,2.5,CHROMOCARB,,ANTISPASMODIC,BRD:BRD-K94720315-001-10-4,
REP.PRIMARY,2.5,RUTAECARPINE,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K94723713-001-10-6,
REP.PRIMARY,2.5,S-NITROSOGLUTATHIONE,PTPN1,NITRIC OXIDE STIMULANT,BRD:BRD-K94780074-001-06-7,
REP.PRIMARY,2.5,ATALUREN,DMD,"CFTR CHANNEL AGONIST, DYSTROPHIN STIMULANT",BRD:BRD-K94830329-001-03-0,
REP.PRIMARY,2.5,Y-134,"ESR1, ESR2",ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K94832621-001-02-3,
REP.PRIMARY,5,2-CYANOPYRIMIDINE,,CATHEPSIN INHIBITOR,BRD:BRD-K95015809-001-02-8,
REP.PRIMARY,2.5,TEMPOL,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-01-9,
REP.PRIMARY,2.5,TEMPOL,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-02-7,
REP.PRIMARY,2.5,TEMPOL,,FREE RADICAL SCAVENGER,BRD:BRD-K95053546-001-03-5,
REP.PRIMARY,2.5,BETA-FUNALTREXAMINE,"OPRD1, OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K95110148-003-01-5,
REP.PRIMARY,2.5,TALAZOPARIB,PARP2,PARP INHIBITOR,BRD:BRD-K95142244-001-01-5,
REP.PRIMARY,2.5,OCTISALATE,,,BRD:BRD-K95161686-001-02-8,
REP.PRIMARY,2.5,PROBENECID,"PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1",URICOSURIC BLOCKER,BRD:BRD-K95237249-001-26-5,
REP.PRIMARY,2.5,ASENAPINE,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K95260951-050-03-1,
REP.PRIMARY,2.5,SB-657510,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K95292280-001-01-3,
REP.PRIMARY,2.5,DIENESTROL,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K95309561-001-24-7,
REP.PRIMARY,2.5,ISTAROXIME,ATP1A1,ATPASE INHIBITOR,BRD:BRD-K95412502-003-01-5,
REP.PRIMARY,2.5,PHA-665752,MET,C-MET INHIBITOR,BRD:BRD-K95435023-001-08-5,
REP.PRIMARY,2.5,PHA-665752,MET,C-MET INHIBITOR,BRD:BRD-K95435023-001-10-1,
REP.PRIMARY,2.5,OLDA,GPR119,TRPV AGONIST,BRD:BRD-K95523387-001-09-6,
REP.PRIMARY,2.5,PFK-015,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K95573441-001-01-2,
REP.PRIMARY,2.5,RN-1734,TRPV4,TRPV ANTAGONIST,BRD:BRD-K95581532-001-01-5,
REP.PRIMARY,2.5,NPY-5RA972,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K95600043-001-01-5,
REP.PRIMARY,2.5,BMS-191011,KCNMA1,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K95609758-001-03-7,
REP.PRIMARY,2.5,TETRABENAZINE,"DRD2, SLC18A1, SLC18A2",VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K95739795-001-03-7,
REP.PRIMARY,2.5,TRAPIDIL,PDGFRA,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K95763993-001-19-3,
REP.PRIMARY,2.5,DARIFENACIN,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K95773607-004-03-8,
REP.PRIMARY,2.5,THIAMINE,"SLC19A2, SLC19A3, TPK1",VITAMIN B,BRD:BRD-K95785345-300-14-8,
REP.PRIMARY,2.5,PP-2,"ABL1, LCK, LYN, RIPK2, SRC",SRC INHIBITOR,BRD:BRD-K95785537-001-23-1,
REP.PRIMARY,2.5,MK-3697,HCRTR2,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K95828359-001-01-0,
REP.PRIMARY,2.5,JDTIC,OPRK1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K95837862-300-01-7,
REP.PRIMARY,2.5,CGP-13501,GABBR1,GABA RECEPTOR MODULATOR,BRD:BRD-K95851186-001-07-8,
REP.PRIMARY,2.5,PH-797804,"MAPK11, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K95880107-001-02-4,
REP.PRIMARY,2.5,LY344864,"HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K95899059-003-02-8,
REP.PRIMARY,2.5,XL-147,"PIK3CA, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K95901403-001-04-5,XL147
REP.PRIMARY,2.5,XL147,"PIK3CA, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K95901403-001-04-5,XL147
REP.PRIMARY,2.5,RESERPINE,"SLC18A1, SLC18A2",VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K95921201-001-14-6,
REP.PRIMARY,2.5,SRT1720,SIRT1,SIRT ACTIVATOR,BRD:BRD-K95926480-003-03-6,
REP.PRIMARY,2.5,ISAXONINE,,NERVE GROWTH FACTOR AGONIST,BRD:BRD-K95957366-001-02-6,
REP.PRIMARY,2.5,DEFLAZACORT,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K96006502-001-02-6,
REP.PRIMARY,2.5,ALAGEBRIUM,,GLYCOSYLATION INHIBITOR,BRD:BRD-K96029467-003-01-9,
REP.PRIMARY,2.5,ETANIDAZOLE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96042922-001-09-8,
REP.PRIMARY,2.5,1-ACETYL-4-METHYLPIPERAZINE,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K96055017-003-02-7,
REP.PRIMARY,2.5,AZALOMYCIN-B,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K96104201-001-01-5,
REP.PRIMARY,2.5,BREQUINAR,DHODH,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K96123349-236-02-8,
REP.PRIMARY,2.5,ENOXOLONE,HSD11B1,GAP JUNCTION MODULATOR,BRD:BRD-K96137854-001-17-1,
REP.PRIMARY,2.52,CIDOFOVIR,,DNA POLYMERASE INHIBITOR,BRD:BRD-K96153583-001-05-1,
REP.PRIMARY,2.5,ADEFOVIR-DIPIVOXIL,,DNA POLYMERASE INHIBITOR,BRD:BRD-K96159438-001-06-3,
REP.PRIMARY,2.5,CAFFEIC-ACID-PHENETHYL-ESTER,RELA,HIV INTEGRASE INHIBITOR,BRD:BRD-K96188950-001-16-9,
REP.PRIMARY,2.5,CEPHARANTHINE,,NFKB PATHWAY INHIBITOR,BRD:BRD-K96194081-001-10-2,
REP.PRIMARY,2.5,TMS,,,BRD:BRD-K96233303-001-01-9,
REP.PRIMARY,2.5,METARAMINOL,ADRA1A,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K96253961-046-03-1,
REP.PRIMARY,2.5,Y-320,IL17A,INTERLEUKIN INHIBITOR,BRD:BRD-K96259238-001-01-4,
REP.PRIMARY,2.5,GW-7647,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K96263742-001-14-8,
REP.PRIMARY,2.5,NEOHESPERIDIN,,,BRD:BRD-K96299080-001-02-7,
REP.PRIMARY,2.5,PHENTERMINE,"MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4","DOPAMINE UPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K96319534-003-03-9,
REP.PRIMARY,0.94,HARRINGTONINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K96358241-001-01-9,
REP.PRIMARY,2.5,ALOPERINE,,,BRD:BRD-K96391852-001-02-8,
REP.PRIMARY,2.5,CHLORAMPHENICOL-PALMITATE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K96424892-001-02-9,
REP.PRIMARY,2.5,PELANSERIN,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K96436774-001-01-8,
REP.PRIMARY,2.5,LINAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K96550715-001-02-6,
REP.PRIMARY,2.5,AV-608,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K96615647-001-01-2,
REP.PRIMARY,2.43,10-DEACETYLBACCATIN,,ANTITUMOR AGENT,BRD:BRD-K96631475-001-02-4,
REP.PRIMARY,2.5,10-DEACETYLBACCATIN,,ANTITUMOR AGENT,BRD:BRD-K96631475-001-04-0,
REP.PRIMARY,2.5,PA-824,FASN,NITRIC OXIDE DONOR,BRD:BRD-K96671969-001-03-1,PRETOMANID
REP.PRIMARY,2.5,PRETOMANID,FASN,NITRIC OXIDE DONOR,BRD:BRD-K96671969-001-03-1,PRETOMANID
REP.PRIMARY,2.5,ISOBUTAMBEN,,LOCAL ANESTHETIC,BRD:BRD-K96714749-001-01-0,
REP.PRIMARY,2.5,RELCOVAPTAN,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K96720755-001-02-6,
REP.PRIMARY,2.5,ITOPRIDE,"CHRM3, DRD2",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K96740444-001-02-1,
REP.PRIMARY,2.5,WAY-213613,SLC1A2,GLUTAMATE INHIBITOR,BRD:BRD-K96758128-001-01-8,
REP.PRIMARY,2.5,OXACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96786677-236-02-4,
REP.PRIMARY,2.58,OXACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96786677-323-02-0,
REP.PRIMARY,2.5,PIFITHRIN-MU,"HSPA1A, TP53",HSP INHIBITOR,BRD:BRD-K96799727-001-06-6,
REP.PRIMARY,2.5,SKF-86002,"ALOX5, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K96809896-300-02-3,
REP.PRIMARY,2.5,PIRFENIDONE,"FURIN, TNF",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K96862998-001-15-5,
REP.PRIMARY,2.5,BRETAZENIL,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6",GABA BENZODIAZEPINE SITE RECEPTOR PARTIAL AGONIST,BRD:BRD-K96936751-001-01-4,
REP.PRIMARY,2.58,CALCIUM-LEVOFOLINATE,,,BRD:BRD-K97009491-238-03-8,
REP.PRIMARY,2.5,DEFERASIROX,CYP3A4,CHELATING AGENT,BRD:BRD-K97010173-001-04-1,
REP.PRIMARY,2.5,"4-ACETYL-1,1-DIMETHYLPIPERAZINIUM",,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K97019106-005-02-9,
REP.PRIMARY,2.5,CAPADENOSON,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K97025174-001-01-4,
REP.PRIMARY,2.5,QUININE-ETHYL-CARBONATE,,,BRD:BRD-K97028990-001-04-4,
REP.PRIMARY,2.5,PRANLUKAST,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K97045029-001-02-7,
REP.PRIMARY,2.5,PRANLUKAST,"CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K97045029-001-04-3,
REP.PRIMARY,2.5,GNF-2,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K97056771-001-13-1,
REP.PRIMARY,2.63,AZACYCLONOL,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97061094-001-21-4,
REP.PRIMARY,2.5,TG-003,"CLK1, CLK4, DYRK1A, DYRK1B",CLK INHIBITOR,BRD:BRD-K97072811-001-11-4,
REP.PRIMARY,2.5,TEZACAFTOR,,CFTR CHANNEL AGONIST,BRD:BRD-K97101532-001-02-8,
REP.PRIMARY,2.5,"4,5,6,7-TETRABROMOBENZOTRIAZOLE","AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1",CASEIN KINASE INHIBITOR,BRD:BRD-K97118047-001-03-8,
REP.PRIMARY,2.5,DROPERIDOL,"ADRA1A, DRD2, DRD3, DRD4, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97158071-001-18-1,
REP.PRIMARY,2.5,L-ASPARTIC-ACID,"ACY1, ACY3, ADSS, ADSSL1, ASNS, ASPA, ASPH, ASRGL1, ASS1, CAD, DARS, DARS2, GOT1, GOT2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, LYZ, PAICS, RNASE1, SLC1A1, SLC25A12, SLC25A13",METALLIC RADICAL FORMATION STIMULANT,BRD:BRD-K97163964-001-03-3,
REP.PRIMARY,2.5,AMILORIDE,"AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2",SODIUM CHANNEL BLOCKER,BRD:BRD-K97181089-003-24-7,
REP.PRIMARY,2.5,BENIDIPINE,"CACNA1C, CACNA1G",CALCIUM CHANNEL BLOCKER,BRD:BRD-K97181463-003-01-1,
REP.PRIMARY,2.5,GESTODENE,,CONTRACEPTIVE AGENT,BRD:BRD-K97197005-001-03-2,
REP.PRIMARY,2.5,ABT-491,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K97233161-003-01-5,
REP.PRIMARY,2.5,THIOTHIXENE,"DRD1, DRD2, HRH1, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97309399-001-09-4,
REP.PRIMARY,2.5,PI-828,,PI3K INHIBITOR,BRD:BRD-K97365803-001-02-1,
REP.PRIMARY,2.5,QUERCETIN,"ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1",POLAR AUXIN TRANSPORT INHIBITOR,BRD:BRD-K97399794-001-15-3,
REP.PRIMARY,2.5,ACEDAPSONE,,,BRD:BRD-K97417064-001-02-4,
REP.PRIMARY,2.5,NETUPITANT,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K97428065-001-01-2,
REP.PRIMARY,2.5,DIHYDROERGOCRISTINE,"ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7","ADRENERGIC RECEPTOR ANTAGONIST, PROLACTIN INHIBITOR",BRD:BRD-K97440753-066-18-1,
REP.PRIMARY,2.5,DIAVERIDINE,,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K97464279-001-03-5,
REP.PRIMARY,2.5,GESTRINONE,"AR, ESR1, PGR",PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K97472745-001-01-8,
REP.PRIMARY,2.5,CLORSULON,,GLYCOLYSIS INHIBITOR,BRD:BRD-K97521363-001-16-1,
REP.PRIMARY,2.5,MELATONIN,"ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB","MELATONIN RECEPTOR AGONIST, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K97530723-001-20-9,
REP.PRIMARY,2.5,MEPYRAMINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K97564742-050-32-7,
REP.PRIMARY,2.5,AMIPRILOSE,,CD ANTAGONIST,BRD:BRD-K97643133-003-09-3,
REP.PRIMARY,2.5,P22077,USP7,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K97714174-001-01-3,
REP.PRIMARY,2.5,CHLORPROPAMIDE,"ABCC8, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K97746869-001-27-0,
REP.PRIMARY,2.5,NICORANDIL,KCNJ11,"NITRIC OXIDE DONOR, POTASSIUM CHANNEL ACTIVATOR",BRD:BRD-K97752965-001-16-4,
REP.PRIMARY,2.5,PD-173074,"FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K97764662-001-17-3,
REP.PRIMARY,2.5,AMINOPHYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-001-16-0,THEOPHYLLINE
REP.PRIMARY,2.5,THEOPHYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-001-16-0,THEOPHYLLINE
REP.PRIMARY,2.5,AMINOPHYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-230-01-7,THEOPHYLLINE
REP.PRIMARY,2.5,THEOPHYLLINE,"ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K97799481-230-01-7,THEOPHYLLINE
REP.PRIMARY,2.5,2-DEOXYGLUCOSE,"SLC2A1, SLC2A2, SLC2A3, SLC2A4",GLYCOLYSIS INHIBITOR,BRD:BRD-K97808269-001-02-7,
REP.PRIMARY,2.54,BECLOMETHASONE-DIPROPIONATE,"GPR97, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K97810537-001-12-8,
REP.PRIMARY,2.5,BECLOMETHASONE-DIPROPIONATE,"GPR97, NR3C1",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K97810537-001-13-6,
REP.PRIMARY,2.5,BMS-626529,,HIV ATTACHMENT INHIBITOR,BRD:BRD-K97883416-001-01-4,
REP.PRIMARY,2.5,MALOTILATE,,PROTEIN SYNTHESIS STIMULANT,BRD:BRD-K97884852-001-05-4,
REP.PRIMARY,2.5,EMD-1214063,MET,HEPATOCYTE GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K97963946-001-01-3,
REP.PRIMARY,2.5,RUPATADINE,"HRH1, PTAFR","HISTAMINE RECEPTOR ANTAGONIST, PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K98004573-051-02-8,
REP.PRIMARY,2.5,COMPOUND-W,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K98143539-001-02-2,
REP.PRIMARY,2.5,GR46611,HTR1D,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K98155362-001-07-7,
REP.PRIMARY,2.5,SIB-1757,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K98157055-001-10-9,
REP.PRIMARY,2.5,CHLORZOXAZONE,"KCNMA1, KCNN4",BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K98174813-001-18-0,
REP.PRIMARY,2.5,GSK-J4,"KDM6A, KDM6B",HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K98203492-003-04-1,
REP.PRIMARY,2.5,IOX2,"EGLN1, KDM2A, KDM5C",HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K98251413-001-04-0,
REP.PRIMARY,2.5,IRL-2500,EDNRB,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K98357249-001-02-9,
REP.PRIMARY,2.5,L-165041,PPARD,PPAR RECEPTOR AGONIST,BRD:BRD-K98372770-001-08-2,
REP.PRIMARY,2.5,FINAFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K98384930-003-01-5,
REP.PRIMARY,2.5,SALIRASIB,TRPA1,MTOR INHIBITOR,BRD:BRD-K98453471-001-01-7,
REP.PRIMARY,2.5,HONOKIOL,"ALOX5, PTGS1, PTGS2",AKT INHIBITOR,BRD:BRD-K98493452-001-14-9,
REP.PRIMARY,2.5,DESOXYCORTONE,"NR3C1, NR3C2",MINERALOCORTICOID RECEPTOR AGONIST,BRD:BRD-K98521173-001-19-4,
REP.PRIMARY,2.5,CLONIDINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K98530306-003-18-3,
REP.PRIMARY,2.5,PARTHENOLIDE,,NFKB PATHWAY INHIBITOR,BRD:BRD-K98548675-001-05-9,
REP.PRIMARY,2.5,AZD8931,"EGFR, ERBB2, ERBB3",EGFR INHIBITOR,BRD:BRD-K98572433-001-02-9,
REP.PRIMARY,2.5,BEPOTASTINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K98624455-074-02-8,
REP.PRIMARY,2.5,GSK-0660,PPARD,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K98684188-001-02-9,GSK0660
REP.PRIMARY,2.5,GSK0660,PPARD,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K98684188-001-02-9,GSK0660
REP.PRIMARY,2.5,NIFLUMIC-ACID,"ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K98763141-001-30-8,
REP.PRIMARY,2.5,FLUMAZENIL,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",BENZODIAZEPINE RECEPTOR ANTAGONIST,BRD:BRD-K98769987-001-23-7,
REP.PRIMARY,2.5,SB-2343,"MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG","MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K98795921-001-01-7,
REP.PRIMARY,2.5,EZATIOSTAT,GSTP1,GLUTATHIONE TRANSFERASE INHIBITOR,BRD:BRD-K98963219-001-01-2,
REP.PRIMARY,2.5,AZD5363,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K99023089-001-03-7,
REP.PRIMARY,2.5,ACETARSOL,,,BRD:BRD-K99048103-001-18-4,
REP.PRIMARY,2.5,DIDANOSINE,PNP,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K99063460-001-13-1,
REP.PRIMARY,2.5,PS178990,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K99092662-001-01-1,
REP.PRIMARY,2.5,FELBAMATE,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K99107520-001-24-1,
REP.PRIMARY,2.5,AZD2014,MTOR,MTOR INHIBITOR,BRD:BRD-K99113996-001-02-0,
REP.PRIMARY,2.5,CINCHOCAINE,"CALM1, SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K99121711-003-19-7,
REP.PRIMARY,2.5,PLURISIN-#1,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K99149715-001-01-6,PLURISIN-1
REP.PRIMARY,2.5,PLURISIN-1,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K99149715-001-01-6,PLURISIN-1
REP.PRIMARY,2.5,NSC-319726,,P53 ACTIVATOR,BRD:BRD-K99170882-001-04-3,
REP.PRIMARY,2.5,CARDIOGENOL-C,,CARDIOMYOGENESIS INDUCER,BRD:BRD-K99174507-003-02-0,
REP.PRIMARY,2.5,METRIZOIC-ACID,,RADIOPAQUE MEDIUM,BRD:BRD-K99241550-001-03-5,
REP.PRIMARY,2.5,ANTAZOLINE,HRH1,ANTIHISTAMINE,BRD:BRD-K99300445-003-21-6,
REP.PRIMARY,2.5,SODIUM-MONOFLUOROPHOSPHATE,PYGM,,BRD:BRD-K99308954-304-02-4,
REP.PRIMARY,2.5,FTORAFUR,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K99383816-001-02-7,
REP.PRIMARY,2.5,FTORAFUR,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K99383816-001-03-5,
REP.PRIMARY,2.5,LOPINAVIR,,HIV PROTEASE INHIBITOR,BRD:BRD-K99451608-001-07-3,
REP.PRIMARY,2.5,GENZ-644282,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K99475619-001-01-2,
REP.PRIMARY,2.5,PLINABULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K99498722-001-02-6,
REP.PRIMARY,2.5,GOSERELIN-ACETATE,"GNRHR, LHCGR",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K99504665-001-01-2,
REP.PRIMARY,2.5,PF-562271,"PTK2, PTK2B",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K99545815-001-06-3,
REP.PRIMARY,2.5,TANAPROGET,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K99604664-001-01-1,
REP.PRIMARY,2.5,MEDROXYPROGESTERONE,"ESR1, PGR",PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K99615199-001-18-5,
REP.PRIMARY,2.5,TUBOCURARINE,"ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K99621550-300-01-8,
REP.PRIMARY,2.5,BUTACAINE,,LOCAL ANESTHETIC,BRD:BRD-K99622919-001-23-0,
REP.PRIMARY,2.5,SANT-1,"SHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K99741577-001-01-7,
REP.PRIMARY,2.5,LINIFANIB,"CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K99749624-001-07-0,
REP.PRIMARY,2.5,HEXACHLOROPHENE,"GLUD1, SDHD",POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K99792991-001-34-9,
REP.PRIMARY,2.5,DPO-1,KCNA5,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K99922388-001-02-0,
REP.PRIMARY,2.5,HEXYLRESORCINOL,TYR,LOCAL ANESTHETIC,BRD:BRD-K99946902-001-07-5,
REP.PRIMARY,2.5,BOSUTINIB,"ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK","ABL KINASE INHIBITOR, BCR-ABL KINASE INHIBITOR, SRC INHIBITOR",BRD:BRD-K99964838-001-11-9,
REP.PRIMARY,2.5,FLUNIXIN-MEGLUMIN,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K99984802-100-13-5,
REP.PRIMARY,2.5,CHROMANOL-(+/-),,POTASSIUM CHANNEL BLOCKER,BRD:BRD-M02075109-001-01-1,
REP.PRIMARY,2.5,BISMUTH-OXALATE,,,BRD:BRD-M02179497-001-01-1,
REP.PRIMARY,2.5,INDIUM(III)-ISOPROPOXIDE,,,BRD:BRD-M08274809-001-01-7,
REP.PRIMARY,2.5,FPA-124,,AKT INHIBITOR,BRD:BRD-M17926088-001-01-3,
REP.PRIMARY,2.5,AMMONIUM-LACTATE,HCAR1,,BRD:BRD-M29182745-001-01-4,
REP.PRIMARY,2.5,CIS-ACPD,"GRM2, GRM3, GRM6, GRM7, GRM8",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-M29936662-001-02-0,
REP.PRIMARY,2.5,G-15,GPER1,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-M30288325-001-01-4,
REP.PRIMARY,2.5,REBOXETINE,SLC6A2,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-M39350793-334-01-1,
REP.PRIMARY,2.5,LITHIUM-CITRATE,,,BRD:BRD-M41245765-001-04-2,
REP.PRIMARY,2.5,SODIUM-GLUCONATE,,,BRD:BRD-M54096567-001-01-9,
REP.PRIMARY,2.5,BISMUTH(III)-TRIFLUOROMETHANESULFONATE,,DIRECT SUBSTITUTION CATALYST,BRD:BRD-M56276249-001-01-1,
REP.PRIMARY,2.5,TBOA-(DL),"SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7",EXCITATORY AMINO ACID TRANSPORTER INHIBITOR,BRD:BRD-M77041484-001-01-8,
REP.PRIMARY,2.5,NEMONAPRIDE,"DRD2, DRD3, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-M80207679-001-01-5,
REP.PRIMARY,2.5,CROMAKALIM,KCNJ8,,BRD:BRD-M89827113-001-01-5,
REP.PRIMARY,2.5,TALC,,,BRD:BRD-M92352362-002-02-3,
REP.PRIMARY,2.5,EFONIDIPINE-MONOETHANOLATE,"CACNA1C, CACNA1G","L-TYPE CALCIUM CHANNEL BLOCKER, T-TYPE CALCIUM CHANNEL BLOCKER",BRD:BRD-M92675308-003-07-1,
REP.PRIMARY,2.5,DICHLOROACETATE,PDK1,PYRUVATE DEHYDROGENASE KINASE INHIBITOR,BRD:BRD-M97302542-001-03-6,
REP.PRIMARY,2.5,CEVIMELINE,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-M98279124-300-01-1,
REP.PRIMARY,2.5,COLESEVALAM,,,BRD:BRD-U08520523-000-01-0,
REP.PRIMARY,2.5,TYLOXAPOL,"LPL, NFKB2",NFKB PATHWAY INHIBITOR,BRD:BRD-U25960968-000-01-9,
REP.PRIMARY,2.5,SEVELAMER,,PHOSPHATE ANTAGONIST,BRD:BRD-U45393375-000-01-6,
REP.PRIMARY,2.5,TYLOXAPOL,"LPL, NFKB2",NFKB PATHWAY INHIBITOR,BRD:BRD-U48018661-000-01-9,
REP.PRIMARY,2.5,PHOSPHATIDYLCHOLINE,PCTP,,BRD:BRD-U51753822-000-01-1,
REP.PRIMARY,2.3258893190000003,RS-0481,,IMMUNOSTIMULANT,BRD:BRD-A00055058-001-01-0,
REP.PRIMARY,2.5,OLEUROPEIN,GPER1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-A00842753-001-01-9,
REP.PRIMARY,2.5,ISOLEUCINE,"ACADSB, BCAT1, BCAT2, IARS, IARS2",,BRD:BRD-A02232681-001-01-8,
REP.PRIMARY,2.5,GEPEFRINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A04447196-001-01-8,
REP.PRIMARY,2.65294603,CLORANOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A04971881-003-01-3,
REP.PRIMARY,2.5,BROXATEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A08316590-001-01-3,
REP.PRIMARY,2.5000288790000003,SQ-109,FDFT1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A08772153-001-02-4,
REP.PRIMARY,2.5,PROLYLLEUCYLGLYCINAMIDE,,MELANOCYTE-STIMULATING HORMONE RELEASE INHIBITOR,BRD:BRD-A09911125-001-01-4,
REP.PRIMARY,2.5,DEXAMETHASONE,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A10188456-001-04-9,
REP.PRIMARY,2.496712929,GLYCEROL-MONOLAURATE,,BETA LACTAMASE INHIBITOR,BRD:BRD-A10773072-001-03-4,
REP.PRIMARY,2.7139674310000004,MABUTEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A13116749-003-01-6,
REP.PRIMARY,2.5,PEFICITINIB,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-A14577621-001-01-5,
REP.PRIMARY,2.5,CLOFEDANOL,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A15687940-001-05-6,
REP.PRIMARY,2.726366321,POLYTHIAZIDE,SLC12A3,SODIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-A15739803-001-01-0,
REP.PRIMARY,2.5,MISONIDAZOLE,,,BRD:BRD-A16263897-001-06-6,
REP.PRIMARY,2.499993124,ISAVUCONAZOLE,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-A17009129-001-01-3,
REP.PRIMARY,2.5,LERCANIDIPINE,"CACNA2D1, CACNG1",CALCIUM CHANNEL BLOCKER,BRD:BRD-A18992208-003-02-7,
REP.PRIMARY,2.5,CLOROTEPINE,"ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6","ADRENERGIC RECEPTOR ANTAGONIST, DOPAMINE RECEPTOR ANTAGONIST",BRD:BRD-A19053834-050-09-5,
REP.PRIMARY,2.596350183,MENADIONE-BISULFITE,"GGCX, VKORC1, VKORC1L1",VITAMIN K,BRD:BRD-A19777893-236-01-9,
REP.PRIMARY,2.5,NIFENALOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A21280314-001-06-8,
REP.PRIMARY,2.5,XIBENOLOL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A21446384-001-01-1,
REP.PRIMARY,2.5,METHOXYPHENAMINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A21474126-001-01-6,
REP.PRIMARY,2.5,PIPECURONIUM,"CHRM2, CHRM3, CHRNA2",NEUROMUSCULAR BLOCKER,BRD:BRD-A21544762-303-01-5,
REP.PRIMARY,2.5,PF-06463922,"ALK, FES, ROS1",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-A23124853-001-01-4,
REP.PRIMARY,2.519094866,FLOCTAFENINE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A23418262-001-01-5,
REP.PRIMARY,2.488183422,N-ACETYL-TYROSINE,,,BRD:BRD-A24857382-001-03-4,
REP.PRIMARY,2.5682115960000003,CHLORTETRACYCLINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A25492003-003-14-1,
REP.PRIMARY,2.4001066310000003,BUTOFILOLOL,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A27274504-001-01-6,
REP.PRIMARY,2.499990706,EFINACONAZOLE,CYP51A1,LANOSTEROL DEMETHYLASE INHIBITOR,BRD:BRD-A30774155-001-01-2,
REP.PRIMARY,2.499984736,CAPREOMYCIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A31362467-065-01-3,
REP.PRIMARY,2.499995956,ORITAVANCIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A33352494-316-01-6,
REP.PRIMARY,2.490825408,TERODILINE,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-A33479817-003-03-7,
REP.PRIMARY,2.312630829,HEXOPRENALINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A33894669-065-01-9,
REP.PRIMARY,2.427905848,TROPESIN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A34603619-001-01-9,
REP.PRIMARY,2.375699424,TETRACYCLINE,PRNP,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A34788695-003-10-2,
REP.PRIMARY,2.5,PROPYLHEXEDRINE,"SLC18A2, TAAR1",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A35667010-001-01-8,
REP.PRIMARY,2.5,DROMOSTANOLONE-PROPIONATE,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-A38706605-001-01-2,
REP.PRIMARY,2.503151999,A-33903,,,BRD:BRD-A40302156-001-01-9,
REP.PRIMARY,2.5000294430000003,MORINIDAZOLE,CYP51A1,OTHER ANTIBIOTIC,BRD:BRD-A40546373-001-01-8,
REP.PRIMARY,2.499982171,BACAMPICILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A41698174-003-12-0,
REP.PRIMARY,2.4956649580000003,BENPROPERINE,SCN5A,ANTITUSSIVE,BRD:BRD-A42423104-001-01-4,
REP.PRIMARY,2.6483805410000003,CYAMEMAZINE,"HTR1A, HTR2A, HTR2C, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A42881122-001-01-1,
REP.PRIMARY,2.666476303,FLUMECINOL,,,BRD:BRD-A44181516-001-01-8,
REP.PRIMARY,2.639346634,AZD1446,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A44188509-001-01-2,
REP.PRIMARY,2.4999870420000003,GINSENOSIDE-RE3,KCNH2,"ANGIOGENESIS INHIBITOR, APOPTOSIS STIMULANT",BRD:BRD-A44511856-001-01-4,GINSENOSIDE-RG3
REP.PRIMARY,2.4999870420000003,GINSENOSIDE-RG3,KCNH2,"ANGIOGENESIS INHIBITOR, APOPTOSIS STIMULANT",BRD:BRD-A44511856-001-01-4,GINSENOSIDE-RG3
REP.PRIMARY,2.5,DAROLUTAMIDE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-A44971162-001-02-7,ODM-201
REP.PRIMARY,2.5,ODM-201,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-A44971162-001-02-7,ODM-201
REP.PRIMARY,2.499949994,PROMETHAZINE,"ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A46335897-003-27-8,
REP.PRIMARY,2.426818202,IGMESINE,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-A48376327-003-01-5,
REP.PRIMARY,2.5,BUPRANOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A48420483-001-02-3,
REP.PRIMARY,2.5,MONOCTANOIN,,,BRD:BRD-A48938994-001-14-1,
REP.PRIMARY,2.4124830690000003,CARAZOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A50675490-001-01-0,
REP.PRIMARY,2.499990763,TIANEPTINE,"OPRD1, OPRK1, OPRM1",SELECTIVE SEROTONIN REUPTAKE ENHANCER (SSRE),BRD:BRD-A53077924-001-01-2,
REP.PRIMARY,2.5,COLFORSIN,"ADCY2, ADCY5",ADENYLYL CYCLASE ACTIVATOR,BRD:BRD-A55416093-001-06-4,
REP.PRIMARY,2.639158457,TRIMETHOQUINOL,"ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A56241705-003-01-2,
REP.PRIMARY,2.6425228730000003,VALETHAMATE,"CHRM1, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A56613951-004-01-1,
REP.PRIMARY,2.5,OMEPRAZOLE-MAGNESIUM,"ATP4A, ATP4B",PROTON PUMP INHIBITOR,BRD:BRD-A56892734-001-09-4,
REP.PRIMARY,2.5,AMG319,PIK3CD,PI3K INHIBITOR,BRD:BRD-A58947127-001-01-6,
REP.PRIMARY,2.499948202,BUTYLPHTHALIDE,KCNK2,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-A59378440-001-01-3,
REP.PRIMARY,2.4999837570000003,NETILMICIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A59825838-326-01-4,
REP.PRIMARY,2.5,BQ-123,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-A59961917-001-01-0,
REP.PRIMARY,2.5081274340000004,TOLAMOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A60498477-001-01-2,
REP.PRIMARY,2.6783941610000004,ULIFLOXACIN,,,BRD:BRD-A61633223-001-02-8,
REP.PRIMARY,2.532450362,ENCIPRAZINE,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-A62197763-001-01-1,
REP.PRIMARY,2.5,SULBACTAM-PIVOXIL,,BETA LACTAMASE INHIBITOR,BRD:BRD-A63431791-001-01-9,
REP.PRIMARY,2.500011906,OCTREOTIDE,"SSTR1, SSTR2, SSTR3, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-A64173453-015-02-3,
REP.PRIMARY,2.4999878420000003,SOLAMARGINE,,APOPTOSIS INHIBITOR,BRD:BRD-A65562236-001-01-2,
REP.PRIMARY,2.499972087,PHENYLPIRACETAM,,NORADRENALINE UPTAKE INHIBITOR,BRD:BRD-A65683612-001-07-7,
REP.PRIMARY,2.5,TOLOXATONE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-A67182178-001-01-7,
REP.PRIMARY,2.5,SPIRAMYCIN,,BACTERIAL 50S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-A67305656-001-01-5,
REP.PRIMARY,2.5,PICARTAMIDE,ATP4A,H+/K+-ATPASE INHIBITOR,BRD:BRD-A71765060-001-01-4,
REP.PRIMARY,2.5,OZOLINONE,,DIURETIC,BRD:BRD-A72297358-001-01-8,
REP.PRIMARY,2.463310717,MISOPROSTOL,"PTGER2, PTGER3, PTGER4, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-A72351335-001-04-5,
REP.PRIMARY,2.551316459,GADOTERIDOL,,RADIOPAQUE MEDIUM,BRD:BRD-A72401848-001-02-2,
REP.PRIMARY,2.5,TIAPROFENIC-ACID,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A72988804-001-11-1,
REP.PRIMARY,2.603473418,BECLOMETHASONE,"NR3C1, SERPINA6",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A73385064-001-01-5,
REP.PRIMARY,2.5,TIPRENOLOL,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A73566563-001-01-6,
REP.PRIMARY,2.499981367,MK-571,"ABCC2, CYSLTR1",LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-A73679382-236-01-8,
REP.PRIMARY,2.5,HOMATROPINE,"CES1, CHRM1",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A74975734-004-09-9,
REP.PRIMARY,2.662563322,IBUPROFEN-PICONOL,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A75224450-001-02-4,
REP.PRIMARY,2.5,BAFETINIB,"ABL1, BCR, LYN","BCR-ABL KINASE INHIBITOR, LYN TYROSINE KINASE INHIBITOR",BRD:BRD-A75975749-001-01-4,
REP.PRIMARY,2.5,LISADIMATE,,TOPICAL SUNSCREEN AGENT,BRD:BRD-A76533773-001-01-9,
REP.PRIMARY,2.492599937,METAZOSIN,ADRA1A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A78277353-001-01-9,
REP.PRIMARY,2.6401683310000004,TAFENOQUINE,,ANTIMALARIAL AGENT,BRD:BRD-A78965079-036-01-8,
REP.PRIMARY,2.5,SIB-1553A,CHRNB4,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-A79052425-003-01-5,
REP.PRIMARY,2.43120883,AD-5467,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-A80280426-001-03-8,
REP.PRIMARY,2.500007302,GINSENOSIDE-RD,,CALCIUM CHANNEL BLOCKER,BRD:BRD-A84810646-001-01-6,
REP.PRIMARY,2.500008824,TIOPRONIN,,"CHELATING AGENT, REDUCING AGENT",BRD:BRD-A85295731-001-06-4,
REP.PRIMARY,2.5,GABAPENTIN-ENACARBIL,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A86665761-001-01-1,
REP.PRIMARY,2.5,ALBUTEROL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A88254928-001-07-9,
REP.PRIMARY,2.5000087950000003,DEGARELIX,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-A88562598-001-01-7,
REP.PRIMARY,2.500026693,PERIFOSINE,AKT1,AKT INHIBITOR,BRD:BRD-A89082344-001-08-7,
REP.PRIMARY,2.378054241,TERGURIDE,"ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A89207210-001-01-6,
REP.PRIMARY,2.5,BUCLIZINE,"CHRM1, HRH1",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-A91444184-300-01-9,
REP.PRIMARY,2.5,CITICOLINE,"ACHE, SLC1A2","GLUTATHIONE TRANSFERASE STIMULANT, MEMBRANE PERMEABILITY ENHANCER",BRD:BRD-A91728607-236-11-9,
REP.PRIMARY,2.5,BETAMETHASONE-ACETATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-A92177080-001-02-1,
REP.PRIMARY,2.5,CHLORPHENESIN,,MUSCLE RELAXANT,BRD:BRD-A92262698-001-02-5,
REP.PRIMARY,2.4999933210000003,PRULIFLOXACIN,,BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-A92341659-001-04-0,
REP.PRIMARY,2.5,MABUPROFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A93683007-001-01-9,
REP.PRIMARY,2.4421319660000003,NUCLOMEDONE,,IMMUNOSUPPRESSANT,BRD:BRD-A96466199-001-01-4,
REP.PRIMARY,2.293696319,CIMETROPIUM,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A99899486-004-01-9,
REP.PRIMARY,2.6083767890000003,CINEPAZET,,VASODILATOR,BRD:BRD-K00531707-001-01-3,
REP.PRIMARY,2.5000428190000004,BRIVARACETAM,SV2A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00634421-001-01-0,
REP.PRIMARY,2.6759047980000004,GUACETISAL,,IMMUNOSUPPRESSANT,BRD:BRD-K00739965-001-01-9,
REP.PRIMARY,2.50002964,MOLIDUSTAT,EGLN2,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K01291782-001-01-1,
REP.PRIMARY,2.5870842360000004,RILMENIDINE,ADRA2A,"ADRENERGIC RECEPTOR AGONIST, IMIDAZOLINE RECEPTOR AGONIST",BRD:BRD-K01638814-011-01-4,
REP.PRIMARY,2.618953925,PRIRALFINAMIDE,CACNA1B,SODIUM CHANNEL BLOCKER,BRD:BRD-K01662324-001-01-8,
REP.PRIMARY,2.5,L-PROLINE,"EPRS, L3HYPDH, P3H1, P3H2, P3H3, P4HA1, P4HA2, PARS2, PPIA, PPIB, PPIC, PPIF, PPIG, PPIH, PRODH, PROSC, PYCR1, PYCR2, PYCRL, SLC6A14, SLC6A7",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K01666412-001-02-0,
REP.PRIMARY,2.303758671,DENOTIVIR,,ANTIVIRAL,BRD:BRD-K01773083-001-01-4,
REP.PRIMARY,2.500013375,SIVELESTAT,"CELA1, ELANE",ELASTASE INHIBITOR,BRD:BRD-K02152879-414-02-1,
REP.PRIMARY,2.499989889,CEFOTIAM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K02275692-300-02-6,
REP.PRIMARY,2.425128585,FLUOROMETHOLONE-ACETATE,NR3C1,,BRD:BRD-K02528732-001-02-4,
REP.PRIMARY,2.5,PF-05190457,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR INVERSE AGONIST,BRD:BRD-K02554563-001-01-6,
REP.PRIMARY,2.50244046,PHENYLBENZIMIDAZOLE-SULFONIC-ACID,,,BRD:BRD-K02729857-001-01-9,
REP.PRIMARY,2.4999620460000003,PIBOSEROD,"HTR2B, HTR4",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K02750403-001-01-4,
REP.PRIMARY,2.5,UNC0737,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K02988401-001-01-2,
REP.PRIMARY,2.499993866,QUINAGOLIDE,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K02995728-003-01-9,
REP.PRIMARY,2.499970324,ELAFIBRANOR,"PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K03165895-001-01-9,
REP.PRIMARY,2.339952449,RAVUCONAZOLE,,STEROL DEMETHYLASE INHIBITOR,BRD:BRD-K03503561-001-01-4,
REP.PRIMARY,2.499986292,XL-647,"EGFR, EPHB4, ERBB2, FLT4, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K03765900-001-01-9,XL647
REP.PRIMARY,2.499986292,XL647,"EGFR, EPHB4, ERBB2, FLT4, KDR","EGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K03765900-001-01-9,XL647
REP.PRIMARY,2.500025266,MK-6096,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K03894385-001-01-1,
REP.PRIMARY,2.542651982,"1,12-BESM",,POLYAMINE BIOSYNTHESIS INHIBITOR,BRD:BRD-K04603573-376-01-3,
REP.PRIMARY,2.6330965010000003,PERZINFOTEL,"GRIN1, GRIN2A, GRIN2B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K04643877-001-03-2,
REP.PRIMARY,2.499987566,VE-822,"ATM, ATR, MTOR, PIK3CG",ATR KINASE INHIBITOR,BRD:BRD-K04701033-001-04-7,
REP.PRIMARY,2.5,HEXAMETHYLENEBISACETAMIDE,AKT1,"AKT INHIBITOR, DIFFERENTIATION INDUCER, NFKB PATHWAY INHIBITOR",BRD:BRD-K04710043-001-17-8,
REP.PRIMARY,2.500017956,GSK2330672,SLC10A2,BILE ACID TRANSPORTER INHIBITOR,BRD:BRD-K05858796-001-01-7,
REP.PRIMARY,2.5,A-366,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K06182768-001-02-3,
REP.PRIMARY,2.5,E-64,CTSS,"CALPAIN INHIBITOR, CYSTEINE PROTEASE INHIBITOR",BRD:BRD-K06273313-001-07-9,
REP.PRIMARY,2.5000042540000003,BREMELANOTIDE,"MC1R, MC2R, MC3R, MC4R, MC5R",MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K06328344-015-01-7,
REP.PRIMARY,2.49996939,VELNEPERIT,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K06357403-001-01-4,
REP.PRIMARY,2.5,LOFEMIZOLE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K06388517-001-01-2,
REP.PRIMARY,2.4999923290000003,DAPRODUSTAT,EGLN1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K06455935-001-01-3,
REP.PRIMARY,2.5,CL316243,"ADRB3, UCP1, UCP2, UCP3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K06467130-304-02-7,
REP.PRIMARY,2.5,L-METHIONINE,"BHMT, BHMT2, METAP2, MTR, MTRR",VOLTAGE-GATED CALCIUM CHANNEL LIGAND,BRD:BRD-K06502269-001-02-6,
REP.PRIMARY,2.5,VINBLASTINE,"JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K06519765-001-01-1,
REP.PRIMARY,2.686662955,APRATASTAT,"ADAM17, MMP1, MMP13, MMP9","MATRIX METALLOPROTEASE INHIBITOR, TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR",BRD:BRD-K06883221-001-01-9,
REP.PRIMARY,2.5,PF-03049423,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K07070922-001-01-4,
REP.PRIMARY,2.391201575,ORG-12962,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K07409305-001-01-1,
REP.PRIMARY,2.50703254,NORETHISTERONE-ENANTHATE,,CONTRACEPTIVE AGENT,BRD:BRD-K07625016-001-01-2,
REP.PRIMARY,2.499993276,PALOSURAN,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K07682953-001-01-8,
REP.PRIMARY,2.29884119,7-KETO-DHEA,,STEROID,BRD:BRD-K07785030-001-01-6,
REP.PRIMARY,2.500001908,MAVOGLURANT,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K07790550-001-01-6,
REP.PRIMARY,2.656154742,FROVATRIPTAN,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K08255599-365-01-1,
REP.PRIMARY,2.4873664570000003,YM-022,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K09436144-001-01-7,YM022
REP.PRIMARY,2.4873664570000003,YM022,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K09436144-001-01-7,YM022
REP.PRIMARY,2.500007896,ELBASVIR,,HCV INHIBITOR,BRD:BRD-K09735259-001-01-3,
REP.PRIMARY,2.499990088,DEFEROXAMINE-MESYLATE,,CHELATING AGENT,BRD:BRD-K09821361-066-25-8,
REP.PRIMARY,2.5,TASULDINE,,MUCOLYTIC AGENT,BRD:BRD-K10415035-001-04-4,
REP.PRIMARY,2.485820406,ETHACIZIN,,ANTICONVULSANT,BRD:BRD-K10667240-001-01-7,
REP.PRIMARY,2.3164583220000003,PERPHENAZINE,"CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K10995081-001-27-9,
REP.PRIMARY,2.5,NICERITROL,,NAD PRECURSOR,BRD:BRD-K11256763-001-01-5,
REP.PRIMARY,2.403980733,NE-100,SIGMAR1,SIGMA RECEPTOR ANTAGONIST,BRD:BRD-K11443721-003-01-6,
REP.PRIMARY,2.5000112,EVATANEPAG,"PTGER2, PTGER4",PROSTAGLANDIN INHIBITOR,BRD:BRD-K11452913-001-01-9,
REP.PRIMARY,2.500052374,EPRODISATE,SAA1,"AMYLOID PROTEIN INHIBITOR, ANTIAMYLOIDOGENIC AGENT",BRD:BRD-K11463116-304-03-5,
REP.PRIMARY,2.5000093050000003,ABT-639,"CACNA1G, CACNA1H, CACNA1I",CALCIUM CHANNEL BLOCKER,BRD:BRD-K11792081-001-01-4,
REP.PRIMARY,2.4999931710000003,PARDOPRUNOX,"DRD2, DRD3, DRD4, HTR1A, HTR7","DOPAMINE RECEPTOR AGONIST, SEROTONIN RECEPTOR AGONIST",BRD:BRD-K11851476-003-01-7,
REP.PRIMARY,2.499953183,ZALTIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K12261274-001-02-4,
REP.PRIMARY,2.512196931,MOXAVERINE,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K12742203-003-01-7,
REP.PRIMARY,2.5847259410000003,VELIFLAPON,ALOX5AP,LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K12852738-001-01-2,
REP.PRIMARY,2.5,CARBENDAZIM,"TP53, TUBB","MICROTUBULE INHIBITOR, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-K12906202-001-06-2,
REP.PRIMARY,2.499994836,UNC0631,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K13060017-001-02-1,
REP.PRIMARY,2.5,RIFAMYCIN-SV,,RNA SYNTHESIS INHIBITOR,BRD:BRD-K13277760-001-01-2,
REP.PRIMARY,2.499991328,RADAFAXINE,SLC6A3,DOPAMINE-NOREPINEPHRINE REUPTAKE INHIBITOR,BRD:BRD-K13394247-003-01-4,
REP.PRIMARY,2.499970601,VESNARINONE,"KCNH2, PDE3A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K13414800-001-01-3,
REP.PRIMARY,2.5,CYCLOSPORIN-A,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3",CALCINEURIN INHIBITOR,BRD:BRD-K13533483-001-16-2,CYCLOSPORINE
REP.PRIMARY,2.5,CYCLOSPORINE,"ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3CA, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3",CALCINEURIN INHIBITOR,BRD:BRD-K13533483-001-16-2,CYCLOSPORINE
REP.PRIMARY,2.500014041,NAPHTHOQUINE-PHOSPHATE,,ANTIMALARIAL AGENT,BRD:BRD-K13664493-316-02-5,
REP.PRIMARY,2.50001379,DANIRIXIN,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K13769342-001-01-5,
REP.PRIMARY,2.499985403,OMARIGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K14171291-001-01-4,
REP.PRIMARY,2.49998187,DAUCOSTEROL,,APOPTOSIS STIMULANT,BRD:BRD-K14276241-001-01-2,
REP.PRIMARY,2.5,ZOMETAPINE,,,BRD:BRD-K14571191-001-01-6,
REP.PRIMARY,2.368766292,DROTAVERINE,"CACNA1C, PDE4A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K14658796-003-01-6,
REP.PRIMARY,2.5,SOMATOSTATIN,"OPRD1, OPRM1, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5",SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K14681867-001-01-6,
REP.PRIMARY,2.500062642,TRANEXAMIC-ACID,PLG,"ANTIFIBRINOLYTIC, PLASMINOGEN ACTIVATOR INHIBITOR",BRD:BRD-K15014948-001-10-3,
REP.PRIMARY,2.5000026930000003,MUPIROCIN,,ISOLEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K15262564-001-15-0,
REP.PRIMARY,2.444207768,FMOC-L-LEUCINE,,PPAR RECEPTOR AGONIST,BRD:BRD-K15327298-001-05-5,
REP.PRIMARY,2.404560312,DEHYDROEPIANDROSTERONE-SULFATE,"AR, ESR1, ESR2","ANDROGEN RECEPTOR AGONIST, ESTROGEN RECEPTOR AGONIST",BRD:BRD-K15360631-325-01-4,
REP.PRIMARY,2.499981005,GSK2190915,ALOX5AP,LIPOXYGENASE INHIBITOR,BRD:BRD-K15691453-236-01-6,
REP.PRIMARY,2.5,BIS(MALTOLATO)OXOVANADIUM(IV),PTPN1,TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K16180792-001-01-7,
REP.PRIMARY,2.49996754,FORODESINE,PNP,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K16505263-003-02-9,
REP.PRIMARY,2.393310671,BICYCLOL,"HSPA1A, HSPB1",NFKB PATHWAY INHIBITOR,BRD:BRD-K16546375-001-01-4,
REP.PRIMARY,2.499987615,NASTORAZEPIDE,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K17295893-001-01-0,
REP.PRIMARY,2.5,DELAMANID,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K17480742-001-01-1,
REP.PRIMARY,2.421190843,INDISULAM,"CA1, CA12, CA14, CA2, CA6, CA7, CA9",CDK INHIBITOR,BRD:BRD-K17610631-001-03-3,
REP.PRIMARY,2.500015146,DECOQUINATE,,ANTIPROTOZOAL AGENT,BRD:BRD-K17641316-001-04-8,
REP.PRIMARY,2.536141856,CINOXATE,,,BRD:BRD-K17828029-001-01-5,
REP.PRIMARY,2.5,CHENODEOXYCHOLIC-ACID,"HSD11B1, NR1H4","11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR, FXR AGONIST",BRD:BRD-K18135438-001-14-2,
REP.PRIMARY,2.5,MELEVODOPA,DDC,"DOPAMINE PRECURSOR, DOPAMINE RECEPTOR AGONIST",BRD:BRD-K18749874-003-08-9,
REP.PRIMARY,2.457947881,SCHISANDROL-B,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K18878288-001-06-4,
REP.PRIMARY,2.5,SALVIANOLIC-ACID-B,MMP9,"EGFR INHIBITOR, METALLOPROTEINASE INHIBITOR",BRD:BRD-K18898553-001-01-1,
REP.PRIMARY,2.33859482,BENDAZAC,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K19515365-001-02-6,
REP.PRIMARY,2.5,BMS-587101,"ITGAL, ITGB2",INTEGRIN ANTAGONIST,BRD:BRD-K20093108-001-02-3,
REP.PRIMARY,2.4999667910000003,LY2606368,CHEK1,CHK INHIBITOR,BRD:BRD-K20463415-300-01-4,
REP.PRIMARY,2.49996519,BNC105,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K20468903-001-01-6,
REP.PRIMARY,2.6560852780000004,AMG-319,PIK3CD,PI3K INHIBITOR,BRD:BRD-K21077415-001-01-5,
REP.PRIMARY,2.5082643,ENOXIMONE,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K21152241-001-07-3,
REP.PRIMARY,2.4999855340000003,SELEXIPAG,PTGIR,"IP1 PROSTACYCLIN RECEPTOR AGONIST, PLATELET AGGREGATION INHIBITOR",BRD:BRD-K21191422-001-01-5,
REP.PRIMARY,2.5,SEMAPIMOD,MAPK14,"CYTOKINE PRODUCTION INHIBITOR, P38 MAPK INHIBITOR",BRD:BRD-K21237892-376-01-3,
REP.PRIMARY,2.50000801,FIMASARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K21586122-001-01-9,
REP.PRIMARY,2.473727942,LETEPRINIM,,NERVE GROWTH FACTOR AGONIST,BRD:BRD-K21612934-001-01-1,
REP.PRIMARY,2.4999896340000003,NAPABUCASIN,STAT3,STAT INHIBITOR,BRD:BRD-K22064724-001-01-8,
REP.PRIMARY,2.371298578,CERITINIB,"ALK, FLT3, IGF1R, INSR, TSSK1B",ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K22149900-001-03-9,
REP.PRIMARY,2.500015058,EGF816,EGFR,EGFR INHIBITOR,BRD:BRD-K22514639-001-05-7,
REP.PRIMARY,2.5,METACRESOL,INS,,BRD:BRD-K22518984-001-01-8,
REP.PRIMARY,2.500010949,DIHYDROTESTOSTERONE,"AR, HSD17B1",ANDROGEN RECEPTOR AGONIST,BRD:BRD-K22525962-001-05-0,
REP.PRIMARY,2.654665484,GIDAZEPAM,,GABA BENZODIAZEPINE SITE RECEPTOR AGONIST,BRD:BRD-K22588750-001-07-0,
REP.PRIMARY,2.499966688,AFN-1252,,FABI INHIBITOR,BRD:BRD-K23791635-001-01-3,
REP.PRIMARY,2.5,FOSAPREPITANT-DIMEGLUMINE,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K23848629-401-03-7,
REP.PRIMARY,2.5,PRALIDOXIME-CHLORIDE,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K24221957-003-01-6,
REP.PRIMARY,2.599377769,METHYLPREDNISOLONE-ACEPONATE,NR3C1,"ANTI-INFLAMMATORY AGENT, GLUCOCORTICOID RECEPTOR AGONIST",BRD:BRD-K24452555-001-01-7,
REP.PRIMARY,2.50002878,ICARITIN,PDE5A,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K24476327-001-01-3,
REP.PRIMARY,2.499993902,SETIPIPRANT,PTGDR2,PROSTAGLANDIN INHIBITOR,BRD:BRD-K24497734-001-01-6,
REP.PRIMARY,2.33438271,AMIBEGRON,ADRB3,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K24610819-003-01-8,
REP.PRIMARY,2.499988887,COPANLISIB,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K24666289-001-04-9,
REP.PRIMARY,2.5,JNJ-26990990,,ANTICONVULSANT,BRD:BRD-K24864897-001-01-0,
REP.PRIMARY,2.446932239,TRICLOCARBAN,,OTHER ANTIBIOTIC,BRD:BRD-K25029121-001-05-8,
REP.PRIMARY,2.5,CIS-UROCANIC ACID,HTR2A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K25146005-001-01-0,CIS-UROCANIC-ACID
REP.PRIMARY,2.5,CIS-UROCANIC-ACID,HTR2A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K25146005-001-01-0,CIS-UROCANIC-ACID
REP.PRIMARY,2.5,CINFLUMIDE,,MUSCLE RELAXANT,BRD:BRD-K25154476-001-01-4,
REP.PRIMARY,2.5,OXYTOCIN,"AVPR1A, AVPR1B, AVPR2, OXTR",OXYTOCIN RECEPTOR AGONIST,BRD:BRD-K25243230-001-01-2,
REP.PRIMARY,2.660853131,CHLORPROGUANIL,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K25494650-003-01-8,
REP.PRIMARY,2.436963824,EZUTROMID,UTRN,UTROPHIN ENHANCER,BRD:BRD-K25570267-001-01-4,
REP.PRIMARY,2.50000335,RESIBUFOGENIN,,NA/K-ATPASE INHIBITOR,BRD:BRD-K25970317-001-01-6,
REP.PRIMARY,2.5,DESOXYCORTICOSTERONE-PIVALATE,NR3C2,CORTICOSTEROID AGONIST,BRD:BRD-K26024145-001-01-9,
REP.PRIMARY,2.499979456,TUCATINIB,ERBB2,EGFR INHIBITOR,BRD:BRD-K26026438-001-01-0,
REP.PRIMARY,2.5,LEUPROLIDE,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K26323068-001-01-8,
REP.PRIMARY,2.5680787780000003,CARBOXYPYRIDINE-DISULFIDE,,,BRD:BRD-K26530649-001-01-6,
REP.PRIMARY,2.46430412,DALTROBAN,TBXA2R,THROMBOXANE RECEPTOR ANTAGONIST,BRD:BRD-K26813177-001-03-2,
REP.PRIMARY,2.5,BIX-01294,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K26818574-305-07-6,
REP.PRIMARY,2.4999985980000003,AMG-337,MET,MET INHIBITOR,BRD:BRD-K27061362-001-01-6,
REP.PRIMARY,2.4503219090000004,TIARAMIDE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K27293958-001-01-5,
REP.PRIMARY,2.5,CEFCAPENE-PIVOXIL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27515606-003-01-3,
REP.PRIMARY,2.499990597,PLECONARIL,,,BRD:BRD-K27625831-001-02-9,
REP.PRIMARY,2.49693186,PF-04937319,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K27755542-001-01-6,
REP.PRIMARY,2.350625651,CEFETAMET,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K27798832-001-01-5,
REP.PRIMARY,2.5000278490000003,COROSOLIC-ACID,"HSD11B1, PTPN1","PKC INHIBITOR, PROTEIN TYROSINE KINASE INHIBITOR",BRD:BRD-K27885593-001-06-8,
REP.PRIMARY,2.5,BETA-LAPACHONE,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K28061410-001-06-6,
REP.PRIMARY,2.499968715,CHIDAMIDE,"HDAC10, HDAC3",HDAC INHIBITOR,BRD:BRD-K28537285-001-01-8,
REP.PRIMARY,2.5,FOSFOSAL,"PTGS1, PTGS2",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K28687144-001-08-7,
REP.PRIMARY,2.4206728720000004,SULMETOZINE,GAST,GASTRIN INHIBITOR,BRD:BRD-K29570907-001-07-3,
REP.PRIMARY,2.682001852,IMIDAFENACIN,"CHRM1, CHRM3",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K29626940-001-01-5,
REP.PRIMARY,2.472474424,DIMEMORFAN,SIGMAR1,SIGMA RECEPTOR AGONIST,BRD:BRD-K29812331-011-01-7,
REP.PRIMARY,2.49998123,RSV604,,RSV REPLICATION INHIBITOR,BRD:BRD-K30159788-001-01-9,
REP.PRIMARY,2.479775098,SUMANIROLE,DRD2,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K30485548-050-01-6,
REP.PRIMARY,2.5,MIOCAMYCIN,,OTHER ANTIBIOTIC,BRD:BRD-K30764557-001-01-5,
REP.PRIMARY,2.500026128,INT-747,,FXR AGONIST,BRD:BRD-K30968378-001-01-9,
REP.PRIMARY,2.4999959890000003,PF-3274167,"AVPR1A, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-K31417912-001-01-9,
REP.PRIMARY,2.5307816250000004,JNJ-37822681,DRD2,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K31802667-001-01-9,
REP.PRIMARY,2.499998021,SOLITHROMYCIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K32256160-001-01-9,
REP.PRIMARY,2.5,VALROCEMIDE,,,BRD:BRD-K32804101-001-01-8,
REP.PRIMARY,2.5,PEMETREXED,"ATIC, DHFR, GART, TYMS","DIHYDROFOLATE REDUCTASE INHIBITOR, THYMIDYLATE SYNTHASE INHIBITOR",BRD:BRD-K32842773-434-01-8,
REP.PRIMARY,2.719791572,CORTODOXONE,AR,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K32891457-001-15-5,
REP.PRIMARY,2.644499841,GENTIOPICRIN,GRIN2B,GLUTAMATE RECEPTOR DOWNREGULATOR,BRD:BRD-K33131085-001-07-2,
REP.PRIMARY,2.5,DAPIPRAZOLE,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K33133047-001-01-8,
REP.PRIMARY,2.50000539,PLERIXAFOR,"ACKR3, CCR4, CXCR4",CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K33240821-001-06-2,
REP.PRIMARY,2.50001558,BMS-833923,SMO,SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K33245965-001-03-4,
REP.PRIMARY,2.500021224,FLIBANSERIN,"DRD4, HTR1A, HTR2A",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33637378-001-01-7,
REP.PRIMARY,2.499970684,DELAVIRDINE,CYP3A4,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K34068325-066-03-7,
REP.PRIMARY,2.459743274,CIBENZOLINE,,SODIUM CHANNEL BLOCKER,BRD:BRD-K34251960-036-01-6,
REP.PRIMARY,2.569027627,L-365260,"CCKAR, CCKBR, KCNQ1",CCK RECEPTOR ANTAGONIST,BRD:BRD-K34277641-001-01-2,
REP.PRIMARY,2.3342664710000003,SLV-320,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K34445261-001-02-2,
REP.PRIMARY,2.4999754650000003,CHF5074,PSEN1,GAMMA SECRETASE MODULATOR,BRD:BRD-K34508702-001-02-4,
REP.PRIMARY,2.5,EXAMORELIN,"GHRHR, GHSR",GROWTH HORMONE RELEASING FACTOR AGONIST,BRD:BRD-K35304636-001-01-0,
REP.PRIMARY,2.5,LY223982,LTB4R,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K35367061-001-01-1,
REP.PRIMARY,2.4999862420000003,TRV130,OPRM1,OPIOID RECEPTOR AGONIST,BRD:BRD-K35626314-003-01-1,
REP.PRIMARY,2.5,POLIDOCANOL,,LOCAL ANESTHETIC,BRD:BRD-K35798650-001-01-4,
REP.PRIMARY,2.444346727,MITOFLAXONE,VWF,ANTITUMOR AGENT,BRD:BRD-K35882976-001-04-7,
REP.PRIMARY,2.547414282,RIODIPINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K36379990-001-01-1,
REP.PRIMARY,2.499956047,OC000459,PTGDR2,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K36463073-001-03-9,
REP.PRIMARY,2.500001799,PAROMOMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K36524108-065-04-0,
REP.PRIMARY,2.5,LAROTRECTINIB,"NTRK1, NTRK2, NTRK3",TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-K36574127-001-01-3,LOXO-101
REP.PRIMARY,2.5,LOXO-101,"NTRK1, NTRK2, NTRK3",TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-K36574127-001-01-3,LOXO-101
REP.PRIMARY,2.518926249,NOLATREXED,TYMS,THYMIDYLATE SYNTHASE INHIBITOR,BRD:BRD-K36636143-001-01-0,
REP.PRIMARY,2.4999630390000003,VERINURAD,SLC22A12,URATE TRANSPORTER INHIBITOR,BRD:BRD-K36741660-001-01-1,
REP.PRIMARY,2.5888290830000003,TREPIBUTONE,"CHRM1, CHRM2, CHRM3, CHRM4",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K37543758-001-01-3,
REP.PRIMARY,2.530276706,EXISULIND,PDE5A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K37708699-001-01-4,
REP.PRIMARY,2.422985058,DABIGATRAN,F2,THROMBIN INHIBITOR,BRD:BRD-K38168441-001-03-7,
REP.PRIMARY,2.418470509,YM-511,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K38398115-001-01-9,
REP.PRIMARY,2.652726792,DROLOXIFENE,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K38477637-001-01-0,
REP.PRIMARY,2.300987371,ATIPRIMOD,"JAK2, STAT3","JAK INHIBITOR, STAT INHIBITOR",BRD:BRD-K38527262-300-01-0,
REP.PRIMARY,2.5,ROLZIRACETAM,,,BRD:BRD-K38564664-001-01-1,
REP.PRIMARY,2.5,ENTRECTINIB,"ALK, NTRK1, NTRK2, NTRK3, ROS1","ALK TYROSINE KINASE RECEPTOR INHIBITOR, PROTO-ONCOGENE TYROSINE PROTEIN KINASE INHIBITOR",BRD:BRD-K39009484-001-01-4,
REP.PRIMARY,2.500010466,ELUXADOLINE,"OPRD1, OPRK1, OPRM1","OPIOID RECEPTOR AGONIST, OPIOID RECEPTOR ANTAGONIST, OPIOID RECEPTOR MODULATOR",BRD:BRD-K39560679-001-01-1,
REP.PRIMARY,2.5,ORG-26576,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K40002998-001-01-5,
REP.PRIMARY,2.5,F351,TGFB1,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K41267922-001-01-4,
REP.PRIMARY,2.500006592,NALOXEGOL,OPRM1,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K41458421-034-01-6,
REP.PRIMARY,2.5,7-METHYLXANTHINE,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K41592905-001-01-6,
REP.PRIMARY,2.5173807050000003,TECALCET,CASR,CALCIUM-SENSING RECEPTOR AGONIST,BRD:BRD-K41662846-003-01-5,
REP.PRIMARY,2.4999955170000003,LOREDIPLON,GABRA1,GABA RECEPTOR MODULATOR,BRD:BRD-K42066335-001-01-0,
REP.PRIMARY,2.500009363,ALARELIN,GNRH1,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K42140276-402-01-4,
REP.PRIMARY,2.5000371770000003,NORELGESTROMIN,PGR,,BRD:BRD-K42504537-001-01-6,
REP.PRIMARY,2.3633557460000003,VERUBULIN,TUBB,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K42673188-001-01-1,
REP.PRIMARY,2.38330586,ZILPATEROL,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K42816473-001-01-0,
REP.PRIMARY,2.50004725,CRISABOROLE,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K43230258-001-01-4,
REP.PRIMARY,2.3568031890000003,MK-2295,TRPV1,TRPV ANTAGONIST,BRD:BRD-K43316319-001-01-8,
REP.PRIMARY,2.500038533,HEMOGLOBIN-MODULATORS-1,,HEMOGLOBIN MODULATOR,BRD:BRD-K43639297-001-01-9,VOXELOTOR
REP.PRIMARY,2.500038533,VOXELOTOR,,HEMOGLOBIN MODULATOR,BRD:BRD-K43639297-001-01-9,VOXELOTOR
REP.PRIMARY,2.5,NERBACADOL,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K43647122-001-01-3,
REP.PRIMARY,2.479237222,PRUVANSERIN,"HTR2A, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K43837174-003-01-3,
REP.PRIMARY,2.5,GEMCADIOL,,ANTILIPEMIC,BRD:BRD-K43890836-001-01-6,
REP.PRIMARY,2.499995729,TERUTROBAN,TBXA2R,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K43975632-001-01-1,
REP.PRIMARY,2.500000065,PONESIMOD,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K44030614-001-01-6,
REP.PRIMARY,2.54181785,PUMOSETRAG,"HTR3A, HTR4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K44164034-003-01-1,
REP.PRIMARY,2.5,OSPEMIFENE,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K44184170-001-01-7,
REP.PRIMARY,2.670187358,BAY-W-9798,,ANTIOXIDANT,BRD:BRD-K44471774-001-01-8,
REP.PRIMARY,2.5,ZOLIMIDINE,,MUCUS PROTECTING AGENT,BRD:BRD-K45125084-001-01-4,
REP.PRIMARY,2.4999914110000003,PRESATOVIR,,RSV FUSION INHIBITOR,BRD:BRD-K45906612-001-01-8,
REP.PRIMARY,2.584121204,PHENSERINE,"ACHE, BCHE","ACETYLCHOLINESTERASE INHIBITOR, BETA AMYLOID SYNTHESIS INHIBITOR",BRD:BRD-K46580984-001-03-6,
REP.PRIMARY,2.50003993,OZANIMOD,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K46625559-001-01-8,
REP.PRIMARY,2.5,ZOTAROLIMUS,FKBP1A,MTOR INHIBITOR,BRD:BRD-K46843573-001-01-9,
REP.PRIMARY,2.4999522080000003,METYRAPONE,CYP11B1,CYTOCHROME P450 INHIBITOR,BRD:BRD-K46862739-001-14-3,
REP.PRIMARY,2.5,ALCLOFENAC,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K47492008-001-02-7,
REP.PRIMARY,2.5,BIPENAMOL,CTSC,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K47690382-001-03-0,
REP.PRIMARY,2.5,NITENPYRAM,,,BRD:BRD-K47887731-001-01-4,
REP.PRIMARY,2.500019706,VERCIRNON,CCR9,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K47929404-001-01-0,
REP.PRIMARY,2.5,PIPOTIAZINE-PALMITATE,"DRD1, DRD2, HTR1A, HTR2A","DOPAMINE RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K48429278-001-01-3,
REP.PRIMARY,2.5,SRT2104,SIRT1,SIRT ACTIVATOR,BRD:BRD-K48452630-001-01-8,
REP.PRIMARY,2.5,MOFEZOLAC,PTGS1,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K49372556-001-04-1,
REP.PRIMARY,2.5000024670000003,TMC647055,,RNA POLYMERASE INHIBITOR,BRD:BRD-K49659468-436-01-2,
REP.PRIMARY,2.5,CASPOFUNGIN-ACETATE,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K49793107-402-02-6,
REP.PRIMARY,2.690488579,ROSOXACIN,,TOPOISOMERASE INHIBITOR,BRD:BRD-K49841478-001-01-6,
REP.PRIMARY,2.5,POZIOTINIB,"EGFR, ERBB2, ERBB4",EGFR INHIBITOR,BRD:BRD-K50010139-001-02-3,
REP.PRIMARY,2.701086832,HALOPEMIDE,"PLD1, PLD2",PHOSPHOLIPASE INHIBITOR,BRD:BRD-K50055394-001-03-6,
REP.PRIMARY,2.5,BORONOPHENYLALANINE,,,BRD:BRD-K50122911-001-01-2,
REP.PRIMARY,2.500007911,RANIRESTAT,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K50489389-001-01-8,
REP.PRIMARY,2.499989832,EPICATECHIN-GALLATE-(-),"BACE1, FASN",BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K50660797-001-05-1,
REP.PRIMARY,2.5928305820000004,AMFLUTIZOLE,XDH,XANTHINE OXIDASE INHIBITOR,BRD:BRD-K50813454-001-01-9,
REP.PRIMARY,2.5,DIPHENCYPRONE,,IMMUNOSTIMULANT,BRD:BRD-K51730347-001-06-4,
REP.PRIMARY,2.297010706,ALACEPRIL,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K51784806-001-01-6,
REP.PRIMARY,2.500004375,AZELIRAGON,AGER,RAGE RECEPTOR ANTAGONIST,BRD:BRD-K51899933-001-02-6,
REP.PRIMARY,2.52122192,IOPODIC-ACID,,,BRD:BRD-K51956333-001-03-8,
REP.PRIMARY,2.499985811,TGR-1202,,PI3K INHIBITOR,BRD:BRD-K52579889-001-01-9,
REP.PRIMARY,2.472084005,ALTINICLINE,"CHRNA4, CHRNB2",NICOTINIC RECEPTOR AGONIST,BRD:BRD-K52681925-050-01-6,
REP.PRIMARY,2.5,LTA,,,BRD:BRD-K52914072-001-01-5,
REP.PRIMARY,2.499955314,ACETOHEXAMIDE,"ABCC8, KCNJ1, KCNJ10, KCNJ11",ATP CHANNEL BLOCKER,BRD:BRD-K52960356-001-15-5,
REP.PRIMARY,2.5,7-METHOXYTACRINE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K53156626-001-01-3,
REP.PRIMARY,2.2985723090000003,SIPATRIGINE,"CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K53195974-001-01-9,
REP.PRIMARY,2.6251723040000003,APRINDINE,"CALM1, SCN5A",VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K53236343-003-03-7,
REP.PRIMARY,2.5,ESTRADIOL-ACETATE,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K53319039-001-01-8,
REP.PRIMARY,2.7277446999999997,FOSPHENYTOIN,SCN5A,SODIUM CHANNEL BLOCKER,BRD:BRD-K53809807-304-02-4,
REP.PRIMARY,2.5,PROQUAZONE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K54339150-001-01-8,
REP.PRIMARY,2.4999713320000003,PEXIDARTINIB,"CSF1R, FLT3, KIT",TYROSINE KINASE INHIBITOR,BRD:BRD-K54519451-001-02-9,
REP.PRIMARY,2.693644572,DARUSENTAN,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K54863166-001-01-9,
REP.PRIMARY,2.4999956,AKBA,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K54907283-001-01-2,
REP.PRIMARY,2.49997945,NIRAPARIB,PARP1,PARP INHIBITOR,BRD:BRD-K54955827-001-02-2,
REP.PRIMARY,2.499962393,JNJ-40411813,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K55029398-001-01-6,
REP.PRIMARY,2.5,APRICITABINE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K55172746-001-01-3,
REP.PRIMARY,2.50001813,TOPOTECAN,"TOP1, TOP1MT",TOPOISOMERASE INHIBITOR,BRD:BRD-K55696337-003-24-4,
REP.PRIMARY,2.500006596,ELAGOLIX,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K55808645-001-01-4,
REP.PRIMARY,2.5,ALCAFTADINE,HRH1,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K55991142-001-01-6,
REP.PRIMARY,2.499996486,CARBETOCIN,OXTR,OXYTOCIN RECEPTOR AGONIST,BRD:BRD-K56107812-001-01-7,
REP.PRIMARY,2.3552516590000003,ERGOCALCIFEROL,VDR,VITAMIN ANALOG,BRD:BRD-K56155962-001-12-1,
REP.PRIMARY,2.5,RTA-408,NFE2L2,NITRIC OXIDE PRODUCTION INHIBITOR,BRD:BRD-K56211775-001-03-8,
REP.PRIMARY,2.5000321860000003,CALCIPOTRIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K56429665-001-09-6,
REP.PRIMARY,2.6015277940000003,FLINDOKALNER,"KCNMA1, KCNN4, KCNQ2, KCNQ4, KCNQ5",POTASSIUM CHANNEL AGONIST,BRD:BRD-K56740996-001-01-3,
REP.PRIMARY,2.500001454,FG-2216,"EGLN1, EGLN2, HIF1A",HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K56807945-001-01-2,
REP.PRIMARY,2.499992214,SAR407899,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K56912469-003-02-0,
REP.PRIMARY,2.500008954,BRIGATINIB,"ALK, EGFR","ALK TYROSINE KINASE RECEPTOR INHIBITOR, EGFR INHIBITOR",BRD:BRD-K56981171-001-01-0,
REP.PRIMARY,2.499996307,TAK-063,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K57155378-001-01-1,
REP.PRIMARY,2.5,RIPAZEPAM,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K57427145-001-01-6,
REP.PRIMARY,2.643351543,FOROPAFANT,PTAFR,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K57774929-001-01-3,
REP.PRIMARY,2.5,FLUOCINONIDE,"NR3C1, SERPINA6, SMO",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K57886322-001-16-6,
REP.PRIMARY,2.5,NPC-01,,STEROID,BRD:BRD-K58277159-001-01-7,
REP.PRIMARY,2.6485779380000003,ONC201,TNFSF10,"AKT INHIBITOR, MAP KINASE INHIBITOR",BRD:BRD-K58529924-001-01-5,
REP.PRIMARY,2.564588683,CLOBETASONE-BUTYRATE,NR3C1,CORTICOSTEROID AGONIST,BRD:BRD-K58810291-001-16-2,
REP.PRIMARY,2.431061328,GABEXATE,"PRSS1, TPSAB1",SERINE PROTEASE INHIBITOR,BRD:BRD-K59256312-066-15-7,
REP.PRIMARY,2.5,LIXIVAPTAN,AVPR2,VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K59391348-001-01-7,
REP.PRIMARY,2.5,VINDESINE,"TUBB, TUBB1",TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K59753975-001-02-6,
REP.PRIMARY,2.379655165,CYCLOVALONE,ABCG2,BREAST CANCER RESISTANCE PROTEIN INHIBITOR,BRD:BRD-K59866480-001-07-3,
REP.PRIMARY,2.591975371,CARAMIPHEN,"CHRM1, CHRM2",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K59895502-001-01-9,
REP.PRIMARY,2.5,UNC0642,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K60130390-001-02-1,
REP.PRIMARY,2.5,ISODIBUT,,ALDEHYDE REDUCTASE INHIBITOR,BRD:BRD-K60241851-001-11-9,
REP.PRIMARY,2.5,TITANOCENE-DICHLORIDE,,APOPTOSIS STIMULANT,BRD:BRD-K60284353-001-01-3,
REP.PRIMARY,2.499975038,OLMUTINIB,"BTK, EGFR","BRUTON'S TYROSINE KINASE (BTK) INHIBITOR, EGFR INHIBITOR",BRD:BRD-K60421517-001-01-4,
REP.PRIMARY,2.467864576,DESIPRAMINE,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR1A, HTR2A, HTR2C, SLC6A2, SLC6A4, SMPD1",TRICYCLIC ANTIDEPRESSANT,BRD:BRD-K60762818-003-26-0,
REP.PRIMARY,2.665505334,FANETIZOLE,,NEUTROPHIL SUPEROXIDE PRODUCTION,BRD:BRD-K60798049-001-03-8,
REP.PRIMARY,2.5,FLUMETHASONE,"NR3C1, PLA2G1B",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K61496577-001-19-4,
REP.PRIMARY,2.4999247280000003,FAGOMINE,GLB1,GLUCOSIDASE INHIBITOR,BRD:BRD-K61536264-001-01-3,
REP.PRIMARY,2.499990535,GDC-0810,ESR1,SELECTIVE ESTROGEN RECEPTOR DESTABILIZER,BRD:BRD-K61923022-001-02-4,
REP.PRIMARY,2.5000153810000003,TOCERANIB,"FLT1, FLT3, KDR, PDGFRA, PDGFRB",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K62040061-001-01-0,
REP.PRIMARY,2.499980818,GRAPIPRANT,PTGER4,PROSTAGLANDIN INHIBITOR,BRD:BRD-K62050508-001-01-0,
REP.PRIMARY,2.500058444,HUPERZINE-A,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K62240499-001-05-9,
REP.PRIMARY,3.1195349940000003,L-GLUTAMIC-ACID,"AADAT, AASS, ABAT, ALDH18A1, ASNS, BCAT1, BCAT2, CCBL2, DNPEP, EARS2, ENPEP, EPRS, FOLH1, FPGS, FTCD, GAD1, GAD2, GATB, GCLC, GCLM, GGCX, GLS, GLS2, GLUD1, GLUD2, GLUL, GMPS, GOT1, GOT2, GPT, GPT2, GRIA1, GRIA2, GRIA3, GRIA4, GRID1, GRID2, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM1, GRM2, GRM3, GRM4, GRM6, GRM7, GRM8, LGSN, NADSYN1, NAGS, OPLAH, PFAS, PGCP, PSAT1, SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7, SLC25A18, SLC25A22, SLC7A11, TAT",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K62309135-001-05-2,
REP.PRIMARY,2.4999726630000003,PI3K-IN-2,,PI3K INHIBITOR,BRD:BRD-K62374002-001-01-5,
REP.PRIMARY,2.4999709830000003,SIPONIMOD,S1PR1,"SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, SPHINGOSINE PHOSPHATE RECEPTOR MODULATOR",BRD:BRD-K62384160-001-02-0,
REP.PRIMARY,2.495325825,IBROLIPIM,LPL,LIPOPROTEIN LIPASE ACTIVATOR,BRD:BRD-K62490786-001-01-1,
REP.PRIMARY,2.5,TASIMELTEON,"MTNR1A, MTNR1B",MELATONIN RECEPTOR AGONIST,BRD:BRD-K62971431-001-01-9,
REP.PRIMARY,2.500011413,RELEBACTAM,,BETA LACTAMASE INHIBITOR,BRD:BRD-K63018010-001-01-7,
REP.PRIMARY,2.499971604,BEMPEDOIC-ACID,ACLY,AMPK INHIBITOR,BRD:BRD-K63177377-001-01-8,ETC-1002
REP.PRIMARY,2.499971604,ETC-1002,ACLY,AMPK INHIBITOR,BRD:BRD-K63177377-001-01-8,ETC-1002
REP.PRIMARY,2.499989061,ICATIBANT-ACETATE,"ANPEP, BDKRB2",BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K63772874-001-02-2,
REP.PRIMARY,2.4999819160000003,ACALABRUTINIB,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K64034691-001-01-9,
REP.PRIMARY,2.5,VINFLUNINE,,MICROTUBULE INHIBITOR,BRD:BRD-K64120610-001-01-4,
REP.PRIMARY,2.5,ABAMETAPIR,MMP9,METALLOPROTEINASE INHIBITOR,BRD:BRD-K65498798-001-01-7,
REP.PRIMARY,2.686421113,CAROVERINE,,"CALCIUM CHANNEL BLOCKER, GLUTAMATE RECEPTOR ANTAGONIST",BRD:BRD-K65900713-003-01-0,
REP.PRIMARY,2.50001534,OPICAPONE,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K66192203-001-02-2,
REP.PRIMARY,2.5,FERULIC-ACID,"CA1, CA12, CA14, CA2, CA4, CA6, CA9",ANTIOXIDANT,BRD:BRD-K66295376-001-13-1,
REP.PRIMARY,2.49636183,KT-433,,URICOSURIC AGENT,BRD:BRD-K66437909-001-01-0,
REP.PRIMARY,2.500037331,PREGABALIN,"CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8",VOLTAGE-GATED CALCIUM CHANNEL LIGAND,BRD:BRD-K66786476-001-01-3,
REP.PRIMARY,2.5,SOPHOCARPINE,,,BRD:BRD-K66845263-001-03-0,
REP.PRIMARY,2.5,DEXTRAN,,,BRD:BRD-K67117832-001-01-9,
REP.PRIMARY,2.500004874,DEHYDROCORYDALINE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K67186445-001-02-1,
REP.PRIMARY,2.500004112,ITACITINIB,JAK1,JAK INHIBITOR,BRD:BRD-K67482377-001-01-8,
REP.PRIMARY,2.500004949,INCB-3284,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K67628093-001-01-9,
REP.PRIMARY,2.4206409950000003,CARBOXYAMIDOTRIAZOLE,CXCL8,CALCIUM CHANNEL BLOCKER,BRD:BRD-K68408772-001-05-4,
REP.PRIMARY,2.500029469,AMPICILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K68432770-236-23-1,
REP.PRIMARY,2.500014712,AVATROMBOPAG,MPL,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K68544925-001-01-1,
REP.PRIMARY,2.5,PANTETHINE,,COENZYME A PRECURSOR,BRD:BRD-K68764924-001-03-2,
REP.PRIMARY,2.49998713,TESTOLACTONE,CYP19A1,AROMATASE INHIBITOR,BRD:BRD-K69636617-001-01-7,
REP.PRIMARY,2.499979212,GSK163090,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K69669039-001-01-8,
REP.PRIMARY,2.4999660770000003,AGN-194310,"RXRA, RXRB, RXRG",RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K70262971-001-01-9,
REP.PRIMARY,2.50000853,JNJ-42165279,FAAH,FAAH INHIBITOR,BRD:BRD-K70330032-001-01-1,
REP.PRIMARY,2.500017504,FRUQUINTINIB,KDR,VEGFR INHIBITOR,BRD:BRD-K70504253-001-01-3,
REP.PRIMARY,2.5,PHENINDIONE,VKORC1,VITAMIN K ANTAGONIST,BRD:BRD-K70592963-001-31-6,
REP.PRIMARY,2.500008826,ENASIDENIB,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K70601687-001-01-3,
REP.PRIMARY,2.500008535,TESTOSTERONE-UNDECANOATE,AR,ANDROGEN RECEPTOR AGONIST,BRD:BRD-K70650177-001-01-7,
REP.PRIMARY,2.3974043870000004,CARUMONAM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K71026158-304-01-0,
REP.PRIMARY,2.5,PIROXIMONE,PDE3A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K71977764-001-01-2,
REP.PRIMARY,2.4448575860000004,DYCLONINE,"SCN10A, SCN5A",SODIUM CHANNEL BLOCKER,BRD:BRD-K72259270-003-25-6,
REP.PRIMARY,2.5,BRD4770,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K72264770-001-03-2,
REP.PRIMARY,2.4999939390000003,GILTERITINIB,FLT3,FLT3 INHIBITOR,BRD:BRD-K72280606-001-01-2,
REP.PRIMARY,2.5,ETOPOSIDE-PHOSPHATE,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K72533376-001-01-2,
REP.PRIMARY,2.6934256430000003,OXYFEDRINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K73027814-003-01-0,
REP.PRIMARY,2.5,VASOPRESSIN,"AVPR1A, AVPR1B, AVPR2, OXTR",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K73028949-001-02-8,
REP.PRIMARY,2.5,PYRONARIDINE,,ANTIMALARIAL AGENT,BRD:BRD-K73132780-001-01-2,
REP.PRIMARY,2.5,TERLIPRESSIN,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K73451719-001-01-2,
REP.PRIMARY,2.5,BIVALIRUDIN,F2,THROMBIN INHIBITOR,BRD:BRD-K73504359-001-01-3,
REP.PRIMARY,2.499988098,GS-9620,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K73585091-001-02-3,
REP.PRIMARY,2.4999572590000003,HEXAMINOLEVULINATE,,,BRD:BRD-K73753850-003-01-6,
REP.PRIMARY,2.500023768,ARBIDOL,CYP3A4,CYTOCHROME P450 INHIBITOR,BRD:BRD-K73881242-003-04-6,
REP.PRIMARY,2.5,UNC0321,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K74236984-001-04-8,
REP.PRIMARY,2.5,IDRONOXIL,"ENOX2, SPHK1",XIAP INHIBITOR,BRD:BRD-K74671368-001-01-8,
REP.PRIMARY,2.5,ISEPAMICIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K74759733-065-01-4,
REP.PRIMARY,2.548558667,DIPT,"HTR1A, HTR2A, HTR2C","DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K75385383-001-01-5,
REP.PRIMARY,2.5,ESTETROL,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K75445017-001-01-1,
REP.PRIMARY,2.5,PYRIDOXAL,PDXK,,BRD:BRD-K76204040-001-03-8,
REP.PRIMARY,2.5,CETRORELIX,"GNRHR, LHCGR",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K76315403-015-02-5,
REP.PRIMARY,2.5000234999999997,MAROPITANT,TACR1,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K76594255-001-01-6,
REP.PRIMARY,2.707477898,ATIZORAM,"PDE4A, PDE4B, PDE4C, PDE4D",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K76614248-001-01-2,
REP.PRIMARY,2.5,IDOXURIDINE,,"DNA DIRECTED DNA POLYMERASE INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K76634210-001-12-1,
REP.PRIMARY,2.499961706,TAVABOROLE,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K76713213-001-02-1,
REP.PRIMARY,2.4666174350000003,GS-9973,SYK,SYK INHIBITOR,BRD:BRD-K76719364-001-02-5,
REP.PRIMARY,2.500019441,NITROFURANTOIN,,DNA INHIBITOR,BRD:BRD-K76927775-001-11-8,
REP.PRIMARY,2.500022896,GARENOXACIN,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K77038618-356-01-3,
REP.PRIMARY,2.5,CEFMINOX,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K77073709-435-01-2,
REP.PRIMARY,2.555048691,CALCIFEDIOL,VDR,VITAMIN D RECEPTOR AGONIST,BRD:BRD-K77175907-001-08-0,
REP.PRIMARY,2.29566066,SECOISOLARICIRESINOL-DIGLUCOSIDE,,ANTIOXIDANT,BRD:BRD-K77320845-001-01-2,
REP.PRIMARY,2.5,UNC0224,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77428767-001-01-7,
REP.PRIMARY,2.715966218,ABAFUNGIN,,STEROL METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77432251-001-01-2,
REP.PRIMARY,2.67296817,FENOVERINE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K77564118-001-03-1,
REP.PRIMARY,2.4999780080000003,LEMBOREXANT,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K78666663-001-01-6,
REP.PRIMARY,2.3885868620000004,ASPARTAME,"TAS1R2, TRPV1",,BRD:BRD-K78841970-001-13-8,
REP.PRIMARY,2.4999976040000003,EPACADOSTAT,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-01-8,INCB-024360
REP.PRIMARY,2.4999976040000003,INCB-024360,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-01-8,INCB-024360
REP.PRIMARY,2.5,EPACADOSTAT,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-02-6,INCB-024360
REP.PRIMARY,2.5,INCB-024360,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K79450420-001-02-6,INCB-024360
REP.PRIMARY,2.5,GKT137831,"NOX1, NOX4",NADPH OXIDASE INHIBITOR,BRD:BRD-K79710622-001-02-9,
REP.PRIMARY,2.5,POZANICLINE,"CHRNA4, CHRNB2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K79803033-300-01-3,
REP.PRIMARY,2.5620092050000003,RUBITECAN,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K79821389-001-03-5,
REP.PRIMARY,2.356620242,DIFTALONE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80076813-001-08-8,
REP.PRIMARY,2.5,KHELLIN,,VASODILATOR,BRD:BRD-K80353807-001-25-3,
REP.PRIMARY,2.500041136,TALAMPANEL,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K80359953-001-01-3,
REP.PRIMARY,2.5,DEBRISOQUIN,SLC6A2,ADRENERGIC NEURON BLOCKER,BRD:BRD-K80419150-001-02-4,
REP.PRIMARY,2.5,FK-962,,SOMATOSTATIN RECEPTOR AGONIST,BRD:BRD-K80607346-001-01-1,
REP.PRIMARY,2.5000378540000003,RESVERATROL,"CSNK2A1, NQO2, PTGS1, PTGS2","CYTOCHROME P450 INHIBITOR, SIRT ACTIVATOR",BRD:BRD-K80738081-001-46-8,
REP.PRIMARY,2.5,INDOCYANINE-GREEN,SLCO1B1,CONTRAST AGENT,BRD:BRD-K80762071-236-02-5,
REP.PRIMARY,2.5,HALOPERIDOL-DECANOATE,"DRD2, DRD3, DRD4, HTR2A",PSYCHOACTIVE DRUG,BRD:BRD-K80859331-001-01-5,
REP.PRIMARY,2.5,JTE-607,"IL10, IL1B, IL6, TNF",CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-K81405859-300-01-4,
REP.PRIMARY,2.665005855,PNU-142633,HTR1D,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K81616657-001-01-4,
REP.PRIMARY,2.5707186130000004,GAVESTINEL,"GLRB, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K81981783-236-02-9,
REP.PRIMARY,2.500073689,HYDRALAZINE,"AOC3, P4HA1",VASODILATOR,BRD:BRD-K82103381-003-09-4,
REP.PRIMARY,2.646883368,PYRANTEL,,"ACETYLCHOLINE RECEPTOR AGONIST, NICOTINIC RECEPTOR AGONIST",BRD:BRD-K82118441-001-03-7,
REP.PRIMARY,2.5,TOLONIDINE,ADRA2A,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K82687598-001-01-6,
REP.PRIMARY,2.434467427,DARGLITAZONE,PPARG,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K82908348-001-01-9,
REP.PRIMARY,2.500024493,LY3023414,MTOR,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K82967180-001-01-6,
REP.PRIMARY,2.500025378,LITRONESIB,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K83029223-001-01-3,
REP.PRIMARY,2.5,OLMESARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K83144676-001-09-5,
REP.PRIMARY,2.5,TRYPTOPHAN,"CASR, IDO1, SLC36A1, WARS, WARS2",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K83776863-001-08-9,
REP.PRIMARY,2.500018826,17-ALPHA-METHYLTESTOSTERONE,AR,AROMATASE INHIBITOR,BRD:BRD-K84036904-001-08-8,
REP.PRIMARY,2.5,UFENAMATE,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K84173274-001-01-6,
REP.PRIMARY,2.500011105,PRALIDOXIME,"ACHE, BCHE",ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K84281997-003-08-4,
REP.PRIMARY,2.4030056390000003,ZOPOLRESTAT,,,BRD:BRD-K84459715-001-01-6,
REP.PRIMARY,2.5000063640000003,ERDAFITINIB,"FGFR1, FGFR2, FGFR3, FGFR4",FGFR INHIBITOR,BRD:BRD-K84868168-001-01-0,
REP.PRIMARY,2.632189712,ETAFENONE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K84971356-001-01-4,
REP.PRIMARY,2.500009065,AVIBACTAM,,BETA LACTAMASE INHIBITOR,BRD:BRD-K85882401-323-01-5,
REP.PRIMARY,2.5,ELTOPRAZINE,"HTR1A, HTR1B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K86171477-001-01-3,
REP.PRIMARY,2.440473496,BROMANTAN,,"DOPAMINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-K86358349-001-02-0,
REP.PRIMARY,2.499987354,ELIGLUSTAT,UGCG,GLYCOSYL TRANSFERASE INHIBITOR,BRD:BRD-K86410485-046-01-0,
REP.PRIMARY,2.500040519,SUTEZOLID,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K86670086-001-02-5,
REP.PRIMARY,2.5,UNC0638,"EHMT1, EHMT2",HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K86856088-001-06-9,
REP.PRIMARY,2.5,CHLOROPROCAINE,"ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3",SODIUM CHANNEL BLOCKER,BRD:BRD-K86864073-001-01-1,
REP.PRIMARY,2.448463554,PIPERACILLIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K86873305-236-14-7,
REP.PRIMARY,2.4999750560000003,PRINABEREL,"ESR2, NCOA1",ESTROGEN RECEPTOR AGONIST,BRD:BRD-K87316765-001-01-4,
REP.PRIMARY,2.5,DIROXIMEL-FUMARATE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K87386013-001-01-7,
REP.PRIMARY,2.5,UNC0646,EHMT2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87465484-001-02-7,
REP.PRIMARY,2.5,CL-225385,,,BRD:BRD-K87573013-001-01-0,
REP.PRIMARY,2.5,IROSUSTAT,"CA2, STS",STEROID SULFATASE INHIBITOR,BRD:BRD-K87777313-001-02-2,
REP.PRIMARY,2.499985333,F-11440,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K87948281-001-01-9,
REP.PRIMARY,2.5,METHARBITAL,"CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2",GABA RECEPTOR MODULATOR,BRD:BRD-K88143662-001-01-5,
REP.PRIMARY,2.499975441,TAPRENEPAG,PTGER2,PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K88854110-001-01-5,
REP.PRIMARY,2.499967871,FENRETINIDE,RARA,"APOPTOSIS STIMULANT, RETINOID RECEPTOR AGONIST",BRD:BRD-K89085489-001-23-2,
REP.PRIMARY,2.499999138,TEDIZOLID-PHOSPHATE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K89121095-001-01-7,
REP.PRIMARY,2.499996082,NALFURAFINE,"OPRK1, OPRM1",OPIOID RECEPTOR AGONIST,BRD:BRD-K89272869-003-01-8,
REP.PRIMARY,2.500023482,REMIMAZOLAM,GABBR1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89413285-074-01-5,
REP.PRIMARY,2.521612095,BENTAZEPAM,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K89490285-001-08-1,
REP.PRIMARY,2.500013597,PARITAPREVIR,,HCV INHIBITOR,BRD:BRD-K89920762-001-01-4,
REP.PRIMARY,2.5,ISOVALERAMIDE,,ALCOHOL DEHYDROGENASE INHIBITOR,BRD:BRD-K90069354-001-03-7,
REP.PRIMARY,2.328630918,LY2452473,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K90171280-001-01-4,
REP.PRIMARY,2.5,NATAMYCIN,,FUNGAL ERGOSTEROL INHIBITOR,BRD:BRD-K90563805-001-02-6,
REP.PRIMARY,2.5,EMORFAZONE,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, CYCLOOXYGENASE INHIBITOR",BRD:BRD-K90629600-001-01-4,
REP.PRIMARY,2.5,ETILEVODOPA,DRD3,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K90982969-001-01-2,
REP.PRIMARY,2.316613157,PROPIVERINE,CHRM1,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K91244729-003-01-3,
REP.PRIMARY,2.500076093,MK-0354,"HCAR2, HCAR3",NIACIN RECEPTOR AGONIST,BRD:BRD-K91405252-001-01-9,
REP.PRIMARY,2.5000443810000004,PENTOSTATIN,ADA,"ADENOSINE DEAMINASE INHIBITOR, RIBONUCLEOTIDE REDUCTASE INHIBITOR",BRD:BRD-K91543828-001-02-0,
REP.PRIMARY,2.500030257,VX-745,"MAPK11, MAPK12, MAPK14",P38 MAPK INHIBITOR,BRD:BRD-K91900765-001-07-6,
REP.PRIMARY,2.5,NORETHINDRONE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92073408-001-15-7,
REP.PRIMARY,2.5,PROCYSTEINE,,GLUTATHIONE SYNTHASE STIMULANT,BRD:BRD-K92413528-001-06-9,
REP.PRIMARY,2.5,ESAPRAZOLE,,,BRD:BRD-K92426617-001-06-3,
REP.PRIMARY,2.500037393,ANETHOLE-TRITHIONE,,GLUTATHIONE TRANSFERASE STIMULANT,BRD:BRD-K92490248-001-06-6,
REP.PRIMARY,2.3890822270000003,OCINAPLON,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR MODULATOR,BRD:BRD-K92581468-001-01-6,
REP.PRIMARY,2.5079525360000003,HYDROXYPROGESTERONE-ACETATE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K92902018-001-01-9,
REP.PRIMARY,2.501017998,MEDICA-16,FFAR1,ATP CITRASE LYASE INHIBITOR,BRD:BRD-K92908289-001-01-8,
REP.PRIMARY,2.5,VORAPAXAR,F2R,"THROMBIN INHIBITOR, THROMBIN RECEPTOR ANTAGONIST",BRD:BRD-K93442924-001-03-4,
REP.PRIMARY,2.6139578240000003,STETADERM,,,BRD:BRD-K93900986-001-15-0,
REP.PRIMARY,2.5,MEDRONIC-ACID,,BONE RESORPTION INHIBITOR,BRD:BRD-K94072573-001-09-9,
REP.PRIMARY,2.500085506,DIDOX,RRM1,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K94146583-001-01-6,
REP.PRIMARY,2.6350056690000003,TOFISOPAM,"CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A","CYTOCHROME P450 INHIBITOR, PHOSPHODIESTERASE INHIBITOR",BRD:BRD-K94830213-001-01-3,
REP.PRIMARY,2.354783058,CIPEMASTAT,"ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K95362002-001-01-1,
REP.PRIMARY,2.5,PIPERAZINEDIONE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K95941975-001-01-5,
REP.PRIMARY,2.591957442,DIFENPIRAMIDE,,"CYCLOOXYGENASE INHIBITOR, PROSTAGLANDIN INHIBITOR",BRD:BRD-K96206066-001-07-9,
REP.PRIMARY,2.500011072,TOFOGLIFLOZIN,GCK,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K96344439-002-02-7,
REP.PRIMARY,2.592774962,NITAZOXANIDE,,PYRUVATE FERREDOXIN OXIDOREDUCTASE INHIBITOR,BRD:BRD-K96471533-001-09-0,
REP.PRIMARY,2.5,PYRIDOXAMINE,,AGE INHIBITOR,BRD:BRD-K96669468-300-01-1,
REP.PRIMARY,2.5,MEBROFENIN,,,BRD:BRD-K96691275-001-01-2,
REP.PRIMARY,2.500007729,CEFTRIAXONE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K96734425-304-01-7,
REP.PRIMARY,2.5000091340000004,GONADORELIN,"GNRHR, GNRHR2",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K96874295-015-01-0,
REP.PRIMARY,2.5,CRIDANIMOD,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K97939847-001-12-0,
REP.PRIMARY,2.494413182,EPALRESTAT,AKR1B1,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K98054437-001-09-9,
REP.PRIMARY,2.5,SURITOZOLE,GABBR1,GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K98557884-001-01-6,
REP.PRIMARY,2.332734192,BEFURALINE,,,BRD:BRD-K99077012-001-01-9,
REP.PRIMARY,2.603211317,HYDROCORTISONE-BUTYRATE,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K99199077-001-16-1,
REP.PRIMARY,2.500018158,PERETINOIN,RXRA,RETINOID RECEPTOR AGONIST,BRD:BRD-K99431849-001-01-7,
REP.PRIMARY,2.37737659,ENALAPRILAT,ACE,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K99447003-335-04-1,
REP.PRIMARY,2.5,XENALIPIN,,,BRD:BRD-K99506538-001-03-8,
REP.PRIMARY,2.4999914210000003,MOTESANIB,"FLT1, FLT4, KDR, KIT","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K99616396-001-05-1,
REP.PRIMARY,2.5187366,LORLATINIB,ALK,ALK TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K99879819-001-02-1,
REP.PRIMARY,2.5,DESLANOSIDE,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2",NA/K-ATPASE INHIBITOR,BRD:BRD-K99919177-001-01-3,
REP.PRIMARY,2.64076472,CLONIXIN-LYSINATE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-M63173034-001-03-6,
REP.PRIMARY,2.5,AMG-487-(+/-),CXCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A01307728-001-01-4,
REP.PRIMARY,2.4999975216199997,CEVIPABULIN,TUBB,"MICROTUBULE STIMULANT, TUBULIN POLYMERIZATION INHIBITOR",BRD:BRD-A02473266-001-01-1,
REP.PRIMARY,2.5,TALOPRAM,SLC6A2,ADRENERGIC INHIBITOR,BRD:BRD-A02532772-003-01-7,
REP.PRIMARY,2.5,ISOTIQUIMIDE,,,BRD:BRD-A02933148-001-01-8,
REP.PRIMARY,2.5,PREGNANOLONE,,GABA RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A03204438-001-01-2,
REP.PRIMARY,2.5,LM11A-31,NGFR,NEUROTROPHIC AGENT,BRD:BRD-A04649065-001-01-7,
REP.PRIMARY,2.5,APR-246,TP53,P53 ACTIVATOR,BRD:BRD-A09004963-001-01-3,
REP.PRIMARY,2.5,FPL-12495,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A09368919-001-01-7,
REP.PRIMARY,2.29564458182,TERCIPRAZINE,,,BRD:BRD-A11725667-001-01-8,
REP.PRIMARY,2.5,ML-213,KCNQ4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-A12633378-001-07-0,
REP.PRIMARY,2.5,BINA,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A13293292-001-02-6,
REP.PRIMARY,2.5,ONO-4059,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-A13689093-001-01-8,
REP.PRIMARY,2.5,SAR405838,MDM2,MDM INHIBITOR,BRD:BRD-A16035238-001-01-7,
REP.PRIMARY,2.5,TCS-5861528,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-A16560607-001-02-5,
REP.PRIMARY,2.5,ANA-12,NTRK2,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-A19609491-001-01-8,
REP.PRIMARY,2.5,GDC-0994,"MAPK1, MAPK3",MAP KINASE INHIBITOR,BRD:BRD-A20830788-001-01-9,
REP.PRIMARY,2.5,BICIFADINE,"DRD2, SLC6A2, SLC6A4","DOPAMINE REUPTAKE INHIBITOR, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-A24208517-003-01-8,
REP.PRIMARY,2.5,EDAGLITAZONE,PPARG,PPAR RECEPTOR AGONIST,BRD:BRD-A25182582-001-01-8,
REP.PRIMARY,2.5,3-DEAZAURIDINE,,CYTIDINE DEAMINASE INHIBITOR,BRD:BRD-A26105646-001-06-1,
REP.PRIMARY,2.4999834059,CKD-712,"JAK2, STAT1",NFKB PATHWAY INHIBITOR,BRD:BRD-A26458246-004-02-1,
REP.PRIMARY,2.5,PX-478,,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-A26835809-300-01-3,
REP.PRIMARY,2.49998563552,AC-55541,PARP2,PARP INHIBITOR,BRD:BRD-A27911617-001-01-7,
REP.PRIMARY,2.5,ML-3403,"CYP3A4, MAPK11, MAPK12, MAPK14",MAP KINASE INHIBITOR,BRD:BRD-A29014990-001-02-3,ML3403
REP.PRIMARY,2.5,ML3403,"CYP3A4, MAPK11, MAPK12, MAPK14",MAP KINASE INHIBITOR,BRD:BRD-A29014990-001-02-3,ML3403
REP.PRIMARY,2.5,SENNOSIDE-A,,GLYCOSIDE AGONIST,BRD:BRD-A30370660-001-04-1,
REP.PRIMARY,2.2532997668399997,CGP-20712A,"ADRB1, ADRB3",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-A31575449-066-07-8,
REP.PRIMARY,2.5,4-GALACTOSYLLACTOSE,AMY2B,,BRD:BRD-A32796301-001-01-6,
REP.PRIMARY,2.5,CIQ,"GRIN2C, GRIN2D",GLUTAMATE RECEPTOR POTENTIATOR,BRD:BRD-A35425966-001-02-3,
REP.PRIMARY,2.5,AZD6738,ATR,ATR KINASE INHIBITOR,BRD:BRD-A36013532-001-01-3,
REP.PRIMARY,2.4467541493,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME,,,BRD:BRD-A37752546-001-01-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME
REP.PRIMARY,2.4467541493,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,,,BRD:BRD-A37752546-001-01-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME
REP.PRIMARY,2.5,DR-4485,HTR7,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A39794701-003-01-6,
REP.PRIMARY,2.5,ACTINOMYCIN-D,,RNA POLYMERASE INHIBITOR,BRD:BRD-A42383464-001-06-3,
REP.PRIMARY,2.5,CYM-5442,S1PR1,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-A43005764-003-01-5,
REP.PRIMARY,2.5,BUTIBUFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A46136514-001-01-2,
REP.PRIMARY,2.5,CE3F4,RAPGEF3,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR INHIBITOR,BRD:BRD-A47940219-001-01-4,
REP.PRIMARY,2.5,LIRAGLUTIDE,GLP1R,GLP RECEPTOR AGONIST,BRD:BRD-A48274390-001-01-8,
REP.PRIMARY,2.60982706216,CI-923,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-A50016482-001-01-7,
REP.PRIMARY,2.5,SECLAZONE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-A53472930-001-01-7,
REP.PRIMARY,2.5,4-CMTB,FFAR2,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-A54139254-001-09-2,
REP.PRIMARY,2.5,SLV-319-(+/-),"CNR1, DRD2, HTR1A",CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-A54228901-001-01-7,
REP.PRIMARY,2.5727598157,HIGENAMINE,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-A55204514-003-01-2,
REP.PRIMARY,2.4740642722799997,BENZOIN,CES1,,BRD:BRD-A55748233-001-08-7,
REP.PRIMARY,2.5,GEPON,,,BRD:BRD-A56754222-001-01-2,
REP.PRIMARY,2.5,LIAROZOLE,"CYP19A1, CYP26A1",CYTOCHROME P450 INHIBITOR,BRD:BRD-A57133765-300-01-7,
REP.PRIMARY,2.48427300116,BRL-26314,LPL,CHOLESTEROL INHIBITOR,BRD:BRD-A57806482-001-01-4,
REP.PRIMARY,2.5,CID-16020046,GPR55,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-A59391172-001-07-7,
REP.PRIMARY,2.5,INDELOXAZINE,,"NOREPINEPHRINE REUPTAKE INHIBITOR, SEROTONIN REUPTAKE INHIBITOR",BRD:BRD-A59747053-003-01-3,
REP.PRIMARY,2.5,NETILMICIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-A59825838-326-01-4,
REP.PRIMARY,2.5,BETP,GLP1R,GLUCAGON-LIKE PEPTIDE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A60153876-001-01-0,
REP.PRIMARY,2.50004653302,NLG919,IDO1,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-A62133859-001-03-7,
REP.PRIMARY,2.5000237633,YK-4-279,"EWSR1, FLI1",APOPTOSIS INHIBITOR,BRD:BRD-A62182663-001-03-0,
REP.PRIMARY,2.5,BIMU-8,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-A62743154-003-01-5,
REP.PRIMARY,2.5,SHA-68,NPSR1,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-A63344375-001-01-8,
REP.PRIMARY,2.5,LY266097,HTR2B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-A64004759-003-01-9,
REP.PRIMARY,2.5,SN-2,MCOLN3,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-A64319165-001-07-0,
REP.PRIMARY,2.42588590712,BTS-72664,GABBR1,GABA RECEPTOR ANTAGONIST,BRD:BRD-A65793993-001-01-6,
REP.PRIMARY,2.5,3-HYDROXY-3-PHENYLPENTANAMIDE,,GABA RECEPTOR MODULATOR,BRD:BRD-A66143912-001-01-1,
REP.PRIMARY,2.5,TC-E-5006,APP,GAMMA SECRETASE MODULATOR,BRD:BRD-A66521565-001-01-8,
REP.PRIMARY,2.5,2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID,FOLH1,GLUTAMATE CARBOXYPEPTIDASE INHIBITOR,BRD:BRD-A66788520-001-01-7,2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID
REP.PRIMARY,2.5,2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID,FOLH1,GLUTAMATE CARBOXYPEPTIDASE INHIBITOR,BRD:BRD-A66788520-001-01-7,2-(3-MERCAPTOPROPYL)PENTANEDIOIC-ACID
REP.PRIMARY,2.48074811462,POLYINOSINE,"ADSSL1, HPRT1, IMPDH2, PYGM",IMMUNOSTIMULANT,BRD:BRD-A67531813-001-01-6,
REP.PRIMARY,2.4999542999799997,CPA-INHIBITOR,"CPA1, CPA2",CARBOXYPEPTIDASE INHIBITOR,BRD:BRD-A69126730-001-01-3,
REP.PRIMARY,2.5,ABC-294640,SPHK2,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-A70814879-001-01-2,
REP.PRIMARY,2.5040911369199996,MINERVAL,,FAAH INHIBITOR,BRD:BRD-A74347210-001-01-7,
REP.PRIMARY,2.5,RG7112,MDM2,MDM INHIBITOR,BRD:BRD-A78210457-001-01-5,
REP.PRIMARY,2.5,FLOSEQUINAN,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-A79643124-001-01-9,
REP.PRIMARY,2.4376454819599997,NORFLUOXETINE,HTR2B,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-A79769222-001-01-3,
REP.PRIMARY,2.6007918475,BIAPENEM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-A80321291-001-03-2,
REP.PRIMARY,2.5,ONO-AE3-208,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A80567330-001-01-7,
REP.PRIMARY,2.4999816248399997,KN-62,"AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1","CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR, PURINERGIC RECEPTOR ANTAGONIST",BRD:BRD-A81177136-001-12-7,
REP.PRIMARY,2.5,CPSI-1306-(+/-),MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-A81603255-001-01-0,
REP.PRIMARY,2.5,PD-168568,"DRD2, DRD4",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-A82013137-300-01-1,
REP.PRIMARY,2.5,TC-I-2000,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-A83792282-001-01-6,
REP.PRIMARY,2.5,NAV-26,SCN9A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-A84202322-001-01-7,
REP.PRIMARY,2.5,NBI-74330-(+/-),CXCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-A86523169-001-01-0,
REP.PRIMARY,2.5,OXFENICINE,"CPT1A, CPT1B",CARNITINE PALMITOYLTRANSFERASE INHIBITOR,BRD:BRD-A86525947-001-01-4,
REP.PRIMARY,2.5,KI-20227,"CSF1R, KDR, KIT, PDGFRB",C-FMS INHIBITOR,BRD:BRD-A88787317-001-01-0,
REP.PRIMARY,2.67347776384,BENAXIBINE,,,BRD:BRD-A90642009-001-03-2,
REP.PRIMARY,2.5,SB-268262,CALCA,CALCITONIN ANTAGONIST,BRD:BRD-A91031770-001-01-8,
REP.PRIMARY,2.58345097116,SARI-59-801,,,BRD:BRD-A92448440-001-01-3,
REP.PRIMARY,2.5,VUF11207,ACKR3,CC CHEMOKINE RECEPTOR AGONIST,BRD:BRD-A93717708-051-01-2,
REP.PRIMARY,2.5,KL-001,"CRY1, CRY2",PROTEASOME INHIBITOR,BRD:BRD-A94580299-001-10-4,
REP.PRIMARY,2.50000357286,AUTOTAXIN-MODULATOR-1,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-A94640958-001-01-7,
REP.PRIMARY,2.50002705042,DECERNOTINIB,JAK3,JAK INHIBITOR,BRD:BRD-A95300432-001-01-3,
REP.PRIMARY,2.5,KW-3902,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A95683721-001-03-8,
REP.PRIMARY,2.38825171466,TANSHINONE-IIA,"IL1B, NR1I2, TNF","ANTI-INFLAMMATORY AGENT, INTERLEUKIN INHIBITOR",BRD:BRD-K00141480-001-15-4,
REP.PRIMARY,2.5,RO-3,P2RX3,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00354853-001-01-2,
REP.PRIMARY,2.5,BAG-956,PIK3CG,PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K00652956-001-01-5,
REP.PRIMARY,2.5,SHP099,PTPN11,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00818915-003-01-8,
REP.PRIMARY,2.50004299042,TROVIRDINE,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K00989047-001-01-2,
REP.PRIMARY,2.49995810748,JNJ-42041935,PDK2,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K01036220-001-01-0,
REP.PRIMARY,2.49998888764,TH-588,NUDT1,MTH1 INHIBITOR,BRD:BRD-K01054709-001-01-3,TH588
REP.PRIMARY,2.49998888764,TH588,NUDT1,MTH1 INHIBITOR,BRD:BRD-K01054709-001-01-3,TH588
REP.PRIMARY,2.49999520008,DAA-1106,TSPO,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K01080633-001-01-9,
REP.PRIMARY,2.50003437186,BMS-191095,,"KATP ACTIVATOR, POTASSIUM CHANNEL AGONIST",BRD:BRD-K01231377-001-01-8,
REP.PRIMARY,2.5,ANTALARMIN,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K01363385-003-01-5,
REP.PRIMARY,2.5,LRRK2-IN-1,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K01436366-001-22-2,
REP.PRIMARY,2.5,BTT-3033,"ITGA2, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K01492390-001-01-9,
REP.PRIMARY,2.50003107404,NVP-231,CERK,CERAMIDASE INHIBITOR,BRD:BRD-K01573278-001-02-1,
REP.PRIMARY,2.4999911879199996,BVT-2733,HSD17B1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K01742705-001-01-7,
REP.PRIMARY,2.50001144696,GINSENOSIDE-C-K,PTGS2,"NFKB PATHWAY INHIBITOR, NITRIC OXIDE SYNTHASE INHIBITOR",BRD:BRD-K01942833-001-01-8,
REP.PRIMARY,2.49998514618,THZ1-R,CDK7,CDK INHIBITOR,BRD:BRD-K02135007-001-01-8,
REP.PRIMARY,2.5,ML-365,"KCNK3, KCNK9",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K02160913-001-02-7,ML365
REP.PRIMARY,2.5,ML365,"KCNK3, KCNK9",POTASSIUM CHANNEL BLOCKER,BRD:BRD-K02160913-001-02-7,ML365
REP.PRIMARY,2.5,CDPPB,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K02213468-001-02-3,
REP.PRIMARY,2.51205308272,SSR-180711,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K02782351-003-01-5,
REP.PRIMARY,2.5,NI-57,"BRD1, BRPF1, BRPF3",BROMODOMAIN INHIBITOR,BRD:BRD-K03042257-001-01-2,
REP.PRIMARY,2.5,ICA-121431,"SCN1A, SCN3A",SODIUM CHANNEL BLOCKER,BRD:BRD-K03149601-001-02-6,
REP.PRIMARY,2.5,BIO-1211,"ITGA4, ITGB1",INTEGRIN ANTAGONIST,BRD:BRD-K03399463-001-01-6,
REP.PRIMARY,2.5,5-HYDROXYECTOINE,,,BRD:BRD-K03871161-001-01-9,
REP.PRIMARY,2.5,SB-399885,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K03988082-001-01-7,
REP.PRIMARY,2.4999846291599996,PD1-PDL-INHIBITOR-1,CD274,PROGRAMMED DEATH LIGAND INHIBITOR,BRD:BRD-K04032780-001-01-8,
REP.PRIMARY,2.57005699068,XL019,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K04266228-001-03-8,
REP.PRIMARY,2.5,AMG-PERK-44,EIF2AK4,PERK INHIBITOR,BRD:BRD-K04374714-003-01-1,
REP.PRIMARY,2.5000205174000003,GLPG0492-R-ENANTIOMER,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K04643927-001-01-6,
REP.PRIMARY,2.5,2-ETHOXYBENZOIC-ACID,,ANALGESIC AGENT,BRD:BRD-K04843302-001-02-5,
REP.PRIMARY,2.50002030332,I-BRD9,BRD9,BROMODOMAIN INHIBITOR,BRD:BRD-K04972057-001-01-1,
REP.PRIMARY,2.5,PSB-603,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K05419687-001-01-0,
REP.PRIMARY,2.49997227768,BRICICLIB,CCND1,CYCLIN D INHIBITOR,BRD:BRD-K05531427-001-01-7,
REP.PRIMARY,2.5,AZ-12080282,DHH,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K05973499-300-01-0,
REP.PRIMARY,2.5,TENOVIN-1,SIRT1,"SIRT INHIBITOR, TP53 ACTIVATOR",BRD:BRD-K05977823-001-05-3,
REP.PRIMARY,2.38991935542,GSK1059615,PIK3CG,PI3K INHIBITOR,BRD:BRD-K06750613-001-07-3,
REP.PRIMARY,2.5,ALDA-1,ALDH2,ALDEHYDE DEHYDROGENASE ACTIVATOR,BRD:BRD-K06890060-001-09-1,
REP.PRIMARY,2.48035472276,BW-616U,MAOA,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K07061232-001-01-8,
REP.PRIMARY,2.405766282,RWJ-67657,"MAPK14, PTGS2",MAP KINASE INHIBITOR,BRD:BRD-K07074923-001-01-5,
REP.PRIMARY,2.68807702254,ASP-2535,SLC6A9,GLYCINE TRANSPORTER INHIBITOR,BRD:BRD-K07150325-001-01-7,
REP.PRIMARY,2.5,APC-100,AR,"ANDROGEN RECEPTOR ANTAGONIST, ANTI-INFLAMMATORY AGENT",BRD:BRD-K07449869-001-01-5,
REP.PRIMARY,2.5,AS-1269574,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K07656463-001-01-5,
REP.PRIMARY,2.50000888882,GSK2838232,,HIV GAG INHIBITOR,BRD:BRD-K08398903-001-01-1,
REP.PRIMARY,2.5,SMER-28,SNCA,AUTOPHAGY INDUCER,BRD:BRD-K08478539-001-13-8,
REP.PRIMARY,2.49999524756,LMI070,SMN1,SURVIVAL MOTOR NEURON PROTEIN MODULATOR,BRD:BRD-K08532119-001-01-5,
REP.PRIMARY,2.5,WAY-207024,"GNRHR, HRH2, TACR2",GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K08657056-300-01-1,
REP.PRIMARY,2.5,TRETAZICAR,NQO2,DNA REPLICATION INHIBITOR,BRD:BRD-K08748705-001-08-2,
REP.PRIMARY,2.5,TCS-PIM-1-1,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K08902330-001-01-3,
REP.PRIMARY,2.47913234352,TRIBOMSALAN,,,BRD:BRD-K09118247-001-03-3,
REP.PRIMARY,2.5,AK-7,SIRT2,SIRT INHIBITOR,BRD:BRD-K09143580-001-01-0,
REP.PRIMARY,2.49997841312,GSK2879552,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K09223495-001-01-4,
REP.PRIMARY,2.5,9-AMINOCAMPTOTHECIN,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K09291936-001-13-3,
REP.PRIMARY,2.5,Y-11,PTK2,FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K09317629-004-01-7,
REP.PRIMARY,2.50002477806,GEMCITABINE-ELAIDATE,"CMPK1, RRM1, TYMS","APOPTOSIS INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K09456915-001-01-2,
REP.PRIMARY,2.5,TCN201,GRIN2A,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K09787262-001-01-9,
REP.PRIMARY,2.5,CP-99994,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K09946180-300-01-6,
REP.PRIMARY,2.5,LUMATEPERONE,"DRD2, HTR2A","DOPAMINE RECEPTOR MODULATOR, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K10031916-075-01-3,
REP.PRIMARY,2.6391257543199997,PKI-166,EGFR,EGFR INHIBITOR,BRD:BRD-K10115470-001-01-8,
REP.PRIMARY,2.5,AC1NDSS5,,,BRD:BRD-K10226125-245-01-5,
REP.PRIMARY,2.56652494984,ADIPIC-ACID,SLC22A6,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K10656395-001-02-1,
REP.PRIMARY,2.5,AH-7614,FFAR4,FREE FATTY ACID RECEPTOR ANTAGONIST,BRD:BRD-K10852420-001-02-5,
REP.PRIMARY,2.5000304335399997,L-778123,"FNTA, FNTB, PGGT1B",FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K10958118-003-01-5,
REP.PRIMARY,2.5,PA-452,RXRA,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K11428250-001-01-0,
REP.PRIMARY,2.4844241873199997,LAURIC-DIETHANOLAMIDE,,,BRD:BRD-K11548689-001-01-6,
REP.PRIMARY,2.62339250512,BENZYLDIMETHYLOCTYLAMMONIUM,,,BRD:BRD-K11576103-003-01-1,
REP.PRIMARY,2.5,CH-5183284,"FGFR1, FGFR2, FGFR3",FIBROBLAST GROWTH FACTOR INHIBITOR,BRD:BRD-K11683436-001-01-7,
REP.PRIMARY,2.5,4SC-202,HDAC1,HDAC INHIBITOR,BRD:BRD-K11773281-075-02-4,
REP.PRIMARY,2.499992996,MOTOLIMOD,TLR8,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K11785681-001-01-2,
REP.PRIMARY,2.4999880481,G007-LK,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K12198961-001-01-8,
REP.PRIMARY,2.50004317274,BMS-863233,"CDC7, PIM1",CDC INHIBITOR,BRD:BRD-K12511835-003-02-0,
REP.PRIMARY,2.49999944002,RO-61-8048,KMO,KYNURENINE 3-MONOOXYGENASE INHIBITOR,BRD:BRD-K12639498-001-01-3,
REP.PRIMARY,2.5,FOXY-5,WNT5A,WNT5A PEPTIDE MIMETIC,BRD:BRD-K13005598-001-02-3,
REP.PRIMARY,2.5,GW-438014A,NPY5R,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K13039700-066-01-2,
REP.PRIMARY,2.5,A-61603,"ADRA1A, ADRA1B, ADRA1D",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K13142315-004-01-2,
REP.PRIMARY,2.5,BENETHAMINE,,,BRD:BRD-K13473780-001-02-1,
REP.PRIMARY,2.5,AMRUBICIN,"TOP2A, TOP2B",TOPOISOMERASE INHIBITOR,BRD:BRD-K13843533-001-01-7,
REP.PRIMARY,2.49997622624,XL228,"IGF1R, SRC","ABL KINASE INHIBITOR, INSULIN GROWTH FACTOR RECEPTOR INHIBITOR, SRC INHIBITOR",BRD:BRD-K14274271-001-02-8,
REP.PRIMARY,2.5,CYCLOCREATINE,,CREATINE KINASE SUBSTRATE,BRD:BRD-K14379200-001-04-7,
REP.PRIMARY,2.39581804096,FARNESYL-THIOSALICYLIC-ACID-AMIDE,HRAS,RAS GTPASE INHIBITOR,BRD:BRD-K14590126-001-01-6,
REP.PRIMARY,2.5,BMS-CCR2-22,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K15119094-001-01-1,
REP.PRIMARY,2.5,TC-E-5002,"KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K15256258-001-01-3,
REP.PRIMARY,2.5,CPI-203,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K15811707-001-02-0,
REP.PRIMARY,2.5,AC-710,"CSF1R, FLT3, KIT, PDGFRA, PDGFRB",PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K15819326-001-01-6,
REP.PRIMARY,2.5,ETP-45658,"PIK3CA, PIK3CB, PIK3CD, PIK3CG",PI3K INHIBITOR,BRD:BRD-K15858023-001-01-0,
REP.PRIMARY,2.5000179129199998,GLPG0492,AR,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K15893360-001-01-8,
REP.PRIMARY,2.5000051377399997,MN-64,TNKS,TANKYRASE INHIBITOR,BRD:BRD-K16183658-001-01-4,
REP.PRIMARY,2.5,SIRREAL-2,SIRT2,SIRT INHIBITOR,BRD:BRD-K16472653-001-01-6,
REP.PRIMARY,2.5,TC-FPR-43,FPR2,FORMYL PEPTIDE RECEPTOR AGONIST,BRD:BRD-K16497916-001-01-6,
REP.PRIMARY,2.50001628166,CC-115,MTOR,"DNA PROTEIN KINASE INHIBITOR, MTOR INHIBITOR",BRD:BRD-K16755045-003-01-7,
REP.PRIMARY,2.5,NIDA-41020,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K17617556-001-01-3,
REP.PRIMARY,2.5,TC-I-15,"ITGA2, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K17621556-001-01-5,
REP.PRIMARY,2.49999501306,NAMPT-IN-1,,,BRD:BRD-K18280217-001-01-0,
REP.PRIMARY,2.5,PF-915275,HSD11B1,11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITOR,BRD:BRD-K18289362-001-02-2,
REP.PRIMARY,2.49998492394,OAC2,POU5F1,OCT ACTIVATOR,BRD:BRD-K18305454-001-07-4,
REP.PRIMARY,2.50002696492,CPI-360,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18319422-001-01-7,
REP.PRIMARY,2.5,GUE-1654,OXER1,OXOEICOSANOID RECEPTOR MODULATOR,BRD:BRD-K18745919-001-01-3,
REP.PRIMARY,2.5,EED226,EED,POLYCOMB PROTEIN INHIBITOR,BRD:BRD-K19002914-001-01-3,
REP.PRIMARY,2.50001753868,WIKI4,TNKS2,"TANKYRASE INHIBITOR, WNT PATHWAY INHIBITOR",BRD:BRD-K19316653-001-02-0,
REP.PRIMARY,2.5000172577799997,GPR120-MODULATOR-1,FFAR4,G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K19409553-001-01-6,
REP.PRIMARY,2.50481217328,OPC-21268,"AVPR1A, AVPR2, OXTR",VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K19426040-001-01-1,
REP.PRIMARY,2.50001761464,JNJ-63533054,GPR139,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K19482962-001-01-8,
REP.PRIMARY,2.5,SULFAMOXOLE,,PABA ANTAGONIST,BRD:BRD-K19742012-001-02-3,
REP.PRIMARY,2.63499964734,ACT-462206,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K19781342-001-01-4,
REP.PRIMARY,2.49996745332,CPI-0610,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-K19871656-001-01-3,
REP.PRIMARY,2.56144412532,TIFENAZOXIDE,"ABCC8, KCNJ11",ATP-SENSITIVE POTASSIUM CHANNEL AGONIST,BRD:BRD-K20568871-001-01-1,
REP.PRIMARY,2.5,GW-6471,PPARA,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K20828910-001-02-0,
REP.PRIMARY,2.4999683155,PT-2385,EPAS1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K20850787-001-01-6,
REP.PRIMARY,2.4999894801,RGB-286638,"CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9",CDK INHIBITOR,BRD:BRD-K20986415-001-01-8,
REP.PRIMARY,2.5000266344,LX7101,"LIMK2, ROCK1, ROCK2","LIM KINASE INHIBITOR, RHO ASSOCIATED KINASE INHIBITOR",BRD:BRD-K21038058-001-01-9,
REP.PRIMARY,2.50000856106,LY3000328,CTSS,CATHEPSIN INHIBITOR,BRD:BRD-K21070437-001-01-4,
REP.PRIMARY,2.5,BIO-5192,"ITGA4, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K21318844-001-01-4,
REP.PRIMARY,2.49998181008,ALS-8112,,RNA POLYMERASE INHIBITOR,BRD:BRD-K21415491-001-01-4,ALS-8176
REP.PRIMARY,2.49998181008,ALS-8176,,RNA POLYMERASE INHIBITOR,BRD:BRD-K21415491-001-01-4,ALS-8176
REP.PRIMARY,2.5,LY2584702,RPS6KB1,RIBOSOMAL PROTEIN INHIBITOR,BRD:BRD-K21833260-075-01-1,
REP.PRIMARY,2.50000590762,NS-018,"JAK1, JAK2, JAK3, TYK2",JAK INHIBITOR,BRD:BRD-K21865955-003-01-5,
REP.PRIMARY,2.5,TC-S-7009,EPAS1,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K21894922-001-01-9,
REP.PRIMARY,2.5,AN2718,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K21920947-001-02-1,
REP.PRIMARY,2.5,UNC-926,L3MBTL1,MBT INHIBITOR,BRD:BRD-K22229656-003-01-5,UNC926
REP.PRIMARY,2.5,UNC926,L3MBTL1,MBT INHIBITOR,BRD:BRD-K22229656-003-01-5,UNC926
REP.PRIMARY,2.50000956214,BMS-983970,,NOTCH SIGNALING INHIBITOR,BRD:BRD-K22316123-001-01-9,
REP.PRIMARY,2.4999709272399997,EBROTIDINE,HRH2,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K22421059-001-02-3,
REP.PRIMARY,2.5,STF-31,"NAMPT, SLC2A1",NAMPT INHIBITOR,BRD:BRD-K22477529-001-02-7,
REP.PRIMARY,2.5,CEFODIZIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K22641081-304-01-8,
REP.PRIMARY,2.50000928516,SP-420,,,BRD:BRD-K23005288-001-01-8,
REP.PRIMARY,2.5,SUBSTANCE-P,"TACR1, TACR2, TACR3",NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K23106423-001-01-0,
REP.PRIMARY,2.3430106570399998,CARBOXYLOSARTAN,AGTR1,ANGIOTENSIN ANTAGONIST,BRD:BRD-K23533833-001-01-9,
REP.PRIMARY,2.5,TUG-891,FFAR4,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K24282351-001-01-4,
REP.PRIMARY,2.5,ME-0328,PARP3,PPAR RECEPTOR ANTAGONIST,BRD:BRD-K24283677-001-01-9,
REP.PRIMARY,2.5,JW-67,"APC, AXIN1, GSK3B",WNT PATHWAY INHIBITOR,BRD:BRD-K24554037-001-08-3,
REP.PRIMARY,2.5,CEFPROZIL,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K24871708-002-04-6,
REP.PRIMARY,2.2667489801,MECLINERTANT,"NTSR1, NTSR2",NEUROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K25075681-001-02-0,
REP.PRIMARY,2.4999646232,MSX-122,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K25143390-001-01-0,
REP.PRIMARY,2.4999860098599997,AZD3965,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K25210703-001-01-9,
REP.PRIMARY,2.38531111144,GSK690693,"AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX",AKT INHIBITOR,BRD:BRD-K25325018-001-05-6,
REP.PRIMARY,2.5,ANTAGONIST-G,MAPK8,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K25863791-001-01-8,
REP.PRIMARY,2.5,TC-F-2,FAAH,FAAH INHIBITOR,BRD:BRD-K26041695-001-02-5,
REP.PRIMARY,2.5,VLX-600,"TP53, USP14","ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",BRD:BRD-K26122255-001-01-7,VLX600
REP.PRIMARY,2.5,VLX600,"TP53, USP14","ANTITUMOR AGENT, UBIQUITIN C-TERMINAL HYDROLASE INHIBITOR",BRD:BRD-K26122255-001-01-7,VLX600
REP.PRIMARY,2.5,ROBALZOTAN,HTR1A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K26169680-003-01-9,
REP.PRIMARY,2.40763969502,TRANS-4-METHOXYCINNAMIC-ACID,,,BRD:BRD-K26273521-001-07-3,
REP.PRIMARY,2.5,PDP-EA,FAAH,FAAH ACTIVATOR,BRD:BRD-K26358347-001-01-7,
REP.PRIMARY,2.5,TOYOCAMYCIN,ERN1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K26420709-001-01-7,
REP.PRIMARY,2.5,H2L-5765834,"LPAR1, LPAR3",LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K26439554-001-01-3,
REP.PRIMARY,2.5,GSK-37647,FFAR4,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K26514105-001-01-7,GSK37647
REP.PRIMARY,2.5,GSK37647,FFAR4,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K26514105-001-01-7,GSK37647
REP.PRIMARY,2.43040212492,DINOPROSTONE,"CATSPER1, CATSPER2, CATSPER3, CATSPER4, PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, TBXA2R",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K26521938-001-09-8,
REP.PRIMARY,2.5,BENZOFENAC,,,BRD:BRD-K26556907-001-01-8,
REP.PRIMARY,2.5,AS-1892802,ROCK1,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K27051047-001-01-0,
REP.PRIMARY,2.5000326131,VU-0240551,SLC12A5,POTASSIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-K27074404-001-08-4,VU0240551
REP.PRIMARY,2.5000326131,VU0240551,SLC12A5,POTASSIUM/CHLORIDE COTRANSPORTER INHIBITOR,BRD:BRD-K27074404-001-08-4,VU0240551
REP.PRIMARY,2.5,AMPHOTERICIN-B,,MEMBRANE PERMEABILITY ENHANCER,BRD:BRD-K27352494-001-03-6,
REP.PRIMARY,2.5,ML-193,GPR55,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K27539181-001-08-5,ML193
REP.PRIMARY,2.5,ML193,GPR55,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K27539181-001-08-5,ML193
REP.PRIMARY,2.5,CYM-50769,NPBWR1,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K27732927-001-03-6,
REP.PRIMARY,2.4999703370199997,PFK-158,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K28010364-001-01-0,
REP.PRIMARY,2.5,N-HYDROXYNICOTINAMIDE,,,BRD:BRD-K28030264-001-02-7,
REP.PRIMARY,2.5,NVS-PAK1-1,PAK1,P21 ACTIVATED KINASE INHIBITOR,BRD:BRD-K28132190-001-02-0,
REP.PRIMARY,2.5,RIFAPENTINE,"CYP2C8, CYP2C9, CYP3A4",RNA POLYMERASE INHIBITOR,BRD:BRD-K28346421-001-06-8,
REP.PRIMARY,2.5,SP-141,MDM2,UBIQUITIN LIGASE INHIBITOR,BRD:BRD-K28571773-001-01-6,
REP.PRIMARY,2.67370283116,NGD-94-1,DRD4,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K28639661-001-01-6,
REP.PRIMARY,2.5,CYM-5520,S1PR2,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K29151923-001-01-5,
REP.PRIMARY,2.5,GSK9027,NR3C1,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K29328421-001-01-6,
REP.PRIMARY,2.5,TC-ASK-10,"MAP3K5, MAP3K6",MAP KINASE INHIBITOR,BRD:BRD-K29660062-300-01-2,
REP.PRIMARY,2.5,GSK2578215A,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K30185465-001-03-0,
REP.PRIMARY,2.49997885218,TIPLAXTININ,SERPINE1,PLASMINOGEN ACTIVATOR INHIBITOR,BRD:BRD-K30882994-001-01-6,
REP.PRIMARY,2.57381053288,WIN-18446,ALDH1A2,ALDEHYDE DEHYDROGENASE INHIBITOR,BRD:BRD-K30930903-001-01-3,
REP.PRIMARY,2.5,OMEGA-3-ACID-ESTERS,,CHOLESTEROL INHIBITOR,BRD:BRD-K31139048-001-03-2,
REP.PRIMARY,2.5,ANR-94,ADORA2A,"A1 ADENOSINE RECEPTOR ANTAGONIST, ADENOSINE RECEPTOR ANTAGONIST",BRD:BRD-K31170746-001-01-6,
REP.PRIMARY,2.5,CENTAZOLONE,,MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K31329721-001-08-2,
REP.PRIMARY,2.38122673754,CP-376395,CRHR1,"CORTICOSTEROID RELEASING FACTOR RECEPTOR ANTAGONIST, CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST",BRD:BRD-K31394475-001-01-9,
REP.PRIMARY,2.5,PIFITHRIN-CYCLIC,TP53,TP53 INHIBITOR,BRD:BRD-K31792052-004-02-7,
REP.PRIMARY,2.5,TC-LPA5-4,LPAR5,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K32031961-001-01-7,
REP.PRIMARY,2.5,BAY-41-2272,"GUCY1A3, GUCY1B3",GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K32033120-001-01-1,
REP.PRIMARY,2.5,AT13148,"AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3",PROTEIN KINASE INHIBITOR,BRD:BRD-K32127727-001-04-2,
REP.PRIMARY,2.49999543224,LPA2-ANTAGONIST-1,LPAR2,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K32322923-001-01-7,
REP.PRIMARY,2.50000918094,AGN-195183,RARA,RETINOID RECEPTOR AGONIST,BRD:BRD-K32533226-001-01-3,
REP.PRIMARY,2.50001536012,GSK-J1,KDM6B,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K32847255-001-01-1,
REP.PRIMARY,2.5,ORG-25543,"GLRB, SLC6A5",GLYCINE TRANSPORTER INHIBITOR,BRD:BRD-K32853922-003-01-8,
REP.PRIMARY,2.5,A-867744,"CHRNA3, CHRNA4, CHRNA7",ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K33059059-001-01-0,
REP.PRIMARY,2.49999335442,INT-767,GPBAR1,FXR AGONIST,BRD:BRD-K33067152-236-01-1,
REP.PRIMARY,2.41481957414,BENFLURALIN,"CYP1A1, CYP1A2, CYP2B6, CYP3A4, ESR1, MMP1, SULT2A1, UGT1A1",,BRD:BRD-K33903083-001-03-5,
REP.PRIMARY,2.6083545298399997,TIENILIC-ACID,"CYP2C9, SLC12A1","CYTOCHROME P450 INHIBITOR, SODIUM/POTASSIUM/CHLORIDE TRANSPORTER INHIBITOR",BRD:BRD-K34098590-001-02-1,
REP.PRIMARY,2.5,HJC-0350,RAPGEF4,GTPASE INHIBITOR,BRD:BRD-K34411045-001-01-9,
REP.PRIMARY,2.5,NS-8593,"KCNN1, KCNN2, KCNN3",CALCIUM-ACTIVATED POTASSIUM CHANNEL MODULATOR,BRD:BRD-K34624869-003-01-6,
REP.PRIMARY,2.5,CBIPES,GRM2,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K34675210-003-01-4,
REP.PRIMARY,2.5,CAMKII-IN-1,"AKT1, CAMK2A, CAMK4, MYLK",CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K35772771-001-02-1,
REP.PRIMARY,2.49998063336,ACTB-1003,"KDR, TEK","FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K35936936-001-01-6,
REP.PRIMARY,2.5,ROSE-BENGAL-LACTONE,,COLORING AGENT,BRD:BRD-K36163066-304-02-4,
REP.PRIMARY,2.4999908451599997,VERBASCOSIDE,,"NFKB PATHWAY INHIBITOR, PKC INHIBITOR",BRD:BRD-K36201510-001-06-7,
REP.PRIMARY,2.5,CP-532623,CETP,CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR,BRD:BRD-K36611520-001-01-6,
REP.PRIMARY,2.5,NAB-2,NEDD4,UBIQUITIN LIGASE TRANSPORT PROMOTER,BRD:BRD-K36804890-001-01-9,
REP.PRIMARY,2.49998011966,ANLOTINIB,"KDR, PDGFRB","PDGFR TYROSINE KINASE RECEPTOR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K36949735-001-01-1,
REP.PRIMARY,2.5,O-MERCAPTO-BENZOIC-ACID,,,BRD:BRD-K36998189-001-03-5,
REP.PRIMARY,2.4999943032000003,DPC-681,,HIV PROTEASE INHIBITOR,BRD:BRD-K37087535-001-01-1,
REP.PRIMARY,2.5,ADAPTAVIR,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K37151368-001-01-7,
REP.PRIMARY,2.5,BI-847325,"AURKA, AURKB, AURKC, MAP2K1, MAP2K2","AURORA KINASE INHIBITOR, MEK INHIBITOR",BRD:BRD-K37492701-001-02-9,
REP.PRIMARY,2.5,SANAZOLE,,,BRD:BRD-K37747025-001-08-2,
REP.PRIMARY,2.48967879374,CEFORANIDE,,PENICILLIN BINDING PROTEIN INHIBITOR,BRD:BRD-K37848908-001-05-6,
REP.PRIMARY,2.50001093246,GW-311616,ELANE,"ELASTASE INHIBITOR, LEUKOCYTE ELASTASE INHIBITOR",BRD:BRD-K37864785-001-01-0,
REP.PRIMARY,2.5000222891,A-317491,P2RX3,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K38019854-323-01-4,
REP.PRIMARY,2.4999896920199998,PDE10-IN-1,PDE10A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K38145871-001-01-8,
REP.PRIMARY,2.41133704298,LY3009120,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K38385169-001-04-5,
REP.PRIMARY,2.5,DEXAMETHASONE,"ANXA1, NOS2, NR0B1, NR3C1, NR3C2",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K38775274-001-22-1,
REP.PRIMARY,2.5000065336599997,TAK-220,CCR5,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K38793468-001-01-4,
REP.PRIMARY,2.5,JZL-195,"FAAH, MGLL","FAAH INHIBITOR, MONOACYLGLYCEROL LIPASE INHIBITOR",BRD:BRD-K38875233-001-03-9,
REP.PRIMARY,2.5,NS-9283,CHRNA4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K40176866-001-01-6,
REP.PRIMARY,2.5,DMH4,KDR,VEGFR INHIBITOR,BRD:BRD-K40575944-001-01-5,
REP.PRIMARY,2.50001167208,LY310762,HTR1D,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K41194171-003-09-7,
REP.PRIMARY,2.5,BISPHENOL-A,"AR, ESR1, ESR2, ESRRG, PPARG",SYNTHETIC ESTROGEN,BRD:BRD-K41494493-001-13-8,
REP.PRIMARY,2.49999512504,AZD3759,EGFR,EGFR INHIBITOR,BRD:BRD-K41626799-001-01-1,
REP.PRIMARY,2.5,EC-144,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K41705163-001-01-1,
REP.PRIMARY,2.5,CURCUMOL,"JAK1, JAK2, JAK3",JAK INHIBITOR,BRD:BRD-K41933240-001-02-4,
REP.PRIMARY,2.4999849474399998,OT-R-ANTAGONIST-1,"AVPR1A, OXTR",OXYTOCIN RECEPTOR ANTAGONIST,BRD:BRD-K42009284-001-01-1,
REP.PRIMARY,2.5,PYRIDOXAL-ISONICOTINOYL-HYDRAZONE,,APOPTOSIS STIMULANT,BRD:BRD-K42019693-001-01-5,
REP.PRIMARY,2.5,EPPTB,TAAR1,TRACE AMINE ASSOCIATED RECEPTOR ANTAGONIST,BRD:BRD-K42536037-001-01-3,
REP.PRIMARY,2.4999609614,BML-284,,WNT AGONIST,BRD:BRD-K42624714-001-04-1,
REP.PRIMARY,2.5,NVP-BGJ398,"FGFR1, FGFR2, FGFR3, FGFR4, KDR",FGFR INHIBITOR,BRD:BRD-K42728290-001-09-1,
REP.PRIMARY,2.5120530789,C34,TLR4,TOLL-LIKE RECEPTOR INHIBITOR,BRD:BRD-K43167535-001-01-3,
REP.PRIMARY,2.3391719586799997,WY-16922,,HISTAMINE RELEASE INHIBITOR,BRD:BRD-K43419711-001-01-4,
REP.PRIMARY,2.5,PF-4800567,"CSNK1D, CSNK1E",CASEIN KINASE INHIBITOR,BRD:BRD-K43428468-003-04-0,
REP.PRIMARY,2.5,ARQ-621,KIF11,KINESIN-LIKE SPINDLE PROTEIN INHIBITOR,BRD:BRD-K43436647-001-01-7,
REP.PRIMARY,2.4999947142199996,CDK9-IN-6,CDK9,CDK INHIBITOR,BRD:BRD-K43914553-001-01-5,
REP.PRIMARY,2.5,ZONIPORIDE,SLC9A1,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K43992824-300-01-0,
REP.PRIMARY,2.32532022994,MRK-016,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K44022883-001-01-7,
REP.PRIMARY,2.5,PK-THPP,KCNK9,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K44043890-001-01-4,
REP.PRIMARY,2.36269626434,FLUPRAZINE,"HTR1A, HTR1B",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K44091134-001-01-9,
REP.PRIMARY,2.5,ML-228,HIF1A,HYPOXIA INDUCIBLE FACTOR ACTIVATOR,BRD:BRD-K44432556-001-05-5,ML228
REP.PRIMARY,2.5,ML228,HIF1A,HYPOXIA INDUCIBLE FACTOR ACTIVATOR,BRD:BRD-K44432556-001-05-5,ML228
REP.PRIMARY,2.4999922076199996,LDC1267,"AXL, MERTK, TYRO3",PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K44715996-001-01-0,
REP.PRIMARY,2.5,AL-8697,MAPK14,P38 MAPK INHIBITOR,BRD:BRD-K44731351-001-01-6,
REP.PRIMARY,2.44787473786,GPI-1046,FKBP1A,FKBP INHIBITOR,BRD:BRD-K44869961-001-01-6,
REP.PRIMARY,2.5,WR99210,TYMS,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K45973863-001-01-4,
REP.PRIMARY,2.5,AURANOFIN,"IKBKB, PRDX5, TRPA1",NFKB PATHWAY INHIBITOR,BRD:BRD-K45995181-001-04-6,
REP.PRIMARY,2.2634430267,PRAVADOLINE,"CNR1, CNR2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K46209126-001-06-4,
REP.PRIMARY,2.5,UNC-3230,PIP5K1C,PHOSPHATIDYL-INOSITOL ACTIVATOR,BRD:BRD-K46344388-001-01-3,UNC3230
REP.PRIMARY,2.5,UNC3230,PIP5K1C,PHOSPHATIDYL-INOSITOL ACTIVATOR,BRD:BRD-K46344388-001-01-3,UNC3230
REP.PRIMARY,2.4999884747000003,ACETRIAZOIC-ACID,,,BRD:BRD-K46416130-001-07-7,
REP.PRIMARY,2.5,L-838417,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR PARTIAL AGONIST,BRD:BRD-K46647427-001-02-0,
REP.PRIMARY,2.49998546822,KML29,MGLL,MONOACYLGLUCEROL LIPASE INHIBITOR,BRD:BRD-K46734292-001-03-6,
REP.PRIMARY,2.5,GDC-0623,,MEK INHIBITOR,BRD:BRD-K46908090-001-02-2,
REP.PRIMARY,2.6808839961,RHODAMINE-123,,,BRD:BRD-K47169076-003-01-6,
REP.PRIMARY,2.5,AZD8186,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-K47289408-001-01-5,
REP.PRIMARY,2.5,LH846,CSNK1D,CASEIN KINASE INHIBITOR,BRD:BRD-K47409078-001-02-6,
REP.PRIMARY,2.5,ANISINDIONE,GGCX,VITAMIN K ANTAGONIST,BRD:BRD-K47458712-001-20-7,
REP.PRIMARY,2.5,WDR5-0103,WDR5,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K47726410-001-01-2,
REP.PRIMARY,2.50000684648,AF38469,SORT1,SORTILIN INHIBITOR,BRD:BRD-K47816470-001-01-8,
REP.PRIMARY,2.5,TAK-960,PLK1,PLK INHIBITOR,BRD:BRD-K48059512-003-01-0,
REP.PRIMARY,2.4999821079599998,GSK2801,"BAZ2A, BAZ2B",BROMODOMAIN INHIBITOR,BRD:BRD-K48062199-001-01-8,
REP.PRIMARY,2.5,ML-281,STK33,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K48188942-001-03-7,ML281
REP.PRIMARY,2.5,ML281,STK33,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K48188942-001-03-7,ML281
REP.PRIMARY,2.5,VU1545,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K48371964-001-06-5,
REP.PRIMARY,2.5,XMD17-109,MAPK7,MAP KINASE INHIBITOR,BRD:BRD-K48449981-001-02-7,
REP.PRIMARY,2.5,CB-5083,VCP,VALOSIN-CONTAINING PROTEIN INHIBITOR,BRD:BRD-K49048664-001-01-2,
REP.PRIMARY,2.5,SB-772077B,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K49110935-300-01-9,
REP.PRIMARY,2.50002054862,DCC-2618,"KIT, PDGFRA","KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K49246350-001-01-1,
REP.PRIMARY,2.5,WWL-113,CES3,CARBOXYLESTERASE INHIBITOR,BRD:BRD-K49389158-001-01-3,
REP.PRIMARY,2.3281778999,IMMETHRIDINE,HRH3,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K49519092-303-03-0,
REP.PRIMARY,2.5,SB-747651A,"AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1",KINASE INHIBITOR,BRD:BRD-K49597925-300-01-9,
REP.PRIMARY,2.5,GW-627368,PTGER4,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K50005760-001-01-1,
REP.PRIMARY,2.5,SR-3576,MAPK10,JNK INHIBITOR,BRD:BRD-K50378376-001-01-8,
REP.PRIMARY,2.5,EG00229,NRP1,NEUROPILIN RECEPTOR ANTAGONIST,BRD:BRD-K50653584-001-01-2,
REP.PRIMARY,2.4999692746199997,ELN-441958,BDKRB1,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K50699835-001-01-2,
REP.PRIMARY,2.4142066349599998,FLUPIRTINE,"ADRA2A, KCNQ1, KCNQ2",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K50720187-051-03-1,
REP.PRIMARY,2.44811008732,PF-03882845,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K51041191-001-01-4,
REP.PRIMARY,2.5,M-25,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K51265828-001-01-0,
REP.PRIMARY,2.50003222832,KUROMANIN,CD38,RIBOSYL CYCLASE INHIBITOR,BRD:BRD-K51337109-003-01-3,
REP.PRIMARY,2.5,AMEZINIUM,ADRB2,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K51387999-067-01-6,
REP.PRIMARY,2.5,TEIJIN-COMPOUND-1,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K51528698-003-01-4,
REP.PRIMARY,2.5,BUPICOMIDE,ADRB1,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K51700582-001-01-2,
REP.PRIMARY,2.5,MOFEGILINE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K52598503-003-01-1,
REP.PRIMARY,2.5,EACT,ANO1,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,BRD:BRD-K53030960-001-01-4,
REP.PRIMARY,2.5,JW-55,"TNKS, TNKS2",TANKYRASE INHIBITOR,BRD:BRD-K53328210-001-04-4,
REP.PRIMARY,2.5,PEXMETINIB,"MAPK14, TEK","MAP KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR",BRD:BRD-K53405000-001-02-8,
REP.PRIMARY,2.49999308484,BI-224436,,HIV INTEGRASE INHIBITOR,BRD:BRD-K53422148-001-01-8,
REP.PRIMARY,2.5,YZ9,"MIF, PFKFB3",PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K53438416-001-01-9,
REP.PRIMARY,2.5,TNP-470,METAP2,METHIONINE AMINOPEPTIDASE INHIBITOR,BRD:BRD-K53597484-001-02-7,
REP.PRIMARY,2.5,TABIMORELIN,GHSR,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K53600683-051-01-5,
REP.PRIMARY,2.5,PROACIPIMOX,,CHOLESTEROL INHIBITOR,BRD:BRD-K53605365-001-01-4,
REP.PRIMARY,2.4999812324799997,PLX8394,BRAF,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K53723268-001-01-3,
REP.PRIMARY,2.5,AC-186,ESR2,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K53788420-001-01-1,
REP.PRIMARY,2.5,CP-316819,PYGL,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-K53913008-001-01-5,
REP.PRIMARY,2.43415457032,CGS-9896,"GABRA1, GABRB2, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K54093161-001-01-8,
REP.PRIMARY,2.5000075273599998,NMS-P715,,PROTEIN KINASE INHIBITOR,BRD:BRD-K54170555-001-01-8,
REP.PRIMARY,2.4999910982399998,ETC-159,PORCN,"BETA CATENIN INHIBITOR, PORCUPINE INHIBITOR",BRD:BRD-K54264768-001-01-2,
REP.PRIMARY,2.4999819195799997,LY450108,,GLUTAMATE RECEPTOR MODULATOR,BRD:BRD-K54538117-001-01-7,
REP.PRIMARY,2.5,VU29,GRM5,GLUTAMATE RECEPTOR POTENTIATOR,BRD:BRD-K54783522-001-01-8,
REP.PRIMARY,2.5,PF-04418948,PTGER2,PROSTAGLANDIN INHIBITOR,BRD:BRD-K54871792-001-02-2,
REP.PRIMARY,2.5,TC-OT-39,"AVPR1A, OXT","OXYTOCIN RECEPTOR AGONIST, VASOPRESSIN RECEPTOR AGONIST",BRD:BRD-K55013981-001-01-3,
REP.PRIMARY,2.5,RIBOSTAMYCIN,P4HB,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K55188888-065-01-2,
REP.PRIMARY,2.5000005385799997,RO-48-8071,LSS,OXIDOSQUALENE CYCLASE INHIBITOR,BRD:BRD-K55192287-051-01-1,
REP.PRIMARY,2.5,TCS-2314,"ITGA4, ITGB1",INTEGRIN INHIBITOR,BRD:BRD-K55216666-001-01-4,
REP.PRIMARY,2.5,GSK-J5,,HISTONE DEMETHYLASE CONTROL,BRD:BRD-K55438324-001-01-8,
REP.PRIMARY,2.49999549448,WEHI-345-ANALOG,,SRC INHIBITOR,BRD:BRD-K55487946-001-01-3,
REP.PRIMARY,2.6058100835399998,FUREGRELATE,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K55529781-236-03-8,
REP.PRIMARY,2.50001357414,EPIGALLOCATECHIN-GALLATE-(-),"ELANE, EP300, FASN, KAT2B, MMP14, MMP2",BACTERIAL DNA GYRASE INHIBITOR,BRD:BRD-K55591206-001-20-7,
REP.PRIMARY,2.5,IMEGLIMIN,,GLUCONEOGENESIS INHIBITOR,BRD:BRD-K55822903-003-01-8,
REP.PRIMARY,2.5000456334599996,TUG-770,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K56086081-001-01-7,
REP.PRIMARY,2.5,CGP-74514,CDK1,CDK INHIBITOR,BRD:BRD-K56239177-300-01-3,
REP.PRIMARY,2.49999626898,TBA-354,,,BRD:BRD-K56405978-001-01-5,
REP.PRIMARY,2.5000094480399997,VIPADENANT,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K56565215-001-01-9,
REP.PRIMARY,2.4589505332,2-IODOHIPPURIC-ACID,,,BRD:BRD-K56634222-001-03-0,
REP.PRIMARY,2.5,DICYCLOHEXYLAMINE,,,BRD:BRD-K57091285-001-07-7,
REP.PRIMARY,2.5,BRIVANIB-ALANINATE,FGFR3,"FGFR INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K57187269-001-02-4,
REP.PRIMARY,2.37127441798,MRK-409,,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K57416838-001-01-1,
REP.PRIMARY,2.5,TFC-007,HPGDS,PROSTAGLANDIN INHIBITOR,BRD:BRD-K57708067-001-01-3,
REP.PRIMARY,2.5,FLUOCINONIDE,"NR3C1, SERPINA6, SMO",GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K57886322-001-16-6,
REP.PRIMARY,2.5,CB-839,GLS,GLUTAMINASE INHIBITOR,BRD:BRD-K58070273-001-03-3,
REP.PRIMARY,2.38878370748,BEGACESTAT,PSEN1,GAMMA SECRETASE INHIBITOR,BRD:BRD-K58319700-001-01-1,
REP.PRIMARY,2.5,HKI-357,EGFR,EGFR INHIBITOR,BRD:BRD-K58811567-001-01-9,
REP.PRIMARY,2.5,ONO-4817,MMP8,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K58894520-001-01-1,
REP.PRIMARY,2.5,CHLORPROPHAM,,ANTIVIRAL,BRD:BRD-K59590127-001-04-5,
REP.PRIMARY,2.5000116398000003,ORY-1001,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K59711701-300-02-1,
REP.PRIMARY,2.50001332628,MDL-29951,FBP1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K59753853-001-02-3,
REP.PRIMARY,2.5,Q-203,,ATP SYNTHASE INHIBITOR,BRD:BRD-K59853741-001-01-9,
REP.PRIMARY,2.5,ML-277,KCNQ1,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K60020910-001-02-5,ML277
REP.PRIMARY,2.5,ML277,KCNQ1,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K60020910-001-02-5,ML277
REP.PRIMARY,2.4999999260199997,ARQ-092,AKT2,AKT INHIBITOR,BRD:BRD-K60171656-001-01-6,
REP.PRIMARY,2.5,ITE,AHR,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K60298136-001-03-3,
REP.PRIMARY,2.7206708085,OSEMOZOTAN,HTR1A,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K60371362-001-01-7,
REP.PRIMARY,2.5,UNC-2327,PRMT3,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K60635008-001-01-5,UNC2327
REP.PRIMARY,2.5,UNC2327,PRMT3,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K60635008-001-01-5,UNC2327
REP.PRIMARY,2.5,CVT-10216,ALDH2,ALDEHYDE DEHYDROGENASE INHIBITOR,BRD:BRD-K60659193-001-02-8,
REP.PRIMARY,2.5,ECTOINE-ZWITTERION,,,BRD:BRD-K60902958-001-01-9,
REP.PRIMARY,2.5,SR-140333,TACR1,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K60931454-003-01-3,
REP.PRIMARY,2.50002252532,SR-3306,"MAPK10, MAPK8, MAPK9",JNK INHIBITOR,BRD:BRD-K60952143-001-01-0,
REP.PRIMARY,2.38271611422,AZD1080,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K61041538-001-03-0,
REP.PRIMARY,2.5,AZD9272,GRM5,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K61043483-001-01-5,
REP.PRIMARY,2.50005914144,KEVETRIN,,P53 ACTIVATOR,BRD:BRD-K61339991-003-01-8,
REP.PRIMARY,2.5,FIPI,"PLD1, PLD2",PHOSPHOLIPASE INHIBITOR,BRD:BRD-K61560897-003-01-4,
REP.PRIMARY,2.50000288746,NQDI-1,CASP3,CASPASE INHIBITOR,BRD:BRD-K61918008-001-07-1,
REP.PRIMARY,2.5,A-412997,DRD4,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K62066682-300-01-0,
REP.PRIMARY,2.5000242079199997,GSK2256294A,EPHX2,EPOXIDE HYDOLASE INHIBITOR,BRD:BRD-K62738477-001-01-7,
REP.PRIMARY,2.5,HIPPURIC-ACID,,,BRD:BRD-K62914667-001-13-9,
REP.PRIMARY,2.5,O-ACETYL-L-SERINE,PTGS1,,BRD:BRD-K63247785-001-01-5,
REP.PRIMARY,2.5,SPP-86,RET,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K63253858-001-01-5,SPP86
REP.PRIMARY,2.5,SPP86,RET,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K63253858-001-01-5,SPP86
REP.PRIMARY,2.5,WAY-208466,"DRD2, HTR2A, HTR2C, HTR6, HTR7",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K63483542-300-01-6,
REP.PRIMARY,2.5,QUAZINONE,"PDE3A, PDE3B",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K63631219-001-01-6,
REP.PRIMARY,2.5,PIRQUINOZOL,,HISTAMINE RELEASE INHIBITOR,BRD:BRD-K63651590-001-01-3,
REP.PRIMARY,2.5,VINFLUNINE,,MICROTUBULE INHIBITOR,BRD:BRD-K64120610-046-01-9,
REP.PRIMARY,2.5,GANT-58,GLI1,GLI ANTAGONIST,BRD:BRD-K64451768-001-05-4,
REP.PRIMARY,2.5,KO143,"ABCB1, ABCC1",BCRP INHIBITOR,BRD:BRD-K64642496-001-04-0,
REP.PRIMARY,2.6741301690399997,ETEROBARB,,ANTICONVULSANT,BRD:BRD-K64834129-001-19-6,
REP.PRIMARY,2.5,TTP-22,CSNK2A1,CASEIN KINASE INHIBITOR,BRD:BRD-K64852730-001-01-7,
REP.PRIMARY,2.5,BIRT-377,ICAM1,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,BRD:BRD-K64880136-001-02-6,
REP.PRIMARY,2.5,INDALPINE,SLC6A4,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K64973364-001-01-4,
REP.PRIMARY,2.5485571438599997,GW-803430,"KCNH2, MCHR1",MELANIN INHIBITOR,BRD:BRD-K65576800-001-01-6,
REP.PRIMARY,2.4999589842799996,RX-3117,"CDK2, DNMT1","CDK INHIBITOR, DNA SYNTHESIS INHIBITOR",BRD:BRD-K66213167-001-01-2,
REP.PRIMARY,2.49999496866,THZ1,CDK7,CDK INHIBITOR,BRD:BRD-K66401437-001-03-3,
REP.PRIMARY,2.6704553870199996,ALPIDEM,GABRA1,BENZODIAZEPINE RECEPTOR AGONIST,BRD:BRD-K66896751-001-02-4,
REP.PRIMARY,2.53742604734,SANGUINARIUM-CHLORIDE,CASP3,APOPTOSIS STIMULANT,BRD:BRD-K66898851-003-03-3,
REP.PRIMARY,2.5,EB-47,PARP1,PARP INHIBITOR,BRD:BRD-K66998413-300-01-6,
REP.PRIMARY,2.5,LUF-5834,"ADORA2A, ADORA2B",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K67079690-001-01-2,
REP.PRIMARY,2.4999836578399997,TAK-593,PDGFRA,VEGFR INHIBITOR,BRD:BRD-K67262033-001-01-0,
REP.PRIMARY,2.5,GPBAR-A,GPBAR1,"G PROTEIN COUPLED RECEPTOR AGONIST, G PROTEIN-COUPLED RECEPTOR AGONIST",BRD:BRD-K67397687-001-01-3,
REP.PRIMARY,2.4999661349,NVP-HSP990,"HSP90AA1, HSP90AB1",HSP INHIBITOR,BRD:BRD-K67915505-001-01-2,
REP.PRIMARY,2.50003043728,APTO-253,KLF4,"KR""""""""UPPEL-LIKE FACTOR EXPRESSION ENHANCER, KRÃPPEL-LIKE FACTOR EXPRESSION ENHANCER",BRD:BRD-K68003372-001-01-6,
REP.PRIMARY,2.50001827286,LY2979165,GRM2,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K68220839-413-02-8,
REP.PRIMARY,2.51205308048,TCS-HDAC6-20B,HDAC6,HDAC INHIBITOR,BRD:BRD-K68358632-001-01-0,
REP.PRIMARY,2.6202195572,SILVER-SULFADIAZINE,,PABA ANTAGONIST,BRD:BRD-K68379918-001-01-1,
REP.PRIMARY,2.52229772218,GS-6201,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K68453341-001-01-1,
REP.PRIMARY,2.49999224352,ST-2825,MYD88,MYELOID DIFFERENTIATION PRIMARY RESPONSE INHIBITOR,BRD:BRD-K68470841-001-01-0,
REP.PRIMARY,2.5,SB-706375,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K68633027-001-01-9,
REP.PRIMARY,2.5,VU-0422288,GRM3,"GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR",BRD:BRD-K68674163-001-01-7,VU0422288
REP.PRIMARY,2.5,VU0422288,GRM3,"GLUTAMATE RECEPTOR ALLOSTERIC MODULATOR, GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR",BRD:BRD-K68674163-001-01-7,VU0422288
REP.PRIMARY,2.50003395678,NECROSTATIN-2,RIPK2,"NECROPTOSIS INHIBITOR, RIPK INHIBITOR",BRD:BRD-K68851986-001-01-6,
REP.PRIMARY,2.5000205212399997,SOLCITINIB,JAK1,JAK INHIBITOR,BRD:BRD-K69215269-001-01-1,
REP.PRIMARY,2.5,CUDC-427,XIAP,APOPTOSIS INHIBITOR,BRD:BRD-K69351586-001-01-0,
REP.PRIMARY,2.5,CUR-61414,"DHH, IHH, SMO",SMOOTHENED RECEPTOR ANTAGONIST,BRD:BRD-K69624312-001-01-1,
REP.PRIMARY,2.49999129252,GMX1778,NAMPT,NAMPT INHIBITOR,BRD:BRD-K69832040-001-01-9,
REP.PRIMARY,2.5,CYM-50260,S1PR4,"SPHINGOSINE 1 PHOSPHATE RECEPTOR AGONIST, SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST",BRD:BRD-K69877120-001-01-7,
REP.PRIMARY,2.5,A-1070722,"GSK3A, GSK3B",GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K70329400-001-02-5,
REP.PRIMARY,2.5,LM-22A4,NTRK2,TROPOMYOSIN RECEPTOR KINASE INHIBITOR,BRD:BRD-K70404782-001-01-6,
REP.PRIMARY,2.50002088962,EPZ015666,PRMT5,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K70446295-001-01-7,
REP.PRIMARY,2.5,DACTINOMYCIN,POLR2A,RNA POLYMERASE INHIBITOR,BRD:BRD-K70578146-001-06-7,
REP.PRIMARY,2.5,SEN-1269,APP,BETA AMYLOID INHIBITOR,BRD:BRD-K70614402-001-01-0,
REP.PRIMARY,2.5,A-967079,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K70744942-001-01-2,
REP.PRIMARY,2.5,IDAZOXANE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K70759443-001-01-4,
REP.PRIMARY,2.5,CEFOXITIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K70976396-236-26-0,
REP.PRIMARY,2.5,SULFAQUINOXALINE,,VITAMIN K ANTAGONIST,BRD:BRD-K71133585-236-14-4,
REP.PRIMARY,2.5,SBE-13,PLK1,PLK INHIBITOR,BRD:BRD-K71667152-003-09-8,
REP.PRIMARY,2.5,TRIFLUSAL,"NFKB1, NOS2, PDE10A, PTGS1","CYCLOOXYGENASE INHIBITOR, PLATELET AGGREGATION INHIBITOR, THROMBOXANE SYNTHASE INHIBITOR",BRD:BRD-K71696703-001-07-9,
REP.PRIMARY,2.4999669173399997,MUT056399,,FABI INHIBITOR,BRD:BRD-K72078047-001-01-7,
REP.PRIMARY,2.4999970494,GSK503,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K72293620-001-01-7,
REP.PRIMARY,2.5,PPY-A,"ABL1, BCR",ABL KINASE INHIBITOR,BRD:BRD-K72514671-001-01-4,
REP.PRIMARY,2.5000320652399997,BET-BAY-002,,BROMODOMAIN INHIBITOR,BRD:BRD-K72735080-001-01-0,
REP.PRIMARY,2.5,APCK-110,"KIT, STAT3",KIT INHIBITOR,BRD:BRD-K72748448-001-01-0,
REP.PRIMARY,2.5,SAR405,PIK3C3,PI3K INHIBITOR,BRD:BRD-K72868067-001-02-4,
REP.PRIMARY,2.49997037562,AZD9496,ESR1,ESTROGEN RECEPTOR AGONIST,BRD:BRD-K73235735-001-02-7,
REP.PRIMARY,2.5,MCOPPB,OPRL1,"NOCICEPTIN/ORPHANIN FQ (NOP) RECEPTOR AGONIST, NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST",BRD:BRD-K73276278-305-01-1,
REP.PRIMARY,2.49998476806,HLCL-61,PRMT5,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K73746696-003-01-8,
REP.PRIMARY,2.50001200186,NSC-5844,CCR1,CC CHEMOKINE RECEPTOR AGONIST,BRD:BRD-K73799155-001-01-5,NSC5844
REP.PRIMARY,2.50001200186,NSC5844,CCR1,CC CHEMOKINE RECEPTOR AGONIST,BRD:BRD-K73799155-001-01-5,NSC5844
REP.PRIMARY,2.49997838016,MLN1117,PIK3CA,PI3K INHIBITOR,BRD:BRD-K73877023-001-01-9,
REP.PRIMARY,2.5,AZD3988,DGAT1,DIACYLGLYCEROL KINASE INHIBITOR,BRD:BRD-K73984371-001-01-1,
REP.PRIMARY,2.5,D-(+)-MALTOSE,"AMY2B, MGAM",,BRD:BRD-K74377520-001-01-7,
REP.PRIMARY,2.5,EW-7197,"ACVR1B, TGFBR1",TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K74396648-001-01-4,
REP.PRIMARY,2.4287165352,PHORTRESS,AHR,ARYL HYDROCARBON RECEPTOR LIGAND,BRD:BRD-K74558903-300-01-5,
REP.PRIMARY,2.5,COR-170,CNR2,CANNABINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K74965187-001-01-3,
REP.PRIMARY,2.61443263948,V-51,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K75052463-001-01-4,
REP.PRIMARY,2.4965344687199997,2-(1-ADAMANTYLAMINO)BENZOIC-ACID,,,BRD:BRD-K75167327-001-01-6,ANTHRANILIC-ACID
REP.PRIMARY,2.4965344687199997,ANTHRANILIC-ACID,,,BRD:BRD-K75167327-001-01-6,ANTHRANILIC-ACID
REP.PRIMARY,2.5,AS-2034178,FFAR1,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K75254015-001-01-9,
REP.PRIMARY,2.5,LIMKI-3,LIMK1,LIM KINASE INHIBITOR,BRD:BRD-K75373031-001-01-7,
REP.PRIMARY,2.5120530793,FLURIZAN,"APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2",GAMMA SECRETASE INHIBITOR,BRD:BRD-K75410565-001-02-9,
REP.PRIMARY,2.50002251562,PI4KIII-BETA-INHIBITOR-1,PI4K2B,PI4K INHIBITOR,BRD:BRD-K75528696-001-01-2,
REP.PRIMARY,2.5,JW-74,"TNKS, TNKS2","TANKYRASE INHIBITOR, WNT SIGNALING INHIBITOR",BRD:BRD-K75664313-001-02-6,
REP.PRIMARY,2.6019512208399997,COMPOUND-58112,,,BRD:BRD-K76139886-003-01-3,
REP.PRIMARY,2.5000039474199998,AZ505,SMYD2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K76244476-362-02-5,
REP.PRIMARY,2.5,CHR-6494,GSG2,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K76259716-019-01-1,
REP.PRIMARY,2.5,SC-236,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K76365178-001-01-5,
REP.PRIMARY,2.39078087122,REBASTINIB,"ABL1, BCR, FGR, FLT3, HCK, LYN, SRC","BCR-ABL KINASE INHIBITOR, TIE TYROSINE KINASE INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K76694128-001-05-0,
REP.PRIMARY,2.4097092820799997,TERAMEPROCOL,"BIRC5, CDK1",LIPOXYGENASE INHIBITOR,BRD:BRD-K76788410-001-01-6,
REP.PRIMARY,2.5,TC-MPS1-12,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K76792630-001-01-2,
REP.PRIMARY,2.5253280924599997,CABOTEGRAVIR,,HIV INTEGRASE INHIBITOR,BRD:BRD-K76819217-001-02-2,
REP.PRIMARY,2.5,U-75799E,GHSR,GROWTH HORMONE RELEASING FACTOR AGONIST,BRD:BRD-K77070363-001-01-5,
REP.PRIMARY,2.40262570332,2-OLEOYLGLYCEROL,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR LIGAND,BRD:BRD-K77087341-001-02-4,
REP.PRIMARY,2.5,ESI-09,"RAPGEF3, RAPGEF4",EPAC INHIBITOR,BRD:BRD-K77139516-001-02-2,
REP.PRIMARY,2.5,RO-1138452,PTGIR,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K77220725-003-01-5,
REP.PRIMARY,2.5,ML-179,NR5A2,LIVER RECEPTOR HOMOLOG INVERSE AGONIST,BRD:BRD-K77547509-001-03-3,ML179
REP.PRIMARY,2.5,ML179,NR5A2,LIVER RECEPTOR HOMOLOG INVERSE AGONIST,BRD:BRD-K77547509-001-03-3,ML179
REP.PRIMARY,2.5,"7,8,9,10-TETRAHYDROAZEPINO[2,1-B]QUINAZOLIN-12(6H)-ONE",,,BRD:BRD-K77756533-001-01-4,
REP.PRIMARY,2.5,ADX-10059,GRM5,GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K77911775-003-01-8,
REP.PRIMARY,2.499986647,ITI214,PDE1A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K77987496-011-01-9,
REP.PRIMARY,2.72360361196,2'-C-METHYLGUANOSINE,,HCV INHIBITOR,BRD:BRD-K78092779-001-01-6,
REP.PRIMARY,2.5,TC-N-1752,SCN9A,SODIUM CHANNEL BLOCKER,BRD:BRD-K78161388-001-01-2,
REP.PRIMARY,2.50001815012,NANDROLONE-DECANOATE,AR,ANDROGENIC STEROID,BRD:BRD-K78352627-001-01-8,
REP.PRIMARY,2.5,RO-3306,CDK1,CDK INHIBITOR,BRD:BRD-K78373679-001-03-7,
REP.PRIMARY,2.4999860362399997,ALTIRATINIB,"KDR, MET, TEK","MET INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K78627070-001-01-5,
REP.PRIMARY,2.5,KHS-101,TACC3,NEURAL STEM CELL INDUCER,BRD:BRD-K78978711-003-01-3,
REP.PRIMARY,2.5,CGP-60474,"CDK1, CDK2",CDK INHIBITOR,BRD:BRD-K79090631-001-22-3,
REP.PRIMARY,2.5,LSN-2463359,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K79337272-001-01-6,
REP.PRIMARY,2.5,2-CHLOROADENOSINE,"ADORA1, ADORA2A, ADORA2B",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K79511609-001-20-0,
REP.PRIMARY,2.5,TC-NTR1-17,NTSR1,NEUROTENSIN AGONIST,BRD:BRD-K79608170-001-02-1,
REP.PRIMARY,2.5,REVERSAN,ABCC1,MRP INHIBITOR,BRD:BRD-K79700588-001-09-7,
REP.PRIMARY,2.50003901804,TA-01,"CSNK1D, CSNK1E, MAPK14","CASEIN KINASE INHIBITOR, MAP KINASE INHIBITOR",BRD:BRD-K79856806-001-01-0,
REP.PRIMARY,2.50001444878,ML204,"TRPC4, TRPC5",TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K80021413-001-08-8,
REP.PRIMARY,2.63789459194,BW-A4C,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-K80194255-001-01-9,
REP.PRIMARY,2.5,ALAFOSFALIN,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K80403280-001-02-1,
REP.PRIMARY,2.5,CYM-50358,S1PR4,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K80666802-003-01-0,
REP.PRIMARY,2.4354748274399998,EC-23,"RARA, RARB, RARG",RETINOID RECEPTOR AGONIST,BRD:BRD-K81004638-001-01-7,
REP.PRIMARY,2.4999778879799996,BMS-817378,"KDR, MET","C-MET INHIBITOR, VEGFR INHIBITOR",BRD:BRD-K81026553-234-01-8,
REP.PRIMARY,2.5,ML-348,LYPLA1,LYSOPHOSPHOLIPASE INHIBITOR,BRD:BRD-K81044214-001-06-4,ML348
REP.PRIMARY,2.5,ML348,LYPLA1,LYSOPHOSPHOLIPASE INHIBITOR,BRD:BRD-K81044214-001-06-4,ML348
REP.PRIMARY,2.5,KS-176,ABCG2,BCRP INHIBITOR,BRD:BRD-K81053848-001-01-0,
REP.PRIMARY,2.5,A-922500,DGAT1,DIACYLGLYCEROL O ACYLTRANSFERASE INHIBITOR,BRD:BRD-K81614372-001-02-1,
REP.PRIMARY,2.5,L-ASPARAGINE-N-HYDROXY,,,BRD:BRD-K82178523-001-01-6,
REP.PRIMARY,2.50001536012,GSK-J2,,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K82484347-001-01-2,
REP.PRIMARY,2.5,RO-5126766,"BRAF, MAP2K1, MAP2K2, RAF1","MEK INHIBITOR, RAF INHIBITOR",BRD:BRD-K82804538-001-01-0,
REP.PRIMARY,2.50001562806,AZD8835,"PIK3CA, PIK3CD",PI3K INHIBITOR,BRD:BRD-K82894950-001-01-0,
REP.PRIMARY,2.49996533224,DBPR108,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K83020231-001-01-2,
REP.PRIMARY,2.5,PF-06447475,LRRK2,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K83114366-001-02-8,
REP.PRIMARY,2.5,WWL-123,ABHD6,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K83176916-001-01-4,
REP.PRIMARY,2.5,GPP-78,NAMPT,NAMPT INHIBITOR,BRD:BRD-K83289131-003-01-0,
REP.PRIMARY,2.5,T-5601640,LIMK2,LIM KINASE INHIBITOR,BRD:BRD-K83492904-001-01-9,
REP.PRIMARY,2.5,LU-AA-47070,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K83970940-001-01-0,
REP.PRIMARY,2.50002582262,TP-0903,AXL,AXL KINASE INHIBITOR,BRD:BRD-K84034737-001-01-1,
REP.PRIMARY,2.5,MR-948,TBXAS1,THROMBOXANE SYNTHASE INHIBITOR,BRD:BRD-K84883208-001-01-1,
REP.PRIMARY,2.5,AIM-100,TNK2,TYROSINE KINASE INHIBITOR,BRD:BRD-K85139301-001-01-3,
REP.PRIMARY,2.5,BMS-688521,ICAM1,"ICAM1 ANTAGONIST, LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN RECEPTOR ANTAGONIST",BRD:BRD-K85649978-001-02-1,
REP.PRIMARY,2.5,TOLRESTAT,"AKR1A1, AKR1B1, AKR1B10",ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K85693895-001-02-9,
REP.PRIMARY,2.5,SOMANTADINE,,ANTIVIRAL,BRD:BRD-K85764479-003-01-0,
REP.PRIMARY,2.50001769992,APD597,GPR119,GLUCOSE DEPENDENT INSULINOTROPIC RECEPTOR AGONIST,BRD:BRD-K86226872-001-01-6,
REP.PRIMARY,2.3219433423,RAVOXERTINIB,"MAPK1, MAPK3",ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K86309810-001-01-5,
REP.PRIMARY,2.5,AMG-548,"MAPK11, MAPK12, MAPK13, MAPK14",MAP KINASE INHIBITOR,BRD:BRD-K86673452-001-01-7,
REP.PRIMARY,2.5,CZC-54252,LRRK2,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K87021635-003-02-2,
REP.PRIMARY,2.5,NARINGENINIC-ACID,"HCAR2, PTGR1",,BRD:BRD-K87122641-001-10-7,
REP.PRIMARY,2.5,TC-G-1008,GPR39,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K87199310-001-01-4,
REP.PRIMARY,2.49999741834,EPZ011989,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87468701-001-01-0,
REP.PRIMARY,2.5,GNF-5,"ABL1, BCR",BCR-ABL KINASE INHIBITOR,BRD:BRD-K87632963-001-03-0,
REP.PRIMARY,2.4999685403000003,FPS-ZM1,AGER,RAGE RECEPTOR ANTAGONIST,BRD:BRD-K87691185-001-01-2,
REP.PRIMARY,2.5,BMS-309403,FABP4,FATTY ACID BINDING PROTEIN INHIBITOR,BRD:BRD-K87956243-001-01-9,
REP.PRIMARY,2.5,KB-SRC-4,SRC,SRC INHIBITOR,BRD:BRD-K88154110-001-01-0,
REP.PRIMARY,2.50000085862,INTEGRIN-ANTAGONIST-1,"ITGAV, ITGB6",INTEGRIN ANTAGONIST,BRD:BRD-K88165431-003-01-4,
REP.PRIMARY,2.50001946986,AM679,"ALOX5AP, CNR1, CNR2","CANNABINOID RECEPTOR AGONIST, LIPOXYGENASE INHIBITOR",BRD:BRD-K88443722-001-01-7,
REP.PRIMARY,2.5,YODA-1,PIEZO1,PIEZO CHANNEL ACTIVATOR,BRD:BRD-K88570498-001-01-9,
REP.PRIMARY,2.4999823647399997,TEGASEROD,"HTR2A, HTR2B, HTR2C, HTR4",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K88743730-050-04-1,
REP.PRIMARY,2.5,BTB1,KIF18A,MITOTIC KINESIN INHIBITOR,BRD:BRD-K89000287-001-01-1,
REP.PRIMARY,2.5,NG-NITRO-ARGININE,"NOS1, NOS2, NOS3",NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K89223384-001-05-2,
REP.PRIMARY,2.5,GSK269962,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K89464729-001-03-1,
REP.PRIMARY,2.5,TC-S-7004,"DYRK1A, DYRK1B",DYRK INHIBITOR,BRD:BRD-K89517477-001-01-4,
REP.PRIMARY,2.5,TC-S-7005,PLK2,PLK INHIBITOR,BRD:BRD-K89584803-001-01-9,
REP.PRIMARY,2.5,ZEATIN,,,BRD:BRD-K90033078-001-08-7,
REP.PRIMARY,2.5,VUF10460,HRH4,HISTAMINE RECEPTOR AGONIST,BRD:BRD-K90082312-001-01-5,
REP.PRIMARY,2.5,ID-1101,INS,INSULIN SENSITIZER,BRD:BRD-K90305467-001-01-3,
REP.PRIMARY,2.4999830303799997,BCX-1470,CFD,"COMPLEMENT INHIBITOR, SERINE PROTEASE INHIBITOR",BRD:BRD-K90472149-066-01-0,
REP.PRIMARY,2.5,PINCAINIDE,,ANTIARRHYTHMIC,BRD:BRD-K90727284-001-05-0,
REP.PRIMARY,2.5,KG-5,"BRAF, FLT3, KIT, PDGFRB",RAF INHIBITOR,BRD:BRD-K90747162-001-01-4,
REP.PRIMARY,2.5,DELTARASIN,KRAS,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K90830492-305-01-4,
REP.PRIMARY,2.6759749507599997,NAPIRIMUS,,IMMUNOSUPPRESSANT,BRD:BRD-K91234829-001-01-7,
REP.PRIMARY,2.50001943412,UNC2025,"FLT3, MERTK","FLT3 INHIBITOR, MER TYROSINE KINASE INHIBITOR",BRD:BRD-K91283740-003-01-6,
REP.PRIMARY,2.5,PALMITOLEIC-ACID,,,BRD:BRD-K91356052-001-04-0,
REP.PRIMARY,2.26155274624,YM-750,SOAT1,ACAT INHIBITOR,BRD:BRD-K91716465-001-01-2,
REP.PRIMARY,2.3834749879199997,SECOISOLARICIRESINOL-(-),,,BRD:BRD-K91733562-001-05-0,
REP.PRIMARY,2.5,CAROXAZONE,"MAOA, MAOB",MONOAMINE OXIDASE INHIBITOR,BRD:BRD-K92129045-001-01-6,
REP.PRIMARY,2.35435097428,URB597,"FAAH, FAAH2, TRPA1",FAAH INHIBITOR,BRD:BRD-K92169341-001-11-2,
REP.PRIMARY,2.4999712055199996,ACALISIB,"PIK3CB, PIK3CD",PI3K INHIBITOR,BRD:BRD-K92517771-001-01-2,
REP.PRIMARY,2.50002297242,ML314,NTSR1,NEUROTENSIN AGONIST,BRD:BRD-K92606079-001-02-0,
REP.PRIMARY,2.5,CID-2011756,PKD1,PROTEIN KINASE INHIBITOR,BRD:BRD-K92781136-001-08-9,
REP.PRIMARY,2.4999924489,IVOSIDENIB,IDH1,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K93073858-001-01-1,
REP.PRIMARY,2.5,VU-0364739,PLD2,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K93317811-003-02-2,VU0364739
REP.PRIMARY,2.5,VU0364739,PLD2,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K93317811-003-02-2,VU0364739
REP.PRIMARY,2.5,LYPRESSIN,"AVPR1A, AVPR1B, AVPR2",VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K93331255-001-02-0,
REP.PRIMARY,2.5,KN-93,CAMK2A,CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K93480852-003-01-0,
REP.PRIMARY,2.5000083101399997,VX-11E,MAPK1,MAP KINASE INHIBITOR,BRD:BRD-K93725829-001-03-8,
REP.PRIMARY,2.5,PF-431396,"PTK2, PTK2B",FOCAL ADHESION KINASE INHIBITOR,BRD:BRD-K93788137-001-04-1,
REP.PRIMARY,2.49996963146,ML-323,USP1,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K93942811-001-01-3,ML323
REP.PRIMARY,2.49996963146,ML323,USP1,UBIQUITIN SPECIFIC PROTEASE INHIBITOR,BRD:BRD-K93942811-001-01-3,ML323
REP.PRIMARY,2.5,RWJ-50271,ICAM1,INTEGRIN INHIBITOR,BRD:BRD-K94623186-001-01-5,
REP.PRIMARY,2.5,SPIZOFURONE,,,BRD:BRD-K94934625-001-01-5,
REP.PRIMARY,2.50002820322,MACELIGNAN,,"ANTI-INFLAMMATORY AGENT, ANTIINFLAMMATORY AGENT, ANTIOXIDANT",BRD:BRD-K94948151-001-07-4,
REP.PRIMARY,2.5,IBMX,"ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A",PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K94979336-001-20-0,
REP.PRIMARY,2.5,GSK2194069,FASN,FATTY ACID SYNTHASE INHIBITOR,BRD:BRD-K95123482-001-01-6,
REP.PRIMARY,2.49999323032,THZ2,CDK7,CDK INHIBITOR,BRD:BRD-K95902121-001-01-0,
REP.PRIMARY,2.4999918453000003,PF-670462,"CSNK1D, CSNK1E",CASEIN KINASE INHIBITOR,BRD:BRD-K96295391-300-01-7,
REP.PRIMARY,2.5,R-1485,HTR6,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K96418224-300-01-8,
REP.PRIMARY,2.5,CP-775146,PPARA,PPAR RECEPTOR AGONIST,BRD:BRD-K96843359-001-02-6,
REP.PRIMARY,2.50002050242,AMG-925,"CDK4, CDK6, FLT3","CDK INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K97452254-001-01-3,
REP.PRIMARY,2.50001280696,OLEANDRIN,,NA/K-ATPASE INHIBITOR,BRD:BRD-K98006098-001-01-6,
REP.PRIMARY,2.5,C-021,CCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K98179423-300-01-3,
REP.PRIMARY,2.5,MM-11253,RARG,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K98353094-001-01-6,
REP.PRIMARY,2.5,OXA-06,"ROCK1, ROCK2",RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-K98736329-300-01-5,
REP.PRIMARY,2.5,SB-243213,"HTR2A, HTR2B, HTR2C, HTR6",SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K99968849-300-01-4,
REP.PRIMARY,2.5,BETA-HYDROXY-BETA-METHYLBUTYRATE,MTOR,PROTEIN SYNTHESIS STIMULANT,BRD:BRD-M02899238-238-01-6,
REP.PRIMARY,2.5,MRS-3777,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-M86143595-034-03-4,
REP.1M,2.5,ARV-825,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-A00047421-001-01-7,
REP.1M,2.5,DOCUSATE,,LAXATIVE,BRD:BRD-A00092689-236-04-9,
REP.1M,2.5,W-54011,C5AR1,ANAPHYLATOXIN CHEMOTACTIC RECEPTOR ANTAGONIST,BRD:BRD-A00559310-003-01-1,
REP.1M,2.5,IBOTENIC-ACID,GRIN1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A02971356-001-09-9,
REP.1M,2.5,MRS-1334,ADORA3,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-A06784547-001-03-9,
REP.1M,2.5,POLYMYXIN-B-SULFATE,,BACTERIAL PERMEABILITY INDUCER,BRD:BRD-A08641215-065-05-5,
REP.1M,2.5,P7C3,NAMPT,NAMPT INHIBITOR,BRD:BRD-A09487507-001-03-9,
REP.1M,2.5,TC-A-2317,AURKA,AURORA KINASE INHIBITOR,BRD:BRD-A12147465-003-02-9,
REP.1M,2.5,TETRAZOL-5-YL-GLYCINE-(RS),"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A14757586-001-04-9,
REP.1M,2.5,WISKOSTATIN,WASL,"ACTIN RELATED PROTEIN INHIBITOR, NEURAL WISKOTT-ALDRICH SYNDROME PROTEIN INHIBITOR",BRD:BRD-A18579359-001-05-9,
REP.1M,2.5,4BP-TQS,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-A18598741-001-02-9,
REP.1M,2.5,PROPYLENE-GLYCOL,,,BRD:BRD-A19232309-001-08-6,
REP.1M,2.5,DIHYDROXYPHENYLGLYCINE,"GRM1, GRM5",GLUTAMATE RECEPTOR AGONIST,BRD:BRD-A20589515-001-03-9,
REP.1M,2.5,DMPS,,CHELATING AGENT,BRD:BRD-A22971209-001-01-0,
REP.1M,2.5,CASIN,CDC42,GTPASE INHIBITOR,BRD:BRD-A25043798-001-02-9,
REP.1M,2.5,GGSTOP,GGT1,GAMMA GLUTAMYLTRANSFERASE INHIBITOR,BRD:BRD-A25625670-001-02-7,
REP.1M,2.5,TENOFOVIR-ALAFENAMIDE,,NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-A25988899-001-01-6,
REP.1M,2.5,ML141,CDC42,GTPASE INHIBITOR,BRD:BRD-A28422330-001-11-9,
REP.1M,2.5,RP-001,S1PR1,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-A29148886-003-02-9,
REP.1M,2.5,A12B4C3,PNKP,POLYNUCLEOTIDE KINASE/PHOSPHATASE INHIBITOR,BRD:BRD-A30000356-001-02-9,
REP.1M,2.5,MITOTANE,"CYP11A1, CYP11B1, ESR1",ANTINEOPLASTIC AGENT,BRD:BRD-A31204924-001-14-2,
REP.1M,2.5,RU-SKI-43,HHAT,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-A33603104-003-02-9,
REP.1M,2.5,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE OXIME,,,BRD:BRD-A37752546-001-02-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME
REP.1M,2.5,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME,,,BRD:BRD-A37752546-001-02-9,1E-1-(2-HYDROXY-5-METHYLPHENYL)-1-DODECANONE-OXIME
REP.1M,2.5,OCTODRINE,,ANTITUMOR AGENT,BRD:BRD-A37873789-003-02-9,
REP.1M,2.5,BQU57,"RALA, RALB",RAS GTPASE INHIBITOR,BRD:BRD-A40257118-001-02-0,
REP.1M,2.5,"4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE",,DOPAMINE RELEASE INHIBITOR,BRD:BRD-A40504327-003-02-9,
REP.1M,2.5,BETA-HYDROXYBUTYRATE,HCAR2,,BRD:BRD-A41387824-001-06-0,
REP.1M,2.5,UBP-296,GRIK1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A45499626-001-04-9,
REP.1M,2.5,LY404187,"GRIA1, GRIA2, GRIA3, GRIA4",GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-A50062753-001-02-9,
REP.1M,2.5,ATB-346,PTGER2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A52551912-001-02-9,
REP.1M,2.5,BW-B70C,ALOX5,LIPOXYGENASE INHIBITOR,BRD:BRD-A55946879-001-04-9,
REP.1M,2.5,ZILEUTON,ALOX5,"LEUKOTRIENE SYNTHESIS INHIBITOR, LIPOXYGENASE INHIBITOR",BRD:BRD-A56359832-001-16-9,
REP.1M,2.5,ITD-1,TGFBR2,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-A56690687-001-02-9,
REP.1M,2.5,ALLICIN,"TRPA1, TRPV1",CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-A60402836-001-01-0,
REP.1M,2.5,SERATRODAST,TBXA2R,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-A60765580-001-03-4,
REP.1M,2.5,RBC8,"RALA, RALB",RAL GTPASE INHIBITOR,BRD:BRD-A67036568-001-03-9,
REP.1M,2.5,SODIUM-ASCORBATE,,,BRD:BRD-A67265925-236-02-6,
REP.1M,2.5,DQP-1105,"GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A67976398-001-02-9,
REP.1M,2.5,AZAPROPAZONE,PTGS2,CYCLOOXYGENASE INHIBITOR,BRD:BRD-A70182876-001-11-9,
REP.1M,2.5,OXF-BD-02,BRD4,BROMODOMAIN INHIBITOR,BRD:BRD-A73891132-001-02-9,
REP.1M,2.5,ANTIMONYL,,,BRD:BRD-A74328360-409-02-8,
REP.1M,2.5,NKY-80,ADCY5,ADENYLYL CYCLASE INHIBITOR,BRD:BRD-A75015151-001-08-9,
REP.1M,2.5,CIM-0216,TRPM3,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-A75514485-001-02-9,
REP.1M,2.5,D609,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-A77118605-237-09-5,
REP.1M,2.5,CCG-1423,"RHOC, SRF",APOPTOSIS STIMULANT,BRD:BRD-A79726147-001-02-9,
REP.1M,2.5,NISOLDIPINE,"CACNA1C, CACNA1D, CACNA1F, CACNA1S",CALCIUM CHANNEL BLOCKER,BRD:BRD-A84465106-001-09-5,
REP.1M,2.5,SR-3677,ROCK2,RHO ASSOCIATED KINASE INHIBITOR,BRD:BRD-A86468475-300-02-9,
REP.1M,2.5,3-MATIDA,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-A87125127-001-03-9,
REP.1M,2.5,AVADOMIDE,,ANTITUMOR AGENT,BRD:BRD-A88644406-001-02-9,
REP.1M,2.5,GPI-688,,GLYCOGEN PHOSPHORYLASE INHIBITOR,BRD:BRD-A90201073-001-02-9,
REP.1M,2.5,CACCINH-A01,CLCA1,CALCIUM-ACTIVATED CHLORIDE CHANNEL INHIBITOR,BRD:BRD-A90751343-001-02-9,
REP.1M,2.5,TROFOSFAMIDE,,DNA ALKYLATING AGENT,BRD:BRD-A91386192-001-07-9,
REP.1M,2.5,MANDELIC-ACID,,,BRD:BRD-A91448670-001-08-9,
REP.1M,2.5,ISO-1,MIF,MACROPHAGE MIGRATION INHIBITING FACTOR INHIBITOR,BRD:BRD-A94055480-001-02-9,
REP.1M,2.5,CICLOPROFEN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-A94965935-001-01-6,
REP.1M,2.5,FUMAGILLIN,METAP2,METHIONINE AMINOPEPTIDASE INHIBITOR,BRD:BRD-A99367815-001-04-9,
REP.1M,2.5,PF-05175157,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00002423-001-02-9,
REP.1M,2.5,CASPOFUNGIN,,"BACTERIAL CELL WALL SYNTHESIS INHIBITOR, FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K00002625-402-02-9,
REP.1M,2.5,SD-0006,,P38 MAPK INHIBITOR,BRD:BRD-K00003093-001-01-9,
REP.1M,2.5,JNJ-38877618,,C-MET INHIBITOR,BRD:BRD-K00003094-001-01-9,
REP.1M,2.5,GLPG1837,,CFTR CHANNEL POTENTIATOR,BRD:BRD-K00003095-001-01-9,
REP.1M,2.5,FN-1501,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003096-001-01-9,
REP.1M,2.5,PF-05180999,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003097-001-01-9,
REP.1M,2.5,IDF-11774,,HYPOXIA INDUCIBLE FACTOR INHIBITOR,BRD:BRD-K00003098-001-01-9,
REP.1M,2.5,PLX51107,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003099-001-01-9,
REP.1M,2.5,AZD7594,,GLUCOCORTICOID RECEPTOR MODULATOR,BRD:BRD-K00003100-001-01-9,
REP.1M,2.5,GDC-0927,,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00003101-001-02-9,
REP.1M,2.5,INCB-057643,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003102-001-01-9,
REP.1M,2.5,DESISOBUTYRYL-CICLESONIDE,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003103-001-01-9,
REP.1M,2.5,IACS-10759,,MITOCHONDRIAL COMPLEX I INHIBITOR,BRD:BRD-K00003105-003-01-9,
REP.1M,2.5,AZD4573,,CDK9 INHIBITOR,BRD:BRD-K00003106-001-01-9,
REP.1M,2.5,LXH254,,RAF INHIBITOR,BRD:BRD-K00003107-001-01-9,
REP.1M,2.5,ABBV-744,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003108-001-01-9,
REP.1M,2.5,AB-423,,HBV CAPSID ASSEMBLY INHIBITOR,BRD:BRD-K00003109-001-01-9,
REP.1M,2.5,BMS-986195,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003110-001-01-9,
REP.1M,2.5,BOS-172722,,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K00003111-001-01-9,
REP.1M,2.5,GDC-0575,,CHK INHIBITOR,BRD:BRD-K00003112-001-01-9,
REP.1M,2.5,O-304,,AMPK ACTIVATOR,BRD:BRD-K00003113-001-01-9,
REP.1M,2.5,C188-9,,STAT INHIBITOR,BRD:BRD-K00003114-001-01-9,
REP.1M,2.5,ETC-206,,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K00003115-001-01-9,
REP.1M,2.5,CC-90003,,MAP KINASE INHIBITOR,BRD:BRD-K00003116-001-01-9,
REP.1M,2.5,CEFTOBIPROLE,,ANTIINFECTIVE DRUG,BRD:BRD-K00003117-001-01-9,
REP.1M,2.5,RETAGLIPTIN,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003118-011-01-9,
REP.1M,2.5,PRADEFOVIR,,CYTOCHROME P450 ACTIVATOR,BRD:BRD-K00003119-066-01-9,
REP.1M,2.5,BI-409306,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003120-001-01-9,
REP.1M,2.5,GSK369796,,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00003121-300-01-9,
REP.1M,2.5,PRINOMASTAT,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003122-001-01-9,
REP.1M,2.5,RESMETIROM,,THYROID HORMONE RECEPTOR AGONIST,BRD:BRD-K00003123-001-01-9,
REP.1M,2.5,TRODUSQUEMINE,,TYROSINE PHOSPHATASE INHIBITOR,BRD:BRD-K00003124-389-01-9,
REP.1M,2.5,SULFATINIB,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003125-001-01-9,
REP.1M,2.5,G-749,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003126-001-01-9,
REP.1M,2.5,PIMODIVIR,,ANTIVIRAL,BRD:BRD-K00003127-001-01-9,
REP.1M,2.5,BECLABUVIR,,ANTIVIRAL,BRD:BRD-K00003128-001-01-9,
REP.1M,2.5,CRENIGACESTAT,,NOTCH SIGNALING INHIBITOR,BRD:BRD-K00003129-001-01-9,
REP.1M,2.5,EPETRABOROLE,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K00003130-003-01-9,
REP.1M,2.5,LY2510924,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003131-001-01-9,
REP.1M,2.5,LGD-6972,,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K00003132-001-01-9,
REP.1M,2.5,VELPATASVIR,,ANTIVIRAL,BRD:BRD-K00003133-001-01-9,
REP.1M,2.5,DESLORELIN,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K00003134-001-01-9,
REP.1M,2.5,ALISPORIVIR,,CYCLOPHILIN INHIBITOR,BRD:BRD-K00003135-001-01-9,
REP.1M,2.5,MITAPIVAT,,PYRUVATE KINASE ISOZYME ACTIVATOR,BRD:BRD-K00003136-001-01-9,
REP.1M,2.5,LOTAMILAST,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003137-001-01-9,
REP.1M,2.5,ASIVATREP,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00003138-001-01-9,
REP.1M,2.5,ETRASIMOD,,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K00003139-001-01-9,
REP.1M,2.5,HPGDS-IN-1,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003140-001-01-9,
REP.1M,2.5,VIXOTRIGINE,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00003141-003-01-9,
REP.1M,2.5,DASOTRALINE,,DOPAMINE-NOREPINEPHRINE-SEROTONIN REUPTAKE INHIBITOR,BRD:BRD-K00003142-003-01-9,
REP.1M,2.5,BAY1217389,,KINASE INHIBITOR,BRD:BRD-K00003143-001-01-9,
REP.1M,2.5,ATUVECICLIB,,CDK9 INHIBITOR,BRD:BRD-K00003144-001-01-9,
REP.1M,2.5,PF-05089771,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00003145-001-01-9,
REP.1M,2.5,MIW-815,,INTERFERON INDUCER,BRD:BRD-K00003146-318-01-9,
REP.1M,2.5,S49076,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003147-001-01-9,
REP.1M,2.5,BATEFENTEROL,,"ACETYLCHOLINE RECEPTOR ANTAGONIST, ADRENERGIC RECEPTOR AGONIST",BRD:BRD-K00003148-001-01-9,
REP.1M,2.5,RO-5028442,,VASOPRESSIN RECEPTOR ANTAGONIST,BRD:BRD-K00003149-001-01-9,
REP.1M,2.5,SEGESTERONE-ACETATE,PGR,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K00003150-001-01-9,
REP.1M,2.5,OLODANRIGAN,,ANGIOTENSIN ANTAGONIST,BRD:BRD-K00003151-001-01-9,
REP.1M,2.5,AM211,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003152-001-01-9,
REP.1M,2.5,IMISOPASEM-MANGANESE,,SUPEROXIDE DISMUTASE MIMETIC,BRD:BRD-K00003154-001-01-9,
REP.1M,2.5,TAK-779,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003155-003-01-9,
REP.1M,2.5,ERIBULIN,,MICROTUBULE INHIBITOR,BRD:BRD-K00003156-066-01-9,
REP.1M,2.5,DEBIO-0932,,HSP INHIBITOR,BRD:BRD-K00003157-001-01-9,
REP.1M,2.5,ABARELIX,GNRHR,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00003158-001-01-9,
REP.1M,2.5,BANOXANTRONE,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003159-300-01-9,
REP.1M,2.5,BELOTECAN,,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003160-003-01-9,
REP.1M,2.5,BUSERELIN,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR AGONIST,BRD:BRD-K00003161-015-01-9,
REP.1M,2.5,CROLIBULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00003162-001-01-9,
REP.1M,2.5,OGLUFANIDE,,VEGF ANTAGONIST,BRD:BRD-K00003164-001-01-9,
REP.1M,2.5,SARDOMOZIDE,,S-ADENOSYLMETHIONINE DECARBOXYLASE INHIBITOR,BRD:BRD-K00003165-300-01-9,
REP.1M,2.5,GSK189254,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003166-001-01-9,
REP.1M,2.5,MACITENTAN-N-BUTYL-ANALOGUE,,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K00003167-001-01-9,
REP.1M,2.5,BMS-582949,,P38 MAPK INHIBITOR,BRD:BRD-K00003168-003-01-9,
REP.1M,2.5,RAD140,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K00003169-001-01-9,
REP.1M,2.5,PAVINETANT,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003170-001-01-9,
REP.1M,2.5,DWK-1339,,BETA AMYLOID AGGREGATION INHIBITOR,BRD:BRD-K00003171-001-01-9,
REP.1M,2.5,E7820,,ANGIOGENESIS INHIBITOR,BRD:BRD-K00003172-001-01-9,
REP.1M,2.5,SJG-136,,DNA INTERCALATING AGENT,BRD:BRD-K00003173-001-01-9,
REP.1M,2.5,SOBLIDOTIN,,MICROTUBULE INHIBITOR,BRD:BRD-K00003174-001-01-9,
REP.1M,2.5,ROLAPITANT,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003175-001-01-9,
REP.1M,2.5,KARENITECIN,TOP1,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003176-001-01-9,
REP.1M,2.5,INDEGLITAZAR,"NCOA1, PPARA, PPARD, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K00003177-001-01-9,
REP.1M,2.5,LASMIDITAN,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00003178-003-01-9,
REP.1M,2.5,VERUCERFONT,,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K00003180-001-01-9,
REP.1M,2.5,CENICRIVIROC,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003181-001-01-9,
REP.1M,2.5,GEMIGLIPTIN,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003182-001-01-9,
REP.1M,2.5,SUCCINOBUCOL,VCAM1,ANTIOXIDANT,BRD:BRD-K00003183-001-01-9,
REP.1M,2.5,OZENOXACIN,,ANTIINFECTIVE DRUG,BRD:BRD-K00003184-001-01-9,
REP.1M,2.5,EMD534085,,KINESIN INHIBITOR,BRD:BRD-K00003185-001-01-9,
REP.1M,2.5,SSR240612,,BRADYKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003186-003-01-9,
REP.1M,2.5,GUADECITABINE,,DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K00003187-236-01-9,
REP.1M,2.5,CAPROMORELIN,,GROWTH HORMONE SECRETAGOGUE RECEPTOR AGONIST,BRD:BRD-K00003188-046-01-9,
REP.1M,2.5,BMS-911543,,JAK INHIBITOR,BRD:BRD-K00003189-001-01-9,
REP.1M,2.5,MK-0557,,NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K00003190-001-01-9,
REP.1M,2.5,FOSTEMSAVIR,,ANTIVIRAL,BRD:BRD-K00003191-001-01-9,
REP.1M,2.5,PSI-697,,P SELECTIN INHIBITOR,BRD:BRD-K00003192-001-01-9,
REP.1M,2.5,MK-7622,,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K00003194-001-01-9,
REP.1M,2.5,LY2795050,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00003195-001-01-9,
REP.1M,2.5,ONO-4059,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003197-001-02-9,
REP.1M,2.5,REVEFENACIN,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003198-001-01-9,
REP.1M,2.5,MK-7246,,CRTH RECEPTOR ANTAGONIST,BRD:BRD-K00003199-001-01-9,
REP.1M,2.5,TENAPANOR,,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K00003201-001-01-9,
REP.1M,2.5,CITARINOSTAT,,HDAC INHIBITOR,BRD:BRD-K00003202-001-01-9,
REP.1M,2.5,BMS-214662,,FARNESYLTRANSFERASE INHIBITOR,BRD:BRD-K00003203-001-01-9,
REP.1M,2.5,CELGOSIVIR,,GLUCOSIDASE INHIBITOR,BRD:BRD-K00003204-003-01-9,
REP.1M,2.5,D-3263,,TRANSIENT RECEPTOR POTENTIAL CHANNEL AGONIST,BRD:BRD-K00003205-003-01-9,
REP.1M,2.5,EMIGLITATE,,ALPHA GLUCOSIDE INHIBITOR,BRD:BRD-K00003206-001-01-9,
REP.1M,2.5,ETHYNYLCYTIDINE,,ANTIMETABOLITE,BRD:BRD-K00003207-001-01-9,
REP.1M,2.5,IMIRESTAT,,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K00003208-001-01-9,
REP.1M,2.5,JI-101,,KINASE INHIBITOR,BRD:BRD-K00003209-001-01-9,
REP.1M,2.5,OSILODROSTAT,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003210-001-01-9,
REP.1M,2.5,LURBINECTEDIN,,DNA BINDING AGENT,BRD:BRD-K00003211-001-01-9,
REP.1M,2.5,OMTRIPTOLIDE,,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K00003212-001-01-9,
REP.1M,2.5,PCI-27483,,ERK1 AND ERK2 PHOSPHORYLATION INHIBITOR,BRD:BRD-K00003213-001-01-9,
REP.1M,2.5,SAPACITABINE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K00003214-001-01-9,
REP.1M,2.5,SQUALAMINE,,ANTIVIRAL,BRD:BRD-K00003215-043-01-9,
REP.1M,2.5,RELUGOLIX,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00003216-001-01-9,
REP.1M,2.5,TRANSCROCETINATE,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003217-304-01-9,
REP.1M,2.5,UPAMOSTAT,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003218-001-01-9,
REP.1M,2.5,ACUMAPIMOD,,P38 MAPK INHIBITOR,BRD:BRD-K00003220-001-01-9,
REP.1M,2.5,BASMISANIL,,GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K00003221-001-01-9,
REP.1M,2.5,TRADIPITANT,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003222-001-01-9,
REP.1M,2.5,AMISELIMOD,,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,BRD:BRD-K00003223-003-01-9,
REP.1M,2.5,AVORALSTAT,,KALLIKREIN INHIBITOR,BRD:BRD-K00003224-001-01-9,
REP.1M,2.5,ELECLAZINE,,LATE SODIUM CURRENT INHIBITOR,BRD:BRD-K00003225-003-01-9,
REP.1M,2.5,EMERAMIDE,,ANTIOXIDANT,BRD:BRD-K00003226-001-01-9,
REP.1M,2.5,RALINEPAG,,IP1 PROSTACYCLIN RECEPTOR AGONIST,BRD:BRD-K00003227-001-01-9,
REP.1M,2.5,SELETALISIB,,PI3K INHIBITOR,BRD:BRD-K00003228-001-01-9,
REP.1M,2.5,VERUBECESTAT,,BETA SECRETASE INHIBITOR,BRD:BRD-K00003229-001-01-9,
REP.1M,2.5,ASAPIPRANT,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003230-001-01-9,
REP.1M,2.5,DORAVIRINE,,NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR,BRD:BRD-K00003231-001-01-9,
REP.1M,2.5,FEVIPIPRANT,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00003232-001-01-9,
REP.1M,2.5,VALBENAZINE,,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K00003233-001-01-9,
REP.1M,2.5,VERICIGUAT,,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K00003234-001-01-9,
REP.1M,2.5,VELEDIMEX,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K00003235-001-01-9,
REP.1M,2.5,FIRSOCOSTAT,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00003236-001-01-9,
REP.1M,2.5,MAVATREP,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00003237-001-01-9,
REP.1M,2.5,SITRAVATINIB,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003238-001-01-9,
REP.1M,2.5,FLURALANER,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K00003239-001-01-9,
REP.1M,2.5,ERAVACYCLINE,,ANTIBACTERIAL,BRD:BRD-K00003240-300-01-9,
REP.1M,2.5,SANCYCLINE,,ANTITUMOR AGENT,BRD:BRD-K00003242-001-01-9,
REP.1M,2.5,PANTOPRAZOLE,ATP4A,ATPASE INHIBITOR,BRD:BRD-K00003243-236-01-9,
REP.1M,2.5,AMCASERTIB,,KINASE INHIBITOR,BRD:BRD-K00003244-001-01-9,
REP.1M,2.5,BELIZATINIB,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003245-001-01-9,
REP.1M,2.5,BEXAGLIFLOZIN,,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K00003246-001-01-9,
REP.1M,2.5,BICTEGRAVIR,,HIV INTEGRASE INHIBITOR,BRD:BRD-K00003247-001-01-9,
REP.1M,2.5,CENERIMOD,,SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR,BRD:BRD-K00003248-001-01-9,
REP.1M,2.5,CENOBAMATE,,"GABA RECEPTOR MODULATOR, VOLTAGE-GATED SODIUM CHANNEL BLOCKER",BRD:BRD-K00003249-001-01-9,
REP.1M,2.5,EVOCALCET,,CALCIUM SENSITIZER,BRD:BRD-K00003250-001-01-9,
REP.1M,2.5,PEMAFIBRATE,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003251-001-01-9,
REP.1M,2.5,SACUBITRILAT,,NEPRILYSIN INHIBITOR,BRD:BRD-K00003252-001-01-9,
REP.1M,2.5,SPARSENTAN,,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K00003253-001-01-9,
REP.1M,2.5,TAVILERMIDE,,TYROSINE KINASE PARTIAL AGONIST,BRD:BRD-K00003254-001-01-9,
REP.1M,2.5,ACEBILUSTAT,,LEUKOTRIENE INHIBITOR,BRD:BRD-K00003255-001-01-9,
REP.1M,2.5,AVACOPAN,,COMPLEMENT INHIBITOR,BRD:BRD-K00003256-001-01-9,
REP.1M,2.5,CEFIDEROCOL,,ANTIBACTERIAL,BRD:BRD-K00003257-001-01-9,
REP.1M,2.5,EDASALONEXENT,,NFKB PATHWAY INHIBITOR,BRD:BRD-K00003258-001-01-9,
REP.1M,2.5,EDONERPIC-MALEATE,,BETA AMYLOID INHIBITOR,BRD:BRD-K00003259-050-01-9,
REP.1M,2.5,GLECAPREVIR,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003260-001-01-9,
REP.1M,2.5,LENIOLISIB,,PI3K INHIBITOR,BRD:BRD-K00003261-001-01-9,
REP.1M,2.5,NICODICOSAPENT,,STEROL REGULATORY ELEMENT BINDING PROTEIN (SREBP) INHIBITOR,BRD:BRD-K00003262-001-01-9,
REP.1M,2.5,TENALISIB,,PI3K INHIBITOR,BRD:BRD-K00003263-001-01-9,
REP.1M,2.5,ZOLIFLODACIN,,ANTIBACTERIAL,BRD:BRD-K00003264-001-01-9,
REP.1M,2.5,OMAPATRILAT,"ACE, MME",METALLOPROTEINASE INHIBITOR,BRD:BRD-K00003265-001-01-9,
REP.1M,2.5,UDENAFIL,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00003266-001-01-9,
REP.1M,2.5,OMBRABULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00003267-003-01-9,
REP.1M,2.5,LEQ506,,G PROTEIN SIGNALING INHIBITOR,BRD:BRD-K00003269-001-01-9,
REP.1M,2.5,GALIDESIVIR,,ANTIVIRAL,BRD:BRD-K00003270-003-01-9,
REP.1M,2.5,JD-5037,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00003271-001-01-9,
REP.1M,2.5,DEXTROROTATION-NIMORAZOLE-PHOSPHATE-ESTER,,ANTIINFECTIVE DRUG,BRD:BRD-K00003272-001-01-9,
REP.1M,2.5,CBL0137,,HISTONE CHAPERONE INHIBITOR,BRD:BRD-K00003273-003-01-9,
REP.1M,2.5,SELONSERTIB,,MAP KINASE ACTIVATOR,BRD:BRD-K00003274-001-01-9,
REP.1M,2.5,LIFIRAFENIB,,RAF INHIBITOR,BRD:BRD-K00003275-001-01-9,
REP.1M,2.5,CCT245737,,KINASE INHIBITOR,BRD:BRD-K00003276-001-01-9,
REP.1M,2.5,VATINOXAN,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003277-003-01-9,
REP.1M,2.5,TCV-309,,PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K00003278-003-01-9,
REP.1M,2.5,PF-06282999,,MYELOPEROXIDASE INHIBITOR,BRD:BRD-K00003279-001-01-9,
REP.1M,2.5,PIM-447,,PIM KINASE INHIBITOR,BRD:BRD-K00003280-300-01-9,
REP.1M,2.5,FERROQUINE,,ANTIMALARIAL AGENT,BRD:BRD-K00003281-001-01-9,
REP.1M,2.5,ESONARIMOD,,ANTIRHEUMATIC DRUG,BRD:BRD-K00003282-001-01-9,
REP.1M,2.5,ROLUPERIDONE,,,BRD:BRD-K00003283-001-01-9,
REP.1M,2.5,SELADELPAR,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003284-236-01-9,
REP.1M,2.5,NEMIRALISIB,,,BRD:BRD-K00003285-001-01-9,
REP.1M,2.5,UPADACITINIB,,JAK INHIBITOR,BRD:BRD-K00003286-001-01-9,
REP.1M,2.5,FEZOLINETANT,,NEUROKININ RECEPTOR ANTAGONIST,BRD:BRD-K00003287-001-01-9,
REP.1M,2.5,GLESATINIB,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003288-003-01-9,
REP.1M,2.5,TECADENOSON,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K00003289-001-01-9,
REP.1M,2.5,EMIXUSTAT,,RETINOID ISOMEROHYDROLASE INHIBITOR,BRD:BRD-K00003290-003-01-9,
REP.1M,2.5,BEBT-908,,PI3K INHIBITOR,BRD:BRD-K00003291-001-01-9,
REP.1M,2.5,GSK2981278,,ROR MODULATOR,BRD:BRD-K00003292-001-01-9,
REP.1M,2.5,MERTANSINE,,MICROTUBULE INHIBITOR,BRD:BRD-K00003293-001-01-9,
REP.1M,2.5,AVITINIB,,EGFR INHIBITOR,BRD:BRD-K00003294-050-01-9,
REP.1M,2.5,ELACESTRANT,,ESTROGEN RECEPTOR DEGRADER,BRD:BRD-K00003295-300-01-9,
REP.1M,2.5,PF-06650833,,KINASE INHIBITOR,BRD:BRD-K00003296-001-01-9,
REP.1M,2.5,AZD5069,CXCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003297-001-01-9,
REP.1M,2.5,SETMELANOTIDE,,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K00003298-001-01-9,
REP.1M,2.5,F-16915,,,BRD:BRD-K00003299-001-01-9,
REP.1M,2.5,LTX-315,,ANTICANCER AGENT,BRD:BRD-K00003300-001-01-9,
REP.1M,2.5,ASP-9521,,ALDO-KETO REDUCTASE INHIBITOR,BRD:BRD-K00003301-001-01-9,
REP.1M,2.5,ADOMEGLIVANT,,GLUCAGON RECEPTOR ANTAGONIST,BRD:BRD-K00003302-001-01-9,
REP.1M,2.5,ACOZIBOROLE,,ANTITRYPANOSOMAL,BRD:BRD-K00003303-001-01-9,
REP.1M,2.5,MK-1064,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003304-001-01-9,
REP.1M,2.5,BMS-779788,,LXR AGONIST,BRD:BRD-K00003305-001-01-9,
REP.1M,2.5,VABORBACTAM,,BETA LACTAMASE INHIBITOR,BRD:BRD-K00003306-001-01-9,
REP.1M,2.5,COH29,,RIBONUCLEOTIDE REDUCTASE INHIBITOR,BRD:BRD-K00003307-001-01-9,
REP.1M,2.5,TD139,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003308-001-01-9,
REP.1M,2.5,GDC-0084,,"MTOR INHIBITOR, PI3K INHIBITOR",BRD:BRD-K00003309-001-01-9,
REP.1M,2.5,DERAZANTINIB,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003310-001-01-9,
REP.1M,2.5,PF-06459988,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003311-001-01-9,
REP.1M,2.5,SULTOPRIDE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003312-003-01-9,
REP.1M,2.5,TRABECTEDIN,,ANTITUMOR AGENT,BRD:BRD-K00003313-001-01-9,
REP.1M,2.5,FURAGIN,,ANTIBACTERIAL,BRD:BRD-K00003314-001-01-9,
REP.1M,2.5,NELOCIGUAT,,GUANYLATE CYCLASE STIMULANT,BRD:BRD-K00003315-001-01-9,
REP.1M,2.5,ELDECALCITOL,VDR,BONE FORMATION STIMULANT,BRD:BRD-K00003316-001-01-9,
REP.1M,2.5,PIPOFEZINE,,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K00003317-312-01-9,
REP.1M,2.5,DECLOXIZINE,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003318-300-01-9,
REP.1M,2.5,FELYPRESSIN,,VASOPRESSIN RECEPTOR AGONIST,BRD:BRD-K00003319-001-01-9,
REP.1M,2.5,CERULETIDE,CCKAR,CCK RECEPTOR AGONIST,BRD:BRD-K00003320-001-01-9,
REP.1M,2.5,DALFOPRISTIN,,ANTIBACTERIAL,BRD:BRD-K00003321-001-01-9,
REP.1M,2.5,SUGAMMADEX,,NEUROMUSCULAR BLOCKADE REVERSAL AGENT,BRD:BRD-K00003322-363-01-9,
REP.1M,2.5,TOPILUTAMIDE,,ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00003325-001-01-9,
REP.1M,2.5,GINSENOSIDE-RE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003326-001-01-9,
REP.1M,2.5,HYDROXYSAFFLOR-YELLOW-A,,ANTITUMOR AGENT,BRD:BRD-K00003327-001-01-9,
REP.1M,2.5,MADECASSOSIDE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003328-001-01-9,
REP.1M,2.5,INGENOL,"PRKCD, PRKCE",PKC ACTIVATOR,BRD:BRD-K00003329-001-01-9,
REP.1M,2.5,AFAMELANOTIDE,,MELANOCYTE-STIMULATING HORMONE MIMETIC,BRD:BRD-K00003330-001-01-9,
REP.1M,2.5,NIM811,,MITOCHONDRIAL PERMEABILITY TRANSITION INHIBITOR,BRD:BRD-K00003331-001-01-9,
REP.1M,2.5,ARGIRELINE,,NEUROTRANSMITTER RELEASE INHIBITOR,BRD:BRD-K00003332-001-01-9,
REP.1M,2.5,ORNIPRESSIN,,VASOCONSTRICTOR,BRD:BRD-K00003333-001-01-9,
REP.1M,2.5,SINCALIDE,,CHOLECYSTOKININ AGONIST,BRD:BRD-K00003334-001-01-9,
REP.1M,2.5,IRGD-PEPTIDE,,INTEGRIN SIGNALING ACTIVATOR,BRD:BRD-K00003335-001-01-9,
REP.1M,2.5,TUFTSIN,,MACROPHAGE ACTIVATOR,BRD:BRD-K00003336-001-01-9,
REP.1M,2.5,ALX-40-4C,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003337-019-01-9,
REP.1M,2.5,TRIAMCINOLONE-HEXACETONIDE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003338-001-01-9,
REP.1M,2.5,DIXYRAZINE,,ANTIPSYCHOTIC,BRD:BRD-K00003339-001-01-9,
REP.1M,2.5,JPH203,,SOLUTE CARRIER FAMILY MEMBER INHIBITOR,BRD:BRD-K00003340-300-01-9,
REP.1M,2.5,KETOHEXOKINASE-INHIBITOR-1,,KINASE INHIBITOR,BRD:BRD-K00003341-001-01-9,
REP.1M,2.5,ATICAPRANT,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00003342-001-01-9,
REP.1M,2.5,VLX1570,,DEUBIQUITINASE INHIBITOR,BRD:BRD-K00003343-001-01-9,
REP.1M,2.5,INCYCLINIDE,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003344-001-01-9,
REP.1M,2.5,MINOCYCLINE,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003346-003-01-9,
REP.1M,2.5,DEMECLOCYCLINE,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003347-003-01-9,
REP.1M,2.5,COTI-2,,ANTICANCER AGENT,BRD:BRD-K00003348-001-01-9,
REP.1M,2.5,TIGECYCLINE,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003349-001-01-9,
REP.1M,2.5,METHACYCLINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00003351-003-01-9,
REP.1M,2.5,TETRACYCLINE,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003352-003-01-9,
REP.1M,2.5,CHLORTETRACYCLINE,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00003353-003-01-9,
REP.1M,2.5,CINOBUFOTALIN,,ANTICANCER AGENT,BRD:BRD-K00003354-001-01-9,
REP.1M,2.5,FUCOXANTHIN,,ANTICANCER AGENT,BRD:BRD-K00003355-001-01-9,
REP.1M,2.5,MIVEBRESIB,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003356-001-01-9,
REP.1M,2.5,BAY1125976,,AKT INHIBITOR,BRD:BRD-K00003357-001-01-9,
REP.1M,2.5,ROGARATINIB,,FGFR INHIBITOR,BRD:BRD-K00003358-001-01-9,
REP.1M,2.5,BAY-1436032,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003359-001-01-9,
REP.1M,2.5,CPI-1205,,EZH2 INHIBITOR,BRD:BRD-K00003360-001-01-9,
REP.1M,2.5,TOMIVOSERTIB,,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K00003361-001-01-9,
REP.1M,2.5,MITOQUINONE,,ANTIOXIDANT,BRD:BRD-K00003362-066-01-9,
REP.1M,2.5,DELPAZOLID,,ANTIBACTERIAL,BRD:BRD-K00003363-001-01-9,
REP.1M,2.5,GSK2239633A,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003364-001-01-9,
REP.1M,2.5,AQ-13,,ANTIMALARIAL AGENT,BRD:BRD-K00003365-300-01-9,
REP.1M,2.5,LINAPRAZAN,,ATP-SENSITIVE POTASSIUM CHANNEL INHIBITOR,BRD:BRD-K00003366-001-01-9,
REP.1M,2.5,UKI-1,,UROKINASE INHIBITOR,BRD:BRD-K00003367-001-01-9,
REP.1M,2.5,BFH772,,VEGFR INHIBITOR,BRD:BRD-K00003368-001-01-9,
REP.1M,2.5,ELTANEXOR,,EXPORTIN INHIBITOR,BRD:BRD-K00003369-001-01-9,
REP.1M,2.5,CADAZOLID,,ANTIBACTERIAL,BRD:BRD-K00003370-001-01-9,
REP.1M,2.5,PAQUINIMOD,,S100A9 INHIBITOR,BRD:BRD-K00003371-001-01-9,
REP.1M,2.5,CGP-25454A,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003372-003-01-9,
REP.1M,2.5,GSK3179106,,RET TYROSINE KINASE INHIBITOR,BRD:BRD-K00003373-001-01-9,
REP.1M,2.5,ESAXERENONE,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00003374-001-01-9,
REP.1M,2.5,VISOMITIN,,ANTIOXIDANT,BRD:BRD-K00003375-004-01-9,
REP.1M,2.5,TAK-243,,UBIQUITIN ACTIVATING ENZYME INHIBITOR,BRD:BRD-K00003376-001-01-9,
REP.1M,2.5,FISOGATINIB,,FIBROBLAST GROWTH FACTOR INHIBITOR,BRD:BRD-K00003377-001-01-9,
REP.1M,2.5,FT011,,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K00003378-001-01-9,
REP.1M,2.5,GSK2256098,,KINASE INHIBITOR,BRD:BRD-K00003379-001-01-9,
REP.1M,2.5,GLPG0187,,INTEGRIN ANTAGONIST,BRD:BRD-K00003380-001-01-9,
REP.1M,2.5,MSDC-0160,,INSULIN SENSITIZER,BRD:BRD-K00003381-001-01-9,
REP.1M,2.5,NICAINOPROL,,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00003382-001-01-9,
REP.1M,2.5,UROLITHIN-A,,ANTIOXIDANT,BRD:BRD-K00003383-001-01-9,
REP.1M,2.5,FOSFLUCONAZOLE,,OTHER ANTIFUNGAL,BRD:BRD-K00003384-001-01-9,
REP.1M,2.5,IPI549,,PI3K INHIBITOR,BRD:BRD-K00003385-001-01-9,
REP.1M,2.5,HT-2157,,GALANIN RECEPTOR 3 ANTAGONIST,BRD:BRD-K00003386-001-01-9,
REP.1M,2.5,LANABECESTAT,,BETA SECRETASE INHIBITOR,BRD:BRD-K00003387-001-01-9,
REP.1M,2.5,CXD101,,HDAC INHIBITOR,BRD:BRD-K00003388-001-01-9,
REP.1M,2.5,HTHQ,,ANTIOXIDANT,BRD:BRD-K00003389-001-01-9,
REP.1M,2.5,YL0919,,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K00003390-003-01-9,
REP.1M,2.5,PBI-4050,,FREE FATTY ACID RECEPTOR AGONIST,BRD:BRD-K00003391-236-01-9,
REP.1M,2.5,FUTIBATINIB,,FGFR INHIBITOR,BRD:BRD-K00003392-001-01-9,
REP.1M,2.5,BGP-15,,PARP INHIBITOR,BRD:BRD-K00003393-300-01-9,
REP.1M,2.5,ABX464,,ANTIVIRAL,BRD:BRD-K00003394-001-01-9,
REP.1M,2.5,BISANTRENE,,TOPOISOMERASE INHIBITOR,BRD:BRD-K00003395-001-01-9,
REP.1M,2.5,CEP-40783,,AXL KINASE INHIBITOR,BRD:BRD-K00003396-001-01-9,
REP.1M,2.5,MK-8617,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003397-001-01-9,
REP.1M,2.5,AZD7986,,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K00003398-001-01-9,
REP.1M,2.5,OCAPERIDONE,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003399-001-01-9,
REP.1M,2.5,PF-06840003,,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K00003400-001-01-9,
REP.1M,2.5,THK5351,,PET RADIOTRACER,BRD:BRD-K00003401-001-01-9,
REP.1M,2.5,T-807,,PET RADIOTRACER,BRD:BRD-K00003402-001-01-9,
REP.1M,2.5,JNJ-39758979,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003403-001-01-9,
REP.1M,2.5,CYC065,,CDK INHIBITOR,BRD:BRD-K00003404-001-01-9,
REP.1M,2.5,EVOBRUTINIB,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003405-001-01-9,
REP.1M,2.5,MILADEMETAN,,MDM INHIBITOR,BRD:BRD-K00003406-001-01-9,
REP.1M,2.5,VADADUSTAT,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003407-001-01-9,
REP.1M,2.5,IBERDOMIDE,,CEREBLON MODULATOR,BRD:BRD-K00003408-001-01-9,
REP.1M,2.5,CFI-402257,,DUAL SPECIFICITY PROTEIN KINASE INHIBITOR,BRD:BRD-K00003409-001-01-9,
REP.1M,2.5,GAL-021,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00003410-001-01-9,
REP.1M,2.5,BAMAQUIMAST,,PROTON PUMP INHIBITOR,BRD:BRD-K00003411-001-01-9,
REP.1M,2.5,TRILACICLIB,,CDK INHIBITOR,BRD:BRD-K00003412-300-01-9,
REP.1M,2.5,ZANUBRUTINIB,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003413-001-01-9,
REP.1M,2.5,EMODEPSIDE,,NEMATOCIDE,BRD:BRD-K00003414-001-01-9,
REP.1M,2.5,ICLAPRIM,,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K00003415-001-01-9,
REP.1M,2.5,LY3214996,,ERK INHIBITOR,BRD:BRD-K00003416-001-01-9,
REP.1M,2.5,MRX-2843,,MER TYROSINE KINASE INHIBITOR,BRD:BRD-K00003417-001-01-9,
REP.1M,2.5,BMS-986205,,"INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR",BRD:BRD-K00003418-001-01-9,
REP.1M,2.5,AVAPRITINIB,,KIT INHIBITOR,BRD:BRD-K00003419-001-01-9,
REP.1M,2.5,GDC-0077,,PI3K INHIBITOR,BRD:BRD-K00003420-001-01-9,
REP.1M,2.5,GSK3326595,,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K00003421-001-01-9,
REP.1M,2.5,BAY-1895344,,ATR KINASE INHIBITOR,BRD:BRD-K00003422-003-01-9,
REP.1M,2.5,BMS-986158,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003423-001-01-9,
REP.1M,2.5,ROBLITINIB,,FGFR INHIBITOR,BRD:BRD-K00003424-001-01-9,
REP.1M,2.5,LXS196,,PKC INHIBITOR,BRD:BRD-K00003425-001-01-9,
REP.1M,2.5,PEPOSERTIB,,DNA DEPENDENT PROTEIN KINASE INHIBITOR,BRD:BRD-K00003426-001-01-9,
REP.1M,2.5,ILAPRAZOLE,,PROTON PUMP INHIBITOR,BRD:BRD-K00003427-001-01-9,
REP.1M,2.5,PAGOCLONE,,GABA RECEPTOR AGONIST,BRD:BRD-K00003428-001-01-9,
REP.1M,2.5,GSK2982772,,RIPK INHIBITOR,BRD:BRD-K00003429-001-01-9,
REP.1M,2.5,PRN1371,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003430-001-01-9,
REP.1M,2.5,ZIRITAXESTAT,,AUTOTAXIN INHIBITOR,BRD:BRD-K00003431-001-01-9,
REP.1M,2.5,EDO-S101,,HDAC INHIBITOR,BRD:BRD-K00003432-001-01-9,
REP.1M,2.5,VERALIPRIDE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003433-001-01-9,
REP.1M,2.5,MIRIDESAP,,AMYLOID PROTEIN INHIBITOR,BRD:BRD-K00003434-001-01-9,
REP.1M,2.5,AVEX-73,,SIGMA RECEPTOR AGONIST,BRD:BRD-K00003435-003-01-9,
REP.1M,2.5,AVN-492,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003436-001-01-9,
REP.1M,2.5,BTK-IN-1,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003437-001-01-9,
REP.1M,2.5,CM-4620,,CALCIUM RELEASE ACTIVATED CHANNEL MODULATOR,BRD:BRD-K00003438-001-01-9,
REP.1M,2.5,XL041,,LXR AGONIST,BRD:BRD-K00003439-001-01-9,
REP.1M,2.5,SELITRECTINIB,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003441-001-01-9,
REP.1M,2.5,CPI-444,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00003442-001-01-9,
REP.1M,2.5,AZD4635,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00003443-001-01-9,
REP.1M,2.5,BT-11,,CAMP STIMULANT,BRD:BRD-K00003444-001-01-9,
REP.1M,2.5,VANIPREVIR,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00003445-001-01-9,
REP.1M,2.5,LY3200882,,TGF BETA RECEPTOR INHIBITOR,BRD:BRD-K00003446-001-01-9,
REP.1M,2.5,REPOTRECTINIB,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00003447-001-01-9,
REP.1M,2.5,ZURANOLONE,,GABA RECEPTOR AGONIST,BRD:BRD-K00003448-001-01-9,
REP.1M,2.5,E7046,,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K00003449-001-01-9,
REP.1M,2.5,AAI101,,LACTAMASE INHIBITOR,BRD:BRD-K00003450-001-01-9,
REP.1M,2.5,LY334370,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00003451-001-01-9,
REP.1M,2.5,DESIDUSTAT,,HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITOR,BRD:BRD-K00003452-001-01-9,
REP.1M,2.5,CT7001,,CDK INHIBITOR,BRD:BRD-K00003453-003-01-9,
REP.1M,2.5,SECLIDEMSTAT,,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K00003454-001-01-9,
REP.1M,2.5,S-38093,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003455-001-01-9,
REP.1M,2.5,ASCIMINIB,,BCR-ABL KINASE INHIBITOR,BRD:BRD-K00003456-001-01-9,
REP.1M,2.5,IDH-305,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003457-001-01-9,
REP.1M,2.5,CINTIRORGON,,ROR AGONIST,BRD:BRD-K00003458-001-01-9,
REP.1M,2.5,DILMAPIMOD,,P38 MAPK INHIBITOR,BRD:BRD-K00003459-001-01-9,
REP.1M,2.5,VORASIDENIB,,ISOCITRATE DEHYDROGENASE INHIBITOR,BRD:BRD-K00003460-001-01-9,
REP.1M,2.5,PAMIPARIB,,PARP INHIBITOR,BRD:BRD-K00003461-001-01-9,
REP.1M,2.5,LANIFIBRANOR,,PPAR RECEPTOR AGONIST,BRD:BRD-K00003462-001-01-9,
REP.1M,2.5,PYROTINIB,,KINASE INHIBITOR,BRD:BRD-K00003463-001-01-9,
REP.1M,2.5,POCAPAVIR,,ENTEROVIRUS CAPSID INHIBITOR,BRD:BRD-K00003464-001-01-9,
REP.1M,2.5,FANTOFARONE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00003465-001-01-9,
REP.1M,2.5,NELOTANSERIN,,SEROTONIN RECEPTOR INVERSE AGONIST,BRD:BRD-K00003466-001-01-9,
REP.1M,2.5,TEMANOGREL,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00003467-001-01-9,
REP.1M,2.5,DELCASERTIB,,PKC INHIBITOR,BRD:BRD-K00003468-001-01-9,
REP.1M,2.5,LARAZOTIDE-ACETATE,,TIGHT JUNCTION REGULATOR,BRD:BRD-K00003469-015-01-9,
REP.1M,2.5,NEU2000,,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003470-001-01-9,
REP.1M,2.5,RISLENEMDAZ,,IONOTROPIC GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00003471-001-01-9,
REP.1M,2.5,VOCLOSPORIN,,CALCINEURIN INHIBITOR,BRD:BRD-K00003472-001-01-9,
REP.1M,2.5,PRIDOPIDINE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003473-001-01-9,
REP.1M,2.5,LETRAZURIL,,ANTIINFECTIVE DRUG,BRD:BRD-K00003474-001-01-9,
REP.1M,2.5,S-3304,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00003475-001-01-9,
REP.1M,2.5,NINGETINIB-TOSYLATE,,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K00003476-075-01-9,
REP.1M,2.5,ASIMADOLINE,OPRK1,OPIOID RECEPTOR AGONIST,BRD:BRD-K00003477-001-01-9,
REP.1M,2.5,EPRISTERIDE,,5 ALPHA REDUCTASE INHIBITOR,BRD:BRD-K00003478-001-01-9,
REP.1M,2.5,AX-024,,CYTOKINE PRODUCTION INHIBITOR,BRD:BRD-K00003479-003-01-9,
REP.1M,2.5,TROPIFEXOR,,FXR AGONIST,BRD:BRD-K00003480-001-01-9,
REP.1M,2.5,PAT-1251,,LYSYL OXIDASE INHIBITOR,BRD:BRD-K00003481-001-01-9,
REP.1M,2.5,MK-4074,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00003482-001-01-9,
REP.1M,2.5,GSK656,,LEUCYL-TRNA SYNTHETASE INHIBITOR,BRD:BRD-K00003483-003-01-9,
REP.1M,2.5,MIROGABALIN-BESYLATE,,CALCIUM CHANNEL ANTAGONIST,BRD:BRD-K00003484-074-01-9,
REP.1M,2.5,SB-649868,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003485-001-01-9,
REP.1M,2.5,DG051,,LEUKOTRIENE SYNTHESIS INHIBITOR,BRD:BRD-K00003486-003-01-9,
REP.1M,2.5,TOMEGLOVIR,,ANTIVIRAL,BRD:BRD-K00003487-001-01-9,
REP.1M,2.5,SULTIAME,CA2,CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K00003488-001-01-9,
REP.1M,2.5,GAMITHROMYCIN,,ANTIBACTERIAL,BRD:BRD-K00003489-001-01-9,
REP.1M,2.5,NGP555,,GAMMA SECRETASE MODULATOR,BRD:BRD-K00003490-001-01-9,
REP.1M,2.5,MORPHOTHIADIN,,ANTIINFECTIVE DRUG,BRD:BRD-K00003491-001-01-9,
REP.1M,2.5,APARARENONE,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00003492-001-01-9,
REP.1M,2.5,PADSEVONIL,,ANTIEPILEPTIC,BRD:BRD-K00003493-001-01-9,
REP.1M,2.5,ROSIPTOR,,SHIP1 PHOSPHATASE ACTIVATOR,BRD:BRD-K00003494-001-01-9,
REP.1M,2.5,BALOXAVIR-MARBOXIL,,ENDONUCLEASE INHIBITOR,BRD:BRD-K00003495-001-01-9,
REP.1M,2.5,BALOXAVIR,,ENDONUCLEASE INHIBITOR,BRD:BRD-K00003496-001-01-9,
REP.1M,2.5,MAVACAMTEN,,MYOSIN INHIBITOR,BRD:BRD-K00003497-001-01-9,
REP.1M,2.5,TAPINAROF,,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K00003498-001-01-9,
REP.1M,2.5,ADAVIVINT,,WNT PATHWAY INHIBITOR,BRD:BRD-K00003499-001-01-9,
REP.1M,2.5,DELGOCITINIB,,JAK INHIBITOR,BRD:BRD-K00003500-001-01-9,
REP.1M,2.5,LAZERTINIB,,TYROSINE KINASE INHIBITOR,BRD:BRD-K00003501-001-01-9,
REP.1M,2.5,ROVAZOLAC,,LXR AGONIST,BRD:BRD-K00003502-001-01-9,
REP.1M,2.5,VECABRUTINIB,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00003503-001-01-9,
REP.1M,2.5,LICOGLIFLOZIN,,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K00003504-001-01-9,
REP.1M,2.5,NEMOREXANT,,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K00003505-001-01-9,
REP.1M,2.5,RISDIPLAM,,RNA SPLICING INHIBITOR,BRD:BRD-K00003506-001-01-9,
REP.1M,2.5,FARAMPATOR,,IONOTROPIC GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K00003507-001-01-9,
REP.1M,2.5,ASTX660,,APOPTOSIS INHIBITOR,BRD:BRD-K00003508-001-01-9,
REP.1M,2.5,AZD1390,,ATM KINASE INHIBITOR,BRD:BRD-K00003509-001-01-9,
REP.1M,2.5,FLT3-IN-1,,FLT3 INHIBITOR,BRD:BRD-K00003510-001-01-9,
REP.1M,2.5,CA-4948,,KINASE INHIBITOR,BRD:BRD-K00003511-001-01-9,
REP.1M,2.5,BMS-813160,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K00003512-001-01-9,
REP.1M,2.5,FONDAPARINUX,"F10, SERPINC1",COAGULATION FACTOR INHIBITOR,BRD:BRD-K00003513-363-01-9,
REP.1M,2.5,DIQUAFOSOL,,PURINERGIC RECEPTOR ACTIVATOR,BRD:BRD-K00003514-342-01-9,
REP.1M,2.5,AZ7550,,INSULIN GROWTH FACTOR RECEPTOR INHIBITOR,BRD:BRD-K00003515-003-01-9,
REP.1M,2.5,EMAMECTIN,,GABA RECEPTOR AGONIST,BRD:BRD-K00003516-057-01-9,
REP.1M,2.5,4-(AMINOMETHYL)BENZOIC-ACID,,HEMOSTATIC AGENT,BRD:BRD-K00003517-001-01-9,
REP.1M,2.5,METHYLBENACTYZIUM-BROMIDE,,CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00003518-004-01-9,
REP.1M,2.5,GLYCEROL-PHENYLBUTYRATE,,SIGMA RECEPTOR LIGAND,BRD:BRD-K00003520-001-01-9,
REP.1M,2.5,LUCANTHONE,"APEX1, TOP1, TOP2A",ENDONUCLEASE INHIBITOR,BRD:BRD-K00003521-001-01-9,
REP.1M,2.5,BROMISOVAL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00003522-001-01-9,
REP.1M,2.5,TAUROGLYCOCHOLATE,,MEMBRANE PERMEABILITY ENHANCER,BRD:BRD-K00003523-236-01-9,
REP.1M,2.5,APRONAL,,CYTOCHROME P450 MODULATOR,BRD:BRD-K00003524-001-01-9,
REP.1M,2.5,HYDROXOCOBALAMIN,,VITAMIN B,BRD:BRD-K00003525-003-01-9,
REP.1M,2.5,UPRIFOSBUVIR,,ANTIVIRAL,BRD:BRD-K00003526-001-01-9,
REP.1M,2.5,SOFOSBUVIR-IMPURITY-M,,ANTIVIRAL,BRD:BRD-K00003527-001-01-9,
REP.1M,2.5,AZD5153,,BROMODOMAIN INHIBITOR,BRD:BRD-K00003528-457-01-9,
REP.1M,2.5,CLOPERASTINE-FENDIZOATE,,POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00003529-458-01-9,
REP.1M,2.5,PIRMENOL,,ACETYLCHOLINE RECEPTOR INHIBITOR,BRD:BRD-K00003530-003-01-9,
REP.1M,2.5,ACELARIN,,ANTICANCER AGENT,BRD:BRD-K00003531-001-01-9,
REP.1M,2.5,INARIGIVIR,,ANTIVIRAL,BRD:BRD-K00003532-001-01-9,
REP.1M,2.5,BAY-1251152,,CDK9 INHIBITOR,BRD:BRD-K00003533-001-01-9,
REP.1M,2.5,METHYLCOBALAMIN,,VITAMIN B,BRD:BRD-K00003534-001-01-9,
REP.1M,2.5,POLAPREZINC,,CHELATING AGENT,BRD:BRD-K00003535-001-01-9,
REP.1M,2.5,CHLORPHENOXAMINE,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00003537-001-01-9,
REP.1M,2.5,OMADACYCLINE,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K00003569-003-01-9,
REP.1M,2.5,ENCORAFENIB,BRAF,RAF INHIBITOR,BRD:BRD-K00003576-001-01-9,
REP.1M,2.5,HOKU-81,,BRONCHODILATOR,BRD:BRD-K00003598-001-01-9,
REP.1M,2.5,SODIUM-NITROPRUSSIDE,,NITRIC OXIDE DONOR,BRD:BRD-K00003606-380-01-9,
REP.1M,2.5,IMIDUREA,,OTHER ANTIBIOTIC,BRD:BRD-K00003682-001-01-9,
REP.1M,2.5,HPPH,,PHOTOSENSITIZING AGENT,BRD:BRD-K00003730-001-01-9,
REP.1M,2.5,PF-06409577,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00003731-001-01-9,
REP.1M,2.5,ATRACTYLENOLIDE-I,,JAK INHIBITOR,BRD:BRD-K00003732-001-01-9,
REP.1M,2.5,GANODERIC-ACID-A,,JAK INHIBITOR,BRD:BRD-K00003733-001-01-9,
REP.1M,2.5,NAS-181,HTR1B,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004235-334-01-9,
REP.1M,2.5,SCH-221510,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR AGONIST,BRD:BRD-K00004286-001-01-9,
REP.1M,2.5,EFONIDIPINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00004292-003-02-9,
REP.1M,2.5,TCS-2002,GSK3B,GLYCOGEN SYNTHASE KINASE INHIBITOR,BRD:BRD-K00004294-001-01-9,
REP.1M,2.5,NS-309,"KCNN1, KCNN2, KCNN3, KCNN4",CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004295-001-01-9,
REP.1M,2.5,ML213,KCNQ4,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004301-001-01-9,
REP.1M,2.5,SSR180711,CHRNA7,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K00004316-003-01-9,
REP.1M,2.5,ATROPINE-OXIDE,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00004526-001-01-9,
REP.1M,2.5,ROSAMICIN,,PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K00004538-001-01-9,
REP.1M,2.5,CRISDESALAZINE,,FREE RADICAL SCAVENGER,BRD:BRD-K00004545-001-01-9,
REP.1M,2.5,PERFLUOROHEXYLOCTANE,,,BRD:BRD-K00004546-001-01-9,
REP.1M,2.5,PRISOTINOL,,,BRD:BRD-K00004547-001-01-9,
REP.1M,2.5,NS-11394,,GABA RECEPTOR AGONIST,BRD:BRD-K00004548-001-01-9,
REP.1M,2.5,IRGANOX-1010,,ANTIOXIDANT,BRD:BRD-K00004549-001-01-9,
REP.1M,2.5,BMS-626531,,P38 MAPK INHIBITOR,BRD:BRD-K00004550-001-01-9,
REP.1M,2.5,EFLETIRIZINE,,ANTIHISTAMINE,BRD:BRD-K00004551-001-01-9,
REP.1M,2.5,SAMERIDINE,,OPIOID RECEPTOR MODULATOR,BRD:BRD-K00004552-001-01-9,
REP.1M,2.5,SAM-315,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004553-001-01-9,
REP.1M,2.5,LODENOSINE,,ANTIRETROVIRAL,BRD:BRD-K00004554-001-01-9,
REP.1M,2.5,HBED,,CHELATING AGENT,BRD:BRD-K00004555-001-01-9,
REP.1M,2.5,WAY-255348,,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K00004556-001-01-9,
REP.1M,2.5,MK-0608,,ANTIVIRAL,BRD:BRD-K00004557-001-01-9,
REP.1M,2.5,CONVALLATOXIN,,CARDIAC GLYCOSIDE,BRD:BRD-K00004559-001-01-9,
REP.1M,2.5,PIPOTIAZINE,"DRD1, DRD2, HTR1A, HTR2A",DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00004560-001-01-9,
REP.1M,2.5,E-2001,,ANTIOXIDANT,BRD:BRD-K00004561-001-01-9,
REP.1M,2.5,DEAZAGUANINE,,DNA SYNTHESIS INHIBITOR,BRD:BRD-K00004562-001-01-9,
REP.1M,2.5,NAPAMEZOLE,,"ADRENERGIC RECEPTOR ANTAGONIST, MONOAMINE REUPTAKE INHIBITOR",BRD:BRD-K00004563-001-01-9,
REP.1M,2.5,TETOMILAST,PDE4D,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004564-001-01-9,
REP.1M,2.5,LY311727,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K00004565-001-01-9,
REP.1M,2.5,FEBUPROL,,CHOLERETIC AGENT,BRD:BRD-K00004566-001-01-9,
REP.1M,2.5,FLORIFENINE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004567-001-01-9,
REP.1M,2.5,ENIPORIDE,,SODIUM/HYDROGEN ANTIPORT INHIBITOR,BRD:BRD-K00004568-001-01-9,
REP.1M,2.5,ICI-169369,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004569-001-01-9,
REP.1M,2.5,DSPC,,,BRD:BRD-K00004570-001-01-9,
REP.1M,2.5,FASORACETAM,,GABA RECEPTOR ANTAGONIST,BRD:BRD-K00004571-001-01-9,
REP.1M,2.5,RO-48-6791,,GABA RECEPTOR MODULATOR,BRD:BRD-K00004572-001-01-9,
REP.1M,2.5,RG7834,,ANTIVIRAL,BRD:BRD-K00004573-001-01-9,
REP.1M,2.5,ARIPIPRAZOLE-LAUROXIL,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004574-001-01-9,
REP.1M,2.5,JNJ-54175446,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004575-001-01-9,
REP.1M,2.5,CLAMIKALANT,,ATP-SENSITIVE POTASSIUM CHANNEL ANTAGONIST,BRD:BRD-K00004576-001-01-9,
REP.1M,2.5,VAPENDAVIR,,ANTIVIRAL,BRD:BRD-K00004577-001-01-9,
REP.1M,2.5,KAF-156,,ANTIMALARIAL AGENT,BRD:BRD-K00004578-001-01-9,
REP.1M,2.5,RV1729,,PI3K INHIBITOR,BRD:BRD-K00004579-001-01-9,
REP.1M,2.5,VELARESOL,,,BRD:BRD-K00004580-001-01-9,
REP.1M,2.5,PIROZADIL,,HYPOLIPIDEMIC,BRD:BRD-K00004581-001-01-9,
REP.1M,2.5,SUFUGOLIX,,GONADOTROPIN RELEASING FACTOR HORMONE RECEPTOR ANTAGONIST,BRD:BRD-K00004582-001-01-9,
REP.1M,2.5,AC260584,,CHOLINERGIC RECEPTOR AGONIST,BRD:BRD-K00004583-001-01-9,
REP.1M,2.5,REMETINOSTAT,,HDAC INHIBITOR,BRD:BRD-K00004584-001-01-9,
REP.1M,2.5,SORAPRAZAN,,PROTON PUMP INHIBITOR,BRD:BRD-K00004585-001-01-9,
REP.1M,2.5,BMS-986020,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K00004586-001-01-9,
REP.1M,2.5,KR-33494,,CELL DEATH INHIBITOR,BRD:BRD-K00004587-001-01-9,
REP.1M,2.5,CENTANAFADINE,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K00004588-001-01-9,
REP.1M,2.5,GEFAPIXANT,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004589-001-01-9,
REP.1M,2.5,RG7800,,RNA SPLICING MODIFIER,BRD:BRD-K00004590-001-01-9,
REP.1M,2.5,BMS-986142,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004591-001-01-9,
REP.1M,2.5,PI3KD-IN-2,,PI3K INHIBITOR,BRD:BRD-K00004592-001-01-9,
REP.1M,2.5,BW-348U87,,ANTIVIRAL,BRD:BRD-K00004593-001-01-9,
REP.1M,2.5,PARSACLISIB,,PI3K INHIBITOR,BRD:BRD-K00004594-001-01-9,
REP.1M,2.5,CILOFEXOR,,FXR AGONIST,BRD:BRD-K00004595-001-01-9,
REP.1M,2.5,TELRATOLIMOD,,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K00004596-001-01-9,
REP.1M,2.5,RGX-104,,LXR AGONIST,BRD:BRD-K00004597-001-01-9,
REP.1M,2.5,PF-06751979,,BETA SECRETASE INHIBITOR,BRD:BRD-K00004598-001-01-9,
REP.1M,2.5,PRN1008,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004599-001-01-9,
REP.1M,2.5,JNJ-678,,RSV FUSION INHIBITOR,BRD:BRD-K00004600-001-01-9,
REP.1M,2.5,HC-070,,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K00004601-001-01-9,
REP.1M,2.5,THYMALFASIN,,IMMUNE RESPONSE MODULATOR,BRD:BRD-K00004602-001-01-9,
REP.1M,2.5,ABX-1431,,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K00004603-001-01-9,
REP.1M,2.5,PRLX-93936,,VOLTAGE-DEPENDENT ANION SELECTIVE CHANNEL PROTEIN INHIBITOR,BRD:BRD-K00004604-001-01-9,
REP.1M,2.5,AZD3839,BACE1,BETA-SECRETASE INHIBITOR,BRD:BRD-K00004606-001-01-9,
REP.1M,2.5,MONEPANTEL,,MTOR INHIBITOR,BRD:BRD-K00004607-001-01-9,
REP.1M,2.5,SOGRAZEPIDE,,GASTRIN INHIBITOR,BRD:BRD-K00004608-001-01-9,
REP.1M,2.5,ELACYTARABINE,DCK,ANTINEOPLASTIC AGENT,BRD:BRD-K00004609-001-01-9,
REP.1M,2.5,ENTASOBULIN,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K00004610-001-01-9,
REP.1M,2.5,OLUMACOSTAT-GLASARETIL,,ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K00004611-001-01-9,
REP.1M,2.5,VERDIPERSTAT,,MYELOPEROXIDASE INHIBITOR,BRD:BRD-K00004612-001-01-9,
REP.1M,2.5,GM-1485,FKBP1A,IMMUNOPHILIN LIGAND,BRD:BRD-K00004613-001-01-9,
REP.1M,2.5,GSK3117391,,HDAC INHIBITOR,BRD:BRD-K00004614-001-01-9,
REP.1M,2.5,PBT-1033,,CHELATING AGENT,BRD:BRD-K00004615-001-01-9,
REP.1M,2.5,PRX-07034,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004616-001-01-9,
REP.1M,2.5,IMIDAZOACRIDINONE,,ANTICANCER AGENT,BRD:BRD-K00004617-001-01-9,
REP.1M,2.5,S-17092,,PROLYL ENDOPEPTIDASE INHIBITOR,BRD:BRD-K00004618-001-01-9,
REP.1M,2.5,CENTHAQUIN,,ANALGESIC AGENT,BRD:BRD-K00004619-001-01-9,
REP.1M,2.5,ZD-0947,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00004620-001-01-9,
REP.1M,2.5,MM-206,,STAT INHIBITOR,BRD:BRD-K00004622-001-01-9,
REP.1M,2.5,RO-5263397,,TRACE AMINE ASSOCIATED RECEPTOR AGONIST,BRD:BRD-K00004623-001-01-9,
REP.1M,2.5,CJ-13610,,LIPOXYGENASE INHIBITOR,BRD:BRD-K00004624-001-01-9,
REP.1M,2.5,CIPAMFYLLINE,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004625-001-01-9,
REP.1M,2.5,CGP-39551,,NMDA RECEPTOR ANTAGONIST,BRD:BRD-K00004626-001-01-9,
REP.1M,2.5,TIPELUKAST,,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K00004627-001-01-9,
REP.1M,2.5,PRALMORELIN,,GROWTH HORMONE RELEASING PEPTIDE LIGAND AGONIST,BRD:BRD-K00004629-001-01-9,
REP.1M,2.5,VAL-TYR,,ANGIOTENSIN CONVERTING ENZYME INHIBITOR,BRD:BRD-K00004630-001-01-9,
REP.1M,2.5,T-1095,,SODIUM/GLUCOSE COTRANSPORTER INHIBITOR,BRD:BRD-K00004631-001-01-9,
REP.1M,2.5,PF-02413873,,PROGESTERONE RECEPTOR ANTAGONIST,BRD:BRD-K00004632-001-01-9,
REP.1M,2.5,PF-4191834,,LIPOXYGENASE INHIBITOR,BRD:BRD-K00004633-001-01-9,
REP.1M,2.5,BMS-207940,,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K00004634-001-01-9,
REP.1M,2.5,PF-04995274,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004635-001-01-9,
REP.1M,2.5,DPC,,,BRD:BRD-K00004636-001-01-9,
REP.1M,2.5,PF-06273340,,TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K00004638-001-01-9,
REP.1M,2.5,ORMELOXIFENE,,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K00004639-001-01-9,
REP.1M,2.5,NN-DNJ,GBA,GLUCOSIDASE INHIBITOR,BRD:BRD-K00004640-001-01-9,
REP.1M,2.5,PHA-543613,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K00004641-001-01-9,
REP.1M,2.5,PF-514273,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00004642-001-01-9,
REP.1M,2.5,EF5,,CYTOCHROME P450 ACTIVATOR,BRD:BRD-K00004643-001-01-9,
REP.1M,2.5,PF-06260414,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K00004644-001-01-9,
REP.1M,2.5,RIMEPORIDE,,SODIUM/HYDROGEN EXCHANGER INHIBITOR,BRD:BRD-K00004645-001-01-9,
REP.1M,2.5,ARAMCHOL,,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K00004646-001-01-9,
REP.1M,2.5,NB-001,,ANTIVIRAL,BRD:BRD-K00004647-001-01-9,
REP.1M,2.5,PF-06747775,,EGFR INHIBITOR,BRD:BRD-K00004648-001-01-9,
REP.1M,2.5,E3330,,NFKB PATHWAY INHIBITOR,BRD:BRD-K00004649-001-01-9,
REP.1M,2.5,SGS-742,"GABBR1, GABBR2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K00004650-001-01-9,
REP.1M,2.5,TALSACLIDINE,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K00004651-001-01-9,
REP.1M,2.5,PF-06412562,,DOPAMINE RECEPTOR PARTIAL AGONIST,BRD:BRD-K00004652-001-01-9,
REP.1M,2.5,S15535,,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K00004653-001-01-9,
REP.1M,2.5,"CP-105,696",,LEUKOTRIENE RECEPTOR ANTAGONIST,BRD:BRD-K00004654-001-01-9,
REP.1M,2.5,BMS-770767,,11-BETA-HSD1 INHIBITOR,BRD:BRD-K00004655-001-01-9,
REP.1M,2.5,DENOPAMINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K00004656-001-01-9,
REP.1M,2.5,MOTAPIZONE,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004657-001-01-9,
REP.1M,2.5,ETRABAMINE,,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K00004658-001-01-9,
REP.1M,2.5,DAPANSUTRILE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004659-001-01-9,
REP.1M,2.5,MK-1903,,NIACIN RECEPTOR AGONIST,BRD:BRD-K00004660-001-01-9,
REP.1M,2.5,DECLOPRAMIDE,,CELL CYCLE INHIBITOR,BRD:BRD-K00004661-001-01-9,
REP.1M,2.5,NEMAZOLINE,,"ADRENERGIC RECEPTOR AGONIST, ADRENERGIC RECEPTOR ANTAGONIST",BRD:BRD-K00004662-001-01-9,
REP.1M,2.5,TINAZOLINE,,ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K00004663-001-01-9,
REP.1M,2.5,NDD-094,,,BRD:BRD-K00004664-001-01-9,
REP.1M,2.5,SY-640,,,BRD:BRD-K00004665-001-01-9,
REP.1M,2.5,TRICIRIBINE-PHOSPHATE,,AKT INHIBITOR,BRD:BRD-K00004666-001-01-9,
REP.1M,2.5,CILUPREVIR,,SERINE PROTEASE INHIBITOR,BRD:BRD-K00004667-001-01-9,
REP.1M,2.5,FRESELESTAT,"CELA1, ELANE",ELASTASE INHIBITOR,BRD:BRD-K00004668-001-01-9,
REP.1M,2.5,CANGRELOR,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004669-001-01-9,
REP.1M,2.5,NAXAGOLIDE,,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K00004670-001-01-9,
REP.1M,2.5,PANIPENEM,,ANTIBACTERIAL,BRD:BRD-K00004671-001-01-9,
REP.1M,2.5,BRINCIDOFOVIR,,ANTIVIRAL,BRD:BRD-K00004672-001-01-9,
REP.1M,2.5,LP-533401,,TRYPTOPHAN HYDROXYLASE INHIBITOR,BRD:BRD-K00004673-001-01-9,
REP.1M,2.5,VERDINEXOR,,EXPORTIN ANTAGONIST,BRD:BRD-K00004674-001-01-9,
REP.1M,2.5,LSZ-102,,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K00004675-001-01-9,
REP.1M,2.5,RILAPLADIB,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K00004676-001-01-9,
REP.1M,2.5,2-FLUOROFUCOSE,,,BRD:BRD-K00004677-001-01-9,
REP.1M,2.5,DOTMP,,,BRD:BRD-K00004678-001-01-9,
REP.1M,2.5,5-FLUOROPYRIMIDINE,,KINASE INHIBITOR,BRD:BRD-K00004679-001-01-9,
REP.1M,2.5,BEVENOPRAN,,OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K00004680-001-01-9,
REP.1M,2.5,5-OCTANOYLSALICYLIC-ACID,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00004681-001-01-9,
REP.1M,2.5,TAMINADENANT,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00004682-001-01-9,
REP.1M,2.5,MS-424,,GLUTAMATE TRANSPORTER MODULATOR,BRD:BRD-K00004683-001-01-9,
REP.1M,2.5,SQUARIC-ACID-DIBUTYL-ESTER,,OXIDATIVE STRESS INDUCER,BRD:BRD-K00004684-001-01-9,
REP.1M,2.5,TS-011,,DELAYED VASOSPASM ANTAGONIST,BRD:BRD-K00004685-001-01-9,
REP.1M,2.5,NPS-2407,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K00004686-001-01-9,
REP.1M,2.5,PELRINONE,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004687-001-01-9,
REP.1M,2.5,EVENAMIDE,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00004688-001-01-9,
REP.1M,2.5,GSK239512,,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00004689-001-01-9,
REP.1M,2.5,SKLB-1028,,"ABL KINASE INHIBITOR, EGFR INHIBITOR, FLT3 INHIBITOR",BRD:BRD-K00004690-001-01-9,
REP.1M,2.5,MEGESTROL,,PROGESTERONE RECEPTOR AGONIST,BRD:BRD-K00004691-001-01-9,
REP.1M,2.5,FURVINA,,QUORUM SENSING SIGNALING INHIBITOR,BRD:BRD-K00004693-001-01-9,
REP.1M,2.5,SULTAMICILLIN,,ANTIBACTERIAL,BRD:BRD-K00004694-001-01-9,
REP.1M,2.5,MONOMETHYL-FUMARATE,,,BRD:BRD-K00004695-001-01-9,
REP.1M,2.5,LEONURINE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004696-001-01-9,
REP.1M,2.5,ALOVUDINE,,DNA SYNTHESIS MARKER,BRD:BRD-K00004697-001-01-9,
REP.1M,2.5,TRABODENOSON,,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K00004698-001-01-9,
REP.1M,2.5,J147,,BDNF INDUCER,BRD:BRD-K00004699-001-01-9,
REP.1M,2.5,CORT-108297,,GLUCOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K00004700-001-01-9,
REP.1M,2.5,KPT-9274,,NAMPT INHIBITOR,BRD:BRD-K00004701-001-01-9,
REP.1M,2.5,FUNAPIDE,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00004702-001-01-9,
REP.1M,2.5,MSDC-0602K,,MITOCHONDRIAL PYRUVATE CARRIER MODULATOR,BRD:BRD-K00004703-001-01-9,
REP.1M,2.5,DBPR-211,,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K00004704-001-01-9,
REP.1M,2.5,AQW-051,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K00004705-001-01-9,
REP.1M,2.5,ST-1535,,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K00004706-001-01-9,
REP.1M,2.5,SOLRIAMFETOL,,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K00004707-001-01-9,
REP.1M,2.5,OP-0595,,BETA LACTAMASE INHIBITOR,BRD:BRD-K00004708-001-01-9,
REP.1M,2.5,ALINIDINE,,BRADYCARDIC EFFECT,BRD:BRD-K00004709-001-01-9,
REP.1M,2.5,R-1487,,P38 MAPK INHIBITOR,BRD:BRD-K00004710-001-01-9,
REP.1M,2.5,GSK356278,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004711-001-01-9,
REP.1M,2.5,PF-06305591,,SODIUM CHANNEL BLOCKER,BRD:BRD-K00004712-001-01-9,
REP.1M,2.5,SULOPENEM,,ANTIBACTERIAL,BRD:BRD-K00004713-001-01-9,
REP.1M,2.5,VEDAPROFEN,PTGS2,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004714-001-01-9,
REP.1M,2.5,BUTAPROST,,PROSTAGLANDIN RECEPTOR AGONIST,BRD:BRD-K00004715-001-01-9,
REP.1M,2.5,RADOTINIB,,BCR-ABL KINASE INHIBITOR,BRD:BRD-K00004716-001-01-9,
REP.1M,2.5,R-121919,,CRF RECEPTOR ANTAGONIST,BRD:BRD-K00004717-001-01-9,
REP.1M,2.5,ALANOSINE,,ANTIMETABOLITE,BRD:BRD-K00004718-001-01-9,
REP.1M,2.5,CP-547632,,KINASE INHIBITOR,BRD:BRD-K00004719-001-01-9,
REP.1M,2.5,ACOLBIFENE,,ESTROGEN RECEPTOR ANTAGONIST,BRD:BRD-K00004720-001-01-9,
REP.1M,2.5,BMS-935177,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K00004721-001-01-9,
REP.1M,2.5,LY3295668,,AURORA KINASE INHIBITOR,BRD:BRD-K00004722-001-01-9,
REP.1M,2.5,HP-228,,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K00004723-001-01-9,
REP.1M,2.5,FLURBIPROFEN-AXETIL,,ANALGESIC AGENT,BRD:BRD-K00004724-001-01-9,
REP.1M,2.5,VORUCICLIB,,CDK9 INHIBITOR,BRD:BRD-K00004725-001-01-9,
REP.1M,2.5,AMETANTRONE,,ANTICANCER AGENT,BRD:BRD-K00004726-001-01-9,
REP.1M,2.5,SIMUROSERTIB,,KINASE INHIBITOR,BRD:BRD-K00004727-001-01-9,
REP.1M,2.5,ALLOPURINOL-RIBOSIDE,,"ANTI-LEISHMANIAL AGENT, PHOSPHORYLASE INHIBITOR",BRD:BRD-K00004728-001-01-9,
REP.1M,2.5,MANITIMUS,,DEHYDROGENASE INHIBITOR,BRD:BRD-K00004729-001-01-9,
REP.1M,2.5,ABT-072,,RNA POLYMERASE INHIBITOR,BRD:BRD-K00004730-001-01-9,
REP.1M,2.5,GLN-1062,,CHOLINESTERASE INHIBITOR,BRD:BRD-K00004731-001-01-9,
REP.1M,2.5,CAMOBUCOL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004732-001-01-9,
REP.1M,2.5,NSP-805,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K00004733-001-01-9,
REP.1M,2.5,AVE-3085,,NITRIC OXIDE SYNTHASE STIMULANT,BRD:BRD-K00004734-001-01-9,
REP.1M,2.5,BIA-10-2474,,FATTY ACID HYDROLASE INHIBITOR,BRD:BRD-K00004735-001-01-9,
REP.1M,2.5,BETAMETHASONE-BUTYRATE-PROPIONATE,,,BRD:BRD-K00004736-001-01-9,
REP.1M,2.5,NITROFLURBIPROFEN,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K00004737-001-01-9,
REP.1M,2.5,APYRAMIDE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K00004738-001-01-9,
REP.1M,2.5,HEPSULFAM,,DNA CROSS-LINKING,BRD:BRD-K00004739-001-01-9,
REP.1M,2.5,PARCETASAL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K00004740-001-01-9,
REP.1M,2.5,ESTRADIOL-3-O-SULFAMATE,,STERYL SULFATASE INHIBITOR,BRD:BRD-K00004741-001-01-9,
REP.1M,2.5,LUSAPERIDONE,,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K00004742-001-01-9,
REP.1M,2.5,NUVENZEPINE,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00004743-001-01-9,
REP.1M,2.5,LINTOPRIDE,,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K00004744-001-01-9,
REP.1M,2.5,HSR6071,,ANTIALLERGIC AGENT,BRD:BRD-K00004745-001-01-9,
REP.1M,2.5,YS-201,,CALCIUM RECEPTOR ANTAGONIST,BRD:BRD-K00004746-001-01-9,
REP.1M,2.5,KME-4,,PROSTAGLANDIN INHIBITOR,BRD:BRD-K00004747-001-01-9,
REP.1M,2.5,CI-953,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K00004748-001-01-9,
REP.1M,2.5,NCX-1015,,INTERLEUKIN SYTHESIS STIMULATOR,BRD:BRD-K00004749-001-01-9,
REP.1M,2.5,PF-06873600,,CDK INHIBITOR,BRD:BRD-K00004750-001-01-9,
REP.1M,2.5,INARIGIVIR-SOPROXIL,,ANTIVIRAL,BRD:BRD-K00004751-001-01-9,
REP.1M,2.5,INX-08189,,ANTIVIRAL,BRD:BRD-K00004752-001-01-9,
REP.1M,2.5,TALAPORFIN,,PHOTOSENSITIZING AGENT,BRD:BRD-K00004965-342-01-9,
REP.1M,2.5,AMENAMEVIR,,HELICASE PRIMASE INHIBITOR,BRD:BRD-K00004966-001-01-9,
REP.1M,2.5,ACETYLSPIRAMYCIN,,OTHER ANTIBIOTIC,BRD:BRD-K00004968-001-01-9,
REP.1M,2.5,ALPHA-GLUCOSYL-HESPERIDIN,,ANTIOXIDANT,BRD:BRD-K00005238-001-01-9,
REP.1M,2.5,TP-3654,,"1,4,5-TRISPHOSPHATE INHIBITOR",BRD:BRD-K00005239-001-01-9,
REP.1M,2.5,TULRAMPATOR,,ANTIDEPRESSANT,BRD:BRD-K00005240-001-01-9,
REP.1M,2.5,RIPRETINIB,,RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K00005241-001-01-9,
REP.1M,2.5,TEN-010,,BROMODOMAIN INHIBITOR,BRD:BRD-K00005242-001-01-9,
REP.1M,2.5,FK-409,,GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K00005243-001-01-9,
REP.1M,2.5,CCT196969,,RAF INHIBITOR,BRD:BRD-K00005244-001-01-9,
REP.1M,2.5,KM-0118,,ANTICANCER AGENT,BRD:BRD-K00005245-001-01-9,
REP.1M,2.5,CK-101,,EGFR INHIBITOR,BRD:BRD-K00005246-001-01-9,
REP.1M,2.5,SALVIANOLIC-ACID-A,,MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K00005247-001-01-9,
REP.1M,2.5,WP921,,,BRD:BRD-K00005248-001-01-9,
REP.1M,2.5,LY2828360,,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K00005249-001-01-9,
REP.1M,2.5,AZD5991,,MCL1 INHIBITOR,BRD:BRD-K00005264-001-02-9,
REP.1M,2.5,PF-06928215,,CYCLIC GMP-AMP SYNTHASE INHIBITOR,BRD:BRD-K00005326-001-01-9,
REP.1M,2.5,SCABERTOPIN,,ANTICANCER AGENT,BRD:BRD-K00005327-001-01-9,
REP.1M,2.5,RADIPRODIL,,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K00005328-001-01-9,
REP.1M,2.5,LEVAMLODIPINE,,CALCIUM CHANNEL BLOCKER,BRD:BRD-K00005329-074-01-9,
REP.1M,2.5,AUT-1,,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K00005330-001-01-9,
REP.1M,2.5,BAY-8002,,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K00005331-001-01-9,
REP.1M,2.5,CALCITONIN,,CALCITONIN AGONIST,BRD:BRD-K00005332-019-01-9,
REP.1M,2.5,H-151,,STING ANTAGONIST,BRD:BRD-K00005333-001-01-9,
REP.1M,2.5,GUANCYDINE,,ANTIHYPERTENSIVE AGENT,BRD:BRD-K00005334-001-01-9,
REP.1M,2.5,CYCLUC1,,,BRD:BRD-K00005335-001-01-9,
REP.1M,2.5,PZ-2891,,PANTOTHENATE KINASE ACTIVATOR,BRD:BRD-K00005336-001-01-9,
REP.1M,2.5,DIM-C-PPHCO2ME,,NUCLEAR RECEPTOR ANTAGONIST,BRD:BRD-K00005337-001-01-9,
REP.1M,2.5,VL285,,PROTAC,BRD:BRD-K00005338-001-01-9,
REP.1M,2.5,A-381393,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K00005339-001-01-9,
REP.1M,2.5,SBI-115,GPBAR1,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K00005340-001-01-9,
REP.1M,2.5,OGERIN,,G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K00005341-001-01-9,
REP.1M,2.5,TRIFLOXYSTROBIN,,MITOCHONDRIAL ELECTRON TRANSPORT INHIBITOR,BRD:BRD-K00005342-001-01-9,
REP.1M,2.5,REYNOUTRIN,,ANTIOXIDANT,BRD:BRD-K00005343-001-01-9,
REP.1M,2.5,DCP-LA,,PROTEIN KINASE ACTIVATOR,BRD:BRD-K00005344-001-01-9,
REP.1M,2.5,20-HETE,,ION CHANNEL ANTAGONIST,BRD:BRD-K00005345-001-01-9,
REP.1M,2.5,BETAMETHASONE-PHOSPHATE,,,BRD:BRD-K00005349-304-01-9,
REP.1M,2.5,PYRETHRINS,,,BRD:BRD-K00010129-001-01-9,
REP.1M,2.5,AMG-510,,K-RAS INHIBITOR,BRD:BRD-K00010385-001-01-9,
REP.1M,2.5,RMC-4550,,SHIP2 PHOSPHATASE INHIBITOR,BRD:BRD-K00010386-001-01-9,
REP.1M,2.5,BAFILOMYCIN-A1,,ATPASE INHIBITOR,BRD:BRD-K00010387-001-01-9,
REP.1M,2.5,PTC-028,,BMI-1 INHIBITOR,BRD:BRD-K00010388-001-01-9,
REP.1M,2.5,RAF709,,RAF INHIBITOR,BRD:BRD-K00010389-001-01-9,
REP.1M,2.5,BTS-71321,,,BRD:BRD-K00010938-001-01-9,
REP.1M,2.5,PDD-00017273,,PARG INHIBITOR,BRD:BRD-K00021095-001-01-9,
REP.1M,2.5,EMRICASAN,"CASP1, CASP3, CASP7",CASPASE INHIBITOR,BRD:BRD-K00023644-001-01-9,
REP.1M,2.5,AMZ30,,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-K00256256-001-06-1,
REP.1M,2.5,MEGLUTOL,HMGCR,HMGCR INHIBITOR,BRD:BRD-K00495673-001-05-2,
REP.1M,2.5,CHROMIUM-PICOLINATE,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-02-9,PICOLINIC-ACID
REP.1M,2.5,PICOLINIC-ACID,,"CHELATING AGENT, INSULIN SENSITIZER",BRD:BRD-K01029106-001-02-9,PICOLINIC-ACID
REP.1M,2.5,WALRYCIN-B,,TRANSCRIPTIONAL REGULATORY PROTEIN WALR,BRD:BRD-K01129913-001-01-5,
REP.1M,2.5,METHYL-AMINOLEVULINATE,"FCGR1A, FECH",OXIDIZING AGENT,BRD:BRD-K01292611-003-13-7,
REP.1M,2.5,TANNIC-ACID,ANO1,PARG INHIBITOR,BRD:BRD-K01584643-001-04-9,
REP.1M,2.5,BRL-44408,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K01825677-050-02-9,
REP.1M,2.5,3-METHYL-GABA,ABAT,GABA AMINOTRANSFERASE ACTIVATOR,BRD:BRD-K01825682-074-02-9,
REP.1M,2.5,TEPP-46,PKM,PYRUVATE KINASE ISOZYME ACTIVATOR,BRD:BRD-K01826017-001-02-9,
REP.1M,2.5,ETIFOXINE,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR MODULATOR,BRD:BRD-K01826330-001-01-9,
REP.1M,2.5,ALPHA-METHYLSEROTONIN,"HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR4",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K01826806-050-02-9,
REP.1M,2.5,BUTYLIDENEPHTHALIDE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K02260986-001-03-9,
REP.1M,2.5,SCH-51344,NUDT1,MTH1 INHIBITOR,BRD:BRD-K02460719-001-02-9,
REP.1M,2.5,BQ-788,EDNRB,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K02490038-236-03-8,
REP.1M,2.5,AMD-3465,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K03019184-439-02-9,
REP.1M,2.5,MG-624,CHRNA7,ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K03128577-005-08-9,
REP.1M,2.5,AZD8797,,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K03336321-001-02-9,
REP.1M,2.5,HC-067047,TRPV4,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K03391209-001-02-0,
REP.1M,2.5,SB-452533,TRPV1,TRPV ANTAGONIST,BRD:BRD-K03665769-001-02-9,
REP.1M,2.5,NS-19504,KCNMA1,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K03808106-001-02-9,
REP.1M,2.5,GKA-50,GCK,GLUCOKINASE ACTIVATOR,BRD:BRD-K03827870-001-02-9,
REP.1M,2.5,5-HYDROXYECTOINE,,,BRD:BRD-K03871161-001-02-9,
REP.1M,2.5,MK-5046,"BRS3, GRPR, NMBR",BOMBESIN RECEPTOR AGONIST,BRD:BRD-K03886848-001-01-8,
REP.1M,2.5,PK-44,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K04035716-011-02-9,
REP.1M,2.5,CEFTIZOXIM,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K04301924-236-03-2,
REP.1M,2.5,PD-173212,CACNA1B,CALCIUM CHANNEL BLOCKER,BRD:BRD-K04426574-001-03-9,
REP.1M,2.5,MERCK60,"HDAC1, HDAC2",HDAC INHIBITOR,BRD:BRD-K04466929-001-12-9,
REP.1M,2.5,PNU-177864,DRD3,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K04635846-003-02-9,
REP.1M,2.5,LDN193189,"ACVR1, BMPR1A",BONE MORPHOGENIC PROTEIN INHIBITOR,BRD:BRD-K04853698-376-01-4,
REP.1M,2.5,RISEDRONATE,FDPS,OSTEOCLAST INHIBITOR,BRD:BRD-K05185389-001-02-6,
REP.1M,2.5,TC-I-2014,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K05262258-001-02-9,
REP.1M,2.5,ANAGLIPTIN,DPP4,DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K05355328-001-02-9,
REP.1M,2.5,NHI-2,LDHA,LACTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K05653025-001-02-9,
REP.1M,2.5,AZ 628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ-628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,BRD-K05804044-001-18-5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ 628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ-628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,BRD-K05804044-001-18-5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ 628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ-628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,BRD-K05804044-001-18-5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ 628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,AZ-628,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,BRD-K05804044-001-18-5,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K05804044-001-18-5,AZ-628;BRD-K05804044-001-18-5
REP.1M,2.5,DH-97,MTNR1B,MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-K06014311-001-04-9,
REP.1M,2.5,CCMQ,,HOMOQUINOLINIC ACID BINDING INHIBITOR,BRD:BRD-K06159959-001-03-9,
REP.1M,2.5,SM-164,"BIRC2, BIRC3, XIAP",XIAP INHIBITOR,BRD:BRD-K06191411-001-02-5,
REP.1M,2.5,"3,4-DCPG-(R)",,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K06204668-001-03-9,
REP.1M,2.5,CID-2745687,GPR35,G PROTEIN-COUPLED RECEPTOR ANTAGONIST,BRD:BRD-K06405316-001-04-9,
REP.1M,2.5,FLUDROCORTISONE-ACETATE,"AR, NR3C1, NR3C2",,BRD:BRD-K06408664-001-04-9,
REP.1M,2.5,AT-1015,HTR2A,SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K06496777-003-02-9,
REP.1M,2.5,PROPYPHENAZONE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K06520168-001-03-9,
REP.1M,2.5,YM-90709,"CSF2RB, IL5RA",IL5 INHIBITOR,BRD:BRD-K06712146-001-04-9,
REP.1M,2.5,17-PA,,GLUCOCORTICOID RECEPTOR AGONIST,BRD:BRD-K07395323-001-02-9,
REP.1M,2.5,PHP-501,"GABRA1, GABRB2, GABRG2",GABA RECEPTOR ANTAGONIST,BRD:BRD-K07460388-019-02-9,
REP.1M,2.5,NTRC-824,NTSR2,NEUROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K07788774-001-02-9,
REP.1M,2.5,SB-612111,OPRL1,NOCICEPTIN/ORPHANIN FQ RECEPTOR ANTAGONIST,BRD:BRD-K08333979-003-02-9,
REP.1M,2.5,GANT-61,"GLI1, GLI2",GLI ANTAGONIST,BRD:BRD-K09485525-001-03-9,
REP.1M,2.5,UBP-310,"GRIK1, GRIK5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K09597601-001-02-9,
REP.1M,2.5,THIOTEPA,"CYP2B6, CYP3A4",CYTOCHROME P450 INHIBITOR,BRD:BRD-K09631521-001-12-3,
REP.1M,2.5,S-TRITYL-L-CYSTEINE,,MITOTIC KINESIN INHIBITOR,BRD:BRD-K09774593-001-02-9,
REP.1M,2.5,METHANTHELINE,"CHRM1, HRH2",ACETYLCHOLINE RECEPTOR ANTAGONIST,BRD:BRD-K09859624-004-11-9,
REP.1M,2.5,AZ-10606120,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K09907507-300-02-9,
REP.1M,2.5,DC-260126,FFAR1,FREE FATTY ACID RECEPTOR ANTAGONIST,BRD:BRD-K10596918-001-02-9,
REP.1M,2.5,OMBITASVIR,,HCV INHIBITOR,BRD:BRD-K11072003-001-02-4,
REP.1M,2.5,SR-2211,RORC,RETINOID RECEPTOR INVERSE AGONIST,BRD:BRD-K11641193-001-03-9,
REP.1M,2.5,PF-429242,MBTPS1,SREBP INHIBITOR,BRD:BRD-K11821338-300-02-9,
REP.1M,2.5,ZAMI-633,,UREASE INHIBITOR,BRD:BRD-K11984358-001-01-3,
REP.1M,2.5,K145,SPHK2,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K12106308-003-01-9,
REP.1M,2.5,VU10010,CHRM4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K12483104-001-02-9,
REP.1M,2.5,S1P1-AGONIST-III,S1PR1,SPHINGOSINE KINASE INHIBITOR,BRD:BRD-K12745498-001-03-4,
REP.1M,2.5,ISRIB,"EIF2A, EIF2AK3","EUKARYOTIC TRANSLATION INITIATION FACTOR INHIBITOR, PERK INHIBITOR",BRD:BRD-K12826175-001-02-4,
REP.1M,2.5,DAIDZIN,ALDH2,ANTIOXIDANT,BRD:BRD-K12979078-001-02-9,
REP.1M,2.5,PFI-4,BRPF1,BROMODOMAIN INHIBITOR,BRD:BRD-K13106865-001-02-9,
REP.1M,2.5,A-438079,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13223831-003-02-9,
REP.1M,2.5,ZINC-UNDECYLENATE,,OTHER ANTIFUNGAL,BRD:BRD-K13330768-001-02-9,
REP.1M,2.5,TRIMETREXATE,DHFR,DIHYDROFOLATE REDUCTASE INHIBITOR,BRD:BRD-K13642819-001-02-9,
REP.1M,2.5,AZD9056,,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K13699028-003-02-9,
REP.1M,2.5,IBIGLUSTAT,,GLUCOSYLCERAMIDASE INHIBITOR,BRD:BRD-K14063023-001-02-9,
REP.1M,2.5,AZD3264,IKBKB,IKK INHIBITOR,BRD:BRD-K14287049-001-01-3,
REP.1M,2.5,SIB-1893,"GRM4, GRM5",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K14561059-001-06-9,
REP.1M,2.5,BC-11,PLAU,UROKINASE INHIBITOR,BRD:BRD-K14646328-004-02-9,
REP.1M,2.5,AZ-7371,,ANTIBACTERIAL,BRD:BRD-K14661019-001-02-9,
REP.1M,2.5,AS-252424,PIK3CG,PI3K INHIBITOR,BRD:BRD-K14988953-001-04-4,
REP.1M,2.5,NBI-98782,,VESICULAR MONOAMINE TRANSPORTER INHIBITOR,BRD:BRD-K15241725-001-02-9,
REP.1M,2.5,LY2857785,CDK9,CDK INHIBITOR,BRD:BRD-K15382985-001-01-7,
REP.1M,2.5,PIPOBROMAN,,DNA ALKYLATING AGENT,BRD:BRD-K15656090-001-07-3,
REP.1M,2.5,ANTHRAQUINONE,CDC25B,CDC INHIBITOR,BRD:BRD-K15957397-001-05-9,
REP.1M,2.5,SB-297006,CCR3,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K16107558-001-02-9,
REP.1M,2.5,MACOZINONE,,DPRE1 INHIBITOR,BRD:BRD-K16343284-001-02-9,
REP.1M,2.5,T-025,,CLK INHIBITOR,BRD:BRD-K16605796-001-01-9,
REP.1M,2.5,TC-G-1005,GPBAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K16939217-001-02-9,
REP.1M,2.5,NASTORAZEPIDE,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K17295893-238-03-9,
REP.1M,2.5,GSK2830371,PPM1D,PROTEIN PHOSPHATASE INHIBITOR,BRD:BRD-K17472821-001-01-2,
REP.1M,2.5,APY-29,ERN1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K17511755-001-02-9,
REP.1M,2.5,NDT-9513727,C5AR1,COMPLEMENT ANTAGONIST,BRD:BRD-K17539220-001-02-9,
REP.1M,2.5,CC4,CHRNB2,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K17751100-001-02-9,
REP.1M,2.5,BROMEBRIC-ACID,,"DNA SYNTHESIS INHIBITOR, PURINE ANTAGONIST",BRD:BRD-K17874929-236-02-0,
REP.1M,2.5,ER-50891,RARA,RETINOID RECEPTOR ANTAGONIST,BRD:BRD-K18347943-001-02-9,
REP.1M,2.5,CLONIXIN,"PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K18399440-001-11-9,
REP.1M,2.5,DEXMEDETOMIDINE,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K18423410-003-02-5,
REP.1M,2.5,MPS-BAY-2A,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K18530250-001-02-9,
REP.1M,2.5,PAOPA,DRD2,DOPAMINE RECEPTOR MODULATOR,BRD:BRD-K18573821-001-03-9,
REP.1M,2.5,OR-486,COMT,CATECHOL O METHYLTRANSFERASE INHIBITOR,BRD:BRD-K18602506-001-09-9,
REP.1M,2.5,ICRT-14,"CTNNB1, TCF4","BETA CATENIN INHIBITOR, WNT SIGNALING INHIBITOR",BRD:BRD-K18634484-001-02-9,
REP.1M,2.5,DIHYDROXYACETONE,,,BRD:BRD-K18637542-001-01-7,
REP.1M,2.5,L-694247,"HTR1A, HTR1B, HTR1D",SEROTONIN RECEPTOR AGONIST,BRD:BRD-K18816859-001-06-9,
REP.1M,2.5,UNDECYLENIC-ACID,,OTHER ANTIFUNGAL,BRD:BRD-K19189338-001-03-2,
REP.1M,2.5,UK-5099,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K19558579-001-02-9,
REP.1M,2.5,TREPROSTINIL,"P2RY12, PPARD, PTGIR",PROSTANOID RECEPTOR AGONIST,BRD:BRD-K19706299-236-02-9,
REP.1M,2.5,EUK-134,"APP, SOD2",CATALASE STIMULANT,BRD:BRD-K19741031-001-01-4,
REP.1M,2.5,CALHEX-231,CASR,CALCIUM SENSING RECEPTOR NEGATIVE ALLOSTERIC MODULATOR,BRD:BRD-K19811997-003-02-9,
REP.1M,2.5,TCS-2210,,NEURAL STEM CELL INDUCER,BRD:BRD-K19958299-001-02-9,
REP.1M,2.5,IMPENTAMINE,HRH3,HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K20049318-303-03-9,
REP.1M,2.5,MK-886,,LIPOXYGENASE INHIBITOR,BRD:BRD-K20168484-001-07-9,
REP.1M,2.5,A-887826,SCN10A,SODIUM CHANNEL BLOCKER,BRD:BRD-K20239555-001-02-9,
REP.1M,2.5,UF-010,"HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K20480395-001-02-9,
REP.1M,2.5,AMPYRONE,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K20484910-001-16-9,
REP.1M,2.5,L-KYNURENINE,,ARYL HYDROCARBON RECEPTOR AGONIST,BRD:BRD-K20497775-001-06-9,
REP.1M,2.5,PYRANTEL-PAMOATE,,NEUROMUSCULAR BLOCKER,BRD:BRD-K20672254-046-05-4,
REP.1M,2.5,NU-2058,"CCNA2, CDK2",CYCLIN D INHIBITOR,BRD:BRD-K20976221-001-12-0,
REP.1M,2.5,CJ-033466,HTR4,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K21306330-001-02-9,
REP.1M,2.5,BMS-470539,MC1R,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K22000702-300-02-9,
REP.1M,2.5,"1,4-BUTANEDIOL","MAN1B1, PLA2G2A, PLA2G2E","BENZODIAZEPINE RECEPTOR AGONIST, GAMMA HYDROXYBUTYRIC ACID AGONIST",BRD:BRD-K22346679-001-06-3,
REP.1M,2.5,BAY-2402234,,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K22379844-001-04-9,
REP.1M,2.5,NEURODAZINE,,NEUROGENESIS OF NON-PLURIPOTENT C2C12 MYOBLAST INDUCER,BRD:BRD-K22631935-001-02-7,
REP.1M,2.5,DYNOLE-34-2,DNM1,DYNAMIN INHIBITOR,BRD:BRD-K23479488-001-02-9,
REP.1M,2.5,GW-1100,FFAR1,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K23614267-001-01-2,
REP.1M,2.5,R112,SYK,SYK INHIBITOR,BRD:BRD-K23902832-001-01-7,
REP.1M,2.5,AM095,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-03-4,BMS-986020
REP.1M,2.5,BMS-986020,LPAR1,LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONIST,BRD:BRD-K23952234-236-03-4,BMS-986020
REP.1M,2.5,MC1568,HDAC2,HDAC INHIBITOR,BRD:BRD-K24031866-001-02-1,
REP.1M,2.5,NS-3623,KCNH2,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K24434292-001-01-3,
REP.1M,2.5,LEVCROMAKALIM,KCNJ5,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K24526313-001-17-7,
REP.1M,2.5,TMN-355,PPIA,CYCLOPHILIN INHIBITOR,BRD:BRD-K24527118-001-02-9,
REP.1M,2.5,CINPA-1,"NR1H4, NR1I3, PPARG",CAR ANTAGONIST,BRD:BRD-K24570280-001-07-9,
REP.1M,2.5,ML298,PLD2,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K24600306-003-02-9,
REP.1M,2.5,LY288513,CCKBR,CCK RECEPTOR ANTAGONIST,BRD:BRD-K24675965-001-06-9,
REP.1M,2.5,FENEBRUTINIB,,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K25290930-001-03-9,
REP.1M,2.5,GSK2110183,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K25412176-001-04-9,
REP.1M,2.5,L-PHENYLISOPROPYLADENOSINE,,,BRD:BRD-K25521961-001-06-9,
REP.1M,2.5,ML324,KDM4A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K25611237-001-02-1,
REP.1M,2.5,SR-1078,"RORA, RORC",RETINOID RECEPTOR AGONIST,BRD:BRD-K26501486-001-02-9,
REP.1M,2.5,GS-967,,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K26526496-001-03-9,
REP.1M,2.5,MI-14,PI4KB,PI4K INHIBITOR,BRD:BRD-K26726854-001-02-9,
REP.1M,2.5,CINNAMALDEHYDE,TRPA1,"ALDOSE REDUCTASE INHIBITOR, TRPV AGONIST",BRD:BRD-K26875402-001-13-9,
REP.1M,2.5,CP-640186,"ACACA, ACACB",ACETYL-COA CARBOXYLASE INHIBITOR,BRD:BRD-K26921335-003-01-2,
REP.1M,2.5,TC-G-1000,"ADRA2A, ADRA2B, ADRA2C",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K27010807-050-02-9,
REP.1M,2.5,CFI-400945,,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K27040396-051-02-9,
REP.1M,2.5,EPIGALLOCATECHIN-(-),,,BRD:BRD-K27529556-001-04-9,
REP.1M,2.5,KARTOGENIN,FLNA,CHONDROCYTE DIFFERENTIATION STIMULATOR,BRD:BRD-K27584835-001-02-9,
REP.1M,2.5,RUBOXISTAURIN,,PKC INHIBITOR,BRD:BRD-K27677357-003-04-9,
REP.1M,2.5,CIPARGAMIN,,ANTIMALARIAL AGENT,BRD:BRD-K27811785-001-02-9,
REP.1M,2.5,MK-2894,PTGER4,PROSTAGLANDIN INHIBITOR,BRD:BRD-K27983781-001-01-4,
REP.1M,2.5,NEUROPATHIAZOL,"BMP2, LIF",NEURAL STEM CELL INDUCER,BRD:BRD-K28567778-001-02-7,
REP.1M,2.5,LORACARBEF,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K28935038-002-03-9,
REP.1M,2.5,D-157495,,DECAPPING SCAVENGER ENZYME INHIBITOR,BRD:BRD-K29066607-001-02-9,
REP.1M,2.5,4-DAMP,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",CHOLINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K29313239-005-10-9,
REP.1M,2.5,BMS-906024,,GAMMA SECRETASE INHIBITOR,BRD:BRD-K29343434-001-02-9,
REP.1M,2.5,TCS-OX2-29,HCRTR2,OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K29424831-003-01-3,
REP.1M,2.5,SCH-202676,"CHRM1, CHRM2, DRD1, DRD2",G PROTEIN-COUPLED RECEPTOR MODULATOR,BRD:BRD-K29562203-004-12-9,
REP.1M,2.5,DALBAVANCIN,PNLIP,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K30177383-001-02-9,
REP.1M,2.5,A-485,,HISTONE ACETYLTRANSFERASE INHIBITOR,BRD:BRD-K30233223-001-04-9,
REP.1M,2.5,6-AMINOPENICILLANIC-ACID,,,BRD:BRD-K30284967-001-02-9,
REP.1M,2.5,ASC-J9,AR,ANDROGEN RECEPTOR ENHANCER,BRD:BRD-K30331124-001-04-9,
REP.1M,2.5,BURAMATE,,ANTIEPILEPTIC,BRD:BRD-K30360804-001-02-9,
REP.1M,2.5,JNJ-64619178,,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K30421675-001-04-9,
REP.1M,2.5,L-760735,TACR1,TACHYKININ ANTAGONIST,BRD:BRD-K30425481-003-02-9,
REP.1M,2.5,AC-261066,RARB,RETINOID RECEPTOR AGONIST,BRD:BRD-K31144453-001-03-9,
REP.1M,2.5,MCN-5652-(+/-),,SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI),BRD:BRD-K31168993-001-03-9,
REP.1M,2.5,DEVAZEPIDE,,CCK RECEPTOR ANTAGONIST,BRD:BRD-K31238592-001-02-9,
REP.1M,2.5,SDZ-SER-082,"HTR2A, HTR2B, HTR2C",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K31339597-051-03-9,
REP.1M,2.5,GF109203X,"PDPK1, PIM1, PRKCI, PRKCZ",PKC INHIBITOR,BRD:BRD-K31342827-001-13-8,
REP.1M,2.5,DIHYDREXIDINE,"DRD1, DRD2, DRD3, DRD4, DRD5",DOPAMINE RECEPTOR AGONIST,BRD:BRD-K31471398-003-06-9,
REP.1M,2.5,PEMIROLAST,HRH1,MEDIATOR RELEASE INHIBITOR,BRD:BRD-K31731454-237-04-9,
REP.1M,2.5,FISETIN,"CDK6, FASN",AURORA KINASE INHIBITOR,BRD:BRD-K31836715-001-06-8,
REP.1M,2.5,AP-18,TRPA1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K32143970-001-02-9,
REP.1M,2.5,VER-155008,HSPA1A,HSP INHIBITOR,BRD:BRD-K32330832-001-01-0,
REP.1M,2.5,AMMONIUM-PERFLUOROCAPRYLATE,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K32531356-001-03-9,
REP.1M,2.5,JHW-007,SLC6A3,DOPAMINE REUPTAKE INHIBITOR,BRD:BRD-K32892871-003-02-9,
REP.1M,2.5,BAY-60-6583,"ADORA1, ADORA2A, ADORA2B, ADORA3",ADENOSINE RECEPTOR AGONIST,BRD:BRD-K32952627-001-02-9,
REP.1M,2.5,CP-471474,"MMP1, MMP13, MMP2, MMP3, MMP9",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K33234937-001-02-9,
REP.1M,2.5,PHENYLMETHYLSULFONYL-FLUORIDE,,SERINE PROTEASE INHIBITOR,BRD:BRD-K33422401-001-06-4,
REP.1M,2.5,N-METHYLFORMAMIDE,,,BRD:BRD-K33445938-001-01-8,
REP.1M,2.5,BRONOPOL,,,BRD:BRD-K33457401-001-02-9,
REP.1M,2.5,GEPOTIDACIN,,TOPOISOMERASE INHIBITOR,BRD:BRD-K33499285-001-02-9,
REP.1M,2.5,PSNCBAM-1,CNR1,CANNABINOID RECEPTOR MODULATOR,BRD:BRD-K33502629-001-02-9,
REP.1M,2.5,GSK-LSD-1,KDM1A,HISTONE LYSINE DEMETHYLASE INHIBITOR,BRD:BRD-K33521504-300-01-6,
REP.1M,2.5,EPZ020411,PRMT6,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K33586289-003-02-8,
REP.1M,2.5,CP-94253,HTR1B,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K33860217-003-04-0,
REP.1M,2.5,GNE-7915,,LEUCINE RICH REPEAT KINASE INHIBITOR,BRD:BRD-K33963447-001-03-9,
REP.1M,2.5,CKI-7,CSNK1G2,CASEIN KINASE INHIBITOR,BRD:BRD-K34303607-300-01-4,
REP.1M,2.5,TC-S-7003,LCK,SRC INHIBITOR,BRD:BRD-K34362291-001-02-9,
REP.1M,2.5,ECTOINE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K34566599-001-03-9,
REP.1M,2.5,BMS-536924,"AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB",IGF-1 INHIBITOR,BRD:BRD-K34581968-001-04-6,
REP.1M,2.5,PD-118057,KCNH2,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K34657753-001-01-9,
REP.1M,2.5,SJ-733,,ATPASE INHIBITOR,BRD:BRD-K34798115-001-02-9,
REP.1M,2.5,ACT-132577,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K34843150-001-03-0,
REP.1M,2.5,DSM265,,DIHYDROOROTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K35498911-001-02-9,
REP.1M,2.5,METHYSERGIDE,"HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7",SEROTONIN RECEPTOR ANTAGONIST,BRD:BRD-K35941380-050-28-9,
REP.1M,2.5,ZSET1446,,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K35984734-001-02-9,
REP.1M,2.5,PLUMBAGIN,,ANTICANCER AGENT,BRD:BRD-K36137799-001-06-9,
REP.1M,2.5,AVE-0991,MRGPRX1,ANGIOTENSIN RECEPTOR AGONIST,BRD:BRD-K36154108-001-01-7,
REP.1M,2.5,VBY-825,"CTSB, CTSL, CTSS",CATHEPSIN INHIBITOR,BRD:BRD-K36338614-001-02-1,
REP.1M,2.5,TARTARIC-ACID,,ANTIOXIDANT,BRD:BRD-K36474365-001-09-9,
REP.1M,2.5,GW-542573X,KCNN1,CALCIUM CHANNEL ACTIVATOR,BRD:BRD-K36485341-001-02-9,
REP.1M,2.5,ITX3,TRIO,GEF INHIBITOR,BRD:BRD-K36515744-001-03-5,
REP.1M,2.5,CINCHONINE,CYP2D6,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K36551084-001-04-9,
REP.1M,2.5,GSK1562590,UTS2R,UROTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K36697397-003-02-9,
REP.1M,2.5,S-07662,NR1I3,CAR ANTAGONIST,BRD:BRD-K37635256-001-02-9,
REP.1M,2.5,ISOPENTYL-4-METHOXYCINNAMATE,,,BRD:BRD-K37851352-001-02-9,
REP.1M,2.5,BTB06584,ATP5F1,ATPASE INHIBITOR,BRD:BRD-K37933329-001-03-9,
REP.1M,2.5,OTS514,,TOPK INHIBITOR,BRD:BRD-K38018935-001-01-1,
REP.1M,2.5,SPARTEINE-(+),,,BRD:BRD-K38203080-001-01-2,
REP.1M,2.5,GK921,TGM2,TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K38272302-001-02-7,
REP.1M,2.5,APY0201,"IL12A, IL12B, PIKFYVE",PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K38627885-001-01-9,
REP.1M,2.5,SIS3,"SMAD3, TGFBR1",SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K38905597-003-02-9,
REP.1M,2.5,UAMC-00039,"DPP4, DPP7",DIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K38966689-300-02-9,
REP.1M,2.5,LIQUIRITIN,,ANTIOXIDANT,BRD:BRD-K39084158-001-08-9,
REP.1M,2.5,L-755507,"ADRB1, ADRB2, ADRB3",ADRENERGIC RECEPTOR AGONIST,BRD:BRD-K39359968-001-03-9,
REP.1M,2.5,MIVOBULIN,,MICROTUBULE INHIBITOR,BRD:BRD-K39576764-071-01-6,
REP.1M,2.5,MICAFUNGIN,,"FUNGAL 1,3-BETA-D-GLUCAN SYNTHASE INHIBITOR",BRD:BRD-K40407248-001-04-9,
REP.1M,2.5,BUTABINDIDE,TPP2,TRIPEPTIDYL PEPTIDASE INHIBITOR,BRD:BRD-K40581315-034-02-9,
REP.1M,2.5,KRCA-0008,ALK,ALK INIHIBITOR,BRD:BRD-K40604024-001-02-9,
REP.1M,2.5,ZM-39923,"JAK1, JAK3",JAK INHIBITOR,BRD:BRD-K40624912-003-17-9,
REP.1M,2.5,STAT3-INHIBITOR-VI,STAT3,STAT INHIBITOR,BRD:BRD-K40853697-001-20-5,
REP.1M,2.5,CYPROTERONE-ACETATE,"ADORA1, AR",ANDROGEN RECEPTOR ANTAGONIST,BRD:BRD-K41141507-001-18-9,
REP.1M,2.5,DHBP,,RYANODINE RECEPTOR BLOCKER,BRD:BRD-K41262162-303-11-9,
REP.1M,2.5,RN-1,KDM1A,HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K41415459-300-02-9,
REP.1M,2.5,CABAGIN,,,BRD:BRD-K41504985-003-02-9,
REP.1M,2.5,JNJ-27141491,CCR2,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K41895652-001-02-9,
REP.1M,2.5,AR-C155858,"SLC16A1, SLC16A7",MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K42325600-001-01-8,
REP.1M,2.5,SF-11,"MCOLN3, NPY2R",NEUROPEPTIDE RECEPTOR ANTAGONIST,BRD:BRD-K42629487-001-09-9,
REP.1M,2.5,JTE-013,"P2RY10, S1PR2",LYSOPHOSPHOLIPID RECEPTOR ANTAGONIST,BRD:BRD-K43330982-001-04-9,
REP.1M,2.5,GELDANAMYCIN,HSP90AA1,HSP INHIBITOR,BRD:BRD-K43570081-001-02-4,
REP.1M,2.5,MPS1-IN-5,,PROTEIN KINASE INHIBITOR,BRD:BRD-K43812936-001-01-9,
REP.1M,2.5,LEVOBETAXOLOL,"ADRB1, ADRB2",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K43883465-003-02-9,
REP.1M,2.5,AMG-176,,MCL1 INHIBITOR,BRD:BRD-K43900408-001-02-9,
REP.1M,2.5,THYMOPENTIN,,IMMUNE RESPONSE STIMULATOR,BRD:BRD-K43977121-001-06-9,
REP.1M,2.5,PHENYL-SALICYLATE,,ANTISEPTIC,BRD:BRD-K44091963-001-04-9,
REP.1M,2.5,PHIKAN-083,TP53,P53 STABILIZING AGENT,BRD:BRD-K44400149-003-02-9,
REP.1M,2.5,ASTILBIN,,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K44845912-001-02-9,
REP.1M,2.5,TC-H-106,"HDAC1, HDAC2, HDAC3, HDAC8",HDAC INHIBITOR,BRD:BRD-K45044657-001-01-4,
REP.1M,2.5,MERBARONE,TOP2A,TOPOISOMERASE INHIBITOR,BRD:BRD-K45152786-001-09-9,
REP.1M,2.5,DSR-6434,TLR7,TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K46384285-001-02-9,
REP.1M,2.5,METHYLBENZETHONIUM-CHLORIDE,,OTHER ANTIBIOTIC,BRD:BRD-K46531780-003-19-7,
REP.1M,2.5,GALLIUM-TRIQUINOLIN-8-OLATE,,,BRD:BRD-K46648676-001-01-8,
REP.1M,2.5,PF-06651600,,JAK INHIBITOR,BRD:BRD-K47084954-001-02-9,
REP.1M,2.5,NK-252,NFE2L2,"LIKE (NRF2) ACTIVATOR, NUCLEAR FACTOR ERYTHROID DERIVED",BRD:BRD-K47441935-001-02-9,
REP.1M,2.5,AZASERINE,,PURINE ANTAGONIST,BRD:BRD-K47464228-001-14-9,
REP.1M,2.5,DIPYROCETYL,,CHELATING AGENT,BRD:BRD-K47608922-001-05-9,
REP.1M,2.5,BX-795,"CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1",IKK INHIBITOR,BRD:BRD-K47983010-001-15-3,
REP.1M,2.5,PHA-568487,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K48053228-051-02-9,
REP.1M,2.5,YM-298198-DESMETHYL,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K48059230-003-03-9,
REP.1M,2.5,FH-535,"PPARD, PPARG","PPAR RECEPTOR ANTAGONIST, WNT SIGNALING INHIBITOR",BRD:BRD-K48112880-001-04-9,
REP.1M,2.5,JW-642,MGLL,MONOACYLGLYCEROL LIPASE INHIBITOR,BRD:BRD-K48424871-001-04-9,
REP.1M,2.5,Y-29794,PREP,PROLYL ENDOPEPTIDASE INHIBITOR,BRD:BRD-K48449073-034-03-9,
REP.1M,2.5,CEFMETAZOLE,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K48470486-236-11-6,
REP.1M,2.5,PIM-1-INHIBITOR-2,PIM1,PIM KINASE INHIBITOR,BRD:BRD-K48832421-001-03-9,
REP.1M,2.5,LIGUSTILIDE,TNF,TUMOR NECROSIS FACTOR PRODUCTION INHIBITOR,BRD:BRD-K48875051-001-01-0,
REP.1M,2.5,MADRASIN,,CELL SPLICING INHIBITOR,BRD:BRD-K48905682-001-11-1,
REP.1M,2.5,RIODOXOL,,OTHER ANTIBIOTIC,BRD:BRD-K48963429-001-01-9,
REP.1M,2.5,ETRETINATE,"RARA, RXRG",PROTEIN SYNTHESIS INHIBITOR,BRD:BRD-K49076555-001-05-6,
REP.1M,2.5,TCS-21311,JAK3,JAK INHIBITOR,BRD:BRD-K49461364-001-01-0,
REP.1M,2.5,COT-INHIBITOR-2,MAP3K8,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K49468759-001-04-2,
REP.1M,2.5,HECLIN,"NEDD4, SMURF2, WWP1",UBIQUITIN LIGASE INHIBITOR,BRD:BRD-K49788188-001-02-9,
REP.1M,2.5,WYE-687,MTOR,MTOR INHIBITOR,BRD:BRD-K49900195-300-02-9,
REP.1M,2.5,LMK-235,"HDAC4, HDAC5",HDAC INHIBITOR,BRD:BRD-K49921286-001-02-6,
REP.1M,2.5,WH-4-023,"LCK, SRC",SRC INHIBITOR,BRD:BRD-K50199947-001-07-9,
REP.1M,2.5,XMD8-92,"DCLK2, MAPK7, PLK4, TNK1",MAP KINASE INHIBITOR,BRD:BRD-K50387473-001-11-0,
REP.1M,2.5,BROMINDIONE,,ANTICOAGULANT,BRD:BRD-K50490982-001-09-9,
REP.1M,2.5,GSK2837808A,LDHA,LACTATE DEHYDROGENASE INHIBITOR,BRD:BRD-K50679358-001-02-9,
REP.1M,2.5,PF-8380,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-K50865540-001-02-3,
REP.1M,2.5,MDL-27531,,GLYCINE RECEPTOR AGONIST,BRD:BRD-K50888640-001-01-6,
REP.1M,2.5,CARDIONOGEN-1,CTNNB1,WNT SIGNALING INHIBITOR,BRD:BRD-K50905564-001-08-9,
REP.1M,2.5,PF-03882845,,MINERALOCORTICOID RECEPTOR ANTAGONIST,BRD:BRD-K51041191-001-02-9,
REP.1M,2.5,SD-2590,"MMP1, MMP13, MMP2",MATRIX METALLOPROTEASE INHIBITOR,BRD:BRD-K51102532-003-02-9,
REP.1M,2.5,AZM-475271,SRC,SRC INHIBITOR,BRD:BRD-K51329597-001-02-9,
REP.1M,2.5,LDN-27219,TGM2,TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K51485109-001-02-9,
REP.1M,2.5,TC-S-7006,MAP3K8,MAP KINASE INHIBITOR,BRD:BRD-K51776215-001-03-9,
REP.1M,2.5,TEMEFOS,,CHOLINESTERASE INHIBITOR,BRD:BRD-K51805276-001-10-9,
REP.1M,2.5,YM-244769,,SODIUM/CALCIUM EXCHANGE INHIBITOR,BRD:BRD-K52087522-300-02-9,
REP.1M,2.5,SULFISOMIDIN,,ANTIBACTERIAL,BRD:BRD-K52416806-001-05-9,
REP.1M,2.5,ML786,"BRAF, RAF1",RAF INHIBITOR,BRD:BRD-K52644305-300-02-9,
REP.1M,2.5,PCO-400,KCNJ8,POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K52721684-001-04-8,
REP.1M,2.5,AZAGUANINE-8,PNP,PURINE ANTAGONIST,BRD:BRD-K53114651-001-12-7,
REP.1M,2.5,BAY-61-3606,SYK,SYK INHIBITOR,BRD:BRD-K53281329-300-01-5,
REP.1M,2.5,PROPAGERMANIUM,CCR2,"CCR AGONIST, INTERFERON RECEPTOR AGONIST",BRD:BRD-K53382462-001-02-0,
REP.1M,2.5,ALANTOLACTONE,STAT3,"APOPTOSIS STIMULANT, STAT INHIBITOR",BRD:BRD-K53731810-001-05-9,
REP.1M,2.5,METHANESULFONYL-FLUORIDE,ACHE,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K53896891-001-01-2,
REP.1M,2.5,ISX-9,NEUROD1,NEURAL STEM CELL INDUCER,BRD:BRD-K53903639-001-01-3,
REP.1M,2.5,CARBARIL,,ACETYLCHOLINESTERASE INHIBITOR,BRD:BRD-K54208592-001-10-9,
REP.1M,2.5,DORSOMORPHIN,"ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC",AMPK INHIBITOR,BRD:BRD-K54233340-001-02-2,
REP.1M,2.5,TC-O-9311,GPR139,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K54297077-001-02-9,
REP.1M,2.5,SBHA,"HDAC1, HDAC3",HDAC INHIBITOR,BRD:BRD-K54729176-001-03-9,
REP.1M,2.5,PARETHOXYCAINE,,LOCAL ANESTHETIC,BRD:BRD-K54799382-003-08-4,
REP.1M,2.5,MIRIN,MRE11A,MRE11A EXONUCLEASE INHIBITOR,BRD:BRD-K55420858-001-01-0,
REP.1M,2.5,WAY-629,HTR2C,SEROTONIN RECEPTOR AGONIST,BRD:BRD-K55430733-003-03-9,
REP.1M,2.5,ON-01500,,APOPTOSIS STIMULANT,BRD:BRD-K55790047-001-02-9,
REP.1M,2.5,BMS-182874,EDNRA,ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K56509348-003-04-9,
REP.1M,2.5,ISOFLUROPHATE,"ACHE, BCHE",CHOLINESTERASE INHIBITOR,BRD:BRD-K56575995-001-03-0,
REP.1M,2.5,ETHOXYQUIN,,ANTIOXIDANT,BRD:BRD-K56792340-001-14-9,
REP.1M,2.5,CQS,,,BRD:BRD-K56839624-001-06-9,
REP.1M,2.5,BMS-566419,"IMPDH1, IMPDH2",INOSINE MONOPHOSPHATE DEHYDROGENASE INHIBITOR,BRD:BRD-K56932272-001-02-9,
REP.1M,2.5,UK-356618,"MMP13, MMP14, MMP2, MMP3, MMP9",METALLOPROTEINASE INHIBITOR,BRD:BRD-K57011718-001-01-5,
REP.1M,2.5,I-CBP-112,"CREBBP, EP300",BROMODOMAIN INHIBITOR,BRD:BRD-K57090026-001-04-9,
REP.1M,2.5,FRAX486,"PAK1, PAK2, PAK3, PAK4",SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K57243773-001-01-6,
REP.1M,2.5,MANGAFODIPIR,,CONTRAST AGENT,BRD:BRD-K57365211-314-03-9,
REP.1M,2.5,"3,5-DHPG-(S)",GRM1,GLUTAMATE RECEPTOR AGONIST,BRD:BRD-K57796080-001-04-9,
REP.1M,2.5,CU-CPT-4A,TLR3,TOLL-LIKE RECEPTOR INHIBITOR,BRD:BRD-K58234744-001-02-9,
REP.1M,2.5,3PO,PFKFB3,PHOSPHOFRUCTOKINASE INHIBITOR,BRD:BRD-K58413118-001-01-8,
REP.1M,2.5,HTH-01-015,NUAK1,PROTEIN KINASE INHIBITOR,BRD:BRD-K58726989-001-02-7,
REP.1M,2.5,CYCLOPAMINE,,HEDGEHOG PATHWAY INHIBITOR,BRD:BRD-K58938839-001-06-9,
REP.1M,2.5,A-1120,RBP4,RETINOID RECEPTOR LIGAND,BRD:BRD-K59060513-001-02-5,
REP.1M,2.5,YM-298198,GRM1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K59650319-003-04-9,
REP.1M,2.5,ICA-069673,"KCNQ2, KCNQ3",VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K59839632-001-02-9,
REP.1M,2.5,LIFITEGRAST,,LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN NEGATIVE MODULATOR,BRD:BRD-K60265345-001-02-9,
REP.1M,2.5,CHC,SLC16A1,MONOCARBOXYLATE TRANSPORTER INHIBITOR,BRD:BRD-K60302405-001-04-5,
REP.1M,2.5,BENDAZOL,,NITRIC OXIDE SYNTHASE STIMULANT,BRD:BRD-K60379054-001-09-9,
REP.1M,2.5,A-839977,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K60427831-001-02-9,
REP.1M,2.5,YC-1,"GUCY1A2, GUCY1A3, GUCY1B3, HIF1A",GUANYLYL CYCLASE ACTIVATOR,BRD:BRD-K60476892-001-17-9,
REP.1M,2.5,SODIUM-ORTHOVANADATE,,,BRD:BRD-K60600693-314-03-2,
REP.1M,2.5,PROPYLPARABEN,,,BRD:BRD-K60783397-001-12-9,
REP.1M,2.5,THEAFLAVIN,,ANTIVIRAL,BRD:BRD-K60842365-001-03-9,
REP.1M,2.5,CGP-78608,,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K60946979-003-02-9,
REP.1M,2.5,NSC-636819,"KDM4A, KDM4B",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K61120504-001-01-6,
REP.1M,2.5,SODIUM-NITRITE,,NITRIC OXIDE DONOR,BRD:BRD-K61230716-236-03-5,
REP.1M,2.5,ESOMEPRAZOLE,ATP4A,ATPASE INHIBITOR,BRD:BRD-K61443506-239-03-9,
REP.1M,2.5,PFI-3,"PBRM1, SMARCA4",BROMODOMAIN INHIBITOR,BRD:BRD-K61524559-001-04-7,
REP.1M,2.5,JNJ-10397049,"HCRTR1, HCRTR2",OREXIN RECEPTOR ANTAGONIST,BRD:BRD-K61721596-001-01-0,
REP.1M,2.5,DDR1-IN-1,"DDR1, DDR2",DISCOIDIN DOMAIN RECEPTOR INHIBITOR,BRD:BRD-K61845293-300-03-9,
REP.1M,2.5,WAY-316606,SFRP1,SECRETED FRIZZLED RELATED PROTEIN INHIBITOR,BRD:BRD-K61871885-001-01-3,
REP.1M,2.5,FUMONISIN-B1,CERS1,,BRD:BRD-K61915943-001-02-9,
REP.1M,2.5,LYLAMINE,CNR1,CANNABINOID RECEPTOR AGONIST,BRD:BRD-K62289640-003-05-9,
REP.1M,2.5,CLANFENUR,,ANTICANCER AGENT,BRD:BRD-K62378877-001-05-9,
REP.1M,2.5,9-ANTHRACENECARBOXYLIC-ACID,"ANO1, CLCN1",,BRD:BRD-K62607075-001-04-9,
REP.1M,2.5,SC-51089,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K62715847-003-02-9,
REP.1M,2.5,SR-1664,PPARG,PPAR RECEPTOR LIGAND,BRD:BRD-K62814487-001-03-0,
REP.1M,2.5,SITAXENTAN,"EDNRA, EDNRB",ENDOTHELIN RECEPTOR ANTAGONIST,BRD:BRD-K63806092-236-06-9,
REP.1M,2.5,ETIFENIN,,RENAL FUNCTION DIAGNOSTIC AGENT,BRD:BRD-K63979671-001-11-9,
REP.1M,2.5,ZLN024,"PRKAA1, PRKAB1, PRKAG1",AMPK ACTIVATOR,BRD:BRD-K64103579-003-02-9,
REP.1M,2.5,NAQUOTINIB,,EGFR INHIBITOR,BRD:BRD-K64114733-066-03-9,
REP.1M,2.5,HA-130,ENPP2,AUTOTAXIN INHIBITOR,BRD:BRD-K64452997-001-02-9,
REP.1M,2.5,GNTI,"OPRK1, OPRM1",OPIOID RECEPTOR ANTAGONIST,BRD:BRD-K64748124-300-06-9,
REP.1M,2.5,ERK5-IN-1,MAPK7,MAP KINASE INHIBITOR,BRD:BRD-K64857848-001-06-4,
REP.1M,2.5,TAFLUPROST,PTGFR,PROSTAGLANDIN INHIBITOR,BRD:BRD-K65059905-001-02-9,
REP.1M,2.5,OXACEPROL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K65230684-001-06-9,
REP.1M,2.5,SIREMADLIN,,MDM INHIBITOR,BRD:BRD-K65480835-001-02-9,
REP.1M,2.5,MONOCROTALINE,,ANTITUMOR AGENT,BRD:BRD-K65508953-001-13-9,
REP.1M,2.5,GW274150,,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K65840970-001-02-9,
REP.1M,2.5,BCTC,TRPV1,TRPV ANTAGONIST,BRD:BRD-K66541497-001-02-9,
REP.1M,2.5,TY-52156,S1PR3,SPHINGOSINE 1-PHOSPHATE RECEPTOR ANTAGONIST,BRD:BRD-K66584608-001-03-9,
REP.1M,2.5,BAZ2-ICR,ZNF215,BROMODOMAIN INHIBITOR,BRD:BRD-K66830666-001-02-7,
REP.1M,2.5,URMC-099,"CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2",MIXED LINEAGE KINASE INHIBITOR,BRD:BRD-K66908976-001-01-8,
REP.1M,2.5,LUZINDOLE,"MTNR1A, MTNR1B",MELATONIN RECEPTOR ANTAGONIST,BRD:BRD-K67013324-001-04-9,
REP.1M,2.5,ATENOLOL-(+),,ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K68075732-001-11-8,
REP.1M,2.5,STATIL,,ALDOSE REDUCTASE INHIBITOR,BRD:BRD-K68332390-001-04-9,
REP.1M,2.5,2-METHYLIMIDAZOLE,,CHOLESTEROL INHIBITOR,BRD:BRD-K68534611-001-07-8,
REP.1M,2.5,MRK-560,APP,GAMMA SECRETASE INHIBITOR,BRD:BRD-K68795758-001-02-9,
REP.1M,2.5,A-987306,"ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2",HISTAMINE RECEPTOR ANTAGONIST,BRD:BRD-K68982262-001-02-9,
REP.1M,2.5,GNF-7,"GCK, TNK2","GLUCOKINASE INHIBITOR, PROTEIN KINASE INHIBITOR",BRD:BRD-K69075588-001-02-9,
REP.1M,2.5,GUANIDINOETHYLDISULFIDE-BICARBONATE,NOS2,NITRIC OXIDE SYNTHASE INHIBITOR,BRD:BRD-K69191882-065-01-6,
REP.1M,2.5,XD-14,"BRD2, BRD3, BRD4, BRDT",BROMODOMAIN INHIBITOR,BRD:BRD-K69211575-001-02-9,
REP.1M,2.5,ML10302,"HTR3A, HTR3B, HTR4",SEROTONIN RECEPTOR PARTIAL AGONIST,BRD:BRD-K69343602-003-02-9,
REP.1M,2.5,AZD0156,,ATM KINASE INHIBITOR,BRD:BRD-K69555850-001-02-9,
REP.1M,2.5,TRIBROMOETHANOL,,ANALGESIC AGENT,BRD:BRD-K69632891-001-02-9,
REP.1M,2.5,ATORVASTATIN,"AHR, DPP4, HMGCR",HMGCR INHIBITOR,BRD:BRD-K69726342-238-05-9,
REP.1M,2.5,SONEPIPRAZOLE,,DOPAMINE RECEPTOR ANTAGONIST,BRD:BRD-K69857269-001-03-9,
REP.1M,2.5,CAROVERIN,,CYTOCHROME P450 INHIBITOR,BRD:BRD-K70161083-001-06-9,
REP.1M,2.5,GSK2334470,"AURKA, AURKB, PDPK1",PHOSPHOINOSITIDE DEPENDENT KINASE INHIBITOR,BRD:BRD-K70642949-001-03-7,
REP.1M,2.5,GENZ-123346,UGCG,GLUCOSYLCERAMIDASE INHIBITOR,BRD:BRD-K70693421-001-01-1,
REP.1M,2.5,IOX1,"EGLN1, KDM3A, KDM4C, KDM6B",HISTONE DEMETHYLASE INHIBITOR,BRD:BRD-K70751730-001-10-4,
REP.1M,2.5,PCI-29732,BTK,BRUTON'S TYROSINE KINASE (BTK) INHIBITOR,BRD:BRD-K71223042-001-03-9,
REP.1M,2.5,SUN-11602,FGFR1,FIBROBLAST GROWTH FACTOR MIMETIC,BRD:BRD-K71250460-001-02-9,
REP.1M,2.5,MJ-15,CNR1,CANNABINOID RECEPTOR ANTAGONIST,BRD:BRD-K71315565-001-02-9,
REP.1M,2.5,MORANTEL,,ACETYLCHOLINE RECEPTOR AGONIST,BRD:BRD-K71454870-046-01-8,
REP.1M,2.5,CH55,"RARA, RARB",RETINOID RECEPTOR BINDER,BRD:BRD-K71487808-001-02-8,
REP.1M,2.5,TAK-659,,SPLEEN ASSOCIATED TYROSINE KINASE INHIBITOR,BRD:BRD-K71500795-003-02-9,
REP.1M,2.5,ICA-110381,KCNQ2,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K71686520-001-02-9,
REP.1M,2.5,CIS-ACONITIC-ACID,ACO2,,BRD:BRD-K71756122-001-02-5,
REP.1M,2.5,TRETINOIN,"ALDH1A1, ALDH1A2, GPRC5A, NR0B1, NR2C2, PPARD, RARA, RARB, RARG, RARRES1, RORB, RORC, RXRB, RXRG","RETINOID RECEPTOR AGONIST, RETINOID RECEPTOR LIGAND",BRD:BRD-K71879491-001-51-5,
REP.1M,2.5,SP-100030,"JUN, NFKB1",NFKB PATHWAY INHIBITOR,BRD:BRD-K71900389-001-02-9,
REP.1M,2.5,VU591,KCNJ1,POTASSIUM CHANNEL BLOCKER,BRD:BRD-K72063794-003-02-9,
REP.1M,2.5,A77636,CALY,DOPAMINE RECEPTOR AGONIST,BRD:BRD-K72226571-003-02-9,
REP.1M,2.5,ALPHA-ASARONE,HMGCR,"CYTOCHROME P450 INHIBITOR, HMGCR INHIBITOR",BRD:BRD-K72536715-001-01-5,
REP.1M,2.5,BLU9931,FGFR4,FGFR INHIBITOR,BRD:BRD-K72898849-001-01-8,
REP.1M,2.5,IT1T,CXCR4,CC CHEMOKINE RECEPTOR ANTAGONIST,BRD:BRD-K73499906-300-02-9,
REP.1M,2.5,AS-2444697,IRAK4,INTERLEUKIN INHIBITOR,BRD:BRD-K73565918-003-02-9,
REP.1M,2.5,UC-112,XIAP,XIAP INHIBITOR,BRD:BRD-K73610817-001-10-9,
REP.1M,2.5,NS-1643,"KCNH2, KCNH6, KCNMA1",VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K73738482-001-01-7,
REP.1M,2.5,AMIFOSTINE,"ALPPL2, ENPP1",REDUCING AGENT,BRD:BRD-K73947551-001-04-4,
REP.1M,2.5,ISOQUERCITRIN,,ANTIOXIDANT,BRD:BRD-K73991644-001-07-9,
REP.1M,2.5,HEMIN,,ENZYME INDUCER,BRD:BRD-K74057164-001-01-6,
REP.1M,2.5,RIBOFLAVIN-TETRABUTYRATE,,ANTIOXIDANT,BRD:BRD-K74227494-001-03-9,
REP.1M,2.5,L-689560,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D",GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K74284736-001-04-9,
REP.1M,2.5,HM-30181,,P GLYCOPROTEIN INHIBITOR,BRD:BRD-K74319597-001-02-9,
REP.1M,2.5,SUCROSE,"ACTA1, ATOX1, C22orf28, LYZ",,BRD:BRD-K74724920-001-02-4,
REP.1M,2.5,SNG-1153,ESR1,SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-K75016267-001-02-9,
REP.1M,2.5,AMI-1,PRMT1,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K75114721-304-02-6,
REP.1M,2.5,PUTRESCINE,"AMD1, KCNJ4, ODC1",TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K75282878-300-05-3,
REP.1M,2.5,REMODELIN,NAT10,TRANSFERASE INHIBITOR,BRD:BRD-K75349868-001-03-9,
REP.1M,2.5,DG-172,PPARD,PPAR RECEPTOR INVERSE AGONIST,BRD:BRD-K75748943-300-02-9,
REP.1M,2.5,CYM-5541,S1PR3,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-K75940276-001-04-9,
REP.1M,2.5,PITAVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K75958547-238-04-9,
REP.1M,2.5,MELANOTAN-II,,MELANOCORTIN RECEPTOR AGONIST,BRD:BRD-K75989555-001-02-9,
REP.1M,2.5,LOSARTAN,AGTR1,ANGIOTENSIN RECEPTOR ANTAGONIST,BRD:BRD-K76205745-237-22-9,
REP.1M,2.5,ONO-8130,PTGER1,PROSTANOID RECEPTOR ANTAGONIST,BRD:BRD-K76725781-001-02-9,
REP.1M,2.5,A-804598,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K76894955-001-02-1,
REP.1M,2.5,ITX5061,,SR-BI INHIBITOR,BRD:BRD-K76911699-003-03-9,
REP.1M,2.5,TC-G-1004,ADORA2A,ADENOSINE RECEPTOR ANTAGONIST,BRD:BRD-K76989898-001-02-9,
REP.1M,2.5,REVERSINE,"AURKB, INCENP, MAP2K1",AURORA KINASE INHIBITOR,BRD:BRD-K77286328-001-03-7,
REP.1M,2.5,RAUWOLSCINE,"ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B",ADRENERGIC RECEPTOR ANTAGONIST,BRD:BRD-K77474816-003-15-9,
REP.1M,2.5,FURAMIDINE,PRMT1,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K77758223-300-02-9,
REP.1M,2.5,N-(P-AMYLCINNAMOYL)-ANTHRANILIC-ACID,,PHOSPHOLIPASE INHIBITOR,BRD:BRD-K77817104-001-02-9,
REP.1M,2.5,RIDINILAZOLE,,ANTIBACTERIAL,BRD:BRD-K77897005-001-02-9,
REP.1M,2.5,TCN238,GRM4,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K77915400-001-01-6,
REP.1M,2.5,PD-81723,ADORA1,ADENOSINE RECEPTOR AGONIST,BRD:BRD-K77951111-001-05-9,
REP.1M,2.5,ADELMIDROL,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K78097265-001-02-9,
REP.1M,2.5,METHYLPARABEN,,OTHER ANTIFUNGAL,BRD:BRD-K78321730-001-13-9,
REP.1M,2.5,CEFOTAXIME,,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K78364995-236-18-3,
REP.1M,2.5,MMV-390048,,PI4K INHIBITOR,BRD:BRD-K78973789-001-02-9,
REP.1M,2.5,PLX647,"CSF1R, KIT",RECEPTOR TYROSINE PROTEIN KINASE INHIBITOR,BRD:BRD-K79294107-300-02-9,
REP.1M,2.5,A-582941,CHRNA7,NICOTINIC RECEPTOR AGONIST,BRD:BRD-K79743788-001-02-9,
REP.1M,2.5,SAROGLITAZAR,"PPARA, PPARG",PPAR RECEPTOR AGONIST,BRD:BRD-K79878800-239-02-9,
REP.1M,2.5,AMINOSALICYLATE,"ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2",CYCLOOXYGENASE INHIBITOR,BRD:BRD-K80267133-325-22-9,
REP.1M,2.5,BISMUTH-SUBSALICYLATE,,ANTACID,BRD:BRD-K80528473-001-03-0,
REP.1M,2.5,AG-556,,TYROSINE KINASE INHIBITOR,BRD:BRD-K81048131-001-03-9,
REP.1M,2.5,TRAM-39,KCNN4,CALCIUM-ACTIVATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K81341251-001-02-9,
REP.1M,2.5,GSK2606414,"EIF2AK3, MYLK2",PROTEIN KINASE INHIBITOR,BRD:BRD-K81689258-001-04-8,
REP.1M,2.5,NGD-98-2,CRHR1,CORTICOTROPIN RELEASING FACTOR RECEPTOR ANTAGONIST,BRD:BRD-K81779590-003-02-9,
REP.1M,2.5,LICOSTINEL,,NMDA RECEPTOR ANTAGONIST,BRD:BRD-K81881550-001-03-9,
REP.1M,2.5,TCS-3035,GPR35,G PROTEIN-COUPLED RECEPTOR AGONIST,BRD:BRD-K81935556-001-02-9,
REP.1M,2.5,MECYSTEINE,,ANALGESIC AGENT,BRD:BRD-K81993098-003-15-0,
REP.1M,2.5,ASP-6537,,CYCLOOXYGENASE INHIBITOR,BRD:BRD-K82239282-001-02-9,
REP.1M,2.5,SDZ-220-040,GRIN1,GLUTAMATE RECEPTOR ANTAGONIST,BRD:BRD-K82266792-001-03-9,
REP.1M,2.5,ROSUVASTATIN,HMGCR,HMGCR INHIBITOR,BRD:BRD-K82941592-238-07-9,
REP.1M,2.5,AT-406,,IAP ANTAGONIST,BRD:BRD-K83030136-001-02-9,
REP.1M,2.5,STRONTIUM-RANELATE,CASR,"BONE FORMATION STIMULANT, BONE RESORPTION INHIBITOR",BRD:BRD-K83146339-001-04-0,
REP.1M,2.5,BLZ945,,CSF1R INHIBITOR,BRD:BRD-K83157152-001-02-9,
REP.1M,2.5,PF-750,FAAH,FAAH INHIBITOR,BRD:BRD-K83213911-001-08-9,
REP.1M,2.5,NFKB-ACTIVATION-INHIBITOR-II,RELA,NFKB PATHWAY INHIBITOR,BRD:BRD-K83354763-001-07-9,
REP.1M,2.5,DAMINOZIDE,"KDM2A, KDM7A, PHF8",KDM2A INHIBITOR,BRD:BRD-K83452553-001-07-9,
REP.1M,2.5,JNJ-47965567,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K83547600-001-02-9,
REP.1M,2.5,PAEONIFLORIN,,ANTICONVULSANT,BRD:BRD-K83631119-001-04-9,
REP.1M,2.5,VU0360172,GRM5,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K83649660-003-04-9,
REP.1M,2.5,PTC-209,,BMI-1 INHIBITOR,BRD:BRD-K83834509-001-04-9,
REP.1M,2.5,R-268712,TGFBR1,SERINE/THREONINE KINASE INHIBITOR,BRD:BRD-K83904070-001-02-9,
REP.1M,2.5,C11-ACETATE,"ABAT, ACE, AKR1C3, CA2, CELA1, ESR2, FFAR2, FFAR3, HPRT1, LTA4H, MMP12, NOS1, NOS3, PLA2G1B, PTPN1, SOD1, TXN",,BRD:BRD-K83914624-415-01-3,
REP.1M,2.5,CW-008,PRKACA,PKA ACTIVATOR,BRD:BRD-K84068331-001-02-9,
REP.1M,2.5,ZOLEDRONIC-ACID,"FDPS, GGPS1",BONE RESORPTION INHIBITOR,BRD:BRD-K84253429-001-06-9,
REP.1M,2.5,TINORIDINE,,ANTI-INFLAMMATORY AGENT,BRD:BRD-K84313779-003-03-9,
REP.1M,2.5,KHK-IN-1,KHK,HEXOKINASE INHIBITOR,BRD:BRD-K84605263-003-01-6,
REP.1M,2.5,6-DIAZO-5-OXO-L-NOR-LEUCINE,,"GLUTAMATE RECEPTOR ANTAGONIST, GLUTAMINASE INHIBITOR",BRD:BRD-K84924563-001-04-9,6-DIAZO-5-OXO-L-NORLEUCINE
REP.1M,2.5,6-DIAZO-5-OXO-L-NORLEUCINE,,"GLUTAMATE RECEPTOR ANTAGONIST, GLUTAMINASE INHIBITOR",BRD:BRD-K84924563-001-04-9,6-DIAZO-5-OXO-L-NORLEUCINE
REP.1M,2.5,SPAUTIN-1,"USP10, USP13",DEUBIQUITINASE INHIBITOR,BRD:BRD-K84964099-001-03-9,
REP.1M,2.5,BENACTYZINE,,BUTYRYLCHOLINESTERASE INHIBITOR,BRD:BRD-K85030058-003-16-9,
REP.1M,2.5,LY231617,,LIPID PEROXIDASE INHIBITOR,BRD:BRD-K85804405-003-01-3,
REP.1M,2.5,MK-8998,,T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K86677390-001-02-9,
REP.1M,2.5,SGC-707,PRMT3,PROTEIN ARGININE N-METHYLTRANSFERASE INHIBITOR,BRD:BRD-K86718786-001-03-9,
REP.1M,2.5,SPARTEINE-(-),,,BRD:BRD-K86872788-065-01-5,
REP.1M,2.5,BAY-60-7550,PDE2A,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K86932920-001-02-9,
REP.1M,2.5,WORTMANNIN,"PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC",PI3K INHIBITOR,BRD:BRD-K87343924-001-16-9,
REP.1M,2.5,NVP-TNKS656,TNKS2,TANKYRASE INHIBITOR,BRD:BRD-K87454346-001-01-1,
REP.1M,2.5,TC-SP-14,S1PR1,SPHINGOSINE 1-PHOSPHATE RECEPTOR AGONIST,BRD:BRD-K87461578-001-02-9,
REP.1M,2.5,SOBUZOXANE,,TOPOISOMERASE INHIBITOR,BRD:BRD-K87595680-001-05-9,
REP.1M,2.5,A-784168,TRPV1,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K87665527-001-02-9,
REP.1M,2.5,ZEBULARINE,"CDA, DNMT1",DNA METHYLTRANSFERASE INHIBITOR,BRD:BRD-K87714311-001-05-9,
REP.1M,2.5,DYNASORE,"DNM1, DNM1L, DNM2",DYNAMIN INHIBITOR,BRD:BRD-K87718015-001-04-9,
REP.1M,2.5,VU152100,CHRM4,ACETYLCHOLINE RECEPTOR ALLOSTERIC MODULATOR,BRD:BRD-K87727457-001-02-9,
REP.1M,2.5,TYRPHOSTIN-AG-825,ERBB2,PROTEIN TYROSINE KINASE INHIBITOR,BRD:BRD-K87919739-001-08-9,
REP.1M,2.5,TP-003,"GABRA1, GABRA2, GABRA3, GABRA5",GABA RECEPTOR INVERSE AGONIST,BRD:BRD-K87941707-001-02-9,
REP.1M,2.5,RQ-00203078,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K87973152-001-02-9,
REP.1M,2.5,EIPA,"ADRA2A, ASIC1, PKD2L1","SODIUM/HYDROGEN EXCHANGER INHIBITOR, TRANSIENT RECEPTOR POTENTIAL POLYCYSTIC INHIBITOR",BRD:BRD-K88120876-001-10-9,
REP.1M,2.5,ON123300,"CDK4, NUAK1, PDGFRB",CDK INHIBITOR,BRD:BRD-K88554883-001-03-2,
REP.1M,2.5,CC-223,MTOR,MTOR INHIBITOR,BRD:BRD-K88737571-001-02-2,
REP.1M,2.5,AZD5582,"BIRC2, BIRC3, XIAP",XIAP INHIBITOR,BRD:BRD-K88767641-001-01-7,
REP.1M,2.5,ASCOMYCIN,FKBP1A,CALCINEURIN INHIBITOR,BRD:BRD-K88882192-001-03-3,
REP.1M,2.5,BRD9876,KIF11,KINESIN INHIBITOR,BRD:BRD-K89329876-001-08-9,
REP.1M,2.5,CU-T12-9,"TLR1, TLR2",TOLL-LIKE RECEPTOR AGONIST,BRD:BRD-K89462779-001-02-9,
REP.1M,2.5,HER2-INHIBITOR-1,,EGFR INHIBITOR,BRD:BRD-K89709433-001-03-9,
REP.1M,2.5,AI-10-49,CBFB,CORE BINDING FACTOR INHIBITOR,BRD:BRD-K89899948-001-01-7,
REP.1M,2.5,MK2-IN-1,MAPKAPK2,MAP KINASE INHIBITOR,BRD:BRD-K90316462-003-01-1,
REP.1M,2.5,M8-B,TRPM8,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K90410034-003-02-9,
REP.1M,2.5,GSK2193874,TRPV4,TRANSIENT RECEPTOR POTENTIAL CHANNEL ANTAGONIST,BRD:BRD-K90737788-001-02-9,
REP.1M,2.5,K-RAS(G12C)-INHIBITOR-12,KRAS,K-RAS INHIBITOR,BRD:BRD-K90756851-001-01-1,
REP.1M,2.5,DELAFLOXACIN,,ANTIINFECTIVE DRUG,BRD:BRD-K90991629-100-02-9,
REP.1M,2.5,CCT-031374,CTNNB1,WNT SIGNALING INHIBITOR,BRD:BRD-K90999434-004-02-9,
REP.1M,2.5,SINEFUNGIN,CARM1,"DNA METHYLTRANSFERASE INHIBITOR, RNA SYNTHESIS INHIBITOR",BRD:BRD-K91100918-001-03-8,
REP.1M,2.5,SU16F,PDGFRB,PDGFR TYROSINE KINASE RECEPTOR INHIBITOR,BRD:BRD-K91106808-001-03-9,
REP.1M,2.5,RO-67-7476,GRM1,GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATOR,BRD:BRD-K91333421-001-02-9,
REP.1M,2.5,YIL-781,GHSR,GHRELIN RECEPTOR ANTAGONIST,BRD:BRD-K91403886-003-02-9,
REP.1M,2.5,EI1,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K91535048-001-01-2,
REP.1M,2.5,KASUGAMYCIN,,BACTERIAL 30S RIBOSOMAL SUBUNIT INHIBITOR,BRD:BRD-K91644281-311-02-9,
REP.1M,2.5,S63845,,MCL1 INHIBITOR,BRD:BRD-K91876515-001-03-9,
REP.1M,2.5,CATHARANTHINE,,TUBULIN POLYMERIZATION INHIBITOR,BRD:BRD-K92377961-001-03-7,
REP.1M,2.5,PF-04885614,SCN10A,VOLTAGE-GATED SODIUM CHANNEL BLOCKER,BRD:BRD-K92435527-001-03-9,
REP.1M,2.5,CYSTEAMINE,"NPY2R, SST",TISSUE TRANSGLUTAMINASE INHIBITOR,BRD:BRD-K92611362-003-03-9,
REP.1M,2.5,OF-1,BRD1,BROMODOMAIN INHIBITOR,BRD:BRD-K92658264-001-02-9,
REP.1M,2.5,IMATINIB,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-17-4,
REP.1M,2.5,IMATINIB,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-17-4,
REP.1M,2.5,IMATINIB,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-17-4,
REP.1M,2.5,IMATINIB,"ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET","BCR-ABL KINASE INHIBITOR, KIT INHIBITOR, PDGFR TYROSINE KINASE RECEPTOR INHIBITOR",BRD:BRD-K92723993-001-17-4,
REP.1M,2.5,ML218,"CACNA1G, CACNA1H, CACNA1I",T-TYPE CALCIUM CHANNEL BLOCKER,BRD:BRD-K92995792-003-03-9,
REP.1M,2.5,PD-166285,"EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1",SRC INHIBITOR,BRD:BRD-K93217218-300-03-9,
REP.1M,2.5,LUSUTROMBOPAG,,THROMBOPOIETIN RECEPTOR AGONIST,BRD:BRD-K93228461-001-02-9,
REP.1M,2.5,NS-5806,KCND3,VOLTAGE-GATED POTASSIUM CHANNEL ACTIVATOR,BRD:BRD-K93314017-001-02-9,
REP.1M,2.5,OICR-9429,WDR5,WDR5/MLL INTERACTION INHIBITOR,BRD:BRD-K94083718-001-03-9,
REP.1M,2.5,A-804598,P2RX7,PURINERGIC RECEPTOR ANTAGONIST,BRD:BRD-K94313941-001-03-9,
REP.1M,2.5,PYRINTEGRIN,,INTEGRIN SIGNALING ACTIVATOR,BRD:BRD-K94659840-001-02-9,
REP.1M,2.5,CARBARSONE,,ANTIPROTOZOAL AGENT,BRD:BRD-K94848716-001-12-9,
REP.1M,2.5,MPS1-IN-1,TTK,MONOPOLAR SPINDLE 1 KINASE INHIBITOR,BRD:BRD-K94853001-300-04-9,
REP.1M,2.5,TOLONIUM,,,BRD:BRD-K94882685-003-10-0,
REP.1M,2.5,SU9516,"CDK1, CDK2, CDK4, CDK5",CDK INHIBITOR,BRD:BRD-K94883909-001-17-7,
REP.1M,2.5,DR-2313,"PARP1, PARP3",PARP INHIBITOR,BRD:BRD-K94920105-001-05-9,
REP.1M,2.5,TUCIDINOSTAT,,HDAC INHIBITOR,BRD:BRD-K95216408-001-02-9,
REP.1M,2.5,PINDOLOL-(-),HTR1A,"ADRENERGIC RECEPTOR ANTAGONIST, SEROTONIN RECEPTOR ANTAGONIST",BRD:BRD-K95598440-001-10-9,
REP.1M,2.5,BHQ,ATP2A1,ATPASE INHIBITOR,BRD:BRD-K95603879-001-08-9,
REP.1M,2.5,EXO-IWR-1,TNKS,WNT SIGNALING INHIBITOR NEGATIVE CONTROL,BRD:BRD-K96155658-001-02-9,
REP.1M,2.5,IMAZODAN,,PHOSPHODIESTERASE INHIBITOR,BRD:BRD-K96298462-001-08-9,
REP.1M,2.5,NIFEDIPINE,"CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3",CALCIUM CHANNEL BLOCKER,BRD:BRD-K96354014-001-29-4,
REP.1M,2.5,S4,"CA12, CA9",CARBONIC ANHYDRASE INHIBITOR,BRD:BRD-K96798615-001-02-9,
REP.1M,2.5,CALCIUM-LEVOFOLINATE,,,BRD:BRD-K97009491-238-05-9,
REP.1M,2.5,DEFERASIROX,CYP3A4,CHELATING AGENT,BRD:BRD-K97010173-001-06-9,
REP.1M,2.5,PD-161570,FGFR1,FGFR INHIBITOR,BRD:BRD-K97152684-001-03-9,
REP.1M,2.5,CPI-169,EZH2,HISTONE LYSINE METHYLTRANSFERASE INHIBITOR,BRD:BRD-K97181972-001-01-9,
REP.1M,2.5,FERROSTATIN-1,,FERROPTOSIS INHIBITOR,BRD:BRD-K97375133-001-04-9,
REP.1M,2.5,GSK2881078,,ANDROGEN RECEPTOR MODULATOR,BRD:BRD-K97656802-001-02-9,
REP.1M,2.5,API-1,"AKT1, AKT2, AKT3",AKT INHIBITOR,BRD:BRD-K97840621-001-02-9,
REP.1M,2.5,SAVOLITINIB,MET,C-MET INHIBITOR,BRD:BRD-K98028353-001-02-8,
REP.1M,2.5,COT-INHIBITOR-1,MAP3K8,MAPK-INTERACTING KINASE INHIBITOR,BRD:BRD-K98710228-001-01-6,
REP.1M,2.5,A-939572,SCD,STEAROYL-COA DESATURASE INHIBITOR,BRD:BRD-K99308908-001-02-9,
REP.1M,2.5,SAG,"SMO, TRPC6",SMOOTHENED RECEPTOR AGONIST,BRD:BRD-K99433989-001-02-9,
REP.1M,2.5,CEFAZOLIN,PON1,BACTERIAL CELL WALL SYNTHESIS INHIBITOR,BRD:BRD-K99750640-236-20-3,
REP.1M,2.5,SA-47,FAAH,FAAH INHIBITOR,BRD:BRD-K99819791-001-02-9,
REP.1M,2.5,ACRYLATE,,MUCUS PROTECTING AGENT,BRD:BRD-M00184283-001-01-1,
REP.1M,2.5,THREO-2-METHYLISOCITRATE-(DL),,ISOCITRATE LYASE SUBSTRATE,BRD:BRD-M01344114-348-01-0,
REP.1M,2.5,POTASSIUM-IODIDE,,,BRD:BRD-M55321172-001-03-3,
REP.1M,2.5,SODIUM-DODECYL-SULFATE,ALB,,BRD:BRD-M58433298-001-02-4,
REP.1M,2.5,PAMABROM,,DIURETIC,BRD:BRD-M67659203-001-02-7,
REP.1M,2.5,ETHANOLAMINE-OLEATE,"F12, FABP4, FFAR1, FFAR4, PLD2",IMMUNOSTIMULANT,BRD:BRD-M75061779-001-01-2,
REP.1M,2.5,LASOFOXIFENE,"ESR1, ESR2",SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM),BRD:BRD-M93148412-001-02-6,
